data_2kup_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kup _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 . . . . . 0 CA--C 1.558 1.279 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.73 -11.91 28.33 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.08 2.52 . . . . 0.0 115.478 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 51.5 p -131.87 -16.42 2.92 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 120.155 1.343 . . . . 0.0 114.604 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.9 147.76 37.93 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.614 1.166 . . . . 0.0 111.505 172.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -140.8 118.57 11.71 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.994 0.918 . . . . 0.0 108.844 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -67.35 127.05 31.22 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.801 -0.562 . . . . 0.0 109.706 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.9 m -134.97 159.93 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.696 1.598 . . . . 0.0 110.669 -171.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 m -135.27 119.17 17.34 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.175 0.99 . . . . 0.0 109.039 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -65.8 132.52 48.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.323 0.649 . . . . 0.0 110.267 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 m -127.95 155.59 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.293 1.037 . . . . 0.0 112.665 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -91.05 -168.89 2.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.847 1.259 . . . . 0.0 114.34 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.07 -21.4 66.15 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.228 1.811 . . . . 0.0 114.044 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -95.89 -10.23 29.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.948 1.299 . . . . 0.0 112.95 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.17 16.28 72.31 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 117.934 -1.481 . . . . 0.0 114.239 -172.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.4 m -77.65 149.7 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.12 1.96 . . . . 0.0 111.353 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -86.68 126.96 34.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.349 1.059 . . . . 0.0 111.497 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.6 mt -108.94 -51.11 2.92 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.002 0.921 . . . . 0.0 112.0 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.33 143.44 9.19 Favored Glycine 0 N--CA 1.47 0.928 0 C-N-CA 124.76 1.171 . . . . 0.0 113.854 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.5 p -90.07 150.87 21.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.115 1.366 . . . . 0.0 112.909 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.11 172.63 35.85 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.195 1.855 . . . . 0.0 113.039 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.31 120.85 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.1 tpp -86.29 131.9 34.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.846 0.859 . . . . 0.0 109.354 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -118.5 127.93 54.1 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.405 1.482 . . . . 0.0 109.118 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.5 127.96 55.41 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.618 1.967 . . . . 0.0 107.993 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -160.45 152.28 19.96 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.47 1.908 . . . . 0.0 108.024 -171.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -57.23 -18.06 14.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.86 1.264 . . . . 0.0 113.943 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 t -78.16 -51.94 9.47 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -178.37 174.73 1.25 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.855 1.662 . . . . 0.0 112.501 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt -86.81 139.2 30.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.772 0.829 . . . . 0.0 110.688 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.59 134.42 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.951 0.901 . . . . 0.0 111.696 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.14 131.49 46.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.357 1.463 . . . . 0.0 110.537 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -110.92 139.51 46.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.153 2.181 . . . . 0.0 110.681 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.547 0.837 0 C-N-CA 125.356 1.463 . . . . 0.0 110.848 -173.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.683 0 CA-C-O 120.444 0.164 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 t -133.4 134.34 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.856 0.462 . . . . 0.0 111.566 -170.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -125.74 147.1 49.49 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.591 1.556 . . . . 0.0 112.836 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.2 m-90 -143.91 117.11 5.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.308 1.443 . . . . 0.0 111.429 174.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.86 148.62 58.38 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.73 2.287 . . . . 0.0 110.509 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -60.36 -27.51 67.44 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -56.59 -39.69 73.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.729 1.612 . . . . 0.0 112.076 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.84 -17.7 61.52 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 mt -84.63 81.41 8.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.544 1.066 . . . . 0.0 110.998 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.46 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -59.39 -30.98 68.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.831 0.852 . . . . 0.0 113.17 173.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -152.35 148.76 27.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.231 1.412 . . . . 0.0 111.594 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -146.45 112.12 5.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.62 1.568 . . . . 0.0 110.402 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.32 162.93 13.08 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 124.918 1.246 . . . . 0.0 114.566 -168.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -145.66 144.93 30.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.187 1.395 . . . . 0.0 111.879 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -144.05 -175.71 4.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.897 1.679 . . . . 0.0 109.906 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.1 m -56.53 112.48 1.28 Allowed 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.347 -0.846 . . . . 0.0 110.81 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.253 0.8 OUTLIER 49.33 23.59 0.87 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.666 2.387 . . . . 0.0 116.561 -173.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -132.22 129.41 39.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.488 1.515 . . . . 0.0 111.181 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -123.85 139.09 54.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.769 1.628 . . . . 0.0 109.997 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 t -153.57 155.56 36.37 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.962 -1.086 . . . . 0.0 113.41 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.22 148.23 29.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.982 1.313 . . . . 0.0 112.606 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.97 147.77 26.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.625 1.97 . . . . 0.0 108.403 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 m -155.0 134.85 12.86 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.625 -1.297 . . . . 0.0 112.153 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.57 170.44 54.54 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.247 0.927 . . . . 0.0 113.605 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -12.96 7.58 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -77.34 -16.51 58.88 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.4 p -86.42 176.69 7.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -55.75 -41.1 73.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.624 1.57 . . . . 0.0 113.528 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.9 p -91.79 -16.83 26.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.397 1.479 . . . . 0.0 113.94 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.15 -169.98 42.59 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.031 1.776 . . . . 0.0 112.138 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -67.68 126.68 30.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.648 0.779 . . . . 0.0 110.79 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.21 162.71 16.91 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 121.912 0.729 . . . . 0.0 114.345 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.57 133.5 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.107 1.363 . . . . 0.0 108.775 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -125.71 124.45 41.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.626 1.17 . . . . 0.0 109.759 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.44 143.88 49.86 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.473 1.109 . . . . 0.0 112.61 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -140.47 127.8 21.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.493 -169.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -72.47 136.24 45.92 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.085 0.554 . . . . 0.0 110.345 169.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 48.8 t -163.8 131.59 3.51 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.591 1.556 . . . . 0.0 110.644 -172.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.5 t -71.31 -8.31 52.86 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -129.48 26.01 5.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.26 1.824 . . . . 0.0 112.834 -173.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.17 -36.01 38.94 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -70.22 -38.01 75.16 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.429 0.692 . . . . 0.0 112.759 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -67.43 -33.18 74.63 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.497 -0.752 . . . . 0.0 111.612 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.58 -51.09 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 169.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.84 -37.62 82.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.841 0.857 . . . . 0.0 112.662 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.75 -30.33 67.88 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.6 1.16 . . . . 0.0 112.796 175.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.45 -37.11 21.81 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.006 0.821 . . . . 0.0 112.419 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 23.1 mt -53.43 -54.17 40.69 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.321 0.964 . . . . 0.0 111.832 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -59.0 -26.68 64.74 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -70.8 -30.71 67.24 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.723 1.209 . . . . 0.0 112.766 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.59 -38.33 12.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.6 1.56 . . . . 0.0 111.135 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 125.2 1.4 . . . . 0.0 113.012 -178.95 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 32.1 t80 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 119.849 -0.12 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -90.88 109.69 20.91 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.264 1.026 . . . . 0.0 109.607 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 37.7 mt -74.66 156.89 36.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.953 0.901 . . . . 0.0 113.015 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -79.76 -24.71 41.36 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.11 1.364 . . . . 0.0 113.582 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -162.05 169.75 20.45 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.535 1.934 . . . . 0.0 111.344 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -80.78 124.73 81.5 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.259 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.34 6.27 5.72 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.859 3.04 . . . . 0.0 113.786 -172.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 47.9 t -127.98 131.84 49.23 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.001 1.32 . . . . 0.0 112.07 -171.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.13 -17.31 40.75 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.91 1.243 . . . . 0.0 115.122 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -113.61 112.66 23.89 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.177 1.391 . . . . 0.0 110.286 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -154.89 134.51 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.777 0.799 . . . . 0.0 111.993 -169.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -93.8 120.03 33.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.043 2.137 . . . . 0.0 110.271 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 123.794 0.837 . . . . 0.0 110.242 177.926 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 . . . . . 0 CA--C 1.555 1.144 0 CA-C-O 118.841 -0.599 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.87 -15.0 47.25 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.163 2.575 . . . . 0.0 115.141 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.6 p -128.41 -18.14 4.06 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.19 1.359 . . . . 0.0 114.459 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 113.18 24.99 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.186 0.903 . . . . 0.0 111.112 174.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -107.94 113.23 26.28 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.127 0.971 . . . . 0.0 109.333 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -67.11 131.29 45.51 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.581 -0.7 . . . . 0.0 110.253 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.5 152.79 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.261 1.425 . . . . 0.0 111.125 -169.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.5 m -130.45 118.37 21.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.837 0.855 . . . . 0.0 109.09 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -66.29 133.97 51.66 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.941 0.896 . . . . 0.0 110.642 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.36 155.08 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.924 0.89 . . . . 0.0 112.733 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.83 -168.3 2.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.576 1.151 . . . . 0.0 113.695 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -72.52 -20.09 61.41 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.637 1.175 . . . . 0.0 113.592 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.76 -15.48 44.87 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.951 1.301 . . . . 0.0 112.408 171.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.98 16.48 67.44 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.042 -1.421 . . . . 0.0 114.449 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.49 151.08 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 119.844 1.822 . . . . 0.0 111.667 173.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.27 128.16 35.17 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.857 1.263 . . . . 0.0 111.308 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.0 mt -110.09 -52.17 2.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.964 0.906 . . . . 0.0 112.347 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.11 152.71 23.78 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.669 1.604 . . . . 0.0 112.569 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.0 t -116.28 149.35 39.37 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.939 0.896 . . . . 0.0 112.82 -172.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.99 174.7 33.19 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 126.784 2.135 . . . . 0.0 113.643 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.2 t -114.83 120.5 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.1 tpp -86.65 131.52 34.13 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.95 0.9 . . . . 0.0 109.475 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -127.36 129.99 48.6 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.63 1.572 . . . . 0.0 108.818 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.22 131.1 53.11 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.384 1.873 . . . . 0.0 107.804 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.0 p -130.55 171.3 13.18 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.023 1.329 . . . . 0.0 109.774 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -70.6 -7.65 45.72 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.218 -0.926 . . . . 0.0 112.62 172.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.3 m -102.4 -43.59 5.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.453 1.101 . . . . 0.0 113.428 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -173.94 170.68 3.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.174 1.389 . . . . 0.0 113.151 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.87 140.89 29.2 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.856 1.262 . . . . 0.0 110.275 168.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.6 t -135.31 129.99 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.545 1.138 . . . . 0.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.7 mt -100.23 126.36 46.52 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.679 1.192 . . . . 0.0 110.251 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -98.95 127.52 44.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.55 1.54 . . . . 0.0 110.704 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 CA--C 1.541 0.606 0 C-N-CA 127.167 2.187 . . . . 0.0 110.065 -172.348 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.24 134.49 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.129 0.971 . . . . 0.0 109.724 -174.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.3 150.21 48.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.574 1.15 . . . . 0.0 112.71 -168.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 -142.26 115.22 6.4 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.751 1.22 . . . . 0.0 111.421 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.09 146.6 71.11 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.549 2.166 . . . . 0.0 110.017 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -60.7 -29.98 69.67 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -34.13 70.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.196 1.798 . . . . 0.0 112.679 173.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.9 m -83.28 -9.38 59.14 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.57 88.17 7.03 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.641 1.109 . . . . 0.0 110.199 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -64.98 -29.74 70.69 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.758 0.823 . . . . 0.0 113.114 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -154.71 154.75 33.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.95 0.9 . . . . 0.0 112.691 167.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -151.41 144.84 24.84 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.255 1.422 . . . . 0.0 109.633 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.49 -179.65 34.45 Favored Glycine 0 N--CA 1.464 0.566 0 CA-C-O 121.558 0.532 . . . . 0.0 114.222 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -149.09 165.06 32.85 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.227 1.011 . . . . 0.0 113.12 -172.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.85 -169.47 3.37 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.706 2.002 . . . . 0.0 109.578 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 93.8 p -69.23 -18.22 63.86 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -152.49 8.79 0.46 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.795 1.638 . . . . 0.0 113.891 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.63 129.23 26.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.574 1.55 . . . . 0.0 110.754 -168.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -120.98 140.06 52.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.037 1.735 . . . . 0.0 109.504 174.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.4 t -153.35 159.24 42.41 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.31 1.044 . . . . 0.0 112.791 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.42 149.48 30.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.724 1.61 . . . . 0.0 111.689 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -113.22 134.23 54.68 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.525 1.93 . . . . 0.0 109.628 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -132.87 154.91 49.9 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.686 1.195 . . . . 0.0 112.192 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.9 167.51 18.54 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.069 1.319 . . . . 0.0 114.28 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -54.54 -27.34 37.74 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -73.43 -15.44 61.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.67 1.988 . . . . 0.0 115.706 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.2 p -83.47 -176.46 6.32 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -60.48 -46.34 90.45 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.391 1.076 . . . . 0.0 112.779 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.6 p -89.3 -21.39 23.19 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.595 1.158 . . . . 0.0 113.146 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.38 -156.39 33.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.824 1.678 . . . . 0.0 112.271 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -63.64 134.02 54.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.601 0.76 . . . . 0.0 111.691 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.76 175.35 26.67 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 122.156 0.864 . . . . 0.0 113.074 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.8 mt -124.65 138.82 52.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.724 1.609 . . . . 0.0 108.368 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -134.2 123.58 24.56 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.878 1.271 . . . . 0.0 109.96 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.86 143.4 50.37 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.347 1.059 . . . . 0.0 112.962 -169.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -139.54 126.49 20.94 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.851 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -71.07 133.88 46.62 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.739 0.815 . . . . 0.0 110.914 169.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.6 p -168.15 147.96 4.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.016 1.726 . . . . 0.0 111.924 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.0 t -82.55 -0.4 46.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.088 0.955 . . . . 0.0 113.103 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.25 22.56 6.08 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.038 1.735 . . . . 0.0 112.661 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.22 -41.26 49.58 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.567 1.147 . . . . 0.0 113.923 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.35 -35.29 73.48 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.479 1.112 . . . . 0.0 113.225 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -66.33 -39.61 89.34 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.468 -0.77 . . . . 0.0 110.816 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.81 -47.54 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.243 0.617 . . . . 0.0 110.167 172.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -37.83 85.69 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.843 0.857 . . . . 0.0 112.673 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -72.54 -30.69 64.67 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.16 -42.22 21.19 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.911 0.778 . . . . 0.0 110.684 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.9 mt -50.24 -56.93 9.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.667 1.187 . . . . 0.0 113.096 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -60.79 -20.54 61.69 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.06 -23.37 33.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.663 1.185 . . . . 0.0 113.012 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.4 mt -94.9 -35.72 11.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.513 1.125 . . . . 0.0 111.749 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.1 mtp . . . . . 0 N--CA 1.469 0.52 0 C-N-CA 124.557 1.143 . . . . 0.0 112.808 176.69 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 33.0 t80 . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.83 100.09 11.82 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.098 1.359 . . . . 0.0 111.081 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 56.8 mt -77.15 151.97 35.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.418 -0.801 . . . . 0.0 112.705 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -87.46 -30.22 20.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.364 1.466 . . . . 0.0 113.265 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -143.64 159.36 42.59 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.181 1.792 . . . . 0.0 111.521 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -80.12 124.26 82.93 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.408 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.47 -25.34 2.6 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.193 2.595 . . . . 0.0 114.071 -170.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.53 126.4 31.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.65 0.78 . . . . 0.0 111.28 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.25 -15.8 80.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.984 0.802 . . . . 0.0 113.999 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -122.69 120.25 33.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.468 1.507 . . . . 0.0 109.3 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.74 164.48 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.584 1.553 . . . . 0.0 111.018 -174.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -145.78 159.82 42.63 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.508 1.523 . . . . 0.0 111.721 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 . . . . . 0 CA--C 1.542 0.639 0 C-N-CA 125.018 1.327 . . . . 0.0 110.322 -169.705 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 . . . . . 0 CA--C 1.553 1.091 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.665 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.32 -7.7 21.84 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.461 2.774 . . . . 0.0 114.808 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.8 p -132.67 -24.94 1.93 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.08 90.03 3.19 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.782 1.173 . . . . 0.0 110.677 174.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -91.14 118.4 30.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.777 1.231 . . . . 0.0 109.346 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -78.61 133.76 37.25 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.172 -0.955 . . . . 0.0 110.29 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.17 165.27 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.865 1.266 . . . . 0.0 111.548 -168.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.6 m -143.53 121.74 12.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.463 1.105 . . . . 0.0 109.063 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.77 133.67 53.9 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.097 0.559 . . . . 0.0 109.955 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.48 153.07 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.045 0.938 . . . . 0.0 112.346 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -85.98 -169.69 2.76 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -61.41 -31.66 71.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.016 1.326 . . . . 0.0 114.201 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.09 -9.66 59.78 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.109 1.363 . . . . 0.0 112.45 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.22 12.85 83.52 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 117.76 -1.578 . . . . 0.0 114.225 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 m -80.7 150.35 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 120.108 1.954 . . . . 0.0 111.662 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -83.0 124.52 30.49 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.567 -173.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.9 mt -104.02 -54.3 2.58 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.75 0.82 . . . . 0.0 111.948 -173.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.64 139.27 6.51 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 124.737 1.161 . . . . 0.0 114.003 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 p -85.23 153.16 22.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.248 1.419 . . . . 0.0 113.309 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.05 171.59 37.13 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.664 1.602 . . . . 0.0 113.327 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.11 120.74 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.7 tpp -89.14 134.34 34.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.031 1.332 . . . . 0.0 110.135 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -133.08 130.28 39.11 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.568 1.547 . . . . 0.0 109.461 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.51 128.4 54.48 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.874 2.07 . . . . 0.0 107.694 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -128.03 172.57 10.82 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.64 1.176 . . . . 0.0 110.601 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.49 3.16 4.1 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 121.28 -0.888 . . . . 0.0 112.759 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.7 m -110.89 -45.51 3.46 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.499 1.119 . . . . 0.0 113.34 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -173.63 173.71 3.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.338 1.055 . . . . 0.0 113.343 -169.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.99 139.77 30.25 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.033 0.933 . . . . 0.0 109.946 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.6 t -134.89 132.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.441 1.096 . . . . 0.0 111.413 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.9 mt -104.25 130.9 52.04 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.01 1.724 . . . . 0.0 110.558 168.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -105.13 129.02 53.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.691 1.996 . . . . 0.0 110.579 170.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.543 0.683 0 C-N-CA 127.029 2.131 . . . . 0.0 111.397 -173.558 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 t -126.06 136.86 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.275 1.03 . . . . 0.0 109.485 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.66 152.0 46.38 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.637 0.775 . . . . 0.0 111.842 -171.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -139.16 116.67 8.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.518 1.127 . . . . 0.0 111.37 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.98 145.42 73.89 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.59 2.193 . . . . 0.0 109.883 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -60.85 -24.83 66.21 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.84 -42.69 99.84 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.057 1.343 . . . . 0.0 111.992 173.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.4 m -79.74 -3.55 48.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.1 mt -86.71 106.98 18.02 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.686 1.13 . . . . 0.0 109.912 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -38.43 42.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.384 0.674 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -149.47 155.91 41.14 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.101 1.36 . . . . 0.0 111.085 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -150.78 136.31 17.96 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.868 1.667 . . . . 0.0 108.514 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -156.81 173.26 34.5 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-O 122.139 0.855 . . . . 0.0 113.979 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -142.2 159.76 41.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.52 1.128 . . . . 0.0 112.024 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -151.47 -174.75 4.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.111 1.764 . . . . 0.0 109.771 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -60.19 119.17 7.37 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.376 -0.828 . . . . 0.0 110.473 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.64 21.93 0.99 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 127.703 2.401 . . . . 0.0 116.464 -175.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -138.72 131.23 28.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.067 1.347 . . . . 0.0 111.214 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -125.86 141.29 52.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.218 1.807 . . . . 0.0 109.956 173.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -153.8 162.05 41.56 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.941 -1.099 . . . . 0.0 112.971 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -154.33 153.77 32.21 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.598 1.559 . . . . 0.0 112.412 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -112.65 128.74 56.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.513 1.925 . . . . 0.0 109.222 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.2 p -123.37 142.63 50.77 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.77 154.38 52.83 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.641 1.115 . . . . 0.0 113.138 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -61.81 -14.07 29.68 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -83.11 -17.42 43.12 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.0 p -74.66 -179.54 4.18 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -170.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.94 -38.1 69.87 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.645 1.178 . . . . 0.0 113.199 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -96.58 -23.19 16.63 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.246 1.418 . . . . 0.0 113.588 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.98 -160.7 43.03 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.356 1.455 . . . . 0.0 112.535 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -65.54 129.07 38.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.547 1.139 . . . . 0.0 112.378 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.8 172.59 30.46 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.231 1.396 . . . . 0.0 112.899 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 59.0 mt -119.36 136.3 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.55 1.54 . . . . 0.0 108.298 170.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -129.21 117.95 21.59 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.78 1.232 . . . . 0.0 109.801 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.8 141.18 48.7 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.675 1.19 . . . . 0.0 112.199 -172.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -138.33 127.7 24.59 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.192 0.997 . . . . 0.0 111.865 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -67.34 131.22 45.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.445 0.698 . . . . 0.0 111.044 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.3 t -169.53 118.73 0.64 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.249 1.819 . . . . 0.0 110.36 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.8 t -71.29 -8.06 51.14 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.229 -0.919 . . . . 0.0 113.151 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.73 9.46 35.03 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.538 1.935 . . . . 0.0 113.333 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.5 -38.53 20.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.31 1.844 . . . . 0.0 115.322 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.99 -35.67 80.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.773 0.829 . . . . 0.0 112.908 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -68.39 -37.87 80.78 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.536 -0.728 . . . . 0.0 110.96 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.45 -45.26 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 118.609 0.64 . . . . 0.0 110.24 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.61 -42.99 99.9 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.767 0.827 . . . . 0.0 111.841 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -70.31 -33.97 72.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.23 -33.93 43.24 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.12 0.873 . . . . 0.0 110.682 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.49 -55.21 36.58 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.299 -0.875 . . . . 0.0 111.981 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -61.23 -21.52 63.94 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -81.47 -20.14 40.85 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.215 1.406 . . . . 0.0 112.754 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.13 -35.78 10.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.468 1.507 . . . . 0.0 112.559 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 67.5 mmm . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 124.855 1.262 . . . . 0.0 111.366 175.212 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 22.4 t80 . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 120.484 0.183 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -89.59 110.06 20.95 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.824 1.25 . . . . 0.0 109.962 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 45.0 mt -76.53 157.15 32.31 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -80.32 -24.15 40.12 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.812 1.645 . . . . 0.0 113.702 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -160.26 170.03 21.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.517 1.927 . . . . 0.0 111.55 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -86.68 122.73 71.55 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.789 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -82.43 -24.92 3.42 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.362 2.708 . . . . 0.0 114.428 -170.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.4 m -79.75 129.02 34.12 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.843 0.747 . . . . 0.0 112.223 -171.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.08 -9.44 85.42 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.656 1.122 . . . . 0.0 114.563 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -139.0 128.07 23.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.71 1.604 . . . . 0.0 110.221 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.7 164.07 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.6 1.56 . . . . 0.0 111.252 -173.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -128.93 132.32 47.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.266 1.426 . . . . 0.0 109.376 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 124.861 1.264 . . . . 0.0 110.035 175.877 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 . . . . . 0 CA--C 1.556 1.185 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.76 -18.41 22.09 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.852 2.368 . . . . 0.0 114.944 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.9 p -128.8 -19.22 3.71 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.173 1.352 . . . . 0.0 114.599 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -97.42 142.22 29.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.189 0.904 . . . . 0.0 110.851 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -143.55 107.16 4.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.012 1.325 . . . . 0.0 108.738 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -64.7 137.12 57.62 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.25 -0.906 . . . . 0.0 111.402 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 m -144.9 159.82 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.803 1.241 . . . . 0.0 111.587 -170.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -134.63 117.19 15.83 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.66 1.184 . . . . 0.0 108.824 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -67.59 135.63 53.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.543 0.737 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.0 m -129.07 154.47 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.298 1.039 . . . . 0.0 112.948 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -90.78 -166.62 1.62 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.039 1.336 . . . . 0.0 113.989 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.85 -30.37 71.37 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.555 1.142 . . . . 0.0 113.008 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.9 -12.36 59.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.847 1.259 . . . . 0.0 112.106 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.04 14.52 80.53 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 117.787 -1.563 . . . . 0.0 114.228 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.2 m -76.15 150.34 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.995 1.897 . . . . 0.0 111.563 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -84.45 124.19 31.07 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.416 1.087 . . . . 0.0 110.926 -174.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 mt -104.73 -51.93 2.97 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.086 0.954 . . . . 0.0 112.062 -170.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.33 148.49 17.37 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 125.004 1.288 . . . . 0.0 113.533 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.8 p -90.38 151.74 21.3 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.853 1.261 . . . . 0.0 113.006 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.32 170.95 34.56 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.751 1.643 . . . . 0.0 112.793 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -118.63 120.22 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.8 ttm -88.3 141.19 28.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.098 0.959 . . . . 0.0 110.194 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -135.84 129.85 33.03 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.515 1.526 . . . . 0.0 108.903 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -108.44 130.5 55.24 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.678 1.591 . . . . 0.0 107.919 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.0 p -130.35 167.31 18.74 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.904 1.281 . . . . 0.0 109.941 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -66.47 -9.69 36.85 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.864 -0.522 . . . . 0.0 112.4 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.6 m -98.52 -45.35 6.13 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.449 1.1 . . . . 0.0 113.263 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -172.6 171.11 4.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.64 1.176 . . . . 0.0 113.718 -168.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.7 mt -86.86 139.77 30.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.579 1.552 . . . . 0.0 109.962 168.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.0 t -134.87 137.93 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.056 0.943 . . . . 0.0 111.176 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.84 130.3 55.62 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.449 1.5 . . . . 0.0 109.837 167.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -103.13 130.91 50.45 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.366 1.866 . . . . 0.0 110.833 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 126.848 2.059 . . . . 0.0 111.148 -169.996 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -108.55 135.6 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.208 1.003 . . . . 0.0 110.494 -173.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -120.86 142.38 49.71 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.664 1.186 . . . . 0.0 113.384 -170.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -141.75 112.59 6.4 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.185 1.394 . . . . 0.0 111.42 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -69.56 150.02 68.9 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.386 2.058 . . . . 0.0 110.334 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -63.7 -19.64 65.09 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.9 mt -68.65 -31.52 70.71 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.21 1.404 . . . . 0.0 113.114 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.4 m -89.9 -6.86 55.34 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.5 mt -74.7 117.4 16.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.73 0.695 . . . . 0.0 109.559 172.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -80.34 -32.97 37.73 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.371 1.468 . . . . 0.0 112.305 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -166.58 159.09 13.9 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.006 2.123 . . . . 0.0 110.483 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -152.17 134.08 14.88 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.001 1.321 . . . . 0.0 111.414 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -150.66 175.73 29.54 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.477 1.036 . . . . 0.0 113.836 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.57 162.0 39.3 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.537 1.135 . . . . 0.0 113.535 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -146.2 -178.56 6.2 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.259 2.224 . . . . 0.0 109.327 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -62.37 -13.63 31.31 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -154.08 12.83 0.43 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.448 1.499 . . . . 0.0 114.242 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -141.47 130.98 23.85 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.329 1.452 . . . . 0.0 110.29 -168.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -121.67 142.14 50.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.912 1.685 . . . . 0.0 109.24 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -153.01 155.51 37.06 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.059 -1.026 . . . . 0.0 112.997 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -150.0 152.78 35.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.158 1.383 . . . . 0.0 111.977 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -106.39 140.8 38.74 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.357 1.463 . . . . 0.0 109.486 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.0 m -124.97 148.58 48.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.175 0.99 . . . . 0.0 112.136 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.62 164.57 45.28 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.276 0.941 . . . . 0.0 112.765 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -63.55 -15.07 57.0 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -82.39 -15.73 51.64 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.216 1.806 . . . . 0.0 115.154 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -79.7 -179.52 6.95 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.526 0.73 . . . . 0.0 112.872 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -58.26 -46.02 86.74 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.286 1.035 . . . . 0.0 112.836 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 36.1 p -89.16 -18.98 26.06 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.04 1.336 . . . . 0.0 113.721 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.49 -164.54 41.76 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.728 1.632 . . . . 0.0 112.474 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -66.68 134.25 51.87 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.923 0.889 . . . . 0.0 112.02 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.09 172.82 23.94 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.288 0.947 . . . . 0.0 113.065 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.6 mt -114.69 137.87 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.474 1.509 . . . . 0.0 108.396 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -129.95 122.97 29.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.64 1.176 . . . . 0.0 110.311 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.15 144.41 48.59 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.679 1.192 . . . . 0.0 113.03 -172.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -142.71 125.15 15.65 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.974 0.91 . . . . 0.0 112.397 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -70.46 134.49 47.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.28 1.032 . . . . 0.0 111.418 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.1 p -170.84 144.55 2.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.411 1.884 . . . . 0.0 111.566 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.4 p -78.03 0.79 23.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.177 1.391 . . . . 0.0 114.08 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -134.65 24.95 3.71 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.841 2.056 . . . . 0.0 112.811 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.98 -41.11 46.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.813 1.645 . . . . 0.0 113.911 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -67.87 -37.13 81.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.503 0.721 . . . . 0.0 112.521 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -68.41 -33.1 73.63 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.416 -0.802 . . . . 0.0 111.958 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.2 mt -63.4 -49.28 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 169.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.12 -42.62 91.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.072 0.949 . . . . 0.0 112.172 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -64.84 -34.87 79.4 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.881 1.273 . . . . 0.0 112.556 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -81.27 -37.8 27.9 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.22 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.9 mt -53.48 -55.75 22.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.369 0.986 . . . . 0.0 111.845 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -58.3 -31.43 67.5 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -28.47 65.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.607 1.163 . . . . 0.0 112.931 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 71.2 mt -93.22 -35.21 13.25 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.334 1.453 . . . . 0.0 111.082 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.8 mtp . . . . . 0 N--CA 1.467 0.406 0 C-N-CA 124.978 1.311 . . . . 0.0 113.593 -178.686 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.6 t80 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.283 0.087 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -82.52 107.76 15.42 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.887 1.275 . . . . 0.0 110.742 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -77.28 161.39 28.14 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.604 1.162 . . . . 0.0 112.13 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -101.02 -18.81 16.1 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.127 1.371 . . . . 0.0 114.233 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -139.12 154.3 48.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.524 1.93 . . . . 0.0 111.54 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -84.23 122.22 75.55 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.249 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.34 -20.34 2.73 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.051 2.501 . . . . 0.0 115.249 -169.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 86.9 m -81.59 -31.96 32.3 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.11 -64.44 2.0 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 125.189 1.375 . . . . 0.0 112.902 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -74.61 68.83 1.68 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.764 1.626 . . . . 0.0 111.382 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.7 156.29 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.367 1.867 . . . . 0.0 112.117 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -121.29 137.62 54.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.77 1.628 . . . . 0.0 110.167 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 124.776 1.23 . . . . 0.0 110.778 -179.714 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 . . . . . 0 CA--C 1.558 1.264 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.39 -15.02 47.49 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.271 2.648 . . . . 0.0 115.458 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.7 p -124.03 -24.91 4.3 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.827 1.194 . . . . 0.0 113.843 172.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -100.16 118.25 36.1 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.819 1.19 . . . . 0.0 111.943 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -114.51 110.57 20.03 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.281 1.433 . . . . 0.0 108.638 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -71.25 139.79 50.16 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.483 -0.761 . . . . 0.0 110.421 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -145.7 164.5 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.897 1.279 . . . . 0.0 111.964 -170.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.8 m -136.44 120.36 17.52 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.739 1.215 . . . . 0.0 109.271 172.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -67.3 137.53 56.15 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.859 0.864 . . . . 0.0 111.371 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.9 156.71 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.235 1.014 . . . . 0.0 112.706 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -90.8 -167.54 1.85 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.75 1.22 . . . . 0.0 113.705 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.23 -32.19 73.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.87 -11.54 59.81 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.821 1.248 . . . . 0.0 112.817 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 17.47 77.41 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.099 -1.39 . . . . 0.0 113.904 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 m -79.71 150.51 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.829 1.815 . . . . 0.0 111.339 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.57 126.43 34.93 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.308 1.043 . . . . 0.0 111.356 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.6 mt -109.08 -43.3 4.21 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.533 1.133 . . . . 0.0 112.681 -169.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.96 144.8 9.33 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.468 1.033 . . . . 0.0 114.2 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 p -83.79 148.26 27.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.448 1.099 . . . . 0.0 112.224 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.08 170.21 32.04 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.322 1.439 . . . . 0.0 113.457 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.04 119.8 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.7 ttm -91.11 134.05 34.84 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.058 0.943 . . . . 0.0 109.488 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -125.39 124.04 40.64 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.986 1.314 . . . . 0.0 109.235 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -111.35 126.87 55.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.546 1.938 . . . . 0.0 107.901 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -162.54 149.92 13.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.514 1.925 . . . . 0.0 108.266 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -58.89 -18.5 33.7 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -172.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 m -70.45 -42.26 71.75 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 170.95 167.05 0.07 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.594 1.958 . . . . 0.0 111.946 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mt -82.18 139.37 34.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.939 0.895 . . . . 0.0 109.545 167.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 t -134.64 138.62 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.331 0.653 . . . . 0.0 110.808 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.1 mt -113.74 130.74 56.39 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 125.735 1.614 . . . . 0.0 109.482 167.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -111.61 122.22 47.23 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.391 1.876 . . . . 0.0 109.945 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 CA--C 1.535 0.394 0 C-N-CA 124.84 1.256 . . . . 0.0 111.489 -177.264 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.711 0 CA-C-O 120.738 0.304 . . . . 0.0 111.666 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.95 136.95 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.515 1.126 . . . . 0.0 111.694 -169.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -117.15 146.83 42.94 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.844 1.658 . . . . 0.0 113.213 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -142.54 121.52 7.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.474 1.51 . . . . 0.0 111.797 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.77 149.99 61.31 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.094 2.529 . . . . 0.0 110.895 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -63.43 -19.42 64.69 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.4 mt -63.21 -33.67 75.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.422 1.089 . . . . 0.0 113.693 171.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.2 p -83.99 -9.35 58.73 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -89.9 73.6 7.43 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 111.87 -173.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -63.99 -41.24 97.58 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.042 -0.412 . . . . 0.0 112.058 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -134.03 129.6 36.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.098 1.759 . . . . 0.0 110.363 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -153.09 141.67 20.86 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.714 2.006 . . . . 0.0 109.764 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.67 179.44 41.56 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-O 122.053 0.807 . . . . 0.0 114.612 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -142.33 157.61 44.62 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.38 1.472 . . . . 0.0 112.56 -171.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.78 -173.17 4.28 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.699 2.0 . . . . 0.0 109.845 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 p -59.33 110.6 1.12 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.272 -0.892 . . . . 0.0 111.506 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 61.7 15.58 7.06 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 126.41 1.884 . . . . 0.0 114.268 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -133.04 129.3 37.9 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.231 1.378 . . . . 0.0 112.065 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -124.12 142.09 51.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.676 1.591 . . . . 0.0 110.474 171.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.8 t -153.87 157.06 38.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.489 1.116 . . . . 0.0 113.581 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.36 155.46 37.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.17 1.388 . . . . 0.0 113.488 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.04 154.32 17.7 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.142 1.777 . . . . 0.0 111.605 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 t -148.37 161.8 40.84 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.733 0.813 . . . . 0.0 113.054 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.37 173.63 19.75 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 126.481 1.991 . . . . 0.0 114.593 -170.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -26.54 68.44 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -169.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -81.21 -15.06 56.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.2 p -79.13 -178.45 6.16 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -61.62 -35.88 79.13 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.95 1.3 . . . . 0.0 113.341 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.9 p -99.41 -22.85 15.35 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.546 1.539 . . . . 0.0 114.374 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.76 -165.8 46.31 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.776 1.655 . . . . 0.0 112.925 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -58.34 132.48 53.76 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.006 0.922 . . . . 0.0 111.998 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.68 172.49 31.22 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 123.997 0.808 . . . . 0.0 113.375 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.7 mt -114.94 137.85 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.367 1.467 . . . . 0.0 108.261 169.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -131.53 126.9 36.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.745 1.218 . . . . 0.0 110.213 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.31 144.95 50.24 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.496 1.119 . . . . 0.0 113.284 -170.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -141.82 129.67 21.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.354 1.061 . . . . 0.0 111.75 -168.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -76.95 134.81 38.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.877 0.871 . . . . 0.0 111.608 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 22.3 p -174.45 137.31 0.49 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.635 1.974 . . . . 0.0 111.565 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -73.68 -3.8 30.42 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.993 -1.067 . . . . 0.0 113.273 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -110.94 13.31 22.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.163 2.585 . . . . 0.0 112.758 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.59 -43.25 35.86 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.204 1.402 . . . . 0.0 114.215 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -68.12 -35.18 77.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.521 0.728 . . . . 0.0 112.769 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.46 -31.27 66.98 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.379 -0.826 . . . . 0.0 112.141 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.42 -45.6 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.755 0.707 . . . . 0.0 109.861 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.82 -45.09 93.47 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.159 0.983 . . . . 0.0 111.735 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -65.24 -40.94 94.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.199 1.4 . . . . 0.0 112.261 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.5 tp -74.05 -38.57 63.95 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.955 0.798 . . . . 0.0 111.505 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 mt -54.76 -55.74 26.78 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.018 0.827 . . . . 0.0 111.247 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -62.17 -24.79 67.4 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -41.03 75.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.152 0.981 . . . . 0.0 112.219 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.7 mt -73.71 -40.12 63.82 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.787 0.835 . . . . 0.0 111.099 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 70.0 mmm . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 124.912 1.285 . . . . 0.0 112.737 178.516 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 36.1 t80 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -82.56 112.5 19.52 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.386 1.075 . . . . 0.0 111.256 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 57.8 mt -85.68 153.55 22.27 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.708 0.803 . . . . 0.0 112.103 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -88.34 -29.88 19.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.342 1.457 . . . . 0.0 112.794 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -137.86 157.09 47.14 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.235 1.814 . . . . 0.0 111.65 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -79.2 128.15 76.81 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.999 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -84.95 6.28 5.8 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.0 3.134 . . . . 0.0 114.066 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 t -127.01 139.44 53.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.411 1.485 . . . . 0.0 111.565 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.3 -39.38 7.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.182 0.896 . . . . 0.0 112.713 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.1 52.11 1.25 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.523 1.529 . . . . 0.0 113.199 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.53 141.66 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.236 -0.915 . . . . 0.0 111.407 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -111.42 118.44 35.81 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.388 1.475 . . . . 0.0 107.992 167.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 . . . . . 0 CA--C 1.541 0.606 0 O-C-N 121.521 -0.737 . . . . 0.0 111.361 179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 . . . . . 0 CA--C 1.554 1.128 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.71 -11.0 30.14 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.326 2.684 . . . . 0.0 115.086 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 p -130.32 -19.24 3.14 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.65 118.14 32.26 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.996 0.918 . . . . 0.0 111.295 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -116.37 105.42 12.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.328 1.051 . . . . 0.0 109.221 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -67.04 130.99 44.91 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.48 -0.763 . . . . 0.0 110.438 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.27 157.27 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.085 1.354 . . . . 0.0 112.024 -169.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.7 m -130.89 115.79 17.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.693 1.197 . . . . 0.0 108.822 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -62.34 128.42 35.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.372 0.533 . . . . 0.0 109.934 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.42 155.92 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.89 0.876 . . . . 0.0 112.522 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.26 -168.68 2.32 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.436 1.094 . . . . 0.0 113.758 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.37 -31.43 71.32 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.289 1.435 . . . . 0.0 114.344 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -84.06 -8.98 58.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.773 0.829 . . . . 0.0 113.018 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.24 15.62 78.17 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.431 -1.205 . . . . 0.0 113.979 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 m -79.72 150.61 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.49 1.645 . . . . 0.0 111.247 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -91.53 123.43 34.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.802 1.241 . . . . 0.0 110.922 -169.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.4 mt -106.55 -53.47 2.62 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.514 0.726 . . . . 0.0 112.114 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.77 160.98 29.32 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 125.535 1.541 . . . . 0.0 113.073 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 m -125.41 147.08 49.32 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.624 0.769 . . . . 0.0 112.824 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.86 174.58 30.13 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.775 1.655 . . . . 0.0 113.858 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.0 t -113.01 120.22 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.2 tpp -86.08 138.78 31.69 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.614 1.166 . . . . 0.0 109.819 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.1 130.0 26.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.672 1.589 . . . . 0.0 108.799 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.27 127.43 53.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.311 1.844 . . . . 0.0 107.344 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.1 p -127.55 172.83 10.37 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.802 1.241 . . . . 0.0 110.664 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -72.85 -0.48 13.59 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 121.235 -0.916 . . . . 0.0 112.541 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.1 t -106.47 -46.64 3.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.061 1.344 . . . . 0.0 112.971 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -174.8 174.41 2.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.943 1.297 . . . . 0.0 113.297 -166.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.9 138.61 31.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.234 1.014 . . . . 0.0 109.391 167.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.35 127.81 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.133 0.973 . . . . 0.0 111.109 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.17 130.73 46.34 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.816 1.647 . . . . 0.0 109.809 168.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -107.63 118.7 37.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.517 1.927 . . . . 0.0 110.188 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 126.064 1.746 . . . . 0.0 110.929 -177.885 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 t -134.76 133.78 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.67 0.788 . . . . 0.0 111.293 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -125.63 143.32 51.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.96 1.304 . . . . 0.0 112.311 -172.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 -140.11 112.53 7.41 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.788 1.235 . . . . 0.0 111.153 174.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.76 145.73 76.17 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.64 2.227 . . . . 0.0 110.284 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -60.33 -25.58 65.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.55 -38.84 90.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.028 1.331 . . . . 0.0 111.728 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.4 -5.31 58.57 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 99.3 mt -83.38 123.4 29.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.339 0.972 . . . . 0.0 109.861 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -83.94 -38.71 20.68 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.097 0.559 . . . . 0.0 112.123 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -161.97 156.18 21.99 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.462 1.505 . . . . 0.0 111.428 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -151.25 123.82 8.45 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.278 1.431 . . . . 0.0 109.538 -172.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.67 167.39 25.91 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 124.264 0.935 . . . . 0.0 113.795 -169.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -145.13 164.13 32.2 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.349 1.06 . . . . 0.0 113.342 -169.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -146.78 -166.99 2.64 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.223 2.209 . . . . 0.0 109.385 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 93.9 p -69.55 -19.06 63.7 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.277 -1.514 . . . . 0.0 114.71 -175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -150.32 9.5 0.65 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.286 1.434 . . . . 0.0 114.032 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -137.42 132.21 33.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.774 1.63 . . . . 0.0 110.075 -169.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -126.89 139.66 52.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.078 1.751 . . . . 0.0 109.404 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.1 t -153.15 156.46 38.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.31 1.044 . . . . 0.0 112.448 -175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -153.78 156.08 37.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.252 1.421 . . . . 0.0 111.901 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -116.86 137.65 52.06 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.743 1.617 . . . . 0.0 110.104 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -141.16 156.58 45.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.235 1.014 . . . . 0.0 112.011 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.6 175.39 37.24 Favored Glycine 0 N--CA 1.472 1.1 0 C-N-CA 125.458 1.504 . . . . 0.0 114.986 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -13.52 28.51 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -172.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.8 ptm85 -86.96 -15.82 37.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.58 1.552 . . . . 0.0 115.182 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.6 p -76.34 179.79 5.59 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.79 0.836 . . . . 0.0 112.81 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -59.01 -41.25 87.29 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.36 1.064 . . . . 0.0 113.052 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.3 p -92.09 -20.61 21.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.079 1.351 . . . . 0.0 113.758 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.59 -173.1 49.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.252 1.406 . . . . 0.0 112.43 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -67.7 127.65 33.56 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.55 0.74 . . . . 0.0 112.234 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.45 -177.39 38.62 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.124 0.869 . . . . 0.0 113.604 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -123.48 139.65 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.238 1.815 . . . . 0.0 109.128 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -134.63 126.96 30.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.127 1.371 . . . . 0.0 109.768 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.76 139.26 54.18 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.624 1.17 . . . . 0.0 112.442 -171.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -137.18 126.89 25.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.242 1.017 . . . . 0.0 111.549 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -74.25 134.46 42.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.644 0.777 . . . . 0.0 111.847 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.0 p -176.27 128.2 0.21 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.02 2.528 . . . . 0.0 110.331 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.4 m -68.36 -10.47 55.21 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.807 -1.183 . . . . 0.0 113.326 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -93.36 10.21 33.1 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.01 2.124 . . . . 0.0 112.883 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.9 -40.59 66.77 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.692 1.597 . . . . 0.0 114.658 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -70.95 -35.26 72.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.481 0.712 . . . . 0.0 112.68 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 -67.09 -37.58 84.2 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.199 -0.938 . . . . 0.0 111.314 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.6 mt -61.43 -46.34 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 118.751 0.705 . . . . 0.0 110.135 172.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.44 -43.16 97.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.382 1.073 . . . . 0.0 112.099 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -70.42 -32.32 69.88 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.245 1.018 . . . . 0.0 113.423 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -78.04 -37.33 47.07 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.126 0.875 . . . . 0.0 110.063 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.89 -52.02 65.54 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.434 -0.791 . . . . 0.0 112.567 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -60.24 -23.95 64.48 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.24 -17.51 52.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.991 1.317 . . . . 0.0 113.377 176.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.4 mt -102.41 -36.32 8.47 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.316 1.446 . . . . 0.0 111.929 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 62.7 mmm . . . . . 0 N--CA 1.471 0.623 0 C-N-CA 125.599 1.559 . . . . 0.0 112.741 178.06 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 37.3 t80 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.26 0.076 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -78.96 116.98 19.62 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.497 1.119 . . . . 0.0 110.957 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.8 mt -88.16 153.71 21.02 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.525 -0.734 . . . . 0.0 112.467 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -94.6 -2.11 52.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.815 1.646 . . . . 0.0 113.49 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -160.95 164.31 31.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.454 2.302 . . . . 0.0 110.737 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -94.78 119.01 66.68 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.227 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.39 -22.16 7.06 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.004 2.47 . . . . 0.0 113.489 -170.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.5 m -91.06 112.16 23.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.926 0.891 . . . . 0.0 111.047 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.18 -25.72 72.55 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.778 0.704 . . . . 0.0 112.881 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -91.97 119.17 31.46 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.675 1.19 . . . . 0.0 109.258 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.69 154.03 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.484 1.514 . . . . 0.0 110.749 -169.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -144.82 175.88 9.86 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.961 1.704 . . . . 0.0 112.25 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 CA--C 1.544 0.742 0 C-N-CA 125.637 1.575 . . . . 0.0 110.444 -169.021 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 . . . . . 0 CA--C 1.557 1.244 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.33 -11.02 26.37 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.899 2.399 . . . . 0.0 115.259 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.7 p -130.96 -16.95 3.17 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 120.373 1.442 . . . . 0.0 114.088 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -111.61 144.69 40.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.816 1.247 . . . . 0.0 110.579 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -140.83 119.17 12.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.159 0.983 . . . . 0.0 109.099 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -70.24 129.71 40.07 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.65 -0.656 . . . . 0.0 110.227 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 m -136.74 160.73 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.844 1.658 . . . . 0.0 110.889 -170.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -132.75 118.79 19.48 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.857 0.863 . . . . 0.0 109.193 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.26 128.68 36.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.038 0.935 . . . . 0.0 110.164 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -124.34 155.03 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.918 0.887 . . . . 0.0 113.382 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.51 -170.85 3.26 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.49 -24.15 67.7 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -92.82 -6.22 49.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.142 1.777 . . . . 0.0 112.642 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.19 15.2 75.08 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.282 -1.288 . . . . 0.0 114.29 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -76.67 143.98 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.721 1.76 . . . . 0.0 110.849 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -88.24 119.45 28.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.078 1.351 . . . . 0.0 110.495 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.6 mt -104.93 -54.73 2.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.149 0.58 . . . . 0.0 112.025 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.26 142.61 10.41 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 124.834 1.207 . . . . 0.0 113.799 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.5 p -94.56 142.19 27.73 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.943 1.297 . . . . 0.0 112.354 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.75 171.28 29.1 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.736 1.636 . . . . 0.0 113.486 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.56 120.71 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.2 tpp -87.19 139.23 30.77 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.698 1.199 . . . . 0.0 109.67 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.07 128.82 24.76 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.7 1.6 . . . . 0.0 108.667 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mp -108.52 134.26 51.54 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.211 1.804 . . . . 0.0 108.138 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.3 p -134.26 170.76 15.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.117 1.367 . . . . 0.0 109.745 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.05 -5.93 30.14 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.233 -0.917 . . . . 0.0 113.076 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.5 t -107.48 -43.52 4.52 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.247 1.019 . . . . 0.0 113.34 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -169.88 169.04 8.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.41 1.084 . . . . 0.0 113.194 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.2 mt -86.74 142.4 28.18 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.535 1.134 . . . . 0.0 110.031 168.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.69 130.15 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.616 1.166 . . . . 0.0 110.847 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.1 mt -105.55 133.62 49.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.145 1.778 . . . . 0.0 110.565 168.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -115.8 117.84 31.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.872 2.069 . . . . 0.0 110.329 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 125.662 1.585 . . . . 0.0 110.57 -178.58 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.58 136.33 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.917 0.887 . . . . 0.0 110.757 -172.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -134.44 148.96 50.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -140.76 112.58 6.97 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.426 1.491 . . . . 0.0 111.059 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.66 148.11 86.75 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.794 2.329 . . . . 0.0 110.347 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -61.95 -19.69 63.03 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.53 -44.83 95.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.635 1.574 . . . . 0.0 112.974 171.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.2 p -77.4 -15.18 59.5 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.94 115.14 10.8 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.783 0.833 . . . . 0.0 109.986 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -79.08 -32.67 44.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.447 1.099 . . . . 0.0 111.723 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -166.6 159.88 14.61 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.228 1.811 . . . . 0.0 111.528 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -150.07 126.35 10.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.167 1.387 . . . . 0.0 110.804 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.9 172.63 24.41 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.976 1.274 . . . . 0.0 113.45 -170.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -153.49 145.72 23.85 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.161 0.985 . . . . 0.0 112.161 -170.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -141.04 -177.5 5.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.469 1.908 . . . . 0.0 109.362 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -59.45 117.45 4.87 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.019 -1.051 . . . . 0.0 110.708 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.8 t30 60.54 12.85 3.8 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 127.111 2.165 . . . . 0.0 115.158 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -133.91 127.38 32.35 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.752 1.614 . . . . 0.0 111.922 -169.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -122.15 140.94 51.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.824 1.65 . . . . 0.0 109.972 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 t -153.55 155.34 35.99 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.047 -1.033 . . . . 0.0 112.886 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -147.97 153.58 39.2 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.245 1.418 . . . . 0.0 111.88 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -111.35 141.16 45.26 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.574 1.55 . . . . 0.0 109.439 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 p -138.91 150.56 46.08 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.786 0.834 . . . . 0.0 112.7 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.59 173.82 46.01 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.957 1.265 . . . . 0.0 113.715 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -63.66 -14.8 55.32 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -77.44 -16.84 58.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.128 1.771 . . . . 0.0 115.292 -176.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.2 p -79.29 -179.07 6.54 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.32 1.048 . . . . 0.0 113.498 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -62.02 -36.65 82.2 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.54 1.136 . . . . 0.0 113.296 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -94.94 -20.81 19.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.079 1.352 . . . . 0.0 114.338 -174.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.31 -179.07 49.38 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.886 1.232 . . . . 0.0 112.02 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -65.82 129.52 40.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.878 0.871 . . . . 0.0 111.823 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.09 -177.22 42.36 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 122.143 0.857 . . . . 0.0 113.508 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.2 mt -121.75 139.26 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.046 1.739 . . . . 0.0 108.698 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -133.85 128.06 33.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.971 1.308 . . . . 0.0 110.035 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.89 142.72 51.39 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.649 1.179 . . . . 0.0 112.725 -172.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -139.17 129.71 25.82 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.69 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -72.35 133.35 44.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.001 0.52 . . . . 0.0 110.754 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.0 t -168.46 124.34 0.98 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.185 1.794 . . . . 0.0 111.044 -171.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.8 m -70.97 -9.48 58.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -117.68 22.48 12.32 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.434 1.894 . . . . 0.0 112.405 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.67 -38.15 31.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.265 1.426 . . . . 0.0 114.299 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.56 -36.66 73.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.751 0.82 . . . . 0.0 112.926 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -65.07 -40.09 94.19 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.58 -0.7 . . . . 0.0 110.788 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.19 -47.89 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.941 0.497 . . . . 0.0 110.296 173.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.31 -44.64 92.54 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.555 1.142 . . . . 0.0 112.11 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -70.0 -33.63 72.29 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.854 0.862 . . . . 0.0 113.088 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -74.88 -41.67 59.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.951 0.796 . . . . 0.0 110.4 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.3 mt -52.12 -55.13 22.82 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.728 0.811 . . . . 0.0 112.869 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.59 -25.43 68.07 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.88 -29.42 68.52 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.505 1.048 . . . . 0.0 112.677 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.6 mt -96.09 -39.38 9.76 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.354 1.462 . . . . 0.0 110.999 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.3 mtp . . . . . 0 N--CA 1.466 0.332 0 C-N-CA 124.306 1.042 . . . . 0.0 113.3 -179.162 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 36.9 t80 . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 120.557 0.218 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -78.97 109.24 13.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.996 1.319 . . . . 0.0 111.005 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.53 153.4 24.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.536 0.735 . . . . 0.0 112.024 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -81.73 -28.22 33.47 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.89 1.276 . . . . 0.0 112.534 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -157.03 162.83 39.54 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.441 1.896 . . . . 0.0 111.359 -170.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -78.56 132.22 65.93 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 121.542 -0.724 . . . . 0.0 111.55 -173.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -83.62 -4.78 10.8 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.321 2.681 . . . . 0.0 114.358 -171.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 14.6 t -122.84 145.45 48.43 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.606 1.094 . . . . 0.0 113.44 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.08 -4.53 71.67 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.609 1.576 . . . . 0.0 114.532 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -119.39 123.23 43.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.791 1.636 . . . . 0.0 109.828 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -157.11 152.25 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.394 1.078 . . . . 0.0 110.882 -167.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -122.53 146.94 46.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.134 1.374 . . . . 0.0 110.307 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 126.157 1.783 . . . . 0.0 110.068 -178.17 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 . . . . . 0 CA--C 1.557 1.215 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.67 -10.44 26.58 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.246 2.63 . . . . 0.0 115.177 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.2 p -128.87 -21.1 3.4 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -115.51 134.66 54.86 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.024 0.929 . . . . 0.0 110.83 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.29 121.19 24.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.214 1.406 . . . . 0.0 107.97 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 140.91 44.15 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.28 -0.888 . . . . 0.0 110.447 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.3 m -145.18 163.24 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.295 1.038 . . . . 0.0 111.608 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.1 m -143.87 123.2 13.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.427 1.091 . . . . 0.0 108.774 170.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.46 132.86 51.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.16 0.984 . . . . 0.0 110.339 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.67 156.08 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.806 1.242 . . . . 0.0 113.018 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -93.37 -165.53 1.35 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.644 1.578 . . . . 0.0 114.309 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.14 -35.1 72.91 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.035 1.334 . . . . 0.0 113.656 172.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.27 -13.04 58.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.039 0.836 . . . . 0.0 113.167 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.72 17.84 74.37 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 118.295 -1.28 . . . . 0.0 113.624 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 m -76.31 150.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.537 1.669 . . . . 0.0 111.145 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.1 123.99 32.76 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.276 1.031 . . . . 0.0 111.309 -171.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.7 mt -104.85 -50.06 3.36 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.551 1.14 . . . . 0.0 111.786 -172.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.91 132.38 3.44 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 124.684 1.135 . . . . 0.0 113.633 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p -85.44 149.45 25.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.938 1.295 . . . . 0.0 112.635 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.41 171.7 39.18 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.829 1.204 . . . . 0.0 114.391 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.9 t -113.25 120.34 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 39.1 tpp -86.02 132.03 34.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.762 0.825 . . . . 0.0 109.424 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -128.89 128.74 44.43 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.869 1.668 . . . . 0.0 108.272 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.52 125.43 50.99 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.024 1.73 . . . . 0.0 108.029 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -131.59 168.29 17.95 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.684 1.193 . . . . 0.0 110.072 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -65.17 -10.87 34.74 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.121 0.569 . . . . 0.0 112.344 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -95.91 -41.89 8.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.42 1.088 . . . . 0.0 113.114 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -177.68 171.16 1.91 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.131 1.372 . . . . 0.0 112.837 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -87.29 136.64 32.85 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.064 0.945 . . . . 0.0 109.012 167.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.54 130.95 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.886 0.874 . . . . 0.0 111.492 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 mt -100.34 130.04 46.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.502 1.121 . . . . 0.0 110.532 168.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -106.26 131.53 53.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.461 1.904 . . . . 0.0 110.961 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 125.709 1.603 . . . . 0.0 110.73 -177.231 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 120.373 0.13 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 t -131.04 128.52 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.569 0.747 . . . . 0.0 110.79 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.29 147.18 48.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.442 1.497 . . . . 0.0 112.588 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -139.34 118.99 9.23 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.795 1.238 . . . . 0.0 111.437 173.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.89 146.25 64.9 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.503 2.135 . . . . 0.0 109.559 171.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -59.73 -26.41 65.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.1 mt -58.17 -27.76 64.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.281 1.833 . . . . 0.0 114.397 171.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.5 p -90.56 -9.71 46.13 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -94.6 84.96 4.38 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.873 1.269 . . . . 0.0 110.932 -172.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -73.44 -19.42 60.96 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -157.84 123.52 4.6 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.836 1.655 . . . . 0.0 110.051 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -140.87 109.66 6.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.987 1.715 . . . . 0.0 111.097 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.63 169.89 13.11 Favored Glycine 0 N--CA 1.462 0.411 0 C-N-CA 124.713 1.149 . . . . 0.0 113.731 -169.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -140.35 159.46 42.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.39 1.076 . . . . 0.0 112.738 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -154.45 174.98 14.15 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.508 2.323 . . . . 0.0 109.643 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 m -61.34 -12.56 14.36 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -172.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -154.63 18.29 0.46 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.151 1.38 . . . . 0.0 112.865 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.53 128.35 18.33 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.472 -1.393 . . . . 0.0 110.486 -169.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -118.98 133.2 55.98 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.124 1.77 . . . . 0.0 108.852 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 t -153.04 151.11 29.87 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.013 -1.054 . . . . 0.0 112.494 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -149.67 148.75 29.66 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.99 0.916 . . . . 0.0 112.388 -173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -104.8 135.09 46.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.293 1.437 . . . . 0.0 110.058 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -126.47 145.89 50.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.292 1.037 . . . . 0.0 112.188 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.1 168.23 46.57 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.41 1.005 . . . . 0.0 113.282 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -65.94 -11.35 46.79 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -70.14 -19.87 63.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.659 1.584 . . . . 0.0 114.967 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -85.87 -179.88 6.9 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -63.21 -39.28 94.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.488 1.115 . . . . 0.0 113.181 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.5 p -96.45 -22.61 17.02 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.972 1.309 . . . . 0.0 113.492 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.99 -162.04 29.67 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.566 2.031 . . . . 0.0 113.644 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -56.75 125.88 24.34 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.354 1.062 . . . . 0.0 111.524 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.78 171.98 27.47 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.453 1.025 . . . . 0.0 113.304 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.2 mt -115.04 131.45 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.531 1.532 . . . . 0.0 108.337 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.49 113.64 18.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.91 1.284 . . . . 0.0 109.669 -172.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.27 140.57 45.73 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.177 1.391 . . . . 0.0 112.298 -173.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -138.76 125.55 20.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.199 1.0 . . . . 0.0 111.405 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -63.75 126.79 28.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.822 0.849 . . . . 0.0 110.434 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.6 t -167.86 126.65 1.25 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.635 1.574 . . . . 0.0 111.462 -170.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -69.74 -44.21 70.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.185 0.594 . . . . 0.0 112.459 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.1 mtm-85 -90.45 31.28 1.04 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.566 1.546 . . . . 0.0 113.889 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.04 -37.32 61.47 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.666 1.187 . . . . 0.0 113.967 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -70.53 -36.85 73.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.598 0.759 . . . . 0.0 112.843 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -64.54 -42.11 95.93 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.719 -0.613 . . . . 0.0 110.249 173.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.97 -48.44 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.322 0.649 . . . . 0.0 110.626 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.52 -40.47 83.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.51 1.124 . . . . 0.0 112.304 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -73.75 -31.87 63.55 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -77.93 -39.04 44.11 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.064 0.847 . . . . 0.0 110.342 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.51 -53.0 19.78 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.223 1.409 . . . . 0.0 113.852 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -64.82 -22.54 67.01 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -74.05 -25.06 59.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.088 0.955 . . . . 0.0 112.547 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.2 mt -96.47 -32.67 12.19 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.138 1.375 . . . . 0.0 111.795 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.1 mtt . . . . . 0 N--CA 1.47 0.552 0 C-N-CA 123.566 0.746 . . . . 0.0 112.685 171.085 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 39.4 t80 . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 120.417 0.151 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.81 94.73 2.63 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.755 2.022 . . . . 0.0 110.514 172.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 15.8 mt -67.78 150.03 49.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.032 0.933 . . . . 0.0 112.521 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -84.92 -14.71 46.83 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -159.44 165.26 33.51 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.548 1.539 . . . . 0.0 111.708 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -87.0 123.33 70.44 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.091 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.48 -20.46 5.81 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.283 2.655 . . . . 0.0 114.009 -171.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 82.6 m -89.76 129.53 36.15 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.982 0.913 . . . . 0.0 111.937 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.25 -3.16 84.99 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.696 1.141 . . . . 0.0 114.795 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -141.49 136.82 31.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.326 1.451 . . . . 0.0 109.668 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -164.94 142.24 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.553 1.541 . . . . 0.0 111.36 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -109.68 127.81 54.82 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.864 2.066 . . . . 0.0 109.243 172.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 123.692 0.797 . . . . 0.0 110.905 177.542 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 . . . . . 0 CA--C 1.56 1.342 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.72 -17.85 25.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.876 2.384 . . . . 0.0 115.253 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.1 p -127.51 -20.29 4.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.386 1.448 . . . . 0.0 114.688 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 149.63 28.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.11 0.868 . . . . 0.0 110.109 169.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.52 109.11 6.57 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -68.97 130.58 43.18 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.59 -0.694 . . . . 0.0 109.93 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.2 m -139.6 164.86 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.758 1.223 . . . . 0.0 112.219 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.4 m -139.62 121.03 15.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.785 1.234 . . . . 0.0 108.615 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -66.61 133.18 49.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.819 0.448 . . . . 0.0 110.127 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.39 155.63 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.085 0.954 . . . . 0.0 112.592 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -82.3 -166.95 1.39 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.452 1.501 . . . . 0.0 113.12 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -66.18 -33.71 76.38 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -81.6 -28.69 33.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.322 0.964 . . . . 0.0 112.173 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.22 16.88 7.5 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 125.202 1.382 . . . . 0.0 112.261 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 t -74.3 140.53 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.345 2.258 . . . . 0.0 108.948 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -88.36 123.77 33.26 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.529 1.532 . . . . 0.0 110.393 -171.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.9 mt -108.52 -53.25 2.66 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.896 0.878 . . . . 0.0 112.575 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.98 142.01 9.17 Favored Glycine 0 N--CA 1.47 0.953 0 C-N-CA 124.82 1.2 . . . . 0.0 113.602 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -87.89 148.03 24.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.633 1.173 . . . . 0.0 112.666 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.03 170.09 33.73 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.529 1.061 . . . . 0.0 114.045 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.3 t -116.85 120.41 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 38.4 tpp -88.16 139.56 30.38 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.942 1.297 . . . . 0.0 110.204 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.01 130.25 25.18 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.791 1.636 . . . . 0.0 109.185 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mp -106.46 138.54 42.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.67 1.988 . . . . 0.0 108.313 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -140.27 174.47 10.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.086 1.355 . . . . 0.0 111.049 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -76.73 9.57 2.74 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.259 -0.901 . . . . 0.0 112.535 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.6 t -118.19 -49.64 2.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.95 1.3 . . . . 0.0 112.954 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -173.3 171.3 4.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.072 1.349 . . . . 0.0 112.509 -168.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 mt -85.8 140.15 30.69 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.77 0.828 . . . . 0.0 109.528 168.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 36.0 t -134.61 127.88 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.884 0.874 . . . . 0.0 111.418 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.9 mt -100.38 132.92 45.49 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.169 1.388 . . . . 0.0 109.696 167.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -107.6 125.45 51.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.623 1.969 . . . . 0.0 110.315 171.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.475 0.776 0 C-N-CA 126.346 1.858 . . . . 0.0 111.279 -177.6 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 111.453 0.168 . . . . 0.0 111.453 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.5 t -129.24 127.15 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.459 0.704 . . . . 0.0 111.118 -175.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.9 mtm-85 -119.14 143.63 47.09 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.204 1.802 . . . . 0.0 112.153 -169.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -139.37 114.2 8.16 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.367 1.067 . . . . 0.0 111.936 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.72 143.65 68.56 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.98 2.453 . . . . 0.0 110.391 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -60.71 -21.79 63.29 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.03 -46.76 89.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.946 1.698 . . . . 0.0 111.728 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 p -78.2 -17.31 56.93 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.53 65.96 6.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.993 1.717 . . . . 0.0 111.111 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -70.89 -24.15 62.43 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -172.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -147.43 118.53 7.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.157 1.783 . . . . 0.0 108.492 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -140.54 110.77 6.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.322 1.849 . . . . 0.0 110.717 -173.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.88 168.19 15.16 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 124.644 1.116 . . . . 0.0 114.104 -168.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -138.63 163.14 32.85 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.578 1.151 . . . . 0.0 112.648 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -148.7 -169.95 3.49 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.06 2.144 . . . . 0.0 109.524 170.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.3 m -68.4 -14.86 63.3 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -156.49 11.75 0.26 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.49 1.516 . . . . 0.0 114.126 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -136.59 129.89 31.52 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.915 1.686 . . . . 0.0 110.06 -168.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -123.39 135.85 54.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.924 1.69 . . . . 0.0 109.249 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 t -153.02 155.68 37.37 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.219 1.008 . . . . 0.0 112.277 -174.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.34 154.69 32.43 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.269 1.028 . . . . 0.0 112.647 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -91.77 152.22 20.25 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.334 1.854 . . . . 0.0 110.66 171.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 90.8 p -141.29 152.1 44.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.414 1.085 . . . . 0.0 112.108 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.33 162.2 18.02 Favored Glycine 0 N--CA 1.473 1.144 0 C-N-CA 125.035 1.302 . . . . 0.0 114.312 -171.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -56.38 -20.69 20.55 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -82.49 -15.5 52.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.9 p -85.15 -178.27 6.74 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -56.11 -49.9 72.59 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.944 1.298 . . . . 0.0 112.173 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.4 p -88.1 -23.19 23.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.945 1.298 . . . . 0.0 112.938 -174.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.22 -154.62 35.26 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.89 1.709 . . . . 0.0 112.174 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -59.58 130.46 46.97 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.358 1.063 . . . . 0.0 111.895 173.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.09 164.41 18.06 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.152 0.882 . . . . 0.0 113.564 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.4 mt -113.49 134.02 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.687 1.195 . . . . 0.0 108.512 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -130.25 125.74 35.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.947 1.299 . . . . 0.0 109.941 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.78 141.82 50.83 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.587 1.155 . . . . 0.0 112.734 -172.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -140.87 127.86 20.66 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.83 0.852 . . . . 0.0 111.874 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -65.59 133.53 51.37 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.398 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.1 t -161.48 132.53 5.29 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.271 1.428 . . . . 0.0 111.587 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 m -68.64 -15.6 63.57 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -133.69 35.85 3.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.044 1.738 . . . . 0.0 112.967 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.57 -40.36 71.87 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -70.07 -39.49 75.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.782 0.719 . . . . 0.0 112.013 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -61.71 -39.72 92.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.286 1.034 . . . . 0.0 110.927 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.4 mt -62.19 -47.99 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 118.95 0.795 . . . . 0.0 110.631 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -58.04 -37.06 73.65 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.195 0.998 . . . . 0.0 112.426 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -79.62 -28.63 40.96 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 113.702 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt -80.47 -41.28 24.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.436 1.017 . . . . 0.0 110.184 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.1 mt -49.32 -56.47 9.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.62 1.168 . . . . 0.0 112.723 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -61.48 -21.68 64.4 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.88 -27.08 61.69 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.166 0.894 . . . . 0.0 112.589 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.4 mt -97.28 -41.83 8.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.772 1.629 . . . . 0.0 110.968 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 124.938 1.295 . . . . 0.0 113.294 -178.814 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 21.3 t80 . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 120.486 0.184 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -77.92 113.92 16.29 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.605 1.162 . . . . 0.0 110.728 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 59.4 mt -82.37 153.36 25.79 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.731 0.777 . . . . 0.0 112.714 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -78.69 -26.12 44.85 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.939 1.696 . . . . 0.0 112.831 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -159.44 166.88 30.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.351 1.86 . . . . 0.0 111.725 -169.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -88.49 124.13 66.67 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.52 -0.753 . . . . 0.0 111.924 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -87.02 -22.48 1.79 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.209 2.606 . . . . 0.0 114.336 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 92.9 m -83.9 130.0 34.92 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.996 0.816 . . . . 0.0 112.281 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.17 -1.01 88.63 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.68 1.133 . . . . 0.0 115.142 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -143.32 142.15 31.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.851 1.26 . . . . 0.0 110.243 170.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -166.38 146.82 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.222 1.409 . . . . 0.0 111.639 -168.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -118.54 142.43 47.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.396 2.278 . . . . 0.0 109.814 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 . . . . . 0 CA--C 1.544 0.721 0 C-N-CA 124.924 1.289 . . . . 0.0 109.676 177.102 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 . . . . . 0 CA--C 1.552 1.039 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.41 -11.03 30.78 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.079 2.519 . . . . 0.0 114.921 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.1 p -132.73 -22.76 2.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.27 97.63 7.19 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.542 1.065 . . . . 0.0 111.295 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -96.94 126.78 42.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.219 1.408 . . . . 0.0 109.751 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -81.55 136.03 35.59 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.099 -1.001 . . . . 0.0 110.273 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.22 168.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.737 1.215 . . . . 0.0 112.329 -168.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.6 m -141.8 121.99 13.86 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.569 1.147 . . . . 0.0 109.49 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.92 130.72 44.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.211 1.004 . . . . 0.0 110.755 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.21 159.48 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.01 -171.03 2.99 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -58.41 -21.99 52.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.825 1.65 . . . . 0.0 114.705 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -103.93 -4.66 23.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.92 1.288 . . . . 0.0 112.606 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.51 17.28 66.62 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.057 -1.413 . . . . 0.0 114.38 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.95 144.76 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.081 1.94 . . . . 0.0 109.999 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -91.42 120.89 32.66 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.38 1.072 . . . . 0.0 110.27 -175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.7 mt -107.94 -53.36 2.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.032 0.933 . . . . 0.0 112.027 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.14 132.03 3.93 Favored Glycine 0 N--CA 1.472 1.043 0 C-N-CA 124.726 1.155 . . . . 0.0 113.576 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.0 m -86.81 154.65 20.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.677 0.791 . . . . 0.0 112.659 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.13 171.34 33.93 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.099 1.333 . . . . 0.0 114.021 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -115.57 120.95 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 169.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.9 ttm -94.3 116.57 28.97 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.195 1.398 . . . . 0.0 109.754 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -109.18 128.5 55.08 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.832 1.653 . . . . 0.0 108.838 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.06 137.36 42.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.552 1.541 . . . . 0.0 108.278 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.6 p -135.41 173.2 11.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.006 1.322 . . . . 0.0 110.755 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -72.2 -0.25 11.56 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.558 -0.714 . . . . 0.0 112.608 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -115.37 -40.66 3.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -172.88 166.16 5.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.977 1.311 . . . . 0.0 112.963 -168.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mt -86.76 138.39 31.65 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.123 1.369 . . . . 0.0 109.272 168.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 t -134.75 131.77 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.664 0.785 . . . . 0.0 111.395 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.3 mt -104.75 130.66 52.78 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.221 1.408 . . . . 0.0 110.39 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -109.06 126.87 53.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.98 2.112 . . . . 0.0 110.245 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.54 0.566 0 C-N-CA 126.006 1.723 . . . . 0.0 112.136 -172.776 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 t -122.5 125.73 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.239 0.616 . . . . 0.0 111.172 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -115.81 143.79 44.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.86 1.664 . . . . 0.0 111.485 -173.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 -138.73 117.23 9.24 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.461 1.105 . . . . 0.0 111.167 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.25 144.53 68.86 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.237 1.958 . . . . 0.0 109.264 170.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -60.69 -27.29 67.75 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.02 -43.75 91.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.902 1.681 . . . . 0.0 111.588 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 79.1 m -78.86 1.58 22.97 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.26 117.29 25.92 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.844 1.202 . . . . 0.0 109.728 172.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -73.33 -35.66 66.07 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -166.13 162.75 17.88 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.721 2.008 . . . . 0.0 110.647 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -149.67 108.13 3.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.235 1.014 . . . . 0.0 110.418 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.31 161.88 12.66 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 124.875 1.226 . . . . 0.0 113.369 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -139.58 163.69 31.88 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.689 1.196 . . . . 0.0 112.61 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -153.63 -169.58 3.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.798 2.039 . . . . 0.0 109.566 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 t -64.82 -24.2 67.47 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.841 -1.162 . . . . 0.0 114.091 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -155.84 19.19 0.38 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.23 1.412 . . . . 0.0 112.996 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -142.67 128.33 19.19 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.999 1.319 . . . . 0.0 110.43 -169.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -120.84 140.98 51.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.081 1.752 . . . . 0.0 109.599 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -153.39 157.72 40.4 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.177 -0.952 . . . . 0.0 113.123 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -154.57 153.26 31.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.877 1.671 . . . . 0.0 111.136 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -108.13 133.09 52.89 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.798 0.839 . . . . 0.0 110.126 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 m -107.45 141.73 38.41 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.127 0.971 . . . . 0.0 112.588 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.79 157.12 53.53 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.832 1.206 . . . . 0.0 112.646 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -65.84 -15.79 63.23 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -168.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -91.49 -10.79 39.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.125 1.77 . . . . 0.0 115.367 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.4 p -75.86 -177.52 3.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -55.89 -40.23 72.71 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.504 1.122 . . . . 0.0 112.941 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.4 p -93.54 -23.4 18.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.943 1.297 . . . . 0.0 113.556 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.47 -161.85 41.2 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.056 1.312 . . . . 0.0 111.544 -171.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -66.12 128.46 36.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.811 0.844 . . . . 0.0 111.375 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.62 161.38 18.59 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 123.154 0.407 . . . . 0.0 114.036 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 88.1 mt -104.89 131.28 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.002 1.321 . . . . 0.0 108.514 169.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -127.76 125.23 39.52 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.819 1.248 . . . . 0.0 109.491 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.35 143.45 50.58 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.146 0.978 . . . . 0.0 112.663 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.93 124.3 19.28 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.901 -168.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -64.62 131.2 46.32 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.234 0.614 . . . . 0.0 110.706 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 37.3 t -169.98 122.88 0.71 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.111 1.764 . . . . 0.0 110.462 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -68.64 -14.42 63.0 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.62 -0.675 . . . . 0.0 112.812 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 mtt85 -108.56 22.76 15.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.442 1.897 . . . . 0.0 113.519 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.93 -37.81 21.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.583 1.153 . . . . 0.0 113.654 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.85 -40.45 79.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.451 1.101 . . . . 0.0 113.144 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.3 -34.65 77.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.466 -0.771 . . . . 0.0 111.384 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.44 -49.55 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.163 0.585 . . . . 0.0 110.291 170.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -37.31 82.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.559 0.744 . . . . 0.0 112.35 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -71.1 -29.39 65.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.758 0.823 . . . . 0.0 113.178 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.7 tp -86.77 -36.54 18.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.49 1.041 . . . . 0.0 112.419 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.1 mt -52.59 -55.9 19.07 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.971 0.908 . . . . 0.0 112.068 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -57.86 -21.01 40.62 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.53 -25.33 25.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.627 1.171 . . . . 0.0 113.42 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.5 mt -95.98 -33.53 12.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.797 1.239 . . . . 0.0 111.728 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 97.0 mtp . . . . . 0 N--CA 1.47 0.57 0 C-N-CA 125.857 1.663 . . . . 0.0 113.734 174.292 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.8 t80 . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -85.54 121.29 28.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.304 1.042 . . . . 0.0 110.844 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 80.4 mt -83.83 164.1 19.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.629 0.728 . . . . 0.0 112.718 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -106.59 2.21 25.87 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.812 1.645 . . . . 0.0 113.835 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -160.33 164.93 32.13 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.509 2.324 . . . . 0.0 110.472 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -90.94 118.31 68.5 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.307 174.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.87 -24.47 3.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.314 2.676 . . . . 0.0 114.772 -168.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 81.7 m -80.19 127.84 32.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.028 0.831 . . . . 0.0 111.873 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.58 -7.07 88.77 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.522 1.058 . . . . 0.0 114.449 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.42 131.01 31.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.337 1.855 . . . . 0.0 109.814 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 p -164.62 147.27 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.176 1.39 . . . . 0.0 111.112 -169.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -132.05 170.42 14.97 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.612 2.365 . . . . 0.0 111.874 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 125.359 1.464 . . . . 0.0 110.96 -169.372 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.15 -11.54 31.9 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.279 2.653 . . . . 0.0 115.253 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.0 p -131.42 -16.51 3.06 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.92 99.01 7.15 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.479 1.036 . . . . 0.0 111.29 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -97.47 116.38 29.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.777 1.231 . . . . 0.0 109.054 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -76.58 133.44 39.67 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.976 -1.078 . . . . 0.0 110.344 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.25 167.19 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.115 0.966 . . . . 0.0 112.485 -168.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.9 m -146.09 125.47 13.12 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.007 1.323 . . . . 0.0 108.797 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -66.37 132.6 48.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.515 0.726 . . . . 0.0 110.096 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.1 156.79 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.699 1.2 . . . . 0.0 112.809 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.36 -166.49 1.61 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.965 1.306 . . . . 0.0 113.988 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.93 -35.14 74.3 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.415 1.486 . . . . 0.0 114.319 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -80.38 -12.98 59.52 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.285 0.948 . . . . 0.0 113.063 176.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.67 17.52 72.85 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.345 -1.253 . . . . 0.0 113.554 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.41 149.3 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.668 1.734 . . . . 0.0 110.936 173.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -90.58 124.91 35.41 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.358 1.063 . . . . 0.0 111.321 -170.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.2 mt -107.42 -49.82 3.18 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.23 1.012 . . . . 0.0 111.991 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.69 135.37 4.44 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.782 1.182 . . . . 0.0 113.602 176.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 p -84.06 154.66 23.09 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.769 1.228 . . . . 0.0 112.984 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.07 171.07 38.75 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.858 1.218 . . . . 0.0 113.88 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.51 120.9 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 41.5 tpp -90.9 137.36 32.42 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.685 1.194 . . . . 0.0 110.283 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -138.95 130.14 26.8 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.216 1.406 . . . . 0.0 109.251 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.61 134.78 49.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.338 1.855 . . . . 0.0 107.656 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.4 p -132.07 173.4 11.26 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.078 0.951 . . . . 0.0 111.01 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -66.2 0.23 2.14 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.678 0.791 . . . . 0.0 112.685 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -116.32 -43.25 2.96 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -172.98 177.07 2.87 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -169.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.13 138.28 31.56 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.387 1.075 . . . . 0.0 110.132 167.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.65 128.69 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.308 1.043 . . . . 0.0 111.184 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.2 mt -102.12 135.12 44.25 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.504 1.522 . . . . 0.0 110.378 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -110.21 124.86 52.36 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.39 1.876 . . . . 0.0 111.068 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 127.202 2.201 . . . . 0.0 111.164 -179.637 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.641 0 CA-C-O 120.411 0.148 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -123.14 126.59 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.272 0.629 . . . . 0.0 110.546 -173.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -120.76 138.43 54.01 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.569 1.548 . . . . 0.0 111.524 -169.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -139.1 114.08 8.33 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.389 1.076 . . . . 0.0 111.093 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.55 150.13 74.83 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 0.0 110.307 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -60.95 -20.67 62.59 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -65.27 -34.67 78.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.142 1.777 . . . . 0.0 113.268 170.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 89.1 m -92.63 -5.05 52.32 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.18 105.63 13.43 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.837 0.855 . . . . 0.0 109.253 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -79.76 -20.93 45.12 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -170.1 133.42 1.15 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.698 1.999 . . . . 0.0 108.753 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -142.27 119.09 11.17 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.325 1.45 . . . . 0.0 110.26 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.55 164.87 22.91 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 124.077 0.846 . . . . 0.0 112.992 -169.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -130.45 155.32 46.63 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.343 1.057 . . . . 0.0 111.492 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.99 -174.11 4.76 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.878 1.671 . . . . 0.0 110.349 173.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.7 p -59.54 111.58 1.46 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.256 -0.902 . . . . 0.0 111.57 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.257 0.7 OUTLIER 51.52 23.15 1.74 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.391 2.276 . . . . 0.0 116.158 -174.25 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.33 126.39 29.6 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.424 1.49 . . . . 0.0 110.871 -172.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -120.18 135.16 55.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.748 1.619 . . . . 0.0 109.622 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -153.29 155.01 35.72 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.312 -0.867 . . . . 0.0 112.159 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -154.61 152.73 30.35 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.532 1.133 . . . . 0.0 112.268 -174.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -115.45 133.84 55.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.337 1.855 . . . . 0.0 110.493 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.6 m -133.26 154.38 50.73 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.354 1.062 . . . . 0.0 112.476 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.89 166.57 34.04 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.888 1.233 . . . . 0.0 113.588 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -6.37 16.71 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -174.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -82.69 -19.53 37.9 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.7 p -81.63 -179.46 7.39 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -55.13 -42.97 73.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.095 1.358 . . . . 0.0 113.003 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.4 p -93.15 -22.25 19.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.348 1.459 . . . . 0.0 113.637 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.1 -163.38 43.32 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.298 1.428 . . . . 0.0 112.539 -173.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -70.76 137.59 49.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.091 0.956 . . . . 0.0 112.793 -174.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.53 171.9 24.08 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.614 1.102 . . . . 0.0 113.355 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.63 123.11 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.091 1.356 . . . . 0.0 108.579 170.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -114.17 119.33 36.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.998 1.319 . . . . 0.0 109.393 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.61 139.15 53.39 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.394 1.078 . . . . 0.0 112.914 -169.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -140.29 131.22 26.07 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.887 0.851 . . . . 0.0 112.287 -169.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -69.39 135.32 50.14 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.813 168.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.7 t -159.03 142.75 15.05 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.131 1.372 . . . . 0.0 111.431 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.3 m -77.35 -27.48 52.68 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -127.66 40.24 3.73 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.692 1.197 . . . . 0.0 113.348 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.93 -40.88 15.09 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.52 -35.24 78.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.452 0.701 . . . . 0.0 112.8 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.93 -30.48 66.81 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.419 -0.8 . . . . 0.0 112.153 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.49 -47.28 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.688 0.676 . . . . 0.0 109.608 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -58.6 -42.61 88.51 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.177 0.991 . . . . 0.0 111.919 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -67.78 -42.44 81.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.687 1.195 . . . . 0.0 112.418 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.9 tp -75.21 -32.51 61.2 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.847 0.749 . . . . 0.0 112.177 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.2 mt -53.92 -54.36 39.92 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.698 0.799 . . . . 0.0 112.221 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -63.75 -30.97 72.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -34.19 77.38 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.221 1.008 . . . . 0.0 112.83 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.03 -35.57 21.82 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.341 1.056 . . . . 0.0 111.37 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 48.7 mtt . . . . . 0 N--CA 1.471 0.595 0 C-N-CA 123.593 0.757 . . . . 0.0 112.513 172.918 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 19.4 t80 . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 119.678 -0.201 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.81 116.76 32.5 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.779 1.232 . . . . 0.0 109.721 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 98.3 mt -78.52 157.77 28.76 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -87.22 -7.97 57.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.798 1.639 . . . . 0.0 113.919 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -161.38 163.08 30.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.959 2.104 . . . . 0.0 110.499 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -86.95 122.84 71.09 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.769 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.67 -12.24 11.21 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.387 2.725 . . . . 0.0 113.75 -171.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 84.5 m -99.82 121.7 41.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.367 1.067 . . . . 0.0 111.531 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.45 -14.6 82.32 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.385 0.993 . . . . 0.0 114.576 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -127.16 138.45 53.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.478 1.511 . . . . 0.0 110.876 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 p -163.97 142.45 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.888 1.675 . . . . 0.0 110.868 -173.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -115.76 114.22 24.5 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.321 2.249 . . . . 0.0 107.921 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 . . . . . 0 CA--C 1.543 0.687 0 O-C-N 121.634 -0.666 . . . . 0.0 110.449 178.848 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 . . . . . 0 CA--C 1.558 1.265 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.34 -11.23 26.53 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.244 2.63 . . . . 0.0 115.287 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.2 p -127.5 -25.05 3.23 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.752 1.16 . . . . 0.0 114.0 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -104.79 134.47 47.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.066 0.946 . . . . 0.0 111.103 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -131.2 105.25 7.54 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.155 1.382 . . . . 0.0 108.478 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -65.82 127.56 32.48 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.638 0.775 . . . . 0.0 110.488 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.4 m -137.35 163.64 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.347 1.459 . . . . 0.0 111.352 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.1 m -134.25 119.44 18.76 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.307 1.043 . . . . 0.0 109.013 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.82 128.0 34.12 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.108 0.963 . . . . 0.0 109.961 175.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.99 154.88 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.547 0.739 . . . . 0.0 112.906 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -89.87 -166.94 1.71 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.649 1.18 . . . . 0.0 113.952 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.5 -29.57 70.83 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -83.33 -8.96 59.34 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.001 1.32 . . . . 0.0 112.562 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.15 16.51 80.57 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.182 -1.344 . . . . 0.0 113.729 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.1 m -81.28 150.45 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.568 1.684 . . . . 0.0 111.63 176.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.12 121.94 31.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.641 1.176 . . . . 0.0 111.151 -170.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.7 mt -102.8 -53.58 2.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.37 0.668 . . . . 0.0 111.843 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.76 149.05 20.72 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.795 1.188 . . . . 0.0 114.356 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.4 p -88.29 153.01 21.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.208 1.403 . . . . 0.0 113.152 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.46 171.39 35.26 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.243 1.401 . . . . 0.0 113.628 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.45 120.22 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.0 tpp -85.27 140.15 31.07 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.482 1.113 . . . . 0.0 109.259 170.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -133.32 129.96 38.22 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.119 1.368 . . . . 0.0 108.546 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.88 131.2 55.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.821 2.048 . . . . 0.0 108.471 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 p -133.83 173.36 11.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.847 1.259 . . . . 0.0 110.877 178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -71.91 5.4 2.65 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.079 -1.013 . . . . 0.0 112.776 170.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.8 m -114.73 -45.85 2.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.773 1.229 . . . . 0.0 113.619 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -172.21 169.92 5.31 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.754 1.161 . . . . 0.0 113.449 -169.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.9 mt -87.44 139.96 30.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.356 1.063 . . . . 0.0 109.952 168.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.4 127.6 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.041 0.936 . . . . 0.0 111.496 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 mt -100.06 128.65 46.11 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.233 1.413 . . . . 0.0 110.374 168.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -108.24 129.48 55.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.305 2.242 . . . . 0.0 109.654 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.04 135.04 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.922 1.289 . . . . 0.0 108.119 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -131.63 149.78 52.38 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -166.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -141.82 116.44 6.85 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 124.549 1.14 . . . . 0.0 111.997 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.41 145.1 58.06 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.55 2.167 . . . . 0.0 109.565 170.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -61.6 -21.95 64.8 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.56 -47.64 85.28 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.705 2.002 . . . . 0.0 111.692 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.4 m -80.12 -16.56 54.69 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.13 119.63 11.19 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.939 0.791 . . . . 0.0 110.382 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -82.82 -32.08 27.78 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.356 1.063 . . . . 0.0 112.065 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -168.28 160.68 11.68 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.179 2.192 . . . . 0.0 110.725 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -149.45 116.96 6.14 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.831 1.252 . . . . 0.0 109.667 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.83 165.7 21.56 Favored Glycine 0 N--CA 1.463 0.466 0 C-N-CA 124.836 1.208 . . . . 0.0 113.358 -169.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -141.59 176.74 8.65 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.456 1.102 . . . . 0.0 113.136 -170.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -163.6 -168.01 1.55 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.677 2.391 . . . . 0.0 108.756 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 t -72.21 -19.66 61.69 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.691 -1.256 . . . . 0.0 113.198 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -152.22 8.19 0.47 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.619 1.167 . . . . 0.0 113.893 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -137.11 129.77 30.23 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.425 1.49 . . . . 0.0 110.242 -169.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -124.51 138.01 54.37 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.194 1.797 . . . . 0.0 109.208 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -153.33 152.84 31.56 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.094 -1.004 . . . . 0.0 112.326 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -150.84 153.58 35.65 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.262 1.025 . . . . 0.0 112.312 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -110.8 142.56 42.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.026 1.331 . . . . 0.0 109.379 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 t -129.32 150.55 50.64 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.476 0.71 . . . . 0.0 112.643 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.98 158.57 53.12 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.028 1.299 . . . . 0.0 113.619 -175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -60.99 -20.93 63.04 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -170.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -80.12 -14.38 58.54 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.778 1.769 . . . . 0.0 115.778 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.87 -179.4 5.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -56.46 -47.18 79.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.495 1.518 . . . . 0.0 113.102 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.9 p -81.78 -26.13 34.7 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.52 -163.46 38.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.691 1.138 . . . . 0.0 111.79 -172.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -66.3 128.43 36.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.339 1.056 . . . . 0.0 111.342 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.37 164.2 22.6 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-O 121.557 0.532 . . . . 0.0 114.08 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.6 mt -114.89 136.07 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.493 1.517 . . . . 0.0 108.572 171.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -132.07 127.03 35.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.662 1.185 . . . . 0.0 110.614 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.29 140.88 52.57 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.3 1.44 . . . . 0.0 113.187 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -140.77 128.48 21.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.464 1.106 . . . . 0.0 111.988 -169.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -74.82 135.86 41.62 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.621 0.768 . . . . 0.0 111.738 171.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.5 p -172.33 140.06 1.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.063 2.145 . . . . 0.0 111.473 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.7 m -68.88 -20.28 64.25 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.344 -0.847 . . . . 0.0 113.272 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -100.63 17.88 20.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.989 1.716 . . . . 0.0 112.738 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.18 -39.92 31.21 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.839 1.255 . . . . 0.0 113.779 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -68.25 -37.71 81.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.302 1.041 . . . . 0.0 113.211 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.73 -34.05 76.08 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.149 -0.97 . . . . 0.0 111.911 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.95 -46.07 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.983 -0.448 . . . . 0.0 110.075 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.71 -43.15 94.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.33 1.052 . . . . 0.0 112.023 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -66.48 -37.45 85.13 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.845 1.258 . . . . 0.0 112.556 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.1 tp -80.63 -32.61 36.23 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.914 0.779 . . . . 0.0 112.43 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.6 mt -56.25 -50.42 71.39 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.65 0.659 . . . . 0.0 112.55 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -65.95 -18.79 65.57 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.69 -43.71 16.55 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.425 1.09 . . . . 0.0 110.977 173.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.0 mt -71.55 -28.18 63.68 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.845 -1.159 . . . . 0.0 111.959 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 33.6 mtt . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 167.942 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 39.8 t80 . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.15 109.09 18.64 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.989 0.916 . . . . 0.0 109.909 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 40.0 mt -77.46 154.78 32.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.748 0.819 . . . . 0.0 112.819 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -87.13 -19.02 29.1 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.576 1.55 . . . . 0.0 112.792 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -149.8 167.76 25.61 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.332 1.853 . . . . 0.0 111.751 -175.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -93.22 123.56 60.4 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.627 -0.702 . . . . 0.0 111.389 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.92 -18.03 6.64 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.197 2.598 . . . . 0.0 114.129 -171.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 84.0 m -101.15 115.35 30.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.154 0.982 . . . . 0.0 111.284 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.49 -41.1 45.71 Favored Glycine 0 N--CA 1.476 1.343 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -77.73 113.92 16.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.543 1.537 . . . . 0.0 110.055 169.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.36 151.03 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.737 2.015 . . . . 0.0 110.234 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -131.96 160.35 36.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.72 1.608 . . . . 0.0 111.484 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 124.989 1.316 . . . . 0.0 111.207 -169.165 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 . . . . . 0 CA--C 1.558 1.269 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.1 -14.71 32.02 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.051 2.501 . . . . 0.0 115.421 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.3 p -131.04 -18.74 2.93 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 120.229 1.377 . . . . 0.0 114.516 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -104.68 142.02 35.42 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.192 0.997 . . . . 0.0 110.447 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -141.73 108.32 5.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 145.35 52.0 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.254 -0.904 . . . . 0.0 110.51 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.36 156.7 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.609 0.763 . . . . 0.0 111.5 -172.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -132.95 115.15 14.85 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -65.24 133.52 51.66 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.86 154.46 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.076 0.95 . . . . 0.0 112.431 -176.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -88.01 -167.5 1.9 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.342 1.057 . . . . 0.0 113.599 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.89 -32.35 73.85 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.751 1.221 . . . . 0.0 114.234 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -79.53 -9.08 59.55 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.959 0.799 . . . . 0.0 112.533 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.92 14.5 81.93 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 117.931 -1.483 . . . . 0.0 113.923 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.1 m -76.24 150.11 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.85 1.825 . . . . 0.0 111.338 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.28 125.31 34.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.53 1.132 . . . . 0.0 111.183 -171.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.7 mt -107.4 -52.35 2.78 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.994 0.918 . . . . 0.0 112.107 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.17 147.14 14.96 Favored Glycine 0 N--CA 1.47 0.924 0 C-N-CA 124.591 1.091 . . . . 0.0 113.737 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 p -91.12 150.05 21.55 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.943 1.297 . . . . 0.0 113.104 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.05 168.13 32.38 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.947 1.737 . . . . 0.0 113.006 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.76 120.63 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.8 ttm -93.9 140.95 29.07 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.938 1.295 . . . . 0.0 110.619 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -140.06 130.26 25.12 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.592 1.557 . . . . 0.0 108.935 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -107.91 137.77 45.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.166 1.787 . . . . 0.0 108.016 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.9 p -137.53 174.71 10.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.779 1.232 . . . . 0.0 110.649 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -73.59 3.21 6.55 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.408 -0.807 . . . . 0.0 112.616 171.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.6 m -120.77 -45.04 2.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.532 1.133 . . . . 0.0 113.663 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.96 166.17 11.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.194 1.398 . . . . 0.0 113.706 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.13 136.97 34.26 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.855 1.262 . . . . 0.0 109.34 168.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.6 t -134.4 132.56 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.523 0.729 . . . . 0.0 110.98 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.2 mt -109.65 130.35 55.52 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.151 1.78 . . . . 0.0 110.777 169.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -100.15 125.32 46.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.531 1.933 . . . . 0.0 110.285 169.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 126.921 2.088 . . . . 0.0 111.087 -173.429 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.3 134.53 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.293 0.637 . . . . 0.0 110.464 -174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.44 144.37 48.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.585 1.154 . . . . 0.0 112.022 -169.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -144.29 122.05 6.69 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.877 1.271 . . . . 0.0 111.571 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.26 141.48 39.37 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.042 2.494 . . . . 0.0 110.303 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -58.8 -26.02 63.7 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.43 -41.78 69.78 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.451 1.9 . . . . 0.0 112.852 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.9 p -87.97 -10.69 49.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.9 mt -89.94 69.07 7.43 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.491 1.516 . . . . 0.0 110.775 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -67.67 -23.86 65.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.852 0.861 . . . . 0.0 113.269 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -141.54 119.65 12.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.513 1.525 . . . . 0.0 110.278 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -142.0 109.31 5.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.104 1.762 . . . . 0.0 110.591 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.56 170.26 14.0 Favored Glycine 0 N--CA 1.465 0.601 0 C-N-CA 124.733 1.159 . . . . 0.0 113.612 -169.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -141.61 158.68 43.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.054 0.942 . . . . 0.0 111.67 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.24 -173.89 4.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.136 1.774 . . . . 0.0 109.964 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.4 p -58.16 109.73 0.81 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.944 0.878 . . . . 0.0 111.771 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.261 0.8 OUTLIER 49.36 27.73 2.06 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 127.292 2.237 . . . . 0.0 115.836 -173.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -134.99 130.02 35.08 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.736 1.614 . . . . 0.0 110.564 -172.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -124.45 137.75 54.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.685 1.594 . . . . 0.0 109.852 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 t -153.44 156.7 38.68 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.259 1.024 . . . . 0.0 113.021 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.77 156.69 39.58 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.051 1.34 . . . . 0.0 112.082 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -121.87 137.86 54.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.374 1.87 . . . . 0.0 109.705 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.0 p -145.31 150.5 36.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.201 1.0 . . . . 0.0 112.887 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.84 166.9 49.36 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.863 1.221 . . . . 0.0 114.031 -175.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -63.52 -12.35 31.51 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -171.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -20.17 60.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.335 1.454 . . . . 0.0 114.709 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.55 176.58 8.18 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -57.4 -41.15 79.75 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.979 1.311 . . . . 0.0 113.137 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -91.54 -21.02 21.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.344 1.458 . . . . 0.0 113.884 -173.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.34 -176.56 52.79 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.253 1.406 . . . . 0.0 112.637 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.42 130.74 45.71 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.142 0.977 . . . . 0.0 112.671 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.76 178.91 36.08 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.862 1.22 . . . . 0.0 113.041 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.31 136.69 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.775 1.63 . . . . 0.0 108.834 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -130.57 121.54 25.88 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.735 1.214 . . . . 0.0 110.068 -173.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.36 141.98 50.99 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.54 1.136 . . . . 0.0 112.797 -170.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -141.11 130.62 23.9 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.817 0.847 . . . . 0.0 111.913 -170.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -69.57 131.98 45.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.798 0.839 . . . . 0.0 110.79 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.1 t -170.55 120.21 0.57 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.438 1.895 . . . . 0.0 110.337 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.4 t -71.11 -7.84 49.34 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 121.029 -1.044 . . . . 0.0 113.226 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -101.34 7.69 42.66 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.671 1.988 . . . . 0.0 112.688 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.85 -39.62 54.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.207 1.803 . . . . 0.0 115.592 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -68.48 -34.0 75.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.676 0.671 . . . . 0.0 112.789 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -70.59 -33.74 71.4 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.642 -0.661 . . . . 0.0 111.146 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.33 -47.0 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.59 0.632 . . . . 0.0 110.088 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.05 -43.06 99.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.758 0.823 . . . . 0.0 111.675 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -70.3 -30.58 67.61 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -80.68 -35.71 33.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.703 1.138 . . . . 0.0 111.861 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 mt -54.95 -50.36 69.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.29 0.95 . . . . 0.0 112.341 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -63.53 -24.92 68.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -25.75 47.08 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.32 1.048 . . . . 0.0 112.576 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.54 -30.15 17.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.423 1.089 . . . . 0.0 111.588 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 14.9 mmt . . . . . 0 N--CA 1.475 0.825 0 C-N-CA 125.208 1.403 . . . . 0.0 112.939 168.32 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 31.4 t80 . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -88.39 117.26 27.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.49 1.116 . . . . 0.0 111.309 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 72.2 mt -84.0 156.34 22.32 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.98 0.912 . . . . 0.0 112.27 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -92.34 -5.37 52.32 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.643 1.577 . . . . 0.0 113.423 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -169.41 161.14 9.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.208 2.203 . . . . 0.0 110.977 -169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -89.14 124.72 64.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.534 -173.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.6 -24.13 2.46 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.128 2.552 . . . . 0.0 113.813 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.7 m -83.4 124.23 30.46 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.636 0.775 . . . . 0.0 111.399 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.36 -4.46 89.07 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.342 0.972 . . . . 0.0 114.583 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -138.46 136.91 36.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.746 1.618 . . . . 0.0 110.219 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -162.8 139.73 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.075 1.35 . . . . 0.0 111.197 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -100.67 125.43 47.09 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.627 1.971 . . . . 0.0 108.945 171.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 123.229 0.612 . . . . 0.0 111.395 -179.707 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 CA--C 1.555 1.165 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.74 -12.64 35.12 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.0 2.466 . . . . 0.0 115.199 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.7 p -136.49 -18.39 1.46 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -112.58 148.56 34.29 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.431 1.093 . . . . 0.0 110.002 171.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -143.11 115.88 8.73 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.296 -0.878 . . . . 0.0 110.408 -173.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -71.02 133.93 46.72 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.458 -0.776 . . . . 0.0 110.242 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.44 163.77 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.927 1.291 . . . . 0.0 112.19 -169.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.3 m -134.46 119.77 18.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.426 1.091 . . . . 0.0 108.968 174.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.69 126.62 27.96 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 109.775 174.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.75 153.61 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -91.88 -168.91 2.12 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.2 -22.66 67.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.481 1.512 . . . . 0.0 114.438 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -93.53 -5.84 48.1 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.665 1.186 . . . . 0.0 112.387 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.65 14.83 82.01 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 118.065 -1.408 . . . . 0.0 114.045 -173.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.2 m -81.04 150.99 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.674 1.737 . . . . 0.0 111.55 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.56 122.47 32.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.724 1.21 . . . . 0.0 110.996 -170.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.9 mt -103.65 -54.51 2.56 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.254 0.621 . . . . 0.0 111.86 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.59 146.72 16.98 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.869 1.223 . . . . 0.0 114.476 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 p -94.33 144.64 25.37 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.486 1.515 . . . . 0.0 112.558 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.41 171.68 32.92 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.701 1.143 . . . . 0.0 114.597 -177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.5 t -115.35 121.17 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.663 1.185 . . . . 0.0 108.622 170.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.2 tpp -86.94 135.28 33.35 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.602 1.561 . . . . 0.0 109.933 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -138.85 129.82 26.57 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.564 1.546 . . . . 0.0 109.375 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mp -111.61 134.03 53.46 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.293 1.837 . . . . 0.0 108.247 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -137.12 167.68 21.07 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.949 1.299 . . . . 0.0 110.436 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -68.86 -6.85 29.59 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.449 -0.782 . . . . 0.0 112.68 173.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.9 m -95.74 -46.13 6.72 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.989 0.916 . . . . 0.0 112.832 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -176.02 174.33 2.11 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.704 1.201 . . . . 0.0 113.544 -168.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.8 mt -86.55 140.34 29.98 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.167 1.387 . . . . 0.0 110.035 168.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.57 136.57 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.532 1.133 . . . . 0.0 111.323 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.3 mt -108.94 133.28 53.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.371 1.869 . . . . 0.0 110.648 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -114.01 121.15 43.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.993 2.117 . . . . 0.0 110.377 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.477 0.877 0 C-N-CA 125.605 1.562 . . . . 0.0 111.323 -176.025 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.757 0.313 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 t -128.99 137.0 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.603 0.761 . . . . 0.0 109.941 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 mtp85 -132.36 143.64 49.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.439 1.096 . . . . 0.0 112.388 -167.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -138.9 109.42 7.75 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.691 1.196 . . . . 0.0 111.622 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.5 150.99 83.94 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.914 2.409 . . . . 0.0 112.15 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -65.68 -7.27 14.52 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.58 -35.02 30.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.778 1.631 . . . . 0.0 113.583 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 16.5 p -88.11 -23.91 23.55 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.707 1.139 . . . . 0.0 113.709 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.11 107.25 0.84 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.619 1.568 . . . . 0.0 110.366 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -78.16 -38.33 43.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.35 1.46 . . . . 0.0 112.021 -174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -163.94 156.52 17.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.836 2.055 . . . . 0.0 110.442 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.64 132.05 16.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.387 1.075 . . . . 0.0 109.877 -175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.26 170.75 28.8 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-O 121.996 0.775 . . . . 0.0 114.373 -169.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.92 156.36 49.12 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.606 1.163 . . . . 0.0 112.136 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.05 -176.21 5.67 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.075 1.75 . . . . 0.0 110.107 175.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 t -63.13 114.86 3.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.107 0.956 . . . . 0.0 111.577 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 t30 57.02 18.66 4.11 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.035 2.134 . . . . 0.0 114.495 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.35 126.32 25.97 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.213 -1.554 . . . . 0.0 111.251 -169.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -119.88 138.06 53.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.536 1.535 . . . . 0.0 109.592 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.8 t -153.33 155.01 35.67 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.232 -0.917 . . . . 0.0 112.636 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -146.64 152.29 38.64 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.049 1.34 . . . . 0.0 111.759 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -110.51 143.05 41.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.713 1.605 . . . . 0.0 109.695 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -144.43 154.79 43.32 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.024 0.93 . . . . 0.0 111.983 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.22 176.62 37.38 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.403 1.478 . . . . 0.0 113.855 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -64.96 -8.91 17.72 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -76.81 -17.01 59.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.769 2.028 . . . . 0.0 115.424 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.0 p -85.66 -177.38 6.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.501 1.12 . . . . 0.0 113.961 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -61.53 -42.07 98.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.178 1.391 . . . . 0.0 112.879 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.4 p -93.01 -20.36 20.65 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.302 1.441 . . . . 0.0 114.123 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.45 -174.19 43.04 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.39 1.471 . . . . 0.0 112.7 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -67.63 134.41 51.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.655 0.782 . . . . 0.0 112.617 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.56 -176.37 35.49 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.503 1.049 . . . . 0.0 113.287 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.8 mt -121.26 137.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.799 1.64 . . . . 0.0 109.342 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -127.08 118.53 24.58 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.239 1.416 . . . . 0.0 109.32 -171.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.77 140.05 53.37 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.43 1.092 . . . . 0.0 113.196 -169.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -139.37 127.92 23.05 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.005 -169.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -67.7 129.02 38.62 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 168.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 35.3 t -165.31 126.63 1.99 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 111.103 -171.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.9 t -75.1 -10.22 59.27 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -107.39 18.6 21.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.311 1.845 . . . . 0.0 112.842 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.89 -40.27 79.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -169.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -71.0 -36.99 72.68 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.01 0.924 . . . . 0.0 112.274 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -64.64 -40.74 95.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.246 1.019 . . . . 0.0 110.707 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.0 -46.54 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.353 0.661 . . . . 0.0 110.63 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -39.36 83.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.503 1.121 . . . . 0.0 112.221 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -74.27 -30.88 62.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.256 1.022 . . . . 0.0 113.48 175.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -80.36 -34.96 36.07 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.354 0.979 . . . . 0.0 111.091 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.4 mt -52.44 -56.51 14.58 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.151 0.981 . . . . 0.0 112.897 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -55.65 -34.2 64.76 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.91 -17.03 56.21 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.285 1.434 . . . . 0.0 112.769 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.5 mt -95.24 -37.23 11.11 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.396 1.078 . . . . 0.0 110.917 169.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 57.8 mtp . . . . . 0 N--CA 1.471 0.577 0 C-N-CA 123.874 0.87 . . . . 0.0 112.663 178.445 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 29.1 t80 . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 120.643 0.259 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.03 97.4 5.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.911 1.684 . . . . 0.0 109.801 -173.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 57.7 mt -72.72 156.34 39.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.831 0.852 . . . . 0.0 111.872 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -98.56 -12.06 21.57 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.619 1.568 . . . . 0.0 113.0 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -144.8 149.64 35.8 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.509 1.924 . . . . 0.0 111.073 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -85.79 121.16 73.22 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.498 -0.751 . . . . 0.0 110.981 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.22 -19.88 4.42 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.291 2.661 . . . . 0.0 114.65 -169.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 87.3 m -89.54 124.64 34.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.163 0.892 . . . . 0.0 112.358 -172.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.68 -14.43 81.12 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.103 0.859 . . . . 0.0 114.42 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -115.31 129.39 56.6 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.371 1.468 . . . . 0.0 109.325 170.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 p -158.03 151.36 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.285 1.434 . . . . 0.0 110.921 -169.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -155.76 179.63 9.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.959 1.704 . . . . 0.0 112.442 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 126.185 1.794 . . . . 0.0 109.669 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 . . . . . 0 CA--C 1.558 1.261 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.9 -11.56 25.7 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.109 2.539 . . . . 0.0 115.359 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.5 p -131.35 -21.96 2.53 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 120.355 1.434 . . . . 0.0 114.553 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -102.34 140.9 36.01 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.306 1.042 . . . . 0.0 110.363 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.44 111.72 9.11 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.757 1.223 . . . . 0.0 108.35 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -67.94 133.22 48.73 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.647 -0.658 . . . . 0.0 110.293 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.54 164.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.324 1.449 . . . . 0.0 111.59 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.3 m -139.96 120.78 14.44 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.376 1.07 . . . . 0.0 109.117 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -64.58 131.9 48.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.453 0.701 . . . . 0.0 110.023 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.16 157.52 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.429 1.092 . . . . 0.0 112.389 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.76 -167.05 1.71 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.451 1.1 . . . . 0.0 113.28 176.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.38 -26.58 63.78 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.495 1.118 . . . . 0.0 113.639 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -80.42 -18.12 49.78 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.566 1.146 . . . . 0.0 112.567 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.36 17.94 59.76 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.115 -1.38 . . . . 0.0 114.167 -173.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 m -77.22 150.65 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.841 1.82 . . . . 0.0 111.269 171.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.65 126.73 35.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.839 1.256 . . . . 0.0 110.923 -172.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.5 mt -109.69 -51.21 2.9 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.115 0.966 . . . . 0.0 111.814 -170.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.14 136.38 5.2 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 124.593 1.092 . . . . 0.0 114.08 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 p -84.1 146.29 27.98 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.07 1.348 . . . . 0.0 112.652 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.93 170.06 32.53 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.369 1.462 . . . . 0.0 113.721 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.36 120.22 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.6 ttm -87.6 136.38 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.922 0.889 . . . . 0.0 109.636 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -130.94 129.66 42.46 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.392 1.477 . . . . 0.0 108.67 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.77 116.24 31.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.978 1.711 . . . . 0.0 106.967 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.5 p -114.95 168.0 10.29 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.61 1.164 . . . . 0.0 110.046 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -72.1 -2.4 18.37 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.528 -0.732 . . . . 0.0 112.659 170.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.5 m -96.77 -48.7 5.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.447 1.099 . . . . 0.0 112.51 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -176.31 175.91 1.75 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.016 1.726 . . . . 0.0 112.813 -170.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 mt -84.73 137.87 32.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.302 1.041 . . . . 0.0 110.214 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.01 134.38 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.027 0.931 . . . . 0.0 111.502 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.7 mt -104.08 133.72 48.55 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.894 1.677 . . . . 0.0 109.769 168.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -112.61 129.88 56.22 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.944 2.098 . . . . 0.0 110.899 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 125.748 1.619 . . . . 0.0 111.086 -178.408 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 CA-C-O 120.762 0.315 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.04 130.19 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.815 0.846 . . . . 0.0 110.141 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 mtp85 -126.99 144.39 51.03 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.725 1.21 . . . . 0.0 112.416 -168.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -139.63 116.89 8.45 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.781 1.232 . . . . 0.0 111.581 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -64.13 143.2 83.48 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.714 2.276 . . . . 0.0 110.068 172.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -55.81 -31.66 62.87 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.45 -44.15 76.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.702 2.001 . . . . 0.0 112.752 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.2 p -75.41 -7.93 55.35 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.8 mt -83.17 108.78 16.66 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.152 0.981 . . . . 0.0 110.514 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -74.81 -37.94 62.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.842 0.857 . . . . 0.0 112.125 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -157.84 163.31 38.11 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.587 1.555 . . . . 0.0 110.961 170.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -151.9 141.05 21.3 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.613 1.565 . . . . 0.0 109.074 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.0 177.81 34.56 Favored Glycine 0 N--CA 1.463 0.447 0 CA-C-O 121.484 0.491 . . . . 0.0 113.794 -171.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -143.61 166.11 25.73 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.202 1.001 . . . . 0.0 113.44 -170.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -151.39 -170.52 3.68 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.681 1.992 . . . . 0.0 109.787 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 t -72.94 -13.05 61.17 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.596 -1.315 . . . . 0.0 114.234 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -157.39 5.85 0.14 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.631 1.572 . . . . 0.0 114.25 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.86 132.87 37.16 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.818 1.647 . . . . 0.0 110.451 -168.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -124.48 142.11 51.57 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.428 1.891 . . . . 0.0 109.773 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 t -157.08 161.15 39.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.648 1.179 . . . . 0.0 112.508 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.34 149.34 29.96 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.496 1.518 . . . . 0.0 112.013 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -93.86 139.47 30.85 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.92 1.288 . . . . 0.0 109.456 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.1 p -142.33 148.73 38.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.96 172.54 35.43 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.098 1.332 . . . . 0.0 113.986 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -13.75 54.37 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -174.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -72.81 -16.98 61.61 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.016 1.727 . . . . 0.0 115.653 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 p -83.73 -178.79 7.13 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.373 1.069 . . . . 0.0 113.723 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.2 -41.37 92.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.106 1.362 . . . . 0.0 113.049 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.5 p -91.04 -21.15 21.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.101 1.36 . . . . 0.0 113.876 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.24 -177.72 49.09 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.139 1.352 . . . . 0.0 112.271 -170.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -64.73 137.25 57.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.152 0.981 . . . . 0.0 112.789 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.06 -178.96 35.91 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.263 0.935 . . . . 0.0 113.483 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.3 mt -118.3 133.71 64.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.616 1.566 . . . . 0.0 108.81 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -127.92 124.57 37.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.98 1.312 . . . . 0.0 109.458 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.03 143.92 48.8 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.088 0.955 . . . . 0.0 112.886 -172.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -138.87 128.58 24.81 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.52 1.128 . . . . 0.0 111.36 -169.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -69.85 136.1 50.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.966 0.506 . . . . 0.0 110.667 169.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 23.8 t -163.42 138.95 6.59 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.243 1.417 . . . . 0.0 110.971 -174.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t -74.4 -11.32 60.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -137.3 34.48 2.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.979 1.712 . . . . 0.0 113.776 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.89 -37.86 33.22 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.964 1.306 . . . . 0.0 113.659 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.94 -37.48 81.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.222 1.009 . . . . 0.0 113.141 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.81 -37.78 82.43 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.319 -0.863 . . . . 0.0 110.931 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 77.4 mt -62.43 -46.4 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.156 0.582 . . . . 0.0 110.097 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -38.26 84.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.296 1.038 . . . . 0.0 112.481 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -72.11 -28.38 63.25 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.25 1.02 . . . . 0.0 113.469 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -85.63 -41.95 14.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.078 0.854 . . . . 0.0 110.713 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.2 mt -50.81 -54.48 23.33 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.299 1.04 . . . . 0.0 112.603 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -59.47 -22.46 61.59 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.08 -21.57 36.75 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.725 1.21 . . . . 0.0 112.867 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.1 mt -95.81 -35.34 11.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.097 1.359 . . . . 0.0 112.039 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 66.2 mmm . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 125.49 1.516 . . . . 0.0 112.249 170.945 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 29.0 t80 . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.78 122.98 30.62 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.022 0.929 . . . . 0.0 111.246 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 52.2 mt -90.29 153.13 20.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.6 0.76 . . . . 0.0 112.752 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -88.27 -17.49 30.61 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.613 1.565 . . . . 0.0 113.469 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -156.16 168.64 26.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.269 1.828 . . . . 0.0 111.459 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.89 119.29 70.46 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.706 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.29 -23.69 3.4 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.125 2.55 . . . . 0.0 114.369 -169.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 81.8 m -78.68 126.96 31.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.13 0.877 . . . . 0.0 111.551 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.78 -22.63 63.67 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 124.031 0.824 . . . . 0.0 114.428 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -118.93 126.49 51.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.021 1.328 . . . . 0.0 109.645 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.23 164.42 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.743 1.617 . . . . 0.0 110.835 -172.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -134.25 134.43 41.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.037 1.335 . . . . 0.0 109.69 174.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 124.587 1.155 . . . . 0.0 110.941 -177.088 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 CA--C 1.556 1.188 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.61 -16.75 51.64 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.184 2.589 . . . . 0.0 115.302 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.0 p -125.26 -15.7 6.16 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.916 1.234 . . . . 0.0 114.316 176.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -103.47 125.1 49.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.223 0.92 . . . . 0.0 112.119 172.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.29 106.71 10.94 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.12 1.768 . . . . 0.0 109.092 -176.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -69.2 132.49 46.6 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.618 -0.676 . . . . 0.0 109.982 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 m -140.8 158.95 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.722 1.209 . . . . 0.0 112.245 -169.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -134.18 118.37 17.58 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.679 1.192 . . . . 0.0 108.214 174.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -66.92 131.37 45.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 m -125.53 154.49 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.663 0.785 . . . . 0.0 112.557 -177.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -81.95 -169.6 2.45 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.747 1.219 . . . . 0.0 113.884 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -64.6 -29.13 70.14 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.658 1.583 . . . . 0.0 115.001 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.09 -24.22 20.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.137 0.575 . . . . 0.0 112.026 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.49 14.98 6.63 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 126.109 1.814 . . . . 0.0 112.459 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.57 140.48 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 126.681 1.992 . . . . 0.0 109.43 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.24 125.93 31.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.878 1.671 . . . . 0.0 110.652 -171.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.2 mt -109.88 -53.22 2.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.973 0.909 . . . . 0.0 112.141 -171.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.2 140.33 7.93 Favored Glycine 0 N--CA 1.469 0.848 0 C-N-CA 124.814 1.197 . . . . 0.0 113.574 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 p -92.18 143.64 26.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.194 1.398 . . . . 0.0 112.344 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.1 171.73 34.53 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.312 1.434 . . . . 0.0 113.028 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -118.62 119.47 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.9 tpp -83.16 133.62 35.02 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.144 0.977 . . . . 0.0 109.444 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -126.99 130.54 50.24 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.217 1.407 . . . . 0.0 108.877 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.69 119.17 38.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.329 1.852 . . . . 0.0 107.72 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -122.61 173.68 7.55 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.974 1.309 . . . . 0.0 110.307 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -74.69 2.54 9.71 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.386 -0.821 . . . . 0.0 113.209 172.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.8 p -107.39 -45.93 3.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.897 -1.127 . . . . 0.0 113.473 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -172.78 173.49 3.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.776 1.231 . . . . 0.0 113.09 -174.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -83.67 136.77 34.07 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.511 -0.743 . . . . 0.0 109.523 168.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.9 t -134.74 130.4 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.216 1.006 . . . . 0.0 111.632 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.7 mt -100.19 126.7 46.49 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.442 1.497 . . . . 0.0 110.19 168.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -102.74 133.83 47.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.283 2.233 . . . . 0.0 110.979 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 125.196 1.398 . . . . 0.0 111.322 -177.183 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.054 0.454 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.62 135.52 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.217 1.007 . . . . 0.0 110.226 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -134.24 152.08 51.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.833 0.853 . . . . 0.0 113.222 -173.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -142.1 119.81 7.43 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.293 1.437 . . . . 0.0 111.794 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.22 145.93 68.01 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.957 2.438 . . . . 0.0 110.463 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -60.11 -22.88 63.33 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.8 tp -63.4 -41.61 98.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.659 1.984 . . . . 0.0 113.11 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.4 p -73.32 -14.23 61.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.65 84.57 7.63 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.9 1.28 . . . . 0.0 110.715 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.4 tpp85 -63.22 -30.77 71.85 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.986 0.914 . . . . 0.0 112.503 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.7 ttp-105 -156.0 128.51 7.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.499 1.52 . . . . 0.0 109.834 -170.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -138.92 104.84 5.16 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.535 1.534 . . . . 0.0 111.008 -175.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.18 167.14 12.24 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.088 1.328 . . . . 0.0 113.984 -168.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -144.92 159.0 43.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.248 1.019 . . . . 0.0 112.593 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -151.36 177.52 10.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.1 2.16 . . . . 0.0 109.588 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 m -60.91 -12.22 10.46 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -154.58 11.52 0.38 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.549 1.54 . . . . 0.0 114.248 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.52 131.99 26.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.415 1.486 . . . . 0.0 110.491 -168.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -122.98 133.64 54.36 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.985 1.714 . . . . 0.0 109.016 171.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.3 t -152.6 152.93 32.4 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.131 -0.981 . . . . 0.0 112.052 -174.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -149.71 151.35 33.52 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.351 1.06 . . . . 0.0 111.839 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -104.84 126.59 52.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.606 1.162 . . . . 0.0 109.106 171.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.4 p -124.44 122.58 38.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.449 1.1 . . . . 0.0 111.294 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.25 162.39 40.22 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.816 1.198 . . . . 0.0 114.856 -171.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -57.74 -16.98 12.81 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -23.04 61.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.526 1.53 . . . . 0.0 114.925 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.3 p -73.24 173.43 9.49 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -171.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -54.56 -39.77 68.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.76 1.624 . . . . 0.0 113.341 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -91.06 -20.91 21.55 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.469 1.508 . . . . 0.0 113.874 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.26 175.1 48.9 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.156 1.36 . . . . 0.0 112.169 -170.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -66.31 130.56 43.63 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.848 1.259 . . . . 0.0 111.86 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.54 -179.35 41.55 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.776 1.179 . . . . 0.0 113.13 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.6 mt -116.46 131.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.708 1.603 . . . . 0.0 108.616 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -125.56 121.13 32.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.742 1.217 . . . . 0.0 110.238 -174.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.2 136.36 53.11 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.856 1.263 . . . . 0.0 112.943 -171.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -137.07 129.2 29.47 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.077 0.951 . . . . 0.0 111.717 -170.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -75.63 135.22 40.48 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.639 1.176 . . . . 0.0 111.988 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.6 p -171.0 151.28 3.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.505 1.922 . . . . 0.0 112.146 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.3 m -73.58 -37.31 65.52 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.156 -0.965 . . . . 0.0 112.111 171.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -85.96 20.48 2.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.099 1.36 . . . . 0.0 114.216 -171.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.07 -42.48 50.0 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.159 1.384 . . . . 0.0 114.145 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -69.57 -36.71 76.53 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.795 0.838 . . . . 0.0 112.716 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -68.39 -34.11 75.45 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.464 -0.772 . . . . 0.0 111.743 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.33 -47.65 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 118.678 0.672 . . . . 0.0 109.871 169.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.68 -43.33 94.07 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.658 1.183 . . . . 0.0 112.109 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -67.01 -34.67 78.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.792 1.237 . . . . 0.0 112.841 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -78.7 -41.12 31.91 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.789 0.722 . . . . 0.0 110.367 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.01 -51.46 61.59 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.26 1.024 . . . . 0.0 112.911 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -62.19 -24.12 67.02 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.3 -28.18 56.87 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.662 0.785 . . . . 0.0 112.544 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.25 -35.0 23.71 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.258 1.023 . . . . 0.0 111.199 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.6 mmt . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 123.993 0.917 . . . . 0.0 112.348 169.507 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 21.4 t80 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -91.58 112.5 24.45 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.122 0.969 . . . . 0.0 109.495 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 78.2 mt -78.76 155.26 29.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.531 0.681 . . . . 0.0 112.283 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -91.72 -26.78 18.45 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.079 1.352 . . . . 0.0 113.077 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -140.68 158.61 43.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.418 1.887 . . . . 0.0 111.663 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -84.3 128.45 62.01 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.434 0.694 . . . . 0.0 112.008 -172.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -86.1 -10.97 6.64 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.431 2.754 . . . . 0.0 114.475 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 90.0 m -102.27 126.31 49.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.306 1.043 . . . . 0.0 111.511 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.49 -31.19 34.27 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.11 0.862 . . . . 0.0 114.2 -176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -108.35 131.32 54.87 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.842 1.257 . . . . 0.0 110.494 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.18 140.61 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.638 1.175 . . . . 0.0 111.885 -173.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -102.49 147.65 26.49 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.571 2.348 . . . . 0.0 111.716 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 125.01 1.324 . . . . 0.0 109.125 175.541 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.07 -8.74 22.72 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.114 2.542 . . . . 0.0 114.933 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.0 p -129.89 -17.36 3.56 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 174.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 131.84 56.59 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.468 1.107 . . . . 0.0 111.796 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -127.46 113.13 15.77 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.907 1.283 . . . . 0.0 108.748 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -69.84 131.77 44.99 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.507 -0.746 . . . . 0.0 110.326 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.09 165.41 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.814 1.645 . . . . 0.0 111.795 -169.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.3 m -134.27 122.78 23.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.507 1.123 . . . . 0.0 109.087 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.4 127.83 33.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.291 1.037 . . . . 0.0 109.797 174.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.64 155.97 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.494 0.718 . . . . 0.0 112.707 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.12 -167.85 2.02 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.608 1.163 . . . . 0.0 113.6 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.91 -30.3 71.43 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.944 1.298 . . . . 0.0 114.335 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -84.09 -10.38 57.86 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.944 0.793 . . . . 0.0 113.072 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.85 16.47 75.02 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.365 -1.242 . . . . 0.0 113.953 -172.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.4 m -78.25 149.89 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.599 1.699 . . . . 0.0 111.202 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -89.52 122.56 32.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.922 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.3 mt -103.41 -51.7 3.16 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.602 0.761 . . . . 0.0 111.68 -174.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.93 144.76 12.16 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 124.874 1.226 . . . . 0.0 114.277 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.3 p -89.8 150.36 22.29 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.08 1.352 . . . . 0.0 112.55 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.4 171.06 37.32 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 124.147 0.88 . . . . 0.0 115.094 -174.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -114.79 120.54 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 58.0 tpp -86.59 133.1 33.74 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.929 0.891 . . . . 0.0 109.118 170.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -130.14 130.17 44.43 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.034 1.334 . . . . 0.0 109.008 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.75 115.04 29.42 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.312 1.845 . . . . 0.0 107.004 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 p -110.57 174.55 5.81 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.237 1.015 . . . . 0.0 109.869 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -75.88 13.76 0.79 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 121.244 -0.91 . . . . 0.0 112.186 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.4 t -125.74 -41.51 1.98 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.557 1.543 . . . . 0.0 112.626 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -170.43 171.06 6.72 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.144 -0.972 . . . . 0.0 113.442 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.3 mt -87.36 133.88 33.65 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 165.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 t -133.36 134.2 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.797 0.839 . . . . 0.0 111.177 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.2 mt -101.03 129.36 46.86 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 124.461 1.104 . . . . 0.0 109.836 168.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -109.98 118.74 37.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.429 1.892 . . . . 0.0 109.734 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 N--CA 1.471 0.602 0 C-N-CA 124.824 1.249 . . . . 0.0 110.329 -175.089 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.427 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 t -134.94 131.63 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.154 0.582 . . . . 0.0 110.961 -168.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -121.71 142.07 50.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.478 1.511 . . . . 0.0 112.118 -169.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -138.16 112.14 8.69 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.912 1.285 . . . . 0.0 110.703 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.19 146.69 82.23 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.489 2.126 . . . . 0.0 110.475 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -57.79 -28.13 63.73 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 mt -65.35 -25.23 67.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.762 1.625 . . . . 0.0 114.131 173.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.4 p -93.25 -8.17 43.0 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -79.48 115.2 18.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.885 0.874 . . . . 0.0 109.958 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -76.26 -37.91 56.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.361 0.665 . . . . 0.0 111.698 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -161.19 163.24 31.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.663 1.585 . . . . 0.0 111.947 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -150.44 138.03 19.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.368 1.867 . . . . 0.0 109.012 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -145.17 -178.94 21.13 Favored Glycine 0 N--CA 1.461 0.353 0 C-N-CA 123.859 0.742 . . . . 0.0 113.052 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -152.11 166.23 32.29 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.031 0.932 . . . . 0.0 112.916 -174.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -157.19 -178.41 7.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.309 2.244 . . . . 0.0 109.319 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.2 p -63.6 -21.65 66.47 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -152.68 10.65 0.49 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -133.65 127.7 33.52 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.747 -1.221 . . . . 0.0 110.463 -172.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -118.85 135.7 54.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.902 1.681 . . . . 0.0 109.678 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -153.75 156.67 38.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.656 1.182 . . . . 0.0 112.676 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -149.08 151.96 35.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.031 1.733 . . . . 0.0 111.518 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -111.68 132.84 54.33 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.024 1.33 . . . . 0.0 111.139 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m -132.89 147.85 52.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.765 1.226 . . . . 0.0 112.368 -172.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.65 174.51 41.31 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.787 1.184 . . . . 0.0 114.387 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -11.97 18.16 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -87.93 -15.45 36.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -174.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.7 p -80.08 179.21 7.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.949 0.899 . . . . 0.0 112.901 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -57.71 -37.88 74.26 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.843 1.257 . . . . 0.0 113.336 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.9 p -95.13 -20.88 18.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.426 1.49 . . . . 0.0 114.082 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.89 -167.46 42.12 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.371 1.462 . . . . 0.0 112.586 -173.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -67.08 132.28 47.53 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.62 0.768 . . . . 0.0 112.118 -173.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.05 -175.58 35.24 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 122.506 1.059 . . . . 0.0 113.454 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.8 mt -124.22 139.19 51.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 126.009 1.724 . . . . 0.0 108.432 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.11 127.72 36.62 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.842 1.257 . . . . 0.0 109.859 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.04 145.59 50.94 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.322 1.049 . . . . 0.0 113.594 -169.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -139.88 128.03 22.41 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.337 -168.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -66.38 127.68 33.22 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 43.8 t -164.92 114.85 1.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.189 1.396 . . . . 0.0 111.377 -167.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 m -71.19 -2.15 14.96 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -133.34 22.12 4.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.443 2.297 . . . . 0.0 112.427 -170.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.63 -36.07 33.52 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.388 1.475 . . . . 0.0 113.841 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -67.86 -37.87 82.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.639 0.775 . . . . 0.0 112.762 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.47 -33.68 73.24 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.434 -0.791 . . . . 0.0 111.665 175.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.79 -47.53 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.782 -0.574 . . . . 0.0 110.163 169.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.29 -42.9 87.64 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.025 1.33 . . . . 0.0 111.808 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -66.31 -33.22 75.24 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.738 1.215 . . . . 0.0 113.044 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.41 -42.52 20.28 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.082 0.855 . . . . 0.0 110.282 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.7 mt -49.69 -54.49 18.42 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.152 0.981 . . . . 0.0 112.273 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -59.48 -28.76 67.31 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -19.44 61.21 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.918 1.287 . . . . 0.0 113.045 175.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.1 mt -95.36 -35.83 11.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.434 1.493 . . . . 0.0 111.025 173.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 47.9 mmm . . . . . 0 N--CA 1.469 0.499 0 C-N-CA 124.617 1.167 . . . . 0.0 111.962 177.102 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 33.5 t80 . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 120.332 0.111 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.72 124.76 28.16 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.579 1.151 . . . . 0.0 111.269 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 64.6 mt -94.47 154.13 17.58 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.007 0.923 . . . . 0.0 112.662 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -84.07 -21.2 31.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.447 1.499 . . . . 0.0 113.367 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -153.66 166.03 34.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.088 1.755 . . . . 0.0 111.751 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -87.9 118.53 69.79 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.223 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.0 -16.24 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.541 2.827 . . . . 0.0 114.076 -170.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 82.2 m -89.43 123.63 33.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.866 0.867 . . . . 0.0 110.749 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.06 -35.19 35.29 Favored Glycine 0 N--CA 1.473 1.128 0 C-N-CA 123.836 0.732 . . . . 0.0 113.043 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -97.05 120.31 37.17 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.55 1.14 . . . . 0.0 109.72 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.06 160.97 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.792 1.637 . . . . 0.0 110.447 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -122.14 124.89 44.94 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.537 1.135 . . . . 0.0 109.103 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 123.965 0.906 . . . . 0.0 110.709 179.683 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 . . . . . 0 CA--C 1.56 1.349 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.0 -20.19 29.29 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.062 2.508 . . . . 0.0 115.668 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.3 p -126.14 -22.18 4.14 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.296 1.407 . . . . 0.0 114.303 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -97.11 144.74 26.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.231 1.012 . . . . 0.0 110.279 169.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -140.1 119.0 12.53 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.286 1.435 . . . . 0.0 108.207 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.44 135.24 45.71 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.382 -0.823 . . . . 0.0 109.932 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.83 169.34 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.966 1.306 . . . . 0.0 111.287 -171.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 m -142.67 122.39 13.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.67 1.188 . . . . 0.0 107.849 172.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -68.9 134.14 49.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.364 0.666 . . . . 0.0 110.462 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.71 155.87 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.521 1.128 . . . . 0.0 113.816 -173.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -84.62 -170.17 2.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -63.41 -21.62 66.4 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.689 1.596 . . . . 0.0 115.112 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.34 -0.5 32.63 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.323 1.449 . . . . 0.0 112.403 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.94 14.57 77.09 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.0 -1.444 . . . . 0.0 114.389 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -73.58 144.87 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.901 1.85 . . . . 0.0 110.674 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -87.27 120.87 29.0 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.796 1.238 . . . . 0.0 110.143 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.9 mt -105.75 -52.68 2.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.721 0.809 . . . . 0.0 112.048 -169.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.14 137.16 5.78 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.185 1.374 . . . . 0.0 111.958 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.7 t -83.69 149.43 26.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.941 0.876 . . . . 0.0 111.555 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.54 167.44 27.55 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 125.991 1.758 . . . . 0.0 113.378 -172.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.1 t -120.43 120.24 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.9 ttm -97.13 143.03 28.34 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.152 1.381 . . . . 0.0 109.388 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -145.4 126.53 14.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.835 1.254 . . . . 0.0 109.695 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.48 132.17 54.68 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.123 1.369 . . . . 0.0 108.688 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.7 p -135.31 171.09 14.94 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.937 1.295 . . . . 0.0 110.385 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -68.32 0.05 4.28 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 170.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t -103.2 -52.18 3.08 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.596 1.089 . . . . 0.0 112.399 178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.18 173.1 2.65 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.724 1.21 . . . . 0.0 112.844 -170.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.18 118.44 25.63 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.06 1.344 . . . . 0.0 110.38 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.8 t -109.77 140.03 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.864 1.266 . . . . 0.0 109.178 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -139.69 124.9 18.87 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.513 1.525 . . . . 0.0 109.84 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -115.48 137.26 52.24 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.561 1.944 . . . . 0.0 110.417 -172.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.475 0.786 0 C-N-CA 124.842 1.257 . . . . 0.0 112.617 -170.087 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 120.672 0.272 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.08 130.82 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.198 1.399 . . . . 0.0 109.881 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.98 141.28 52.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.637 1.175 . . . . 0.0 111.406 -171.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -134.91 112.81 11.48 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.702 1.201 . . . . 0.0 111.587 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.21 138.3 42.82 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.991 2.46 . . . . 0.0 110.755 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -60.21 -28.47 68.01 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -65.85 -35.27 80.2 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 0.0 112.453 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.0 m -92.22 3.27 55.69 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.57 120.52 24.63 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.964 0.905 . . . . 0.0 109.053 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -83.2 -23.31 32.89 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.0 ttp-105 -176.24 140.51 0.39 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.909 2.084 . . . . 0.0 109.478 -169.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -144.89 106.46 4.24 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.214 1.405 . . . . 0.0 111.54 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.14 165.16 12.01 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 126.231 1.872 . . . . 0.0 113.522 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -150.85 154.08 36.57 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.7 1.2 . . . . 0.0 113.218 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -144.97 -168.99 3.08 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.855 1.662 . . . . 0.0 110.064 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 t -68.75 -11.67 60.59 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -158.19 10.87 0.17 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.926 1.69 . . . . 0.0 114.225 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -140.61 133.24 28.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.614 1.566 . . . . 0.0 110.549 -168.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -126.29 138.43 53.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.93 1.692 . . . . 0.0 109.18 172.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -153.06 152.95 31.92 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.888 -1.133 . . . . 0.0 112.277 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -153.69 158.11 40.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.045 0.938 . . . . 0.0 112.545 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -115.07 135.2 54.46 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.723 1.609 . . . . 0.0 111.231 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 62.6 p -120.31 152.46 37.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.233 1.413 . . . . 0.0 112.905 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.44 164.44 31.87 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.984 1.278 . . . . 0.0 113.27 176.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -66.07 -9.26 29.18 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -171.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -84.83 -11.49 55.57 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.566 1.946 . . . . 0.0 115.231 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.3 m -68.01 173.5 4.52 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.841 1.256 . . . . 0.0 112.965 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -57.25 -40.74 78.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 112.285 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.3 p -90.03 -23.01 21.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.442 1.497 . . . . 0.0 113.161 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.29 -146.74 27.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.992 1.282 . . . . 0.0 111.612 -171.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -75.23 141.37 43.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.254 1.022 . . . . 0.0 112.206 -175.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.79 171.02 23.25 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.295 0.95 . . . . 0.0 113.245 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.33 133.33 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.391 1.476 . . . . 0.0 108.346 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -130.39 123.81 30.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.496 1.118 . . . . 0.0 110.606 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.03 139.96 49.75 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.638 1.175 . . . . 0.0 112.368 -175.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -136.84 124.11 21.86 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.787 1.235 . . . . 0.0 111.258 -172.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -70.0 133.87 47.7 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.245 0.618 . . . . 0.0 110.791 169.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 36.7 t -166.49 130.64 2.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.123 1.769 . . . . 0.0 110.517 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.5 t -66.97 -26.5 66.85 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.614 -0.678 . . . . 0.0 112.812 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -109.32 29.21 7.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.206 1.802 . . . . 0.0 113.226 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.16 -35.49 26.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.064 1.346 . . . . 0.0 114.185 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -70.24 -37.97 75.08 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.767 0.827 . . . . 0.0 113.024 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -65.94 -36.83 84.42 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.387 -0.821 . . . . 0.0 111.424 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.91 -48.94 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.915 0.486 . . . . 0.0 110.124 171.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -38.42 86.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.265 1.026 . . . . 0.0 112.93 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.36 -35.46 65.96 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.743 0.817 . . . . 0.0 112.427 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -76.18 -34.53 59.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.074 0.852 . . . . 0.0 112.008 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.7 mt -54.64 -59.61 4.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.156 0.889 . . . . 0.0 111.45 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -60.8 -24.49 65.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -29.4 64.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.977 0.911 . . . . 0.0 113.374 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.6 mt -96.32 -35.5 11.2 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.384 1.473 . . . . 0.0 111.434 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.5 mtp . . . . . 0 N--CA 1.469 0.5 0 C-N-CA 125.339 1.456 . . . . 0.0 112.594 179.074 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 31.2 t80 . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 110.954 -0.017 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -87.15 116.84 25.5 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.334 1.054 . . . . 0.0 111.169 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 32.9 mt -81.74 159.42 23.87 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.632 0.773 . . . . 0.0 112.711 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -100.66 -12.13 19.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.526 1.53 . . . . 0.0 113.614 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -163.11 167.14 22.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.087 2.155 . . . . 0.0 110.906 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -84.8 126.49 68.23 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.874 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.15 -2.37 11.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.836 3.024 . . . . 0.0 113.956 -174.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 22.2 t -115.0 135.51 54.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.052 1.341 . . . . 0.0 112.088 -171.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.55 -5.81 56.68 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.485 1.517 . . . . 0.0 115.656 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -137.07 111.73 8.73 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.043 1.422 . . . . 0.0 110.278 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.75 138.18 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -168.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -99.3 117.24 33.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.875 2.07 . . . . 0.0 109.921 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 123.709 0.804 . . . . 0.0 110.466 174.465 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 CA--C 1.559 1.312 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.13 -21.58 23.6 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.723 2.282 . . . . 0.0 115.111 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.0 p -126.03 -20.83 4.46 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 120.691 1.587 . . . . 0.0 114.265 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -97.32 146.41 25.18 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.97 0.908 . . . . 0.0 109.145 168.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -141.6 113.5 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -67.85 134.4 50.83 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.565 -0.709 . . . . 0.0 110.12 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.28 164.44 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.82 1.248 . . . . 0.0 111.616 -171.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.4 m -139.97 123.08 16.8 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.502 1.121 . . . . 0.0 108.59 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -65.58 130.46 43.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.301 0.641 . . . . 0.0 109.722 175.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.32 156.46 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.327 1.051 . . . . 0.0 112.235 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -85.15 -166.37 1.48 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.52 1.128 . . . . 0.0 113.126 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.11 -26.14 63.83 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.543 1.137 . . . . 0.0 113.695 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.51 -18.6 44.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.761 1.224 . . . . 0.0 112.591 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.06 17.39 59.43 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.021 1.296 . . . . 0.0 114.295 -173.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -76.77 150.25 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.68 1.74 . . . . 0.0 111.183 171.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -88.26 125.78 34.83 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.657 1.183 . . . . 0.0 110.849 -172.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -108.15 -49.57 3.18 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.184 0.994 . . . . 0.0 111.767 -171.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.57 137.21 5.56 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.919 1.247 . . . . 0.0 113.654 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.0 p -84.03 148.87 26.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.755 1.222 . . . . 0.0 112.356 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.06 170.82 34.95 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.794 1.188 . . . . 0.0 114.637 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.19 120.57 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.7 tpp -84.91 141.3 30.48 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.661 1.184 . . . . 0.0 109.576 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -140.26 130.31 24.85 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.071 1.348 . . . . 0.0 109.494 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.95 133.73 47.58 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.093 1.757 . . . . 0.0 108.133 175.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -133.89 173.87 11.08 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.091 1.357 . . . . 0.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -78.45 6.08 9.29 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.435 -0.791 . . . . 0.0 112.577 169.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.6 t -107.4 -49.31 3.28 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.537 1.135 . . . . 0.0 112.268 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -174.27 172.45 3.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.563 1.545 . . . . 0.0 112.484 -169.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.6 mt -85.04 139.79 31.5 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.17 0.988 . . . . 0.0 109.215 168.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.5 t -134.44 130.95 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.051 0.94 . . . . 0.0 111.217 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 mt -103.76 130.53 51.29 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.654 1.581 . . . . 0.0 110.026 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -111.42 124.09 51.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.868 2.067 . . . . 0.0 110.177 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 125.194 1.398 . . . . 0.0 111.838 -179.351 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.721 0 CA-C-O 120.549 0.214 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 t -138.0 143.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.615 1.166 . . . . 0.0 109.842 -170.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.83 153.4 52.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.725 0.81 . . . . 0.0 113.003 -169.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -142.85 115.31 6.07 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.922 1.289 . . . . 0.0 111.348 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.02 150.26 66.36 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.628 2.219 . . . . 0.0 110.468 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -61.59 -22.98 65.69 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -38.84 92.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.112 1.765 . . . . 0.0 112.605 171.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.2 m -90.2 -9.56 47.65 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -69.43 127.94 34.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.572 0.749 . . . . 0.0 109.393 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -96.86 -26.8 14.96 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.574 0.75 . . . . 0.0 112.83 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -164.09 158.68 19.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.797 1.639 . . . . 0.0 111.454 169.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -144.84 107.96 4.55 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.773 1.229 . . . . 0.0 110.502 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.28 174.74 16.01 Favored Glycine 0 N--CA 1.463 0.478 0 C-N-CA 124.092 0.853 . . . . 0.0 113.531 -169.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -144.49 155.93 43.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.118 0.967 . . . . 0.0 111.384 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.37 -178.76 6.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.34 1.456 . . . . 0.0 110.532 171.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 t -62.59 120.44 11.15 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.359 -0.838 . . . . 0.0 110.774 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.33 15.16 0.62 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.81 2.444 . . . . 0.0 116.561 -174.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.11 126.25 26.26 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.893 1.277 . . . . 0.0 111.627 -169.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -118.13 134.42 55.01 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.693 1.597 . . . . 0.0 110.063 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.5 t -153.46 154.91 35.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.532 1.133 . . . . 0.0 112.385 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -148.69 150.61 33.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.423 1.489 . . . . 0.0 111.298 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -112.78 130.32 56.12 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.997 1.319 . . . . 0.0 109.747 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m -130.87 136.02 48.25 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.501 1.12 . . . . 0.0 110.594 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.74 175.54 51.73 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 123.783 0.706 . . . . 0.0 113.225 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -16.0 7.2 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -74.01 -18.38 60.86 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.028 2.531 . . . . 0.0 115.883 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.5 p -80.21 178.84 7.99 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -61.1 -44.4 97.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.832 1.253 . . . . 0.0 113.019 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.3 p -90.39 -18.81 24.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.73 1.212 . . . . 0.0 114.093 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.07 179.79 36.97 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.609 1.576 . . . . 0.0 112.391 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -66.94 126.51 29.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.273 0.629 . . . . 0.0 111.941 -169.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.85 178.42 40.34 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 122.448 1.026 . . . . 0.0 114.264 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.3 mt -116.1 133.74 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.968 1.707 . . . . 0.0 108.542 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -126.31 123.51 38.22 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.136 1.374 . . . . 0.0 109.627 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.1 143.01 50.71 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.297 1.046 . . . . 0.0 113.317 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -140.82 129.8 23.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.555 -169.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -68.07 131.26 45.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.81 0.444 . . . . 0.0 109.946 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 45.9 t -160.38 131.35 5.62 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.217 1.407 . . . . 0.0 111.377 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.8 t -71.32 -21.98 61.99 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -122.04 30.3 6.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.236 1.814 . . . . 0.0 113.4 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.66 -42.59 56.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.16 -36.64 77.62 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.248 0.619 . . . . 0.0 112.537 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.6 -35.77 80.99 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.602 -0.686 . . . . 0.0 111.588 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.8 mt -63.64 -47.73 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.534 0.606 . . . . 0.0 110.163 170.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.3 -38.47 77.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.333 1.053 . . . . 0.0 112.332 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -74.31 -29.0 61.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.237 1.415 . . . . 0.0 113.529 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 tt -84.22 -40.03 18.59 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.298 0.954 . . . . 0.0 110.464 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.8 mt -53.01 -54.01 41.53 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.737 0.815 . . . . 0.0 112.286 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -60.09 -25.08 65.14 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -20.37 53.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.96 1.304 . . . . 0.0 113.05 175.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.9 mt -91.59 -38.93 12.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.128 1.371 . . . . 0.0 110.873 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 60.6 mmm . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 124.842 1.257 . . . . 0.0 112.421 -179.547 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 23.6 t80 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 110.767 -0.086 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.26 127.35 46.57 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.189 1.396 . . . . 0.0 111.327 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 44.7 mt -93.58 153.62 18.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -80.48 -36.7 33.05 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.818 1.647 . . . . 0.0 112.598 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -138.99 160.98 38.47 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.492 1.917 . . . . 0.0 111.764 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -78.61 121.33 83.48 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.9 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -84.28 -15.0 6.74 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.227 2.618 . . . . 0.0 113.833 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 85.6 m -90.79 116.87 28.97 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.95 0.9 . . . . 0.0 110.882 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.73 -16.28 80.75 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.91 0.767 . . . . 0.0 114.022 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -120.96 133.6 55.28 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.836 1.654 . . . . 0.0 109.507 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -162.1 145.49 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.945 1.298 . . . . 0.0 111.475 -169.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -111.76 130.52 55.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.045 1.738 . . . . 0.0 109.393 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 CA--C 1.542 0.639 0 C-N-CA 124.513 1.125 . . . . 0.0 110.818 -178.84 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 . . . . . 0 CA--C 1.56 1.35 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.49 -14.98 47.64 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.073 2.515 . . . . 0.0 115.529 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.7 p -125.6 -19.13 5.04 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.043 1.292 . . . . 0.0 114.432 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.71 144.02 44.55 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.377 1.071 . . . . 0.0 112.682 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -139.8 120.88 14.69 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.097 1.359 . . . . 0.0 108.973 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -72.57 134.02 45.0 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.462 -0.774 . . . . 0.0 110.207 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.43 163.62 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.796 1.239 . . . . 0.0 111.572 -170.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.8 m -138.66 118.68 13.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.301 1.041 . . . . 0.0 109.576 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -64.68 131.22 46.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.484 0.714 . . . . 0.0 110.491 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.46 157.69 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 113.054 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.01 -168.95 2.38 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.97 -28.6 69.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.044 1.738 . . . . 0.0 114.037 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -87.24 -13.38 43.99 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.257 1.023 . . . . 0.0 113.143 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.61 15.94 67.16 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.137 -1.368 . . . . 0.0 114.255 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 m -76.89 150.41 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.947 1.874 . . . . 0.0 111.181 173.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -87.56 124.98 34.06 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.451 1.1 . . . . 0.0 111.303 -171.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 mt -108.3 -52.41 2.77 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.741 0.817 . . . . 0.0 112.038 -172.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.71 136.52 5.65 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 124.46 1.028 . . . . 0.0 114.339 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.0 p -85.71 139.38 31.4 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.038 1.335 . . . . 0.0 112.291 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.61 170.52 24.74 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.376 1.941 . . . . 0.0 112.986 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.4 t -116.71 120.25 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.7 ttm -92.54 118.6 31.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.057 1.343 . . . . 0.0 109.775 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -109.23 130.14 55.49 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.911 1.684 . . . . 0.0 108.969 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.9 122.02 45.59 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.77 1.628 . . . . 0.0 107.164 174.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.4 p -114.57 173.59 6.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.549 1.14 . . . . 0.0 109.762 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -70.17 -3.38 16.55 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.415 -0.803 . . . . 0.0 112.904 173.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -120.23 -35.24 3.49 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -167.29 163.79 15.3 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.086 -1.009 . . . . 0.0 113.331 -169.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -87.43 136.35 32.97 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.37 1.468 . . . . 0.0 109.524 168.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.69 126.34 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.758 0.823 . . . . 0.0 110.853 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.9 mt -100.89 130.05 46.84 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.883 1.273 . . . . 0.0 110.298 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -101.59 122.3 43.59 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.997 1.719 . . . . 0.0 111.31 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 CA--C 1.545 0.755 0 C-N-CA 127.69 2.396 . . . . 0.0 110.692 -176.269 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -108.46 126.68 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -169.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -127.66 141.44 51.61 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -166.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -140.95 116.25 7.35 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.839 1.256 . . . . 0.0 111.168 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.87 144.96 66.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.036 1.824 . . . . 0.0 108.878 169.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -58.1 -29.98 65.91 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.04 -41.32 78.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.073 1.749 . . . . 0.0 112.283 175.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.9 m -86.48 4.62 38.97 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.4 mt -85.4 118.34 24.88 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.416 1.007 . . . . 0.0 109.487 171.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -75.43 -34.86 61.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.026 0.53 . . . . 0.0 111.781 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -165.92 158.4 14.83 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.011 2.125 . . . . 0.0 111.206 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -145.67 107.84 4.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.222 1.409 . . . . 0.0 112.045 -174.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -117.27 161.72 13.08 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.879 1.704 . . . . 0.0 114.172 -169.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -148.01 152.8 38.07 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.129 1.372 . . . . 0.0 113.109 -170.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -145.95 -179.14 6.5 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.387 1.875 . . . . 0.0 109.815 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 m -61.45 -12.7 15.76 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -154.13 10.0 0.38 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.406 1.482 . . . . 0.0 114.67 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -139.94 133.92 30.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.704 1.601 . . . . 0.0 110.633 -168.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -126.84 137.33 53.17 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.81 1.644 . . . . 0.0 110.013 172.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.1 t -153.47 158.16 40.94 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.444 1.098 . . . . 0.0 112.871 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -158.03 156.1 30.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.088 1.355 . . . . 0.0 112.938 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.47 139.77 32.08 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.421 1.489 . . . . 0.0 110.166 170.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.7 p -122.33 151.32 41.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.589 1.156 . . . . 0.0 112.718 169.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.43 164.28 26.79 Favored Glycine 0 N--CA 1.477 1.4 0 C-N-CA 125.228 1.394 . . . . 0.0 114.044 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -20.51 65.03 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -170.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 -82.52 -15.32 52.81 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.2 p -82.05 179.4 7.83 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -59.52 -44.28 93.21 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.686 1.594 . . . . 0.0 112.872 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.0 p -82.8 -29.14 29.76 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.55 -155.1 33.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.446 1.498 . . . . 0.0 112.157 -172.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -63.2 137.67 58.29 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.826 0.85 . . . . 0.0 112.363 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.66 165.55 18.74 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.217 0.913 . . . . 0.0 113.117 169.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.35 128.63 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.882 1.273 . . . . 0.0 107.756 168.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -127.18 122.92 35.43 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.59 1.156 . . . . 0.0 109.374 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.22 140.84 48.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.313 1.045 . . . . 0.0 112.132 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -133.44 122.02 23.1 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.503 1.121 . . . . 0.0 110.953 -171.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -71.46 132.93 45.47 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.4 0.68 . . . . 0.0 110.974 170.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 25.0 p -169.3 140.72 2.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.006 1.723 . . . . 0.0 111.448 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.4 m -83.09 4.83 24.66 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -133.18 25.85 4.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.158 1.383 . . . . 0.0 113.748 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.19 -37.71 23.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.599 1.559 . . . . 0.0 114.122 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.71 -36.47 80.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.0 0.92 . . . . 0.0 112.984 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.68 -32.54 71.21 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.236 0.925 . . . . 0.0 111.863 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.59 -48.01 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 122.976 0.51 . . . . 0.0 109.658 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -37.78 83.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.401 1.081 . . . . 0.0 112.721 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -68.75 -33.43 73.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.486 1.114 . . . . 0.0 112.478 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.0 tp -84.63 -37.49 21.01 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.961 0.8 . . . . 0.0 112.168 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.76 -56.35 14.39 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.143 0.883 . . . . 0.0 112.211 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -59.75 -23.57 63.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -24.7 45.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.627 1.171 . . . . 0.0 113.042 176.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.4 mt -98.05 -34.5 10.76 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.806 1.642 . . . . 0.0 111.686 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 96.8 mtp . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 125.236 1.415 . . . . 0.0 113.034 176.468 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.8 t80 . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.33 121.53 25.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.157 0.583 . . . . 0.0 111.251 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 78.6 mt -86.46 155.19 20.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -84.71 -13.96 49.8 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.637 1.575 . . . . 0.0 113.506 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -163.35 169.21 19.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.527 2.331 . . . . 0.0 110.706 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -86.19 120.52 72.42 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.01 -9.23 17.97 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.488 2.792 . . . . 0.0 114.209 -172.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 44.7 t -92.03 -74.27 0.52 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.056 0.942 . . . . 0.0 113.13 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.02 -41.7 3.04 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.774 1.654 . . . . 0.0 114.066 -172.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -81.47 91.87 6.38 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.544 1.172 . . . . 0.0 109.997 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.41 139.88 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -100.06 141.77 32.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.138 2.175 . . . . 0.0 111.108 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 124.618 1.167 . . . . 0.0 111.273 -177.258 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.475 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -165.49 175.3 9.13 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.044 1.738 . . . . 0.0 110.671 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.6 p -164.14 168.45 18.99 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.205 1.402 . . . . 0.0 112.841 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.45 143.04 5.8 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.443 1.497 . . . . 0.0 112.783 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -154.28 157.3 38.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.239 1.816 . . . . 0.0 110.537 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 m -159.96 146.64 16.11 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.344 1.458 . . . . 0.0 111.32 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.77 36.63 2.48 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 125.303 1.43 . . . . 0.0 113.938 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.6 mt -103.1 136.59 42.61 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.592 1.557 . . . . 0.0 111.17 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -71.05 165.04 24.34 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.134 0.974 . . . . 0.0 111.905 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -128.23 118.15 22.8 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.811 1.245 . . . . 0.0 109.466 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.88 -20.21 53.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.012 1.325 . . . . 0.0 113.44 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.5 p -169.43 162.33 10.18 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.979 2.112 . . . . 0.0 110.045 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.457 HG12 ' HE2' ' A' ' 22' ' ' LYS . 10.7 p -96.81 127.8 37.99 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.911 0.885 . . . . 0.0 109.89 175.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.05 166.53 20.8 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.028 2.485 . . . . 0.0 111.701 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.79 -6.89 29.45 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.958 1.303 . . . . 0.0 113.582 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.0 p30 -131.1 18.6 4.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.596 1.558 . . . . 0.0 114.802 -170.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -58.13 145.48 73.3 Favored Pre-proline 0 CA--C 1.558 1.279 0 O-C-N 121.143 -0.973 . . . . 0.0 112.747 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.73 -11.91 28.33 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.08 2.52 . . . . 0.0 115.478 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 51.5 p -131.87 -16.42 2.92 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 120.155 1.343 . . . . 0.0 114.604 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.9 147.76 37.93 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.614 1.166 . . . . 0.0 111.505 172.715 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -140.8 118.57 11.71 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.994 0.918 . . . . 0.0 108.844 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.457 ' HE2' HG12 ' A' ' 13' ' ' VAL . 51.2 mttm -67.35 127.05 31.22 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.801 -0.562 . . . . 0.0 109.706 170.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.9 m -134.97 159.93 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.696 1.598 . . . . 0.0 110.669 -171.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 m -135.27 119.17 17.34 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.175 0.99 . . . . 0.0 109.039 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -65.8 132.52 48.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.323 0.649 . . . . 0.0 110.267 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 m -127.95 155.59 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.293 1.037 . . . . 0.0 112.665 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -91.05 -168.89 2.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.847 1.259 . . . . 0.0 114.34 -177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.07 -21.4 66.15 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.228 1.811 . . . . 0.0 114.044 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -95.89 -10.23 29.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.948 1.299 . . . . 0.0 112.95 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.17 16.28 72.31 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 117.934 -1.481 . . . . 0.0 114.239 -172.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 13.4 m -77.65 149.7 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.12 1.96 . . . . 0.0 111.353 174.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -86.68 126.96 34.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.349 1.059 . . . . 0.0 111.497 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.6 mt -108.94 -51.11 2.92 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.002 0.921 . . . . 0.0 112.0 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.33 143.44 9.19 Favored Glycine 0 N--CA 1.47 0.928 0 C-N-CA 124.76 1.171 . . . . 0.0 113.854 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.5 p -90.07 150.87 21.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.115 1.366 . . . . 0.0 112.909 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.11 172.63 35.85 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.195 1.855 . . . . 0.0 113.039 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.31 120.85 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.1 tpp -86.29 131.9 34.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.846 0.859 . . . . 0.0 109.354 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -118.5 127.93 54.1 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.405 1.482 . . . . 0.0 109.118 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.5 127.96 55.41 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.618 1.967 . . . . 0.0 107.993 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -160.45 152.28 19.96 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.47 1.908 . . . . 0.0 108.024 -171.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -57.23 -18.06 14.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.86 1.264 . . . . 0.0 113.943 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 t -78.16 -51.94 9.47 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -178.37 174.73 1.25 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.855 1.662 . . . . 0.0 112.501 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt -86.81 139.2 30.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.772 0.829 . . . . 0.0 110.688 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.59 134.42 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.951 0.901 . . . . 0.0 111.696 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.14 131.49 46.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.357 1.463 . . . . 0.0 110.537 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -110.92 139.51 46.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.153 2.181 . . . . 0.0 110.681 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.31 -151.25 0.37 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.356 1.463 . . . . 0.0 110.848 -173.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.585 ' CG ' ' H ' ' A' ' 51' ' ' ARG . 16.6 t60 -70.65 -159.97 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.592 1.557 . . . . 0.0 113.379 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.585 ' H ' ' CG ' ' A' ' 50' ' ' HIS . 22.9 mmm180 -58.64 -12.68 4.4 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.928 1.691 . . . . 0.0 114.471 174.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -57.49 159.45 4.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.49 1.916 . . . . 0.0 111.679 168.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.14 140.56 57.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.297 0.639 . . . . 0.0 112.071 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.39 159.37 32.43 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.028 0.931 . . . . 0.0 111.247 171.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 t -133.4 134.34 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.856 0.462 . . . . 0.0 111.566 -170.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -125.74 147.1 49.49 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.591 1.556 . . . . 0.0 112.836 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.2 m-90 -143.91 117.11 5.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.308 1.443 . . . . 0.0 111.429 174.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.86 148.62 58.38 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.73 2.287 . . . . 0.0 110.509 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -60.36 -27.51 67.44 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -56.59 -39.69 73.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.729 1.612 . . . . 0.0 112.076 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.84 -17.7 61.52 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 mt -84.63 81.41 8.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.544 1.066 . . . . 0.0 110.998 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.46 ' H ' ' HD2' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -59.39 -30.98 68.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.831 0.852 . . . . 0.0 113.17 173.662 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -152.35 148.76 27.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.231 1.412 . . . . 0.0 111.594 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -146.45 112.12 5.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.62 1.568 . . . . 0.0 110.402 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.32 162.93 13.08 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 124.918 1.246 . . . . 0.0 114.566 -168.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -145.66 144.93 30.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.187 1.395 . . . . 0.0 111.879 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -144.05 -175.71 4.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.897 1.679 . . . . 0.0 109.906 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.1 m -56.53 112.48 1.28 Allowed 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.347 -0.846 . . . . 0.0 110.81 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.253 0.8 OUTLIER 49.33 23.59 0.87 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.666 2.387 . . . . 0.0 116.561 -173.133 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -132.22 129.41 39.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.488 1.515 . . . . 0.0 111.181 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -123.85 139.09 54.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.769 1.628 . . . . 0.0 109.997 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 t -153.57 155.56 36.37 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.962 -1.086 . . . . 0.0 113.41 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.22 148.23 29.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.982 1.313 . . . . 0.0 112.606 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.97 147.77 26.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.625 1.97 . . . . 0.0 108.403 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 m -155.0 134.85 12.86 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.625 -1.297 . . . . 0.0 112.153 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.57 170.44 54.54 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.247 0.927 . . . . 0.0 113.605 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -12.96 7.58 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -77.34 -16.51 58.88 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.4 p -86.42 176.69 7.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -55.75 -41.1 73.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.624 1.57 . . . . 0.0 113.528 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.9 p -91.79 -16.83 26.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.397 1.479 . . . . 0.0 113.94 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.15 -169.98 42.59 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.031 1.776 . . . . 0.0 112.138 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -67.68 126.68 30.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.648 0.779 . . . . 0.0 110.79 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.21 162.71 16.91 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 121.912 0.729 . . . . 0.0 114.345 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.57 133.5 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.107 1.363 . . . . 0.0 108.775 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -125.71 124.45 41.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.626 1.17 . . . . 0.0 109.759 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.44 143.88 49.86 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.473 1.109 . . . . 0.0 112.61 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -140.47 127.8 21.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.493 -169.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -72.47 136.24 45.92 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.085 0.554 . . . . 0.0 110.345 169.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 48.8 t -163.8 131.59 3.51 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.591 1.556 . . . . 0.0 110.644 -172.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.5 t -71.31 -8.31 52.86 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -129.48 26.01 5.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.26 1.824 . . . . 0.0 112.834 -173.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.17 -36.01 38.94 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -70.22 -38.01 75.16 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.429 0.692 . . . . 0.0 112.759 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -67.43 -33.18 74.63 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.497 -0.752 . . . . 0.0 111.612 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.58 -51.09 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 169.166 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.84 -37.62 82.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.841 0.857 . . . . 0.0 112.662 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.75 -30.33 67.88 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.6 1.16 . . . . 0.0 112.796 175.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.45 -37.11 21.81 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.006 0.821 . . . . 0.0 112.419 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 23.1 mt -53.43 -54.17 40.69 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.321 0.964 . . . . 0.0 111.832 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -59.0 -26.68 64.74 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -70.8 -30.71 67.24 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.723 1.209 . . . . 0.0 112.766 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.59 -38.33 12.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.6 1.56 . . . . 0.0 111.135 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.8 mtp -71.87 -27.88 63.16 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.2 1.4 . . . . 0.0 113.012 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -75.66 -16.15 60.23 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.332 0.653 . . . . 0.0 112.54 168.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.7 t -89.09 -27.75 20.56 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -170.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.1 m120 64.86 -24.86 0.08 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.851 2.86 . . . . 0.0 116.581 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.1 m 60.41 34.25 20.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.823 1.649 . . . . 0.0 114.886 167.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . 0.462 HD11 ' H ' ' A' ' 110' ' ' ILE . 4.5 mp -54.45 98.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.527 2.331 . . . . 0.0 111.299 -167.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 51.21 32.19 7.76 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.366 1.466 . . . . 0.0 112.815 -175.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.6 p -51.31 -24.05 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.06 154.95 50.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.005 1.722 . . . . 0.0 111.154 170.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.48 105.53 5.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.343 0.657 . . . . 0.0 110.716 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.67 156.29 65.02 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.045 1.338 . . . . 0.0 112.194 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.42 178.9 4.49 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.017 3.145 . . . . 0.0 111.905 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.8 p -61.07 134.15 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.212 1.005 . . . . 0.0 111.379 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.1 mm -141.23 154.71 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.288 1.835 . . . . 0.0 109.651 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.7 pt -63.56 0.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 126.498 1.919 . . . . 0.0 115.602 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.4 t -71.16 -17.86 62.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.757 1.623 . . . . 0.0 112.456 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -56.28 155.31 6.98 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.702 1.601 . . . . 0.0 113.055 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -64.82 136.63 57.1 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.194 0.597 . . . . 0.0 111.7 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 86.6 p -171.6 -171.89 0.97 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.037 1.735 . . . . 0.0 111.063 -173.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -55.69 147.2 42.17 Favored Pre-proline 0 CA--C 1.556 1.174 0 O-C-N 121.034 -1.041 . . . . 0.0 113.104 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.29 152.36 66.56 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.372 2.715 . . . . 0.0 111.168 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.62 172.33 16.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.855 1.662 . . . . 0.0 111.063 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.07 116.94 9.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.086 0.554 . . . . 0.0 109.638 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.8 tt -150.88 139.03 20.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.1 1.76 . . . . 0.0 108.62 -170.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -58.11 138.39 56.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.03 1.332 . . . . 0.0 114.364 -171.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.4 pp -92.46 151.98 41.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.906 1.282 . . . . 0.0 111.943 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.58 -178.4 4.21 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.386 2.724 . . . . 0.0 111.493 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -60.53 160.68 8.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.811 0.845 . . . . 0.0 112.597 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -138.39 145.61 47.66 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.19 1.396 . . . . 0.0 111.196 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.59 153.56 49.36 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.522 2.815 . . . . 0.0 111.538 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -74.42 129.9 83.13 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.406 0.682 . . . . 0.0 109.595 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.89 141.69 49.63 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.033 2.489 . . . . 0.0 111.351 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.93 158.62 34.59 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.844 3.029 . . . . 0.0 112.215 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -78.08 145.99 35.48 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.325 1.05 . . . . 0.0 112.764 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.09 161.45 22.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.343 1.057 . . . . 0.0 112.197 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.2 tp -113.79 143.77 44.1 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.544 1.537 . . . . 0.0 110.432 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.82 -162.44 27.86 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.599 1.095 . . . . 0.0 113.471 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -154.17 151.61 29.42 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.069 1.348 . . . . 0.0 112.068 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.0 t -79.17 176.5 9.61 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.435 1.094 . . . . 0.0 111.493 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.43 136.23 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.797 1.639 . . . . 0.0 110.793 -171.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 t -87.1 171.04 11.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.451 1.101 . . . . 0.0 113.141 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.254 1.342 0 C-N-CA 126.131 1.772 . . . . 0.0 113.694 -177.676 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -78.78 130.56 35.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.968 0.907 . . . . 0.0 111.141 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -90.88 109.69 20.91 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.264 1.026 . . . . 0.0 109.607 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 37.7 mt -74.66 156.89 36.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.953 0.901 . . . . 0.0 113.015 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -79.76 -24.71 41.36 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.11 1.364 . . . . 0.0 113.582 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -162.05 169.75 20.45 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.535 1.934 . . . . 0.0 111.344 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -80.78 124.73 81.5 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.259 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.34 6.27 5.72 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.859 3.04 . . . . 0.0 113.786 -172.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 47.9 t -127.98 131.84 49.23 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.001 1.32 . . . . 0.0 112.07 -171.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.13 -17.31 40.75 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.91 1.243 . . . . 0.0 115.122 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -113.61 112.66 23.89 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.177 1.391 . . . . 0.0 110.286 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -154.89 134.51 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.777 0.799 . . . . 0.0 111.993 -169.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -93.8 120.03 33.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.043 2.137 . . . . 0.0 110.271 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -83.75 111.35 19.09 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.794 0.837 . . . . 0.0 110.242 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.06 -67.48 1.34 Allowed Glycine 0 N--CA 1.47 0.934 0 C-N-CA 124.277 0.942 . . . . 0.0 112.511 -172.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -98.54 121.06 40.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.279 1.032 . . . . 0.0 111.177 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -94.9 27.74 3.01 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.584 1.554 . . . . 0.0 112.616 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -126.79 149.37 49.7 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.025 1.73 . . . . 0.0 109.618 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.462 1.505 . . . . 0.0 113.973 -169.82 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.0 p -165.89 173.79 10.19 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.692 1.597 . . . . 0.0 111.576 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.0 p -156.11 151.67 27.02 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.742 1.217 . . . . 0.0 112.14 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.95 -171.15 47.43 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.697 1.141 . . . . 0.0 113.696 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 t -160.26 166.14 30.11 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.579 1.552 . . . . 0.0 110.931 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 t -164.12 169.34 17.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.538 1.535 . . . . 0.0 111.557 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.24 -160.83 14.05 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.265 1.412 . . . . 0.0 113.355 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -154.65 166.47 33.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.623 1.569 . . . . 0.0 111.658 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -145.78 140.66 27.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.253 1.421 . . . . 0.0 111.262 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -73.63 169.51 17.14 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.999 1.32 . . . . 0.0 112.336 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.85 -11.51 59.58 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.473 1.109 . . . . 0.0 113.91 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 t -95.28 123.95 39.06 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.522 1.129 . . . . 0.0 111.877 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.0 t -79.26 123.06 84.78 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.576 1.15 . . . . 0.0 110.228 -173.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.54 154.86 27.72 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.999 2.466 . . . . 0.0 110.995 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.74 -5.16 10.93 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 174.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -113.99 9.42 17.37 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.537 1.935 . . . . 0.0 113.936 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -55.39 138.65 67.66 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 121.05 -1.031 . . . . 0.0 112.29 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.87 -15.0 47.25 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.163 2.575 . . . . 0.0 115.141 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.6 p -128.41 -18.14 4.06 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.19 1.359 . . . . 0.0 114.459 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 113.18 24.99 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.186 0.903 . . . . 0.0 111.112 174.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -107.94 113.23 26.28 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.127 0.971 . . . . 0.0 109.333 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -67.11 131.29 45.51 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.581 -0.7 . . . . 0.0 110.253 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.5 152.79 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.261 1.425 . . . . 0.0 111.125 -169.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.5 m -130.45 118.37 21.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.837 0.855 . . . . 0.0 109.09 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -66.29 133.97 51.66 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.941 0.896 . . . . 0.0 110.642 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.36 155.08 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.924 0.89 . . . . 0.0 112.733 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.83 -168.3 2.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.576 1.151 . . . . 0.0 113.695 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -72.52 -20.09 61.41 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.637 1.175 . . . . 0.0 113.592 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.76 -15.48 44.87 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.951 1.301 . . . . 0.0 112.408 171.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.98 16.48 67.44 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.042 -1.421 . . . . 0.0 114.449 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.49 151.08 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 119.844 1.822 . . . . 0.0 111.667 173.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.27 128.16 35.17 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.857 1.263 . . . . 0.0 111.308 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.0 mt -110.09 -52.17 2.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.964 0.906 . . . . 0.0 112.347 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.11 152.71 23.78 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.669 1.604 . . . . 0.0 112.569 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.0 t -116.28 149.35 39.37 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.939 0.896 . . . . 0.0 112.82 -172.447 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.99 174.7 33.19 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 126.784 2.135 . . . . 0.0 113.643 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.2 t -114.83 120.5 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.1 tpp -86.65 131.52 34.13 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.95 0.9 . . . . 0.0 109.475 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -127.36 129.99 48.6 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.63 1.572 . . . . 0.0 108.818 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.22 131.1 53.11 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.384 1.873 . . . . 0.0 107.804 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.0 p -130.55 171.3 13.18 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.023 1.329 . . . . 0.0 109.774 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -70.6 -7.65 45.72 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.218 -0.926 . . . . 0.0 112.62 172.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.3 m -102.4 -43.59 5.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.453 1.101 . . . . 0.0 113.428 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -173.94 170.68 3.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.174 1.389 . . . . 0.0 113.151 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.87 140.89 29.2 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.856 1.262 . . . . 0.0 110.275 168.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.6 t -135.31 129.99 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.545 1.138 . . . . 0.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.7 mt -100.23 126.36 46.52 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.679 1.192 . . . . 0.0 110.251 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -98.95 127.52 44.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.55 1.54 . . . . 0.0 110.704 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.8 mt -136.39 158.13 45.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.167 2.187 . . . . 0.0 110.065 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.65 -82.43 0.11 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.963 0.905 . . . . 0.0 112.604 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 57.7 mmm-85 -85.53 -2.87 58.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.567 1.147 . . . . 0.0 113.793 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -107.85 155.26 20.46 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.97 1.708 . . . . 0.0 110.874 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.5 148.37 51.59 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.223 1.009 . . . . 0.0 111.231 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.54 137.74 55.97 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.684 0.794 . . . . 0.0 111.769 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.24 134.49 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.129 0.971 . . . . 0.0 109.724 -174.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.3 150.21 48.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.574 1.15 . . . . 0.0 112.71 -168.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 -142.26 115.22 6.4 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.751 1.22 . . . . 0.0 111.421 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.09 146.6 71.11 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.549 2.166 . . . . 0.0 110.017 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -60.7 -29.98 69.67 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -34.13 70.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.196 1.798 . . . . 0.0 112.679 173.31 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.9 m -83.28 -9.38 59.14 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.57 88.17 7.03 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.641 1.109 . . . . 0.0 110.199 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -64.98 -29.74 70.69 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.758 0.823 . . . . 0.0 113.114 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -154.71 154.75 33.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.95 0.9 . . . . 0.0 112.691 167.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -151.41 144.84 24.84 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.255 1.422 . . . . 0.0 109.633 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.49 -179.65 34.45 Favored Glycine 0 N--CA 1.464 0.566 0 CA-C-O 121.558 0.532 . . . . 0.0 114.222 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -149.09 165.06 32.85 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.227 1.011 . . . . 0.0 113.12 -172.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.85 -169.47 3.37 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.706 2.002 . . . . 0.0 109.578 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 93.8 p -69.23 -18.22 63.86 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -152.49 8.79 0.46 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.795 1.638 . . . . 0.0 113.891 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.63 129.23 26.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.574 1.55 . . . . 0.0 110.754 -168.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -120.98 140.06 52.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.037 1.735 . . . . 0.0 109.504 174.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.4 t -153.35 159.24 42.41 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.31 1.044 . . . . 0.0 112.791 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.42 149.48 30.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.724 1.61 . . . . 0.0 111.689 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -113.22 134.23 54.68 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.525 1.93 . . . . 0.0 109.628 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -132.87 154.91 49.9 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.686 1.195 . . . . 0.0 112.192 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.9 167.51 18.54 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.069 1.319 . . . . 0.0 114.28 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -54.54 -27.34 37.74 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -73.43 -15.44 61.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.67 1.988 . . . . 0.0 115.706 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.2 p -83.47 -176.46 6.32 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -60.48 -46.34 90.45 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.391 1.076 . . . . 0.0 112.779 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.6 p -89.3 -21.39 23.19 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.595 1.158 . . . . 0.0 113.146 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.38 -156.39 33.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.824 1.678 . . . . 0.0 112.271 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -63.64 134.02 54.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.601 0.76 . . . . 0.0 111.691 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.76 175.35 26.67 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 122.156 0.864 . . . . 0.0 113.074 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.8 mt -124.65 138.82 52.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.724 1.609 . . . . 0.0 108.368 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -134.2 123.58 24.56 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.878 1.271 . . . . 0.0 109.96 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.86 143.4 50.37 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.347 1.059 . . . . 0.0 112.962 -169.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -139.54 126.49 20.94 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.851 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -71.07 133.88 46.62 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.739 0.815 . . . . 0.0 110.914 169.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.6 p -168.15 147.96 4.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.016 1.726 . . . . 0.0 111.924 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.0 t -82.55 -0.4 46.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.088 0.955 . . . . 0.0 113.103 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.25 22.56 6.08 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.038 1.735 . . . . 0.0 112.661 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.22 -41.26 49.58 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.567 1.147 . . . . 0.0 113.923 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.35 -35.29 73.48 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.479 1.112 . . . . 0.0 113.225 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -66.33 -39.61 89.34 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.468 -0.77 . . . . 0.0 110.816 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.81 -47.54 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.243 0.617 . . . . 0.0 110.167 172.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -37.83 85.69 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.843 0.857 . . . . 0.0 112.673 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -72.54 -30.69 64.67 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.16 -42.22 21.19 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.911 0.778 . . . . 0.0 110.684 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.9 mt -50.24 -56.93 9.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.667 1.187 . . . . 0.0 113.096 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -60.79 -20.54 61.69 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.06 -23.37 33.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.663 1.185 . . . . 0.0 113.012 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.4 mt -94.9 -35.72 11.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.513 1.125 . . . . 0.0 111.749 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.1 mtp -64.48 -27.03 68.7 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.557 1.143 . . . . 0.0 112.808 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -83.44 -10.76 58.18 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 169.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 19.7 t -101.26 -28.02 12.87 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.463 1.505 . . . . 0.0 112.604 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -59.9 147.63 37.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.142 1.777 . . . . 0.0 111.505 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -64.22 98.98 0.25 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.971 1.309 . . . . 0.0 113.445 -173.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.8 mm -76.99 -40.67 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.371 -0.831 . . . . 0.0 111.929 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -143.81 5.06 1.34 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -171.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.1 t -77.68 -28.33 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 125.323 1.449 . . . . 0.0 111.518 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 26.3 mmt -128.03 147.26 50.51 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.106 1.763 . . . . 0.0 110.893 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -82.34 128.37 34.15 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.015 0.926 . . . . 0.0 110.271 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.84 144.63 80.18 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.604 0.762 . . . . 0.0 112.137 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.99 159.12 41.76 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.44 2.76 . . . . 0.0 111.284 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.9 p -97.68 133.12 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.398 1.079 . . . . 0.0 110.196 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.97 126.39 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.095 1.358 . . . . 0.0 107.972 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.8 mm -106.93 138.41 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.923 1.289 . . . . 0.0 108.484 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t -136.41 157.22 47.3 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.304 1.442 . . . . 0.0 110.384 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -57.78 140.05 52.54 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.841 1.256 . . . . 0.0 112.396 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -113.09 164.18 13.81 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.782 1.233 . . . . 0.0 112.426 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 t -159.64 151.93 20.98 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.225 1.41 . . . . 0.0 110.334 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -69.52 141.1 90.29 Favored Pre-proline 0 CA--C 1.554 1.129 0 O-C-N 121.238 -0.914 . . . . 0.0 112.409 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.82 157.77 54.43 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.531 2.821 . . . . 0.0 111.541 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.25 145.92 51.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.771 0.828 . . . . 0.0 112.172 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -110.06 135.98 50.03 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.646 1.578 . . . . 0.0 110.523 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.9 tt -87.93 141.34 28.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.116 1.366 . . . . 0.0 111.084 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -118.53 144.75 45.84 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.702 1.601 . . . . 0.0 111.318 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 pp -95.95 156.25 37.4 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.153 1.381 . . . . 0.0 112.347 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.72 153.5 20.04 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.138 2.558 . . . . 0.0 112.372 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.54 167.89 15.83 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.962 1.305 . . . . 0.0 113.334 172.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -141.98 149.63 53.31 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.646 1.578 . . . . 0.0 111.509 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.7 159.59 42.13 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.764 2.976 . . . . 0.0 112.328 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -91.33 151.3 42.67 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.442 1.097 . . . . 0.0 111.727 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.14 157.06 51.07 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.319 2.679 . . . . 0.0 111.727 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.73 154.94 49.32 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.786 2.991 . . . . 0.0 112.025 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -83.74 176.29 9.06 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.572 1.149 . . . . 0.0 113.3 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.53 167.23 25.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.905 1.682 . . . . 0.0 111.594 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -147.82 127.17 13.08 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.346 1.458 . . . . 0.0 109.303 -173.037 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -83.69 -120.94 0.79 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.448 1.499 . . . . 0.0 112.715 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -155.07 157.58 37.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.263 1.425 . . . . 0.0 112.345 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.2 p -74.99 -23.45 58.26 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.756 1.622 . . . . 0.0 114.499 -176.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 t 64.32 58.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.722 2.009 . . . . 0.0 109.854 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.0 m -74.72 139.97 43.81 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.878 0.871 . . . . 0.0 112.02 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 C--O 1.254 1.29 0 C-N-CA 125.557 1.543 . . . . 0.0 112.035 -179.24 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -78.41 131.65 37.02 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.094 0.558 . . . . 0.0 111.84 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.83 100.09 11.82 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.098 1.359 . . . . 0.0 111.081 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 56.8 mt -77.15 151.97 35.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.418 -0.801 . . . . 0.0 112.705 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -87.46 -30.22 20.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.364 1.466 . . . . 0.0 113.265 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -143.64 159.36 42.59 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.181 1.792 . . . . 0.0 111.521 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -80.12 124.26 82.93 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.408 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.47 -25.34 2.6 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.193 2.595 . . . . 0.0 114.071 -170.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.53 126.4 31.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.65 0.78 . . . . 0.0 111.28 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.25 -15.8 80.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.984 0.802 . . . . 0.0 113.999 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -122.69 120.25 33.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.468 1.507 . . . . 0.0 109.3 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.74 164.48 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.584 1.553 . . . . 0.0 111.018 -174.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -145.78 159.82 42.63 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.508 1.523 . . . . 0.0 111.721 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -124.39 108.28 12.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.018 1.327 . . . . 0.0 110.322 -169.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.6 -18.63 54.46 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 124.251 0.929 . . . . 0.0 113.993 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -135.78 133.54 38.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.932 1.693 . . . . 0.0 110.538 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -163.76 158.36 20.11 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.858 1.663 . . . . 0.0 110.434 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.18 161.33 22.13 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.413 1.485 . . . . 0.0 110.802 -175.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.188 0 C-N-CA 125.697 1.599 . . . . 0.0 112.917 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -84.94 166.98 16.34 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.844 -0.798 . . . . 0.0 112.258 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 m -157.69 113.82 2.85 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.42 1.488 . . . . 0.0 110.574 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.0 136.75 13.76 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.637 1.113 . . . . 0.0 111.687 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.2 m -151.94 144.19 23.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.446 1.098 . . . . 0.0 111.026 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 p -84.1 135.99 34.18 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.047 -1.033 . . . . 0.0 111.987 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.32 -166.35 29.93 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.296 1.427 . . . . 0.0 113.049 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.5 mt -133.77 118.93 18.63 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.453 1.501 . . . . 0.0 109.119 175.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -89.62 -12.21 40.37 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.27 142.51 45.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.392 1.077 . . . . 0.0 111.366 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -90.68 -0.0 57.55 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.286 1.434 . . . . 0.0 113.642 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.0 m -135.18 141.94 45.99 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.906 1.682 . . . . 0.0 110.78 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -71.65 131.31 86.24 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.983 0.913 . . . . 0.0 111.441 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.95 155.59 43.17 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.713 2.942 . . . . 0.0 112.185 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -68.44 -6.16 23.24 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.726 1.21 . . . . 0.0 114.039 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -123.72 21.41 9.22 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.546 1.939 . . . . 0.0 113.116 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -53.46 137.51 51.03 Favored Pre-proline 0 CA--C 1.553 1.091 0 O-C-N 121.162 -0.961 . . . . 0.0 112.665 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.32 -7.7 21.84 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.461 2.774 . . . . 0.0 114.808 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.8 p -132.67 -24.94 1.93 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.08 90.03 3.19 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.782 1.173 . . . . 0.0 110.677 174.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -91.14 118.4 30.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.777 1.231 . . . . 0.0 109.346 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -78.61 133.76 37.25 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.172 -0.955 . . . . 0.0 110.29 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.17 165.27 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.865 1.266 . . . . 0.0 111.548 -168.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.6 m -143.53 121.74 12.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.463 1.105 . . . . 0.0 109.063 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.77 133.67 53.9 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.097 0.559 . . . . 0.0 109.955 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.48 153.07 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.045 0.938 . . . . 0.0 112.346 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -85.98 -169.69 2.76 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -61.41 -31.66 71.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.016 1.326 . . . . 0.0 114.201 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.09 -9.66 59.78 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.109 1.363 . . . . 0.0 112.45 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.22 12.85 83.52 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 117.76 -1.578 . . . . 0.0 114.225 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 m -80.7 150.35 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 120.108 1.954 . . . . 0.0 111.662 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -83.0 124.52 30.49 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.567 -173.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.9 mt -104.02 -54.3 2.58 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.75 0.82 . . . . 0.0 111.948 -173.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.64 139.27 6.51 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 124.737 1.161 . . . . 0.0 114.003 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 p -85.23 153.16 22.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.248 1.419 . . . . 0.0 113.309 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.05 171.59 37.13 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.664 1.602 . . . . 0.0 113.327 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.11 120.74 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.7 tpp -89.14 134.34 34.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.031 1.332 . . . . 0.0 110.135 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -133.08 130.28 39.11 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.568 1.547 . . . . 0.0 109.461 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.51 128.4 54.48 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.874 2.07 . . . . 0.0 107.694 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -128.03 172.57 10.82 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.64 1.176 . . . . 0.0 110.601 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.49 3.16 4.1 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 121.28 -0.888 . . . . 0.0 112.759 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.7 m -110.89 -45.51 3.46 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.499 1.119 . . . . 0.0 113.34 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -173.63 173.71 3.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.338 1.055 . . . . 0.0 113.343 -169.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.99 139.77 30.25 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.033 0.933 . . . . 0.0 109.946 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.6 t -134.89 132.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.441 1.096 . . . . 0.0 111.413 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.9 mt -104.25 130.9 52.04 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.01 1.724 . . . . 0.0 110.558 168.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -105.13 129.02 53.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.691 1.996 . . . . 0.0 110.579 170.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -160.87 169.68 22.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.029 2.131 . . . . 0.0 111.397 -173.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -111.97 -18.44 12.64 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -73.62 -28.0 61.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.102 0.961 . . . . 0.0 113.044 -176.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -142.43 174.29 10.76 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.866 2.466 . . . . 0.0 108.963 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.04 162.54 7.01 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.461 0.704 . . . . 0.0 110.835 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.04 147.56 19.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.847 0.859 . . . . 0.0 112.423 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 t -126.06 136.86 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.275 1.03 . . . . 0.0 109.485 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.66 152.0 46.38 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.637 0.775 . . . . 0.0 111.842 -171.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -139.16 116.67 8.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.518 1.127 . . . . 0.0 111.37 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.98 145.42 73.89 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.59 2.193 . . . . 0.0 109.883 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -60.85 -24.83 66.21 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.84 -42.69 99.84 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.057 1.343 . . . . 0.0 111.992 173.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.4 m -79.74 -3.55 48.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.1 mt -86.71 106.98 18.02 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.686 1.13 . . . . 0.0 109.912 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -38.43 42.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.384 0.674 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -149.47 155.91 41.14 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.101 1.36 . . . . 0.0 111.085 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -150.78 136.31 17.96 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.868 1.667 . . . . 0.0 108.514 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -156.81 173.26 34.5 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-O 122.139 0.855 . . . . 0.0 113.979 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -142.2 159.76 41.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.52 1.128 . . . . 0.0 112.024 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -151.47 -174.75 4.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.111 1.764 . . . . 0.0 109.771 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -60.19 119.17 7.37 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.376 -0.828 . . . . 0.0 110.473 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.64 21.93 0.99 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 127.703 2.401 . . . . 0.0 116.464 -175.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -138.72 131.23 28.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.067 1.347 . . . . 0.0 111.214 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -125.86 141.29 52.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.218 1.807 . . . . 0.0 109.956 173.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -153.8 162.05 41.56 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.941 -1.099 . . . . 0.0 112.971 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -154.33 153.77 32.21 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.598 1.559 . . . . 0.0 112.412 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -112.65 128.74 56.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.513 1.925 . . . . 0.0 109.222 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.2 p -123.37 142.63 50.77 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.77 154.38 52.83 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.641 1.115 . . . . 0.0 113.138 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -61.81 -14.07 29.68 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -83.11 -17.42 43.12 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.0 p -74.66 -179.54 4.18 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -170.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.94 -38.1 69.87 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.645 1.178 . . . . 0.0 113.199 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -96.58 -23.19 16.63 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.246 1.418 . . . . 0.0 113.588 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.98 -160.7 43.03 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.356 1.455 . . . . 0.0 112.535 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -65.54 129.07 38.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.547 1.139 . . . . 0.0 112.378 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.8 172.59 30.46 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.231 1.396 . . . . 0.0 112.899 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 59.0 mt -119.36 136.3 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.55 1.54 . . . . 0.0 108.298 170.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -129.21 117.95 21.59 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.78 1.232 . . . . 0.0 109.801 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.8 141.18 48.7 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.675 1.19 . . . . 0.0 112.199 -172.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -138.33 127.7 24.59 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.192 0.997 . . . . 0.0 111.865 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -67.34 131.22 45.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.445 0.698 . . . . 0.0 111.044 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.3 t -169.53 118.73 0.64 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.249 1.819 . . . . 0.0 110.36 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.8 t -71.29 -8.06 51.14 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.229 -0.919 . . . . 0.0 113.151 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.73 9.46 35.03 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.538 1.935 . . . . 0.0 113.333 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.5 -38.53 20.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.31 1.844 . . . . 0.0 115.322 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.99 -35.67 80.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.773 0.829 . . . . 0.0 112.908 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -68.39 -37.87 80.78 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.536 -0.728 . . . . 0.0 110.96 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.45 -45.26 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 118.609 0.64 . . . . 0.0 110.24 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.61 -42.99 99.9 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.767 0.827 . . . . 0.0 111.841 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -70.31 -33.97 72.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.23 -33.93 43.24 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.12 0.873 . . . . 0.0 110.682 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.49 -55.21 36.58 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.299 -0.875 . . . . 0.0 111.981 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -61.23 -21.52 63.94 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -81.47 -20.14 40.85 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.215 1.406 . . . . 0.0 112.754 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.13 -35.78 10.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.468 1.507 . . . . 0.0 112.559 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 67.5 mmm -59.06 -33.83 71.24 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.855 1.262 . . . . 0.0 111.366 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -83.19 -8.77 59.44 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.5 t -87.57 0.55 55.45 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.813 1.245 . . . . 0.0 113.491 -172.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -73.75 171.71 12.83 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.446 1.098 . . . . 0.0 112.983 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.3 p -74.24 92.07 2.21 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.255 1.422 . . . . 0.0 112.17 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 21.0 mm -78.08 74.17 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.581 1.152 . . . . 0.0 109.545 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.53 -14.77 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 128.563 2.745 . . . . 0.0 116.248 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.4 m -59.21 -14.79 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 127.43 2.292 . . . . 0.0 115.473 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 74.2 mtm -140.77 141.89 34.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.256 1.423 . . . . 0.0 110.831 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.62 132.03 39.77 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.2 1.4 . . . . 0.0 110.836 174.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.31 149.73 16.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 125.66 1.584 . . . . 0.0 111.029 -175.921 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.82 148.31 40.86 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.06 2.507 . . . . 0.0 110.801 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.6 p -110.88 125.32 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.838 1.255 . . . . 0.0 109.387 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.1 mm -82.53 143.76 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.894 0.854 . . . . 0.0 110.349 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.2 pt -100.97 131.76 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.469 1.107 . . . . 0.0 110.681 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.5 p -139.71 142.69 36.85 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.371 1.869 . . . . 0.0 108.809 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -166.17 97.77 0.61 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.591 1.557 . . . . 0.0 109.107 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -122.08 71.95 1.02 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.091 1.356 . . . . 0.0 109.889 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.3 p -170.73 162.55 7.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 0.0 111.849 -168.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -77.48 146.25 73.32 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.607 1.163 . . . . 0.0 113.181 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.04 144.6 27.12 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.197 2.598 . . . . 0.0 110.247 169.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.24 142.66 5.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.467 1.507 . . . . 0.0 111.058 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -145.15 158.01 43.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.583 1.553 . . . . 0.0 110.181 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 54.8 tp -152.48 145.74 24.72 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.277 1.431 . . . . 0.0 110.928 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.01 134.33 55.99 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.739 1.216 . . . . 0.0 112.138 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.56 153.26 47.98 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.984 1.314 . . . . 0.0 111.81 -176.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.29 99.76 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.465 2.11 . . . . 0.0 110.575 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.88 163.73 27.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.375 1.07 . . . . 0.0 112.595 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -145.52 150.7 44.82 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.097 1.359 . . . . 0.0 111.929 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.5 175.41 11.31 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.05 3.167 . . . . 0.0 112.01 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -131.48 146.96 64.17 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.366 1.466 . . . . 0.0 109.848 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.35 141.29 38.63 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.132 2.555 . . . . 0.0 111.774 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -77.4 171.71 17.19 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.992 3.128 . . . . 0.0 111.894 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -153.29 144.84 23.32 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.891 1.276 . . . . 0.0 111.615 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -156.25 173.2 17.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.994 1.717 . . . . 0.0 111.641 -176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.9 tt -146.54 132.21 18.89 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.368 1.467 . . . . 0.0 110.623 -175.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.18 155.29 18.61 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.449 1.499 . . . . 0.0 112.446 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -159.53 160.53 34.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.384 1.474 . . . . 0.0 111.784 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.1 t -155.48 171.45 19.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.554 1.542 . . . . 0.0 111.623 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 m -150.46 171.93 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 127.701 2.4 . . . . 0.0 110.764 -169.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 t -152.96 161.93 41.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.902 1.281 . . . . 0.0 111.58 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.3 p . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.822 1.649 . . . . 0.0 114.864 -175.445 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -82.45 119.28 23.99 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.31 0.504 . . . . 0.0 110.944 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -89.59 110.06 20.95 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.824 1.25 . . . . 0.0 109.962 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 45.0 mt -76.53 157.15 32.31 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -80.32 -24.15 40.12 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.812 1.645 . . . . 0.0 113.702 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -160.26 170.03 21.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.517 1.927 . . . . 0.0 111.55 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -86.68 122.73 71.55 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.789 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -82.43 -24.92 3.42 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.362 2.708 . . . . 0.0 114.428 -170.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.4 m -79.75 129.02 34.12 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.843 0.747 . . . . 0.0 112.223 -171.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.08 -9.44 85.42 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.656 1.122 . . . . 0.0 114.563 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -139.0 128.07 23.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.71 1.604 . . . . 0.0 110.221 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.7 164.07 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.6 1.56 . . . . 0.0 111.252 -173.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -128.93 132.32 47.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.266 1.426 . . . . 0.0 109.376 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -99.01 111.86 24.15 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.861 1.264 . . . . 0.0 110.035 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.33 -92.9 0.88 Allowed Glycine 0 N--CA 1.468 0.782 0 C-N-CA 124.509 1.052 . . . . 0.0 113.002 -171.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -72.62 122.36 21.28 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.444 1.098 . . . . 0.0 110.815 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -148.25 176.37 10.3 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.862 2.065 . . . . 0.0 109.762 -170.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -132.68 157.17 45.52 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.912 1.285 . . . . 0.0 111.19 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.382 1.473 . . . . 0.0 112.716 -179.676 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.0 m -148.48 141.81 25.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.809 1.243 . . . . 0.0 111.277 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 p -101.76 -1.83 31.52 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.962 1.305 . . . . 0.0 114.181 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.03 -149.58 21.3 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.923 1.725 . . . . 0.0 112.276 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.1 m -142.17 142.78 32.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.977 1.311 . . . . 0.0 111.16 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.3 t -163.58 161.75 24.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.327 1.451 . . . . 0.0 110.744 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.61 8.95 86.33 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.46 1.028 . . . . 0.0 114.5 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.24 136.09 57.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.223 1.409 . . . . 0.0 111.406 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -160.3 151.46 19.23 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.141 1.376 . . . . 0.0 111.739 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -112.84 84.85 2.06 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.874 1.269 . . . . 0.0 109.696 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -165.55 143.39 5.88 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.311 1.845 . . . . 0.0 110.542 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.8 m 59.34 34.04 22.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.416 1.087 . . . . 0.0 113.797 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -41.51 121.25 2.13 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 126.521 1.928 . . . . 0.0 113.252 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.07 151.72 39.56 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.173 2.582 . . . . 0.0 110.811 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.43 -8.8 57.38 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -103.23 8.86 38.37 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.425 1.49 . . . . 0.0 113.26 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -59.61 140.34 89.13 Favored Pre-proline 0 CA--C 1.556 1.185 0 O-C-N 120.615 -1.303 . . . . 0.0 112.961 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.76 -18.41 22.09 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.852 2.368 . . . . 0.0 114.944 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.9 p -128.8 -19.22 3.71 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.173 1.352 . . . . 0.0 114.599 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -97.42 142.22 29.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.189 0.904 . . . . 0.0 110.851 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -143.55 107.16 4.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.012 1.325 . . . . 0.0 108.738 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -64.7 137.12 57.62 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.25 -0.906 . . . . 0.0 111.402 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 m -144.9 159.82 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.803 1.241 . . . . 0.0 111.587 -170.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -134.63 117.19 15.83 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.66 1.184 . . . . 0.0 108.824 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -67.59 135.63 53.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.543 0.737 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.0 m -129.07 154.47 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.298 1.039 . . . . 0.0 112.948 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 p-10 -90.78 -166.62 1.62 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.039 1.336 . . . . 0.0 113.989 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.85 -30.37 71.37 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.555 1.142 . . . . 0.0 113.008 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.9 -12.36 59.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.847 1.259 . . . . 0.0 112.106 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.04 14.52 80.53 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 117.787 -1.563 . . . . 0.0 114.228 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.2 m -76.15 150.34 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.995 1.897 . . . . 0.0 111.563 176.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -84.45 124.19 31.07 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.416 1.087 . . . . 0.0 110.926 -174.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 mt -104.73 -51.93 2.97 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.086 0.954 . . . . 0.0 112.062 -170.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.33 148.49 17.37 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 125.004 1.288 . . . . 0.0 113.533 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.8 p -90.38 151.74 21.3 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.853 1.261 . . . . 0.0 113.006 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.32 170.95 34.56 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.751 1.643 . . . . 0.0 112.793 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -118.63 120.22 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.8 ttm -88.3 141.19 28.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.098 0.959 . . . . 0.0 110.194 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -135.84 129.85 33.03 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.515 1.526 . . . . 0.0 108.903 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -108.44 130.5 55.24 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.678 1.591 . . . . 0.0 107.919 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.0 p -130.35 167.31 18.74 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.904 1.281 . . . . 0.0 109.941 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -66.47 -9.69 36.85 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.864 -0.522 . . . . 0.0 112.4 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.6 m -98.52 -45.35 6.13 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.449 1.1 . . . . 0.0 113.263 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -172.6 171.11 4.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.64 1.176 . . . . 0.0 113.718 -168.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.7 mt -86.86 139.77 30.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.579 1.552 . . . . 0.0 109.962 168.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.0 t -134.87 137.93 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.056 0.943 . . . . 0.0 111.176 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.84 130.3 55.62 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.449 1.5 . . . . 0.0 109.837 167.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -103.13 130.91 50.45 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.366 1.866 . . . . 0.0 110.833 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.3 mt -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.848 2.059 . . . . 0.0 111.148 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -95.42 -63.94 1.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.683 1.193 . . . . 0.0 113.543 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -82.95 2.67 33.49 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.068 1.347 . . . . 0.0 113.884 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -134.75 159.22 41.99 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.926 2.09 . . . . 0.0 110.286 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.78 164.87 25.9 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.92 0.888 . . . . 0.0 111.589 172.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.96 134.87 51.48 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.46 -0.775 . . . . 0.0 111.767 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -108.55 135.6 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.208 1.003 . . . . 0.0 110.494 -173.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -120.86 142.38 49.71 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.664 1.186 . . . . 0.0 113.384 -170.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -141.75 112.59 6.4 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.185 1.394 . . . . 0.0 111.42 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -69.56 150.02 68.9 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.386 2.058 . . . . 0.0 110.334 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -63.7 -19.64 65.09 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.9 mt -68.65 -31.52 70.71 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.21 1.404 . . . . 0.0 113.114 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.4 m -89.9 -6.86 55.34 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.5 mt -74.7 117.4 16.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.73 0.695 . . . . 0.0 109.559 172.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -80.34 -32.97 37.73 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.371 1.468 . . . . 0.0 112.305 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -166.58 159.09 13.9 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.006 2.123 . . . . 0.0 110.483 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -152.17 134.08 14.88 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.001 1.321 . . . . 0.0 111.414 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -150.66 175.73 29.54 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.477 1.036 . . . . 0.0 113.836 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.57 162.0 39.3 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.537 1.135 . . . . 0.0 113.535 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -146.2 -178.56 6.2 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.259 2.224 . . . . 0.0 109.327 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -62.37 -13.63 31.31 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -154.08 12.83 0.43 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.448 1.499 . . . . 0.0 114.242 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -141.47 130.98 23.85 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.329 1.452 . . . . 0.0 110.29 -168.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -121.67 142.14 50.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.912 1.685 . . . . 0.0 109.24 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -153.01 155.51 37.06 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.059 -1.026 . . . . 0.0 112.997 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -150.0 152.78 35.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.158 1.383 . . . . 0.0 111.977 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -106.39 140.8 38.74 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.357 1.463 . . . . 0.0 109.486 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.0 m -124.97 148.58 48.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.175 0.99 . . . . 0.0 112.136 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.62 164.57 45.28 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.276 0.941 . . . . 0.0 112.765 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -63.55 -15.07 57.0 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -82.39 -15.73 51.64 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.216 1.806 . . . . 0.0 115.154 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -79.7 -179.52 6.95 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.526 0.73 . . . . 0.0 112.872 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -58.26 -46.02 86.74 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.286 1.035 . . . . 0.0 112.836 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 36.1 p -89.16 -18.98 26.06 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.04 1.336 . . . . 0.0 113.721 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.49 -164.54 41.76 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.728 1.632 . . . . 0.0 112.474 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -66.68 134.25 51.87 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.923 0.889 . . . . 0.0 112.02 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.09 172.82 23.94 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.288 0.947 . . . . 0.0 113.065 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.6 mt -114.69 137.87 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.474 1.509 . . . . 0.0 108.396 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -129.95 122.97 29.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.64 1.176 . . . . 0.0 110.311 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.15 144.41 48.59 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.679 1.192 . . . . 0.0 113.03 -172.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -142.71 125.15 15.65 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.974 0.91 . . . . 0.0 112.397 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -70.46 134.49 47.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.28 1.032 . . . . 0.0 111.418 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.1 p -170.84 144.55 2.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.411 1.884 . . . . 0.0 111.566 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.4 p -78.03 0.79 23.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.177 1.391 . . . . 0.0 114.08 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -134.65 24.95 3.71 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.841 2.056 . . . . 0.0 112.811 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.98 -41.11 46.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.813 1.645 . . . . 0.0 113.911 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -67.87 -37.13 81.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.503 0.721 . . . . 0.0 112.521 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -68.41 -33.1 73.63 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.416 -0.802 . . . . 0.0 111.958 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.2 mt -63.4 -49.28 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 169.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.12 -42.62 91.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.072 0.949 . . . . 0.0 112.172 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -64.84 -34.87 79.4 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.881 1.273 . . . . 0.0 112.556 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -81.27 -37.8 27.9 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.22 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.9 mt -53.48 -55.75 22.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.369 0.986 . . . . 0.0 111.845 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -58.3 -31.43 67.5 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -28.47 65.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.607 1.163 . . . . 0.0 112.931 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 71.2 mt -93.22 -35.21 13.25 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.334 1.453 . . . . 0.0 111.082 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.8 mtp -78.54 -28.73 46.12 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.978 1.311 . . . . 0.0 113.593 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -65.56 -22.34 66.68 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.814 0.734 . . . . 0.0 112.578 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 12.1 t -69.23 -33.34 73.15 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 118.111 0.414 . . . . 0.0 111.989 -172.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 53.14 36.27 21.96 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.724 1.61 . . . . 0.0 112.433 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.7 m -39.33 112.37 0.24 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.964 2.506 . . . . 0.0 115.148 -169.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.74 -63.79 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.594 0.757 . . . . 0.0 110.933 -174.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -110.26 -18.07 13.37 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.6 p -78.51 -15.96 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.2 1.4 . . . . 0.0 113.92 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.4 mmt -121.22 174.54 6.63 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.342 1.857 . . . . 0.0 111.697 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -55.83 131.08 46.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.875 1.27 . . . . 0.0 111.749 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -151.95 146.62 18.8 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.162 1.385 . . . . 0.0 112.967 -168.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.5 178.04 7.47 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.421 3.414 . . . . 0.0 112.006 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.22 111.17 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.697 0.799 . . . . 0.0 111.092 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.45 140.64 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.907 2.083 . . . . 0.0 109.439 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.34 146.0 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.233 1.013 . . . . 0.0 112.144 173.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.7 t -137.68 150.0 46.99 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.442 1.497 . . . . 0.0 112.089 -171.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -85.87 73.2 10.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.281 1.433 . . . . 0.0 110.371 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.0 t30 57.83 30.5 19.13 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.82 1.648 . . . . 0.0 114.149 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.7 m -138.32 135.95 35.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.811 1.244 . . . . 0.0 111.284 -171.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -156.0 151.22 21.26 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.411 1.085 . . . . 0.0 112.85 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -72.97 152.12 51.25 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.396 2.731 . . . . 0.0 111.231 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.27 63.23 3.13 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.862 1.265 . . . . 0.0 111.954 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -67.42 108.88 2.96 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.341 1.456 . . . . 0.0 110.855 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.7 tt -165.83 148.28 7.38 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.911 2.084 . . . . 0.0 109.485 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -135.82 148.72 48.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.455 1.502 . . . . 0.0 110.981 173.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.14 135.78 19.41 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.401 1.08 . . . . 0.0 111.263 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.1 153.01 18.79 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.407 2.738 . . . . 0.0 111.07 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.63 171.27 14.6 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.614 0.721 . . . . 0.0 112.008 170.084 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.77 138.02 21.38 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.498 1.119 . . . . 0.0 111.715 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.34 172.07 16.8 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.571 2.848 . . . . 0.0 112.068 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -138.42 135.39 18.15 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.428 1.491 . . . . 0.0 108.891 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.3 136.01 35.85 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.675 2.25 . . . . 0.0 110.896 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -78.49 174.76 11.9 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.771 2.98 . . . . 0.0 112.039 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -125.66 155.7 40.43 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.516 1.527 . . . . 0.0 111.462 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -150.48 167.82 26.03 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.578 1.551 . . . . 0.0 111.893 -174.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.3 tt -148.41 130.3 15.23 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.147 1.379 . . . . 0.0 110.363 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -115.2 179.62 18.27 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.748 1.642 . . . . 0.0 112.705 173.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -155.29 155.55 33.95 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.993 1.317 . . . . 0.0 112.015 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 68.2 p -140.13 170.25 16.19 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.199 1.8 . . . . 0.0 111.191 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.58 149.18 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.64 1.576 . . . . 0.0 110.483 -172.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.6 m -142.48 153.45 43.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.127 1.371 . . . . 0.0 111.909 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 C--O 1.256 1.4 0 C-N-CA 125.678 1.591 . . . . 0.0 114.366 177.985 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -85.82 121.67 28.8 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.105 0.962 . . . . 0.0 111.193 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -82.52 107.76 15.42 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.887 1.275 . . . . 0.0 110.742 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -77.28 161.39 28.14 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.604 1.162 . . . . 0.0 112.13 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -101.02 -18.81 16.1 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.127 1.371 . . . . 0.0 114.233 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -139.12 154.3 48.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.524 1.93 . . . . 0.0 111.54 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -84.23 122.22 75.55 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.249 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.34 -20.34 2.73 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.051 2.501 . . . . 0.0 115.249 -169.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 86.9 m -81.59 -31.96 32.3 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.11 -64.44 2.0 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 125.189 1.375 . . . . 0.0 112.902 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -74.61 68.83 1.68 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.764 1.626 . . . . 0.0 111.382 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.7 156.29 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.367 1.867 . . . . 0.0 112.117 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -121.29 137.62 54.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.77 1.628 . . . . 0.0 110.167 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -107.6 101.63 10.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.776 1.23 . . . . 0.0 110.778 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.57 173.17 45.46 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.144 1.354 . . . . 0.0 112.083 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 56.7 37.28 28.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.584 1.154 . . . . 0.0 112.719 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -149.35 138.85 21.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.884 1.674 . . . . 0.0 109.635 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -101.48 159.77 15.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.569 1.148 . . . . 0.0 111.621 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.852 1.661 . . . . 0.0 111.815 -176.631 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -104.81 1.11 28.8 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -160.76 140.1 10.62 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.331 1.452 . . . . 0.0 110.678 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.98 -123.53 5.27 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.386 1.47 . . . . 0.0 111.798 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -139.13 147.0 41.33 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.313 1.445 . . . . 0.0 110.048 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.9 p -145.82 13.65 1.33 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.914 1.286 . . . . 0.0 113.652 -168.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.41 -147.07 18.43 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.635 1.112 . . . . 0.0 112.435 -174.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.86 147.92 51.88 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.1 0.96 . . . . 0.0 111.58 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -152.78 103.19 2.75 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.46 1.504 . . . . 0.0 110.6 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -81.25 128.1 33.43 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.96 0.904 . . . . 0.0 110.34 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -104.03 124.45 49.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.341 1.856 . . . . 0.0 110.754 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p -76.02 111.9 11.89 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.492 1.117 . . . . 0.0 111.273 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 p -149.2 123.59 4.74 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.63 1.172 . . . . 0.0 110.989 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.94 156.48 43.28 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.796 2.331 . . . . 0.0 110.421 169.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.53 -18.21 58.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.904 0.882 . . . . 0.0 112.883 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -115.12 16.42 17.0 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.42 1.888 . . . . 0.0 113.792 -172.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -48.96 142.68 9.25 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.768 1.227 . . . . 0.0 113.311 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.39 -15.02 47.49 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.271 2.648 . . . . 0.0 115.458 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.7 p -124.03 -24.91 4.3 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.827 1.194 . . . . 0.0 113.843 172.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -100.16 118.25 36.1 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.819 1.19 . . . . 0.0 111.943 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -114.51 110.57 20.03 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.281 1.433 . . . . 0.0 108.638 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -71.25 139.79 50.16 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.483 -0.761 . . . . 0.0 110.421 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -145.7 164.5 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.897 1.279 . . . . 0.0 111.964 -170.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.8 m -136.44 120.36 17.52 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.739 1.215 . . . . 0.0 109.271 172.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -67.3 137.53 56.15 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.859 0.864 . . . . 0.0 111.371 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.9 156.71 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.235 1.014 . . . . 0.0 112.706 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -90.8 -167.54 1.85 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.75 1.22 . . . . 0.0 113.705 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.23 -32.19 73.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.87 -11.54 59.81 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.821 1.248 . . . . 0.0 112.817 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 17.47 77.41 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.099 -1.39 . . . . 0.0 113.904 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 m -79.71 150.51 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.829 1.815 . . . . 0.0 111.339 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.57 126.43 34.93 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.308 1.043 . . . . 0.0 111.356 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.6 mt -109.08 -43.3 4.21 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.533 1.133 . . . . 0.0 112.681 -169.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.96 144.8 9.33 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.468 1.033 . . . . 0.0 114.2 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 p -83.79 148.26 27.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.448 1.099 . . . . 0.0 112.224 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.08 170.21 32.04 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.322 1.439 . . . . 0.0 113.457 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.04 119.8 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.7 ttm -91.11 134.05 34.84 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.058 0.943 . . . . 0.0 109.488 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -125.39 124.04 40.64 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.986 1.314 . . . . 0.0 109.235 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -111.35 126.87 55.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.546 1.938 . . . . 0.0 107.901 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -162.54 149.92 13.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.514 1.925 . . . . 0.0 108.266 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -58.89 -18.5 33.7 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -172.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 m -70.45 -42.26 71.75 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 170.95 167.05 0.07 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.594 1.958 . . . . 0.0 111.946 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mt -82.18 139.37 34.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.939 0.895 . . . . 0.0 109.545 167.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 t -134.64 138.62 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.331 0.653 . . . . 0.0 110.808 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.1 mt -113.74 130.74 56.39 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 125.735 1.614 . . . . 0.0 109.482 167.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -111.61 122.22 47.23 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.391 1.876 . . . . 0.0 109.945 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.34 127.29 8.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.84 1.256 . . . . 0.0 111.489 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -73.3 -14.31 61.28 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.536 1.134 . . . . 0.0 113.681 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -66.97 -25.97 66.59 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.568 1.547 . . . . 0.0 113.056 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -143.61 -72.36 0.29 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.66 1.584 . . . . 0.0 111.675 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -171.65 161.97 6.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.555 2.342 . . . . 0.0 109.863 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.75 148.97 39.97 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.884 -0.51 . . . . 0.0 111.666 170.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.95 136.95 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.515 1.126 . . . . 0.0 111.694 -169.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -117.15 146.83 42.94 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.844 1.658 . . . . 0.0 113.213 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -142.54 121.52 7.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.474 1.51 . . . . 0.0 111.797 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.77 149.99 61.31 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.094 2.529 . . . . 0.0 110.895 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -63.43 -19.42 64.69 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.4 mt -63.21 -33.67 75.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.422 1.089 . . . . 0.0 113.693 171.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.2 p -83.99 -9.35 58.73 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -89.9 73.6 7.43 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 111.87 -173.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -63.99 -41.24 97.58 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.042 -0.412 . . . . 0.0 112.058 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -134.03 129.6 36.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.098 1.759 . . . . 0.0 110.363 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -153.09 141.67 20.86 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.714 2.006 . . . . 0.0 109.764 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.67 179.44 41.56 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-O 122.053 0.807 . . . . 0.0 114.612 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -142.33 157.61 44.62 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.38 1.472 . . . . 0.0 112.56 -171.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.78 -173.17 4.28 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.699 2.0 . . . . 0.0 109.845 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 p -59.33 110.6 1.12 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.272 -0.892 . . . . 0.0 111.506 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 61.7 15.58 7.06 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 126.41 1.884 . . . . 0.0 114.268 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -133.04 129.3 37.9 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.231 1.378 . . . . 0.0 112.065 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -124.12 142.09 51.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.676 1.591 . . . . 0.0 110.474 171.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.8 t -153.87 157.06 38.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.489 1.116 . . . . 0.0 113.581 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.36 155.46 37.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.17 1.388 . . . . 0.0 113.488 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.04 154.32 17.7 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.142 1.777 . . . . 0.0 111.605 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 t -148.37 161.8 40.84 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.733 0.813 . . . . 0.0 113.054 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.37 173.63 19.75 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 126.481 1.991 . . . . 0.0 114.593 -170.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -26.54 68.44 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -169.633 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -81.21 -15.06 56.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.2 p -79.13 -178.45 6.16 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -61.62 -35.88 79.13 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.95 1.3 . . . . 0.0 113.341 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.9 p -99.41 -22.85 15.35 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.546 1.539 . . . . 0.0 114.374 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.76 -165.8 46.31 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.776 1.655 . . . . 0.0 112.925 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -58.34 132.48 53.76 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.006 0.922 . . . . 0.0 111.998 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.68 172.49 31.22 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 123.997 0.808 . . . . 0.0 113.375 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.7 mt -114.94 137.85 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.367 1.467 . . . . 0.0 108.261 169.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -131.53 126.9 36.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.745 1.218 . . . . 0.0 110.213 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.31 144.95 50.24 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.496 1.119 . . . . 0.0 113.284 -170.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -141.82 129.67 21.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.354 1.061 . . . . 0.0 111.75 -168.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -76.95 134.81 38.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.877 0.871 . . . . 0.0 111.608 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 22.3 p -174.45 137.31 0.49 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.635 1.974 . . . . 0.0 111.565 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -73.68 -3.8 30.42 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.993 -1.067 . . . . 0.0 113.273 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -110.94 13.31 22.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.163 2.585 . . . . 0.0 112.758 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.59 -43.25 35.86 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.204 1.402 . . . . 0.0 114.215 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -68.12 -35.18 77.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.521 0.728 . . . . 0.0 112.769 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.46 -31.27 66.98 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.379 -0.826 . . . . 0.0 112.141 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.42 -45.6 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.755 0.707 . . . . 0.0 109.861 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.82 -45.09 93.47 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.159 0.983 . . . . 0.0 111.735 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -65.24 -40.94 94.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.199 1.4 . . . . 0.0 112.261 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.5 tp -74.05 -38.57 63.95 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.955 0.798 . . . . 0.0 111.505 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 mt -54.76 -55.74 26.78 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.018 0.827 . . . . 0.0 111.247 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -62.17 -24.79 67.4 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -41.03 75.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.152 0.981 . . . . 0.0 112.219 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.7 mt -73.71 -40.12 63.82 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.787 0.835 . . . . 0.0 111.099 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 70.0 mmm -64.32 -34.0 77.13 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.912 1.285 . . . . 0.0 112.737 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -90.41 -12.97 35.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.4 t -61.82 -51.12 69.57 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.103 0.865 . . . . 0.0 111.713 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -152.52 119.63 5.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.705 1.602 . . . . 0.0 109.834 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 t -113.87 10.15 17.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.434 1.094 . . . . 0.0 112.529 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.3 mp -95.25 73.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.294 1.437 . . . . 0.0 109.384 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 43.2 45.54 4.88 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.542 2.337 . . . . 0.0 115.168 172.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.7 m -75.63 35.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 126.971 2.108 . . . . 0.0 114.021 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.6 mmt -128.29 26.45 5.72 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.274 2.23 . . . . 0.0 112.704 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -94.97 36.71 1.18 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.948 1.699 . . . . 0.0 112.284 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -127.91 148.38 66.98 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 126.279 1.832 . . . . 0.0 110.76 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.07 162.9 40.41 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.763 2.975 . . . . 0.0 111.977 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 83.5 t -102.7 129.27 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.97 1.308 . . . . 0.0 109.336 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.84 150.33 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.725 1.61 . . . . 0.0 109.012 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.4 pt -73.61 42.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.975 1.71 . . . . 0.0 113.006 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 88.2 m -54.08 117.34 3.15 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.917 2.087 . . . . 0.0 111.208 -172.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.29 7.67 35.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.498 1.519 . . . . 0.0 113.761 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -63.15 127.03 29.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.114 0.966 . . . . 0.0 110.877 173.358 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 t -162.08 95.25 0.95 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.326 1.051 . . . . 0.0 109.737 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -70.83 129.3 89.88 Favored Pre-proline 0 CA--C 1.551 0.989 0 O-C-N 121.265 -0.897 . . . . 0.0 111.822 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.11 163.23 39.38 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.115 2.543 . . . . 0.0 110.676 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -151.06 146.37 26.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.563 1.145 . . . . 0.0 111.112 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -68.98 154.5 41.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.458 0.703 . . . . 0.0 111.404 172.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.46 163.81 29.21 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.014 1.326 . . . . 0.0 112.186 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -116.12 131.32 56.97 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.371 1.468 . . . . 0.0 110.51 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.32 145.36 51.85 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.91 0.884 . . . . 0.0 110.742 174.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.14 165.65 25.65 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.146 2.564 . . . . 0.0 111.481 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -143.31 170.66 15.36 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.728 1.211 . . . . 0.0 112.207 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.12 148.07 35.57 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.225 1.41 . . . . 0.0 111.294 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -79.89 179.31 6.36 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.743 2.962 . . . . 0.0 110.281 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -134.57 131.62 20.39 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.28 1.032 . . . . 0.0 108.938 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.14 139.9 27.31 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.761 2.307 . . . . 0.0 111.132 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.84 163.06 34.12 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.541 2.827 . . . . 0.0 111.486 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -153.87 140.78 19.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.685 1.194 . . . . 0.0 111.961 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -165.09 160.44 18.8 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.093 1.757 . . . . 0.0 111.002 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . 0.476 ' H ' HD22 ' A' ' 140' ' ' LEU . 2.1 pt? -77.72 37.48 0.23 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.895 1.678 . . . . 0.0 112.705 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.43 150.73 27.12 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.842 1.686 . . . . 0.0 110.907 -168.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -140.48 101.63 4.15 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.883 0.873 . . . . 0.0 111.692 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.6 m -151.46 114.85 4.81 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.154 1.782 . . . . 0.0 108.058 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.9 m -153.24 162.99 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.49 1.916 . . . . 0.0 110.251 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.6 t -157.24 163.77 38.43 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.941 1.296 . . . . 0.0 111.558 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 C--O 1.254 1.327 0 C-N-CA 126.476 1.911 . . . . 0.0 111.573 -174.427 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -143.28 127.18 17.28 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.973 1.309 . . . . 0.0 109.92 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -82.56 112.5 19.52 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.386 1.075 . . . . 0.0 111.256 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 57.8 mt -85.68 153.55 22.27 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.708 0.803 . . . . 0.0 112.103 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -88.34 -29.88 19.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.342 1.457 . . . . 0.0 112.794 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -137.86 157.09 47.14 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.235 1.814 . . . . 0.0 111.65 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -79.2 128.15 76.81 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.999 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -84.95 6.28 5.8 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.0 3.134 . . . . 0.0 114.066 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 t -127.01 139.44 53.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.411 1.485 . . . . 0.0 111.565 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.3 -39.38 7.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.182 0.896 . . . . 0.0 112.713 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.1 52.11 1.25 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.523 1.529 . . . . 0.0 113.199 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.53 141.66 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.236 -0.915 . . . . 0.0 111.407 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -111.42 118.44 35.81 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.388 1.475 . . . . 0.0 107.992 167.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -87.66 114.36 24.2 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.521 -0.737 . . . . 0.0 111.361 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.28 168.03 20.71 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.972 1.272 . . . . 0.0 114.255 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 55.11 36.61 27.35 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.452 1.501 . . . . 0.0 113.497 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -68.85 149.1 49.32 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.59 1.156 . . . . 0.0 111.044 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -144.47 159.4 42.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.251 1.42 . . . . 0.0 110.999 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 125.403 1.481 . . . . 0.0 112.905 -179.137 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t -163.29 164.8 24.76 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.469 1.507 . . . . 0.0 111.014 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 p -165.95 152.16 9.31 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.416 1.486 . . . . 0.0 112.119 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.53 170.02 47.94 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.489 1.042 . . . . 0.0 113.118 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.1 t -161.65 155.26 21.53 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.026 1.33 . . . . 0.0 111.357 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.5 p -166.34 164.64 17.51 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.704 1.602 . . . . 0.0 111.775 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.57 152.85 24.47 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.583 1.087 . . . . 0.0 113.077 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -165.12 173.13 11.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.34 1.856 . . . . 0.0 111.452 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -149.91 120.51 7.48 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.906 1.282 . . . . 0.0 110.881 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -145.93 157.55 43.89 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.995 2.118 . . . . 0.0 109.52 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -133.62 29.23 3.9 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.846 1.258 . . . . 0.0 113.922 -167.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -149.16 159.8 43.92 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.986 -1.071 . . . . 0.0 112.829 177.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.5 t -150.82 124.49 4.37 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 126.925 2.09 . . . . 0.0 108.395 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.08 164.05 19.94 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.177 2.585 . . . . 0.0 111.979 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -67.77 -8.06 32.57 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.52 1.128 . . . . 0.0 113.666 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -118.13 8.03 12.3 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.398 1.479 . . . . 0.0 114.427 -172.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -54.0 141.63 48.51 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 124.464 1.106 . . . . 0.0 112.679 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.71 -11.0 30.14 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.326 2.684 . . . . 0.0 115.086 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 p -130.32 -19.24 3.14 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.65 118.14 32.26 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.996 0.918 . . . . 0.0 111.295 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -116.37 105.42 12.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.328 1.051 . . . . 0.0 109.221 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -67.04 130.99 44.91 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.48 -0.763 . . . . 0.0 110.438 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.27 157.27 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.085 1.354 . . . . 0.0 112.024 -169.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.7 m -130.89 115.79 17.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.693 1.197 . . . . 0.0 108.822 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -62.34 128.42 35.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.372 0.533 . . . . 0.0 109.934 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.42 155.92 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.89 0.876 . . . . 0.0 112.522 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -87.26 -168.68 2.32 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.436 1.094 . . . . 0.0 113.758 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.37 -31.43 71.32 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.289 1.435 . . . . 0.0 114.344 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -84.06 -8.98 58.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.773 0.829 . . . . 0.0 113.018 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.24 15.62 78.17 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.431 -1.205 . . . . 0.0 113.979 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.6 m -79.72 150.61 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.49 1.645 . . . . 0.0 111.247 174.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -91.53 123.43 34.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.802 1.241 . . . . 0.0 110.922 -169.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.4 mt -106.55 -53.47 2.62 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.514 0.726 . . . . 0.0 112.114 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.77 160.98 29.32 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 125.535 1.541 . . . . 0.0 113.073 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 m -125.41 147.08 49.32 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.624 0.769 . . . . 0.0 112.824 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.86 174.58 30.13 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.775 1.655 . . . . 0.0 113.858 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.0 t -113.01 120.22 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.2 tpp -86.08 138.78 31.69 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.614 1.166 . . . . 0.0 109.819 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.1 130.0 26.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.672 1.589 . . . . 0.0 108.799 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.27 127.43 53.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.311 1.844 . . . . 0.0 107.344 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.1 p -127.55 172.83 10.37 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.802 1.241 . . . . 0.0 110.664 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -72.85 -0.48 13.59 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 121.235 -0.916 . . . . 0.0 112.541 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.1 t -106.47 -46.64 3.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.061 1.344 . . . . 0.0 112.971 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -174.8 174.41 2.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.943 1.297 . . . . 0.0 113.297 -166.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.9 138.61 31.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.234 1.014 . . . . 0.0 109.391 167.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.35 127.81 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.133 0.973 . . . . 0.0 111.109 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.17 130.73 46.34 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.816 1.647 . . . . 0.0 109.809 168.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -107.63 118.7 37.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.517 1.927 . . . . 0.0 110.188 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.6 mp -122.63 162.81 21.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.064 1.746 . . . . 0.0 110.929 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -90.9 -72.32 0.58 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.678 1.191 . . . . 0.0 113.08 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -74.12 -24.66 59.47 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -112.0 162.4 15.41 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.892 1.677 . . . . 0.0 110.297 174.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.6 158.9 23.1 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.697 1.599 . . . . 0.0 112.548 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.65 152.92 43.06 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.755 0.822 . . . . 0.0 111.877 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 t -134.76 133.78 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.67 0.788 . . . . 0.0 111.293 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -125.63 143.32 51.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.96 1.304 . . . . 0.0 112.311 -172.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 -140.11 112.53 7.41 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.788 1.235 . . . . 0.0 111.153 174.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.76 145.73 76.17 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.64 2.227 . . . . 0.0 110.284 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -60.33 -25.58 65.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.55 -38.84 90.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.028 1.331 . . . . 0.0 111.728 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.4 -5.31 58.57 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 99.3 mt -83.38 123.4 29.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.339 0.972 . . . . 0.0 109.861 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -83.94 -38.71 20.68 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.097 0.559 . . . . 0.0 112.123 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -161.97 156.18 21.99 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.462 1.505 . . . . 0.0 111.428 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -151.25 123.82 8.45 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.278 1.431 . . . . 0.0 109.538 -172.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.67 167.39 25.91 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 124.264 0.935 . . . . 0.0 113.795 -169.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -145.13 164.13 32.2 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.349 1.06 . . . . 0.0 113.342 -169.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -146.78 -166.99 2.64 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.223 2.209 . . . . 0.0 109.385 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 93.9 p -69.55 -19.06 63.7 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.277 -1.514 . . . . 0.0 114.71 -175.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -150.32 9.5 0.65 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.286 1.434 . . . . 0.0 114.032 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -137.42 132.21 33.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.774 1.63 . . . . 0.0 110.075 -169.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -126.89 139.66 52.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.078 1.751 . . . . 0.0 109.404 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.1 t -153.15 156.46 38.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.31 1.044 . . . . 0.0 112.448 -175.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -153.78 156.08 37.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.252 1.421 . . . . 0.0 111.901 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -116.86 137.65 52.06 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.743 1.617 . . . . 0.0 110.104 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -141.16 156.58 45.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.235 1.014 . . . . 0.0 112.011 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.6 175.39 37.24 Favored Glycine 0 N--CA 1.472 1.1 0 C-N-CA 125.458 1.504 . . . . 0.0 114.986 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -13.52 28.51 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -172.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.8 ptm85 -86.96 -15.82 37.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.58 1.552 . . . . 0.0 115.182 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.6 p -76.34 179.79 5.59 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.79 0.836 . . . . 0.0 112.81 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -59.01 -41.25 87.29 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.36 1.064 . . . . 0.0 113.052 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.3 p -92.09 -20.61 21.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.079 1.351 . . . . 0.0 113.758 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.59 -173.1 49.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.252 1.406 . . . . 0.0 112.43 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -67.7 127.65 33.56 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.55 0.74 . . . . 0.0 112.234 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.45 -177.39 38.62 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.124 0.869 . . . . 0.0 113.604 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -123.48 139.65 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.238 1.815 . . . . 0.0 109.128 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -134.63 126.96 30.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.127 1.371 . . . . 0.0 109.768 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.76 139.26 54.18 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.624 1.17 . . . . 0.0 112.442 -171.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -137.18 126.89 25.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.242 1.017 . . . . 0.0 111.549 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -74.25 134.46 42.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.644 0.777 . . . . 0.0 111.847 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.0 p -176.27 128.2 0.21 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.02 2.528 . . . . 0.0 110.331 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.4 m -68.36 -10.47 55.21 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.807 -1.183 . . . . 0.0 113.326 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -93.36 10.21 33.1 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.01 2.124 . . . . 0.0 112.883 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.9 -40.59 66.77 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.692 1.597 . . . . 0.0 114.658 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -70.95 -35.26 72.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.481 0.712 . . . . 0.0 112.68 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 -67.09 -37.58 84.2 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.199 -0.938 . . . . 0.0 111.314 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.6 mt -61.43 -46.34 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 118.751 0.705 . . . . 0.0 110.135 172.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.44 -43.16 97.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.382 1.073 . . . . 0.0 112.099 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -70.42 -32.32 69.88 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.245 1.018 . . . . 0.0 113.423 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -78.04 -37.33 47.07 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.126 0.875 . . . . 0.0 110.063 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.89 -52.02 65.54 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.434 -0.791 . . . . 0.0 112.567 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -60.24 -23.95 64.48 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.24 -17.51 52.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.991 1.317 . . . . 0.0 113.377 176.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.4 mt -102.41 -36.32 8.47 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.316 1.446 . . . . 0.0 111.929 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 62.7 mmm -61.7 -26.97 68.37 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.599 1.559 . . . . 0.0 112.741 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -13.88 62.05 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 35.7 t -71.3 -28.95 64.47 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -170.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 55.52 61.7 2.75 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.132 1.373 . . . . 0.0 110.755 -172.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.1 p -80.81 65.97 6.15 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.159 1.784 . . . . 0.0 112.814 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.2 mm -75.3 103.15 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.686 -1.259 . . . . 0.0 109.936 -174.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.9 p30 53.54 15.44 0.74 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 128.025 2.53 . . . . 0.0 116.342 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.96 -16.21 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 99.4 mtp -139.09 166.42 24.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.739 2.016 . . . . 0.0 111.782 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -52.53 114.58 1.42 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.582 1.953 . . . . 0.0 111.346 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -84.64 155.65 62.06 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -167.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.29 -169.56 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 124.327 3.351 . . . . 0.0 111.096 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.6 129.56 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.938 0.895 . . . . 0.0 109.924 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.35 146.05 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.781 1.632 . . . . 0.0 108.058 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.4 pt -67.65 20.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 126.713 2.005 . . . . 0.0 115.548 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.8 p -123.26 161.21 25.03 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.849 2.06 . . . . 0.0 111.143 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -64.21 107.72 1.38 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.331 1.053 . . . . 0.0 110.425 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -168.33 170.28 10.08 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.783 2.033 . . . . 0.0 110.047 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 t -70.08 139.74 52.62 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.124 -0.985 . . . . 0.0 110.481 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -128.78 136.6 29.4 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.973 1.309 . . . . 0.0 111.912 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.36 160.78 41.47 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.434 2.756 . . . . 0.0 112.218 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.09 -179.3 5.23 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.202 1.401 . . . . 0.0 112.682 175.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -120.8 161.91 20.68 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.873 1.669 . . . . 0.0 112.114 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.2 mt -111.71 151.51 28.81 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.159 1.384 . . . . 0.0 112.191 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.05 160.28 14.4 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.384 1.874 . . . . 0.0 112.795 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 pp -95.8 154.26 39.11 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.911 1.284 . . . . 0.0 112.541 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.84 150.85 27.45 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.06 2.507 . . . . 0.0 111.588 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -98.39 139.39 34.23 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.673 1.189 . . . . 0.0 111.127 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -77.22 149.17 78.99 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.685 1.194 . . . . 0.0 112.302 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.02 175.8 10.37 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.779 2.986 . . . . 0.0 111.667 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -126.59 147.81 62.06 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.136 1.375 . . . . 0.0 110.1 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.18 152.78 56.57 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.299 2.666 . . . . 0.0 112.105 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.86 174.77 12.16 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.026 3.151 . . . . 0.0 111.95 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -150.58 163.2 39.06 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.046 1.339 . . . . 0.0 112.232 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -156.93 170.55 22.26 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.709 1.604 . . . . 0.0 111.576 -174.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.2 tp -149.89 126.96 11.23 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.206 1.402 . . . . 0.0 110.234 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.96 -170.02 42.78 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.032 1.301 . . . . 0.0 113.562 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -156.13 150.22 25.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.155 1.382 . . . . 0.0 112.049 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 74.4 m -137.88 145.52 42.27 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.602 1.961 . . . . 0.0 108.987 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.9 p -131.5 140.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.569 1.548 . . . . 0.0 110.504 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.6 m -107.84 169.23 8.73 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.223 1.409 . . . . 0.0 113.301 -170.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.185 1.794 . . . . 0.0 113.5 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -132.36 124.62 29.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.382 1.073 . . . . 0.0 111.044 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -78.96 116.98 19.62 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.497 1.119 . . . . 0.0 110.957 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.8 mt -88.16 153.71 21.02 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.525 -0.734 . . . . 0.0 112.467 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -94.6 -2.11 52.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.815 1.646 . . . . 0.0 113.49 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -160.95 164.31 31.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.454 2.302 . . . . 0.0 110.737 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -94.78 119.01 66.68 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.227 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.39 -22.16 7.06 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.004 2.47 . . . . 0.0 113.489 -170.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.5 m -91.06 112.16 23.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.926 0.891 . . . . 0.0 111.047 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.18 -25.72 72.55 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.778 0.704 . . . . 0.0 112.881 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -91.97 119.17 31.46 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.675 1.19 . . . . 0.0 109.258 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.69 154.03 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.484 1.514 . . . . 0.0 110.749 -169.492 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -144.82 175.88 9.86 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.961 1.704 . . . . 0.0 112.25 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -138.62 134.08 33.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.637 1.575 . . . . 0.0 110.444 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.73 -25.4 5.18 Favored Glycine 0 N--CA 1.476 1.335 0 N-CA-C 115.561 0.984 . . . . 0.0 115.561 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 51.3 m-85 -123.47 131.16 53.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.098 1.359 . . . . 0.0 110.361 -175.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -163.55 158.72 21.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.81 1.644 . . . . 0.0 111.162 -169.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -83.97 53.3 2.54 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.306 1.442 . . . . 0.0 112.977 -175.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.702 1.601 . . . . 0.0 111.756 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -164.09 168.72 18.76 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.231 1.412 . . . . 0.0 111.385 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -151.67 145.45 25.08 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.899 1.68 . . . . 0.0 110.937 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.35 -167.77 40.75 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.498 1.046 . . . . 0.0 113.495 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -163.71 179.28 7.25 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.567 1.547 . . . . 0.0 111.131 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 p -160.17 144.34 14.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.555 1.542 . . . . 0.0 111.9 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.12 -171.71 30.77 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.139 1.352 . . . . 0.0 113.153 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.75 139.57 47.22 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.34 1.056 . . . . 0.0 111.208 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -90.56 18.48 6.26 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.648 1.579 . . . . 0.0 113.757 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -74.83 28.32 0.09 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.581 2.352 . . . . 0.0 115.403 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -149.77 150.71 32.45 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.052 1.741 . . . . 0.0 110.952 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.8 m -76.4 139.34 40.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.812 0.845 . . . . 0.0 111.919 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 p -54.34 123.32 42.15 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 124.367 1.067 . . . . 0.0 111.964 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -84.08 159.58 13.51 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.093 2.528 . . . . 0.0 110.543 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -68.29 -14.11 62.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.959 0.903 . . . . 0.0 113.293 173.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -106.46 9.87 31.53 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.519 1.928 . . . . 0.0 113.863 -172.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -59.97 145.54 84.35 Favored Pre-proline 0 CA--C 1.557 1.244 0 O-C-N 120.82 -1.175 . . . . 0.0 112.431 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.33 -11.02 26.37 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.899 2.399 . . . . 0.0 115.259 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.7 p -130.96 -16.95 3.17 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 120.373 1.442 . . . . 0.0 114.088 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -111.61 144.69 40.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.816 1.247 . . . . 0.0 110.579 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -140.83 119.17 12.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.159 0.983 . . . . 0.0 109.099 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -70.24 129.71 40.07 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.65 -0.656 . . . . 0.0 110.227 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 m -136.74 160.73 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.844 1.658 . . . . 0.0 110.889 -170.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -132.75 118.79 19.48 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.857 0.863 . . . . 0.0 109.193 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.26 128.68 36.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.038 0.935 . . . . 0.0 110.164 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -124.34 155.03 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.918 0.887 . . . . 0.0 113.382 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -83.51 -170.85 3.26 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.49 -24.15 67.7 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -92.82 -6.22 49.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.142 1.777 . . . . 0.0 112.642 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.19 15.2 75.08 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.282 -1.288 . . . . 0.0 114.29 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -76.67 143.98 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.721 1.76 . . . . 0.0 110.849 179.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -88.24 119.45 28.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.078 1.351 . . . . 0.0 110.495 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.6 mt -104.93 -54.73 2.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.149 0.58 . . . . 0.0 112.025 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.26 142.61 10.41 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 124.834 1.207 . . . . 0.0 113.799 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.5 p -94.56 142.19 27.73 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.943 1.297 . . . . 0.0 112.354 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.75 171.28 29.1 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.736 1.636 . . . . 0.0 113.486 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.56 120.71 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.2 tpp -87.19 139.23 30.77 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.698 1.199 . . . . 0.0 109.67 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.07 128.82 24.76 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.7 1.6 . . . . 0.0 108.667 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mp -108.52 134.26 51.54 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.211 1.804 . . . . 0.0 108.138 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.3 p -134.26 170.76 15.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.117 1.367 . . . . 0.0 109.745 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.05 -5.93 30.14 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.233 -0.917 . . . . 0.0 113.076 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.5 t -107.48 -43.52 4.52 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.247 1.019 . . . . 0.0 113.34 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -169.88 169.04 8.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.41 1.084 . . . . 0.0 113.194 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.2 mt -86.74 142.4 28.18 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.535 1.134 . . . . 0.0 110.031 168.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.69 130.15 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.616 1.166 . . . . 0.0 110.847 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.1 mt -105.55 133.62 49.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.145 1.778 . . . . 0.0 110.565 168.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -115.8 117.84 31.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.872 2.069 . . . . 0.0 110.329 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.0 mp -124.51 159.96 29.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.662 1.585 . . . . 0.0 110.57 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -100.92 -7.15 23.7 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -114.99 0.18 13.59 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.472 1.909 . . . . 0.0 113.634 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -148.36 157.3 43.39 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.697 1.999 . . . . 0.0 110.22 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -61.68 159.24 13.76 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.427 1.091 . . . . 0.0 110.414 168.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.34 140.97 58.92 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.475 -0.766 . . . . 0.0 111.413 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.58 136.33 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.917 0.887 . . . . 0.0 110.757 -172.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -134.44 148.96 50.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -140.76 112.58 6.97 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.426 1.491 . . . . 0.0 111.059 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.66 148.11 86.75 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.794 2.329 . . . . 0.0 110.347 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -61.95 -19.69 63.03 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.53 -44.83 95.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.635 1.574 . . . . 0.0 112.974 171.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.2 p -77.4 -15.18 59.5 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.94 115.14 10.8 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.783 0.833 . . . . 0.0 109.986 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -79.08 -32.67 44.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.447 1.099 . . . . 0.0 111.723 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -166.6 159.88 14.61 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.228 1.811 . . . . 0.0 111.528 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -150.07 126.35 10.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.167 1.387 . . . . 0.0 110.804 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.9 172.63 24.41 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.976 1.274 . . . . 0.0 113.45 -170.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -153.49 145.72 23.85 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.161 0.985 . . . . 0.0 112.161 -170.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -141.04 -177.5 5.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.469 1.908 . . . . 0.0 109.362 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -59.45 117.45 4.87 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.019 -1.051 . . . . 0.0 110.708 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.8 t30 60.54 12.85 3.8 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 127.111 2.165 . . . . 0.0 115.158 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -133.91 127.38 32.35 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.752 1.614 . . . . 0.0 111.922 -169.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -122.15 140.94 51.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.824 1.65 . . . . 0.0 109.972 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 t -153.55 155.34 35.99 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.047 -1.033 . . . . 0.0 112.886 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -147.97 153.58 39.2 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.245 1.418 . . . . 0.0 111.88 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -111.35 141.16 45.26 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.574 1.55 . . . . 0.0 109.439 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 p -138.91 150.56 46.08 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.786 0.834 . . . . 0.0 112.7 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.59 173.82 46.01 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.957 1.265 . . . . 0.0 113.715 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -63.66 -14.8 55.32 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -77.44 -16.84 58.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.128 1.771 . . . . 0.0 115.292 -176.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.2 p -79.29 -179.07 6.54 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.32 1.048 . . . . 0.0 113.498 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -62.02 -36.65 82.2 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.54 1.136 . . . . 0.0 113.296 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -94.94 -20.81 19.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.079 1.352 . . . . 0.0 114.338 -174.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.31 -179.07 49.38 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.886 1.232 . . . . 0.0 112.02 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -65.82 129.52 40.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.878 0.871 . . . . 0.0 111.823 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.09 -177.22 42.36 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 122.143 0.857 . . . . 0.0 113.508 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.2 mt -121.75 139.26 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.046 1.739 . . . . 0.0 108.698 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -133.85 128.06 33.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.971 1.308 . . . . 0.0 110.035 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.89 142.72 51.39 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.649 1.179 . . . . 0.0 112.725 -172.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -139.17 129.71 25.82 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.69 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -72.35 133.35 44.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.001 0.52 . . . . 0.0 110.754 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.0 t -168.46 124.34 0.98 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.185 1.794 . . . . 0.0 111.044 -171.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.8 m -70.97 -9.48 58.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -117.68 22.48 12.32 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.434 1.894 . . . . 0.0 112.405 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.67 -38.15 31.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.265 1.426 . . . . 0.0 114.299 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.56 -36.66 73.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.751 0.82 . . . . 0.0 112.926 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -65.07 -40.09 94.19 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.58 -0.7 . . . . 0.0 110.788 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.19 -47.89 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.941 0.497 . . . . 0.0 110.296 173.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.31 -44.64 92.54 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.555 1.142 . . . . 0.0 112.11 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -70.0 -33.63 72.29 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.854 0.862 . . . . 0.0 113.088 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -74.88 -41.67 59.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.951 0.796 . . . . 0.0 110.4 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.3 mt -52.12 -55.13 22.82 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.728 0.811 . . . . 0.0 112.869 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.59 -25.43 68.07 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.88 -29.42 68.52 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.505 1.048 . . . . 0.0 112.677 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.6 mt -96.09 -39.38 9.76 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.354 1.462 . . . . 0.0 110.999 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.3 mtp -70.82 -29.76 66.01 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.306 1.042 . . . . 0.0 113.3 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -65.27 -20.0 66.22 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 14.1 t -71.37 -26.17 62.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.372 0.669 . . . . 0.0 112.539 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 50.61 38.92 20.17 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.379 1.472 . . . . 0.0 112.582 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.5 t -60.82 135.04 57.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.58 -41.67 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.213 1.405 . . . . 0.0 109.616 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -70.7 -12.97 61.88 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.7 m -88.06 3.7 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.511 1.125 . . . . 0.0 113.422 171.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 47.0 mtt -136.61 -179.11 5.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.304 1.842 . . . . 0.0 111.283 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -79.77 175.66 10.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.032 0.933 . . . . 0.0 111.72 169.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.66 143.99 80.89 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.742 0.817 . . . . 0.0 112.984 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.92 159.12 53.54 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.579 2.853 . . . . 0.0 112.147 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -116.44 135.13 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.452 1.501 . . . . 0.0 110.658 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mp -87.91 121.93 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.663 1.185 . . . . 0.0 108.199 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.9 mt -89.2 108.89 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.606 0.763 . . . . 0.0 109.454 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.4 t -63.8 -32.12 73.53 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.89 1.276 . . . . 0.0 113.525 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -89.86 111.43 22.47 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.019 0.928 . . . . 0.0 110.052 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -154.56 160.0 41.23 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.266 1.426 . . . . 0.0 111.563 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -172.04 171.03 5.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.542 1.937 . . . . 0.0 110.286 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -158.09 147.57 15.01 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 125.704 1.602 . . . . 0.0 112.388 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.4 166.8 28.63 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.701 2.934 . . . . 0.0 111.425 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -134.22 126.64 30.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.619 1.167 . . . . 0.0 110.931 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -147.63 146.03 29.2 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.303 2.241 . . . . 0.0 108.993 -175.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.1 tp -156.78 131.21 8.65 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.544 1.138 . . . . 0.0 110.845 -176.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -85.71 166.65 15.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.356 1.462 . . . . 0.0 112.715 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.92 144.82 48.08 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.824 1.25 . . . . 0.0 111.91 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -80.51 160.25 22.39 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.833 3.022 . . . . 0.0 111.656 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -156.96 160.05 38.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.052 1.341 . . . . 0.0 111.868 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -164.55 148.17 7.72 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 126.153 1.781 . . . . 0.0 111.156 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.06 175.74 10.93 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.662 2.908 . . . . 0.0 111.0 172.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -128.07 116.11 20.38 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.294 1.038 . . . . 0.0 109.161 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.63 139.2 15.8 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.649 2.233 . . . . 0.0 111.108 -173.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.94 159.91 37.53 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.48 2.787 . . . . 0.0 111.271 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -156.05 132.47 10.17 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.308 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -159.26 135.92 9.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.537 1.535 . . . . 0.0 110.889 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.7 tp -163.01 131.06 3.75 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.092 1.757 . . . . 0.0 109.513 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.99 142.97 12.31 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.906 1.241 . . . . 0.0 112.512 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -163.91 158.64 20.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.881 1.672 . . . . 0.0 111.429 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 45.3 p -138.93 156.28 47.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.838 1.655 . . . . 0.0 110.88 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.1 m -143.76 156.44 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.921 1.689 . . . . 0.0 110.938 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.2 m -110.75 134.3 52.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.756 1.222 . . . . 0.0 111.512 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.254 1.335 0 C-N-CA 126.118 1.767 . . . . 0.0 111.388 -177.566 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -102.41 121.37 42.19 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.396 0.678 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -78.97 109.24 13.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.996 1.319 . . . . 0.0 111.005 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.53 153.4 24.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.536 0.735 . . . . 0.0 112.024 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -81.73 -28.22 33.47 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.89 1.276 . . . . 0.0 112.534 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -157.03 162.83 39.54 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.441 1.896 . . . . 0.0 111.359 -170.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -78.56 132.22 65.93 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 121.542 -0.724 . . . . 0.0 111.55 -173.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -83.62 -4.78 10.8 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.321 2.681 . . . . 0.0 114.358 -171.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 14.6 t -122.84 145.45 48.43 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.606 1.094 . . . . 0.0 113.44 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.08 -4.53 71.67 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.609 1.576 . . . . 0.0 114.532 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -119.39 123.23 43.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.791 1.636 . . . . 0.0 109.828 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -157.11 152.25 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.394 1.078 . . . . 0.0 110.882 -167.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -122.53 146.94 46.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.134 1.374 . . . . 0.0 110.307 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -118.7 112.3 19.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.157 1.783 . . . . 0.0 110.068 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.27 -64.15 0.9 Allowed Glycine 0 N--CA 1.473 1.155 0 C-N-CA 124.302 0.953 . . . . 0.0 112.874 -172.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -86.68 3.03 46.42 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -130.57 116.62 18.4 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.858 1.263 . . . . 0.0 109.02 171.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -90.06 71.82 7.38 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.383 1.073 . . . . 0.0 109.664 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 C-N-CA 125.695 1.598 . . . . 0.0 114.461 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.519 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.0 p -161.41 158.1 26.24 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.332 1.453 . . . . 0.0 110.724 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.5 t -165.66 167.2 17.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.134 1.374 . . . . 0.0 111.121 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.42 174.61 43.17 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.156 1.36 . . . . 0.0 113.549 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.5 t -158.92 134.06 8.37 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 110.559 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.5 m -169.92 143.47 2.58 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.983 2.113 . . . . 0.0 110.084 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.47 -136.95 30.31 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.679 0.657 . . . . 0.0 112.349 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt -105.56 131.14 53.33 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.989 1.316 . . . . 0.0 110.175 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -87.54 147.19 25.46 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.05 1.34 . . . . 0.0 112.721 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.06 141.94 49.24 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.526 0.73 . . . . 0.0 112.667 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -159.55 147.1 17.04 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.238 2.215 . . . . 0.0 110.008 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t 62.67 24.15 14.38 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.626 1.17 . . . . 0.0 113.247 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.5 t -58.14 128.04 81.09 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 125.565 1.546 . . . . 0.0 111.138 -170.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.13 148.96 85.85 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.155 2.57 . . . . 0.0 111.053 175.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -62.79 -8.05 6.13 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -124.04 19.96 9.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.318 1.447 . . . . 0.0 114.281 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -53.4 141.54 42.65 Favored Pre-proline 0 CA--C 1.557 1.215 0 O-C-N 121.171 -0.956 . . . . 0.0 113.4 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.67 -10.44 26.58 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.246 2.63 . . . . 0.0 115.177 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.2 p -128.87 -21.1 3.4 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -115.51 134.66 54.86 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.024 0.929 . . . . 0.0 110.83 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.29 121.19 24.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.214 1.406 . . . . 0.0 107.97 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 140.91 44.15 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.28 -0.888 . . . . 0.0 110.447 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.3 m -145.18 163.24 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.295 1.038 . . . . 0.0 111.608 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.1 m -143.87 123.2 13.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.427 1.091 . . . . 0.0 108.774 170.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.46 132.86 51.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.16 0.984 . . . . 0.0 110.339 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.67 156.08 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.806 1.242 . . . . 0.0 113.018 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -93.37 -165.53 1.35 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.644 1.578 . . . . 0.0 114.309 -179.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.14 -35.1 72.91 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.035 1.334 . . . . 0.0 113.656 172.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.27 -13.04 58.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.039 0.836 . . . . 0.0 113.167 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.72 17.84 74.37 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 118.295 -1.28 . . . . 0.0 113.624 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.3 m -76.31 150.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.537 1.669 . . . . 0.0 111.145 173.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.1 123.99 32.76 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.276 1.031 . . . . 0.0 111.309 -171.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.7 mt -104.85 -50.06 3.36 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.551 1.14 . . . . 0.0 111.786 -172.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.91 132.38 3.44 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 124.684 1.135 . . . . 0.0 113.633 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p -85.44 149.45 25.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.938 1.295 . . . . 0.0 112.635 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.41 171.7 39.18 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.829 1.204 . . . . 0.0 114.391 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.9 t -113.25 120.34 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 39.1 tpp -86.02 132.03 34.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.762 0.825 . . . . 0.0 109.424 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -128.89 128.74 44.43 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.869 1.668 . . . . 0.0 108.272 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.52 125.43 50.99 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.024 1.73 . . . . 0.0 108.029 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -131.59 168.29 17.95 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.684 1.193 . . . . 0.0 110.072 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -65.17 -10.87 34.74 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.121 0.569 . . . . 0.0 112.344 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -95.91 -41.89 8.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.42 1.088 . . . . 0.0 113.114 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -177.68 171.16 1.91 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.131 1.372 . . . . 0.0 112.837 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -87.29 136.64 32.85 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.064 0.945 . . . . 0.0 109.012 167.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.54 130.95 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.886 0.874 . . . . 0.0 111.492 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 mt -100.34 130.04 46.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.502 1.121 . . . . 0.0 110.532 168.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -106.26 131.53 53.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.461 1.904 . . . . 0.0 110.961 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mp -135.19 151.62 50.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.709 1.603 . . . . 0.0 110.73 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -70.07 112.81 6.71 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.632 -0.668 . . . . 0.0 111.984 173.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? 59.65 13.63 3.53 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.663 1.985 . . . . 0.0 115.859 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -107.99 160.39 15.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.058 1.743 . . . . 0.0 110.707 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -62.29 137.14 58.2 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.654 0.782 . . . . 0.0 110.496 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.75 151.72 46.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.52 0.728 . . . . 0.0 111.266 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 t -131.04 128.52 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.569 0.747 . . . . 0.0 110.79 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.29 147.18 48.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.442 1.497 . . . . 0.0 112.588 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -139.34 118.99 9.23 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.795 1.238 . . . . 0.0 111.437 173.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.89 146.25 64.9 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.503 2.135 . . . . 0.0 109.559 171.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -59.73 -26.41 65.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.1 mt -58.17 -27.76 64.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.281 1.833 . . . . 0.0 114.397 171.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.5 p -90.56 -9.71 46.13 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -94.6 84.96 4.38 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.873 1.269 . . . . 0.0 110.932 -172.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -73.44 -19.42 60.96 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 54.5 ttp180 -157.84 123.52 4.6 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.836 1.655 . . . . 0.0 110.051 -173.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -140.87 109.66 6.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.987 1.715 . . . . 0.0 111.097 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.63 169.89 13.11 Favored Glycine 0 N--CA 1.462 0.411 0 C-N-CA 124.713 1.149 . . . . 0.0 113.731 -169.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -140.35 159.46 42.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.39 1.076 . . . . 0.0 112.738 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -154.45 174.98 14.15 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.508 2.323 . . . . 0.0 109.643 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 m -61.34 -12.56 14.36 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -172.052 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -154.63 18.29 0.46 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.151 1.38 . . . . 0.0 112.865 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.53 128.35 18.33 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.472 -1.393 . . . . 0.0 110.486 -169.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -118.98 133.2 55.98 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.124 1.77 . . . . 0.0 108.852 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 t -153.04 151.11 29.87 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.013 -1.054 . . . . 0.0 112.494 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -149.67 148.75 29.66 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.99 0.916 . . . . 0.0 112.388 -173.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -104.8 135.09 46.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.293 1.437 . . . . 0.0 110.058 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -126.47 145.89 50.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.292 1.037 . . . . 0.0 112.188 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.1 168.23 46.57 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.41 1.005 . . . . 0.0 113.282 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -65.94 -11.35 46.79 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -70.14 -19.87 63.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.659 1.584 . . . . 0.0 114.967 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -85.87 -179.88 6.9 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -63.21 -39.28 94.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.488 1.115 . . . . 0.0 113.181 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.5 p -96.45 -22.61 17.02 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.972 1.309 . . . . 0.0 113.492 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.99 -162.04 29.67 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.566 2.031 . . . . 0.0 113.644 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -56.75 125.88 24.34 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.354 1.062 . . . . 0.0 111.524 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.78 171.98 27.47 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.453 1.025 . . . . 0.0 113.304 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.2 mt -115.04 131.45 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.531 1.532 . . . . 0.0 108.337 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.49 113.64 18.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.91 1.284 . . . . 0.0 109.669 -172.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.27 140.57 45.73 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.177 1.391 . . . . 0.0 112.298 -173.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -138.76 125.55 20.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.199 1.0 . . . . 0.0 111.405 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -63.75 126.79 28.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.822 0.849 . . . . 0.0 110.434 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.6 t -167.86 126.65 1.25 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.635 1.574 . . . . 0.0 111.462 -170.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -69.74 -44.21 70.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.185 0.594 . . . . 0.0 112.459 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.1 mtm-85 -90.45 31.28 1.04 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.566 1.546 . . . . 0.0 113.889 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.04 -37.32 61.47 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.666 1.187 . . . . 0.0 113.967 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -70.53 -36.85 73.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.598 0.759 . . . . 0.0 112.843 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -64.54 -42.11 95.93 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.719 -0.613 . . . . 0.0 110.249 173.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.97 -48.44 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.322 0.649 . . . . 0.0 110.626 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.52 -40.47 83.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.51 1.124 . . . . 0.0 112.304 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -73.75 -31.87 63.55 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -77.93 -39.04 44.11 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.064 0.847 . . . . 0.0 110.342 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.51 -53.0 19.78 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.223 1.409 . . . . 0.0 113.852 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -64.82 -22.54 67.01 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -74.05 -25.06 59.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.088 0.955 . . . . 0.0 112.547 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.2 mt -96.47 -32.67 12.19 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.138 1.375 . . . . 0.0 111.795 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.1 mtt -55.1 -40.2 70.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.566 0.746 . . . . 0.0 112.685 171.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -75.05 -17.34 60.51 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 10.3 t -91.76 -22.15 20.33 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.32 1.448 . . . . 0.0 112.306 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -68.33 176.32 2.86 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.782 2.033 . . . . 0.0 114.399 -173.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.0 m 73.74 41.71 0.42 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.34 1.856 . . . . 0.0 111.908 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 mp -85.37 71.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.579 1.151 . . . . 0.0 109.893 -173.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 54.97 49.06 18.52 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.19 1.396 . . . . 0.0 112.094 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.4 m -60.22 -9.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -172.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.06 112.5 3.01 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.229 0.922 . . . . 0.0 110.239 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -161.91 167.15 25.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.908 1.683 . . . . 0.0 109.783 -169.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.69 145.37 61.81 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.443 1.097 . . . . 0.0 113.258 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.62 159.93 49.68 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.689 2.926 . . . . 0.0 112.105 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.6 t -113.28 126.11 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.177 1.391 . . . . 0.0 109.506 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.1 mp -78.38 129.91 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.439 1.096 . . . . 0.0 108.908 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.5 pt -73.05 136.27 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.858 -0.526 . . . . 0.0 111.927 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.8 p -78.39 161.88 26.83 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.335 1.454 . . . . 0.0 110.515 171.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.2 tpp85 -45.81 123.38 4.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.246 1.418 . . . . 0.0 111.752 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -63.98 124.21 21.0 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.279 1.032 . . . . 0.0 111.476 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.1 t -66.31 148.14 52.28 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.315 0.578 . . . . 0.0 112.158 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -63.35 143.67 97.72 Favored Pre-proline 0 CA--C 1.556 1.19 0 O-C-N 120.985 -1.072 . . . . 0.0 113.45 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.21 178.27 7.52 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.924 3.083 . . . . 0.0 111.759 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -144.04 169.75 17.25 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.535 1.534 . . . . 0.0 111.686 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.28 148.08 52.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.322 1.049 . . . . 0.0 112.085 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.42 171.41 9.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.101 1.76 . . . . 0.0 112.008 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -140.48 135.78 32.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.214 1.406 . . . . 0.0 110.545 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 pp -79.86 137.21 54.12 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.035 0.934 . . . . 0.0 110.834 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.94 126.48 8.76 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.411 2.074 . . . . 0.0 110.146 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -63.68 151.23 42.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.117 0.967 . . . . 0.0 111.374 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.13 144.3 60.34 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 124.709 1.203 . . . . 0.0 113.104 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.48 -178.54 4.55 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.281 3.321 . . . . 0.0 111.962 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -143.65 148.34 42.79 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.158 1.383 . . . . 0.0 110.761 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.1 131.76 15.83 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.963 2.442 . . . . 0.0 111.037 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.69 149.48 20.9 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.333 2.689 . . . . 0.0 111.448 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -90.58 140.76 29.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.108 0.963 . . . . 0.0 111.353 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -154.09 156.18 36.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.275 1.43 . . . . 0.0 111.598 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 pp -76.25 160.06 30.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.654 1.182 . . . . 0.0 113.021 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -86.82 -99.32 0.82 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 125.207 1.384 . . . . 0.0 111.434 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -158.85 150.05 20.41 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.887 1.275 . . . . 0.0 112.425 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 m -93.25 2.06 56.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.839 1.656 . . . . 0.0 113.675 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.1 t 68.06 35.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 126.189 1.795 . . . . 0.0 111.025 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.4 m -83.72 25.99 0.74 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.786 1.634 . . . . 0.0 114.044 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.255 1.379 0 C-N-CA 126.193 1.797 . . . . 0.0 113.129 179.202 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.981 -0.533 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -154.59 -175.88 5.63 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.389 1.875 . . . . 0.0 110.623 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.81 94.73 2.63 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.755 2.022 . . . . 0.0 110.514 172.096 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 15.8 mt -67.78 150.03 49.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.032 0.933 . . . . 0.0 112.521 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -84.92 -14.71 46.83 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -159.44 165.26 33.51 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.548 1.539 . . . . 0.0 111.708 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -87.0 123.33 70.44 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.091 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.48 -20.46 5.81 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.283 2.655 . . . . 0.0 114.009 -171.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 82.6 m -89.76 129.53 36.15 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.982 0.913 . . . . 0.0 111.937 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.25 -3.16 84.99 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.696 1.141 . . . . 0.0 114.795 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -141.49 136.82 31.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.326 1.451 . . . . 0.0 109.668 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.7 p -164.94 142.24 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.553 1.541 . . . . 0.0 111.36 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -109.68 127.81 54.82 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.864 2.066 . . . . 0.0 109.243 172.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -83.02 117.85 23.11 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.692 0.797 . . . . 0.0 110.905 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.15 -110.67 1.41 Allowed Glycine 0 N--CA 1.469 0.884 0 C-N-CA 124.959 1.266 . . . . 0.0 112.082 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -62.47 111.39 2.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.072 0.949 . . . . 0.0 110.613 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -158.13 152.28 24.22 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.382 1.473 . . . . 0.0 109.197 -168.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -69.7 126.7 30.52 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.938 -0.476 . . . . 0.0 111.581 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 C--O 1.252 1.225 0 C-N-CA 125.639 1.576 . . . . 0.0 111.536 171.48 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 m -163.49 145.19 9.49 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.404 1.882 . . . . 0.0 110.441 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -166.58 177.99 6.29 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.422 1.489 . . . . 0.0 111.379 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 122.74 144.73 6.76 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 126.199 1.857 . . . . 0.0 113.223 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.9 t -167.95 162.06 13.22 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.291 1.837 . . . . 0.0 110.614 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.1 m -151.88 138.36 18.6 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.179 1.392 . . . . 0.0 111.531 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.63 179.03 30.29 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.097 1.332 . . . . 0.0 113.61 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.89 166.3 28.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.568 1.947 . . . . 0.0 111.578 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -157.82 157.27 32.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.167 1.387 . . . . 0.0 111.455 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -142.3 139.18 31.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.062 1.745 . . . . 0.0 111.234 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -81.57 -18.6 44.3 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.473 1.109 . . . . 0.0 113.432 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.7 t -162.08 171.6 17.25 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.845 1.658 . . . . 0.0 110.355 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.19 119.14 70.08 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.438 1.095 . . . . 0.0 110.252 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.61 166.75 23.49 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.224 2.616 . . . . 0.0 111.304 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.65 -5.15 7.55 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.65 1.18 . . . . 0.0 113.274 171.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -129.86 21.75 5.42 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.198 1.799 . . . . 0.0 114.043 -169.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -58.23 146.64 69.82 Favored Pre-proline 0 CA--C 1.56 1.342 0 O-C-N 120.886 -1.133 . . . . 0.0 112.899 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.72 -17.85 25.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.876 2.384 . . . . 0.0 115.253 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.1 p -127.51 -20.29 4.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.386 1.448 . . . . 0.0 114.688 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 149.63 28.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.11 0.868 . . . . 0.0 110.109 169.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.52 109.11 6.57 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -68.97 130.58 43.18 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.59 -0.694 . . . . 0.0 109.93 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.2 m -139.6 164.86 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.758 1.223 . . . . 0.0 112.219 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.4 m -139.62 121.03 15.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.785 1.234 . . . . 0.0 108.615 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -66.61 133.18 49.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.819 0.448 . . . . 0.0 110.127 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.39 155.63 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.085 0.954 . . . . 0.0 112.592 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -82.3 -166.95 1.39 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.452 1.501 . . . . 0.0 113.12 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -66.18 -33.71 76.38 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -81.6 -28.69 33.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.322 0.964 . . . . 0.0 112.173 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.22 16.88 7.5 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 125.202 1.382 . . . . 0.0 112.261 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 t -74.3 140.53 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.345 2.258 . . . . 0.0 108.948 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -88.36 123.77 33.26 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.529 1.532 . . . . 0.0 110.393 -171.146 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.9 mt -108.52 -53.25 2.66 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.896 0.878 . . . . 0.0 112.575 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.98 142.01 9.17 Favored Glycine 0 N--CA 1.47 0.953 0 C-N-CA 124.82 1.2 . . . . 0.0 113.602 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -87.89 148.03 24.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.633 1.173 . . . . 0.0 112.666 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.03 170.09 33.73 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.529 1.061 . . . . 0.0 114.045 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.3 t -116.85 120.41 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 38.4 tpp -88.16 139.56 30.38 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.942 1.297 . . . . 0.0 110.204 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.01 130.25 25.18 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.791 1.636 . . . . 0.0 109.185 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mp -106.46 138.54 42.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.67 1.988 . . . . 0.0 108.313 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -140.27 174.47 10.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.086 1.355 . . . . 0.0 111.049 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -76.73 9.57 2.74 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.259 -0.901 . . . . 0.0 112.535 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.6 t -118.19 -49.64 2.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.95 1.3 . . . . 0.0 112.954 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -173.3 171.3 4.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.072 1.349 . . . . 0.0 112.509 -168.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 mt -85.8 140.15 30.69 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.77 0.828 . . . . 0.0 109.528 168.068 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 36.0 t -134.61 127.88 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.884 0.874 . . . . 0.0 111.418 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.9 mt -100.38 132.92 45.49 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.169 1.388 . . . . 0.0 109.696 167.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -107.6 125.45 51.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.623 1.969 . . . . 0.0 110.315 171.411 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.23 171.62 13.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.346 1.858 . . . . 0.0 111.279 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -124.68 -8.44 7.35 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -116.71 7.98 13.63 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 126.214 1.806 . . . . 0.0 112.477 170.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -150.63 159.12 44.72 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 128.018 2.527 . . . . 0.0 109.696 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -67.29 160.1 27.83 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.966 0.506 . . . . 0.0 110.022 168.588 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.38 150.04 40.77 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.742 -0.599 . . . . 0.0 111.453 172.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.5 t -129.24 127.15 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.459 0.704 . . . . 0.0 111.118 -175.121 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.9 mtm-85 -119.14 143.63 47.09 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.204 1.802 . . . . 0.0 112.153 -169.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -139.37 114.2 8.16 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.367 1.067 . . . . 0.0 111.936 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.72 143.65 68.56 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.98 2.453 . . . . 0.0 110.391 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -60.71 -21.79 63.29 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.03 -46.76 89.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.946 1.698 . . . . 0.0 111.728 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 p -78.2 -17.31 56.93 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.53 65.96 6.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.993 1.717 . . . . 0.0 111.111 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -70.89 -24.15 62.43 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -172.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -147.43 118.53 7.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.157 1.783 . . . . 0.0 108.492 -175.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -140.54 110.77 6.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.322 1.849 . . . . 0.0 110.717 -173.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.88 168.19 15.16 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 124.644 1.116 . . . . 0.0 114.104 -168.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -138.63 163.14 32.85 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.578 1.151 . . . . 0.0 112.648 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -148.7 -169.95 3.49 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.06 2.144 . . . . 0.0 109.524 170.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.3 m -68.4 -14.86 63.3 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -156.49 11.75 0.26 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.49 1.516 . . . . 0.0 114.126 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -136.59 129.89 31.52 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.915 1.686 . . . . 0.0 110.06 -168.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -123.39 135.85 54.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.924 1.69 . . . . 0.0 109.249 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 t -153.02 155.68 37.37 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.219 1.008 . . . . 0.0 112.277 -174.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.34 154.69 32.43 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.269 1.028 . . . . 0.0 112.647 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -91.77 152.22 20.25 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.334 1.854 . . . . 0.0 110.66 171.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 90.8 p -141.29 152.1 44.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.414 1.085 . . . . 0.0 112.108 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.33 162.2 18.02 Favored Glycine 0 N--CA 1.473 1.144 0 C-N-CA 125.035 1.302 . . . . 0.0 114.312 -171.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -56.38 -20.69 20.55 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -82.49 -15.5 52.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.9 p -85.15 -178.27 6.74 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -56.11 -49.9 72.59 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.944 1.298 . . . . 0.0 112.173 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.4 p -88.1 -23.19 23.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.945 1.298 . . . . 0.0 112.938 -174.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.22 -154.62 35.26 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.89 1.709 . . . . 0.0 112.174 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -59.58 130.46 46.97 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.358 1.063 . . . . 0.0 111.895 173.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.09 164.41 18.06 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.152 0.882 . . . . 0.0 113.564 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.4 mt -113.49 134.02 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.687 1.195 . . . . 0.0 108.512 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -130.25 125.74 35.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.947 1.299 . . . . 0.0 109.941 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.78 141.82 50.83 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.587 1.155 . . . . 0.0 112.734 -172.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -140.87 127.86 20.66 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.83 0.852 . . . . 0.0 111.874 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -65.59 133.53 51.37 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.398 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.1 t -161.48 132.53 5.29 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.271 1.428 . . . . 0.0 111.587 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 m -68.64 -15.6 63.57 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -133.69 35.85 3.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.044 1.738 . . . . 0.0 112.967 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.57 -40.36 71.87 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -70.07 -39.49 75.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.782 0.719 . . . . 0.0 112.013 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -61.71 -39.72 92.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.286 1.034 . . . . 0.0 110.927 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.4 mt -62.19 -47.99 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 118.95 0.795 . . . . 0.0 110.631 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -58.04 -37.06 73.65 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.195 0.998 . . . . 0.0 112.426 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -79.62 -28.63 40.96 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 113.702 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt -80.47 -41.28 24.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.436 1.017 . . . . 0.0 110.184 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.1 mt -49.32 -56.47 9.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.62 1.168 . . . . 0.0 112.723 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -61.48 -21.68 64.4 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.88 -27.08 61.69 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.166 0.894 . . . . 0.0 112.589 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.4 mt -97.28 -41.83 8.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.772 1.629 . . . . 0.0 110.968 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.4 mtp -64.7 -28.74 69.8 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.938 1.295 . . . . 0.0 113.294 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -19.45 62.29 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 173.589 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.5 t -66.69 -30.26 70.47 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.642 0.656 . . . . 0.0 112.09 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 51.65 43.91 29.53 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.827 1.251 . . . . 0.0 110.959 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.1 p -56.06 127.54 31.06 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.771 1.628 . . . . 0.0 114.57 -169.332 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.46 -51.75 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.12 1.368 . . . . 0.0 111.307 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -69.18 -10.93 60.09 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -172.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.3 p -74.77 -13.22 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.39 1.876 . . . . 0.0 113.647 171.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.9 mtt -74.11 168.47 19.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.565 1.146 . . . . 0.0 112.422 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.19 176.41 3.89 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.22 1.008 . . . . 0.0 112.697 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -51.32 139.95 25.23 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.204 1.402 . . . . 0.0 113.693 -169.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.32 151.02 76.6 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.692 2.928 . . . . 0.0 112.498 -171.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 74.4 t -138.17 128.67 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.915 1.686 . . . . 0.0 108.601 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mp -76.81 130.41 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.882 0.873 . . . . 0.0 108.788 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -115.43 158.09 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.88 1.272 . . . . 0.0 110.618 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.5 t -64.61 131.02 45.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.928 0.891 . . . . 0.0 110.906 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -83.08 135.94 34.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.041 0.936 . . . . 0.0 111.137 -176.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -120.42 169.52 10.23 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.797 1.639 . . . . 0.0 111.3 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.3 p -62.76 151.58 38.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.157 0.983 . . . . 0.0 112.652 174.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -149.13 149.51 29.83 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.639 1.176 . . . . 0.0 113.137 -169.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.0 171.7 17.66 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.904 3.069 . . . . 0.0 111.567 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -148.96 149.75 31.72 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.841 1.257 . . . . 0.0 111.785 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -81.51 148.94 28.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.424 1.09 . . . . 0.0 111.965 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 pp -88.13 -175.25 4.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.181 1.393 . . . . 0.0 112.541 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -146.66 155.68 42.62 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.96 1.704 . . . . 0.0 111.819 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.4 pp -99.75 148.98 35.5 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.823 1.249 . . . . 0.0 112.474 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.7 152.03 19.51 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.653 2.902 . . . . 0.0 111.714 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.19 162.89 28.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.487 0.715 . . . . 0.0 112.867 171.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.23 154.29 39.79 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.802 1.641 . . . . 0.0 111.709 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -71.41 167.62 25.81 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.665 2.91 . . . . 0.0 111.767 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -129.44 130.76 23.32 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.969 1.307 . . . . 0.0 109.664 -176.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.52 162.13 33.54 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.633 2.889 . . . . 0.0 112.344 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.8 170.56 16.34 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.936 3.091 . . . . 0.0 111.802 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -141.5 132.08 25.48 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.397 1.079 . . . . 0.0 112.003 -172.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.93 175.29 10.81 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.185 1.394 . . . . 0.0 113.21 -176.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 40.2 tp -148.85 141.95 24.92 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.372 1.469 . . . . 0.0 110.883 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.67 -172.12 47.83 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.849 1.214 . . . . 0.0 113.819 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -157.9 160.92 38.15 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.309 1.444 . . . . 0.0 112.131 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -156.23 172.99 17.5 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.79 1.636 . . . . 0.0 111.39 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.3 p -164.37 154.17 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.802 2.041 . . . . 0.0 110.188 -169.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -155.64 172.97 17.39 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.111 1.364 . . . . 0.0 111.519 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.28 1.832 . . . . 0.0 111.512 -174.146 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -83.46 116.78 22.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.072 0.549 . . . . 0.0 111.435 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -77.92 113.92 16.29 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.605 1.162 . . . . 0.0 110.728 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 59.4 mt -82.37 153.36 25.79 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.731 0.777 . . . . 0.0 112.714 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -78.69 -26.12 44.85 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.939 1.696 . . . . 0.0 112.831 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -159.44 166.88 30.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.351 1.86 . . . . 0.0 111.725 -169.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -88.49 124.13 66.67 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.52 -0.753 . . . . 0.0 111.924 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -87.02 -22.48 1.79 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.209 2.606 . . . . 0.0 114.336 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 92.9 m -83.9 130.0 34.92 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.996 0.816 . . . . 0.0 112.281 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.17 -1.01 88.63 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.68 1.133 . . . . 0.0 115.142 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -143.32 142.15 31.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.851 1.26 . . . . 0.0 110.243 170.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 3.0 p -166.38 146.82 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.222 1.409 . . . . 0.0 111.639 -168.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -118.54 142.43 47.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.396 2.278 . . . . 0.0 109.814 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -102.75 107.61 18.56 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.924 1.289 . . . . 0.0 109.676 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.25 -25.03 45.46 Favored Glycine 0 N--CA 1.476 1.317 0 N-CA-C 115.83 1.092 . . . . 0.0 115.83 -168.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.6 16.61 19.67 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.426 1.49 . . . . 0.0 112.792 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -131.89 151.38 51.74 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.175 1.79 . . . . 0.0 110.091 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -160.66 152.54 19.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.088 1.355 . . . . 0.0 110.186 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 124.983 1.313 . . . . 0.0 114.299 177.719 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -165.73 -171.52 2.1 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.917 1.687 . . . . 0.0 110.613 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 t -153.56 132.27 12.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.386 1.474 . . . . 0.0 110.845 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.58 -150.05 21.28 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.404 1.478 . . . . 0.0 113.65 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -146.92 160.83 41.85 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.938 1.695 . . . . 0.0 110.793 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 t -158.61 -179.41 8.06 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.452 1.101 . . . . 0.0 111.87 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.61 163.41 29.21 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.795 1.664 . . . . 0.0 112.776 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -77.13 154.07 33.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.462 1.105 . . . . 0.0 111.793 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -136.34 129.64 31.65 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.031 1.732 . . . . 0.0 109.476 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -161.15 88.99 0.76 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.137 1.375 . . . . 0.0 109.281 -173.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -153.79 162.17 41.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.124 1.77 . . . . 0.0 110.921 -169.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.9 m -63.12 154.41 31.13 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.189 0.996 . . . . 0.0 111.875 169.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 p -51.79 122.73 22.63 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 124.257 1.023 . . . . 0.0 112.448 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.46 155.29 24.69 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.459 2.773 . . . . 0.0 112.187 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -65.17 -4.71 5.37 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.322 1.449 . . . . 0.0 113.885 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -117.03 10.77 14.06 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.553 1.941 . . . . 0.0 113.822 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -55.8 136.66 72.12 Favored Pre-proline 0 CA--C 1.552 1.039 0 O-C-N 121.298 -0.877 . . . . 0.0 112.41 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.41 -11.03 30.78 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.079 2.519 . . . . 0.0 114.921 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.1 p -132.73 -22.76 2.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.27 97.63 7.19 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.542 1.065 . . . . 0.0 111.295 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -96.94 126.78 42.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.219 1.408 . . . . 0.0 109.751 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -81.55 136.03 35.59 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.099 -1.001 . . . . 0.0 110.273 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.22 168.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.737 1.215 . . . . 0.0 112.329 -168.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.6 m -141.8 121.99 13.86 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.569 1.147 . . . . 0.0 109.49 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.92 130.72 44.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.211 1.004 . . . . 0.0 110.755 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.21 159.48 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.01 -171.03 2.99 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -58.41 -21.99 52.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.825 1.65 . . . . 0.0 114.705 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -103.93 -4.66 23.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.92 1.288 . . . . 0.0 112.606 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.51 17.28 66.62 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.057 -1.413 . . . . 0.0 114.38 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.95 144.76 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.081 1.94 . . . . 0.0 109.999 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -91.42 120.89 32.66 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.38 1.072 . . . . 0.0 110.27 -175.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.7 mt -107.94 -53.36 2.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.032 0.933 . . . . 0.0 112.027 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.14 132.03 3.93 Favored Glycine 0 N--CA 1.472 1.043 0 C-N-CA 124.726 1.155 . . . . 0.0 113.576 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.0 m -86.81 154.65 20.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.677 0.791 . . . . 0.0 112.659 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.13 171.34 33.93 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.099 1.333 . . . . 0.0 114.021 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -115.57 120.95 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 169.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.9 ttm -94.3 116.57 28.97 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.195 1.398 . . . . 0.0 109.754 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -109.18 128.5 55.08 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.832 1.653 . . . . 0.0 108.838 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.06 137.36 42.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.552 1.541 . . . . 0.0 108.278 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.6 p -135.41 173.2 11.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.006 1.322 . . . . 0.0 110.755 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -72.2 -0.25 11.56 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.558 -0.714 . . . . 0.0 112.608 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -115.37 -40.66 3.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -172.88 166.16 5.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.977 1.311 . . . . 0.0 112.963 -168.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mt -86.76 138.39 31.65 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.123 1.369 . . . . 0.0 109.272 168.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 t -134.75 131.77 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.664 0.785 . . . . 0.0 111.395 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.3 mt -104.75 130.66 52.78 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.221 1.408 . . . . 0.0 110.39 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -109.06 126.87 53.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.98 2.112 . . . . 0.0 110.245 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -159.28 166.46 31.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.006 1.723 . . . . 0.0 112.136 -172.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -108.24 -14.65 14.66 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -81.31 -3.29 52.13 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.261 1.425 . . . . 0.0 113.66 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -165.97 177.37 7.12 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.094 2.158 . . . . 0.0 110.102 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.89 160.71 31.32 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.407 0.683 . . . . 0.0 110.277 167.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.26 142.19 57.01 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.647 -0.658 . . . . 0.0 111.546 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 t -122.5 125.73 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.239 0.616 . . . . 0.0 111.172 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -115.81 143.79 44.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.86 1.664 . . . . 0.0 111.485 -173.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 -138.73 117.23 9.24 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.461 1.105 . . . . 0.0 111.167 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.25 144.53 68.86 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.237 1.958 . . . . 0.0 109.264 170.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -60.69 -27.29 67.75 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.02 -43.75 91.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.902 1.681 . . . . 0.0 111.588 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 79.1 m -78.86 1.58 22.97 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.26 117.29 25.92 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.844 1.202 . . . . 0.0 109.728 172.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -73.33 -35.66 66.07 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -166.13 162.75 17.88 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.721 2.008 . . . . 0.0 110.647 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -149.67 108.13 3.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.235 1.014 . . . . 0.0 110.418 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.31 161.88 12.66 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 124.875 1.226 . . . . 0.0 113.369 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -139.58 163.69 31.88 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.689 1.196 . . . . 0.0 112.61 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -153.63 -169.58 3.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.798 2.039 . . . . 0.0 109.566 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 t -64.82 -24.2 67.47 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.841 -1.162 . . . . 0.0 114.091 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -155.84 19.19 0.38 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.23 1.412 . . . . 0.0 112.996 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -142.67 128.33 19.19 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.999 1.319 . . . . 0.0 110.43 -169.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -120.84 140.98 51.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.081 1.752 . . . . 0.0 109.599 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -153.39 157.72 40.4 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.177 -0.952 . . . . 0.0 113.123 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -154.57 153.26 31.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.877 1.671 . . . . 0.0 111.136 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -108.13 133.09 52.89 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.798 0.839 . . . . 0.0 110.126 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 m -107.45 141.73 38.41 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.127 0.971 . . . . 0.0 112.588 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.79 157.12 53.53 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.832 1.206 . . . . 0.0 112.646 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -65.84 -15.79 63.23 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -168.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -91.49 -10.79 39.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.125 1.77 . . . . 0.0 115.367 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.4 p -75.86 -177.52 3.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -55.89 -40.23 72.71 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.504 1.122 . . . . 0.0 112.941 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.4 p -93.54 -23.4 18.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.943 1.297 . . . . 0.0 113.556 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.47 -161.85 41.2 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.056 1.312 . . . . 0.0 111.544 -171.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -66.12 128.46 36.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.811 0.844 . . . . 0.0 111.375 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.62 161.38 18.59 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 123.154 0.407 . . . . 0.0 114.036 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 88.1 mt -104.89 131.28 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.002 1.321 . . . . 0.0 108.514 169.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -127.76 125.23 39.52 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.819 1.248 . . . . 0.0 109.491 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.35 143.45 50.58 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.146 0.978 . . . . 0.0 112.663 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.93 124.3 19.28 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.901 -168.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -64.62 131.2 46.32 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.234 0.614 . . . . 0.0 110.706 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 37.3 t -169.98 122.88 0.71 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.111 1.764 . . . . 0.0 110.462 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -68.64 -14.42 63.0 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.62 -0.675 . . . . 0.0 112.812 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 mtt85 -108.56 22.76 15.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.442 1.897 . . . . 0.0 113.519 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.93 -37.81 21.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.583 1.153 . . . . 0.0 113.654 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.85 -40.45 79.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.451 1.101 . . . . 0.0 113.144 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.3 -34.65 77.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.466 -0.771 . . . . 0.0 111.384 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.44 -49.55 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.163 0.585 . . . . 0.0 110.291 170.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -37.31 82.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.559 0.744 . . . . 0.0 112.35 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -71.1 -29.39 65.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.758 0.823 . . . . 0.0 113.178 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.7 tp -86.77 -36.54 18.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.49 1.041 . . . . 0.0 112.419 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.1 mt -52.59 -55.9 19.07 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.971 0.908 . . . . 0.0 112.068 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -57.86 -21.01 40.62 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.53 -25.33 25.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.627 1.171 . . . . 0.0 113.42 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.5 mt -95.98 -33.53 12.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.797 1.239 . . . . 0.0 111.728 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 97.0 mtp -66.0 -19.55 65.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.857 1.663 . . . . 0.0 113.734 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -92.13 -8.18 46.42 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.117 1.367 . . . . 0.0 113.73 169.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.7 t -96.78 -1.49 46.19 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.248 1.419 . . . . 0.0 113.524 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -71.0 175.71 4.94 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.857 1.263 . . . . 0.0 112.643 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -71.62 96.25 1.54 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.5 1.12 . . . . 0.0 112.896 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.5 mm -86.33 -44.31 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.317 -0.864 . . . . 0.0 111.769 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -131.65 17.8 4.77 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.304 1.442 . . . . 0.0 113.062 -171.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.8 t -85.75 83.31 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 126.32 1.848 . . . . 0.0 108.057 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.0 ptp -40.6 119.19 1.06 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.448 2.299 . . . . 0.0 112.812 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -168.78 155.94 7.36 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.504 1.922 . . . . 0.0 109.174 -169.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.82 139.64 90.09 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.44 0.696 . . . . 0.0 112.49 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.58 156.69 36.13 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.677 2.918 . . . . 0.0 111.635 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.32 114.27 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.997 1.319 . . . . 0.0 109.174 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.51 123.26 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.848 1.659 . . . . 0.0 108.172 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.5 pt -82.53 -15.46 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.4 m -165.58 119.29 1.19 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.849 2.459 . . . . 0.0 108.145 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -85.09 159.36 20.19 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.558 1.143 . . . . 0.0 111.868 176.097 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -153.84 149.77 27.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.641 1.576 . . . . 0.0 110.865 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -77.84 148.49 34.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.83 0.852 . . . . 0.0 111.837 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -66.22 147.3 98.93 Favored Pre-proline 0 CA--C 1.556 1.186 0 O-C-N 121.073 -1.017 . . . . 0.0 112.855 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.56 147.68 58.28 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.337 2.691 . . . . 0.0 111.509 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.85 74.9 7.8 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.599 1.16 . . . . 0.0 111.291 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.89 143.86 57.24 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.207 1.403 . . . . 0.0 111.242 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.16 163.98 31.49 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.49 1.516 . . . . 0.0 112.239 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -166.33 174.01 9.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.414 1.886 . . . . 0.0 111.448 -172.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.97 147.12 64.63 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.327 1.451 . . . . 0.0 111.103 175.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.55 140.64 21.55 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.3 2.667 . . . . 0.0 111.39 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.72 176.06 8.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.052 0.941 . . . . 0.0 112.336 172.376 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.13 142.64 33.92 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.422 1.489 . . . . 0.0 111.346 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.82 158.42 38.99 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.504 2.803 . . . . 0.0 111.381 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -69.23 142.1 92.22 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.665 0.786 . . . . 0.0 111.042 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.54 145.96 43.22 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.868 2.378 . . . . 0.0 111.126 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.59 157.84 36.04 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.66 2.907 . . . . 0.0 111.476 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -142.85 132.51 23.86 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.07 1.348 . . . . 0.0 110.867 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -164.05 166.75 21.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.303 1.841 . . . . 0.0 111.101 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 pp -156.25 170.85 21.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.71 1.604 . . . . 0.0 111.755 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.93 178.35 31.68 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.025 1.297 . . . . 0.0 113.563 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -145.31 158.26 43.87 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.645 1.578 . . . . 0.0 112.183 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.0 m -133.09 143.91 49.62 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.388 1.875 . . . . 0.0 109.265 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 62.3 t -133.94 137.76 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.886 1.674 . . . . 0.0 108.89 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.8 t -158.55 169.92 23.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.202 1.401 . . . . 0.0 111.517 -176.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.254 1.338 0 C-N-CA 126.34 1.856 . . . . 0.0 111.54 -174.948 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -108.25 121.17 44.32 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.64 0.776 . . . . 0.0 110.005 171.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -85.54 121.29 28.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.304 1.042 . . . . 0.0 110.844 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 80.4 mt -83.83 164.1 19.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.629 0.728 . . . . 0.0 112.718 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -106.59 2.21 25.87 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.812 1.645 . . . . 0.0 113.835 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -160.33 164.93 32.13 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.509 2.324 . . . . 0.0 110.472 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -90.94 118.31 68.5 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.307 174.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.87 -24.47 3.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.314 2.676 . . . . 0.0 114.772 -168.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 81.7 m -80.19 127.84 32.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.028 0.831 . . . . 0.0 111.873 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.58 -7.07 88.77 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.522 1.058 . . . . 0.0 114.449 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.42 131.01 31.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.337 1.855 . . . . 0.0 109.814 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 p -164.62 147.27 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.176 1.39 . . . . 0.0 111.112 -169.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -132.05 170.42 14.97 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.612 2.365 . . . . 0.0 111.874 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -132.18 125.74 31.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.359 1.464 . . . . 0.0 110.96 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.81 -35.84 5.23 Favored Glycine 0 N--CA 1.476 1.316 0 C-N-CA 124.266 0.936 . . . . 0.0 113.778 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -103.39 73.92 1.24 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.094 1.357 . . . . 0.0 110.349 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -71.79 125.87 28.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.991 0.917 . . . . 0.0 110.042 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -101.97 170.43 8.14 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.726 1.21 . . . . 0.0 111.098 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 126.044 1.738 . . . . 0.0 111.617 -178.368 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 t -168.05 159.14 10.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.452 1.501 . . . . 0.0 110.305 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.2 t -161.33 152.93 19.11 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.986 1.315 . . . . 0.0 111.15 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.05 132.89 2.67 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.142 1.354 . . . . 0.0 111.52 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.0 p -149.3 116.26 5.99 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.928 0.891 . . . . 0.0 111.239 -173.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.5 p -93.19 151.17 19.99 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.35 144.79 9.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.287 1.899 . . . . 0.0 111.288 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.43 97.22 5.41 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.855 1.262 . . . . 0.0 108.999 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -169.48 173.7 6.34 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.582 1.953 . . . . 0.0 111.65 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -112.14 132.3 54.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.56 1.544 . . . . 0.0 111.469 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -160.7 145.39 14.17 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.879 2.072 . . . . 0.0 110.18 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.9 p -75.15 111.05 9.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.77 0.828 . . . . 0.0 110.396 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.69 122.07 74.39 Favored Pre-proline 0 N--CA 1.48 1.031 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.933 -174.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.89 149.37 42.21 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.04 2.494 . . . . 0.0 111.215 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -63.25 -13.27 36.23 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.56 1.144 . . . . 0.0 113.052 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -99.22 0.15 42.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.468 1.907 . . . . 0.0 113.244 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -51.92 137.41 35.81 Favored Pre-proline 0 CA--C 1.555 1.154 0 O-C-N 120.945 -1.097 . . . . 0.0 113.869 -171.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.15 -11.54 31.9 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.279 2.653 . . . . 0.0 115.253 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.0 p -131.42 -16.51 3.06 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.92 99.01 7.15 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.479 1.036 . . . . 0.0 111.29 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -97.47 116.38 29.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.777 1.231 . . . . 0.0 109.054 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -76.58 133.44 39.67 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.976 -1.078 . . . . 0.0 110.344 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.25 167.19 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.115 0.966 . . . . 0.0 112.485 -168.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.9 m -146.09 125.47 13.12 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.007 1.323 . . . . 0.0 108.797 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -66.37 132.6 48.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.515 0.726 . . . . 0.0 110.096 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.1 156.79 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.699 1.2 . . . . 0.0 112.809 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -89.36 -166.49 1.61 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.965 1.306 . . . . 0.0 113.988 178.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.93 -35.14 74.3 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.415 1.486 . . . . 0.0 114.319 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -80.38 -12.98 59.52 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.285 0.948 . . . . 0.0 113.063 176.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.67 17.52 72.85 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.345 -1.253 . . . . 0.0 113.554 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.8 m -75.41 149.3 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.668 1.734 . . . . 0.0 110.936 173.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -90.58 124.91 35.41 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.358 1.063 . . . . 0.0 111.321 -170.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.2 mt -107.42 -49.82 3.18 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.23 1.012 . . . . 0.0 111.991 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.69 135.37 4.44 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.782 1.182 . . . . 0.0 113.602 176.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 p -84.06 154.66 23.09 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.769 1.228 . . . . 0.0 112.984 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.07 171.07 38.75 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.858 1.218 . . . . 0.0 113.88 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.51 120.9 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 41.5 tpp -90.9 137.36 32.42 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.685 1.194 . . . . 0.0 110.283 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -138.95 130.14 26.8 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.216 1.406 . . . . 0.0 109.251 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.61 134.78 49.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.338 1.855 . . . . 0.0 107.656 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.4 p -132.07 173.4 11.26 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.078 0.951 . . . . 0.0 111.01 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -66.2 0.23 2.14 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.678 0.791 . . . . 0.0 112.685 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -116.32 -43.25 2.96 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -172.98 177.07 2.87 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -169.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.13 138.28 31.56 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.387 1.075 . . . . 0.0 110.132 167.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.65 128.69 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.308 1.043 . . . . 0.0 111.184 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.2 mt -102.12 135.12 44.25 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.504 1.522 . . . . 0.0 110.378 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -110.21 124.86 52.36 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.39 1.876 . . . . 0.0 111.068 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.74 168.92 17.47 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.202 2.201 . . . . 0.0 111.164 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -98.43 -62.91 1.18 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.612 1.165 . . . . 0.0 113.565 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.59 -7.43 54.21 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -176.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.433 ' HA ' ' HE ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -125.97 161.7 26.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.237 1.815 . . . . 0.0 110.24 175.046 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.5 pm0 -68.14 159.72 30.46 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.293 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.5 144.71 55.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.993 0.517 . . . . 0.0 111.054 172.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -123.14 126.59 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.272 0.629 . . . . 0.0 110.546 -173.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -120.76 138.43 54.01 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.569 1.548 . . . . 0.0 111.524 -169.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -139.1 114.08 8.33 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.389 1.076 . . . . 0.0 111.093 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.55 150.13 74.83 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 0.0 110.307 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -60.95 -20.67 62.59 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -65.27 -34.67 78.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.142 1.777 . . . . 0.0 113.268 170.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 89.1 m -92.63 -5.05 52.32 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.18 105.63 13.43 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.837 0.855 . . . . 0.0 109.253 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -79.76 -20.93 45.12 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.9 ttt180 -170.1 133.42 1.15 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.698 1.999 . . . . 0.0 108.753 -172.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -142.27 119.09 11.17 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.325 1.45 . . . . 0.0 110.26 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.55 164.87 22.91 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 124.077 0.846 . . . . 0.0 112.992 -169.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -130.45 155.32 46.63 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.343 1.057 . . . . 0.0 111.492 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.99 -174.11 4.76 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.878 1.671 . . . . 0.0 110.349 173.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.7 p -59.54 111.58 1.46 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.256 -0.902 . . . . 0.0 111.57 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.257 0.7 OUTLIER 51.52 23.15 1.74 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.391 2.276 . . . . 0.0 116.158 -174.25 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.33 126.39 29.6 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.424 1.49 . . . . 0.0 110.871 -172.019 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -120.18 135.16 55.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.748 1.619 . . . . 0.0 109.622 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -153.29 155.01 35.72 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.312 -0.867 . . . . 0.0 112.159 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -154.61 152.73 30.35 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.532 1.133 . . . . 0.0 112.268 -174.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -115.45 133.84 55.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.337 1.855 . . . . 0.0 110.493 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.6 m -133.26 154.38 50.73 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.354 1.062 . . . . 0.0 112.476 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.89 166.57 34.04 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.888 1.233 . . . . 0.0 113.588 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -6.37 16.71 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -174.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -82.69 -19.53 37.9 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.7 p -81.63 -179.46 7.39 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -55.13 -42.97 73.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.095 1.358 . . . . 0.0 113.003 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.4 p -93.15 -22.25 19.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.348 1.459 . . . . 0.0 113.637 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.1 -163.38 43.32 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.298 1.428 . . . . 0.0 112.539 -173.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -70.76 137.59 49.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.091 0.956 . . . . 0.0 112.793 -174.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.53 171.9 24.08 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.614 1.102 . . . . 0.0 113.355 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.63 123.11 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.091 1.356 . . . . 0.0 108.579 170.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -114.17 119.33 36.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.998 1.319 . . . . 0.0 109.393 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.61 139.15 53.39 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.394 1.078 . . . . 0.0 112.914 -169.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -140.29 131.22 26.07 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.887 0.851 . . . . 0.0 112.287 -169.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -69.39 135.32 50.14 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.813 168.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.7 t -159.03 142.75 15.05 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.131 1.372 . . . . 0.0 111.431 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.3 m -77.35 -27.48 52.68 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -127.66 40.24 3.73 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.692 1.197 . . . . 0.0 113.348 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.93 -40.88 15.09 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.52 -35.24 78.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.452 0.701 . . . . 0.0 112.8 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.93 -30.48 66.81 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.419 -0.8 . . . . 0.0 112.153 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.49 -47.28 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.688 0.676 . . . . 0.0 109.608 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -58.6 -42.61 88.51 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.177 0.991 . . . . 0.0 111.919 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -67.78 -42.44 81.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.687 1.195 . . . . 0.0 112.418 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.9 tp -75.21 -32.51 61.2 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.847 0.749 . . . . 0.0 112.177 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.2 mt -53.92 -54.36 39.92 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.698 0.799 . . . . 0.0 112.221 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -63.75 -30.97 72.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -34.19 77.38 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.221 1.008 . . . . 0.0 112.83 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.03 -35.57 21.82 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.341 1.056 . . . . 0.0 111.37 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 48.7 mtt -63.64 -46.81 83.97 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.593 0.757 . . . . 0.0 112.513 172.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -70.44 -17.62 63.0 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 13.9 t -67.76 -26.9 66.35 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.287 0.494 . . . . 0.0 112.104 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 53.47 74.72 0.29 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.981 2.112 . . . . 0.0 112.191 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 p -60.83 125.87 25.29 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.015 0.926 . . . . 0.0 112.203 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 42.2 mm -97.34 -49.94 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.174 0.99 . . . . 0.0 110.669 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.49 0.94 10.96 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.9 1.28 . . . . 0.0 114.214 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.01 -42.23 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.967 2.107 . . . . 0.0 112.613 169.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 67.3 mtm 58.54 24.92 12.48 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.414 2.286 . . . . 0.0 116.355 170.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -86.4 47.76 1.52 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.51 1.524 . . . . 0.0 111.596 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -146.71 157.91 46.87 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.903 2.081 . . . . 0.0 110.989 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.43 -176.13 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.332 3.354 . . . . 0.0 111.468 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.74 115.82 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.766 0.826 . . . . 0.0 110.961 172.851 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.4 mm -147.72 149.29 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 127.088 2.155 . . . . 0.0 109.111 -172.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -98.21 125.26 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.685 1.194 . . . . 0.0 108.862 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.0 t -161.21 155.25 22.5 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.452 1.501 . . . . 0.0 111.299 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -77.51 120.04 21.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.151 1.38 . . . . 0.0 110.655 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -63.17 147.27 51.35 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.976 0.911 . . . . 0.0 112.65 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.7 p -165.76 174.8 9.31 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.729 1.612 . . . . 0.0 111.649 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -150.23 128.63 5.97 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.636 1.174 . . . . 0.0 112.321 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.82 -176.12 3.07 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.236 3.291 . . . . 0.0 112.144 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -142.85 164.31 30.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.089 1.356 . . . . 0.0 112.568 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.2 170.82 17.17 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.596 1.958 . . . . 0.0 110.832 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.3 173.83 11.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.803 1.241 . . . . 0.0 113.072 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -145.79 134.11 21.81 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.98 1.712 . . . . 0.0 110.211 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 pp -87.42 140.06 31.95 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 123.473 0.709 . . . . 0.0 111.705 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.59 147.42 22.24 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.013 2.475 . . . . 0.0 111.295 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -77.52 137.5 38.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.713 0.805 . . . . 0.0 111.501 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.23 149.78 41.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.964 1.306 . . . . 0.0 112.251 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.83 176.18 10.34 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.039 3.159 . . . . 0.0 111.729 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -126.82 134.24 25.88 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.29 1.436 . . . . 0.0 109.7 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.67 153.25 54.16 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.305 2.67 . . . . 0.0 112.09 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.38 154.74 40.97 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.025 3.15 . . . . 0.0 112.38 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -93.27 164.77 13.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.932 1.293 . . . . 0.0 113.245 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -107.21 -174.59 2.57 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.764 1.626 . . . . 0.0 112.063 175.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.81 162.64 41.06 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.259 1.823 . . . . 0.0 112.265 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -113.19 -148.51 10.23 Favored Glycine 0 N--CA 1.474 1.232 0 C-N-CA 125.799 1.666 . . . . 0.0 113.518 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -154.78 170.52 21.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.576 1.55 . . . . 0.0 112.625 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 34.0 m -138.97 146.0 40.43 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.169 1.788 . . . . 0.0 109.505 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.35 153.25 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.584 1.154 . . . . 0.0 112.575 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.4 m -147.04 161.59 40.51 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.678 1.591 . . . . 0.0 111.815 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.252 1.235 0 C-N-CA 126.672 1.989 . . . . 0.0 112.767 177.941 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -78.45 137.57 38.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.696 0.799 . . . . 0.0 111.447 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.81 116.76 32.5 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.779 1.232 . . . . 0.0 109.721 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 98.3 mt -78.52 157.77 28.76 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -87.22 -7.97 57.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.798 1.639 . . . . 0.0 113.919 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -161.38 163.08 30.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.959 2.104 . . . . 0.0 110.499 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -86.95 122.84 71.09 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.769 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.67 -12.24 11.21 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.387 2.725 . . . . 0.0 113.75 -171.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 84.5 m -99.82 121.7 41.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.367 1.067 . . . . 0.0 111.531 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.45 -14.6 82.32 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.385 0.993 . . . . 0.0 114.576 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -127.16 138.45 53.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.478 1.511 . . . . 0.0 110.876 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.0 p -163.97 142.45 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.888 1.675 . . . . 0.0 110.868 -173.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -115.76 114.22 24.5 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.321 2.249 . . . . 0.0 107.921 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -74.45 126.75 31.4 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.634 -0.666 . . . . 0.0 110.449 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.22 -104.74 0.76 Allowed Glycine 0 N--CA 1.469 0.872 0 C-N-CA 124.521 1.058 . . . . 0.0 112.986 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -57.82 -42.83 85.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.135 0.974 . . . . 0.0 113.106 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 48.06 48.27 18.38 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.13 1.772 . . . . 0.0 112.331 170.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -68.82 155.92 39.33 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? . . . . . 0 C--O 1.251 1.183 0 C-N-CA 126.274 1.83 . . . . 0.0 112.998 -171.812 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.7 p -164.42 161.74 21.66 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.312 1.445 . . . . 0.0 111.798 -176.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.4 t -163.0 156.31 19.61 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.451 1.501 . . . . 0.0 110.997 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.97 176.38 34.96 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.108 1.337 . . . . 0.0 114.052 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 t -165.17 163.94 20.26 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.902 1.681 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 t -162.65 135.8 5.89 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.322 1.449 . . . . 0.0 111.051 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.76 152.04 20.36 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.908 1.242 . . . . 0.0 112.699 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt -145.58 158.73 43.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.486 1.914 . . . . 0.0 110.713 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -159.1 151.33 21.21 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.634 1.574 . . . . 0.0 112.009 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -143.61 137.42 28.31 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.917 1.687 . . . . 0.0 110.821 -176.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -94.68 -4.57 47.32 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.115 1.366 . . . . 0.0 113.525 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.5 m -128.38 140.92 51.6 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.873 1.669 . . . . 0.0 110.453 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.84 121.59 71.91 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.715 0.806 . . . . 0.0 111.601 -175.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.12 172.48 12.85 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.84 3.027 . . . . 0.0 112.527 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -69.87 6.64 1.13 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.64 1.976 . . . . 0.0 114.535 170.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -149.59 20.57 0.92 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -168.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -61.38 143.97 92.44 Favored Pre-proline 0 CA--C 1.558 1.265 0 O-C-N 120.749 -1.219 . . . . 0.0 113.023 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.34 -11.23 26.53 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.244 2.63 . . . . 0.0 115.287 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.2 p -127.5 -25.05 3.23 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.752 1.16 . . . . 0.0 114.0 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -104.79 134.47 47.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.066 0.946 . . . . 0.0 111.103 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -131.2 105.25 7.54 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.155 1.382 . . . . 0.0 108.478 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -65.82 127.56 32.48 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.638 0.775 . . . . 0.0 110.488 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.4 m -137.35 163.64 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.347 1.459 . . . . 0.0 111.352 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.1 m -134.25 119.44 18.76 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.307 1.043 . . . . 0.0 109.013 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.82 128.0 34.12 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.108 0.963 . . . . 0.0 109.961 175.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.99 154.88 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.547 0.739 . . . . 0.0 112.906 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -89.87 -166.94 1.71 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.649 1.18 . . . . 0.0 113.952 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.5 -29.57 70.83 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -83.33 -8.96 59.34 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.001 1.32 . . . . 0.0 112.562 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.15 16.51 80.57 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.182 -1.344 . . . . 0.0 113.729 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.1 m -81.28 150.45 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.568 1.684 . . . . 0.0 111.63 176.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.12 121.94 31.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.641 1.176 . . . . 0.0 111.151 -170.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.7 mt -102.8 -53.58 2.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.37 0.668 . . . . 0.0 111.843 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.76 149.05 20.72 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.795 1.188 . . . . 0.0 114.356 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.4 p -88.29 153.01 21.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.208 1.403 . . . . 0.0 113.152 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.46 171.39 35.26 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.243 1.401 . . . . 0.0 113.628 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.45 120.22 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.0 tpp -85.27 140.15 31.07 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.482 1.113 . . . . 0.0 109.259 170.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -133.32 129.96 38.22 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.119 1.368 . . . . 0.0 108.546 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.88 131.2 55.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.821 2.048 . . . . 0.0 108.471 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 p -133.83 173.36 11.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.847 1.259 . . . . 0.0 110.877 178.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -71.91 5.4 2.65 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.079 -1.013 . . . . 0.0 112.776 170.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.8 m -114.73 -45.85 2.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.773 1.229 . . . . 0.0 113.619 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -172.21 169.92 5.31 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.754 1.161 . . . . 0.0 113.449 -169.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.9 mt -87.44 139.96 30.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.356 1.063 . . . . 0.0 109.952 168.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.4 127.6 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.041 0.936 . . . . 0.0 111.496 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 mt -100.06 128.65 46.11 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.233 1.413 . . . . 0.0 110.374 168.13 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -108.24 129.48 55.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.305 2.242 . . . . 0.0 109.654 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.72 -11.92 0.68 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . 0.502 ' CG ' ' H ' ' A' ' 51' ' ' ARG . 38.6 t-80 -169.18 -176.01 2.44 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.137 1.775 . . . . 0.0 110.971 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.502 ' H ' ' CG ' ' A' ' 50' ' ' HIS . 26.0 mmt85 -63.27 -25.71 68.44 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.276 1.83 . . . . 0.0 111.885 168.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.78 153.31 24.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.377 1.871 . . . . 0.0 111.312 169.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -53.28 142.76 20.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.018 1.327 . . . . 0.0 113.301 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.32 154.78 41.51 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.998 0.919 . . . . 0.0 112.52 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.04 135.04 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.922 1.289 . . . . 0.0 108.119 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -131.63 149.78 52.38 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -166.831 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -141.82 116.44 6.85 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 124.549 1.14 . . . . 0.0 111.997 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.41 145.1 58.06 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.55 2.167 . . . . 0.0 109.565 170.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -61.6 -21.95 64.8 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.56 -47.64 85.28 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.705 2.002 . . . . 0.0 111.692 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.4 m -80.12 -16.56 54.69 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.13 119.63 11.19 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.939 0.791 . . . . 0.0 110.382 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -82.82 -32.08 27.78 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.356 1.063 . . . . 0.0 112.065 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -168.28 160.68 11.68 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.179 2.192 . . . . 0.0 110.725 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -149.45 116.96 6.14 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.831 1.252 . . . . 0.0 109.667 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.83 165.7 21.56 Favored Glycine 0 N--CA 1.463 0.466 0 C-N-CA 124.836 1.208 . . . . 0.0 113.358 -169.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -141.59 176.74 8.65 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.456 1.102 . . . . 0.0 113.136 -170.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -163.6 -168.01 1.55 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.677 2.391 . . . . 0.0 108.756 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 t -72.21 -19.66 61.69 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.691 -1.256 . . . . 0.0 113.198 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -152.22 8.19 0.47 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.619 1.167 . . . . 0.0 113.893 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -137.11 129.77 30.23 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.425 1.49 . . . . 0.0 110.242 -169.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -124.51 138.01 54.37 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.194 1.797 . . . . 0.0 109.208 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -153.33 152.84 31.56 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.094 -1.004 . . . . 0.0 112.326 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -150.84 153.58 35.65 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.262 1.025 . . . . 0.0 112.312 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -110.8 142.56 42.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.026 1.331 . . . . 0.0 109.379 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 t -129.32 150.55 50.64 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.476 0.71 . . . . 0.0 112.643 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.98 158.57 53.12 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.028 1.299 . . . . 0.0 113.619 -175.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -60.99 -20.93 63.04 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -170.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -80.12 -14.38 58.54 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.778 1.769 . . . . 0.0 115.778 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.87 -179.4 5.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -56.46 -47.18 79.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.495 1.518 . . . . 0.0 113.102 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.9 p -81.78 -26.13 34.7 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.52 -163.46 38.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.691 1.138 . . . . 0.0 111.79 -172.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -66.3 128.43 36.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.339 1.056 . . . . 0.0 111.342 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.37 164.2 22.6 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-O 121.557 0.532 . . . . 0.0 114.08 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.6 mt -114.89 136.07 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.493 1.517 . . . . 0.0 108.572 171.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -132.07 127.03 35.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.662 1.185 . . . . 0.0 110.614 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.29 140.88 52.57 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.3 1.44 . . . . 0.0 113.187 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -140.77 128.48 21.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.464 1.106 . . . . 0.0 111.988 -169.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -74.82 135.86 41.62 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.621 0.768 . . . . 0.0 111.738 171.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.5 p -172.33 140.06 1.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.063 2.145 . . . . 0.0 111.473 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.7 m -68.88 -20.28 64.25 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.344 -0.847 . . . . 0.0 113.272 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -100.63 17.88 20.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.989 1.716 . . . . 0.0 112.738 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.18 -39.92 31.21 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.839 1.255 . . . . 0.0 113.779 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -68.25 -37.71 81.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.302 1.041 . . . . 0.0 113.211 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.73 -34.05 76.08 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.149 -0.97 . . . . 0.0 111.911 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.95 -46.07 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.983 -0.448 . . . . 0.0 110.075 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.71 -43.15 94.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.33 1.052 . . . . 0.0 112.023 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -66.48 -37.45 85.13 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.845 1.258 . . . . 0.0 112.556 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.1 tp -80.63 -32.61 36.23 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.914 0.779 . . . . 0.0 112.43 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.6 mt -56.25 -50.42 71.39 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.65 0.659 . . . . 0.0 112.55 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -65.95 -18.79 65.57 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.69 -43.71 16.55 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.425 1.09 . . . . 0.0 110.977 173.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.0 mt -71.55 -28.18 63.68 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.845 -1.159 . . . . 0.0 111.959 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 33.6 mtt -61.32 -17.04 51.82 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 167.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -122.36 -16.22 7.42 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.8 m -91.82 4.81 52.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.527 1.931 . . . . 0.0 113.116 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -68.64 168.77 12.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.238 1.815 . . . . 0.0 112.253 169.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.4 m -73.48 79.71 1.43 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.051 1.34 . . . . 0.0 112.612 -175.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.9 mm -119.82 -54.58 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.795 1.638 . . . . 0.0 109.526 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -76.8 38.92 0.21 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.218 1.407 . . . . 0.0 112.627 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.1 p -156.4 113.88 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 128.565 2.746 . . . . 0.0 106.149 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.1 ptm -49.51 141.86 8.74 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.921 1.689 . . . . 0.0 113.274 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.0 -174.25 4.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.77 1.628 . . . . 0.0 112.228 -169.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -61.89 143.15 94.68 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.023 0.929 . . . . 0.0 111.777 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.66 154.33 73.67 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.527 2.818 . . . . 0.0 112.218 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.9 p -127.3 136.71 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.716 1.606 . . . . 0.0 110.578 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.6 mp -93.22 123.87 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.256 1.022 . . . . 0.0 108.782 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.55 21.02 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.559 1.544 . . . . 0.0 112.662 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.1 p -62.29 146.29 51.41 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.761 1.624 . . . . 0.0 112.197 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -168.19 170.81 9.89 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.975 1.71 . . . . 0.0 111.904 -170.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -67.58 137.85 56.0 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.466 0.707 . . . . 0.0 110.748 169.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.7 p -110.86 115.0 28.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.702 1.201 . . . . 0.0 110.147 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -85.08 147.57 48.19 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.834 0.854 . . . . 0.0 112.852 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.28 159.63 52.35 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.5 2.8 . . . . 0.0 111.271 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.98 150.79 27.74 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.907 1.283 . . . . 0.0 111.581 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.84 129.39 36.92 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.451 1.1 . . . . 0.0 110.916 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.06 150.95 25.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.519 1.128 . . . . 0.0 111.277 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -154.96 147.09 23.72 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.286 1.435 . . . . 0.0 111.299 -175.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 pp -92.7 146.64 32.62 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.875 1.27 . . . . 0.0 111.982 -174.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.16 145.51 21.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.059 2.506 . . . . 0.0 111.094 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 -70.65 152.4 43.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.422 0.689 . . . . 0.0 111.355 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -143.75 152.92 57.12 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.336 1.454 . . . . 0.0 111.798 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.53 174.56 12.0 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.938 3.092 . . . . 0.0 111.743 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -129.96 145.7 58.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.151 1.381 . . . . 0.0 110.059 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.51 147.27 45.84 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.21 2.607 . . . . 0.0 111.775 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.03 150.63 38.31 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.674 2.916 . . . . 0.0 111.87 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -84.77 164.21 18.66 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.431 1.092 . . . . 0.0 112.447 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.87 167.71 27.45 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.652 1.581 . . . . 0.0 111.81 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.9 165.0 37.78 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.539 1.535 . . . . 0.0 112.435 -174.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -122.81 -155.47 9.34 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.861 1.696 . . . . 0.0 113.178 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -156.7 175.11 14.48 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.565 1.546 . . . . 0.0 112.191 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.2 t -154.25 176.5 12.21 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.693 1.597 . . . . 0.0 111.068 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.0 p -166.8 148.95 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 127.006 2.122 . . . . 0.0 109.836 -171.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -156.28 151.38 26.4 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.382 1.473 . . . . 0.0 111.572 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 26.2 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 127.653 2.381 . . . . 0.0 112.151 -177.934 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -88.9 124.36 34.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.391 0.676 . . . . 0.0 110.428 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.15 109.09 18.64 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.989 0.916 . . . . 0.0 109.909 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 40.0 mt -77.46 154.78 32.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.748 0.819 . . . . 0.0 112.819 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -87.13 -19.02 29.1 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.576 1.55 . . . . 0.0 112.792 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -149.8 167.76 25.61 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.332 1.853 . . . . 0.0 111.751 -175.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -93.22 123.56 60.4 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.627 -0.702 . . . . 0.0 111.389 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.92 -18.03 6.64 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.197 2.598 . . . . 0.0 114.129 -171.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 84.0 m -101.15 115.35 30.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.154 0.982 . . . . 0.0 111.284 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.49 -41.1 45.71 Favored Glycine 0 N--CA 1.476 1.343 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -77.73 113.92 16.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.543 1.537 . . . . 0.0 110.055 169.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.36 151.03 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.737 2.015 . . . . 0.0 110.234 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -131.96 160.35 36.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.72 1.608 . . . . 0.0 111.484 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -113.77 123.9 50.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.989 1.316 . . . . 0.0 111.207 -169.165 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.28 160.29 38.07 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.35 0.976 . . . . 0.0 112.62 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 53.82 48.18 21.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.741 1.216 . . . . 0.0 112.785 171.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -61.4 130.25 45.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.386 1.074 . . . . 0.0 110.478 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -163.1 159.25 22.94 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.255 1.422 . . . . 0.0 110.058 -169.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.217 1.407 . . . . 0.0 113.126 174.308 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 112.039 -0.425 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.8 p -166.27 170.72 12.91 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.39 1.476 . . . . 0.0 111.819 -174.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -132.59 159.62 38.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.342 1.457 . . . . 0.0 111.425 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.07 -23.52 0.11 Allowed Glycine 0 N--CA 1.474 1.177 0 N-CA-C 115.254 0.862 . . . . 0.0 115.254 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.2 t -69.08 149.06 49.13 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.415 1.108 . . . . 0.0 111.54 169.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.6 t -160.59 148.71 16.3 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.803 1.241 . . . . 0.0 111.344 -174.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.16 111.21 3.2 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.074 0.845 . . . . 0.0 111.027 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 99.5 mt -137.15 128.01 27.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.921 1.688 . . . . 0.0 109.3 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -163.39 161.63 24.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.621 1.568 . . . . 0.0 111.745 -174.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -88.64 147.85 24.34 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.836 1.254 . . . . 0.0 111.228 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -85.05 -1.65 57.08 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.914 1.286 . . . . 0.0 113.313 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -142.61 145.66 33.74 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.074 1.75 . . . . 0.0 109.388 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.12 124.87 65.85 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.932 0.893 . . . . 0.0 110.961 -169.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.34 164.78 30.39 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.674 2.916 . . . . 0.0 112.092 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -74.4 5.35 4.71 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.557 1.543 . . . . 0.0 114.197 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -130.0 11.72 5.59 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.056 1.742 . . . . 0.0 113.263 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.01 145.08 45.63 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 124.521 1.128 . . . . 0.0 113.414 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.1 -14.71 32.02 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.051 2.501 . . . . 0.0 115.421 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.3 p -131.04 -18.74 2.93 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 120.229 1.377 . . . . 0.0 114.516 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -104.68 142.02 35.42 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.192 0.997 . . . . 0.0 110.447 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -141.73 108.32 5.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 145.35 52.0 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.254 -0.904 . . . . 0.0 110.51 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.36 156.7 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.609 0.763 . . . . 0.0 111.5 -172.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -132.95 115.15 14.85 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -65.24 133.52 51.66 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.86 154.46 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.076 0.95 . . . . 0.0 112.431 -176.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -88.01 -167.5 1.9 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.342 1.057 . . . . 0.0 113.599 178.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.89 -32.35 73.85 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.751 1.221 . . . . 0.0 114.234 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -79.53 -9.08 59.55 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.959 0.799 . . . . 0.0 112.533 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.92 14.5 81.93 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 117.931 -1.483 . . . . 0.0 113.923 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.1 m -76.24 150.11 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.85 1.825 . . . . 0.0 111.338 175.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.28 125.31 34.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.53 1.132 . . . . 0.0 111.183 -171.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.7 mt -107.4 -52.35 2.78 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.994 0.918 . . . . 0.0 112.107 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.17 147.14 14.96 Favored Glycine 0 N--CA 1.47 0.924 0 C-N-CA 124.591 1.091 . . . . 0.0 113.737 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 p -91.12 150.05 21.55 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.943 1.297 . . . . 0.0 113.104 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.05 168.13 32.38 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.947 1.737 . . . . 0.0 113.006 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.76 120.63 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.8 ttm -93.9 140.95 29.07 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.938 1.295 . . . . 0.0 110.619 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -140.06 130.26 25.12 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.592 1.557 . . . . 0.0 108.935 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -107.91 137.77 45.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.166 1.787 . . . . 0.0 108.016 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.9 p -137.53 174.71 10.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.779 1.232 . . . . 0.0 110.649 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -73.59 3.21 6.55 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.408 -0.807 . . . . 0.0 112.616 171.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.6 m -120.77 -45.04 2.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.532 1.133 . . . . 0.0 113.663 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.96 166.17 11.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.194 1.398 . . . . 0.0 113.706 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.13 136.97 34.26 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.855 1.262 . . . . 0.0 109.34 168.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.6 t -134.4 132.56 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.523 0.729 . . . . 0.0 110.98 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.2 mt -109.65 130.35 55.52 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.151 1.78 . . . . 0.0 110.777 169.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -100.15 125.32 46.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.531 1.933 . . . . 0.0 110.285 169.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.3 mt -131.62 162.88 29.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.921 2.088 . . . . 0.0 111.087 -173.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -113.4 -20.27 11.39 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -172.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -117.41 7.64 12.84 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.422 1.889 . . . . 0.0 112.875 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -145.6 161.59 39.44 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 127.028 2.131 . . . . 0.0 110.649 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 -61.27 151.78 30.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.703 1.601 . . . . 0.0 110.488 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.5 138.43 58.02 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.718 -0.614 . . . . 0.0 110.512 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.3 134.53 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.293 0.637 . . . . 0.0 110.464 -174.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.44 144.37 48.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.585 1.154 . . . . 0.0 112.022 -169.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -144.29 122.05 6.69 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.877 1.271 . . . . 0.0 111.571 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.26 141.48 39.37 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.042 2.494 . . . . 0.0 110.303 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -58.8 -26.02 63.7 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.43 -41.78 69.78 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.451 1.9 . . . . 0.0 112.852 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.9 p -87.97 -10.69 49.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.9 mt -89.94 69.07 7.43 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.491 1.516 . . . . 0.0 110.775 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -67.67 -23.86 65.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.852 0.861 . . . . 0.0 113.269 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -141.54 119.65 12.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.513 1.525 . . . . 0.0 110.278 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -142.0 109.31 5.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.104 1.762 . . . . 0.0 110.591 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.56 170.26 14.0 Favored Glycine 0 N--CA 1.465 0.601 0 C-N-CA 124.733 1.159 . . . . 0.0 113.612 -169.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -141.61 158.68 43.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.054 0.942 . . . . 0.0 111.67 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.24 -173.89 4.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.136 1.774 . . . . 0.0 109.964 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.4 p -58.16 109.73 0.81 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.944 0.878 . . . . 0.0 111.771 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.261 0.8 OUTLIER 49.36 27.73 2.06 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 127.292 2.237 . . . . 0.0 115.836 -173.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -134.99 130.02 35.08 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.736 1.614 . . . . 0.0 110.564 -172.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -124.45 137.75 54.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.685 1.594 . . . . 0.0 109.852 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 t -153.44 156.7 38.68 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.259 1.024 . . . . 0.0 113.021 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.77 156.69 39.58 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.051 1.34 . . . . 0.0 112.082 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -121.87 137.86 54.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.374 1.87 . . . . 0.0 109.705 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.0 p -145.31 150.5 36.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.201 1.0 . . . . 0.0 112.887 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.84 166.9 49.36 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.863 1.221 . . . . 0.0 114.031 -175.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -63.52 -12.35 31.51 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -171.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -20.17 60.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.335 1.454 . . . . 0.0 114.709 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.55 176.58 8.18 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -57.4 -41.15 79.75 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.979 1.311 . . . . 0.0 113.137 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -91.54 -21.02 21.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.344 1.458 . . . . 0.0 113.884 -173.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.34 -176.56 52.79 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.253 1.406 . . . . 0.0 112.637 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.42 130.74 45.71 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.142 0.977 . . . . 0.0 112.671 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.76 178.91 36.08 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.862 1.22 . . . . 0.0 113.041 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.31 136.69 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.775 1.63 . . . . 0.0 108.834 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -130.57 121.54 25.88 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.735 1.214 . . . . 0.0 110.068 -173.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.36 141.98 50.99 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.54 1.136 . . . . 0.0 112.797 -170.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -141.11 130.62 23.9 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.817 0.847 . . . . 0.0 111.913 -170.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -69.57 131.98 45.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.798 0.839 . . . . 0.0 110.79 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.1 t -170.55 120.21 0.57 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.438 1.895 . . . . 0.0 110.337 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.4 t -71.11 -7.84 49.34 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 121.029 -1.044 . . . . 0.0 113.226 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -101.34 7.69 42.66 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.671 1.988 . . . . 0.0 112.688 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.85 -39.62 54.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.207 1.803 . . . . 0.0 115.592 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -68.48 -34.0 75.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.676 0.671 . . . . 0.0 112.789 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -70.59 -33.74 71.4 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.642 -0.661 . . . . 0.0 111.146 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.33 -47.0 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.59 0.632 . . . . 0.0 110.088 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.05 -43.06 99.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.758 0.823 . . . . 0.0 111.675 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -70.3 -30.58 67.61 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -80.68 -35.71 33.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.703 1.138 . . . . 0.0 111.861 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 mt -54.95 -50.36 69.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.29 0.95 . . . . 0.0 112.341 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -63.53 -24.92 68.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -25.75 47.08 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.32 1.048 . . . . 0.0 112.576 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.54 -30.15 17.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.423 1.089 . . . . 0.0 111.588 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 14.9 mmt -56.36 -24.89 47.13 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.208 1.403 . . . . 0.0 112.939 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -101.74 -6.16 24.03 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.278 1.431 . . . . 0.0 114.633 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 37.1 t -85.08 -27.8 26.06 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.363 1.065 . . . . 0.0 113.63 -171.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -67.05 155.75 37.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.211 1.004 . . . . 0.0 112.667 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.8 t -91.78 121.45 33.43 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.568 0.747 . . . . 0.0 110.738 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.5 mp -96.68 66.7 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 62.55 29.21 16.99 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.49 1.916 . . . . 0.0 113.536 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.36 8.56 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.084 1.353 . . . . 0.0 113.612 -175.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 60.0 mtt -143.61 158.42 43.68 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.426 1.891 . . . . 0.0 110.829 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -67.67 142.3 56.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.532 0.733 . . . . 0.0 110.642 173.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -148.47 154.73 41.87 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.165 1.386 . . . . 0.0 112.174 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.87 176.4 9.91 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.948 3.099 . . . . 0.0 111.903 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 80.6 t -84.25 124.37 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.411 1.084 . . . . 0.0 110.181 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.53 139.35 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.892 1.677 . . . . 0.0 108.346 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.83 119.1 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.776 0.83 . . . . 0.0 109.653 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.2 p -144.76 154.58 42.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.317 1.847 . . . . 0.0 110.778 -174.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -73.26 -23.03 60.27 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -149.23 134.38 18.21 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.048 1.739 . . . . 0.0 110.272 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 t -77.27 143.39 38.92 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.432 0.693 . . . . 0.0 111.297 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -61.47 123.7 77.68 Favored Pre-proline 0 CA--C 1.558 1.267 0 O-C-N 121.075 -1.016 . . . . 0.0 112.15 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.48 149.63 39.62 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.256 2.637 . . . . 0.0 111.163 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.19 67.82 3.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.505 1.122 . . . . 0.0 111.607 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -76.27 99.83 4.89 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.092 1.357 . . . . 0.0 110.22 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 pp -167.07 -175.9 3.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.217 2.207 . . . . 0.0 110.97 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -149.36 152.81 36.42 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.12 1.768 . . . . 0.0 109.844 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tt -49.95 114.43 4.27 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.549 1.94 . . . . 0.0 111.385 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.77 141.34 17.07 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.726 2.284 . . . . 0.0 111.566 -169.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.97 163.12 26.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.32 0.648 . . . . 0.0 112.183 172.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -147.72 149.1 32.62 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.413 1.485 . . . . 0.0 110.942 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.73 140.62 39.45 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.188 2.592 . . . . 0.0 110.852 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -94.55 129.44 36.56 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.744 0.817 . . . . 0.0 109.898 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.42 131.47 13.85 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.687 2.258 . . . . 0.0 110.406 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.73 114.17 3.97 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.857 2.372 . . . . 0.0 109.8 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -79.24 113.35 17.3 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.322 0.649 . . . . 0.0 111.316 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.52 130.46 39.64 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.987 0.915 . . . . 0.0 111.28 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.9 tt -97.06 109.32 22.1 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.703 1.201 . . . . 0.0 108.623 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.04 139.2 4.49 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.192 0.901 . . . . 0.0 113.241 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -152.62 171.39 18.23 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.942 2.097 . . . . 0.0 111.09 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 t -152.32 176.71 11.34 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.023 1.329 . . . . 0.0 111.646 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.97 137.2 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.66 1.984 . . . . 0.0 109.171 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.9 m -51.8 125.14 14.24 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.411 1.484 . . . . 0.0 113.627 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.2 p . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.915 1.686 . . . . 0.0 114.328 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -140.56 128.08 21.42 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.44 1.496 . . . . 0.0 110.184 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -88.39 117.26 27.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.49 1.116 . . . . 0.0 111.309 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 72.2 mt -84.0 156.34 22.32 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.98 0.912 . . . . 0.0 112.27 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -92.34 -5.37 52.32 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.643 1.577 . . . . 0.0 113.423 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -169.41 161.14 9.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.208 2.203 . . . . 0.0 110.977 -169.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -89.14 124.72 64.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.534 -173.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.6 -24.13 2.46 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.128 2.552 . . . . 0.0 113.813 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.7 m -83.4 124.23 30.46 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.636 0.775 . . . . 0.0 111.399 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.36 -4.46 89.07 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.342 0.972 . . . . 0.0 114.583 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -138.46 136.91 36.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.746 1.618 . . . . 0.0 110.219 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -162.8 139.73 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.075 1.35 . . . . 0.0 111.197 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -100.67 125.43 47.09 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.627 1.971 . . . . 0.0 108.945 171.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -86.11 124.1 32.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.229 0.612 . . . . 0.0 111.395 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.17 -101.11 0.59 Allowed Glycine 0 N--CA 1.47 0.951 0 C-N-CA 125.312 1.434 . . . . 0.0 112.574 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -75.87 67.1 2.22 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.017 1.327 . . . . 0.0 112.819 -173.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -73.23 -11.33 60.47 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.262 1.425 . . . . 0.0 113.259 172.458 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -136.35 149.18 48.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.843 2.057 . . . . 0.0 107.854 169.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 125.625 1.57 . . . . 0.0 111.34 -170.429 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.6 m -151.44 156.66 41.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.11 1.364 . . . . 0.0 111.434 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.5 p -162.95 170.09 18.64 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.896 1.279 . . . . 0.0 112.455 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.17 171.24 36.69 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.145 1.355 . . . . 0.0 113.686 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.4 t -164.2 168.7 18.58 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.646 1.578 . . . . 0.0 111.413 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.3 p -170.49 178.73 3.58 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.451 1.901 . . . . 0.0 111.679 -171.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.27 27.13 23.9 Favored Glycine 0 N--CA 1.474 1.204 0 O-C-N 121.4 -0.812 . . . . 0.0 114.646 173.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.54 149.26 43.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.656 1.182 . . . . 0.0 110.837 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -152.56 177.71 10.36 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.733 1.213 . . . . 0.0 113.55 -170.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -148.75 166.67 27.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.265 1.826 . . . . 0.0 111.676 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -76.88 -27.8 55.14 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.339 1.056 . . . . 0.0 113.06 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.1 m -75.96 52.69 0.72 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.859 1.664 . . . . 0.0 112.096 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.22 121.52 66.83 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.041 1.737 . . . . 0.0 111.815 -173.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.38 165.59 14.36 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.808 3.006 . . . . 0.0 111.431 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -73.7 6.11 3.44 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.351 1.461 . . . . 0.0 113.89 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -126.51 11.31 7.36 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.595 1.958 . . . . 0.0 113.138 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -58.0 145.2 73.32 Favored Pre-proline 0 CA--C 1.555 1.165 0 O-C-N 120.76 -1.212 . . . . 0.0 112.521 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.74 -12.64 35.12 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.0 2.466 . . . . 0.0 115.199 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.7 p -136.49 -18.39 1.46 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -112.58 148.56 34.29 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.431 1.093 . . . . 0.0 110.002 171.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -143.11 115.88 8.73 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.296 -0.878 . . . . 0.0 110.408 -173.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -71.02 133.93 46.72 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.458 -0.776 . . . . 0.0 110.242 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.44 163.77 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.927 1.291 . . . . 0.0 112.19 -169.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.3 m -134.46 119.77 18.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.426 1.091 . . . . 0.0 108.968 174.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.69 126.62 27.96 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 109.775 174.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.75 153.61 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -91.88 -168.91 2.12 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.2 -22.66 67.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.481 1.512 . . . . 0.0 114.438 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -93.53 -5.84 48.1 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.665 1.186 . . . . 0.0 112.387 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.65 14.83 82.01 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 118.065 -1.408 . . . . 0.0 114.045 -173.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 18.2 m -81.04 150.99 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.674 1.737 . . . . 0.0 111.55 176.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.56 122.47 32.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.724 1.21 . . . . 0.0 110.996 -170.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.9 mt -103.65 -54.51 2.56 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.254 0.621 . . . . 0.0 111.86 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.59 146.72 16.98 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.869 1.223 . . . . 0.0 114.476 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 p -94.33 144.64 25.37 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.486 1.515 . . . . 0.0 112.558 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.41 171.68 32.92 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.701 1.143 . . . . 0.0 114.597 -177.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.5 t -115.35 121.17 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.663 1.185 . . . . 0.0 108.622 170.711 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.2 tpp -86.94 135.28 33.35 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.602 1.561 . . . . 0.0 109.933 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -138.85 129.82 26.57 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.564 1.546 . . . . 0.0 109.375 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mp -111.61 134.03 53.46 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.293 1.837 . . . . 0.0 108.247 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -137.12 167.68 21.07 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.949 1.299 . . . . 0.0 110.436 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -68.86 -6.85 29.59 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.449 -0.782 . . . . 0.0 112.68 173.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.9 m -95.74 -46.13 6.72 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.989 0.916 . . . . 0.0 112.832 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -176.02 174.33 2.11 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.704 1.201 . . . . 0.0 113.544 -168.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.8 mt -86.55 140.34 29.98 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.167 1.387 . . . . 0.0 110.035 168.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.57 136.57 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.532 1.133 . . . . 0.0 111.323 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.3 mt -108.94 133.28 53.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.371 1.869 . . . . 0.0 110.648 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -114.01 121.15 43.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.993 2.117 . . . . 0.0 110.377 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.7 mp -116.35 166.57 11.91 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.605 1.562 . . . . 0.0 111.323 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -51.72 -62.87 1.36 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.774 1.63 . . . . 0.0 114.504 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -134.71 -2.72 2.64 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.412 1.485 . . . . 0.0 113.795 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -72.97 154.33 40.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.975 0.807 . . . . 0.0 109.241 167.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -62.99 151.19 40.39 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.971 0.415 . . . . 0.0 111.074 172.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.58 147.24 53.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.219 0.608 . . . . 0.0 111.221 175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 t -128.99 137.0 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.603 0.761 . . . . 0.0 109.941 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 mtp85 -132.36 143.64 49.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.439 1.096 . . . . 0.0 112.388 -167.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -138.9 109.42 7.75 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.691 1.196 . . . . 0.0 111.622 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.5 150.99 83.94 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.914 2.409 . . . . 0.0 112.15 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -65.68 -7.27 14.52 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.58 -35.02 30.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.778 1.631 . . . . 0.0 113.583 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 16.5 p -88.11 -23.91 23.55 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.707 1.139 . . . . 0.0 113.709 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.11 107.25 0.84 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.619 1.568 . . . . 0.0 110.366 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -78.16 -38.33 43.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.35 1.46 . . . . 0.0 112.021 -174.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -163.94 156.52 17.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.836 2.055 . . . . 0.0 110.442 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.64 132.05 16.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.387 1.075 . . . . 0.0 109.877 -175.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.26 170.75 28.8 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-O 121.996 0.775 . . . . 0.0 114.373 -169.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.92 156.36 49.12 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.606 1.163 . . . . 0.0 112.136 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.05 -176.21 5.67 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.075 1.75 . . . . 0.0 110.107 175.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 t -63.13 114.86 3.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.107 0.956 . . . . 0.0 111.577 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 t30 57.02 18.66 4.11 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.035 2.134 . . . . 0.0 114.495 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.35 126.32 25.97 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.213 -1.554 . . . . 0.0 111.251 -169.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -119.88 138.06 53.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.536 1.535 . . . . 0.0 109.592 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.8 t -153.33 155.01 35.67 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.232 -0.917 . . . . 0.0 112.636 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -146.64 152.29 38.64 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.049 1.34 . . . . 0.0 111.759 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -110.51 143.05 41.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.713 1.605 . . . . 0.0 109.695 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -144.43 154.79 43.32 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.024 0.93 . . . . 0.0 111.983 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.22 176.62 37.38 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.403 1.478 . . . . 0.0 113.855 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -64.96 -8.91 17.72 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -76.81 -17.01 59.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.769 2.028 . . . . 0.0 115.424 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.0 p -85.66 -177.38 6.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.501 1.12 . . . . 0.0 113.961 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -61.53 -42.07 98.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.178 1.391 . . . . 0.0 112.879 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.4 p -93.01 -20.36 20.65 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.302 1.441 . . . . 0.0 114.123 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.45 -174.19 43.04 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.39 1.471 . . . . 0.0 112.7 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -67.63 134.41 51.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.655 0.782 . . . . 0.0 112.617 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.56 -176.37 35.49 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.503 1.049 . . . . 0.0 113.287 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.8 mt -121.26 137.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.799 1.64 . . . . 0.0 109.342 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -127.08 118.53 24.58 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.239 1.416 . . . . 0.0 109.32 -171.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.77 140.05 53.37 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.43 1.092 . . . . 0.0 113.196 -169.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -139.37 127.92 23.05 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.005 -169.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -67.7 129.02 38.62 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 168.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 35.3 t -165.31 126.63 1.99 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 111.103 -171.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.9 t -75.1 -10.22 59.27 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -107.39 18.6 21.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.311 1.845 . . . . 0.0 112.842 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.89 -40.27 79.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -169.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -71.0 -36.99 72.68 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.01 0.924 . . . . 0.0 112.274 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -64.64 -40.74 95.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.246 1.019 . . . . 0.0 110.707 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.0 -46.54 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.353 0.661 . . . . 0.0 110.63 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -39.36 83.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.503 1.121 . . . . 0.0 112.221 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -74.27 -30.88 62.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.256 1.022 . . . . 0.0 113.48 175.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -80.36 -34.96 36.07 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.354 0.979 . . . . 0.0 111.091 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.4 mt -52.44 -56.51 14.58 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.151 0.981 . . . . 0.0 112.897 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -55.65 -34.2 64.76 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.91 -17.03 56.21 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.285 1.434 . . . . 0.0 112.769 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.5 mt -95.24 -37.23 11.11 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.396 1.078 . . . . 0.0 110.917 169.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 57.8 mtp -65.86 -30.97 71.66 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.874 0.87 . . . . 0.0 112.663 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -78.09 -10.35 59.58 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.1 t -84.26 -9.24 58.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 113.04 -176.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -62.62 153.35 32.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.624 1.17 . . . . 0.0 112.726 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.0 m -94.94 73.03 3.48 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.555 1.142 . . . . 0.0 110.979 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -87.33 -159.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.556 1.143 . . . . 0.0 109.6 173.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -67.85 36.09 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.736 2.414 . . . . 0.0 115.105 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 p -82.88 14.0 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 128.129 2.572 . . . . 0.0 115.029 -168.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 21.7 ptp 51.99 29.4 6.16 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.802 2.441 . . . . 0.0 115.435 171.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -142.82 167.93 20.9 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.12 2.168 . . . . 0.0 109.816 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -60.59 142.31 91.41 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.18 0.992 . . . . 0.0 112.574 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.08 157.14 46.9 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.515 2.81 . . . . 0.0 111.989 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.23 118.51 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.889 1.676 . . . . 0.0 111.331 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.94 137.13 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.455 1.902 . . . . 0.0 108.515 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.8 pt -110.08 160.05 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.577 1.151 . . . . 0.0 111.198 170.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.8 p -125.45 148.52 48.8 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.321 1.448 . . . . 0.0 110.613 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -161.95 175.1 12.2 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.162 1.785 . . . . 0.0 111.517 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -131.77 -168.11 1.98 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.222 1.409 . . . . 0.0 112.839 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.4 p -144.76 177.92 8.37 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.951 2.1 . . . . 0.0 109.808 169.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -152.99 132.23 6.94 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.381 1.072 . . . . 0.0 111.772 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.17 152.19 27.35 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.443 2.762 . . . . 0.0 112.57 -172.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.55 166.21 15.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.634 1.174 . . . . 0.0 112.511 174.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -68.91 139.45 55.12 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.983 0.913 . . . . 0.0 111.539 176.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -85.42 176.44 8.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.339 1.456 . . . . 0.0 113.48 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -147.88 167.85 23.72 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.482 1.913 . . . . 0.0 111.41 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 pp -96.91 148.6 34.63 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.664 1.186 . . . . 0.0 112.448 -169.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.57 157.38 21.89 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.541 2.827 . . . . 0.0 111.84 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -69.96 139.39 52.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.818 0.847 . . . . 0.0 111.543 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.18 144.46 95.18 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.176 0.99 . . . . 0.0 112.768 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -78.15 168.22 22.17 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.057 3.171 . . . . 0.0 112.115 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -84.28 149.23 54.86 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.236 1.014 . . . . 0.0 111.175 174.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.08 154.38 52.4 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.569 2.846 . . . . 0.0 112.339 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.29 161.89 34.44 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.148 3.232 . . . . 0.0 112.357 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -92.99 148.04 22.33 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.608 1.163 . . . . 0.0 112.69 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.99 -174.23 5.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.198 1.399 . . . . 0.0 112.707 175.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -150.78 161.28 42.95 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.798 1.639 . . . . 0.0 112.444 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -92.83 -146.03 18.24 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.382 1.468 . . . . 0.0 113.42 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -155.5 -177.13 6.33 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.266 1.826 . . . . 0.0 111.987 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.8 t -148.05 175.6 10.88 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.206 1.402 . . . . 0.0 112.074 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.61 143.49 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.424 1.89 . . . . 0.0 112.178 -174.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.4 p -121.9 144.11 49.05 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.743 1.617 . . . . 0.0 112.269 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 126.669 1.987 . . . . 0.0 113.073 179.395 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -87.05 149.47 24.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.011 0.369 . . . . 0.0 110.972 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.03 97.4 5.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.911 1.684 . . . . 0.0 109.801 -173.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 57.7 mt -72.72 156.34 39.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.831 0.852 . . . . 0.0 111.872 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -98.56 -12.06 21.57 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.619 1.568 . . . . 0.0 113.0 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -144.8 149.64 35.8 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.509 1.924 . . . . 0.0 111.073 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -85.79 121.16 73.22 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.498 -0.751 . . . . 0.0 110.981 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.22 -19.88 4.42 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.291 2.661 . . . . 0.0 114.65 -169.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 87.3 m -89.54 124.64 34.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.163 0.892 . . . . 0.0 112.358 -172.131 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.68 -14.43 81.12 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.103 0.859 . . . . 0.0 114.42 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -115.31 129.39 56.6 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.371 1.468 . . . . 0.0 109.325 170.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 p -158.03 151.36 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.285 1.434 . . . . 0.0 110.921 -169.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -155.76 179.63 9.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.959 1.704 . . . . 0.0 112.442 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.43 135.35 33.52 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.185 1.794 . . . . 0.0 109.669 -173.653 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.13 -11.33 28.06 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -169.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -105.64 155.7 18.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.09 1.356 . . . . 0.0 112.427 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -156.7 151.74 26.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.455 1.502 . . . . 0.0 110.62 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -164.01 147.88 9.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.294 1.438 . . . . 0.0 109.581 -173.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 . . . . . 0 C--O 1.254 1.301 0 C-N-CA 124.879 1.271 . . . . 0.0 112.194 177.147 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -163.29 138.89 6.69 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.186 1.395 . . . . 0.0 110.517 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 t -167.37 161.6 14.24 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.543 1.537 . . . . 0.0 111.289 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.01 135.29 2.94 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.523 1.535 . . . . 0.0 113.082 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -156.17 162.56 40.19 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.135 1.774 . . . . 0.0 110.949 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 t -81.91 71.03 8.94 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 120.968 -1.082 . . . . 0.0 112.205 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.22 99.62 2.26 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.669 1.128 . . . . 0.0 111.892 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.6 mt -145.03 135.63 24.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.046 1.738 . . . . 0.0 110.486 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -169.81 161.63 9.17 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.083 2.153 . . . . 0.0 110.941 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -161.21 146.3 13.87 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.755 1.222 . . . . 0.0 111.661 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.37 0.04 47.76 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.431 1.492 . . . . 0.0 114.06 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -156.67 157.18 34.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.278 1.831 . . . . 0.0 110.466 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 p -72.9 119.54 76.04 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.595 0.758 . . . . 0.0 111.413 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.4 172.19 13.91 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.691 2.927 . . . . 0.0 111.835 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -73.3 6.59 2.76 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.176 1.39 . . . . 0.0 113.711 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -143.52 17.66 1.85 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.484 1.514 . . . . 0.0 114.982 -169.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -60.39 147.05 83.25 Favored Pre-proline 0 CA--C 1.558 1.261 0 O-C-N 121.041 -1.037 . . . . 0.0 113.256 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.9 -11.56 25.7 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.109 2.539 . . . . 0.0 115.359 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.5 p -131.35 -21.96 2.53 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 120.355 1.434 . . . . 0.0 114.553 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -102.34 140.9 36.01 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.306 1.042 . . . . 0.0 110.363 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.44 111.72 9.11 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.757 1.223 . . . . 0.0 108.35 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -67.94 133.22 48.73 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.647 -0.658 . . . . 0.0 110.293 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.54 164.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.324 1.449 . . . . 0.0 111.59 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.3 m -139.96 120.78 14.44 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.376 1.07 . . . . 0.0 109.117 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -64.58 131.9 48.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.453 0.701 . . . . 0.0 110.023 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.16 157.52 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.429 1.092 . . . . 0.0 112.389 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -85.76 -167.05 1.71 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.451 1.1 . . . . 0.0 113.28 176.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.38 -26.58 63.78 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.495 1.118 . . . . 0.0 113.639 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -80.42 -18.12 49.78 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.566 1.146 . . . . 0.0 112.567 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.36 17.94 59.76 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.115 -1.38 . . . . 0.0 114.167 -173.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.5 m -77.22 150.65 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.841 1.82 . . . . 0.0 111.269 171.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.65 126.73 35.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.839 1.256 . . . . 0.0 110.923 -172.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.5 mt -109.69 -51.21 2.9 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.115 0.966 . . . . 0.0 111.814 -170.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.14 136.38 5.2 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 124.593 1.092 . . . . 0.0 114.08 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 p -84.1 146.29 27.98 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.07 1.348 . . . . 0.0 112.652 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.93 170.06 32.53 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.369 1.462 . . . . 0.0 113.721 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.36 120.22 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.6 ttm -87.6 136.38 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.922 0.889 . . . . 0.0 109.636 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -130.94 129.66 42.46 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.392 1.477 . . . . 0.0 108.67 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.77 116.24 31.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.978 1.711 . . . . 0.0 106.967 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.5 p -114.95 168.0 10.29 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.61 1.164 . . . . 0.0 110.046 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -72.1 -2.4 18.37 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.528 -0.732 . . . . 0.0 112.659 170.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.5 m -96.77 -48.7 5.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.447 1.099 . . . . 0.0 112.51 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -176.31 175.91 1.75 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.016 1.726 . . . . 0.0 112.813 -170.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 mt -84.73 137.87 32.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.302 1.041 . . . . 0.0 110.214 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.01 134.38 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.027 0.931 . . . . 0.0 111.502 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.7 mt -104.08 133.72 48.55 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.894 1.677 . . . . 0.0 109.769 168.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -112.61 129.88 56.22 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.944 2.098 . . . . 0.0 110.899 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mp -130.92 167.37 19.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.748 1.619 . . . . 0.0 111.086 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -78.5 0.09 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.612 1.165 . . . . 0.0 112.764 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -95.16 -4.52 45.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.587 1.155 . . . . 0.0 113.969 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mmp_? -98.52 154.74 17.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.649 1.58 . . . . 0.0 111.13 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.13 156.63 31.03 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.29 1.036 . . . . 0.0 112.204 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.27 150.1 48.66 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.424 0.69 . . . . 0.0 111.621 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.04 130.19 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.815 0.846 . . . . 0.0 110.141 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 mtp85 -126.99 144.39 51.03 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.725 1.21 . . . . 0.0 112.416 -168.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -139.63 116.89 8.45 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.781 1.232 . . . . 0.0 111.581 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -64.13 143.2 83.48 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.714 2.276 . . . . 0.0 110.068 172.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -55.81 -31.66 62.87 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.45 -44.15 76.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.702 2.001 . . . . 0.0 112.752 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.2 p -75.41 -7.93 55.35 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.8 mt -83.17 108.78 16.66 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.152 0.981 . . . . 0.0 110.514 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -74.81 -37.94 62.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.842 0.857 . . . . 0.0 112.125 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -157.84 163.31 38.11 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.587 1.555 . . . . 0.0 110.961 170.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -151.9 141.05 21.3 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.613 1.565 . . . . 0.0 109.074 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.0 177.81 34.56 Favored Glycine 0 N--CA 1.463 0.447 0 CA-C-O 121.484 0.491 . . . . 0.0 113.794 -171.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -143.61 166.11 25.73 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.202 1.001 . . . . 0.0 113.44 -170.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -151.39 -170.52 3.68 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.681 1.992 . . . . 0.0 109.787 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 t -72.94 -13.05 61.17 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.596 -1.315 . . . . 0.0 114.234 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -157.39 5.85 0.14 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.631 1.572 . . . . 0.0 114.25 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.86 132.87 37.16 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.818 1.647 . . . . 0.0 110.451 -168.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -124.48 142.11 51.57 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.428 1.891 . . . . 0.0 109.773 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 t -157.08 161.15 39.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.648 1.179 . . . . 0.0 112.508 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.34 149.34 29.96 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.496 1.518 . . . . 0.0 112.013 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -93.86 139.47 30.85 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.92 1.288 . . . . 0.0 109.456 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.1 p -142.33 148.73 38.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.96 172.54 35.43 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.098 1.332 . . . . 0.0 113.986 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -13.75 54.37 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -174.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -72.81 -16.98 61.61 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.016 1.727 . . . . 0.0 115.653 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 p -83.73 -178.79 7.13 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.373 1.069 . . . . 0.0 113.723 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.2 -41.37 92.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.106 1.362 . . . . 0.0 113.049 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.5 p -91.04 -21.15 21.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.101 1.36 . . . . 0.0 113.876 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.24 -177.72 49.09 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.139 1.352 . . . . 0.0 112.271 -170.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -64.73 137.25 57.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.152 0.981 . . . . 0.0 112.789 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.06 -178.96 35.91 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.263 0.935 . . . . 0.0 113.483 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.3 mt -118.3 133.71 64.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.616 1.566 . . . . 0.0 108.81 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -127.92 124.57 37.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.98 1.312 . . . . 0.0 109.458 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.03 143.92 48.8 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.088 0.955 . . . . 0.0 112.886 -172.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -138.87 128.58 24.81 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.52 1.128 . . . . 0.0 111.36 -169.577 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -69.85 136.1 50.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.966 0.506 . . . . 0.0 110.667 169.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 23.8 t -163.42 138.95 6.59 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.243 1.417 . . . . 0.0 110.971 -174.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t -74.4 -11.32 60.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -137.3 34.48 2.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.979 1.712 . . . . 0.0 113.776 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.89 -37.86 33.22 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.964 1.306 . . . . 0.0 113.659 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.94 -37.48 81.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.222 1.009 . . . . 0.0 113.141 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.81 -37.78 82.43 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.319 -0.863 . . . . 0.0 110.931 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 77.4 mt -62.43 -46.4 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.156 0.582 . . . . 0.0 110.097 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -38.26 84.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.296 1.038 . . . . 0.0 112.481 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -72.11 -28.38 63.25 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.25 1.02 . . . . 0.0 113.469 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -85.63 -41.95 14.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.078 0.854 . . . . 0.0 110.713 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.2 mt -50.81 -54.48 23.33 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.299 1.04 . . . . 0.0 112.603 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -59.47 -22.46 61.59 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.08 -21.57 36.75 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.725 1.21 . . . . 0.0 112.867 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.1 mt -95.81 -35.34 11.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.097 1.359 . . . . 0.0 112.039 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 66.2 mmm -57.46 -28.64 63.53 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.49 1.516 . . . . 0.0 112.249 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -96.45 -9.3 30.1 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.767 1.227 . . . . 0.0 114.169 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 24.7 t -82.74 -32.57 27.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.187 0.995 . . . . 0.0 111.926 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -60.48 133.59 56.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.572 0.749 . . . . 0.0 109.602 169.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.1 m -58.52 106.58 0.41 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.785 1.234 . . . . 0.0 113.583 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.7 mm -91.74 92.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.13 -0.981 . . . . 0.0 109.167 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.5 m120 62.38 18.53 10.36 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.438 1.895 . . . . 0.0 114.365 175.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.56 -35.07 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.948 1.699 . . . . 0.0 111.657 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.8 mtt -81.66 144.68 31.02 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.232 1.013 . . . . 0.0 111.154 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -67.98 154.98 40.48 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.277 0.631 . . . . 0.0 111.746 171.734 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -145.25 146.56 30.8 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.279 1.432 . . . . 0.0 110.79 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.57 143.02 37.36 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.983 2.455 . . . . 0.0 110.736 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -81.51 100.03 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.1 tp -70.72 154.79 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.002 1.721 . . . . 0.0 112.302 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.78 142.56 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.478 -0.764 . . . . 0.0 110.112 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.1 t -154.63 135.33 13.57 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.782 1.233 . . . . 0.0 110.648 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -78.36 141.45 38.38 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.026 0.931 . . . . 0.0 110.872 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -147.57 156.47 42.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.263 1.425 . . . . 0.0 111.728 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.1 m -133.68 25.06 4.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.684 1.193 . . . . 0.0 112.418 -169.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -146.1 151.11 43.98 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.617 1.567 . . . . 0.0 112.774 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.56 159.63 39.1 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.694 2.93 . . . . 0.0 111.666 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.84 133.01 52.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.71 0.804 . . . . 0.0 111.968 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -92.79 171.15 9.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.85 1.26 . . . . 0.0 112.02 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.2 170.77 15.11 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.122 1.769 . . . . 0.0 111.51 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -145.01 135.99 24.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.034 1.334 . . . . 0.0 111.036 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 pp -95.37 146.74 31.85 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 124.903 1.281 . . . . 0.0 111.729 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.91 147.58 39.29 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.037 2.491 . . . . 0.0 110.875 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -138.56 142.58 39.24 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.977 1.311 . . . . 0.0 110.688 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -151.21 152.2 30.73 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.995 1.718 . . . . 0.0 110.87 -175.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.4 148.59 61.26 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.423 2.749 . . . . 0.0 111.308 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -103.46 128.74 26.81 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.319 1.048 . . . . 0.0 109.453 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.51 154.85 40.43 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.193 2.595 . . . . 0.0 111.848 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -72.68 167.34 27.41 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.852 3.035 . . . . 0.0 111.495 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -128.11 124.8 37.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.62 1.168 . . . . 0.0 111.18 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -165.95 173.43 10.48 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.18 2.192 . . . . 0.0 110.527 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.5 tp -150.83 128.57 11.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.78 1.232 . . . . 0.0 110.888 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -98.4 162.9 20.76 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.242 1.401 . . . . 0.0 113.116 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -161.96 157.12 23.26 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.849 1.66 . . . . 0.0 111.651 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -157.27 170.12 23.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.975 1.71 . . . . 0.0 110.874 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.0 p -163.79 144.38 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.434 1.894 . . . . 0.0 110.485 -169.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.1 t -161.74 162.13 29.54 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.869 1.668 . . . . 0.0 110.762 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.004 1.721 . . . . 0.0 111.892 -177.141 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -78.63 124.31 28.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.782 0.433 . . . . 0.0 111.27 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.78 122.98 30.62 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.022 0.929 . . . . 0.0 111.246 177.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 52.2 mt -90.29 153.13 20.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.6 0.76 . . . . 0.0 112.752 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -88.27 -17.49 30.61 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.613 1.565 . . . . 0.0 113.469 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -156.16 168.64 26.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.269 1.828 . . . . 0.0 111.459 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.89 119.29 70.46 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.706 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.29 -23.69 3.4 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.125 2.55 . . . . 0.0 114.369 -169.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 81.8 m -78.68 126.96 31.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.13 0.877 . . . . 0.0 111.551 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.78 -22.63 63.67 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 124.031 0.824 . . . . 0.0 114.428 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -118.93 126.49 51.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.021 1.328 . . . . 0.0 109.645 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.23 164.42 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.743 1.617 . . . . 0.0 110.835 -172.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -134.25 134.43 41.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.037 1.335 . . . . 0.0 109.69 174.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -99.01 113.12 25.14 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.587 1.155 . . . . 0.0 110.941 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.29 -85.58 1.44 Allowed Glycine 0 N--CA 1.467 0.761 0 C-N-CA 124.678 1.132 . . . . 0.0 111.377 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -81.55 90.53 6.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.226 1.011 . . . . 0.0 110.635 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -155.55 132.91 10.96 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.87 1.668 . . . . 0.0 108.653 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -91.36 153.77 19.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.67 0.788 . . . . 0.0 110.979 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.139 1.776 . . . . 0.0 113.744 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.476 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.9 m -147.56 127.41 13.52 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.65 1.18 . . . . 0.0 110.878 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 m -151.7 159.05 44.14 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.338 1.455 . . . . 0.0 111.624 -173.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.91 -167.99 40.83 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.442 1.496 . . . . 0.0 112.546 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.4 p -146.6 140.96 26.45 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.652 0.781 . . . . 0.0 112.725 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.7 p -164.56 158.47 18.13 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.584 1.554 . . . . 0.0 111.154 -174.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.4 -143.22 4.7 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.937 1.256 . . . . 0.0 113.13 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.96 162.91 27.16 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.595 1.158 . . . . 0.0 112.473 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -121.18 131.57 54.32 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.019 1.328 . . . . 0.0 110.35 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -120.38 20.56 11.89 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.276 1.831 . . . . 0.0 112.751 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -157.93 159.08 36.15 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.543 1.937 . . . . 0.0 111.002 -175.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 t -79.32 37.47 0.33 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.451 1.5 . . . . 0.0 114.293 -168.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.417 HG21 ' HZ3' ' A' ' 22' ' ' LYS . 14.0 p -147.23 133.55 9.69 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.167 1.787 . . . . 0.0 110.596 -178.851 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -81.99 148.68 15.42 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.161 2.574 . . . . 0.0 111.806 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -64.92 2.67 0.67 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.298 1.439 . . . . 0.0 114.334 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -130.09 11.83 5.56 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.119 1.768 . . . . 0.0 114.248 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -53.75 135.51 55.36 Favored Pre-proline 0 CA--C 1.556 1.188 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.61 -16.75 51.64 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.184 2.589 . . . . 0.0 115.302 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.0 p -125.26 -15.7 6.16 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.916 1.234 . . . . 0.0 114.316 176.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -103.47 125.1 49.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.223 0.92 . . . . 0.0 112.119 172.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.29 106.71 10.94 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.12 1.768 . . . . 0.0 109.092 -176.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.417 ' HZ3' HG21 ' A' ' 13' ' ' VAL . 41.1 mttp -69.2 132.49 46.6 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.618 -0.676 . . . . 0.0 109.982 -179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 m -140.8 158.95 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.722 1.209 . . . . 0.0 112.245 -169.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -134.18 118.37 17.58 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.679 1.192 . . . . 0.0 108.214 174.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -66.92 131.37 45.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 m -125.53 154.49 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.663 0.785 . . . . 0.0 112.557 -177.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -81.95 -169.6 2.45 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.747 1.219 . . . . 0.0 113.884 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -64.6 -29.13 70.14 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.658 1.583 . . . . 0.0 115.001 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.09 -24.22 20.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.137 0.575 . . . . 0.0 112.026 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.49 14.98 6.63 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 126.109 1.814 . . . . 0.0 112.459 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.57 140.48 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 126.681 1.992 . . . . 0.0 109.43 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.24 125.93 31.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.878 1.671 . . . . 0.0 110.652 -171.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.2 mt -109.88 -53.22 2.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.973 0.909 . . . . 0.0 112.141 -171.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.2 140.33 7.93 Favored Glycine 0 N--CA 1.469 0.848 0 C-N-CA 124.814 1.197 . . . . 0.0 113.574 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 p -92.18 143.64 26.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.194 1.398 . . . . 0.0 112.344 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.1 171.73 34.53 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.312 1.434 . . . . 0.0 113.028 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -118.62 119.47 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.198 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.9 tpp -83.16 133.62 35.02 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.144 0.977 . . . . 0.0 109.444 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -126.99 130.54 50.24 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.217 1.407 . . . . 0.0 108.877 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.69 119.17 38.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.329 1.852 . . . . 0.0 107.72 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -122.61 173.68 7.55 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.974 1.309 . . . . 0.0 110.307 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -74.69 2.54 9.71 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.386 -0.821 . . . . 0.0 113.209 172.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.8 p -107.39 -45.93 3.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.897 -1.127 . . . . 0.0 113.473 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -172.78 173.49 3.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.776 1.231 . . . . 0.0 113.09 -174.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -83.67 136.77 34.07 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.511 -0.743 . . . . 0.0 109.523 168.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.9 t -134.74 130.4 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.216 1.006 . . . . 0.0 111.632 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.7 mt -100.19 126.7 46.49 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.442 1.497 . . . . 0.0 110.19 168.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -102.74 133.83 47.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.283 2.233 . . . . 0.0 110.979 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp -133.79 150.74 51.45 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.196 1.398 . . . . 0.0 111.322 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -74.13 118.34 16.97 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.763 0.825 . . . . 0.0 111.506 169.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 56.67 27.13 12.11 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.532 1.533 . . . . 0.0 114.714 173.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -137.77 153.03 49.75 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.325 1.85 . . . . 0.0 110.591 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -61.33 136.94 58.21 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.239 1.415 . . . . 0.0 111.684 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.1 153.01 43.69 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.04 0.936 . . . . 0.0 112.004 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.62 135.52 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.217 1.007 . . . . 0.0 110.226 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -134.24 152.08 51.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.833 0.853 . . . . 0.0 113.222 -173.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -142.1 119.81 7.43 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.293 1.437 . . . . 0.0 111.794 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.22 145.93 68.01 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.957 2.438 . . . . 0.0 110.463 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -60.11 -22.88 63.33 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.8 tp -63.4 -41.61 98.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.659 1.984 . . . . 0.0 113.11 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.4 p -73.32 -14.23 61.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.65 84.57 7.63 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.9 1.28 . . . . 0.0 110.715 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.4 tpp85 -63.22 -30.77 71.85 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.986 0.914 . . . . 0.0 112.503 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 38.7 ttp-105 -156.0 128.51 7.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.499 1.52 . . . . 0.0 109.834 -170.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -138.92 104.84 5.16 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.535 1.534 . . . . 0.0 111.008 -175.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.18 167.14 12.24 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.088 1.328 . . . . 0.0 113.984 -168.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -144.92 159.0 43.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.248 1.019 . . . . 0.0 112.593 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -151.36 177.52 10.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.1 2.16 . . . . 0.0 109.588 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 m -60.91 -12.22 10.46 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -154.58 11.52 0.38 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.549 1.54 . . . . 0.0 114.248 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.52 131.99 26.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.415 1.486 . . . . 0.0 110.491 -168.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -122.98 133.64 54.36 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.985 1.714 . . . . 0.0 109.016 171.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.3 t -152.6 152.93 32.4 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.131 -0.981 . . . . 0.0 112.052 -174.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -149.71 151.35 33.52 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.351 1.06 . . . . 0.0 111.839 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -104.84 126.59 52.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.606 1.162 . . . . 0.0 109.106 171.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.4 p -124.44 122.58 38.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.449 1.1 . . . . 0.0 111.294 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.25 162.39 40.22 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.816 1.198 . . . . 0.0 114.856 -171.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -57.74 -16.98 12.81 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -23.04 61.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.526 1.53 . . . . 0.0 114.925 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.3 p -73.24 173.43 9.49 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -171.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -54.56 -39.77 68.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.76 1.624 . . . . 0.0 113.341 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -91.06 -20.91 21.55 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.469 1.508 . . . . 0.0 113.874 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.26 175.1 48.9 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.156 1.36 . . . . 0.0 112.169 -170.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -66.31 130.56 43.63 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.848 1.259 . . . . 0.0 111.86 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.54 -179.35 41.55 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.776 1.179 . . . . 0.0 113.13 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.6 mt -116.46 131.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.708 1.603 . . . . 0.0 108.616 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -125.56 121.13 32.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.742 1.217 . . . . 0.0 110.238 -174.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.2 136.36 53.11 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.856 1.263 . . . . 0.0 112.943 -171.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -137.07 129.2 29.47 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.077 0.951 . . . . 0.0 111.717 -170.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -75.63 135.22 40.48 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.639 1.176 . . . . 0.0 111.988 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.6 p -171.0 151.28 3.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.505 1.922 . . . . 0.0 112.146 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.3 m -73.58 -37.31 65.52 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.156 -0.965 . . . . 0.0 112.111 171.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -85.96 20.48 2.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.099 1.36 . . . . 0.0 114.216 -171.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.07 -42.48 50.0 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.159 1.384 . . . . 0.0 114.145 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -69.57 -36.71 76.53 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.795 0.838 . . . . 0.0 112.716 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -68.39 -34.11 75.45 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.464 -0.772 . . . . 0.0 111.743 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.33 -47.65 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 118.678 0.672 . . . . 0.0 109.871 169.497 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.68 -43.33 94.07 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.658 1.183 . . . . 0.0 112.109 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -67.01 -34.67 78.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.792 1.237 . . . . 0.0 112.841 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -78.7 -41.12 31.91 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.789 0.722 . . . . 0.0 110.367 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.01 -51.46 61.59 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.26 1.024 . . . . 0.0 112.911 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -62.19 -24.12 67.02 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.3 -28.18 56.87 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.662 0.785 . . . . 0.0 112.544 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.25 -35.0 23.71 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.258 1.023 . . . . 0.0 111.199 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.6 mmt -55.88 -35.68 66.77 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.993 0.917 . . . . 0.0 112.348 169.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -89.92 -8.47 51.75 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 174.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 15.7 t -83.21 -24.1 32.54 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.431 1.092 . . . . 0.0 112.549 173.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -72.78 164.61 26.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.18 1.392 . . . . 0.0 111.405 170.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.3 m -81.87 106.91 14.17 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.03 -1.043 . . . . 0.0 111.281 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.57 -51.03 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.778 0.831 . . . . 0.0 111.242 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -69.73 -3.0 13.46 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.7 m -80.5 -11.66 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.485 1.514 . . . . 0.0 113.013 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 58.7 mtt -77.6 147.09 35.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.004 0.921 . . . . 0.0 111.233 171.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 66.51 59.24 0.63 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.963 1.705 . . . . 0.0 110.36 -174.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.68 154.73 12.36 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 127.574 2.349 . . . . 0.0 113.917 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.01 171.91 5.57 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.943 3.096 . . . . 0.0 111.54 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.5 p -50.69 124.94 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.601 1.16 . . . . 0.0 113.021 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.0 mm -111.17 163.5 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.966 1.706 . . . . 0.0 109.986 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.4 pt -66.69 -13.5 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.972 1.309 . . . . 0.0 114.233 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 54.3 m -92.85 140.77 29.16 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.768 2.027 . . . . 0.0 109.324 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -49.88 134.87 20.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.194 0.998 . . . . 0.0 113.194 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -161.04 151.08 17.43 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.69 1.596 . . . . 0.0 111.225 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.4 t -99.68 139.81 34.79 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.152 0.981 . . . . 0.0 111.699 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -106.2 124.32 36.22 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.78 1.232 . . . . 0.0 111.902 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.55 161.38 37.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.295 2.664 . . . . 0.0 111.146 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.77 40.96 0.4 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.186 1.394 . . . . 0.0 112.581 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.68 117.05 24.32 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.887 1.675 . . . . 0.0 110.254 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -163.45 155.53 17.68 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.088 1.755 . . . . 0.0 111.793 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -163.34 152.49 14.62 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.624 1.97 . . . . 0.0 109.815 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.44 164.9 40.69 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.037 1.335 . . . . 0.0 111.532 -175.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.86 158.92 8.88 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.979 1.786 . . . . 0.0 112.406 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 -152.98 143.78 22.85 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.368 1.467 . . . . 0.0 110.514 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -153.76 149.57 21.31 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.5 1.52 . . . . 0.0 111.279 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.4 171.05 18.85 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.676 2.918 . . . . 0.0 111.234 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -129.35 128.57 23.21 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.44 1.096 . . . . 0.0 109.172 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.01 142.91 28.39 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.165 2.577 . . . . 0.0 111.745 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -79.6 166.67 21.63 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 124.0 3.133 . . . . 0.0 112.001 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -65.46 140.19 58.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.151 0.98 . . . . 0.0 112.002 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.31 -66.45 0.8 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.009 0.923 . . . . 0.0 112.967 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mp -147.02 151.26 36.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.526 1.93 . . . . 0.0 111.083 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -96.39 -155.44 30.75 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.399 1.476 . . . . 0.0 112.484 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -156.16 153.76 29.77 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.178 1.391 . . . . 0.0 112.165 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.3 m -141.35 144.6 34.64 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.621 1.568 . . . . 0.0 110.279 -169.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.92 171.43 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.577 1.951 . . . . 0.0 110.691 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.8 t -152.03 159.54 43.69 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.96 1.304 . . . . 0.0 111.568 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.37 1.868 . . . . 0.0 111.577 -173.915 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -86.25 128.39 34.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.663 0.785 . . . . 0.0 111.893 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -91.58 112.5 24.45 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.122 0.969 . . . . 0.0 109.495 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 78.2 mt -78.76 155.26 29.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.531 0.681 . . . . 0.0 112.283 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -91.72 -26.78 18.45 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.079 1.352 . . . . 0.0 113.077 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -140.68 158.61 43.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.418 1.887 . . . . 0.0 111.663 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -84.3 128.45 62.01 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.434 0.694 . . . . 0.0 112.008 -172.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -86.1 -10.97 6.64 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.431 2.754 . . . . 0.0 114.475 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 90.0 m -102.27 126.31 49.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.306 1.043 . . . . 0.0 111.511 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.49 -31.19 34.27 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.11 0.862 . . . . 0.0 114.2 -176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -108.35 131.32 54.87 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.842 1.257 . . . . 0.0 110.494 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.2 p -165.18 140.61 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.638 1.175 . . . . 0.0 111.885 -173.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -102.49 147.65 26.49 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.571 2.348 . . . . 0.0 111.716 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.86 113.54 27.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.01 1.324 . . . . 0.0 109.125 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.95 -64.95 1.4 Allowed Glycine 0 N--CA 1.474 1.188 0 C-N-CA 124.134 0.873 . . . . 0.0 112.171 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -75.94 166.49 23.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.186 0.994 . . . . 0.0 111.368 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -54.18 146.23 15.57 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.304 1.042 . . . . 0.0 112.799 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.15 131.31 38.52 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.366 1.067 . . . . 0.0 111.193 -171.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 127.607 2.363 . . . . 0.0 110.585 -170.562 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.562 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -163.75 167.66 20.67 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.507 1.523 . . . . 0.0 110.761 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -165.64 170.59 14.01 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.577 1.551 . . . . 0.0 111.66 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.7 120.56 2.86 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.106 1.812 . . . . 0.0 112.581 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.0 t -167.08 118.04 0.9 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.885 1.674 . . . . 0.0 109.79 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.6 t -169.46 161.43 9.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.578 1.551 . . . . 0.0 110.986 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.59 145.66 22.03 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.438 1.018 . . . . 0.0 112.07 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.52 -33.74 73.27 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.976 0.91 . . . . 0.0 112.21 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -175.12 143.07 0.67 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.742 2.417 . . . . 0.0 110.452 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -144.78 63.44 1.3 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.865 1.666 . . . . 0.0 110.179 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -150.07 166.04 30.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.867 2.067 . . . . 0.0 109.999 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 p -65.54 139.3 58.46 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.486 0.714 . . . . 0.0 111.234 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.8 p -58.36 118.52 28.39 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 124.038 0.935 . . . . 0.0 112.543 -169.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.18 159.81 40.29 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.016 2.477 . . . . 0.0 110.686 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.0 -22.12 62.17 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -116.16 19.85 14.68 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.226 1.81 . . . . 0.0 113.848 -171.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -51.66 143.45 20.89 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.381 1.072 . . . . 0.0 112.556 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.07 -8.74 22.72 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.114 2.542 . . . . 0.0 114.933 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.0 p -129.89 -17.36 3.56 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 174.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 131.84 56.59 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.468 1.107 . . . . 0.0 111.796 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -127.46 113.13 15.77 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.907 1.283 . . . . 0.0 108.748 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -69.84 131.77 44.99 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.507 -0.746 . . . . 0.0 110.326 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.09 165.41 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.814 1.645 . . . . 0.0 111.795 -169.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.3 m -134.27 122.78 23.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.507 1.123 . . . . 0.0 109.087 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.4 127.83 33.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.291 1.037 . . . . 0.0 109.797 174.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.64 155.97 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.494 0.718 . . . . 0.0 112.707 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.1 p-10 -88.12 -167.85 2.02 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.608 1.163 . . . . 0.0 113.6 178.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.91 -30.3 71.43 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.944 1.298 . . . . 0.0 114.335 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -84.09 -10.38 57.86 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.944 0.793 . . . . 0.0 113.072 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.85 16.47 75.02 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.365 -1.242 . . . . 0.0 113.953 -172.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.4 m -78.25 149.89 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.599 1.699 . . . . 0.0 111.202 173.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -89.52 122.56 32.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.922 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.3 mt -103.41 -51.7 3.16 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.602 0.761 . . . . 0.0 111.68 -174.269 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.93 144.76 12.16 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 124.874 1.226 . . . . 0.0 114.277 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.3 p -89.8 150.36 22.29 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.08 1.352 . . . . 0.0 112.55 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.4 171.06 37.32 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 124.147 0.88 . . . . 0.0 115.094 -174.383 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -114.79 120.54 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 58.0 tpp -86.59 133.1 33.74 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.929 0.891 . . . . 0.0 109.118 170.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -130.14 130.17 44.43 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.034 1.334 . . . . 0.0 109.008 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.75 115.04 29.42 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.312 1.845 . . . . 0.0 107.004 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 p -110.57 174.55 5.81 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.237 1.015 . . . . 0.0 109.869 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -75.88 13.76 0.79 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 121.244 -0.91 . . . . 0.0 112.186 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.4 t -125.74 -41.51 1.98 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.557 1.543 . . . . 0.0 112.626 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -170.43 171.06 6.72 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.144 -0.972 . . . . 0.0 113.442 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.3 mt -87.36 133.88 33.65 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 165.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 t -133.36 134.2 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.797 0.839 . . . . 0.0 111.177 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.2 mt -101.03 129.36 46.86 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 124.461 1.104 . . . . 0.0 109.836 168.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -109.98 118.74 37.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.429 1.892 . . . . 0.0 109.734 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.2 mt -119.09 144.6 46.51 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.824 1.249 . . . . 0.0 110.329 -175.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -69.52 112.35 5.98 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.458 -0.776 . . . . 0.0 112.011 176.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 59.92 8.15 1.33 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.952 2.101 . . . . 0.0 116.05 174.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -96.4 -86.16 0.32 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.78 1.232 . . . . 0.0 110.63 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -158.53 172.55 18.11 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.665 2.386 . . . . 0.0 109.154 -171.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.1 138.26 52.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.257 1.023 . . . . 0.0 108.889 167.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 t -134.94 131.63 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.154 0.582 . . . . 0.0 110.961 -168.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -121.71 142.07 50.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.478 1.511 . . . . 0.0 112.118 -169.132 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -138.16 112.14 8.69 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.912 1.285 . . . . 0.0 110.703 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.19 146.69 82.23 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.489 2.126 . . . . 0.0 110.475 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -57.79 -28.13 63.73 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 mt -65.35 -25.23 67.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.762 1.625 . . . . 0.0 114.131 173.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.4 p -93.25 -8.17 43.0 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -79.48 115.2 18.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.885 0.874 . . . . 0.0 109.958 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -76.26 -37.91 56.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.361 0.665 . . . . 0.0 111.698 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -161.19 163.24 31.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.663 1.585 . . . . 0.0 111.947 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -150.44 138.03 19.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.368 1.867 . . . . 0.0 109.012 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -145.17 -178.94 21.13 Favored Glycine 0 N--CA 1.461 0.353 0 C-N-CA 123.859 0.742 . . . . 0.0 113.052 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -152.11 166.23 32.29 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.031 0.932 . . . . 0.0 112.916 -174.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -157.19 -178.41 7.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.309 2.244 . . . . 0.0 109.319 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.2 p -63.6 -21.65 66.47 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -152.68 10.65 0.49 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -133.65 127.7 33.52 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.747 -1.221 . . . . 0.0 110.463 -172.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -118.85 135.7 54.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.902 1.681 . . . . 0.0 109.678 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -153.75 156.67 38.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.656 1.182 . . . . 0.0 112.676 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -149.08 151.96 35.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.031 1.733 . . . . 0.0 111.518 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -111.68 132.84 54.33 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.024 1.33 . . . . 0.0 111.139 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m -132.89 147.85 52.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.765 1.226 . . . . 0.0 112.368 -172.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.65 174.51 41.31 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.787 1.184 . . . . 0.0 114.387 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -11.97 18.16 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -87.93 -15.45 36.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -174.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.7 p -80.08 179.21 7.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.949 0.899 . . . . 0.0 112.901 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -57.71 -37.88 74.26 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.843 1.257 . . . . 0.0 113.336 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.9 p -95.13 -20.88 18.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.426 1.49 . . . . 0.0 114.082 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.89 -167.46 42.12 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.371 1.462 . . . . 0.0 112.586 -173.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -67.08 132.28 47.53 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.62 0.768 . . . . 0.0 112.118 -173.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.05 -175.58 35.24 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 122.506 1.059 . . . . 0.0 113.454 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.8 mt -124.22 139.19 51.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 126.009 1.724 . . . . 0.0 108.432 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.11 127.72 36.62 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.842 1.257 . . . . 0.0 109.859 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.04 145.59 50.94 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.322 1.049 . . . . 0.0 113.594 -169.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -139.88 128.03 22.41 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.337 -168.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -66.38 127.68 33.22 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 43.8 t -164.92 114.85 1.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.189 1.396 . . . . 0.0 111.377 -167.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 m -71.19 -2.15 14.96 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -133.34 22.12 4.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.443 2.297 . . . . 0.0 112.427 -170.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.63 -36.07 33.52 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.388 1.475 . . . . 0.0 113.841 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -67.86 -37.87 82.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.639 0.775 . . . . 0.0 112.762 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.47 -33.68 73.24 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.434 -0.791 . . . . 0.0 111.665 175.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.79 -47.53 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.782 -0.574 . . . . 0.0 110.163 169.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.29 -42.9 87.64 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.025 1.33 . . . . 0.0 111.808 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -66.31 -33.22 75.24 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.738 1.215 . . . . 0.0 113.044 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.41 -42.52 20.28 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.082 0.855 . . . . 0.0 110.282 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.7 mt -49.69 -54.49 18.42 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.152 0.981 . . . . 0.0 112.273 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -59.48 -28.76 67.31 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -19.44 61.21 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.918 1.287 . . . . 0.0 113.045 175.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.1 mt -95.36 -35.83 11.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.434 1.493 . . . . 0.0 111.025 173.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 47.9 mmm -66.95 -34.19 77.23 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.617 1.167 . . . . 0.0 111.962 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -73.12 -9.45 58.73 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 174.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 12.4 t -69.98 -21.29 63.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.121 0.873 . . . . 0.0 112.434 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 63.0 t30 57.83 41.62 24.56 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.576 1.55 . . . . 0.0 112.479 172.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.9 p -27.4 109.41 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.486 2.714 . . . . 0.0 115.57 -170.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.1 mp -88.32 87.09 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 O-C-N 121.361 -0.837 . . . . 0.0 109.295 -172.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 62.62 21.51 12.74 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 126.14 1.776 . . . . 0.0 114.347 169.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.14 66.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.408 2.283 . . . . 0.0 111.205 -172.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 75.8 mtm 71.48 15.3 6.18 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 129.374 3.07 . . . . 0.0 115.506 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -103.33 -168.16 1.47 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.558 1.943 . . . . 0.0 109.174 167.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.48 154.26 17.5 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 121.164 -0.96 . . . . 0.0 112.498 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.26 140.26 52.79 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.43 2.087 . . . . 0.0 110.594 170.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.17 122.67 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.703 1.601 . . . . 0.0 109.025 -177.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 mp -80.76 115.91 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.6 mt -79.06 -53.77 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.984 0.513 . . . . 0.0 110.535 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.275 5.9 t 49.7 28.78 2.8 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.888 2.475 . . . . 0.0 114.778 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -156.7 159.0 37.96 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.901 1.681 . . . . 0.0 112.091 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -155.91 151.63 27.28 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.637 1.975 . . . . 0.0 109.856 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.5 m -158.4 148.56 19.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.795 1.638 . . . . 0.0 110.282 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -136.59 123.92 14.36 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.811 1.244 . . . . 0.0 111.136 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.99 166.45 27.96 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.363 2.709 . . . . 0.0 111.34 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.38 158.03 38.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.097 1.359 . . . . 0.0 111.408 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.28 167.2 28.04 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.945 1.698 . . . . 0.0 111.274 -174.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.3 pp -155.52 158.75 38.99 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.529 1.531 . . . . 0.0 111.475 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -149.18 142.46 25.12 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.198 1.799 . . . . 0.0 110.037 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.4 pp -95.38 145.7 30.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.3 1.04 . . . . 0.0 111.937 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.24 168.44 18.54 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.659 2.906 . . . . 0.0 111.574 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -147.96 144.18 27.82 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.96 1.304 . . . . 0.0 110.833 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -149.37 146.64 21.41 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.576 1.55 . . . . 0.0 111.352 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.99 176.18 10.29 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.04 3.16 . . . . 0.0 111.636 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -126.3 127.9 24.52 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.049 1.34 . . . . 0.0 108.78 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.06 150.91 30.12 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.458 2.772 . . . . 0.0 111.833 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.84 162.97 34.26 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.89 3.06 . . . . 0.0 111.743 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -157.94 138.7 13.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.736 1.214 . . . . 0.0 111.833 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -157.94 141.93 15.81 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.942 1.697 . . . . 0.0 110.782 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.3 tt -162.15 124.3 2.82 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.28 1.432 . . . . 0.0 109.547 -173.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -135.05 164.14 24.79 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.271 1.415 . . . . 0.0 113.814 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -151.12 151.62 32.22 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.012 1.725 . . . . 0.0 112.366 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.6 m -84.67 142.24 30.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.777 1.631 . . . . 0.0 109.714 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.9 m -142.15 153.24 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.776 1.631 . . . . 0.0 111.052 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.3 t -80.83 154.55 27.07 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.205 1.002 . . . . 0.0 112.677 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.6 p . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.007 1.723 . . . . 0.0 113.688 -178.368 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -143.34 122.42 12.88 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.294 1.038 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.72 124.76 28.16 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.579 1.151 . . . . 0.0 111.269 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 64.6 mt -94.47 154.13 17.58 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.007 0.923 . . . . 0.0 112.662 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -84.07 -21.2 31.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.447 1.499 . . . . 0.0 113.367 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -153.66 166.03 34.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.088 1.755 . . . . 0.0 111.751 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -87.9 118.53 69.79 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.223 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.0 -16.24 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.541 2.827 . . . . 0.0 114.076 -170.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 82.2 m -89.43 123.63 33.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.866 0.867 . . . . 0.0 110.749 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.06 -35.19 35.29 Favored Glycine 0 N--CA 1.473 1.128 0 C-N-CA 123.836 0.732 . . . . 0.0 113.043 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -97.05 120.31 37.17 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.55 1.14 . . . . 0.0 109.72 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.06 160.97 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.792 1.637 . . . . 0.0 110.447 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -122.14 124.89 44.94 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.537 1.135 . . . . 0.0 109.103 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -86.07 110.7 19.7 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.965 0.906 . . . . 0.0 110.709 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.73 -124.32 3.52 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.235 1.397 . . . . 0.0 112.124 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -57.8 121.94 11.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.799 1.24 . . . . 0.0 111.852 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -96.64 3.68 52.36 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.543 1.137 . . . . 0.0 113.474 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -76.93 159.06 30.28 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.154 0.982 . . . . 0.0 110.381 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 116.924 -1.512 . . . . 0.0 112.117 178.567 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 t -95.35 -6.41 41.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -124.01 128.01 48.75 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.263 1.425 . . . . 0.0 110.927 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.12 -133.05 7.57 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.415 1.483 . . . . 0.0 112.504 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -159.08 -163.39 1.21 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.985 1.714 . . . . 0.0 110.415 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.2 t -150.57 140.13 21.56 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.667 -1.271 . . . . 0.0 111.667 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.06 123.63 1.99 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.323 1.44 . . . . 0.0 111.707 -173.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -93.75 149.71 21.01 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.688 1.195 . . . . 0.0 110.745 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -145.38 -43.76 0.22 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.841 1.256 . . . . 0.0 112.281 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -69.15 151.72 46.01 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.804 0.841 . . . . 0.0 111.471 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -149.3 -62.12 0.22 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.025 1.33 . . . . 0.0 110.987 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.5 p -114.91 -2.56 12.85 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.7 t -151.83 120.41 3.36 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 128.021 2.528 . . . . 0.0 108.421 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.61 152.1 29.26 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.061 2.507 . . . . 0.0 110.612 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -68.72 -2.59 9.63 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.86 1.264 . . . . 0.0 114.091 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -134.04 31.12 3.59 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.451 1.9 . . . . 0.0 111.967 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -62.75 150.5 86.85 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.866 1.266 . . . . 0.0 112.983 173.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.0 -20.19 29.29 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.062 2.508 . . . . 0.0 115.668 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.3 p -126.14 -22.18 4.14 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.296 1.407 . . . . 0.0 114.303 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -97.11 144.74 26.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.231 1.012 . . . . 0.0 110.279 169.277 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -140.1 119.0 12.53 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.286 1.435 . . . . 0.0 108.207 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.44 135.24 45.71 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.382 -0.823 . . . . 0.0 109.932 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.83 169.34 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.966 1.306 . . . . 0.0 111.287 -171.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 20.9 m -142.67 122.39 13.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.67 1.188 . . . . 0.0 107.849 172.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -68.9 134.14 49.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.364 0.666 . . . . 0.0 110.462 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.71 155.87 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.521 1.128 . . . . 0.0 113.816 -173.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -84.62 -170.17 2.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -63.41 -21.62 66.4 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.689 1.596 . . . . 0.0 115.112 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.34 -0.5 32.63 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.323 1.449 . . . . 0.0 112.403 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.94 14.57 77.09 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.0 -1.444 . . . . 0.0 114.389 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -73.58 144.87 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.901 1.85 . . . . 0.0 110.674 178.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -87.27 120.87 29.0 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.796 1.238 . . . . 0.0 110.143 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.9 mt -105.75 -52.68 2.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.721 0.809 . . . . 0.0 112.048 -169.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.14 137.16 5.78 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.185 1.374 . . . . 0.0 111.958 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.7 t -83.69 149.43 26.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.941 0.876 . . . . 0.0 111.555 176.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.54 167.44 27.55 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 125.991 1.758 . . . . 0.0 113.378 -172.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.1 t -120.43 120.24 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.9 ttm -97.13 143.03 28.34 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.152 1.381 . . . . 0.0 109.388 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -145.4 126.53 14.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.835 1.254 . . . . 0.0 109.695 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.48 132.17 54.68 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.123 1.369 . . . . 0.0 108.688 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.7 p -135.31 171.09 14.94 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.937 1.295 . . . . 0.0 110.385 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -68.32 0.05 4.28 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 170.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t -103.2 -52.18 3.08 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.596 1.089 . . . . 0.0 112.399 178.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.18 173.1 2.65 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.724 1.21 . . . . 0.0 112.844 -170.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.18 118.44 25.63 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.06 1.344 . . . . 0.0 110.38 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.8 t -109.77 140.03 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.864 1.266 . . . . 0.0 109.178 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -139.69 124.9 18.87 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.513 1.525 . . . . 0.0 109.84 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -115.48 137.26 52.24 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.561 1.944 . . . . 0.0 110.417 -172.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mp -136.61 169.61 17.43 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.842 1.257 . . . . 0.0 112.617 -170.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.02 -6.9 23.8 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.71 1.604 . . . . 0.0 115.145 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -134.98 13.44 3.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.685 1.994 . . . . 0.0 113.193 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -160.14 153.93 22.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.598 1.959 . . . . 0.0 109.819 -173.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -65.01 164.67 12.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.231 1.012 . . . . 0.0 110.913 173.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.79 134.84 57.41 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.259 -0.901 . . . . 0.0 111.15 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.08 130.82 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.198 1.399 . . . . 0.0 109.881 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.98 141.28 52.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.637 1.175 . . . . 0.0 111.406 -171.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -134.91 112.81 11.48 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.702 1.201 . . . . 0.0 111.587 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.21 138.3 42.82 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.991 2.46 . . . . 0.0 110.755 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -60.21 -28.47 68.01 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -65.85 -35.27 80.2 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 0.0 112.453 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.0 m -92.22 3.27 55.69 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.57 120.52 24.63 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.964 0.905 . . . . 0.0 109.053 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -83.2 -23.31 32.89 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 30.0 ttp-105 -176.24 140.51 0.39 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.909 2.084 . . . . 0.0 109.478 -169.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -144.89 106.46 4.24 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.214 1.405 . . . . 0.0 111.54 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.14 165.16 12.01 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 126.231 1.872 . . . . 0.0 113.522 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -150.85 154.08 36.57 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.7 1.2 . . . . 0.0 113.218 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -144.97 -168.99 3.08 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.855 1.662 . . . . 0.0 110.064 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 t -68.75 -11.67 60.59 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -173.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -158.19 10.87 0.17 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.926 1.69 . . . . 0.0 114.225 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -140.61 133.24 28.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.614 1.566 . . . . 0.0 110.549 -168.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -126.29 138.43 53.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.93 1.692 . . . . 0.0 109.18 172.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -153.06 152.95 31.92 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.888 -1.133 . . . . 0.0 112.277 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -153.69 158.11 40.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.045 0.938 . . . . 0.0 112.545 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -115.07 135.2 54.46 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.723 1.609 . . . . 0.0 111.231 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 62.6 p -120.31 152.46 37.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.233 1.413 . . . . 0.0 112.905 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.44 164.44 31.87 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.984 1.278 . . . . 0.0 113.27 176.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -66.07 -9.26 29.18 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -171.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -84.83 -11.49 55.57 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.566 1.946 . . . . 0.0 115.231 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.3 m -68.01 173.5 4.52 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.841 1.256 . . . . 0.0 112.965 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -57.25 -40.74 78.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 112.285 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.3 p -90.03 -23.01 21.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.442 1.497 . . . . 0.0 113.161 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.29 -146.74 27.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.992 1.282 . . . . 0.0 111.612 -171.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -75.23 141.37 43.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.254 1.022 . . . . 0.0 112.206 -175.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.79 171.02 23.25 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.295 0.95 . . . . 0.0 113.245 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.33 133.33 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.391 1.476 . . . . 0.0 108.346 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -130.39 123.81 30.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.496 1.118 . . . . 0.0 110.606 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.03 139.96 49.75 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.638 1.175 . . . . 0.0 112.368 -175.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -136.84 124.11 21.86 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.787 1.235 . . . . 0.0 111.258 -172.406 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -70.0 133.87 47.7 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.245 0.618 . . . . 0.0 110.791 169.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 36.7 t -166.49 130.64 2.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.123 1.769 . . . . 0.0 110.517 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.5 t -66.97 -26.5 66.85 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.614 -0.678 . . . . 0.0 112.812 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -109.32 29.21 7.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.206 1.802 . . . . 0.0 113.226 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.16 -35.49 26.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.064 1.346 . . . . 0.0 114.185 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -70.24 -37.97 75.08 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.767 0.827 . . . . 0.0 113.024 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -65.94 -36.83 84.42 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.387 -0.821 . . . . 0.0 111.424 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.91 -48.94 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.915 0.486 . . . . 0.0 110.124 171.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -38.42 86.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.265 1.026 . . . . 0.0 112.93 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.36 -35.46 65.96 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.743 0.817 . . . . 0.0 112.427 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -76.18 -34.53 59.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.074 0.852 . . . . 0.0 112.008 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.7 mt -54.64 -59.61 4.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.156 0.889 . . . . 0.0 111.45 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -60.8 -24.49 65.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -29.4 64.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.977 0.911 . . . . 0.0 113.374 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.6 mt -96.32 -35.5 11.2 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.384 1.473 . . . . 0.0 111.434 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.5 mtp -69.89 -29.91 67.23 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.339 1.456 . . . . 0.0 112.594 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -71.26 -13.16 61.81 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 172.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 21.8 t -77.1 -25.26 52.01 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.719 0.808 . . . . 0.0 112.509 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.65 37.13 27.61 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.647 1.579 . . . . 0.0 112.521 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.2 t -52.26 125.7 16.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.093 1.357 . . . . 0.0 113.427 -169.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.0 mp -100.05 67.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.785 1.234 . . . . 0.0 108.568 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 38.85 53.46 1.99 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.592 2.357 . . . . 0.0 113.991 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -75.95 4.92 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -169.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 62.1 mtt -137.5 152.44 49.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.54 1.936 . . . . 0.0 110.282 177.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.93 154.28 39.76 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.049 0.54 . . . . 0.0 111.785 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -143.72 151.83 54.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.177 1.391 . . . . 0.0 111.379 -172.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.63 146.63 55.28 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.12 2.547 . . . . 0.0 110.993 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.3 t -114.9 123.99 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.245 1.418 . . . . 0.0 108.169 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.2 mm -77.43 150.89 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 122.366 1.079 . . . . 0.0 111.582 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.4 pt -77.82 7.75 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.633 1.573 . . . . 0.0 114.185 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.4 t -162.56 153.72 17.61 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.037 2.535 . . . . 0.0 109.336 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -159.28 120.99 3.36 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.942 1.297 . . . . 0.0 109.935 -174.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.47 156.47 17.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.988 1.315 . . . . 0.0 112.65 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.2 p -86.07 169.23 13.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.839 1.255 . . . . 0.0 112.275 170.625 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -113.9 91.27 21.46 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.434 1.094 . . . . 0.0 110.855 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.09 173.98 13.55 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.576 2.851 . . . . 0.0 111.418 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -149.34 152.27 35.54 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.032 1.333 . . . . 0.0 111.482 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.54 125.17 26.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.353 1.061 . . . . 0.0 110.935 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 pp -78.45 149.68 33.18 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.015 0.926 . . . . 0.0 111.422 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -161.15 149.51 15.91 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.282 1.433 . . . . 0.0 110.83 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 pp -86.88 144.17 36.41 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.449 1.1 . . . . 0.0 111.441 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.69 153.5 30.03 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.165 2.577 . . . . 0.0 111.323 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.72 169.98 10.27 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.978 0.894 . . . . 0.0 112.773 175.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.78 145.81 31.24 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.237 1.415 . . . . 0.0 111.828 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.65 168.88 23.29 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.65 2.9 . . . . 0.0 111.642 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -65.96 141.29 97.49 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.261 0.624 . . . . 0.0 110.868 176.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.13 149.56 58.41 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.327 2.685 . . . . 0.0 111.893 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.66 151.29 46.49 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.778 2.985 . . . . 0.0 111.761 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -77.41 163.76 26.09 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.169 0.987 . . . . 0.0 112.231 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -129.59 168.38 16.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.964 1.705 . . . . 0.0 111.979 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 48.1 tp -151.33 137.63 18.47 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.046 1.338 . . . . 0.0 110.858 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.49 -154.8 30.55 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.087 1.327 . . . . 0.0 113.312 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -157.32 175.63 13.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.721 1.609 . . . . 0.0 111.527 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -144.62 -177.75 5.66 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.424 1.49 . . . . 0.0 111.755 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.66 136.55 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.363 1.865 . . . . 0.0 110.935 -171.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 56.5 p -101.11 167.91 9.92 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.909 1.683 . . . . 0.0 113.237 -176.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.139 1.375 . . . . 0.0 112.54 179.134 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -65.28 124.85 23.3 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.604 -0.685 . . . . 0.0 110.954 175.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -87.15 116.84 25.5 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.334 1.054 . . . . 0.0 111.169 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 32.9 mt -81.74 159.42 23.87 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.632 0.773 . . . . 0.0 112.711 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -100.66 -12.13 19.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.526 1.53 . . . . 0.0 113.614 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -163.11 167.14 22.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.087 2.155 . . . . 0.0 110.906 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -84.8 126.49 68.23 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.874 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.15 -2.37 11.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.836 3.024 . . . . 0.0 113.956 -174.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 22.2 t -115.0 135.51 54.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.052 1.341 . . . . 0.0 112.088 -171.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.55 -5.81 56.68 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.485 1.517 . . . . 0.0 115.656 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -137.07 111.73 8.73 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.043 1.422 . . . . 0.0 110.278 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.5 p -147.75 138.18 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -168.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -99.3 117.24 33.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.875 2.07 . . . . 0.0 109.921 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -87.38 113.81 23.42 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.709 0.804 . . . . 0.0 110.466 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.15 -70.98 1.32 Allowed Glycine 0 N--CA 1.471 1.003 0 C-N-CA 124.409 1.004 . . . . 0.0 112.314 -174.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -80.14 114.24 18.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 110.238 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -164.6 157.29 16.77 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.989 1.716 . . . . 0.0 109.246 -173.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -67.65 134.03 50.4 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.687 -0.633 . . . . 0.0 110.881 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 C--O 1.257 1.449 0 C-N-CA 126.64 1.976 . . . . 0.0 111.686 -178.111 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.476 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 m -164.38 142.63 7.01 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.265 1.826 . . . . 0.0 110.52 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 m -149.61 153.71 37.5 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.123 1.369 . . . . 0.0 111.589 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.23 166.61 10.97 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.419 1.485 . . . . 0.0 113.675 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 p -163.58 140.1 6.94 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.103 1.361 . . . . 0.0 111.721 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.3 p -172.4 166.29 5.76 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.997 1.719 . . . . 0.0 111.455 -175.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.14 110.93 0.27 Allowed Glycine 0 C--N 1.341 0.845 0 C-N-CA 124.103 0.859 . . . . 0.0 112.839 174.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -168.69 162.33 11.7 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.807 2.043 . . . . 0.0 111.433 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -145.17 154.09 42.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.978 1.711 . . . . 0.0 111.007 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -161.87 147.6 13.43 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.557 1.543 . . . . 0.0 111.769 -173.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -114.38 7.67 16.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.655 1.582 . . . . 0.0 113.237 -172.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.6 p -150.52 143.34 24.64 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.794 1.638 . . . . 0.0 110.654 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.2 122.61 80.77 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.513 0.725 . . . . 0.0 111.071 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.82 163.9 18.27 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.464 2.776 . . . . 0.0 111.022 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.73 3.4 3.22 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.389 1.476 . . . . 0.0 113.021 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -135.62 16.12 3.37 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.459 1.903 . . . . 0.0 113.494 -169.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -59.62 147.21 78.37 Favored Pre-proline 0 CA--C 1.559 1.312 0 O-C-N 120.893 -1.129 . . . . 0.0 113.005 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.13 -21.58 23.6 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.723 2.282 . . . . 0.0 115.111 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.0 p -126.03 -20.83 4.46 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 120.691 1.587 . . . . 0.0 114.265 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -97.32 146.41 25.18 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.97 0.908 . . . . 0.0 109.145 168.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -141.6 113.5 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -67.85 134.4 50.83 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.565 -0.709 . . . . 0.0 110.12 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.28 164.44 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.82 1.248 . . . . 0.0 111.616 -171.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.4 m -139.97 123.08 16.8 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.502 1.121 . . . . 0.0 108.59 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -65.58 130.46 43.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.301 0.641 . . . . 0.0 109.722 175.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.32 156.46 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.327 1.051 . . . . 0.0 112.235 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.4 p-10 -85.15 -166.37 1.48 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.52 1.128 . . . . 0.0 113.126 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.11 -26.14 63.83 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.543 1.137 . . . . 0.0 113.695 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.51 -18.6 44.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.761 1.224 . . . . 0.0 112.591 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.06 17.39 59.43 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.021 1.296 . . . . 0.0 114.295 -173.163 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.7 m -76.77 150.25 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.68 1.74 . . . . 0.0 111.183 171.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -88.26 125.78 34.83 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.657 1.183 . . . . 0.0 110.849 -172.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -108.15 -49.57 3.18 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.184 0.994 . . . . 0.0 111.767 -171.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.57 137.21 5.56 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.919 1.247 . . . . 0.0 113.654 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.0 p -84.03 148.87 26.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.755 1.222 . . . . 0.0 112.356 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.06 170.82 34.95 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.794 1.188 . . . . 0.0 114.637 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.19 120.57 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.7 tpp -84.91 141.3 30.48 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.661 1.184 . . . . 0.0 109.576 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -140.26 130.31 24.85 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.071 1.348 . . . . 0.0 109.494 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.95 133.73 47.58 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.093 1.757 . . . . 0.0 108.133 175.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -133.89 173.87 11.08 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.091 1.357 . . . . 0.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -78.45 6.08 9.29 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.435 -0.791 . . . . 0.0 112.577 169.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.6 t -107.4 -49.31 3.28 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.537 1.135 . . . . 0.0 112.268 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -174.27 172.45 3.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.563 1.545 . . . . 0.0 112.484 -169.293 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.6 mt -85.04 139.79 31.5 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.17 0.988 . . . . 0.0 109.215 168.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.5 t -134.44 130.95 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.051 0.94 . . . . 0.0 111.217 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 mt -103.76 130.53 51.29 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.654 1.581 . . . . 0.0 110.026 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -111.42 124.09 51.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.868 2.067 . . . . 0.0 110.177 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.72 163.39 24.41 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.194 1.398 . . . . 0.0 111.838 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -89.25 -62.86 1.39 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.679 1.191 . . . . 0.0 113.087 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.8 mtt-85 -80.05 -13.58 59.19 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -120.58 162.39 19.71 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.713 2.005 . . . . 0.0 111.511 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -65.28 159.42 23.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.691 1.596 . . . . 0.0 112.618 174.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.27 145.7 41.67 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.385 0.674 . . . . 0.0 111.26 170.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 t -138.0 143.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.615 1.166 . . . . 0.0 109.842 -170.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.83 153.4 52.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.725 0.81 . . . . 0.0 113.003 -169.851 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -142.85 115.31 6.07 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.922 1.289 . . . . 0.0 111.348 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.02 150.26 66.36 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.628 2.219 . . . . 0.0 110.468 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -61.59 -22.98 65.69 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -38.84 92.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.112 1.765 . . . . 0.0 112.605 171.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.2 m -90.2 -9.56 47.65 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -69.43 127.94 34.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.572 0.749 . . . . 0.0 109.393 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -96.86 -26.8 14.96 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.574 0.75 . . . . 0.0 112.83 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -164.09 158.68 19.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.797 1.639 . . . . 0.0 111.454 169.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -144.84 107.96 4.55 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.773 1.229 . . . . 0.0 110.502 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.28 174.74 16.01 Favored Glycine 0 N--CA 1.463 0.478 0 C-N-CA 124.092 0.853 . . . . 0.0 113.531 -169.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -144.49 155.93 43.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.118 0.967 . . . . 0.0 111.384 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.37 -178.76 6.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.34 1.456 . . . . 0.0 110.532 171.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 t -62.59 120.44 11.15 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.359 -0.838 . . . . 0.0 110.774 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.33 15.16 0.62 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.81 2.444 . . . . 0.0 116.561 -174.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.11 126.25 26.26 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.893 1.277 . . . . 0.0 111.627 -169.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -118.13 134.42 55.01 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.693 1.597 . . . . 0.0 110.063 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.5 t -153.46 154.91 35.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.532 1.133 . . . . 0.0 112.385 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -148.69 150.61 33.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.423 1.489 . . . . 0.0 111.298 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -112.78 130.32 56.12 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.997 1.319 . . . . 0.0 109.747 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m -130.87 136.02 48.25 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.501 1.12 . . . . 0.0 110.594 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.74 175.54 51.73 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 123.783 0.706 . . . . 0.0 113.225 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -16.0 7.2 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -74.01 -18.38 60.86 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.028 2.531 . . . . 0.0 115.883 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.5 p -80.21 178.84 7.99 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -61.1 -44.4 97.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.832 1.253 . . . . 0.0 113.019 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.3 p -90.39 -18.81 24.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.73 1.212 . . . . 0.0 114.093 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.07 179.79 36.97 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.609 1.576 . . . . 0.0 112.391 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -66.94 126.51 29.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.273 0.629 . . . . 0.0 111.941 -169.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.85 178.42 40.34 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 122.448 1.026 . . . . 0.0 114.264 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.3 mt -116.1 133.74 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.968 1.707 . . . . 0.0 108.542 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -126.31 123.51 38.22 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.136 1.374 . . . . 0.0 109.627 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.1 143.01 50.71 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.297 1.046 . . . . 0.0 113.317 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -140.82 129.8 23.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.555 -169.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -68.07 131.26 45.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.81 0.444 . . . . 0.0 109.946 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 45.9 t -160.38 131.35 5.62 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.217 1.407 . . . . 0.0 111.377 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.8 t -71.32 -21.98 61.99 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -122.04 30.3 6.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.236 1.814 . . . . 0.0 113.4 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.66 -42.59 56.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.16 -36.64 77.62 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.248 0.619 . . . . 0.0 112.537 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.6 -35.77 80.99 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.602 -0.686 . . . . 0.0 111.588 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.8 mt -63.64 -47.73 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.534 0.606 . . . . 0.0 110.163 170.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.3 -38.47 77.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.333 1.053 . . . . 0.0 112.332 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -74.31 -29.0 61.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.237 1.415 . . . . 0.0 113.529 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 tt -84.22 -40.03 18.59 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.298 0.954 . . . . 0.0 110.464 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.8 mt -53.01 -54.01 41.53 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.737 0.815 . . . . 0.0 112.286 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -60.09 -25.08 65.14 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -20.37 53.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.96 1.304 . . . . 0.0 113.05 175.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.9 mt -91.59 -38.93 12.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.128 1.371 . . . . 0.0 110.873 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 60.6 mmm -66.29 -34.89 79.02 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.842 1.257 . . . . 0.0 112.421 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -74.01 -6.93 50.42 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 20.6 t -65.41 -25.06 67.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 119.067 0.849 . . . . 0.0 112.334 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 60.04 22.81 11.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.24 1.816 . . . . 0.0 113.368 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.5 m -17.51 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 130.528 3.531 . . . . 0.0 116.563 -170.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 28.6 mt -80.1 -51.21 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.601 0.76 . . . . 0.0 111.389 -171.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -122.06 6.51 9.77 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.107 1.363 . . . . 0.0 113.363 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.2 t -84.33 -21.59 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.079 1.752 . . . . 0.0 112.09 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.5 mmt -78.58 156.92 28.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.609 1.164 . . . . 0.0 112.313 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.99 -173.64 2.4 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.532 1.133 . . . . 0.0 112.289 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -55.4 144.17 53.55 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.413 1.085 . . . . 0.0 112.947 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.2 150.11 71.23 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.495 2.797 . . . . 0.0 112.094 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.2 t -103.83 122.97 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.033 1.333 . . . . 0.0 109.275 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 mp -88.5 126.8 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.379 1.072 . . . . 0.0 108.578 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 74.5 mt -116.97 142.05 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.53 1.532 . . . . 0.0 108.83 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 t -59.35 152.17 21.85 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.027 1.331 . . . . 0.0 112.285 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -55.82 133.41 51.14 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.048 0.939 . . . . 0.0 111.377 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.78 150.63 39.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.655 1.582 . . . . 0.0 111.45 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.5 p -84.85 158.11 20.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.891 1.276 . . . . 0.0 114.021 -170.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -141.28 146.29 42.05 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.621 1.569 . . . . 0.0 111.996 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.74 162.98 32.09 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.909 3.073 . . . . 0.0 112.205 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.07 150.39 24.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.52 1.128 . . . . 0.0 112.223 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -77.35 135.12 38.34 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.565 1.146 . . . . 0.0 111.219 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.33 123.97 35.17 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.004 1.322 . . . . 0.0 109.661 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -72.97 152.14 41.5 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.332 1.453 . . . . 0.0 113.968 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.97 146.3 34.87 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.587 1.155 . . . . 0.0 111.829 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.91 146.08 18.2 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.281 2.654 . . . . 0.0 111.766 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.88 156.5 39.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.816 0.847 . . . . 0.0 113.177 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.95 153.56 38.13 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.262 1.425 . . . . 0.0 111.839 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.4 177.09 8.36 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.94 3.093 . . . . 0.0 111.643 174.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -124.5 151.51 67.16 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.131 1.372 . . . . 0.0 111.179 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.52 152.21 59.73 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.163 2.576 . . . . 0.0 111.892 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.71 154.97 39.62 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.841 3.028 . . . . 0.0 112.12 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -81.17 165.47 21.51 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.471 1.108 . . . . 0.0 112.622 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -122.99 176.1 6.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.953 1.701 . . . . 0.0 111.598 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.2 tp -143.49 135.5 26.72 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.043 1.337 . . . . 0.0 110.846 -175.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.09 -138.92 7.41 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.296 1.427 . . . . 0.0 112.261 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -154.83 166.82 32.28 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.849 1.259 . . . . 0.0 112.603 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.7 p -125.84 163.63 22.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.35 1.86 . . . . 0.0 110.453 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.7 p -150.72 142.63 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.826 1.251 . . . . 0.0 110.41 -171.686 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.2 m -71.96 144.1 49.01 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.991 0.916 . . . . 0.0 113.034 -175.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.253 1.283 0 C-N-CA 125.36 1.464 . . . . 0.0 112.277 177.904 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -73.31 129.47 38.08 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.049 -0.407 . . . . 0.0 110.767 170.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.26 127.35 46.57 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.189 1.396 . . . . 0.0 111.327 179.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 44.7 mt -93.58 153.62 18.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -80.48 -36.7 33.05 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.818 1.647 . . . . 0.0 112.598 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -138.99 160.98 38.47 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.492 1.917 . . . . 0.0 111.764 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -78.61 121.33 83.48 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.9 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -84.28 -15.0 6.74 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.227 2.618 . . . . 0.0 113.833 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 85.6 m -90.79 116.87 28.97 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.95 0.9 . . . . 0.0 110.882 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.73 -16.28 80.75 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.91 0.767 . . . . 0.0 114.022 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -120.96 133.6 55.28 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.836 1.654 . . . . 0.0 109.507 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -162.1 145.49 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.945 1.298 . . . . 0.0 111.475 -169.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -111.76 130.52 55.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.045 1.738 . . . . 0.0 109.393 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -96.2 107.3 19.62 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.513 1.125 . . . . 0.0 110.818 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.66 172.05 20.67 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.447 1.498 . . . . 0.0 113.233 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 60.16 21.0 10.3 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.877 1.671 . . . . 0.0 113.744 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -79.68 163.86 24.21 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.619 1.968 . . . . 0.0 112.243 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -156.47 138.09 14.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.708 1.203 . . . . 0.0 110.066 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . 0.269 29.9 pt20 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 127.504 2.322 . . . . 0.0 114.815 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t -161.6 155.85 22.45 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.826 1.65 . . . . 0.0 110.268 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 t -166.38 176.65 7.29 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.269 1.427 . . . . 0.0 111.902 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.51 156.45 32.6 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.796 1.665 . . . . 0.0 113.459 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -162.52 117.57 1.84 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.126 1.37 . . . . 0.0 110.077 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.9 t -170.12 163.56 9.15 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.045 1.738 . . . . 0.0 110.668 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.35 149.02 9.13 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.698 1.142 . . . . 0.0 113.342 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -91.34 152.4 20.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.024 1.33 . . . . 0.0 110.961 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -71.44 162.4 29.51 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.914 0.886 . . . . 0.0 112.288 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -148.13 136.88 21.75 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.323 1.449 . . . . 0.0 110.637 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.58 -27.67 62.33 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.0 m -151.14 138.58 19.5 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.844 1.658 . . . . 0.0 110.336 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 p -62.13 122.29 71.58 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 124.202 1.001 . . . . 0.0 111.973 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.75 163.79 20.9 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.202 2.601 . . . . 0.0 111.313 171.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.28 -10.51 55.22 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 176.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -124.02 16.14 9.25 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.708 1.603 . . . . 0.0 113.872 -171.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -54.46 145.41 38.27 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 124.482 1.113 . . . . 0.0 112.787 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.49 -14.98 47.64 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.073 2.515 . . . . 0.0 115.529 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.7 p -125.6 -19.13 5.04 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.043 1.292 . . . . 0.0 114.432 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.71 144.02 44.55 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.377 1.071 . . . . 0.0 112.682 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -139.8 120.88 14.69 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.097 1.359 . . . . 0.0 108.973 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -72.57 134.02 45.0 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.462 -0.774 . . . . 0.0 110.207 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.43 163.62 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.796 1.239 . . . . 0.0 111.572 -170.745 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.8 m -138.66 118.68 13.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.301 1.041 . . . . 0.0 109.576 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -64.68 131.22 46.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.484 0.714 . . . . 0.0 110.491 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.46 157.69 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 113.054 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -88.01 -168.95 2.38 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.97 -28.6 69.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.044 1.738 . . . . 0.0 114.037 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -87.24 -13.38 43.99 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.257 1.023 . . . . 0.0 113.143 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.61 15.94 67.16 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.137 -1.368 . . . . 0.0 114.255 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 16.8 m -76.89 150.41 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.947 1.874 . . . . 0.0 111.181 173.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -87.56 124.98 34.06 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.451 1.1 . . . . 0.0 111.303 -171.418 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 mt -108.3 -52.41 2.77 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.741 0.817 . . . . 0.0 112.038 -172.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.71 136.52 5.65 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 124.46 1.028 . . . . 0.0 114.339 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.0 p -85.71 139.38 31.4 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.038 1.335 . . . . 0.0 112.291 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.61 170.52 24.74 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.376 1.941 . . . . 0.0 112.986 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.4 t -116.71 120.25 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.7 ttm -92.54 118.6 31.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.057 1.343 . . . . 0.0 109.775 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -109.23 130.14 55.49 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.911 1.684 . . . . 0.0 108.969 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.9 122.02 45.59 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.77 1.628 . . . . 0.0 107.164 174.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.4 p -114.57 173.59 6.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.549 1.14 . . . . 0.0 109.762 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -70.17 -3.38 16.55 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.415 -0.803 . . . . 0.0 112.904 173.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -120.23 -35.24 3.49 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -167.29 163.79 15.3 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.086 -1.009 . . . . 0.0 113.331 -169.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -87.43 136.35 32.97 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.37 1.468 . . . . 0.0 109.524 168.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.69 126.34 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.758 0.823 . . . . 0.0 110.853 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.9 mt -100.89 130.05 46.84 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.883 1.273 . . . . 0.0 110.298 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -101.59 122.3 43.59 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.997 1.719 . . . . 0.0 111.31 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -125.34 165.99 17.36 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.69 2.396 . . . . 0.0 110.692 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -85.1 -71.68 0.51 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.504 1.122 . . . . 0.0 113.414 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -88.73 -17.21 30.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.836 1.254 . . . . 0.0 114.284 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -92.49 159.52 15.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.935 1.294 . . . . 0.0 110.369 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -60.46 154.03 21.69 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.862 0.865 . . . . 0.0 111.129 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.45 132.11 49.09 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.746 -0.596 . . . . 0.0 109.496 169.702 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -108.46 126.68 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -169.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -127.66 141.44 51.61 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -166.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -140.95 116.25 7.35 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.839 1.256 . . . . 0.0 111.168 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.87 144.96 66.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.036 1.824 . . . . 0.0 108.878 169.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -58.1 -29.98 65.91 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.04 -41.32 78.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.073 1.749 . . . . 0.0 112.283 175.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.9 m -86.48 4.62 38.97 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.4 mt -85.4 118.34 24.88 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.416 1.007 . . . . 0.0 109.487 171.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -75.43 -34.86 61.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.026 0.53 . . . . 0.0 111.781 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -165.92 158.4 14.83 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.011 2.125 . . . . 0.0 111.206 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -145.67 107.84 4.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.222 1.409 . . . . 0.0 112.045 -174.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -117.27 161.72 13.08 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.879 1.704 . . . . 0.0 114.172 -169.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -148.01 152.8 38.07 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.129 1.372 . . . . 0.0 113.109 -170.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -145.95 -179.14 6.5 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.387 1.875 . . . . 0.0 109.815 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 m -61.45 -12.7 15.76 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -154.13 10.0 0.38 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.406 1.482 . . . . 0.0 114.67 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -139.94 133.92 30.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.704 1.601 . . . . 0.0 110.633 -168.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -126.84 137.33 53.17 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.81 1.644 . . . . 0.0 110.013 172.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.1 t -153.47 158.16 40.94 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.444 1.098 . . . . 0.0 112.871 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -158.03 156.1 30.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.088 1.355 . . . . 0.0 112.938 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.47 139.77 32.08 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.421 1.489 . . . . 0.0 110.166 170.472 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.7 p -122.33 151.32 41.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.589 1.156 . . . . 0.0 112.718 169.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.43 164.28 26.79 Favored Glycine 0 N--CA 1.477 1.4 0 C-N-CA 125.228 1.394 . . . . 0.0 114.044 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -20.51 65.03 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -170.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 -82.52 -15.32 52.81 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.2 p -82.05 179.4 7.83 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -59.52 -44.28 93.21 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.686 1.594 . . . . 0.0 112.872 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.0 p -82.8 -29.14 29.76 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.55 -155.1 33.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.446 1.498 . . . . 0.0 112.157 -172.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -63.2 137.67 58.29 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.826 0.85 . . . . 0.0 112.363 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.66 165.55 18.74 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.217 0.913 . . . . 0.0 113.117 169.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.35 128.63 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.882 1.273 . . . . 0.0 107.756 168.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -127.18 122.92 35.43 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.59 1.156 . . . . 0.0 109.374 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.22 140.84 48.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.313 1.045 . . . . 0.0 112.132 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -133.44 122.02 23.1 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.503 1.121 . . . . 0.0 110.953 -171.35 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -71.46 132.93 45.47 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.4 0.68 . . . . 0.0 110.974 170.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 25.0 p -169.3 140.72 2.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.006 1.723 . . . . 0.0 111.448 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.4 m -83.09 4.83 24.66 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -133.18 25.85 4.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.158 1.383 . . . . 0.0 113.748 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.19 -37.71 23.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.599 1.559 . . . . 0.0 114.122 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.71 -36.47 80.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.0 0.92 . . . . 0.0 112.984 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.68 -32.54 71.21 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.236 0.925 . . . . 0.0 111.863 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.59 -48.01 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 122.976 0.51 . . . . 0.0 109.658 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -37.78 83.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.401 1.081 . . . . 0.0 112.721 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -68.75 -33.43 73.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.486 1.114 . . . . 0.0 112.478 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.0 tp -84.63 -37.49 21.01 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.961 0.8 . . . . 0.0 112.168 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.76 -56.35 14.39 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.143 0.883 . . . . 0.0 112.211 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -59.75 -23.57 63.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -24.7 45.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.627 1.171 . . . . 0.0 113.042 176.17 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.4 mt -98.05 -34.5 10.76 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.806 1.642 . . . . 0.0 111.686 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 96.8 mtp -68.85 -27.52 65.9 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.236 1.415 . . . . 0.0 113.034 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -78.49 -10.75 59.83 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 169.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 13.3 t -80.95 -28.81 35.55 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.926 0.785 . . . . 0.0 112.683 -171.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.4 m120 59.98 27.66 17.09 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.487 1.915 . . . . 0.0 114.72 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.3 m -79.79 75.96 6.47 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.378 -1.451 . . . . 0.0 110.911 171.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.8 mm -86.25 -138.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.76 1.224 . . . . 0.0 108.88 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.01 50.7 0.61 Allowed 'General case' 0 CA--C 1.552 1.056 0 O-C-N 119.616 -1.928 . . . . 0.0 112.142 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.9 m -90.56 2.3 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 126.386 1.874 . . . . 0.0 114.404 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 61.2 mtt -91.0 -161.17 0.78 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.364 1.466 . . . . 0.0 111.04 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -68.09 80.58 0.22 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 120.938 -1.101 . . . . 0.0 112.513 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -149.07 156.96 40.39 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.606 2.363 . . . . 0.0 110.161 -169.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.3 174.29 11.02 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.758 2.972 . . . . 0.0 112.443 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.2 t -89.52 133.07 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.052 1.341 . . . . 0.0 110.25 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.68 146.8 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.165 1.786 . . . . 0.0 108.46 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.0 mm -77.19 83.24 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.793 0.837 . . . . 0.0 109.903 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.8 p -145.86 145.7 30.84 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.962 2.105 . . . . 0.0 110.573 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -67.98 134.71 51.19 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.618 1.167 . . . . 0.0 111.331 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -161.15 179.99 7.93 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.826 1.651 . . . . 0.0 112.276 -176.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.0 m -146.82 162.66 38.14 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.611 1.565 . . . . 0.0 110.543 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -57.55 124.04 65.57 Favored Pre-proline 0 CA--C 1.555 1.139 0 O-C-N 121.324 -0.86 . . . . 0.0 112.414 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.8 166.3 21.54 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.606 2.87 . . . . 0.0 111.933 -175.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.79 -177.66 6.42 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.651 1.18 . . . . 0.0 112.221 171.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -150.94 156.61 41.55 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.509 1.524 . . . . 0.0 111.072 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 45.4 tp -72.04 134.67 46.0 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.296 1.038 . . . . 0.0 111.736 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.95 150.0 46.14 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.648 1.179 . . . . 0.0 112.624 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 pp -86.87 154.37 55.44 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.553 1.141 . . . . 0.0 111.84 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.91 152.6 25.04 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.746 2.297 . . . . 0.0 111.662 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 25.1 ttp-105 -74.9 155.66 37.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.328 1.051 . . . . 0.0 111.723 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.56 146.38 55.55 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.867 1.267 . . . . 0.0 112.674 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.58 163.37 36.12 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 124.1 3.2 . . . . 0.0 112.821 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -81.49 151.0 68.13 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.603 1.161 . . . . 0.0 112.284 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.81 157.22 43.72 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.582 2.855 . . . . 0.0 112.254 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.59 162.0 33.5 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 124.212 3.275 . . . . 0.0 112.536 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -82.08 160.51 23.16 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.733 1.213 . . . . 0.0 113.452 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.66 145.55 31.58 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.741 1.217 . . . . 0.0 112.381 177.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.55 148.73 26.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.139 1.376 . . . . 0.0 111.972 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.8 -157.7 23.29 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.093 1.33 . . . . 0.0 113.429 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -155.9 161.73 40.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.862 1.265 . . . . 0.0 112.806 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p -127.66 175.13 8.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.71 2.004 . . . . 0.0 111.423 -170.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.76 139.39 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.674 1.19 . . . . 0.0 111.391 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.4 m -75.14 158.52 32.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.103 1.361 . . . . 0.0 113.759 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.1 p . . . . . 0 C--O 1.253 1.262 0 C-N-CA 125.488 1.515 . . . . 0.0 113.815 174.501 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 79.6 mt . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -143.39 119.17 10.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.92 1.288 . . . . 0.0 109.821 172.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.33 121.53 25.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.157 0.583 . . . . 0.0 111.251 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 78.6 mt -86.46 155.19 20.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -84.71 -13.96 49.8 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.637 1.575 . . . . 0.0 113.506 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -163.35 169.21 19.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.527 2.331 . . . . 0.0 110.706 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -86.19 120.52 72.42 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.01 -9.23 17.97 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.488 2.792 . . . . 0.0 114.209 -172.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 44.7 t -92.03 -74.27 0.52 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.056 0.942 . . . . 0.0 113.13 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.02 -41.7 3.04 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.774 1.654 . . . . 0.0 114.066 -172.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -81.47 91.87 6.38 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.544 1.172 . . . . 0.0 109.997 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.41 139.88 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -100.06 141.77 32.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.138 2.175 . . . . 0.0 111.108 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -106.23 129.31 54.3 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.618 1.167 . . . . 0.0 111.273 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.38 -72.32 1.06 Allowed Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.657 1.122 . . . . 0.0 112.371 -175.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -92.75 18.09 9.4 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.141 1.376 . . . . 0.0 113.315 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -122.7 122.87 39.8 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.249 1.42 . . . . 0.0 108.278 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -99.25 144.94 27.81 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.445 1.098 . . . . 0.0 111.089 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 125.527 1.531 . . . . 0.0 112.514 -176.396 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 . . . . . 0 CA--C 1.558 1.279 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.73 -11.91 28.33 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.08 2.52 . . . . 0.0 115.478 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 51.5 p -131.87 -16.42 2.92 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 120.155 1.343 . . . . 0.0 114.604 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.9 147.76 37.93 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.614 1.166 . . . . 0.0 111.505 172.715 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -140.8 118.57 11.71 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.994 0.918 . . . . 0.0 108.844 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -67.35 127.05 31.22 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.801 -0.562 . . . . 0.0 109.706 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.9 m -134.97 159.93 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.696 1.598 . . . . 0.0 110.669 -171.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 m -135.27 119.17 17.34 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.175 0.99 . . . . 0.0 109.039 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.577 HD22 ' N ' ' B' ' 2' ' ' PHE . 57.4 t30 -65.8 132.52 48.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.323 0.649 . . . . 0.0 110.267 178.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 m -127.95 155.59 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.293 1.037 . . . . 0.0 112.665 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.3 p-10 -91.05 -168.89 2.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.847 1.259 . . . . 0.0 114.34 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.07 -21.4 66.15 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.228 1.811 . . . . 0.0 114.044 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -95.89 -10.23 29.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.948 1.299 . . . . 0.0 112.95 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.17 16.28 72.31 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 117.934 -1.481 . . . . 0.0 114.239 -172.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.405 HG22 ' OD1' ' A' ' 27' ' ' ASP . 13.4 m -77.65 149.7 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.12 1.96 . . . . 0.0 111.353 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -86.68 126.96 34.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.349 1.059 . . . . 0.0 111.497 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.6 mt -108.94 -51.11 2.92 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.002 0.921 . . . . 0.0 112.0 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.33 143.44 9.19 Favored Glycine 0 N--CA 1.47 0.928 0 C-N-CA 124.76 1.171 . . . . 0.0 113.854 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.5 p -90.07 150.87 21.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.115 1.366 . . . . 0.0 112.909 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.11 172.63 35.85 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.195 1.855 . . . . 0.0 113.039 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.31 120.85 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.1 tpp -86.29 131.9 34.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.846 0.859 . . . . 0.0 109.354 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -118.5 127.93 54.1 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.405 1.482 . . . . 0.0 109.118 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.5 127.96 55.41 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.618 1.967 . . . . 0.0 107.993 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -160.45 152.28 19.96 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.47 1.908 . . . . 0.0 108.024 -171.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -57.23 -18.06 14.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.86 1.264 . . . . 0.0 113.943 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 t -78.16 -51.94 9.47 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -178.37 174.73 1.25 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.855 1.662 . . . . 0.0 112.501 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt -86.81 139.2 30.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.772 0.829 . . . . 0.0 110.688 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.59 134.42 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.951 0.901 . . . . 0.0 111.696 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.14 131.49 46.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.357 1.463 . . . . 0.0 110.537 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -110.92 139.51 46.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.153 2.181 . . . . 0.0 110.681 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.547 0.837 0 C-N-CA 125.356 1.463 . . . . 0.0 110.848 -173.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.683 0 CA-C-O 120.444 0.164 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 t -133.4 134.34 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.856 0.462 . . . . 0.0 111.566 -170.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -125.74 147.1 49.49 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.591 1.556 . . . . 0.0 112.836 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.2 m-90 -143.91 117.11 5.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.308 1.443 . . . . 0.0 111.429 174.134 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.86 148.62 58.38 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.73 2.287 . . . . 0.0 110.509 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -60.36 -27.51 67.44 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -56.59 -39.69 73.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.729 1.612 . . . . 0.0 112.076 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.84 -17.7 61.52 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 mt -84.63 81.41 8.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.544 1.066 . . . . 0.0 110.998 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.529 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -59.39 -30.98 68.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.831 0.852 . . . . 0.0 113.17 173.662 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -152.35 148.76 27.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.231 1.412 . . . . 0.0 111.594 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -146.45 112.12 5.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.62 1.568 . . . . 0.0 110.402 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.32 162.93 13.08 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 124.918 1.246 . . . . 0.0 114.566 -168.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -145.66 144.93 30.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.187 1.395 . . . . 0.0 111.879 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -144.05 -175.71 4.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.897 1.679 . . . . 0.0 109.906 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.1 m -56.53 112.48 1.28 Allowed 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.347 -0.846 . . . . 0.0 110.81 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.253 0.8 OUTLIER 49.33 23.59 0.87 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.666 2.387 . . . . 0.0 116.561 -173.133 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -132.22 129.41 39.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.488 1.515 . . . . 0.0 111.181 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -123.85 139.09 54.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.769 1.628 . . . . 0.0 109.997 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 t -153.57 155.56 36.37 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.962 -1.086 . . . . 0.0 113.41 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.22 148.23 29.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.982 1.313 . . . . 0.0 112.606 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.97 147.77 26.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.625 1.97 . . . . 0.0 108.403 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 m -155.0 134.85 12.86 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.625 -1.297 . . . . 0.0 112.153 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.57 170.44 54.54 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.247 0.927 . . . . 0.0 113.605 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -12.96 7.58 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -77.34 -16.51 58.88 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.4 p -86.42 176.69 7.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -55.75 -41.1 73.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.624 1.57 . . . . 0.0 113.528 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.9 p -91.79 -16.83 26.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.397 1.479 . . . . 0.0 113.94 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.15 -169.98 42.59 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.031 1.776 . . . . 0.0 112.138 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -67.68 126.68 30.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.648 0.779 . . . . 0.0 110.79 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.21 162.71 16.91 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 121.912 0.729 . . . . 0.0 114.345 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.57 133.5 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.107 1.363 . . . . 0.0 108.775 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -125.71 124.45 41.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.626 1.17 . . . . 0.0 109.759 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.44 143.88 49.86 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.473 1.109 . . . . 0.0 112.61 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -140.47 127.8 21.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.493 -169.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -72.47 136.24 45.92 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.085 0.554 . . . . 0.0 110.345 169.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 48.8 t -163.8 131.59 3.51 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.591 1.556 . . . . 0.0 110.644 -172.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.5 t -71.31 -8.31 52.86 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -129.48 26.01 5.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.26 1.824 . . . . 0.0 112.834 -173.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.17 -36.01 38.94 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -70.22 -38.01 75.16 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.429 0.692 . . . . 0.0 112.759 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -67.43 -33.18 74.63 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.497 -0.752 . . . . 0.0 111.612 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.58 -51.09 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 169.166 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.84 -37.62 82.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.841 0.857 . . . . 0.0 112.662 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.75 -30.33 67.88 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.6 1.16 . . . . 0.0 112.796 175.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.45 -37.11 21.81 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.006 0.821 . . . . 0.0 112.419 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 23.1 mt -53.43 -54.17 40.69 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.321 0.964 . . . . 0.0 111.832 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -59.0 -26.68 64.74 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -70.8 -30.71 67.24 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.723 1.209 . . . . 0.0 112.766 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.59 -38.33 12.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.6 1.56 . . . . 0.0 111.135 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 125.2 1.4 . . . . 0.0 113.012 -178.95 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.577 ' N ' HD22 ' A' ' 25' ' ' ASN . 32.1 t80 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 119.849 -0.12 . . . . 0.0 111.141 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -90.88 109.69 20.91 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.264 1.026 . . . . 0.0 109.607 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 37.7 mt -74.66 156.89 36.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.953 0.901 . . . . 0.0 113.015 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -79.76 -24.71 41.36 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.11 1.364 . . . . 0.0 113.582 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -162.05 169.75 20.45 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.535 1.934 . . . . 0.0 111.344 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -80.78 124.73 81.5 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.259 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.34 6.27 5.72 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.859 3.04 . . . . 0.0 113.786 -172.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 47.9 t -127.98 131.84 49.23 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.001 1.32 . . . . 0.0 112.07 -171.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.13 -17.31 40.75 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.91 1.243 . . . . 0.0 115.122 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -113.61 112.66 23.89 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.177 1.391 . . . . 0.0 110.286 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -154.89 134.51 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.777 0.799 . . . . 0.0 111.993 -169.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -93.8 120.03 33.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.043 2.137 . . . . 0.0 110.271 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 123.794 0.837 . . . . 0.0 110.242 177.926 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 . . . . . 0 CA--C 1.555 1.144 0 CA-C-O 118.841 -0.599 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.87 -15.0 47.25 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.163 2.575 . . . . 0.0 115.141 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.6 p -128.41 -18.14 4.06 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.19 1.359 . . . . 0.0 114.459 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 113.18 24.99 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.186 0.903 . . . . 0.0 111.112 174.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -107.94 113.23 26.28 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.127 0.971 . . . . 0.0 109.333 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -67.11 131.29 45.51 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.581 -0.7 . . . . 0.0 110.253 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.5 152.79 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.261 1.425 . . . . 0.0 111.125 -169.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.5 m -130.45 118.37 21.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.837 0.855 . . . . 0.0 109.09 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.549 HD22 ' N ' ' B' ' 2' ' ' PHE . 57.7 t30 -66.29 133.97 51.66 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.941 0.896 . . . . 0.0 110.642 -179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.36 155.08 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.924 0.89 . . . . 0.0 112.733 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.83 -168.3 2.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.576 1.151 . . . . 0.0 113.695 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -72.52 -20.09 61.41 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.637 1.175 . . . . 0.0 113.592 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.76 -15.48 44.87 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.951 1.301 . . . . 0.0 112.408 171.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.98 16.48 67.44 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.042 -1.421 . . . . 0.0 114.449 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.49 151.08 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 119.844 1.822 . . . . 0.0 111.667 173.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.27 128.16 35.17 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.857 1.263 . . . . 0.0 111.308 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.0 mt -110.09 -52.17 2.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.964 0.906 . . . . 0.0 112.347 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.11 152.71 23.78 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.669 1.604 . . . . 0.0 112.569 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.0 t -116.28 149.35 39.37 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.939 0.896 . . . . 0.0 112.82 -172.447 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.99 174.7 33.19 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 126.784 2.135 . . . . 0.0 113.643 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.2 t -114.83 120.5 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.1 tpp -86.65 131.52 34.13 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.95 0.9 . . . . 0.0 109.475 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -127.36 129.99 48.6 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.63 1.572 . . . . 0.0 108.818 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.22 131.1 53.11 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.384 1.873 . . . . 0.0 107.804 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.0 p -130.55 171.3 13.18 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.023 1.329 . . . . 0.0 109.774 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -70.6 -7.65 45.72 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.218 -0.926 . . . . 0.0 112.62 172.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.3 m -102.4 -43.59 5.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.453 1.101 . . . . 0.0 113.428 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -173.94 170.68 3.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.174 1.389 . . . . 0.0 113.151 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.87 140.89 29.2 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.856 1.262 . . . . 0.0 110.275 168.451 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.6 t -135.31 129.99 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.545 1.138 . . . . 0.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.7 mt -100.23 126.36 46.52 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.679 1.192 . . . . 0.0 110.251 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -98.95 127.52 44.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.55 1.54 . . . . 0.0 110.704 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 CA--C 1.541 0.606 0 C-N-CA 127.167 2.187 . . . . 0.0 110.065 -172.348 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.24 134.49 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.129 0.971 . . . . 0.0 109.724 -174.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.3 150.21 48.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.574 1.15 . . . . 0.0 112.71 -168.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 -142.26 115.22 6.4 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.751 1.22 . . . . 0.0 111.421 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.09 146.6 71.11 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.549 2.166 . . . . 0.0 110.017 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -60.7 -29.98 69.67 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -34.13 70.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.196 1.798 . . . . 0.0 112.679 173.31 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.9 m -83.28 -9.38 59.14 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.57 88.17 7.03 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.641 1.109 . . . . 0.0 110.199 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -64.98 -29.74 70.69 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.758 0.823 . . . . 0.0 113.114 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -154.71 154.75 33.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.95 0.9 . . . . 0.0 112.691 167.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -151.41 144.84 24.84 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.255 1.422 . . . . 0.0 109.633 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.49 -179.65 34.45 Favored Glycine 0 N--CA 1.464 0.566 0 CA-C-O 121.558 0.532 . . . . 0.0 114.222 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -149.09 165.06 32.85 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.227 1.011 . . . . 0.0 113.12 -172.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.85 -169.47 3.37 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.706 2.002 . . . . 0.0 109.578 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 93.8 p -69.23 -18.22 63.86 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -152.49 8.79 0.46 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.795 1.638 . . . . 0.0 113.891 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.63 129.23 26.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.574 1.55 . . . . 0.0 110.754 -168.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -120.98 140.06 52.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.037 1.735 . . . . 0.0 109.504 174.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.4 t -153.35 159.24 42.41 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.31 1.044 . . . . 0.0 112.791 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.42 149.48 30.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.724 1.61 . . . . 0.0 111.689 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -113.22 134.23 54.68 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.525 1.93 . . . . 0.0 109.628 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -132.87 154.91 49.9 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.686 1.195 . . . . 0.0 112.192 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.9 167.51 18.54 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.069 1.319 . . . . 0.0 114.28 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -54.54 -27.34 37.74 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -73.43 -15.44 61.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.67 1.988 . . . . 0.0 115.706 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.2 p -83.47 -176.46 6.32 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -60.48 -46.34 90.45 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.391 1.076 . . . . 0.0 112.779 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.6 p -89.3 -21.39 23.19 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.595 1.158 . . . . 0.0 113.146 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.38 -156.39 33.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.824 1.678 . . . . 0.0 112.271 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -63.64 134.02 54.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.601 0.76 . . . . 0.0 111.691 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.76 175.35 26.67 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 122.156 0.864 . . . . 0.0 113.074 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.8 mt -124.65 138.82 52.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.724 1.609 . . . . 0.0 108.368 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -134.2 123.58 24.56 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.878 1.271 . . . . 0.0 109.96 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.86 143.4 50.37 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.347 1.059 . . . . 0.0 112.962 -169.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -139.54 126.49 20.94 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.851 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -71.07 133.88 46.62 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.739 0.815 . . . . 0.0 110.914 169.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.6 p -168.15 147.96 4.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.016 1.726 . . . . 0.0 111.924 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.0 t -82.55 -0.4 46.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.088 0.955 . . . . 0.0 113.103 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.25 22.56 6.08 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.038 1.735 . . . . 0.0 112.661 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.22 -41.26 49.58 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.567 1.147 . . . . 0.0 113.923 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.35 -35.29 73.48 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.479 1.112 . . . . 0.0 113.225 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -66.33 -39.61 89.34 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.468 -0.77 . . . . 0.0 110.816 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.81 -47.54 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.243 0.617 . . . . 0.0 110.167 172.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -37.83 85.69 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.843 0.857 . . . . 0.0 112.673 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -72.54 -30.69 64.67 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.16 -42.22 21.19 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.911 0.778 . . . . 0.0 110.684 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.9 mt -50.24 -56.93 9.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.667 1.187 . . . . 0.0 113.096 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -60.79 -20.54 61.69 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.06 -23.37 33.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.663 1.185 . . . . 0.0 113.012 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.4 mt -94.9 -35.72 11.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.513 1.125 . . . . 0.0 111.749 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.1 mtp . . . . . 0 N--CA 1.469 0.52 0 C-N-CA 124.557 1.143 . . . . 0.0 112.808 176.69 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.549 ' N ' HD22 ' A' ' 25' ' ' ASN . 33.0 t80 . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.83 100.09 11.82 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.098 1.359 . . . . 0.0 111.081 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 56.8 mt -77.15 151.97 35.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.418 -0.801 . . . . 0.0 112.705 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -87.46 -30.22 20.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.364 1.466 . . . . 0.0 113.265 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -143.64 159.36 42.59 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.181 1.792 . . . . 0.0 111.521 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -80.12 124.26 82.93 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.408 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.47 -25.34 2.6 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.193 2.595 . . . . 0.0 114.071 -170.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.53 126.4 31.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.65 0.78 . . . . 0.0 111.28 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.25 -15.8 80.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.984 0.802 . . . . 0.0 113.999 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -122.69 120.25 33.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.468 1.507 . . . . 0.0 109.3 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.74 164.48 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.584 1.553 . . . . 0.0 111.018 -174.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -145.78 159.82 42.63 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.508 1.523 . . . . 0.0 111.721 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 . . . . . 0 CA--C 1.542 0.639 0 C-N-CA 125.018 1.327 . . . . 0.0 110.322 -169.705 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 . . . . . 0 CA--C 1.553 1.091 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.665 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.32 -7.7 21.84 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.461 2.774 . . . . 0.0 114.808 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.8 p -132.67 -24.94 1.93 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.08 90.03 3.19 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.782 1.173 . . . . 0.0 110.677 174.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -91.14 118.4 30.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.777 1.231 . . . . 0.0 109.346 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -78.61 133.76 37.25 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.172 -0.955 . . . . 0.0 110.29 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.17 165.27 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.865 1.266 . . . . 0.0 111.548 -168.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.6 m -143.53 121.74 12.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.463 1.105 . . . . 0.0 109.063 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -63.77 133.67 53.9 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.097 0.559 . . . . 0.0 109.955 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.48 153.07 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.045 0.938 . . . . 0.0 112.346 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -85.98 -169.69 2.76 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -61.41 -31.66 71.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.016 1.326 . . . . 0.0 114.201 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.09 -9.66 59.78 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.109 1.363 . . . . 0.0 112.45 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.22 12.85 83.52 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 117.76 -1.578 . . . . 0.0 114.225 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 m -80.7 150.35 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 120.108 1.954 . . . . 0.0 111.662 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -83.0 124.52 30.49 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.567 -173.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.9 mt -104.02 -54.3 2.58 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.75 0.82 . . . . 0.0 111.948 -173.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.64 139.27 6.51 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 124.737 1.161 . . . . 0.0 114.003 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 p -85.23 153.16 22.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.248 1.419 . . . . 0.0 113.309 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.05 171.59 37.13 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.664 1.602 . . . . 0.0 113.327 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.11 120.74 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.7 tpp -89.14 134.34 34.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.031 1.332 . . . . 0.0 110.135 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -133.08 130.28 39.11 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.568 1.547 . . . . 0.0 109.461 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.51 128.4 54.48 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.874 2.07 . . . . 0.0 107.694 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -128.03 172.57 10.82 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.64 1.176 . . . . 0.0 110.601 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.49 3.16 4.1 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 121.28 -0.888 . . . . 0.0 112.759 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.7 m -110.89 -45.51 3.46 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.499 1.119 . . . . 0.0 113.34 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -173.63 173.71 3.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.338 1.055 . . . . 0.0 113.343 -169.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.99 139.77 30.25 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.033 0.933 . . . . 0.0 109.946 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.6 t -134.89 132.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.441 1.096 . . . . 0.0 111.413 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.9 mt -104.25 130.9 52.04 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.01 1.724 . . . . 0.0 110.558 168.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -105.13 129.02 53.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.691 1.996 . . . . 0.0 110.579 170.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.543 0.683 0 C-N-CA 127.029 2.131 . . . . 0.0 111.397 -173.558 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 t -126.06 136.86 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.275 1.03 . . . . 0.0 109.485 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.66 152.0 46.38 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.637 0.775 . . . . 0.0 111.842 -171.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -139.16 116.67 8.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.518 1.127 . . . . 0.0 111.37 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.98 145.42 73.89 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.59 2.193 . . . . 0.0 109.883 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -60.85 -24.83 66.21 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.84 -42.69 99.84 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.057 1.343 . . . . 0.0 111.992 173.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.4 m -79.74 -3.55 48.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.1 mt -86.71 106.98 18.02 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.686 1.13 . . . . 0.0 109.912 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -38.43 42.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.384 0.674 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -149.47 155.91 41.14 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.101 1.36 . . . . 0.0 111.085 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -150.78 136.31 17.96 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.868 1.667 . . . . 0.0 108.514 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -156.81 173.26 34.5 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-O 122.139 0.855 . . . . 0.0 113.979 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -142.2 159.76 41.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.52 1.128 . . . . 0.0 112.024 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -151.47 -174.75 4.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.111 1.764 . . . . 0.0 109.771 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -60.19 119.17 7.37 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.376 -0.828 . . . . 0.0 110.473 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.64 21.93 0.99 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 127.703 2.401 . . . . 0.0 116.464 -175.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -138.72 131.23 28.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.067 1.347 . . . . 0.0 111.214 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -125.86 141.29 52.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.218 1.807 . . . . 0.0 109.956 173.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -153.8 162.05 41.56 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.941 -1.099 . . . . 0.0 112.971 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -154.33 153.77 32.21 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.598 1.559 . . . . 0.0 112.412 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -112.65 128.74 56.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.513 1.925 . . . . 0.0 109.222 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.2 p -123.37 142.63 50.77 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.77 154.38 52.83 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.641 1.115 . . . . 0.0 113.138 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -61.81 -14.07 29.68 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -83.11 -17.42 43.12 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.0 p -74.66 -179.54 4.18 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -170.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.94 -38.1 69.87 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.645 1.178 . . . . 0.0 113.199 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -96.58 -23.19 16.63 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.246 1.418 . . . . 0.0 113.588 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.98 -160.7 43.03 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.356 1.455 . . . . 0.0 112.535 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -65.54 129.07 38.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.547 1.139 . . . . 0.0 112.378 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.8 172.59 30.46 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.231 1.396 . . . . 0.0 112.899 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 59.0 mt -119.36 136.3 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.55 1.54 . . . . 0.0 108.298 170.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -129.21 117.95 21.59 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.78 1.232 . . . . 0.0 109.801 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.8 141.18 48.7 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.675 1.19 . . . . 0.0 112.199 -172.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -138.33 127.7 24.59 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.192 0.997 . . . . 0.0 111.865 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -67.34 131.22 45.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.445 0.698 . . . . 0.0 111.044 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.3 t -169.53 118.73 0.64 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.249 1.819 . . . . 0.0 110.36 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.8 t -71.29 -8.06 51.14 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.229 -0.919 . . . . 0.0 113.151 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.73 9.46 35.03 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.538 1.935 . . . . 0.0 113.333 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.5 -38.53 20.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.31 1.844 . . . . 0.0 115.322 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.99 -35.67 80.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.773 0.829 . . . . 0.0 112.908 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -68.39 -37.87 80.78 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.536 -0.728 . . . . 0.0 110.96 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.45 -45.26 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 118.609 0.64 . . . . 0.0 110.24 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.61 -42.99 99.9 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.767 0.827 . . . . 0.0 111.841 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -70.31 -33.97 72.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.23 -33.93 43.24 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.12 0.873 . . . . 0.0 110.682 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.49 -55.21 36.58 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.299 -0.875 . . . . 0.0 111.981 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -61.23 -21.52 63.94 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -81.47 -20.14 40.85 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.215 1.406 . . . . 0.0 112.754 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.13 -35.78 10.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.468 1.507 . . . . 0.0 112.559 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 67.5 mmm . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 124.855 1.262 . . . . 0.0 111.366 175.212 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 22.4 t80 . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 120.484 0.183 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -89.59 110.06 20.95 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.824 1.25 . . . . 0.0 109.962 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 45.0 mt -76.53 157.15 32.31 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -80.32 -24.15 40.12 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.812 1.645 . . . . 0.0 113.702 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -160.26 170.03 21.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.517 1.927 . . . . 0.0 111.55 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -86.68 122.73 71.55 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.789 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -82.43 -24.92 3.42 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.362 2.708 . . . . 0.0 114.428 -170.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.4 m -79.75 129.02 34.12 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.843 0.747 . . . . 0.0 112.223 -171.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.08 -9.44 85.42 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.656 1.122 . . . . 0.0 114.563 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -139.0 128.07 23.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.71 1.604 . . . . 0.0 110.221 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.7 164.07 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.6 1.56 . . . . 0.0 111.252 -173.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -128.93 132.32 47.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.266 1.426 . . . . 0.0 109.376 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 124.861 1.264 . . . . 0.0 110.035 175.877 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 . . . . . 0 CA--C 1.556 1.185 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.76 -18.41 22.09 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.852 2.368 . . . . 0.0 114.944 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.9 p -128.8 -19.22 3.71 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.173 1.352 . . . . 0.0 114.599 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -97.42 142.22 29.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.189 0.904 . . . . 0.0 110.851 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -143.55 107.16 4.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.012 1.325 . . . . 0.0 108.738 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -64.7 137.12 57.62 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.25 -0.906 . . . . 0.0 111.402 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 m -144.9 159.82 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.803 1.241 . . . . 0.0 111.587 -170.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -134.63 117.19 15.83 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.66 1.184 . . . . 0.0 108.824 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.587 HD22 ' N ' ' B' ' 2' ' ' PHE . 58.4 t30 -67.59 135.63 53.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.543 0.737 . . . . 0.0 110.904 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.0 m -129.07 154.47 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.298 1.039 . . . . 0.0 112.948 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.427 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.7 p-10 -90.78 -166.62 1.62 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.039 1.336 . . . . 0.0 113.989 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.85 -30.37 71.37 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.555 1.142 . . . . 0.0 113.008 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.9 -12.36 59.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.847 1.259 . . . . 0.0 112.106 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.04 14.52 80.53 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 117.787 -1.563 . . . . 0.0 114.228 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.427 HG22 ' OD1' ' A' ' 27' ' ' ASP . 14.2 m -76.15 150.34 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.995 1.897 . . . . 0.0 111.563 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -84.45 124.19 31.07 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.416 1.087 . . . . 0.0 110.926 -174.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 mt -104.73 -51.93 2.97 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.086 0.954 . . . . 0.0 112.062 -170.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.33 148.49 17.37 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 125.004 1.288 . . . . 0.0 113.533 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.8 p -90.38 151.74 21.3 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.853 1.261 . . . . 0.0 113.006 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.32 170.95 34.56 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.751 1.643 . . . . 0.0 112.793 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -118.63 120.22 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.8 ttm -88.3 141.19 28.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.098 0.959 . . . . 0.0 110.194 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -135.84 129.85 33.03 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.515 1.526 . . . . 0.0 108.903 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -108.44 130.5 55.24 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.678 1.591 . . . . 0.0 107.919 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.0 p -130.35 167.31 18.74 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.904 1.281 . . . . 0.0 109.941 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -66.47 -9.69 36.85 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.864 -0.522 . . . . 0.0 112.4 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.6 m -98.52 -45.35 6.13 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.449 1.1 . . . . 0.0 113.263 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -172.6 171.11 4.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.64 1.176 . . . . 0.0 113.718 -168.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.7 mt -86.86 139.77 30.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.579 1.552 . . . . 0.0 109.962 168.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.0 t -134.87 137.93 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.056 0.943 . . . . 0.0 111.176 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.84 130.3 55.62 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.449 1.5 . . . . 0.0 109.837 167.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -103.13 130.91 50.45 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.366 1.866 . . . . 0.0 110.833 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 126.848 2.059 . . . . 0.0 111.148 -169.996 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -108.55 135.6 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.208 1.003 . . . . 0.0 110.494 -173.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -120.86 142.38 49.71 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.664 1.186 . . . . 0.0 113.384 -170.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -141.75 112.59 6.4 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.185 1.394 . . . . 0.0 111.42 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -69.56 150.02 68.9 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.386 2.058 . . . . 0.0 110.334 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -63.7 -19.64 65.09 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.9 mt -68.65 -31.52 70.71 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.21 1.404 . . . . 0.0 113.114 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.4 m -89.9 -6.86 55.34 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.5 mt -74.7 117.4 16.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.73 0.695 . . . . 0.0 109.559 172.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -80.34 -32.97 37.73 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.371 1.468 . . . . 0.0 112.305 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -166.58 159.09 13.9 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.006 2.123 . . . . 0.0 110.483 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -152.17 134.08 14.88 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.001 1.321 . . . . 0.0 111.414 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -150.66 175.73 29.54 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.477 1.036 . . . . 0.0 113.836 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.57 162.0 39.3 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.537 1.135 . . . . 0.0 113.535 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -146.2 -178.56 6.2 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.259 2.224 . . . . 0.0 109.327 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -62.37 -13.63 31.31 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -154.08 12.83 0.43 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.448 1.499 . . . . 0.0 114.242 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -141.47 130.98 23.85 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.329 1.452 . . . . 0.0 110.29 -168.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -121.67 142.14 50.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.912 1.685 . . . . 0.0 109.24 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -153.01 155.51 37.06 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.059 -1.026 . . . . 0.0 112.997 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -150.0 152.78 35.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.158 1.383 . . . . 0.0 111.977 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -106.39 140.8 38.74 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.357 1.463 . . . . 0.0 109.486 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.0 m -124.97 148.58 48.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.175 0.99 . . . . 0.0 112.136 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.62 164.57 45.28 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.276 0.941 . . . . 0.0 112.765 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -63.55 -15.07 57.0 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -82.39 -15.73 51.64 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.216 1.806 . . . . 0.0 115.154 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -79.7 -179.52 6.95 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.526 0.73 . . . . 0.0 112.872 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -58.26 -46.02 86.74 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.286 1.035 . . . . 0.0 112.836 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 36.1 p -89.16 -18.98 26.06 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.04 1.336 . . . . 0.0 113.721 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.49 -164.54 41.76 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.728 1.632 . . . . 0.0 112.474 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -66.68 134.25 51.87 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.923 0.889 . . . . 0.0 112.02 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.09 172.82 23.94 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.288 0.947 . . . . 0.0 113.065 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.6 mt -114.69 137.87 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.474 1.509 . . . . 0.0 108.396 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -129.95 122.97 29.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.64 1.176 . . . . 0.0 110.311 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.15 144.41 48.59 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.679 1.192 . . . . 0.0 113.03 -172.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -142.71 125.15 15.65 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.974 0.91 . . . . 0.0 112.397 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -70.46 134.49 47.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.28 1.032 . . . . 0.0 111.418 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.1 p -170.84 144.55 2.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.411 1.884 . . . . 0.0 111.566 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.4 p -78.03 0.79 23.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.177 1.391 . . . . 0.0 114.08 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -134.65 24.95 3.71 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.841 2.056 . . . . 0.0 112.811 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.98 -41.11 46.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.813 1.645 . . . . 0.0 113.911 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -67.87 -37.13 81.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.503 0.721 . . . . 0.0 112.521 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -68.41 -33.1 73.63 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.416 -0.802 . . . . 0.0 111.958 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.2 mt -63.4 -49.28 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 169.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.12 -42.62 91.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.072 0.949 . . . . 0.0 112.172 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -64.84 -34.87 79.4 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.881 1.273 . . . . 0.0 112.556 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -81.27 -37.8 27.9 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.22 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.9 mt -53.48 -55.75 22.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.369 0.986 . . . . 0.0 111.845 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -58.3 -31.43 67.5 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -28.47 65.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.607 1.163 . . . . 0.0 112.931 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 71.2 mt -93.22 -35.21 13.25 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.334 1.453 . . . . 0.0 111.082 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.8 mtp . . . . . 0 N--CA 1.467 0.406 0 C-N-CA 124.978 1.311 . . . . 0.0 113.593 -178.686 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.587 ' N ' HD22 ' A' ' 25' ' ' ASN . 25.6 t80 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.283 0.087 . . . . 0.0 111.193 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -82.52 107.76 15.42 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.887 1.275 . . . . 0.0 110.742 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -77.28 161.39 28.14 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.604 1.162 . . . . 0.0 112.13 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -101.02 -18.81 16.1 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.127 1.371 . . . . 0.0 114.233 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -139.12 154.3 48.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.524 1.93 . . . . 0.0 111.54 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -84.23 122.22 75.55 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.249 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.34 -20.34 2.73 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.051 2.501 . . . . 0.0 115.249 -169.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 86.9 m -81.59 -31.96 32.3 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.11 -64.44 2.0 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 125.189 1.375 . . . . 0.0 112.902 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -74.61 68.83 1.68 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.764 1.626 . . . . 0.0 111.382 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.7 156.29 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.367 1.867 . . . . 0.0 112.117 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -121.29 137.62 54.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.77 1.628 . . . . 0.0 110.167 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 124.776 1.23 . . . . 0.0 110.778 -179.714 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 . . . . . 0 CA--C 1.558 1.264 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.39 -15.02 47.49 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.271 2.648 . . . . 0.0 115.458 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.7 p -124.03 -24.91 4.3 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.827 1.194 . . . . 0.0 113.843 172.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -100.16 118.25 36.1 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.819 1.19 . . . . 0.0 111.943 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -114.51 110.57 20.03 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.281 1.433 . . . . 0.0 108.638 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -71.25 139.79 50.16 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.483 -0.761 . . . . 0.0 110.421 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -145.7 164.5 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.897 1.279 . . . . 0.0 111.964 -170.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.8 m -136.44 120.36 17.52 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.739 1.215 . . . . 0.0 109.271 172.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -67.3 137.53 56.15 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.859 0.864 . . . . 0.0 111.371 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.9 156.71 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.235 1.014 . . . . 0.0 112.706 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -90.8 -167.54 1.85 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.75 1.22 . . . . 0.0 113.705 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.23 -32.19 73.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.87 -11.54 59.81 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.821 1.248 . . . . 0.0 112.817 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 17.47 77.41 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.099 -1.39 . . . . 0.0 113.904 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 m -79.71 150.51 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.829 1.815 . . . . 0.0 111.339 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.57 126.43 34.93 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.308 1.043 . . . . 0.0 111.356 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.6 mt -109.08 -43.3 4.21 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.533 1.133 . . . . 0.0 112.681 -169.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.96 144.8 9.33 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.468 1.033 . . . . 0.0 114.2 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 p -83.79 148.26 27.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.448 1.099 . . . . 0.0 112.224 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.08 170.21 32.04 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.322 1.439 . . . . 0.0 113.457 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.04 119.8 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.7 ttm -91.11 134.05 34.84 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.058 0.943 . . . . 0.0 109.488 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -125.39 124.04 40.64 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.986 1.314 . . . . 0.0 109.235 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -111.35 126.87 55.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.546 1.938 . . . . 0.0 107.901 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -162.54 149.92 13.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.514 1.925 . . . . 0.0 108.266 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -58.89 -18.5 33.7 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -172.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 m -70.45 -42.26 71.75 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 170.95 167.05 0.07 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.594 1.958 . . . . 0.0 111.946 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mt -82.18 139.37 34.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.939 0.895 . . . . 0.0 109.545 167.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 t -134.64 138.62 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.331 0.653 . . . . 0.0 110.808 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.1 mt -113.74 130.74 56.39 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 125.735 1.614 . . . . 0.0 109.482 167.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -111.61 122.22 47.23 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.391 1.876 . . . . 0.0 109.945 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 CA--C 1.535 0.394 0 C-N-CA 124.84 1.256 . . . . 0.0 111.489 -177.264 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.711 0 CA-C-O 120.738 0.304 . . . . 0.0 111.666 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.95 136.95 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.515 1.126 . . . . 0.0 111.694 -169.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -117.15 146.83 42.94 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.844 1.658 . . . . 0.0 113.213 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -142.54 121.52 7.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.474 1.51 . . . . 0.0 111.797 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.77 149.99 61.31 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.094 2.529 . . . . 0.0 110.895 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -63.43 -19.42 64.69 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.4 mt -63.21 -33.67 75.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.422 1.089 . . . . 0.0 113.693 171.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.2 p -83.99 -9.35 58.73 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -89.9 73.6 7.43 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 111.87 -173.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -63.99 -41.24 97.58 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.042 -0.412 . . . . 0.0 112.058 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -134.03 129.6 36.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.098 1.759 . . . . 0.0 110.363 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -153.09 141.67 20.86 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.714 2.006 . . . . 0.0 109.764 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.67 179.44 41.56 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-O 122.053 0.807 . . . . 0.0 114.612 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -142.33 157.61 44.62 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.38 1.472 . . . . 0.0 112.56 -171.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.78 -173.17 4.28 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.699 2.0 . . . . 0.0 109.845 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 p -59.33 110.6 1.12 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.272 -0.892 . . . . 0.0 111.506 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 61.7 15.58 7.06 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 126.41 1.884 . . . . 0.0 114.268 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -133.04 129.3 37.9 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.231 1.378 . . . . 0.0 112.065 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -124.12 142.09 51.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.676 1.591 . . . . 0.0 110.474 171.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.8 t -153.87 157.06 38.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.489 1.116 . . . . 0.0 113.581 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.36 155.46 37.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.17 1.388 . . . . 0.0 113.488 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.04 154.32 17.7 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.142 1.777 . . . . 0.0 111.605 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 t -148.37 161.8 40.84 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.733 0.813 . . . . 0.0 113.054 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.37 173.63 19.75 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 126.481 1.991 . . . . 0.0 114.593 -170.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -26.54 68.44 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -169.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -81.21 -15.06 56.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.2 p -79.13 -178.45 6.16 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -61.62 -35.88 79.13 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.95 1.3 . . . . 0.0 113.341 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.9 p -99.41 -22.85 15.35 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.546 1.539 . . . . 0.0 114.374 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.76 -165.8 46.31 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.776 1.655 . . . . 0.0 112.925 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -58.34 132.48 53.76 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.006 0.922 . . . . 0.0 111.998 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.68 172.49 31.22 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 123.997 0.808 . . . . 0.0 113.375 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.7 mt -114.94 137.85 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.367 1.467 . . . . 0.0 108.261 169.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -131.53 126.9 36.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.745 1.218 . . . . 0.0 110.213 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.31 144.95 50.24 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.496 1.119 . . . . 0.0 113.284 -170.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -141.82 129.67 21.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.354 1.061 . . . . 0.0 111.75 -168.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -76.95 134.81 38.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.877 0.871 . . . . 0.0 111.608 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 22.3 p -174.45 137.31 0.49 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.635 1.974 . . . . 0.0 111.565 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -73.68 -3.8 30.42 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.993 -1.067 . . . . 0.0 113.273 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -110.94 13.31 22.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.163 2.585 . . . . 0.0 112.758 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.59 -43.25 35.86 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.204 1.402 . . . . 0.0 114.215 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -68.12 -35.18 77.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.521 0.728 . . . . 0.0 112.769 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.46 -31.27 66.98 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.379 -0.826 . . . . 0.0 112.141 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.42 -45.6 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.755 0.707 . . . . 0.0 109.861 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.82 -45.09 93.47 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.159 0.983 . . . . 0.0 111.735 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -65.24 -40.94 94.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.199 1.4 . . . . 0.0 112.261 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.5 tp -74.05 -38.57 63.95 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.955 0.798 . . . . 0.0 111.505 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 mt -54.76 -55.74 26.78 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.018 0.827 . . . . 0.0 111.247 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -62.17 -24.79 67.4 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -41.03 75.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.152 0.981 . . . . 0.0 112.219 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.7 mt -73.71 -40.12 63.82 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.787 0.835 . . . . 0.0 111.099 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 70.0 mmm . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 124.912 1.285 . . . . 0.0 112.737 178.516 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 36.1 t80 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -82.56 112.5 19.52 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.386 1.075 . . . . 0.0 111.256 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 57.8 mt -85.68 153.55 22.27 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.708 0.803 . . . . 0.0 112.103 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -88.34 -29.88 19.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.342 1.457 . . . . 0.0 112.794 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -137.86 157.09 47.14 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.235 1.814 . . . . 0.0 111.65 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -79.2 128.15 76.81 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.999 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -84.95 6.28 5.8 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.0 3.134 . . . . 0.0 114.066 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 t -127.01 139.44 53.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.411 1.485 . . . . 0.0 111.565 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.3 -39.38 7.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.182 0.896 . . . . 0.0 112.713 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.1 52.11 1.25 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.523 1.529 . . . . 0.0 113.199 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.53 141.66 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.236 -0.915 . . . . 0.0 111.407 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -111.42 118.44 35.81 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.388 1.475 . . . . 0.0 107.992 167.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 . . . . . 0 CA--C 1.541 0.606 0 O-C-N 121.521 -0.737 . . . . 0.0 111.361 179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 . . . . . 0 CA--C 1.554 1.128 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.71 -11.0 30.14 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.326 2.684 . . . . 0.0 115.086 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 p -130.32 -19.24 3.14 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.65 118.14 32.26 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.996 0.918 . . . . 0.0 111.295 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -116.37 105.42 12.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.328 1.051 . . . . 0.0 109.221 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -67.04 130.99 44.91 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.48 -0.763 . . . . 0.0 110.438 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.27 157.27 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.085 1.354 . . . . 0.0 112.024 -169.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.7 m -130.89 115.79 17.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.693 1.197 . . . . 0.0 108.822 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -62.34 128.42 35.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.372 0.533 . . . . 0.0 109.934 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.42 155.92 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.89 0.876 . . . . 0.0 112.522 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.422 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -87.26 -168.68 2.32 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.436 1.094 . . . . 0.0 113.758 179.001 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.37 -31.43 71.32 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.289 1.435 . . . . 0.0 114.344 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -84.06 -8.98 58.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.773 0.829 . . . . 0.0 113.018 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.24 15.62 78.17 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.431 -1.205 . . . . 0.0 113.979 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.422 HG22 ' OD1' ' A' ' 27' ' ' ASP . 18.6 m -79.72 150.61 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.49 1.645 . . . . 0.0 111.247 174.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -91.53 123.43 34.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.802 1.241 . . . . 0.0 110.922 -169.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.4 mt -106.55 -53.47 2.62 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.514 0.726 . . . . 0.0 112.114 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.77 160.98 29.32 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 125.535 1.541 . . . . 0.0 113.073 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 m -125.41 147.08 49.32 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.624 0.769 . . . . 0.0 112.824 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.86 174.58 30.13 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.775 1.655 . . . . 0.0 113.858 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.0 t -113.01 120.22 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.2 tpp -86.08 138.78 31.69 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.614 1.166 . . . . 0.0 109.819 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.1 130.0 26.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.672 1.589 . . . . 0.0 108.799 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.27 127.43 53.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.311 1.844 . . . . 0.0 107.344 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.1 p -127.55 172.83 10.37 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.802 1.241 . . . . 0.0 110.664 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -72.85 -0.48 13.59 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 121.235 -0.916 . . . . 0.0 112.541 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.1 t -106.47 -46.64 3.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.061 1.344 . . . . 0.0 112.971 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -174.8 174.41 2.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.943 1.297 . . . . 0.0 113.297 -166.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.9 138.61 31.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.234 1.014 . . . . 0.0 109.391 167.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.35 127.81 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.133 0.973 . . . . 0.0 111.109 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.17 130.73 46.34 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.816 1.647 . . . . 0.0 109.809 168.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -107.63 118.7 37.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.517 1.927 . . . . 0.0 110.188 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 126.064 1.746 . . . . 0.0 110.929 -177.885 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 t -134.76 133.78 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.67 0.788 . . . . 0.0 111.293 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -125.63 143.32 51.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.96 1.304 . . . . 0.0 112.311 -172.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 -140.11 112.53 7.41 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.788 1.235 . . . . 0.0 111.153 174.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.76 145.73 76.17 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.64 2.227 . . . . 0.0 110.284 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -60.33 -25.58 65.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.55 -38.84 90.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.028 1.331 . . . . 0.0 111.728 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.4 -5.31 58.57 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 99.3 mt -83.38 123.4 29.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.339 0.972 . . . . 0.0 109.861 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -83.94 -38.71 20.68 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.097 0.559 . . . . 0.0 112.123 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -161.97 156.18 21.99 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.462 1.505 . . . . 0.0 111.428 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -151.25 123.82 8.45 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.278 1.431 . . . . 0.0 109.538 -172.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.67 167.39 25.91 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 124.264 0.935 . . . . 0.0 113.795 -169.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -145.13 164.13 32.2 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.349 1.06 . . . . 0.0 113.342 -169.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -146.78 -166.99 2.64 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.223 2.209 . . . . 0.0 109.385 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 93.9 p -69.55 -19.06 63.7 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.277 -1.514 . . . . 0.0 114.71 -175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -150.32 9.5 0.65 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.286 1.434 . . . . 0.0 114.032 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -137.42 132.21 33.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.774 1.63 . . . . 0.0 110.075 -169.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -126.89 139.66 52.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.078 1.751 . . . . 0.0 109.404 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.1 t -153.15 156.46 38.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.31 1.044 . . . . 0.0 112.448 -175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -153.78 156.08 37.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.252 1.421 . . . . 0.0 111.901 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -116.86 137.65 52.06 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.743 1.617 . . . . 0.0 110.104 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -141.16 156.58 45.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.235 1.014 . . . . 0.0 112.011 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.6 175.39 37.24 Favored Glycine 0 N--CA 1.472 1.1 0 C-N-CA 125.458 1.504 . . . . 0.0 114.986 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -13.52 28.51 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -172.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.8 ptm85 -86.96 -15.82 37.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.58 1.552 . . . . 0.0 115.182 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.6 p -76.34 179.79 5.59 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.79 0.836 . . . . 0.0 112.81 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -59.01 -41.25 87.29 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.36 1.064 . . . . 0.0 113.052 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.3 p -92.09 -20.61 21.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.079 1.351 . . . . 0.0 113.758 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.59 -173.1 49.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.252 1.406 . . . . 0.0 112.43 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -67.7 127.65 33.56 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.55 0.74 . . . . 0.0 112.234 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.45 -177.39 38.62 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.124 0.869 . . . . 0.0 113.604 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -123.48 139.65 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.238 1.815 . . . . 0.0 109.128 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -134.63 126.96 30.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.127 1.371 . . . . 0.0 109.768 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.76 139.26 54.18 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.624 1.17 . . . . 0.0 112.442 -171.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -137.18 126.89 25.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.242 1.017 . . . . 0.0 111.549 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -74.25 134.46 42.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.644 0.777 . . . . 0.0 111.847 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.0 p -176.27 128.2 0.21 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.02 2.528 . . . . 0.0 110.331 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.4 m -68.36 -10.47 55.21 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.807 -1.183 . . . . 0.0 113.326 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -93.36 10.21 33.1 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.01 2.124 . . . . 0.0 112.883 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.9 -40.59 66.77 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.692 1.597 . . . . 0.0 114.658 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -70.95 -35.26 72.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.481 0.712 . . . . 0.0 112.68 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 -67.09 -37.58 84.2 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.199 -0.938 . . . . 0.0 111.314 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.6 mt -61.43 -46.34 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 118.751 0.705 . . . . 0.0 110.135 172.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.44 -43.16 97.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.382 1.073 . . . . 0.0 112.099 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -70.42 -32.32 69.88 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.245 1.018 . . . . 0.0 113.423 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -78.04 -37.33 47.07 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.126 0.875 . . . . 0.0 110.063 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.89 -52.02 65.54 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.434 -0.791 . . . . 0.0 112.567 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -60.24 -23.95 64.48 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.24 -17.51 52.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.991 1.317 . . . . 0.0 113.377 176.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.4 mt -102.41 -36.32 8.47 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.316 1.446 . . . . 0.0 111.929 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 62.7 mmm . . . . . 0 N--CA 1.471 0.623 0 C-N-CA 125.599 1.559 . . . . 0.0 112.741 178.06 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 37.3 t80 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.26 0.076 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -78.96 116.98 19.62 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.497 1.119 . . . . 0.0 110.957 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.8 mt -88.16 153.71 21.02 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.525 -0.734 . . . . 0.0 112.467 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -94.6 -2.11 52.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.815 1.646 . . . . 0.0 113.49 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -160.95 164.31 31.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.454 2.302 . . . . 0.0 110.737 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -94.78 119.01 66.68 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.227 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.39 -22.16 7.06 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.004 2.47 . . . . 0.0 113.489 -170.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.5 m -91.06 112.16 23.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.926 0.891 . . . . 0.0 111.047 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.18 -25.72 72.55 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.778 0.704 . . . . 0.0 112.881 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -91.97 119.17 31.46 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.675 1.19 . . . . 0.0 109.258 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.69 154.03 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.484 1.514 . . . . 0.0 110.749 -169.492 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -144.82 175.88 9.86 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.961 1.704 . . . . 0.0 112.25 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 CA--C 1.544 0.742 0 C-N-CA 125.637 1.575 . . . . 0.0 110.444 -169.021 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 . . . . . 0 CA--C 1.557 1.244 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.33 -11.02 26.37 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.899 2.399 . . . . 0.0 115.259 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.7 p -130.96 -16.95 3.17 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 120.373 1.442 . . . . 0.0 114.088 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -111.61 144.69 40.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.816 1.247 . . . . 0.0 110.579 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -140.83 119.17 12.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.159 0.983 . . . . 0.0 109.099 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -70.24 129.71 40.07 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.65 -0.656 . . . . 0.0 110.227 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 m -136.74 160.73 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.844 1.658 . . . . 0.0 110.889 -170.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -132.75 118.79 19.48 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.857 0.863 . . . . 0.0 109.193 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -63.26 128.68 36.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.038 0.935 . . . . 0.0 110.164 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -124.34 155.03 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.918 0.887 . . . . 0.0 113.382 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' CG ' HG22 ' A' ' 31' ' ' VAL . 3.5 p-10 -83.51 -170.85 3.26 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.49 -24.15 67.7 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -92.82 -6.22 49.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.142 1.777 . . . . 0.0 112.642 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.19 15.2 75.08 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.282 -1.288 . . . . 0.0 114.29 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG22 ' CG ' ' A' ' 27' ' ' ASP . 3.3 m -76.67 143.98 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.721 1.76 . . . . 0.0 110.849 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -88.24 119.45 28.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.078 1.351 . . . . 0.0 110.495 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.6 mt -104.93 -54.73 2.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.149 0.58 . . . . 0.0 112.025 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.26 142.61 10.41 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 124.834 1.207 . . . . 0.0 113.799 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.5 p -94.56 142.19 27.73 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.943 1.297 . . . . 0.0 112.354 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.75 171.28 29.1 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.736 1.636 . . . . 0.0 113.486 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.56 120.71 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.2 tpp -87.19 139.23 30.77 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.698 1.199 . . . . 0.0 109.67 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.07 128.82 24.76 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.7 1.6 . . . . 0.0 108.667 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mp -108.52 134.26 51.54 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.211 1.804 . . . . 0.0 108.138 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.3 p -134.26 170.76 15.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.117 1.367 . . . . 0.0 109.745 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.05 -5.93 30.14 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.233 -0.917 . . . . 0.0 113.076 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.5 t -107.48 -43.52 4.52 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.247 1.019 . . . . 0.0 113.34 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -169.88 169.04 8.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.41 1.084 . . . . 0.0 113.194 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.2 mt -86.74 142.4 28.18 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.535 1.134 . . . . 0.0 110.031 168.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.69 130.15 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.616 1.166 . . . . 0.0 110.847 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.1 mt -105.55 133.62 49.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.145 1.778 . . . . 0.0 110.565 168.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -115.8 117.84 31.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.872 2.069 . . . . 0.0 110.329 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 125.662 1.585 . . . . 0.0 110.57 -178.58 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.58 136.33 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.917 0.887 . . . . 0.0 110.757 -172.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -134.44 148.96 50.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -140.76 112.58 6.97 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.426 1.491 . . . . 0.0 111.059 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.66 148.11 86.75 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.794 2.329 . . . . 0.0 110.347 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -61.95 -19.69 63.03 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.53 -44.83 95.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.635 1.574 . . . . 0.0 112.974 171.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.2 p -77.4 -15.18 59.5 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.94 115.14 10.8 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.783 0.833 . . . . 0.0 109.986 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -79.08 -32.67 44.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.447 1.099 . . . . 0.0 111.723 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -166.6 159.88 14.61 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.228 1.811 . . . . 0.0 111.528 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -150.07 126.35 10.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.167 1.387 . . . . 0.0 110.804 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.9 172.63 24.41 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.976 1.274 . . . . 0.0 113.45 -170.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -153.49 145.72 23.85 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.161 0.985 . . . . 0.0 112.161 -170.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -141.04 -177.5 5.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.469 1.908 . . . . 0.0 109.362 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -59.45 117.45 4.87 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.019 -1.051 . . . . 0.0 110.708 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.8 t30 60.54 12.85 3.8 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 127.111 2.165 . . . . 0.0 115.158 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -133.91 127.38 32.35 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.752 1.614 . . . . 0.0 111.922 -169.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -122.15 140.94 51.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.824 1.65 . . . . 0.0 109.972 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 t -153.55 155.34 35.99 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.047 -1.033 . . . . 0.0 112.886 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -147.97 153.58 39.2 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.245 1.418 . . . . 0.0 111.88 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -111.35 141.16 45.26 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.574 1.55 . . . . 0.0 109.439 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 p -138.91 150.56 46.08 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.786 0.834 . . . . 0.0 112.7 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.59 173.82 46.01 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.957 1.265 . . . . 0.0 113.715 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -63.66 -14.8 55.32 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -77.44 -16.84 58.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.128 1.771 . . . . 0.0 115.292 -176.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.2 p -79.29 -179.07 6.54 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.32 1.048 . . . . 0.0 113.498 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -62.02 -36.65 82.2 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.54 1.136 . . . . 0.0 113.296 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -94.94 -20.81 19.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.079 1.352 . . . . 0.0 114.338 -174.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.31 -179.07 49.38 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.886 1.232 . . . . 0.0 112.02 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -65.82 129.52 40.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.878 0.871 . . . . 0.0 111.823 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.09 -177.22 42.36 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 122.143 0.857 . . . . 0.0 113.508 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.2 mt -121.75 139.26 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.046 1.739 . . . . 0.0 108.698 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -133.85 128.06 33.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.971 1.308 . . . . 0.0 110.035 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.89 142.72 51.39 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.649 1.179 . . . . 0.0 112.725 -172.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -139.17 129.71 25.82 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.69 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -72.35 133.35 44.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.001 0.52 . . . . 0.0 110.754 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.0 t -168.46 124.34 0.98 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.185 1.794 . . . . 0.0 111.044 -171.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.8 m -70.97 -9.48 58.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -117.68 22.48 12.32 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.434 1.894 . . . . 0.0 112.405 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.67 -38.15 31.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.265 1.426 . . . . 0.0 114.299 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.56 -36.66 73.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.751 0.82 . . . . 0.0 112.926 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -65.07 -40.09 94.19 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.58 -0.7 . . . . 0.0 110.788 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.19 -47.89 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.941 0.497 . . . . 0.0 110.296 173.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.31 -44.64 92.54 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.555 1.142 . . . . 0.0 112.11 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -70.0 -33.63 72.29 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.854 0.862 . . . . 0.0 113.088 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -74.88 -41.67 59.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.951 0.796 . . . . 0.0 110.4 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.3 mt -52.12 -55.13 22.82 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.728 0.811 . . . . 0.0 112.869 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.59 -25.43 68.07 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.88 -29.42 68.52 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.505 1.048 . . . . 0.0 112.677 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.6 mt -96.09 -39.38 9.76 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.354 1.462 . . . . 0.0 110.999 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.3 mtp . . . . . 0 N--CA 1.466 0.332 0 C-N-CA 124.306 1.042 . . . . 0.0 113.3 -179.162 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 36.9 t80 . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 120.557 0.218 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -78.97 109.24 13.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.996 1.319 . . . . 0.0 111.005 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.53 153.4 24.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.536 0.735 . . . . 0.0 112.024 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -81.73 -28.22 33.47 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.89 1.276 . . . . 0.0 112.534 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -157.03 162.83 39.54 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.441 1.896 . . . . 0.0 111.359 -170.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -78.56 132.22 65.93 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 121.542 -0.724 . . . . 0.0 111.55 -173.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -83.62 -4.78 10.8 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.321 2.681 . . . . 0.0 114.358 -171.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 14.6 t -122.84 145.45 48.43 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.606 1.094 . . . . 0.0 113.44 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.08 -4.53 71.67 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.609 1.576 . . . . 0.0 114.532 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -119.39 123.23 43.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.791 1.636 . . . . 0.0 109.828 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -157.11 152.25 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.394 1.078 . . . . 0.0 110.882 -167.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -122.53 146.94 46.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.134 1.374 . . . . 0.0 110.307 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 126.157 1.783 . . . . 0.0 110.068 -178.17 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 . . . . . 0 CA--C 1.557 1.215 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.67 -10.44 26.58 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.246 2.63 . . . . 0.0 115.177 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.2 p -128.87 -21.1 3.4 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -115.51 134.66 54.86 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.024 0.929 . . . . 0.0 110.83 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.29 121.19 24.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.214 1.406 . . . . 0.0 107.97 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 140.91 44.15 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.28 -0.888 . . . . 0.0 110.447 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.3 m -145.18 163.24 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.295 1.038 . . . . 0.0 111.608 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.1 m -143.87 123.2 13.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.427 1.091 . . . . 0.0 108.774 170.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.46 132.86 51.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.16 0.984 . . . . 0.0 110.339 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.67 156.08 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.806 1.242 . . . . 0.0 113.018 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' A' ' 31' ' ' VAL . 2.3 p-10 -93.37 -165.53 1.35 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.644 1.578 . . . . 0.0 114.309 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.14 -35.1 72.91 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.035 1.334 . . . . 0.0 113.656 172.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.27 -13.04 58.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.039 0.836 . . . . 0.0 113.167 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.72 17.84 74.37 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 118.295 -1.28 . . . . 0.0 113.624 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.432 HG22 ' OD1' ' A' ' 27' ' ' ASP . 11.3 m -76.31 150.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.537 1.669 . . . . 0.0 111.145 173.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.1 123.99 32.76 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.276 1.031 . . . . 0.0 111.309 -171.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.7 mt -104.85 -50.06 3.36 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.551 1.14 . . . . 0.0 111.786 -172.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.91 132.38 3.44 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 124.684 1.135 . . . . 0.0 113.633 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p -85.44 149.45 25.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.938 1.295 . . . . 0.0 112.635 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.41 171.7 39.18 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.829 1.204 . . . . 0.0 114.391 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.9 t -113.25 120.34 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 39.1 tpp -86.02 132.03 34.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.762 0.825 . . . . 0.0 109.424 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -128.89 128.74 44.43 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.869 1.668 . . . . 0.0 108.272 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.52 125.43 50.99 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.024 1.73 . . . . 0.0 108.029 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -131.59 168.29 17.95 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.684 1.193 . . . . 0.0 110.072 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -65.17 -10.87 34.74 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.121 0.569 . . . . 0.0 112.344 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -95.91 -41.89 8.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.42 1.088 . . . . 0.0 113.114 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -177.68 171.16 1.91 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.131 1.372 . . . . 0.0 112.837 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -87.29 136.64 32.85 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.064 0.945 . . . . 0.0 109.012 167.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.54 130.95 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.886 0.874 . . . . 0.0 111.492 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 mt -100.34 130.04 46.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.502 1.121 . . . . 0.0 110.532 168.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -106.26 131.53 53.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.461 1.904 . . . . 0.0 110.961 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 125.709 1.603 . . . . 0.0 110.73 -177.231 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 120.373 0.13 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 t -131.04 128.52 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.569 0.747 . . . . 0.0 110.79 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.29 147.18 48.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.442 1.497 . . . . 0.0 112.588 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -139.34 118.99 9.23 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.795 1.238 . . . . 0.0 111.437 173.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.89 146.25 64.9 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.503 2.135 . . . . 0.0 109.559 171.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -59.73 -26.41 65.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.1 mt -58.17 -27.76 64.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.281 1.833 . . . . 0.0 114.397 171.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.5 p -90.56 -9.71 46.13 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -94.6 84.96 4.38 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.873 1.269 . . . . 0.0 110.932 -172.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -73.44 -19.42 60.96 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.483 ' HG3' HG21 ' B' ' 12' ' ' VAL . 54.5 ttp180 -157.84 123.52 4.6 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.836 1.655 . . . . 0.0 110.051 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -140.87 109.66 6.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.987 1.715 . . . . 0.0 111.097 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.63 169.89 13.11 Favored Glycine 0 N--CA 1.462 0.411 0 C-N-CA 124.713 1.149 . . . . 0.0 113.731 -169.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -140.35 159.46 42.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.39 1.076 . . . . 0.0 112.738 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -154.45 174.98 14.15 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.508 2.323 . . . . 0.0 109.643 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 m -61.34 -12.56 14.36 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -172.052 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -154.63 18.29 0.46 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.151 1.38 . . . . 0.0 112.865 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.53 128.35 18.33 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.472 -1.393 . . . . 0.0 110.486 -169.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -118.98 133.2 55.98 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.124 1.77 . . . . 0.0 108.852 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 t -153.04 151.11 29.87 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.013 -1.054 . . . . 0.0 112.494 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -149.67 148.75 29.66 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.99 0.916 . . . . 0.0 112.388 -173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -104.8 135.09 46.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.293 1.437 . . . . 0.0 110.058 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -126.47 145.89 50.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.292 1.037 . . . . 0.0 112.188 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.1 168.23 46.57 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.41 1.005 . . . . 0.0 113.282 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -65.94 -11.35 46.79 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -70.14 -19.87 63.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.659 1.584 . . . . 0.0 114.967 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -85.87 -179.88 6.9 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -63.21 -39.28 94.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.488 1.115 . . . . 0.0 113.181 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.5 p -96.45 -22.61 17.02 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.972 1.309 . . . . 0.0 113.492 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.99 -162.04 29.67 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.566 2.031 . . . . 0.0 113.644 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -56.75 125.88 24.34 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.354 1.062 . . . . 0.0 111.524 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.78 171.98 27.47 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.453 1.025 . . . . 0.0 113.304 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.2 mt -115.04 131.45 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.531 1.532 . . . . 0.0 108.337 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.49 113.64 18.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.91 1.284 . . . . 0.0 109.669 -172.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.27 140.57 45.73 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.177 1.391 . . . . 0.0 112.298 -173.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -138.76 125.55 20.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.199 1.0 . . . . 0.0 111.405 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -63.75 126.79 28.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.822 0.849 . . . . 0.0 110.434 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.6 t -167.86 126.65 1.25 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.635 1.574 . . . . 0.0 111.462 -170.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -69.74 -44.21 70.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.185 0.594 . . . . 0.0 112.459 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.1 mtm-85 -90.45 31.28 1.04 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.566 1.546 . . . . 0.0 113.889 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.04 -37.32 61.47 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.666 1.187 . . . . 0.0 113.967 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -70.53 -36.85 73.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.598 0.759 . . . . 0.0 112.843 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -64.54 -42.11 95.93 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.719 -0.613 . . . . 0.0 110.249 173.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.97 -48.44 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.322 0.649 . . . . 0.0 110.626 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.52 -40.47 83.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.51 1.124 . . . . 0.0 112.304 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -73.75 -31.87 63.55 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -77.93 -39.04 44.11 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.064 0.847 . . . . 0.0 110.342 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.51 -53.0 19.78 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.223 1.409 . . . . 0.0 113.852 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -64.82 -22.54 67.01 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -74.05 -25.06 59.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.088 0.955 . . . . 0.0 112.547 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.2 mt -96.47 -32.67 12.19 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.138 1.375 . . . . 0.0 111.795 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.1 mtt . . . . . 0 N--CA 1.47 0.552 0 C-N-CA 123.566 0.746 . . . . 0.0 112.685 171.085 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 39.4 t80 . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 120.417 0.151 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.81 94.73 2.63 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.755 2.022 . . . . 0.0 110.514 172.096 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 15.8 mt -67.78 150.03 49.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.032 0.933 . . . . 0.0 112.521 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -84.92 -14.71 46.83 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -159.44 165.26 33.51 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.548 1.539 . . . . 0.0 111.708 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -87.0 123.33 70.44 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.091 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.48 -20.46 5.81 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.283 2.655 . . . . 0.0 114.009 -171.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 82.6 m -89.76 129.53 36.15 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.982 0.913 . . . . 0.0 111.937 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.25 -3.16 84.99 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.696 1.141 . . . . 0.0 114.795 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -141.49 136.82 31.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.326 1.451 . . . . 0.0 109.668 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.483 HG21 ' HG3' ' A' ' 64' ' ' ARG . 2.7 p -164.94 142.24 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.553 1.541 . . . . 0.0 111.36 -169.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -109.68 127.81 54.82 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.864 2.066 . . . . 0.0 109.243 172.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 123.692 0.797 . . . . 0.0 110.905 177.542 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 . . . . . 0 CA--C 1.56 1.342 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.72 -17.85 25.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.876 2.384 . . . . 0.0 115.253 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.1 p -127.51 -20.29 4.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.386 1.448 . . . . 0.0 114.688 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 149.63 28.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.11 0.868 . . . . 0.0 110.109 169.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.52 109.11 6.57 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -68.97 130.58 43.18 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.59 -0.694 . . . . 0.0 109.93 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.2 m -139.6 164.86 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.758 1.223 . . . . 0.0 112.219 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.4 m -139.62 121.03 15.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.785 1.234 . . . . 0.0 108.615 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.419 HD22 ' N ' ' B' ' 2' ' ' PHE . 53.5 t30 -66.61 133.18 49.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.819 0.448 . . . . 0.0 110.127 176.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.39 155.63 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.085 0.954 . . . . 0.0 112.592 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -82.3 -166.95 1.39 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.452 1.501 . . . . 0.0 113.12 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -66.18 -33.71 76.38 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -81.6 -28.69 33.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.322 0.964 . . . . 0.0 112.173 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.22 16.88 7.5 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 125.202 1.382 . . . . 0.0 112.261 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 t -74.3 140.53 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.345 2.258 . . . . 0.0 108.948 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -88.36 123.77 33.26 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.529 1.532 . . . . 0.0 110.393 -171.146 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.9 mt -108.52 -53.25 2.66 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.896 0.878 . . . . 0.0 112.575 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.98 142.01 9.17 Favored Glycine 0 N--CA 1.47 0.953 0 C-N-CA 124.82 1.2 . . . . 0.0 113.602 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -87.89 148.03 24.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.633 1.173 . . . . 0.0 112.666 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.03 170.09 33.73 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.529 1.061 . . . . 0.0 114.045 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.3 t -116.85 120.41 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 38.4 tpp -88.16 139.56 30.38 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.942 1.297 . . . . 0.0 110.204 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.01 130.25 25.18 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.791 1.636 . . . . 0.0 109.185 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mp -106.46 138.54 42.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.67 1.988 . . . . 0.0 108.313 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -140.27 174.47 10.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.086 1.355 . . . . 0.0 111.049 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -76.73 9.57 2.74 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.259 -0.901 . . . . 0.0 112.535 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.6 t -118.19 -49.64 2.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.95 1.3 . . . . 0.0 112.954 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -173.3 171.3 4.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.072 1.349 . . . . 0.0 112.509 -168.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 mt -85.8 140.15 30.69 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.77 0.828 . . . . 0.0 109.528 168.068 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 36.0 t -134.61 127.88 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.884 0.874 . . . . 0.0 111.418 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.9 mt -100.38 132.92 45.49 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.169 1.388 . . . . 0.0 109.696 167.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -107.6 125.45 51.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.623 1.969 . . . . 0.0 110.315 171.411 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.475 0.776 0 C-N-CA 126.346 1.858 . . . . 0.0 111.279 -177.6 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 111.453 0.168 . . . . 0.0 111.453 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.5 t -129.24 127.15 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.459 0.704 . . . . 0.0 111.118 -175.121 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.9 mtm-85 -119.14 143.63 47.09 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.204 1.802 . . . . 0.0 112.153 -169.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -139.37 114.2 8.16 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.367 1.067 . . . . 0.0 111.936 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.72 143.65 68.56 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.98 2.453 . . . . 0.0 110.391 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -60.71 -21.79 63.29 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.03 -46.76 89.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.946 1.698 . . . . 0.0 111.728 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 p -78.2 -17.31 56.93 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.53 65.96 6.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.993 1.717 . . . . 0.0 111.111 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -70.89 -24.15 62.43 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -172.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.619 ' HG3' HG21 ' B' ' 12' ' ' VAL . 53.0 ttp180 -147.43 118.53 7.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.157 1.783 . . . . 0.0 108.492 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -140.54 110.77 6.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.322 1.849 . . . . 0.0 110.717 -173.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.88 168.19 15.16 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 124.644 1.116 . . . . 0.0 114.104 -168.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -138.63 163.14 32.85 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.578 1.151 . . . . 0.0 112.648 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -148.7 -169.95 3.49 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.06 2.144 . . . . 0.0 109.524 170.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.3 m -68.4 -14.86 63.3 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -156.49 11.75 0.26 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.49 1.516 . . . . 0.0 114.126 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -136.59 129.89 31.52 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.915 1.686 . . . . 0.0 110.06 -168.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -123.39 135.85 54.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.924 1.69 . . . . 0.0 109.249 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 t -153.02 155.68 37.37 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.219 1.008 . . . . 0.0 112.277 -174.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.34 154.69 32.43 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.269 1.028 . . . . 0.0 112.647 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HG3' ' HE ' ' A' ' 64' ' ' ARG . 5.7 mm-40 -91.77 152.22 20.25 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.334 1.854 . . . . 0.0 110.66 171.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 90.8 p -141.29 152.1 44.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.414 1.085 . . . . 0.0 112.108 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.33 162.2 18.02 Favored Glycine 0 N--CA 1.473 1.144 0 C-N-CA 125.035 1.302 . . . . 0.0 114.312 -171.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -56.38 -20.69 20.55 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -82.49 -15.5 52.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.9 p -85.15 -178.27 6.74 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -56.11 -49.9 72.59 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.944 1.298 . . . . 0.0 112.173 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.4 p -88.1 -23.19 23.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.945 1.298 . . . . 0.0 112.938 -174.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.22 -154.62 35.26 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.89 1.709 . . . . 0.0 112.174 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -59.58 130.46 46.97 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.358 1.063 . . . . 0.0 111.895 173.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.09 164.41 18.06 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.152 0.882 . . . . 0.0 113.564 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.4 mt -113.49 134.02 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.687 1.195 . . . . 0.0 108.512 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -130.25 125.74 35.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.947 1.299 . . . . 0.0 109.941 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.78 141.82 50.83 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.587 1.155 . . . . 0.0 112.734 -172.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -140.87 127.86 20.66 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.83 0.852 . . . . 0.0 111.874 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -65.59 133.53 51.37 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.398 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.1 t -161.48 132.53 5.29 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.271 1.428 . . . . 0.0 111.587 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 m -68.64 -15.6 63.57 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -133.69 35.85 3.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.044 1.738 . . . . 0.0 112.967 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.57 -40.36 71.87 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -70.07 -39.49 75.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.782 0.719 . . . . 0.0 112.013 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -61.71 -39.72 92.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.286 1.034 . . . . 0.0 110.927 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.4 mt -62.19 -47.99 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 118.95 0.795 . . . . 0.0 110.631 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -58.04 -37.06 73.65 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.195 0.998 . . . . 0.0 112.426 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -79.62 -28.63 40.96 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 113.702 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt -80.47 -41.28 24.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.436 1.017 . . . . 0.0 110.184 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.1 mt -49.32 -56.47 9.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.62 1.168 . . . . 0.0 112.723 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -61.48 -21.68 64.4 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.88 -27.08 61.69 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.166 0.894 . . . . 0.0 112.589 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.4 mt -97.28 -41.83 8.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.772 1.629 . . . . 0.0 110.968 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 124.938 1.295 . . . . 0.0 113.294 -178.814 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.419 ' N ' HD22 ' A' ' 25' ' ' ASN . 21.3 t80 . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 120.486 0.184 . . . . 0.0 111.435 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -77.92 113.92 16.29 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.605 1.162 . . . . 0.0 110.728 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 59.4 mt -82.37 153.36 25.79 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.731 0.777 . . . . 0.0 112.714 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -78.69 -26.12 44.85 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.939 1.696 . . . . 0.0 112.831 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -159.44 166.88 30.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.351 1.86 . . . . 0.0 111.725 -169.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -88.49 124.13 66.67 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.52 -0.753 . . . . 0.0 111.924 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -87.02 -22.48 1.79 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.209 2.606 . . . . 0.0 114.336 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 92.9 m -83.9 130.0 34.92 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.996 0.816 . . . . 0.0 112.281 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.17 -1.01 88.63 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.68 1.133 . . . . 0.0 115.142 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -143.32 142.15 31.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.851 1.26 . . . . 0.0 110.243 170.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.619 HG21 ' HG3' ' A' ' 64' ' ' ARG . 3.0 p -166.38 146.82 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.222 1.409 . . . . 0.0 111.639 -168.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -118.54 142.43 47.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.396 2.278 . . . . 0.0 109.814 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 . . . . . 0 CA--C 1.544 0.721 0 C-N-CA 124.924 1.289 . . . . 0.0 109.676 177.102 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 . . . . . 0 CA--C 1.552 1.039 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.41 -11.03 30.78 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.079 2.519 . . . . 0.0 114.921 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.1 p -132.73 -22.76 2.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.27 97.63 7.19 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.542 1.065 . . . . 0.0 111.295 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -96.94 126.78 42.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.219 1.408 . . . . 0.0 109.751 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -81.55 136.03 35.59 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.099 -1.001 . . . . 0.0 110.273 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.22 168.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.737 1.215 . . . . 0.0 112.329 -168.195 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.6 m -141.8 121.99 13.86 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.569 1.147 . . . . 0.0 109.49 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.92 130.72 44.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.211 1.004 . . . . 0.0 110.755 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.21 159.48 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.01 -171.03 2.99 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -58.41 -21.99 52.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.825 1.65 . . . . 0.0 114.705 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -103.93 -4.66 23.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.92 1.288 . . . . 0.0 112.606 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.51 17.28 66.62 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.057 -1.413 . . . . 0.0 114.38 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.95 144.76 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.081 1.94 . . . . 0.0 109.999 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -91.42 120.89 32.66 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.38 1.072 . . . . 0.0 110.27 -175.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.7 mt -107.94 -53.36 2.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.032 0.933 . . . . 0.0 112.027 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.14 132.03 3.93 Favored Glycine 0 N--CA 1.472 1.043 0 C-N-CA 124.726 1.155 . . . . 0.0 113.576 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.0 m -86.81 154.65 20.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.677 0.791 . . . . 0.0 112.659 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.13 171.34 33.93 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.099 1.333 . . . . 0.0 114.021 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -115.57 120.95 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 169.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.9 ttm -94.3 116.57 28.97 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.195 1.398 . . . . 0.0 109.754 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -109.18 128.5 55.08 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.832 1.653 . . . . 0.0 108.838 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.06 137.36 42.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.552 1.541 . . . . 0.0 108.278 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.6 p -135.41 173.2 11.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.006 1.322 . . . . 0.0 110.755 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -72.2 -0.25 11.56 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.558 -0.714 . . . . 0.0 112.608 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -115.37 -40.66 3.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -172.88 166.16 5.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.977 1.311 . . . . 0.0 112.963 -168.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mt -86.76 138.39 31.65 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.123 1.369 . . . . 0.0 109.272 168.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 t -134.75 131.77 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.664 0.785 . . . . 0.0 111.395 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.3 mt -104.75 130.66 52.78 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.221 1.408 . . . . 0.0 110.39 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -109.06 126.87 53.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.98 2.112 . . . . 0.0 110.245 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.54 0.566 0 C-N-CA 126.006 1.723 . . . . 0.0 112.136 -172.776 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 t -122.5 125.73 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.239 0.616 . . . . 0.0 111.172 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -115.81 143.79 44.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.86 1.664 . . . . 0.0 111.485 -173.267 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 -138.73 117.23 9.24 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.461 1.105 . . . . 0.0 111.167 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.25 144.53 68.86 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.237 1.958 . . . . 0.0 109.264 170.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -60.69 -27.29 67.75 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.02 -43.75 91.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.902 1.681 . . . . 0.0 111.588 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 79.1 m -78.86 1.58 22.97 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.26 117.29 25.92 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.844 1.202 . . . . 0.0 109.728 172.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -73.33 -35.66 66.07 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -166.13 162.75 17.88 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.721 2.008 . . . . 0.0 110.647 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -149.67 108.13 3.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.235 1.014 . . . . 0.0 110.418 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.31 161.88 12.66 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 124.875 1.226 . . . . 0.0 113.369 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -139.58 163.69 31.88 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.689 1.196 . . . . 0.0 112.61 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -153.63 -169.58 3.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.798 2.039 . . . . 0.0 109.566 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 t -64.82 -24.2 67.47 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.841 -1.162 . . . . 0.0 114.091 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -155.84 19.19 0.38 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.23 1.412 . . . . 0.0 112.996 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -142.67 128.33 19.19 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.999 1.319 . . . . 0.0 110.43 -169.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -120.84 140.98 51.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.081 1.752 . . . . 0.0 109.599 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -153.39 157.72 40.4 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.177 -0.952 . . . . 0.0 113.123 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -154.57 153.26 31.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.877 1.671 . . . . 0.0 111.136 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -108.13 133.09 52.89 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.798 0.839 . . . . 0.0 110.126 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 m -107.45 141.73 38.41 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.127 0.971 . . . . 0.0 112.588 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.79 157.12 53.53 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.832 1.206 . . . . 0.0 112.646 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -65.84 -15.79 63.23 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -168.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -91.49 -10.79 39.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.125 1.77 . . . . 0.0 115.367 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.4 p -75.86 -177.52 3.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -55.89 -40.23 72.71 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.504 1.122 . . . . 0.0 112.941 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.4 p -93.54 -23.4 18.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.943 1.297 . . . . 0.0 113.556 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.47 -161.85 41.2 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.056 1.312 . . . . 0.0 111.544 -171.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -66.12 128.46 36.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.811 0.844 . . . . 0.0 111.375 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.62 161.38 18.59 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 123.154 0.407 . . . . 0.0 114.036 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 88.1 mt -104.89 131.28 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.002 1.321 . . . . 0.0 108.514 169.836 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -127.76 125.23 39.52 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.819 1.248 . . . . 0.0 109.491 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.35 143.45 50.58 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.146 0.978 . . . . 0.0 112.663 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.93 124.3 19.28 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.901 -168.46 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -64.62 131.2 46.32 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.234 0.614 . . . . 0.0 110.706 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 37.3 t -169.98 122.88 0.71 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.111 1.764 . . . . 0.0 110.462 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -68.64 -14.42 63.0 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.62 -0.675 . . . . 0.0 112.812 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 mtt85 -108.56 22.76 15.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.442 1.897 . . . . 0.0 113.519 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.93 -37.81 21.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.583 1.153 . . . . 0.0 113.654 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.85 -40.45 79.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.451 1.101 . . . . 0.0 113.144 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.3 -34.65 77.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.466 -0.771 . . . . 0.0 111.384 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.44 -49.55 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.163 0.585 . . . . 0.0 110.291 170.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -37.31 82.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.559 0.744 . . . . 0.0 112.35 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -71.1 -29.39 65.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.758 0.823 . . . . 0.0 113.178 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.7 tp -86.77 -36.54 18.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.49 1.041 . . . . 0.0 112.419 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.1 mt -52.59 -55.9 19.07 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.971 0.908 . . . . 0.0 112.068 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -57.86 -21.01 40.62 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.53 -25.33 25.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.627 1.171 . . . . 0.0 113.42 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.5 mt -95.98 -33.53 12.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.797 1.239 . . . . 0.0 111.728 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 97.0 mtp . . . . . 0 N--CA 1.47 0.57 0 C-N-CA 125.857 1.663 . . . . 0.0 113.734 174.292 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.8 t80 . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -85.54 121.29 28.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.304 1.042 . . . . 0.0 110.844 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 80.4 mt -83.83 164.1 19.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.629 0.728 . . . . 0.0 112.718 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -106.59 2.21 25.87 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.812 1.645 . . . . 0.0 113.835 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -160.33 164.93 32.13 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.509 2.324 . . . . 0.0 110.472 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -90.94 118.31 68.5 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.307 174.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.87 -24.47 3.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.314 2.676 . . . . 0.0 114.772 -168.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 81.7 m -80.19 127.84 32.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.028 0.831 . . . . 0.0 111.873 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.58 -7.07 88.77 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.522 1.058 . . . . 0.0 114.449 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.42 131.01 31.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.337 1.855 . . . . 0.0 109.814 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 p -164.62 147.27 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.176 1.39 . . . . 0.0 111.112 -169.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -132.05 170.42 14.97 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.612 2.365 . . . . 0.0 111.874 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 125.359 1.464 . . . . 0.0 110.96 -169.372 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.15 -11.54 31.9 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.279 2.653 . . . . 0.0 115.253 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.0 p -131.42 -16.51 3.06 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.92 99.01 7.15 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.479 1.036 . . . . 0.0 111.29 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -97.47 116.38 29.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.777 1.231 . . . . 0.0 109.054 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -76.58 133.44 39.67 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.976 -1.078 . . . . 0.0 110.344 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.25 167.19 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.115 0.966 . . . . 0.0 112.485 -168.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.9 m -146.09 125.47 13.12 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.007 1.323 . . . . 0.0 108.797 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.524 HD22 ' N ' ' B' ' 2' ' ' PHE . 48.2 t30 -66.37 132.6 48.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.515 0.726 . . . . 0.0 110.096 177.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.1 156.79 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.699 1.2 . . . . 0.0 112.809 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.4 p-10 -89.36 -166.49 1.61 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.965 1.306 . . . . 0.0 113.988 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.93 -35.14 74.3 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.415 1.486 . . . . 0.0 114.319 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -80.38 -12.98 59.52 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.285 0.948 . . . . 0.0 113.063 176.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.67 17.52 72.85 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.345 -1.253 . . . . 0.0 113.554 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.435 HG22 ' OD1' ' A' ' 27' ' ' ASP . 14.8 m -75.41 149.3 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.668 1.734 . . . . 0.0 110.936 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -90.58 124.91 35.41 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.358 1.063 . . . . 0.0 111.321 -170.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.2 mt -107.42 -49.82 3.18 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.23 1.012 . . . . 0.0 111.991 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.69 135.37 4.44 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.782 1.182 . . . . 0.0 113.602 176.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 p -84.06 154.66 23.09 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.769 1.228 . . . . 0.0 112.984 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.07 171.07 38.75 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.858 1.218 . . . . 0.0 113.88 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.51 120.9 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 41.5 tpp -90.9 137.36 32.42 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.685 1.194 . . . . 0.0 110.283 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -138.95 130.14 26.8 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.216 1.406 . . . . 0.0 109.251 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.61 134.78 49.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.338 1.855 . . . . 0.0 107.656 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.4 p -132.07 173.4 11.26 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.078 0.951 . . . . 0.0 111.01 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -66.2 0.23 2.14 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.678 0.791 . . . . 0.0 112.685 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -116.32 -43.25 2.96 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -172.98 177.07 2.87 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -169.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.13 138.28 31.56 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.387 1.075 . . . . 0.0 110.132 167.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.65 128.69 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.308 1.043 . . . . 0.0 111.184 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.2 mt -102.12 135.12 44.25 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.504 1.522 . . . . 0.0 110.378 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -110.21 124.86 52.36 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.39 1.876 . . . . 0.0 111.068 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 127.202 2.201 . . . . 0.0 111.164 -179.637 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.641 0 CA-C-O 120.411 0.148 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -123.14 126.59 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.272 0.629 . . . . 0.0 110.546 -173.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -120.76 138.43 54.01 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.569 1.548 . . . . 0.0 111.524 -169.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -139.1 114.08 8.33 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.389 1.076 . . . . 0.0 111.093 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.55 150.13 74.83 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 0.0 110.307 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -60.95 -20.67 62.59 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -65.27 -34.67 78.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.142 1.777 . . . . 0.0 113.268 170.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 89.1 m -92.63 -5.05 52.32 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.18 105.63 13.43 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.837 0.855 . . . . 0.0 109.253 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -79.76 -20.93 45.12 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.484 ' HG3' HG21 ' B' ' 12' ' ' VAL . 30.9 ttt180 -170.1 133.42 1.15 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.698 1.999 . . . . 0.0 108.753 -172.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -142.27 119.09 11.17 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.325 1.45 . . . . 0.0 110.26 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.55 164.87 22.91 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 124.077 0.846 . . . . 0.0 112.992 -169.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -130.45 155.32 46.63 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.343 1.057 . . . . 0.0 111.492 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.99 -174.11 4.76 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.878 1.671 . . . . 0.0 110.349 173.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.7 p -59.54 111.58 1.46 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.256 -0.902 . . . . 0.0 111.57 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.257 0.7 OUTLIER 51.52 23.15 1.74 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.391 2.276 . . . . 0.0 116.158 -174.25 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.33 126.39 29.6 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.424 1.49 . . . . 0.0 110.871 -172.019 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -120.18 135.16 55.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.748 1.619 . . . . 0.0 109.622 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -153.29 155.01 35.72 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.312 -0.867 . . . . 0.0 112.159 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -154.61 152.73 30.35 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.532 1.133 . . . . 0.0 112.268 -174.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -115.45 133.84 55.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.337 1.855 . . . . 0.0 110.493 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.6 m -133.26 154.38 50.73 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.354 1.062 . . . . 0.0 112.476 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.89 166.57 34.04 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.888 1.233 . . . . 0.0 113.588 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -6.37 16.71 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -174.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -82.69 -19.53 37.9 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.7 p -81.63 -179.46 7.39 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -55.13 -42.97 73.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.095 1.358 . . . . 0.0 113.003 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.4 p -93.15 -22.25 19.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.348 1.459 . . . . 0.0 113.637 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.1 -163.38 43.32 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.298 1.428 . . . . 0.0 112.539 -173.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -70.76 137.59 49.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.091 0.956 . . . . 0.0 112.793 -174.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.53 171.9 24.08 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.614 1.102 . . . . 0.0 113.355 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.63 123.11 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.091 1.356 . . . . 0.0 108.579 170.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -114.17 119.33 36.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.998 1.319 . . . . 0.0 109.393 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.61 139.15 53.39 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.394 1.078 . . . . 0.0 112.914 -169.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -140.29 131.22 26.07 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.887 0.851 . . . . 0.0 112.287 -169.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -69.39 135.32 50.14 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.813 168.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.7 t -159.03 142.75 15.05 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.131 1.372 . . . . 0.0 111.431 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.3 m -77.35 -27.48 52.68 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -127.66 40.24 3.73 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.692 1.197 . . . . 0.0 113.348 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.93 -40.88 15.09 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.52 -35.24 78.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.452 0.701 . . . . 0.0 112.8 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.93 -30.48 66.81 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.419 -0.8 . . . . 0.0 112.153 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.49 -47.28 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.688 0.676 . . . . 0.0 109.608 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -58.6 -42.61 88.51 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.177 0.991 . . . . 0.0 111.919 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -67.78 -42.44 81.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.687 1.195 . . . . 0.0 112.418 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.9 tp -75.21 -32.51 61.2 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.847 0.749 . . . . 0.0 112.177 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.2 mt -53.92 -54.36 39.92 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.698 0.799 . . . . 0.0 112.221 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -63.75 -30.97 72.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -34.19 77.38 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.221 1.008 . . . . 0.0 112.83 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.03 -35.57 21.82 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.341 1.056 . . . . 0.0 111.37 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 48.7 mtt . . . . . 0 N--CA 1.471 0.595 0 C-N-CA 123.593 0.757 . . . . 0.0 112.513 172.918 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.524 ' N ' HD22 ' A' ' 25' ' ' ASN . 19.4 t80 . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 119.678 -0.201 . . . . 0.0 111.447 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.81 116.76 32.5 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.779 1.232 . . . . 0.0 109.721 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 98.3 mt -78.52 157.77 28.76 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -87.22 -7.97 57.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.798 1.639 . . . . 0.0 113.919 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -161.38 163.08 30.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.959 2.104 . . . . 0.0 110.499 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -86.95 122.84 71.09 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.769 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.67 -12.24 11.21 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.387 2.725 . . . . 0.0 113.75 -171.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 84.5 m -99.82 121.7 41.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.367 1.067 . . . . 0.0 111.531 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.45 -14.6 82.32 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.385 0.993 . . . . 0.0 114.576 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -127.16 138.45 53.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.478 1.511 . . . . 0.0 110.876 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 64' ' ' ARG . 2.0 p -163.97 142.45 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.888 1.675 . . . . 0.0 110.868 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -115.76 114.22 24.5 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.321 2.249 . . . . 0.0 107.921 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 . . . . . 0 CA--C 1.543 0.687 0 O-C-N 121.634 -0.666 . . . . 0.0 110.449 178.848 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 . . . . . 0 CA--C 1.558 1.265 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.34 -11.23 26.53 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.244 2.63 . . . . 0.0 115.287 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.2 p -127.5 -25.05 3.23 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.752 1.16 . . . . 0.0 114.0 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -104.79 134.47 47.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.066 0.946 . . . . 0.0 111.103 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -131.2 105.25 7.54 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.155 1.382 . . . . 0.0 108.478 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -65.82 127.56 32.48 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.638 0.775 . . . . 0.0 110.488 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.4 m -137.35 163.64 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.347 1.459 . . . . 0.0 111.352 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.1 m -134.25 119.44 18.76 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.307 1.043 . . . . 0.0 109.013 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.417 HD22 ' N ' ' B' ' 2' ' ' PHE . 18.3 t-20 -61.82 128.0 34.12 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.108 0.963 . . . . 0.0 109.961 175.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.99 154.88 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.547 0.739 . . . . 0.0 112.906 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -89.87 -166.94 1.71 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.649 1.18 . . . . 0.0 113.952 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.5 -29.57 70.83 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -83.33 -8.96 59.34 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.001 1.32 . . . . 0.0 112.562 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.15 16.51 80.57 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.182 -1.344 . . . . 0.0 113.729 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.1 m -81.28 150.45 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.568 1.684 . . . . 0.0 111.63 176.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.12 121.94 31.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.641 1.176 . . . . 0.0 111.151 -170.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.7 mt -102.8 -53.58 2.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.37 0.668 . . . . 0.0 111.843 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.76 149.05 20.72 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.795 1.188 . . . . 0.0 114.356 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.4 p -88.29 153.01 21.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.208 1.403 . . . . 0.0 113.152 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.46 171.39 35.26 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.243 1.401 . . . . 0.0 113.628 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.45 120.22 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.0 tpp -85.27 140.15 31.07 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.482 1.113 . . . . 0.0 109.259 170.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -133.32 129.96 38.22 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.119 1.368 . . . . 0.0 108.546 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.88 131.2 55.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.821 2.048 . . . . 0.0 108.471 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 p -133.83 173.36 11.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.847 1.259 . . . . 0.0 110.877 178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -71.91 5.4 2.65 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.079 -1.013 . . . . 0.0 112.776 170.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.8 m -114.73 -45.85 2.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.773 1.229 . . . . 0.0 113.619 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -172.21 169.92 5.31 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.754 1.161 . . . . 0.0 113.449 -169.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.9 mt -87.44 139.96 30.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.356 1.063 . . . . 0.0 109.952 168.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.4 127.6 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.041 0.936 . . . . 0.0 111.496 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 mt -100.06 128.65 46.11 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.233 1.413 . . . . 0.0 110.374 168.13 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -108.24 129.48 55.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.305 2.242 . . . . 0.0 109.654 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.04 135.04 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.922 1.289 . . . . 0.0 108.119 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -131.63 149.78 52.38 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -166.831 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -141.82 116.44 6.85 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 124.549 1.14 . . . . 0.0 111.997 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.41 145.1 58.06 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.55 2.167 . . . . 0.0 109.565 170.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -61.6 -21.95 64.8 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.56 -47.64 85.28 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.705 2.002 . . . . 0.0 111.692 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.4 m -80.12 -16.56 54.69 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.13 119.63 11.19 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.939 0.791 . . . . 0.0 110.382 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -82.82 -32.08 27.78 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.356 1.063 . . . . 0.0 112.065 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -168.28 160.68 11.68 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.179 2.192 . . . . 0.0 110.725 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -149.45 116.96 6.14 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.831 1.252 . . . . 0.0 109.667 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.83 165.7 21.56 Favored Glycine 0 N--CA 1.463 0.466 0 C-N-CA 124.836 1.208 . . . . 0.0 113.358 -169.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -141.59 176.74 8.65 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.456 1.102 . . . . 0.0 113.136 -170.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -163.6 -168.01 1.55 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.677 2.391 . . . . 0.0 108.756 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 t -72.21 -19.66 61.69 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.691 -1.256 . . . . 0.0 113.198 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -152.22 8.19 0.47 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.619 1.167 . . . . 0.0 113.893 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -137.11 129.77 30.23 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.425 1.49 . . . . 0.0 110.242 -169.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -124.51 138.01 54.37 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.194 1.797 . . . . 0.0 109.208 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -153.33 152.84 31.56 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.094 -1.004 . . . . 0.0 112.326 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -150.84 153.58 35.65 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.262 1.025 . . . . 0.0 112.312 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -110.8 142.56 42.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.026 1.331 . . . . 0.0 109.379 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 t -129.32 150.55 50.64 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.476 0.71 . . . . 0.0 112.643 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.98 158.57 53.12 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.028 1.299 . . . . 0.0 113.619 -175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -60.99 -20.93 63.04 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -170.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -80.12 -14.38 58.54 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.778 1.769 . . . . 0.0 115.778 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.87 -179.4 5.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -56.46 -47.18 79.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.495 1.518 . . . . 0.0 113.102 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.9 p -81.78 -26.13 34.7 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.52 -163.46 38.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.691 1.138 . . . . 0.0 111.79 -172.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -66.3 128.43 36.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.339 1.056 . . . . 0.0 111.342 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.37 164.2 22.6 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-O 121.557 0.532 . . . . 0.0 114.08 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.6 mt -114.89 136.07 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.493 1.517 . . . . 0.0 108.572 171.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -132.07 127.03 35.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.662 1.185 . . . . 0.0 110.614 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.29 140.88 52.57 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.3 1.44 . . . . 0.0 113.187 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -140.77 128.48 21.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.464 1.106 . . . . 0.0 111.988 -169.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -74.82 135.86 41.62 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.621 0.768 . . . . 0.0 111.738 171.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.5 p -172.33 140.06 1.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.063 2.145 . . . . 0.0 111.473 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.7 m -68.88 -20.28 64.25 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.344 -0.847 . . . . 0.0 113.272 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -100.63 17.88 20.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.989 1.716 . . . . 0.0 112.738 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.18 -39.92 31.21 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.839 1.255 . . . . 0.0 113.779 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -68.25 -37.71 81.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.302 1.041 . . . . 0.0 113.211 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.73 -34.05 76.08 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.149 -0.97 . . . . 0.0 111.911 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.95 -46.07 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.983 -0.448 . . . . 0.0 110.075 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.71 -43.15 94.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.33 1.052 . . . . 0.0 112.023 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -66.48 -37.45 85.13 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.845 1.258 . . . . 0.0 112.556 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.1 tp -80.63 -32.61 36.23 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.914 0.779 . . . . 0.0 112.43 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.6 mt -56.25 -50.42 71.39 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.65 0.659 . . . . 0.0 112.55 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -65.95 -18.79 65.57 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.69 -43.71 16.55 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.425 1.09 . . . . 0.0 110.977 173.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.0 mt -71.55 -28.18 63.68 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.845 -1.159 . . . . 0.0 111.959 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 33.6 mtt . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 167.942 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.417 ' N ' HD22 ' A' ' 25' ' ' ASN . 39.8 t80 . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.15 109.09 18.64 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.989 0.916 . . . . 0.0 109.909 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 40.0 mt -77.46 154.78 32.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.748 0.819 . . . . 0.0 112.819 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -87.13 -19.02 29.1 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.576 1.55 . . . . 0.0 112.792 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -149.8 167.76 25.61 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.332 1.853 . . . . 0.0 111.751 -175.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -93.22 123.56 60.4 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.627 -0.702 . . . . 0.0 111.389 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.92 -18.03 6.64 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.197 2.598 . . . . 0.0 114.129 -171.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 84.0 m -101.15 115.35 30.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.154 0.982 . . . . 0.0 111.284 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.49 -41.1 45.71 Favored Glycine 0 N--CA 1.476 1.343 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -77.73 113.92 16.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.543 1.537 . . . . 0.0 110.055 169.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.36 151.03 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.737 2.015 . . . . 0.0 110.234 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -131.96 160.35 36.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.72 1.608 . . . . 0.0 111.484 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 124.989 1.316 . . . . 0.0 111.207 -169.165 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 . . . . . 0 CA--C 1.558 1.269 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.1 -14.71 32.02 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.051 2.501 . . . . 0.0 115.421 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.3 p -131.04 -18.74 2.93 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 120.229 1.377 . . . . 0.0 114.516 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -104.68 142.02 35.42 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.192 0.997 . . . . 0.0 110.447 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -141.73 108.32 5.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 145.35 52.0 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.254 -0.904 . . . . 0.0 110.51 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.36 156.7 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.609 0.763 . . . . 0.0 111.5 -172.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -132.95 115.15 14.85 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -65.24 133.52 51.66 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.86 154.46 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.076 0.95 . . . . 0.0 112.431 -176.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.4 p-10 -88.01 -167.5 1.9 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.342 1.057 . . . . 0.0 113.599 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.89 -32.35 73.85 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.751 1.221 . . . . 0.0 114.234 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -79.53 -9.08 59.55 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.959 0.799 . . . . 0.0 112.533 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.92 14.5 81.93 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 117.931 -1.483 . . . . 0.0 113.923 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.438 HG22 ' OD1' ' A' ' 27' ' ' ASP . 15.1 m -76.24 150.11 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.85 1.825 . . . . 0.0 111.338 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.28 125.31 34.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.53 1.132 . . . . 0.0 111.183 -171.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.7 mt -107.4 -52.35 2.78 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.994 0.918 . . . . 0.0 112.107 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.17 147.14 14.96 Favored Glycine 0 N--CA 1.47 0.924 0 C-N-CA 124.591 1.091 . . . . 0.0 113.737 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 p -91.12 150.05 21.55 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.943 1.297 . . . . 0.0 113.104 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.05 168.13 32.38 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.947 1.737 . . . . 0.0 113.006 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.76 120.63 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.8 ttm -93.9 140.95 29.07 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.938 1.295 . . . . 0.0 110.619 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -140.06 130.26 25.12 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.592 1.557 . . . . 0.0 108.935 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -107.91 137.77 45.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.166 1.787 . . . . 0.0 108.016 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.9 p -137.53 174.71 10.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.779 1.232 . . . . 0.0 110.649 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -73.59 3.21 6.55 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.408 -0.807 . . . . 0.0 112.616 171.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.6 m -120.77 -45.04 2.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.532 1.133 . . . . 0.0 113.663 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.96 166.17 11.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.194 1.398 . . . . 0.0 113.706 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.13 136.97 34.26 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.855 1.262 . . . . 0.0 109.34 168.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.6 t -134.4 132.56 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.523 0.729 . . . . 0.0 110.98 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.2 mt -109.65 130.35 55.52 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.151 1.78 . . . . 0.0 110.777 169.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -100.15 125.32 46.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.531 1.933 . . . . 0.0 110.285 169.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 126.921 2.088 . . . . 0.0 111.087 -173.429 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.3 134.53 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.293 0.637 . . . . 0.0 110.464 -174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.44 144.37 48.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.585 1.154 . . . . 0.0 112.022 -169.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -144.29 122.05 6.69 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.877 1.271 . . . . 0.0 111.571 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.26 141.48 39.37 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.042 2.494 . . . . 0.0 110.303 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -58.8 -26.02 63.7 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.43 -41.78 69.78 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.451 1.9 . . . . 0.0 112.852 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.9 p -87.97 -10.69 49.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.9 mt -89.94 69.07 7.43 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.491 1.516 . . . . 0.0 110.775 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -67.67 -23.86 65.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.852 0.861 . . . . 0.0 113.269 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -141.54 119.65 12.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.513 1.525 . . . . 0.0 110.278 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -142.0 109.31 5.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.104 1.762 . . . . 0.0 110.591 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.56 170.26 14.0 Favored Glycine 0 N--CA 1.465 0.601 0 C-N-CA 124.733 1.159 . . . . 0.0 113.612 -169.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -141.61 158.68 43.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.054 0.942 . . . . 0.0 111.67 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.24 -173.89 4.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.136 1.774 . . . . 0.0 109.964 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.4 p -58.16 109.73 0.81 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.944 0.878 . . . . 0.0 111.771 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.261 0.8 OUTLIER 49.36 27.73 2.06 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 127.292 2.237 . . . . 0.0 115.836 -173.113 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -134.99 130.02 35.08 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.736 1.614 . . . . 0.0 110.564 -172.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -124.45 137.75 54.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.685 1.594 . . . . 0.0 109.852 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 t -153.44 156.7 38.68 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.259 1.024 . . . . 0.0 113.021 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.77 156.69 39.58 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.051 1.34 . . . . 0.0 112.082 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -121.87 137.86 54.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.374 1.87 . . . . 0.0 109.705 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.0 p -145.31 150.5 36.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.201 1.0 . . . . 0.0 112.887 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.84 166.9 49.36 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.863 1.221 . . . . 0.0 114.031 -175.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -63.52 -12.35 31.51 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -171.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -20.17 60.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.335 1.454 . . . . 0.0 114.709 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.55 176.58 8.18 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -57.4 -41.15 79.75 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.979 1.311 . . . . 0.0 113.137 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -91.54 -21.02 21.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.344 1.458 . . . . 0.0 113.884 -173.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.34 -176.56 52.79 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.253 1.406 . . . . 0.0 112.637 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.42 130.74 45.71 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.142 0.977 . . . . 0.0 112.671 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.76 178.91 36.08 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.862 1.22 . . . . 0.0 113.041 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.31 136.69 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.775 1.63 . . . . 0.0 108.834 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -130.57 121.54 25.88 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.735 1.214 . . . . 0.0 110.068 -173.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.36 141.98 50.99 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.54 1.136 . . . . 0.0 112.797 -170.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -141.11 130.62 23.9 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.817 0.847 . . . . 0.0 111.913 -170.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -69.57 131.98 45.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.798 0.839 . . . . 0.0 110.79 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.1 t -170.55 120.21 0.57 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.438 1.895 . . . . 0.0 110.337 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.4 t -71.11 -7.84 49.34 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 121.029 -1.044 . . . . 0.0 113.226 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -101.34 7.69 42.66 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.671 1.988 . . . . 0.0 112.688 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.85 -39.62 54.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.207 1.803 . . . . 0.0 115.592 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -68.48 -34.0 75.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.676 0.671 . . . . 0.0 112.789 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -70.59 -33.74 71.4 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.642 -0.661 . . . . 0.0 111.146 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.33 -47.0 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.59 0.632 . . . . 0.0 110.088 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.05 -43.06 99.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.758 0.823 . . . . 0.0 111.675 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -70.3 -30.58 67.61 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -80.68 -35.71 33.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.703 1.138 . . . . 0.0 111.861 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 mt -54.95 -50.36 69.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.29 0.95 . . . . 0.0 112.341 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -63.53 -24.92 68.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -25.75 47.08 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.32 1.048 . . . . 0.0 112.576 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.54 -30.15 17.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.423 1.089 . . . . 0.0 111.588 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 14.9 mmt . . . . . 0 N--CA 1.475 0.825 0 C-N-CA 125.208 1.403 . . . . 0.0 112.939 168.32 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 31.4 t80 . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -88.39 117.26 27.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.49 1.116 . . . . 0.0 111.309 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 72.2 mt -84.0 156.34 22.32 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.98 0.912 . . . . 0.0 112.27 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -92.34 -5.37 52.32 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.643 1.577 . . . . 0.0 113.423 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -169.41 161.14 9.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.208 2.203 . . . . 0.0 110.977 -169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -89.14 124.72 64.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.534 -173.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.6 -24.13 2.46 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.128 2.552 . . . . 0.0 113.813 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.7 m -83.4 124.23 30.46 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.636 0.775 . . . . 0.0 111.399 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.36 -4.46 89.07 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.342 0.972 . . . . 0.0 114.583 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -138.46 136.91 36.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.746 1.618 . . . . 0.0 110.219 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -162.8 139.73 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.075 1.35 . . . . 0.0 111.197 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -100.67 125.43 47.09 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.627 1.971 . . . . 0.0 108.945 171.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 123.229 0.612 . . . . 0.0 111.395 -179.707 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 CA--C 1.555 1.165 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.74 -12.64 35.12 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.0 2.466 . . . . 0.0 115.199 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.7 p -136.49 -18.39 1.46 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -112.58 148.56 34.29 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.431 1.093 . . . . 0.0 110.002 171.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -143.11 115.88 8.73 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.296 -0.878 . . . . 0.0 110.408 -173.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -71.02 133.93 46.72 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.458 -0.776 . . . . 0.0 110.242 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.44 163.77 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.927 1.291 . . . . 0.0 112.19 -169.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.3 m -134.46 119.77 18.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.426 1.091 . . . . 0.0 108.968 174.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.444 HD22 ' N ' ' B' ' 2' ' ' PHE . 16.9 t-20 -62.69 126.62 27.96 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 109.775 174.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.75 153.61 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.402 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.3 p-10 -91.88 -168.91 2.12 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.2 -22.66 67.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.481 1.512 . . . . 0.0 114.438 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -93.53 -5.84 48.1 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.665 1.186 . . . . 0.0 112.387 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.65 14.83 82.01 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 118.065 -1.408 . . . . 0.0 114.045 -173.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' OD1' ' A' ' 27' ' ' ASP . 18.2 m -81.04 150.99 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.674 1.737 . . . . 0.0 111.55 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.56 122.47 32.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.724 1.21 . . . . 0.0 110.996 -170.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.9 mt -103.65 -54.51 2.56 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.254 0.621 . . . . 0.0 111.86 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.59 146.72 16.98 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.869 1.223 . . . . 0.0 114.476 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 p -94.33 144.64 25.37 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.486 1.515 . . . . 0.0 112.558 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.41 171.68 32.92 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.701 1.143 . . . . 0.0 114.597 -177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.5 t -115.35 121.17 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.663 1.185 . . . . 0.0 108.622 170.711 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.2 tpp -86.94 135.28 33.35 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.602 1.561 . . . . 0.0 109.933 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -138.85 129.82 26.57 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.564 1.546 . . . . 0.0 109.375 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mp -111.61 134.03 53.46 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.293 1.837 . . . . 0.0 108.247 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -137.12 167.68 21.07 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.949 1.299 . . . . 0.0 110.436 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -68.86 -6.85 29.59 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.449 -0.782 . . . . 0.0 112.68 173.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.9 m -95.74 -46.13 6.72 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.989 0.916 . . . . 0.0 112.832 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -176.02 174.33 2.11 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.704 1.201 . . . . 0.0 113.544 -168.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.8 mt -86.55 140.34 29.98 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.167 1.387 . . . . 0.0 110.035 168.541 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.57 136.57 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.532 1.133 . . . . 0.0 111.323 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.3 mt -108.94 133.28 53.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.371 1.869 . . . . 0.0 110.648 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -114.01 121.15 43.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.993 2.117 . . . . 0.0 110.377 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.477 0.877 0 C-N-CA 125.605 1.562 . . . . 0.0 111.323 -176.025 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.757 0.313 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 t -128.99 137.0 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.603 0.761 . . . . 0.0 109.941 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 mtp85 -132.36 143.64 49.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.439 1.096 . . . . 0.0 112.388 -167.891 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -138.9 109.42 7.75 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.691 1.196 . . . . 0.0 111.622 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.5 150.99 83.94 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.914 2.409 . . . . 0.0 112.15 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -65.68 -7.27 14.52 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.58 -35.02 30.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.778 1.631 . . . . 0.0 113.583 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 16.5 p -88.11 -23.91 23.55 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.707 1.139 . . . . 0.0 113.709 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.11 107.25 0.84 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.619 1.568 . . . . 0.0 110.366 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -78.16 -38.33 43.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.35 1.46 . . . . 0.0 112.021 -174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -163.94 156.52 17.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.836 2.055 . . . . 0.0 110.442 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.64 132.05 16.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.387 1.075 . . . . 0.0 109.877 -175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.26 170.75 28.8 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-O 121.996 0.775 . . . . 0.0 114.373 -169.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.92 156.36 49.12 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.606 1.163 . . . . 0.0 112.136 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.05 -176.21 5.67 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.075 1.75 . . . . 0.0 110.107 175.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 t -63.13 114.86 3.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.107 0.956 . . . . 0.0 111.577 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 t30 57.02 18.66 4.11 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.035 2.134 . . . . 0.0 114.495 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.35 126.32 25.97 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.213 -1.554 . . . . 0.0 111.251 -169.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -119.88 138.06 53.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.536 1.535 . . . . 0.0 109.592 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.8 t -153.33 155.01 35.67 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.232 -0.917 . . . . 0.0 112.636 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -146.64 152.29 38.64 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.049 1.34 . . . . 0.0 111.759 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -110.51 143.05 41.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.713 1.605 . . . . 0.0 109.695 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -144.43 154.79 43.32 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.024 0.93 . . . . 0.0 111.983 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.22 176.62 37.38 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.403 1.478 . . . . 0.0 113.855 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -64.96 -8.91 17.72 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -76.81 -17.01 59.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.769 2.028 . . . . 0.0 115.424 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.0 p -85.66 -177.38 6.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.501 1.12 . . . . 0.0 113.961 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -61.53 -42.07 98.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.178 1.391 . . . . 0.0 112.879 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.4 p -93.01 -20.36 20.65 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.302 1.441 . . . . 0.0 114.123 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.45 -174.19 43.04 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.39 1.471 . . . . 0.0 112.7 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -67.63 134.41 51.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.655 0.782 . . . . 0.0 112.617 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.56 -176.37 35.49 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.503 1.049 . . . . 0.0 113.287 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.8 mt -121.26 137.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.799 1.64 . . . . 0.0 109.342 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -127.08 118.53 24.58 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.239 1.416 . . . . 0.0 109.32 -171.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.77 140.05 53.37 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.43 1.092 . . . . 0.0 113.196 -169.608 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -139.37 127.92 23.05 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.005 -169.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -67.7 129.02 38.62 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 168.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 35.3 t -165.31 126.63 1.99 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 111.103 -171.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.9 t -75.1 -10.22 59.27 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -107.39 18.6 21.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.311 1.845 . . . . 0.0 112.842 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.89 -40.27 79.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -169.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -71.0 -36.99 72.68 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.01 0.924 . . . . 0.0 112.274 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -64.64 -40.74 95.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.246 1.019 . . . . 0.0 110.707 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.0 -46.54 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.353 0.661 . . . . 0.0 110.63 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -39.36 83.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.503 1.121 . . . . 0.0 112.221 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -74.27 -30.88 62.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.256 1.022 . . . . 0.0 113.48 175.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -80.36 -34.96 36.07 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.354 0.979 . . . . 0.0 111.091 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.4 mt -52.44 -56.51 14.58 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.151 0.981 . . . . 0.0 112.897 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -55.65 -34.2 64.76 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.91 -17.03 56.21 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.285 1.434 . . . . 0.0 112.769 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.5 mt -95.24 -37.23 11.11 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.396 1.078 . . . . 0.0 110.917 169.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 57.8 mtp . . . . . 0 N--CA 1.471 0.577 0 C-N-CA 123.874 0.87 . . . . 0.0 112.663 178.445 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.444 ' N ' HD22 ' A' ' 25' ' ' ASN . 29.1 t80 . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 120.643 0.259 . . . . 0.0 110.972 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.03 97.4 5.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.911 1.684 . . . . 0.0 109.801 -173.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 57.7 mt -72.72 156.34 39.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.831 0.852 . . . . 0.0 111.872 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -98.56 -12.06 21.57 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.619 1.568 . . . . 0.0 113.0 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -144.8 149.64 35.8 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.509 1.924 . . . . 0.0 111.073 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -85.79 121.16 73.22 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.498 -0.751 . . . . 0.0 110.981 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.22 -19.88 4.42 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.291 2.661 . . . . 0.0 114.65 -169.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 87.3 m -89.54 124.64 34.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.163 0.892 . . . . 0.0 112.358 -172.131 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.68 -14.43 81.12 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.103 0.859 . . . . 0.0 114.42 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -115.31 129.39 56.6 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.371 1.468 . . . . 0.0 109.325 170.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 p -158.03 151.36 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.285 1.434 . . . . 0.0 110.921 -169.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -155.76 179.63 9.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.959 1.704 . . . . 0.0 112.442 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 126.185 1.794 . . . . 0.0 109.669 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 . . . . . 0 CA--C 1.558 1.261 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.9 -11.56 25.7 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.109 2.539 . . . . 0.0 115.359 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.5 p -131.35 -21.96 2.53 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 120.355 1.434 . . . . 0.0 114.553 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -102.34 140.9 36.01 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.306 1.042 . . . . 0.0 110.363 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.44 111.72 9.11 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.757 1.223 . . . . 0.0 108.35 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -67.94 133.22 48.73 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.647 -0.658 . . . . 0.0 110.293 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.54 164.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.324 1.449 . . . . 0.0 111.59 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.3 m -139.96 120.78 14.44 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.376 1.07 . . . . 0.0 109.117 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -64.58 131.9 48.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.453 0.701 . . . . 0.0 110.023 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.16 157.52 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.429 1.092 . . . . 0.0 112.389 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -85.76 -167.05 1.71 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.451 1.1 . . . . 0.0 113.28 176.774 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.38 -26.58 63.78 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.495 1.118 . . . . 0.0 113.639 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -80.42 -18.12 49.78 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.566 1.146 . . . . 0.0 112.567 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.36 17.94 59.76 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.115 -1.38 . . . . 0.0 114.167 -173.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' OD1' ' A' ' 27' ' ' ASP . 17.5 m -77.22 150.65 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.841 1.82 . . . . 0.0 111.269 171.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.65 126.73 35.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.839 1.256 . . . . 0.0 110.923 -172.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.5 mt -109.69 -51.21 2.9 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.115 0.966 . . . . 0.0 111.814 -170.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.14 136.38 5.2 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 124.593 1.092 . . . . 0.0 114.08 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 p -84.1 146.29 27.98 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.07 1.348 . . . . 0.0 112.652 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.93 170.06 32.53 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.369 1.462 . . . . 0.0 113.721 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.36 120.22 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.231 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.6 ttm -87.6 136.38 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.922 0.889 . . . . 0.0 109.636 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -130.94 129.66 42.46 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.392 1.477 . . . . 0.0 108.67 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.77 116.24 31.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.978 1.711 . . . . 0.0 106.967 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.5 p -114.95 168.0 10.29 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.61 1.164 . . . . 0.0 110.046 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -72.1 -2.4 18.37 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.528 -0.732 . . . . 0.0 112.659 170.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.5 m -96.77 -48.7 5.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.447 1.099 . . . . 0.0 112.51 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -176.31 175.91 1.75 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.016 1.726 . . . . 0.0 112.813 -170.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 mt -84.73 137.87 32.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.302 1.041 . . . . 0.0 110.214 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.01 134.38 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.027 0.931 . . . . 0.0 111.502 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.7 mt -104.08 133.72 48.55 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.894 1.677 . . . . 0.0 109.769 168.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -112.61 129.88 56.22 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.944 2.098 . . . . 0.0 110.899 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 125.748 1.619 . . . . 0.0 111.086 -178.408 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 CA-C-O 120.762 0.315 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.04 130.19 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.815 0.846 . . . . 0.0 110.141 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 mtp85 -126.99 144.39 51.03 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.725 1.21 . . . . 0.0 112.416 -168.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -139.63 116.89 8.45 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.781 1.232 . . . . 0.0 111.581 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -64.13 143.2 83.48 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.714 2.276 . . . . 0.0 110.068 172.916 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -55.81 -31.66 62.87 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.45 -44.15 76.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.702 2.001 . . . . 0.0 112.752 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.2 p -75.41 -7.93 55.35 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.8 mt -83.17 108.78 16.66 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.152 0.981 . . . . 0.0 110.514 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -74.81 -37.94 62.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.842 0.857 . . . . 0.0 112.125 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -157.84 163.31 38.11 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.587 1.555 . . . . 0.0 110.961 170.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -151.9 141.05 21.3 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.613 1.565 . . . . 0.0 109.074 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.0 177.81 34.56 Favored Glycine 0 N--CA 1.463 0.447 0 CA-C-O 121.484 0.491 . . . . 0.0 113.794 -171.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -143.61 166.11 25.73 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.202 1.001 . . . . 0.0 113.44 -170.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -151.39 -170.52 3.68 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.681 1.992 . . . . 0.0 109.787 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 t -72.94 -13.05 61.17 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.596 -1.315 . . . . 0.0 114.234 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -157.39 5.85 0.14 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.631 1.572 . . . . 0.0 114.25 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.86 132.87 37.16 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.818 1.647 . . . . 0.0 110.451 -168.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -124.48 142.11 51.57 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.428 1.891 . . . . 0.0 109.773 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 t -157.08 161.15 39.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.648 1.179 . . . . 0.0 112.508 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.34 149.34 29.96 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.496 1.518 . . . . 0.0 112.013 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -93.86 139.47 30.85 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.92 1.288 . . . . 0.0 109.456 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.1 p -142.33 148.73 38.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.96 172.54 35.43 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.098 1.332 . . . . 0.0 113.986 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -13.75 54.37 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -174.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -72.81 -16.98 61.61 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.016 1.727 . . . . 0.0 115.653 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 p -83.73 -178.79 7.13 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.373 1.069 . . . . 0.0 113.723 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.2 -41.37 92.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.106 1.362 . . . . 0.0 113.049 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.5 p -91.04 -21.15 21.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.101 1.36 . . . . 0.0 113.876 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.24 -177.72 49.09 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.139 1.352 . . . . 0.0 112.271 -170.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -64.73 137.25 57.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.152 0.981 . . . . 0.0 112.789 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.06 -178.96 35.91 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.263 0.935 . . . . 0.0 113.483 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.3 mt -118.3 133.71 64.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.616 1.566 . . . . 0.0 108.81 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -127.92 124.57 37.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.98 1.312 . . . . 0.0 109.458 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.03 143.92 48.8 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.088 0.955 . . . . 0.0 112.886 -172.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -138.87 128.58 24.81 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.52 1.128 . . . . 0.0 111.36 -169.577 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -69.85 136.1 50.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.966 0.506 . . . . 0.0 110.667 169.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 23.8 t -163.42 138.95 6.59 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.243 1.417 . . . . 0.0 110.971 -174.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t -74.4 -11.32 60.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -137.3 34.48 2.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.979 1.712 . . . . 0.0 113.776 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.89 -37.86 33.22 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.964 1.306 . . . . 0.0 113.659 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.94 -37.48 81.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.222 1.009 . . . . 0.0 113.141 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.81 -37.78 82.43 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.319 -0.863 . . . . 0.0 110.931 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 77.4 mt -62.43 -46.4 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.156 0.582 . . . . 0.0 110.097 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -38.26 84.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.296 1.038 . . . . 0.0 112.481 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -72.11 -28.38 63.25 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.25 1.02 . . . . 0.0 113.469 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -85.63 -41.95 14.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.078 0.854 . . . . 0.0 110.713 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.2 mt -50.81 -54.48 23.33 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.299 1.04 . . . . 0.0 112.603 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -59.47 -22.46 61.59 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.08 -21.57 36.75 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.725 1.21 . . . . 0.0 112.867 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.1 mt -95.81 -35.34 11.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.097 1.359 . . . . 0.0 112.039 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 66.2 mmm . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 125.49 1.516 . . . . 0.0 112.249 170.945 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 29.0 t80 . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 3' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' B' ' 3' ' ' ARG . 0.0 OUTLIER -85.78 122.98 30.62 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.022 0.929 . . . . 0.0 111.246 177.567 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 52.2 mt -90.29 153.13 20.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.6 0.76 . . . . 0.0 112.752 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -88.27 -17.49 30.61 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.613 1.565 . . . . 0.0 113.469 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -156.16 168.64 26.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.269 1.828 . . . . 0.0 111.459 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.89 119.29 70.46 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.706 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.29 -23.69 3.4 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.125 2.55 . . . . 0.0 114.369 -169.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 81.8 m -78.68 126.96 31.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.13 0.877 . . . . 0.0 111.551 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.78 -22.63 63.67 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 124.031 0.824 . . . . 0.0 114.428 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -118.93 126.49 51.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.021 1.328 . . . . 0.0 109.645 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.23 164.42 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.743 1.617 . . . . 0.0 110.835 -172.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -134.25 134.43 41.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.037 1.335 . . . . 0.0 109.69 174.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 124.587 1.155 . . . . 0.0 110.941 -177.088 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 CA--C 1.556 1.188 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.61 -16.75 51.64 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.184 2.589 . . . . 0.0 115.302 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.0 p -125.26 -15.7 6.16 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.916 1.234 . . . . 0.0 114.316 176.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -103.47 125.1 49.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.223 0.92 . . . . 0.0 112.119 172.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.29 106.71 10.94 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.12 1.768 . . . . 0.0 109.092 -176.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -69.2 132.49 46.6 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.618 -0.676 . . . . 0.0 109.982 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 m -140.8 158.95 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.722 1.209 . . . . 0.0 112.245 -169.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -134.18 118.37 17.58 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.679 1.192 . . . . 0.0 108.214 174.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.415 HD22 ' N ' ' B' ' 2' ' ' PHE . 47.3 t30 -66.92 131.37 45.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.279 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 m -125.53 154.49 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.663 0.785 . . . . 0.0 112.557 -177.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -81.95 -169.6 2.45 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.747 1.219 . . . . 0.0 113.884 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -64.6 -29.13 70.14 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.658 1.583 . . . . 0.0 115.001 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.09 -24.22 20.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.137 0.575 . . . . 0.0 112.026 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.49 14.98 6.63 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 126.109 1.814 . . . . 0.0 112.459 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.57 140.48 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 126.681 1.992 . . . . 0.0 109.43 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.24 125.93 31.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.878 1.671 . . . . 0.0 110.652 -171.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.2 mt -109.88 -53.22 2.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.973 0.909 . . . . 0.0 112.141 -171.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.2 140.33 7.93 Favored Glycine 0 N--CA 1.469 0.848 0 C-N-CA 124.814 1.197 . . . . 0.0 113.574 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 p -92.18 143.64 26.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.194 1.398 . . . . 0.0 112.344 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.1 171.73 34.53 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.312 1.434 . . . . 0.0 113.028 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -118.62 119.47 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.198 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.9 tpp -83.16 133.62 35.02 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.144 0.977 . . . . 0.0 109.444 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -126.99 130.54 50.24 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.217 1.407 . . . . 0.0 108.877 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.69 119.17 38.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.329 1.852 . . . . 0.0 107.72 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -122.61 173.68 7.55 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.974 1.309 . . . . 0.0 110.307 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -74.69 2.54 9.71 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.386 -0.821 . . . . 0.0 113.209 172.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.8 p -107.39 -45.93 3.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.897 -1.127 . . . . 0.0 113.473 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -172.78 173.49 3.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.776 1.231 . . . . 0.0 113.09 -174.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -83.67 136.77 34.07 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.511 -0.743 . . . . 0.0 109.523 168.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.9 t -134.74 130.4 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.216 1.006 . . . . 0.0 111.632 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.7 mt -100.19 126.7 46.49 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.442 1.497 . . . . 0.0 110.19 168.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -102.74 133.83 47.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.283 2.233 . . . . 0.0 110.979 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 125.196 1.398 . . . . 0.0 111.322 -177.183 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.054 0.454 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.62 135.52 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.217 1.007 . . . . 0.0 110.226 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -134.24 152.08 51.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.833 0.853 . . . . 0.0 113.222 -173.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -142.1 119.81 7.43 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.293 1.437 . . . . 0.0 111.794 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.22 145.93 68.01 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.957 2.438 . . . . 0.0 110.463 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -60.11 -22.88 63.33 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.8 tp -63.4 -41.61 98.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.659 1.984 . . . . 0.0 113.11 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.4 p -73.32 -14.23 61.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.65 84.57 7.63 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.9 1.28 . . . . 0.0 110.715 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.4 tpp85 -63.22 -30.77 71.85 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.986 0.914 . . . . 0.0 112.503 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.408 ' CG ' HG21 ' B' ' 12' ' ' VAL . 38.7 ttp-105 -156.0 128.51 7.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.499 1.52 . . . . 0.0 109.834 -170.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -138.92 104.84 5.16 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.535 1.534 . . . . 0.0 111.008 -175.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.18 167.14 12.24 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.088 1.328 . . . . 0.0 113.984 -168.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -144.92 159.0 43.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.248 1.019 . . . . 0.0 112.593 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -151.36 177.52 10.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.1 2.16 . . . . 0.0 109.588 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 m -60.91 -12.22 10.46 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -154.58 11.52 0.38 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.549 1.54 . . . . 0.0 114.248 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.52 131.99 26.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.415 1.486 . . . . 0.0 110.491 -168.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -122.98 133.64 54.36 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.985 1.714 . . . . 0.0 109.016 171.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.3 t -152.6 152.93 32.4 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.131 -0.981 . . . . 0.0 112.052 -174.232 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -149.71 151.35 33.52 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.351 1.06 . . . . 0.0 111.839 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -104.84 126.59 52.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.606 1.162 . . . . 0.0 109.106 171.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.4 p -124.44 122.58 38.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.449 1.1 . . . . 0.0 111.294 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.25 162.39 40.22 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.816 1.198 . . . . 0.0 114.856 -171.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -57.74 -16.98 12.81 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -23.04 61.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.526 1.53 . . . . 0.0 114.925 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.3 p -73.24 173.43 9.49 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -171.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -54.56 -39.77 68.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.76 1.624 . . . . 0.0 113.341 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -91.06 -20.91 21.55 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.469 1.508 . . . . 0.0 113.874 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.26 175.1 48.9 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.156 1.36 . . . . 0.0 112.169 -170.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -66.31 130.56 43.63 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.848 1.259 . . . . 0.0 111.86 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.54 -179.35 41.55 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.776 1.179 . . . . 0.0 113.13 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.6 mt -116.46 131.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.708 1.603 . . . . 0.0 108.616 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -125.56 121.13 32.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.742 1.217 . . . . 0.0 110.238 -174.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.2 136.36 53.11 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.856 1.263 . . . . 0.0 112.943 -171.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -137.07 129.2 29.47 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.077 0.951 . . . . 0.0 111.717 -170.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -75.63 135.22 40.48 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.639 1.176 . . . . 0.0 111.988 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.6 p -171.0 151.28 3.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.505 1.922 . . . . 0.0 112.146 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.3 m -73.58 -37.31 65.52 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.156 -0.965 . . . . 0.0 112.111 171.922 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -85.96 20.48 2.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.099 1.36 . . . . 0.0 114.216 -171.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.07 -42.48 50.0 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.159 1.384 . . . . 0.0 114.145 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -69.57 -36.71 76.53 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.795 0.838 . . . . 0.0 112.716 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -68.39 -34.11 75.45 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.464 -0.772 . . . . 0.0 111.743 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.33 -47.65 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 118.678 0.672 . . . . 0.0 109.871 169.497 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.68 -43.33 94.07 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.658 1.183 . . . . 0.0 112.109 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -67.01 -34.67 78.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.792 1.237 . . . . 0.0 112.841 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -78.7 -41.12 31.91 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.789 0.722 . . . . 0.0 110.367 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.01 -51.46 61.59 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.26 1.024 . . . . 0.0 112.911 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -62.19 -24.12 67.02 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.3 -28.18 56.87 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.662 0.785 . . . . 0.0 112.544 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.25 -35.0 23.71 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.258 1.023 . . . . 0.0 111.199 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.6 mmt . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 123.993 0.917 . . . . 0.0 112.348 169.507 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 2' ' ' PHE . . . . . 0.415 ' N ' HD22 ' A' ' 25' ' ' ASN . 21.4 t80 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -91.58 112.5 24.45 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.122 0.969 . . . . 0.0 109.495 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 78.2 mt -78.76 155.26 29.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.531 0.681 . . . . 0.0 112.283 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -91.72 -26.78 18.45 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.079 1.352 . . . . 0.0 113.077 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -140.68 158.61 43.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.418 1.887 . . . . 0.0 111.663 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -84.3 128.45 62.01 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.434 0.694 . . . . 0.0 112.008 -172.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -86.1 -10.97 6.64 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.431 2.754 . . . . 0.0 114.475 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 90.0 m -102.27 126.31 49.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.306 1.043 . . . . 0.0 111.511 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.49 -31.19 34.27 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.11 0.862 . . . . 0.0 114.2 -176.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -108.35 131.32 54.87 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.842 1.257 . . . . 0.0 110.494 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.408 HG21 ' CG ' ' A' ' 64' ' ' ARG . 7.2 p -165.18 140.61 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.638 1.175 . . . . 0.0 111.885 -173.124 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -102.49 147.65 26.49 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.571 2.348 . . . . 0.0 111.716 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 125.01 1.324 . . . . 0.0 109.125 175.541 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.07 -8.74 22.72 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.114 2.542 . . . . 0.0 114.933 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.0 p -129.89 -17.36 3.56 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 174.896 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 131.84 56.59 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.468 1.107 . . . . 0.0 111.796 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -127.46 113.13 15.77 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.907 1.283 . . . . 0.0 108.748 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -69.84 131.77 44.99 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.507 -0.746 . . . . 0.0 110.326 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.09 165.41 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.814 1.645 . . . . 0.0 111.795 -169.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.3 m -134.27 122.78 23.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.507 1.123 . . . . 0.0 109.087 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -64.4 127.83 33.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.291 1.037 . . . . 0.0 109.797 174.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.64 155.97 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.494 0.718 . . . . 0.0 112.707 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.1 p-10 -88.12 -167.85 2.02 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.608 1.163 . . . . 0.0 113.6 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.91 -30.3 71.43 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.944 1.298 . . . . 0.0 114.335 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -84.09 -10.38 57.86 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.944 0.793 . . . . 0.0 113.072 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.85 16.47 75.02 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.365 -1.242 . . . . 0.0 113.953 -172.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' OD1' ' A' ' 27' ' ' ASP . 16.4 m -78.25 149.89 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.599 1.699 . . . . 0.0 111.202 173.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -89.52 122.56 32.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.922 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.3 mt -103.41 -51.7 3.16 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.602 0.761 . . . . 0.0 111.68 -174.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.93 144.76 12.16 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 124.874 1.226 . . . . 0.0 114.277 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.3 p -89.8 150.36 22.29 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.08 1.352 . . . . 0.0 112.55 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.4 171.06 37.32 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 124.147 0.88 . . . . 0.0 115.094 -174.383 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -114.79 120.54 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 58.0 tpp -86.59 133.1 33.74 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.929 0.891 . . . . 0.0 109.118 170.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -130.14 130.17 44.43 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.034 1.334 . . . . 0.0 109.008 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.75 115.04 29.42 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.312 1.845 . . . . 0.0 107.004 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 p -110.57 174.55 5.81 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.237 1.015 . . . . 0.0 109.869 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -75.88 13.76 0.79 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 121.244 -0.91 . . . . 0.0 112.186 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.4 t -125.74 -41.51 1.98 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.557 1.543 . . . . 0.0 112.626 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -170.43 171.06 6.72 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.144 -0.972 . . . . 0.0 113.442 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.3 mt -87.36 133.88 33.65 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 165.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 t -133.36 134.2 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.797 0.839 . . . . 0.0 111.177 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.2 mt -101.03 129.36 46.86 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 124.461 1.104 . . . . 0.0 109.836 168.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -109.98 118.74 37.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.429 1.892 . . . . 0.0 109.734 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 N--CA 1.471 0.602 0 C-N-CA 124.824 1.249 . . . . 0.0 110.329 -175.089 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.427 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 t -134.94 131.63 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.154 0.582 . . . . 0.0 110.961 -168.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -121.71 142.07 50.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.478 1.511 . . . . 0.0 112.118 -169.132 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -138.16 112.14 8.69 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.912 1.285 . . . . 0.0 110.703 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.19 146.69 82.23 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.489 2.126 . . . . 0.0 110.475 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -57.79 -28.13 63.73 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 mt -65.35 -25.23 67.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.762 1.625 . . . . 0.0 114.131 173.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.4 p -93.25 -8.17 43.0 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -79.48 115.2 18.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.885 0.874 . . . . 0.0 109.958 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -76.26 -37.91 56.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.361 0.665 . . . . 0.0 111.698 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -161.19 163.24 31.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.663 1.585 . . . . 0.0 111.947 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -150.44 138.03 19.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.368 1.867 . . . . 0.0 109.012 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -145.17 -178.94 21.13 Favored Glycine 0 N--CA 1.461 0.353 0 C-N-CA 123.859 0.742 . . . . 0.0 113.052 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -152.11 166.23 32.29 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.031 0.932 . . . . 0.0 112.916 -174.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -157.19 -178.41 7.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.309 2.244 . . . . 0.0 109.319 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.2 p -63.6 -21.65 66.47 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -152.68 10.65 0.49 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -133.65 127.7 33.52 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.747 -1.221 . . . . 0.0 110.463 -172.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -118.85 135.7 54.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.902 1.681 . . . . 0.0 109.678 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -153.75 156.67 38.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.656 1.182 . . . . 0.0 112.676 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -149.08 151.96 35.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.031 1.733 . . . . 0.0 111.518 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -111.68 132.84 54.33 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.024 1.33 . . . . 0.0 111.139 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m -132.89 147.85 52.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.765 1.226 . . . . 0.0 112.368 -172.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.65 174.51 41.31 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.787 1.184 . . . . 0.0 114.387 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -11.97 18.16 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -87.93 -15.45 36.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -174.048 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.7 p -80.08 179.21 7.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.949 0.899 . . . . 0.0 112.901 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -57.71 -37.88 74.26 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.843 1.257 . . . . 0.0 113.336 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.9 p -95.13 -20.88 18.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.426 1.49 . . . . 0.0 114.082 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.89 -167.46 42.12 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.371 1.462 . . . . 0.0 112.586 -173.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -67.08 132.28 47.53 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.62 0.768 . . . . 0.0 112.118 -173.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.05 -175.58 35.24 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 122.506 1.059 . . . . 0.0 113.454 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.8 mt -124.22 139.19 51.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 126.009 1.724 . . . . 0.0 108.432 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.11 127.72 36.62 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.842 1.257 . . . . 0.0 109.859 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.04 145.59 50.94 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.322 1.049 . . . . 0.0 113.594 -169.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -139.88 128.03 22.41 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.337 -168.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -66.38 127.68 33.22 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 43.8 t -164.92 114.85 1.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.189 1.396 . . . . 0.0 111.377 -167.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 m -71.19 -2.15 14.96 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -133.34 22.12 4.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.443 2.297 . . . . 0.0 112.427 -170.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.63 -36.07 33.52 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.388 1.475 . . . . 0.0 113.841 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -67.86 -37.87 82.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.639 0.775 . . . . 0.0 112.762 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.47 -33.68 73.24 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.434 -0.791 . . . . 0.0 111.665 175.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.79 -47.53 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.782 -0.574 . . . . 0.0 110.163 169.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.29 -42.9 87.64 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.025 1.33 . . . . 0.0 111.808 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -66.31 -33.22 75.24 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.738 1.215 . . . . 0.0 113.044 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.41 -42.52 20.28 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.082 0.855 . . . . 0.0 110.282 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.7 mt -49.69 -54.49 18.42 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.152 0.981 . . . . 0.0 112.273 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -59.48 -28.76 67.31 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -19.44 61.21 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.918 1.287 . . . . 0.0 113.045 175.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.1 mt -95.36 -35.83 11.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.434 1.493 . . . . 0.0 111.025 173.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 47.9 mmm . . . . . 0 N--CA 1.469 0.499 0 C-N-CA 124.617 1.167 . . . . 0.0 111.962 177.102 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 33.5 t80 . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 120.332 0.111 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.72 124.76 28.16 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.579 1.151 . . . . 0.0 111.269 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 64.6 mt -94.47 154.13 17.58 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.007 0.923 . . . . 0.0 112.662 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -84.07 -21.2 31.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.447 1.499 . . . . 0.0 113.367 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -153.66 166.03 34.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.088 1.755 . . . . 0.0 111.751 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -87.9 118.53 69.79 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.223 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.0 -16.24 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.541 2.827 . . . . 0.0 114.076 -170.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 82.2 m -89.43 123.63 33.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.866 0.867 . . . . 0.0 110.749 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.06 -35.19 35.29 Favored Glycine 0 N--CA 1.473 1.128 0 C-N-CA 123.836 0.732 . . . . 0.0 113.043 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -97.05 120.31 37.17 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.55 1.14 . . . . 0.0 109.72 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.06 160.97 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.792 1.637 . . . . 0.0 110.447 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -122.14 124.89 44.94 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.537 1.135 . . . . 0.0 109.103 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 123.965 0.906 . . . . 0.0 110.709 179.683 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 . . . . . 0 CA--C 1.56 1.349 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.0 -20.19 29.29 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.062 2.508 . . . . 0.0 115.668 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.3 p -126.14 -22.18 4.14 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.296 1.407 . . . . 0.0 114.303 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -97.11 144.74 26.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.231 1.012 . . . . 0.0 110.279 169.277 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -140.1 119.0 12.53 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.286 1.435 . . . . 0.0 108.207 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.44 135.24 45.71 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.382 -0.823 . . . . 0.0 109.932 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.83 169.34 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.966 1.306 . . . . 0.0 111.287 -171.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 35' ' ' SER . 20.9 m -142.67 122.39 13.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.67 1.188 . . . . 0.0 107.849 172.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -68.9 134.14 49.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.364 0.666 . . . . 0.0 110.462 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.71 155.87 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.521 1.128 . . . . 0.0 113.816 -173.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' CG ' HG22 ' A' ' 31' ' ' VAL . 2.9 p-10 -84.62 -170.17 2.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -63.41 -21.62 66.4 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.689 1.596 . . . . 0.0 115.112 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.34 -0.5 32.63 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.323 1.449 . . . . 0.0 112.403 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.94 14.57 77.09 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.0 -1.444 . . . . 0.0 114.389 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.444 HG22 ' CG ' ' A' ' 27' ' ' ASP . 3.3 m -73.58 144.87 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.901 1.85 . . . . 0.0 110.674 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -87.27 120.87 29.0 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.796 1.238 . . . . 0.0 110.143 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.9 mt -105.75 -52.68 2.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.721 0.809 . . . . 0.0 112.048 -169.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.14 137.16 5.78 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.185 1.374 . . . . 0.0 111.958 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 46.7 t -83.69 149.43 26.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.941 0.876 . . . . 0.0 111.555 176.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.54 167.44 27.55 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 125.991 1.758 . . . . 0.0 113.378 -172.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.1 t -120.43 120.24 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.9 ttm -97.13 143.03 28.34 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.152 1.381 . . . . 0.0 109.388 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -145.4 126.53 14.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.835 1.254 . . . . 0.0 109.695 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.48 132.17 54.68 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.123 1.369 . . . . 0.0 108.688 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.7 p -135.31 171.09 14.94 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.937 1.295 . . . . 0.0 110.385 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -68.32 0.05 4.28 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 170.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t -103.2 -52.18 3.08 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.596 1.089 . . . . 0.0 112.399 178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.18 173.1 2.65 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.724 1.21 . . . . 0.0 112.844 -170.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.18 118.44 25.63 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.06 1.344 . . . . 0.0 110.38 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.8 t -109.77 140.03 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.864 1.266 . . . . 0.0 109.178 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -139.69 124.9 18.87 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.513 1.525 . . . . 0.0 109.84 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -115.48 137.26 52.24 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.561 1.944 . . . . 0.0 110.417 -172.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.475 0.786 0 C-N-CA 124.842 1.257 . . . . 0.0 112.617 -170.087 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 120.672 0.272 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.08 130.82 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.198 1.399 . . . . 0.0 109.881 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.98 141.28 52.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.637 1.175 . . . . 0.0 111.406 -171.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -134.91 112.81 11.48 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.702 1.201 . . . . 0.0 111.587 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.21 138.3 42.82 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.991 2.46 . . . . 0.0 110.755 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -60.21 -28.47 68.01 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -65.85 -35.27 80.2 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 0.0 112.453 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.0 m -92.22 3.27 55.69 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.57 120.52 24.63 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.964 0.905 . . . . 0.0 109.053 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -83.2 -23.31 32.89 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.505 ' HG3' HG21 ' B' ' 12' ' ' VAL . 30.0 ttp-105 -176.24 140.51 0.39 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.909 2.084 . . . . 0.0 109.478 -169.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -144.89 106.46 4.24 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.214 1.405 . . . . 0.0 111.54 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.14 165.16 12.01 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 126.231 1.872 . . . . 0.0 113.522 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -150.85 154.08 36.57 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.7 1.2 . . . . 0.0 113.218 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -144.97 -168.99 3.08 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.855 1.662 . . . . 0.0 110.064 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 t -68.75 -11.67 60.59 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -158.19 10.87 0.17 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.926 1.69 . . . . 0.0 114.225 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -140.61 133.24 28.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.614 1.566 . . . . 0.0 110.549 -168.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -126.29 138.43 53.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.93 1.692 . . . . 0.0 109.18 172.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -153.06 152.95 31.92 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.888 -1.133 . . . . 0.0 112.277 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -153.69 158.11 40.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.045 0.938 . . . . 0.0 112.545 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -115.07 135.2 54.46 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.723 1.609 . . . . 0.0 111.231 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 62.6 p -120.31 152.46 37.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.233 1.413 . . . . 0.0 112.905 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.44 164.44 31.87 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.984 1.278 . . . . 0.0 113.27 176.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -66.07 -9.26 29.18 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -171.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -84.83 -11.49 55.57 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.566 1.946 . . . . 0.0 115.231 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.3 m -68.01 173.5 4.52 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.841 1.256 . . . . 0.0 112.965 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -57.25 -40.74 78.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 112.285 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.3 p -90.03 -23.01 21.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.442 1.497 . . . . 0.0 113.161 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.29 -146.74 27.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.992 1.282 . . . . 0.0 111.612 -171.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -75.23 141.37 43.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.254 1.022 . . . . 0.0 112.206 -175.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.79 171.02 23.25 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.295 0.95 . . . . 0.0 113.245 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.33 133.33 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.391 1.476 . . . . 0.0 108.346 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -130.39 123.81 30.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.496 1.118 . . . . 0.0 110.606 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.03 139.96 49.75 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.638 1.175 . . . . 0.0 112.368 -175.391 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -136.84 124.11 21.86 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.787 1.235 . . . . 0.0 111.258 -172.406 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -70.0 133.87 47.7 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.245 0.618 . . . . 0.0 110.791 169.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 36.7 t -166.49 130.64 2.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.123 1.769 . . . . 0.0 110.517 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.5 t -66.97 -26.5 66.85 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.614 -0.678 . . . . 0.0 112.812 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -109.32 29.21 7.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.206 1.802 . . . . 0.0 113.226 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.16 -35.49 26.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.064 1.346 . . . . 0.0 114.185 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -70.24 -37.97 75.08 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.767 0.827 . . . . 0.0 113.024 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -65.94 -36.83 84.42 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.387 -0.821 . . . . 0.0 111.424 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.91 -48.94 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.915 0.486 . . . . 0.0 110.124 171.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -38.42 86.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.265 1.026 . . . . 0.0 112.93 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.36 -35.46 65.96 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.743 0.817 . . . . 0.0 112.427 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -76.18 -34.53 59.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.074 0.852 . . . . 0.0 112.008 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.7 mt -54.64 -59.61 4.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.156 0.889 . . . . 0.0 111.45 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -60.8 -24.49 65.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -29.4 64.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.977 0.911 . . . . 0.0 113.374 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.6 mt -96.32 -35.5 11.2 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.384 1.473 . . . . 0.0 111.434 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.5 mtp . . . . . 0 N--CA 1.469 0.5 0 C-N-CA 125.339 1.456 . . . . 0.0 112.594 179.074 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 31.2 t80 . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 110.954 -0.017 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -87.15 116.84 25.5 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.334 1.054 . . . . 0.0 111.169 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 32.9 mt -81.74 159.42 23.87 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.632 0.773 . . . . 0.0 112.711 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -100.66 -12.13 19.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.526 1.53 . . . . 0.0 113.614 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -163.11 167.14 22.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.087 2.155 . . . . 0.0 110.906 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -84.8 126.49 68.23 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.874 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.15 -2.37 11.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.836 3.024 . . . . 0.0 113.956 -174.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 22.2 t -115.0 135.51 54.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.052 1.341 . . . . 0.0 112.088 -171.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.55 -5.81 56.68 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.485 1.517 . . . . 0.0 115.656 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -137.07 111.73 8.73 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.043 1.422 . . . . 0.0 110.278 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 64' ' ' ARG . 7.5 p -147.75 138.18 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -168.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -99.3 117.24 33.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.875 2.07 . . . . 0.0 109.921 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 123.709 0.804 . . . . 0.0 110.466 174.465 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 CA--C 1.559 1.312 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.13 -21.58 23.6 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.723 2.282 . . . . 0.0 115.111 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.0 p -126.03 -20.83 4.46 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 120.691 1.587 . . . . 0.0 114.265 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -97.32 146.41 25.18 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.97 0.908 . . . . 0.0 109.145 168.037 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -141.6 113.5 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -67.85 134.4 50.83 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.565 -0.709 . . . . 0.0 110.12 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.28 164.44 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.82 1.248 . . . . 0.0 111.616 -171.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.4 m -139.97 123.08 16.8 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.502 1.121 . . . . 0.0 108.59 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -65.58 130.46 43.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.301 0.641 . . . . 0.0 109.722 175.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.32 156.46 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.327 1.051 . . . . 0.0 112.235 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.408 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.4 p-10 -85.15 -166.37 1.48 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.52 1.128 . . . . 0.0 113.126 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.11 -26.14 63.83 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.543 1.137 . . . . 0.0 113.695 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.51 -18.6 44.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.761 1.224 . . . . 0.0 112.591 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.06 17.39 59.43 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.021 1.296 . . . . 0.0 114.295 -173.163 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' A' ' 27' ' ' ASP . 16.7 m -76.77 150.25 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.68 1.74 . . . . 0.0 111.183 171.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -88.26 125.78 34.83 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.657 1.183 . . . . 0.0 110.849 -172.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -108.15 -49.57 3.18 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.184 0.994 . . . . 0.0 111.767 -171.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.57 137.21 5.56 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.919 1.247 . . . . 0.0 113.654 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.0 p -84.03 148.87 26.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.755 1.222 . . . . 0.0 112.356 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.06 170.82 34.95 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.794 1.188 . . . . 0.0 114.637 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.19 120.57 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.7 tpp -84.91 141.3 30.48 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.661 1.184 . . . . 0.0 109.576 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -140.26 130.31 24.85 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.071 1.348 . . . . 0.0 109.494 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.95 133.73 47.58 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.093 1.757 . . . . 0.0 108.133 175.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -133.89 173.87 11.08 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.091 1.357 . . . . 0.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -78.45 6.08 9.29 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.435 -0.791 . . . . 0.0 112.577 169.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.6 t -107.4 -49.31 3.28 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.537 1.135 . . . . 0.0 112.268 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -174.27 172.45 3.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.563 1.545 . . . . 0.0 112.484 -169.293 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.6 mt -85.04 139.79 31.5 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.17 0.988 . . . . 0.0 109.215 168.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.5 t -134.44 130.95 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.051 0.94 . . . . 0.0 111.217 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 mt -103.76 130.53 51.29 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.654 1.581 . . . . 0.0 110.026 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -111.42 124.09 51.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.868 2.067 . . . . 0.0 110.177 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 125.194 1.398 . . . . 0.0 111.838 -179.351 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.721 0 CA-C-O 120.549 0.214 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 t -138.0 143.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.615 1.166 . . . . 0.0 109.842 -170.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.83 153.4 52.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.725 0.81 . . . . 0.0 113.003 -169.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -142.85 115.31 6.07 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.922 1.289 . . . . 0.0 111.348 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.02 150.26 66.36 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.628 2.219 . . . . 0.0 110.468 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -61.59 -22.98 65.69 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -38.84 92.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.112 1.765 . . . . 0.0 112.605 171.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.2 m -90.2 -9.56 47.65 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -69.43 127.94 34.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.572 0.749 . . . . 0.0 109.393 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -96.86 -26.8 14.96 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.574 0.75 . . . . 0.0 112.83 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -164.09 158.68 19.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.797 1.639 . . . . 0.0 111.454 169.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -144.84 107.96 4.55 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.773 1.229 . . . . 0.0 110.502 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.28 174.74 16.01 Favored Glycine 0 N--CA 1.463 0.478 0 C-N-CA 124.092 0.853 . . . . 0.0 113.531 -169.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -144.49 155.93 43.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.118 0.967 . . . . 0.0 111.384 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.37 -178.76 6.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.34 1.456 . . . . 0.0 110.532 171.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 t -62.59 120.44 11.15 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.359 -0.838 . . . . 0.0 110.774 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.33 15.16 0.62 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.81 2.444 . . . . 0.0 116.561 -174.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.11 126.25 26.26 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.893 1.277 . . . . 0.0 111.627 -169.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -118.13 134.42 55.01 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.693 1.597 . . . . 0.0 110.063 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.5 t -153.46 154.91 35.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.532 1.133 . . . . 0.0 112.385 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -148.69 150.61 33.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.423 1.489 . . . . 0.0 111.298 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -112.78 130.32 56.12 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.997 1.319 . . . . 0.0 109.747 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m -130.87 136.02 48.25 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.501 1.12 . . . . 0.0 110.594 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.74 175.54 51.73 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 123.783 0.706 . . . . 0.0 113.225 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -16.0 7.2 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -74.01 -18.38 60.86 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.028 2.531 . . . . 0.0 115.883 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.5 p -80.21 178.84 7.99 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -61.1 -44.4 97.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.832 1.253 . . . . 0.0 113.019 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.3 p -90.39 -18.81 24.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.73 1.212 . . . . 0.0 114.093 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.07 179.79 36.97 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.609 1.576 . . . . 0.0 112.391 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -66.94 126.51 29.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.273 0.629 . . . . 0.0 111.941 -169.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.85 178.42 40.34 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 122.448 1.026 . . . . 0.0 114.264 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.3 mt -116.1 133.74 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.968 1.707 . . . . 0.0 108.542 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -126.31 123.51 38.22 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.136 1.374 . . . . 0.0 109.627 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.1 143.01 50.71 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.297 1.046 . . . . 0.0 113.317 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -140.82 129.8 23.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.555 -169.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -68.07 131.26 45.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.81 0.444 . . . . 0.0 109.946 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 45.9 t -160.38 131.35 5.62 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.217 1.407 . . . . 0.0 111.377 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.8 t -71.32 -21.98 61.99 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -122.04 30.3 6.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.236 1.814 . . . . 0.0 113.4 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.66 -42.59 56.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.16 -36.64 77.62 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.248 0.619 . . . . 0.0 112.537 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.6 -35.77 80.99 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.602 -0.686 . . . . 0.0 111.588 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.8 mt -63.64 -47.73 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.534 0.606 . . . . 0.0 110.163 170.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.3 -38.47 77.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.333 1.053 . . . . 0.0 112.332 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -74.31 -29.0 61.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.237 1.415 . . . . 0.0 113.529 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 tt -84.22 -40.03 18.59 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.298 0.954 . . . . 0.0 110.464 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.8 mt -53.01 -54.01 41.53 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.737 0.815 . . . . 0.0 112.286 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -60.09 -25.08 65.14 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -20.37 53.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.96 1.304 . . . . 0.0 113.05 175.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.9 mt -91.59 -38.93 12.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.128 1.371 . . . . 0.0 110.873 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 60.6 mmm . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 124.842 1.257 . . . . 0.0 112.421 -179.547 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 23.6 t80 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 110.767 -0.086 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 3' ' ' ARG . . . . . 0.436 ' H ' ' HD3' ' B' ' 3' ' ' ARG . 0.0 OUTLIER -100.26 127.35 46.57 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.189 1.396 . . . . 0.0 111.327 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 44.7 mt -93.58 153.62 18.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -80.48 -36.7 33.05 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.818 1.647 . . . . 0.0 112.598 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -138.99 160.98 38.47 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.492 1.917 . . . . 0.0 111.764 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -78.61 121.33 83.48 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.9 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -84.28 -15.0 6.74 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.227 2.618 . . . . 0.0 113.833 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 85.6 m -90.79 116.87 28.97 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.95 0.9 . . . . 0.0 110.882 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.73 -16.28 80.75 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.91 0.767 . . . . 0.0 114.022 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -120.96 133.6 55.28 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.836 1.654 . . . . 0.0 109.507 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -162.1 145.49 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.945 1.298 . . . . 0.0 111.475 -169.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -111.76 130.52 55.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.045 1.738 . . . . 0.0 109.393 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 CA--C 1.542 0.639 0 C-N-CA 124.513 1.125 . . . . 0.0 110.818 -178.84 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 . . . . . 0 CA--C 1.56 1.35 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.49 -14.98 47.64 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.073 2.515 . . . . 0.0 115.529 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.7 p -125.6 -19.13 5.04 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.043 1.292 . . . . 0.0 114.432 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.71 144.02 44.55 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.377 1.071 . . . . 0.0 112.682 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -139.8 120.88 14.69 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.097 1.359 . . . . 0.0 108.973 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -72.57 134.02 45.0 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.462 -0.774 . . . . 0.0 110.207 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.43 163.62 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.796 1.239 . . . . 0.0 111.572 -170.745 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.8 m -138.66 118.68 13.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.301 1.041 . . . . 0.0 109.576 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -64.68 131.22 46.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.484 0.714 . . . . 0.0 110.491 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.46 157.69 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 113.054 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' OD1' HG22 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -88.01 -168.95 2.38 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.97 -28.6 69.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.044 1.738 . . . . 0.0 114.037 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -87.24 -13.38 43.99 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.257 1.023 . . . . 0.0 113.143 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.61 15.94 67.16 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.137 -1.368 . . . . 0.0 114.255 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.415 HG22 ' OD1' ' A' ' 27' ' ' ASP . 16.8 m -76.89 150.41 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.947 1.874 . . . . 0.0 111.181 173.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -87.56 124.98 34.06 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.451 1.1 . . . . 0.0 111.303 -171.418 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 mt -108.3 -52.41 2.77 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.741 0.817 . . . . 0.0 112.038 -172.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.71 136.52 5.65 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 124.46 1.028 . . . . 0.0 114.339 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.0 p -85.71 139.38 31.4 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.038 1.335 . . . . 0.0 112.291 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.61 170.52 24.74 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.376 1.941 . . . . 0.0 112.986 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.4 t -116.71 120.25 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.7 ttm -92.54 118.6 31.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.057 1.343 . . . . 0.0 109.775 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -109.23 130.14 55.49 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.911 1.684 . . . . 0.0 108.969 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.9 122.02 45.59 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.77 1.628 . . . . 0.0 107.164 174.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.4 p -114.57 173.59 6.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.549 1.14 . . . . 0.0 109.762 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -70.17 -3.38 16.55 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.415 -0.803 . . . . 0.0 112.904 173.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -120.23 -35.24 3.49 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -167.29 163.79 15.3 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.086 -1.009 . . . . 0.0 113.331 -169.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -87.43 136.35 32.97 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.37 1.468 . . . . 0.0 109.524 168.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.69 126.34 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.758 0.823 . . . . 0.0 110.853 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.9 mt -100.89 130.05 46.84 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.883 1.273 . . . . 0.0 110.298 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -101.59 122.3 43.59 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.997 1.719 . . . . 0.0 111.31 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 CA--C 1.545 0.755 0 C-N-CA 127.69 2.396 . . . . 0.0 110.692 -176.269 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -108.46 126.68 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -169.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -127.66 141.44 51.61 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -166.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -140.95 116.25 7.35 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.839 1.256 . . . . 0.0 111.168 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.87 144.96 66.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.036 1.824 . . . . 0.0 108.878 169.095 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -58.1 -29.98 65.91 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.04 -41.32 78.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.073 1.749 . . . . 0.0 112.283 175.322 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.9 m -86.48 4.62 38.97 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.4 mt -85.4 118.34 24.88 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.416 1.007 . . . . 0.0 109.487 171.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -75.43 -34.86 61.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.026 0.53 . . . . 0.0 111.781 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -165.92 158.4 14.83 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.011 2.125 . . . . 0.0 111.206 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -145.67 107.84 4.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.222 1.409 . . . . 0.0 112.045 -174.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -117.27 161.72 13.08 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.879 1.704 . . . . 0.0 114.172 -169.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -148.01 152.8 38.07 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.129 1.372 . . . . 0.0 113.109 -170.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -145.95 -179.14 6.5 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.387 1.875 . . . . 0.0 109.815 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 m -61.45 -12.7 15.76 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -154.13 10.0 0.38 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.406 1.482 . . . . 0.0 114.67 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -139.94 133.92 30.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.704 1.601 . . . . 0.0 110.633 -168.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -126.84 137.33 53.17 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.81 1.644 . . . . 0.0 110.013 172.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.1 t -153.47 158.16 40.94 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.444 1.098 . . . . 0.0 112.871 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -158.03 156.1 30.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.088 1.355 . . . . 0.0 112.938 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.47 139.77 32.08 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.421 1.489 . . . . 0.0 110.166 170.472 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.7 p -122.33 151.32 41.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.589 1.156 . . . . 0.0 112.718 169.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.43 164.28 26.79 Favored Glycine 0 N--CA 1.477 1.4 0 C-N-CA 125.228 1.394 . . . . 0.0 114.044 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -20.51 65.03 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -170.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 -82.52 -15.32 52.81 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.2 p -82.05 179.4 7.83 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -59.52 -44.28 93.21 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.686 1.594 . . . . 0.0 112.872 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.0 p -82.8 -29.14 29.76 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.55 -155.1 33.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.446 1.498 . . . . 0.0 112.157 -172.295 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -63.2 137.67 58.29 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.826 0.85 . . . . 0.0 112.363 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.66 165.55 18.74 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.217 0.913 . . . . 0.0 113.117 169.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.35 128.63 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.882 1.273 . . . . 0.0 107.756 168.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -127.18 122.92 35.43 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.59 1.156 . . . . 0.0 109.374 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.22 140.84 48.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.313 1.045 . . . . 0.0 112.132 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -133.44 122.02 23.1 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.503 1.121 . . . . 0.0 110.953 -171.35 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -71.46 132.93 45.47 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.4 0.68 . . . . 0.0 110.974 170.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 25.0 p -169.3 140.72 2.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.006 1.723 . . . . 0.0 111.448 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.4 m -83.09 4.83 24.66 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -133.18 25.85 4.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.158 1.383 . . . . 0.0 113.748 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.19 -37.71 23.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.599 1.559 . . . . 0.0 114.122 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.71 -36.47 80.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.0 0.92 . . . . 0.0 112.984 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.68 -32.54 71.21 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.236 0.925 . . . . 0.0 111.863 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.59 -48.01 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 122.976 0.51 . . . . 0.0 109.658 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -37.78 83.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.401 1.081 . . . . 0.0 112.721 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -68.75 -33.43 73.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.486 1.114 . . . . 0.0 112.478 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.0 tp -84.63 -37.49 21.01 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.961 0.8 . . . . 0.0 112.168 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.76 -56.35 14.39 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.143 0.883 . . . . 0.0 112.211 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -59.75 -23.57 63.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -24.7 45.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.627 1.171 . . . . 0.0 113.042 176.17 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.4 mt -98.05 -34.5 10.76 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.806 1.642 . . . . 0.0 111.686 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 96.8 mtp . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 125.236 1.415 . . . . 0.0 113.034 176.468 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.8 t80 . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.33 121.53 25.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.157 0.583 . . . . 0.0 111.251 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 78.6 mt -86.46 155.19 20.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -84.71 -13.96 49.8 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.637 1.575 . . . . 0.0 113.506 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -163.35 169.21 19.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.527 2.331 . . . . 0.0 110.706 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -86.19 120.52 72.42 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.01 -9.23 17.97 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.488 2.792 . . . . 0.0 114.209 -172.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 44.7 t -92.03 -74.27 0.52 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.056 0.942 . . . . 0.0 113.13 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.02 -41.7 3.04 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.774 1.654 . . . . 0.0 114.066 -172.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -81.47 91.87 6.38 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.544 1.172 . . . . 0.0 109.997 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.41 139.88 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -100.06 141.77 32.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.138 2.175 . . . . 0.0 111.108 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 124.618 1.167 . . . . 0.0 111.273 -177.258 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.475 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -165.49 175.3 9.13 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.044 1.738 . . . . 0.0 110.671 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.6 p -164.14 168.45 18.99 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.205 1.402 . . . . 0.0 112.841 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.45 143.04 5.8 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.443 1.497 . . . . 0.0 112.783 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -154.28 157.3 38.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.239 1.816 . . . . 0.0 110.537 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 m -159.96 146.64 16.11 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.344 1.458 . . . . 0.0 111.32 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.77 36.63 2.48 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 125.303 1.43 . . . . 0.0 113.938 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.6 mt -103.1 136.59 42.61 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.592 1.557 . . . . 0.0 111.17 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -71.05 165.04 24.34 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.134 0.974 . . . . 0.0 111.905 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -128.23 118.15 22.8 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.811 1.245 . . . . 0.0 109.466 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.88 -20.21 53.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.012 1.325 . . . . 0.0 113.44 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.5 p -169.43 162.33 10.18 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.979 2.112 . . . . 0.0 110.045 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.627 HG13 ' HE2' ' A' ' 22' ' ' LYS . 10.7 p -96.81 127.8 37.99 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.911 0.885 . . . . 0.0 109.89 175.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.05 166.53 20.8 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.028 2.485 . . . . 0.0 111.701 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.79 -6.89 29.45 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.958 1.303 . . . . 0.0 113.582 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.0 p30 -131.1 18.6 4.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.596 1.558 . . . . 0.0 114.802 -170.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -58.13 145.48 73.3 Favored Pre-proline 0 CA--C 1.558 1.279 0 O-C-N 121.143 -0.973 . . . . 0.0 112.747 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.73 -11.91 28.33 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.08 2.52 . . . . 0.0 115.478 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 51.5 p -131.87 -16.42 2.92 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 120.155 1.343 . . . . 0.0 114.604 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.9 147.76 37.93 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.614 1.166 . . . . 0.0 111.505 172.715 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -140.8 118.57 11.71 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.994 0.918 . . . . 0.0 108.844 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.627 ' HE2' HG13 ' A' ' 13' ' ' VAL . 51.2 mttm -67.35 127.05 31.22 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.801 -0.562 . . . . 0.0 109.706 170.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.9 m -134.97 159.93 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.696 1.598 . . . . 0.0 110.669 -171.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 m -135.27 119.17 17.34 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.175 0.99 . . . . 0.0 109.039 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -65.8 132.52 48.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.323 0.649 . . . . 0.0 110.267 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 m -127.95 155.59 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.293 1.037 . . . . 0.0 112.665 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.3 p-10 -91.05 -168.89 2.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.847 1.259 . . . . 0.0 114.34 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.07 -21.4 66.15 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.228 1.811 . . . . 0.0 114.044 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -95.89 -10.23 29.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.948 1.299 . . . . 0.0 112.95 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.17 16.28 72.31 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 117.934 -1.481 . . . . 0.0 114.239 -172.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.405 HG22 ' OD1' ' A' ' 27' ' ' ASP . 13.4 m -77.65 149.7 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.12 1.96 . . . . 0.0 111.353 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -86.68 126.96 34.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.349 1.059 . . . . 0.0 111.497 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.6 mt -108.94 -51.11 2.92 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.002 0.921 . . . . 0.0 112.0 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.33 143.44 9.19 Favored Glycine 0 N--CA 1.47 0.928 0 C-N-CA 124.76 1.171 . . . . 0.0 113.854 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.5 p -90.07 150.87 21.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.115 1.366 . . . . 0.0 112.909 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.11 172.63 35.85 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.195 1.855 . . . . 0.0 113.039 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.31 120.85 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.1 tpp -86.29 131.9 34.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.846 0.859 . . . . 0.0 109.354 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -118.5 127.93 54.1 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.405 1.482 . . . . 0.0 109.118 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.5 127.96 55.41 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.618 1.967 . . . . 0.0 107.993 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -160.45 152.28 19.96 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.47 1.908 . . . . 0.0 108.024 -171.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -57.23 -18.06 14.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.86 1.264 . . . . 0.0 113.943 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 t -78.16 -51.94 9.47 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -178.37 174.73 1.25 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.855 1.662 . . . . 0.0 112.501 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt -86.81 139.2 30.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.772 0.829 . . . . 0.0 110.688 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.59 134.42 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.951 0.901 . . . . 0.0 111.696 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.14 131.49 46.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.357 1.463 . . . . 0.0 110.537 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -110.92 139.51 46.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.153 2.181 . . . . 0.0 110.681 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.31 -151.25 0.37 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.356 1.463 . . . . 0.0 110.848 -173.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' HIS . . . . . 0.53 ' CG ' ' H ' ' A' ' 51' ' ' ARG . 16.6 t60 -70.65 -159.97 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.592 1.557 . . . . 0.0 113.379 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.53 ' H ' ' CG ' ' A' ' 50' ' ' HIS . 22.9 mmm180 -58.64 -12.68 4.4 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.928 1.691 . . . . 0.0 114.471 174.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -57.49 159.45 4.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.49 1.916 . . . . 0.0 111.679 168.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.14 140.56 57.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.297 0.639 . . . . 0.0 112.071 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.39 159.37 32.43 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.028 0.931 . . . . 0.0 111.247 171.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 t -133.4 134.34 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.856 0.462 . . . . 0.0 111.566 -170.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -125.74 147.1 49.49 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.591 1.556 . . . . 0.0 112.836 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.2 m-90 -143.91 117.11 5.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.308 1.443 . . . . 0.0 111.429 174.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.86 148.62 58.38 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.73 2.287 . . . . 0.0 110.509 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -60.36 -27.51 67.44 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -56.59 -39.69 73.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.729 1.612 . . . . 0.0 112.076 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.84 -17.7 61.52 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 mt -84.63 81.41 8.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.544 1.066 . . . . 0.0 110.998 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.529 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -59.39 -30.98 68.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.831 0.852 . . . . 0.0 113.17 173.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -152.35 148.76 27.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.231 1.412 . . . . 0.0 111.594 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -146.45 112.12 5.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.62 1.568 . . . . 0.0 110.402 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.32 162.93 13.08 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 124.918 1.246 . . . . 0.0 114.566 -168.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -145.66 144.93 30.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.187 1.395 . . . . 0.0 111.879 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -144.05 -175.71 4.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.897 1.679 . . . . 0.0 109.906 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.1 m -56.53 112.48 1.28 Allowed 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.347 -0.846 . . . . 0.0 110.81 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.253 0.8 OUTLIER 49.33 23.59 0.87 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.666 2.387 . . . . 0.0 116.561 -173.133 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -132.22 129.41 39.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.488 1.515 . . . . 0.0 111.181 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -123.85 139.09 54.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.769 1.628 . . . . 0.0 109.997 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 t -153.57 155.56 36.37 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.962 -1.086 . . . . 0.0 113.41 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.22 148.23 29.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.982 1.313 . . . . 0.0 112.606 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.97 147.77 26.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.625 1.97 . . . . 0.0 108.403 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 m -155.0 134.85 12.86 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.625 -1.297 . . . . 0.0 112.153 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.57 170.44 54.54 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.247 0.927 . . . . 0.0 113.605 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -12.96 7.58 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -77.34 -16.51 58.88 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.4 p -86.42 176.69 7.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -55.75 -41.1 73.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.624 1.57 . . . . 0.0 113.528 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.9 p -91.79 -16.83 26.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.397 1.479 . . . . 0.0 113.94 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.15 -169.98 42.59 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.031 1.776 . . . . 0.0 112.138 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -67.68 126.68 30.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.648 0.779 . . . . 0.0 110.79 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.21 162.71 16.91 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 121.912 0.729 . . . . 0.0 114.345 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.57 133.5 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.107 1.363 . . . . 0.0 108.775 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -125.71 124.45 41.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.626 1.17 . . . . 0.0 109.759 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.44 143.88 49.86 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.473 1.109 . . . . 0.0 112.61 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -140.47 127.8 21.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.493 -169.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -72.47 136.24 45.92 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.085 0.554 . . . . 0.0 110.345 169.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 48.8 t -163.8 131.59 3.51 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.591 1.556 . . . . 0.0 110.644 -172.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.5 t -71.31 -8.31 52.86 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -129.48 26.01 5.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.26 1.824 . . . . 0.0 112.834 -173.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.17 -36.01 38.94 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -70.22 -38.01 75.16 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.429 0.692 . . . . 0.0 112.759 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -67.43 -33.18 74.63 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.497 -0.752 . . . . 0.0 111.612 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.58 -51.09 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 169.166 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.84 -37.62 82.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.841 0.857 . . . . 0.0 112.662 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.75 -30.33 67.88 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.6 1.16 . . . . 0.0 112.796 175.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.45 -37.11 21.81 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.006 0.821 . . . . 0.0 112.419 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 23.1 mt -53.43 -54.17 40.69 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.321 0.964 . . . . 0.0 111.832 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -59.0 -26.68 64.74 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -70.8 -30.71 67.24 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.723 1.209 . . . . 0.0 112.766 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.59 -38.33 12.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.6 1.56 . . . . 0.0 111.135 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.8 mtp -71.87 -27.88 63.16 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.2 1.4 . . . . 0.0 113.012 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -75.66 -16.15 60.23 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.332 0.653 . . . . 0.0 112.54 168.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.7 t -89.09 -27.75 20.56 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -170.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.1 m120 64.86 -24.86 0.08 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.851 2.86 . . . . 0.0 116.581 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.1 m 60.41 34.25 20.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.823 1.649 . . . . 0.0 114.886 167.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.62 ' H ' HD12 ' A' ' 110' ' ' ILE . 4.5 mp -54.45 98.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.527 2.331 . . . . 0.0 111.299 -167.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 51.21 32.19 7.76 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.366 1.466 . . . . 0.0 112.815 -175.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.6 p -51.31 -24.05 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.06 154.95 50.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.005 1.722 . . . . 0.0 111.154 170.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.48 105.53 5.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.343 0.657 . . . . 0.0 110.716 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.67 156.29 65.02 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.045 1.338 . . . . 0.0 112.194 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.42 178.9 4.49 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.017 3.145 . . . . 0.0 111.905 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.8 p -61.07 134.15 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.212 1.005 . . . . 0.0 111.379 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.1 mm -141.23 154.71 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.288 1.835 . . . . 0.0 109.651 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.7 pt -63.56 0.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 126.498 1.919 . . . . 0.0 115.602 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.4 t -71.16 -17.86 62.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.757 1.623 . . . . 0.0 112.456 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -56.28 155.31 6.98 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.702 1.601 . . . . 0.0 113.055 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -64.82 136.63 57.1 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.194 0.597 . . . . 0.0 111.7 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 86.6 p -171.6 -171.89 0.97 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.037 1.735 . . . . 0.0 111.063 -173.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -55.69 147.2 42.17 Favored Pre-proline 0 CA--C 1.556 1.174 0 O-C-N 121.034 -1.041 . . . . 0.0 113.104 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.29 152.36 66.56 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.372 2.715 . . . . 0.0 111.168 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.62 172.33 16.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.855 1.662 . . . . 0.0 111.063 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.07 116.94 9.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.086 0.554 . . . . 0.0 109.638 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.8 tt -150.88 139.03 20.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.1 1.76 . . . . 0.0 108.62 -170.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -58.11 138.39 56.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.03 1.332 . . . . 0.0 114.364 -171.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.4 pp -92.46 151.98 41.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.906 1.282 . . . . 0.0 111.943 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.58 -178.4 4.21 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.386 2.724 . . . . 0.0 111.493 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -60.53 160.68 8.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.811 0.845 . . . . 0.0 112.597 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -138.39 145.61 47.66 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.19 1.396 . . . . 0.0 111.196 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.59 153.56 49.36 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.522 2.815 . . . . 0.0 111.538 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -74.42 129.9 83.13 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.406 0.682 . . . . 0.0 109.595 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.89 141.69 49.63 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.033 2.489 . . . . 0.0 111.351 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.93 158.62 34.59 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.844 3.029 . . . . 0.0 112.215 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -78.08 145.99 35.48 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.325 1.05 . . . . 0.0 112.764 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.09 161.45 22.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.343 1.057 . . . . 0.0 112.197 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.2 tp -113.79 143.77 44.1 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.544 1.537 . . . . 0.0 110.432 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.82 -162.44 27.86 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.599 1.095 . . . . 0.0 113.471 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -154.17 151.61 29.42 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.069 1.348 . . . . 0.0 112.068 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.0 t -79.17 176.5 9.61 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.435 1.094 . . . . 0.0 111.493 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.43 136.23 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.797 1.639 . . . . 0.0 110.793 -171.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 t -87.1 171.04 11.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.451 1.101 . . . . 0.0 113.141 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.254 1.342 0 C-N-CA 126.131 1.772 . . . . 0.0 113.694 -177.676 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -78.78 130.56 35.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.968 0.907 . . . . 0.0 111.141 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -90.88 109.69 20.91 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.264 1.026 . . . . 0.0 109.607 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 37.7 mt -74.66 156.89 36.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.953 0.901 . . . . 0.0 113.015 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -79.76 -24.71 41.36 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.11 1.364 . . . . 0.0 113.582 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -162.05 169.75 20.45 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.535 1.934 . . . . 0.0 111.344 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -80.78 124.73 81.5 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.259 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.34 6.27 5.72 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.859 3.04 . . . . 0.0 113.786 -172.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 47.9 t -127.98 131.84 49.23 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.001 1.32 . . . . 0.0 112.07 -171.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.13 -17.31 40.75 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.91 1.243 . . . . 0.0 115.122 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -113.61 112.66 23.89 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.177 1.391 . . . . 0.0 110.286 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -154.89 134.51 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.777 0.799 . . . . 0.0 111.993 -169.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -93.8 120.03 33.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.043 2.137 . . . . 0.0 110.271 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -83.75 111.35 19.09 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.794 0.837 . . . . 0.0 110.242 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.06 -67.48 1.34 Allowed Glycine 0 N--CA 1.47 0.934 0 C-N-CA 124.277 0.942 . . . . 0.0 112.511 -172.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -98.54 121.06 40.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.279 1.032 . . . . 0.0 111.177 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -94.9 27.74 3.01 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.584 1.554 . . . . 0.0 112.616 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -126.79 149.37 49.7 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.025 1.73 . . . . 0.0 109.618 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.462 1.505 . . . . 0.0 113.973 -169.82 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.0 p -165.89 173.79 10.19 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.692 1.597 . . . . 0.0 111.576 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.0 p -156.11 151.67 27.02 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.742 1.217 . . . . 0.0 112.14 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.95 -171.15 47.43 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.697 1.141 . . . . 0.0 113.696 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 t -160.26 166.14 30.11 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.579 1.552 . . . . 0.0 110.931 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 t -164.12 169.34 17.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.538 1.535 . . . . 0.0 111.557 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.24 -160.83 14.05 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.265 1.412 . . . . 0.0 113.355 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -154.65 166.47 33.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.623 1.569 . . . . 0.0 111.658 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -145.78 140.66 27.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.253 1.421 . . . . 0.0 111.262 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -73.63 169.51 17.14 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.999 1.32 . . . . 0.0 112.336 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.85 -11.51 59.58 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.473 1.109 . . . . 0.0 113.91 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 t -95.28 123.95 39.06 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.522 1.129 . . . . 0.0 111.877 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.0 t -79.26 123.06 84.78 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.576 1.15 . . . . 0.0 110.228 -173.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.54 154.86 27.72 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.999 2.466 . . . . 0.0 110.995 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.74 -5.16 10.93 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 174.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -113.99 9.42 17.37 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.537 1.935 . . . . 0.0 113.936 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -55.39 138.65 67.66 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 121.05 -1.031 . . . . 0.0 112.29 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.87 -15.0 47.25 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.163 2.575 . . . . 0.0 115.141 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.6 p -128.41 -18.14 4.06 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.19 1.359 . . . . 0.0 114.459 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 113.18 24.99 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.186 0.903 . . . . 0.0 111.112 174.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -107.94 113.23 26.28 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.127 0.971 . . . . 0.0 109.333 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -67.11 131.29 45.51 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.581 -0.7 . . . . 0.0 110.253 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.5 152.79 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.261 1.425 . . . . 0.0 111.125 -169.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.5 m -130.45 118.37 21.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.837 0.855 . . . . 0.0 109.09 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -66.29 133.97 51.66 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.941 0.896 . . . . 0.0 110.642 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.36 155.08 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.924 0.89 . . . . 0.0 112.733 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.83 -168.3 2.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.576 1.151 . . . . 0.0 113.695 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -72.52 -20.09 61.41 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.637 1.175 . . . . 0.0 113.592 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.76 -15.48 44.87 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.951 1.301 . . . . 0.0 112.408 171.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.98 16.48 67.44 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.042 -1.421 . . . . 0.0 114.449 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.49 151.08 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 119.844 1.822 . . . . 0.0 111.667 173.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.27 128.16 35.17 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.857 1.263 . . . . 0.0 111.308 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.0 mt -110.09 -52.17 2.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.964 0.906 . . . . 0.0 112.347 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.11 152.71 23.78 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.669 1.604 . . . . 0.0 112.569 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.0 t -116.28 149.35 39.37 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.939 0.896 . . . . 0.0 112.82 -172.447 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.99 174.7 33.19 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 126.784 2.135 . . . . 0.0 113.643 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.2 t -114.83 120.5 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.1 tpp -86.65 131.52 34.13 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.95 0.9 . . . . 0.0 109.475 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -127.36 129.99 48.6 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.63 1.572 . . . . 0.0 108.818 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.22 131.1 53.11 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.384 1.873 . . . . 0.0 107.804 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.0 p -130.55 171.3 13.18 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.023 1.329 . . . . 0.0 109.774 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -70.6 -7.65 45.72 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.218 -0.926 . . . . 0.0 112.62 172.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.3 m -102.4 -43.59 5.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.453 1.101 . . . . 0.0 113.428 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -173.94 170.68 3.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.174 1.389 . . . . 0.0 113.151 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.87 140.89 29.2 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.856 1.262 . . . . 0.0 110.275 168.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.6 t -135.31 129.99 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.545 1.138 . . . . 0.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.7 mt -100.23 126.36 46.52 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.679 1.192 . . . . 0.0 110.251 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -98.95 127.52 44.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.55 1.54 . . . . 0.0 110.704 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.8 mt -136.39 158.13 45.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.167 2.187 . . . . 0.0 110.065 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.65 -82.43 0.11 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.963 0.905 . . . . 0.0 112.604 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 57.7 mmm-85 -85.53 -2.87 58.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.567 1.147 . . . . 0.0 113.793 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -107.85 155.26 20.46 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.97 1.708 . . . . 0.0 110.874 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.5 148.37 51.59 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.223 1.009 . . . . 0.0 111.231 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.54 137.74 55.97 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.684 0.794 . . . . 0.0 111.769 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.24 134.49 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.129 0.971 . . . . 0.0 109.724 -174.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.3 150.21 48.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.574 1.15 . . . . 0.0 112.71 -168.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 -142.26 115.22 6.4 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.751 1.22 . . . . 0.0 111.421 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.09 146.6 71.11 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.549 2.166 . . . . 0.0 110.017 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -60.7 -29.98 69.67 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -34.13 70.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.196 1.798 . . . . 0.0 112.679 173.31 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.9 m -83.28 -9.38 59.14 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.57 88.17 7.03 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.641 1.109 . . . . 0.0 110.199 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -64.98 -29.74 70.69 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.758 0.823 . . . . 0.0 113.114 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -154.71 154.75 33.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.95 0.9 . . . . 0.0 112.691 167.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -151.41 144.84 24.84 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.255 1.422 . . . . 0.0 109.633 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.49 -179.65 34.45 Favored Glycine 0 N--CA 1.464 0.566 0 CA-C-O 121.558 0.532 . . . . 0.0 114.222 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -149.09 165.06 32.85 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.227 1.011 . . . . 0.0 113.12 -172.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.85 -169.47 3.37 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.706 2.002 . . . . 0.0 109.578 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 93.8 p -69.23 -18.22 63.86 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -152.49 8.79 0.46 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.795 1.638 . . . . 0.0 113.891 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.63 129.23 26.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.574 1.55 . . . . 0.0 110.754 -168.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -120.98 140.06 52.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.037 1.735 . . . . 0.0 109.504 174.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.4 t -153.35 159.24 42.41 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.31 1.044 . . . . 0.0 112.791 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.42 149.48 30.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.724 1.61 . . . . 0.0 111.689 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -113.22 134.23 54.68 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.525 1.93 . . . . 0.0 109.628 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -132.87 154.91 49.9 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.686 1.195 . . . . 0.0 112.192 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.9 167.51 18.54 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.069 1.319 . . . . 0.0 114.28 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -54.54 -27.34 37.74 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -73.43 -15.44 61.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.67 1.988 . . . . 0.0 115.706 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.2 p -83.47 -176.46 6.32 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -60.48 -46.34 90.45 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.391 1.076 . . . . 0.0 112.779 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.6 p -89.3 -21.39 23.19 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.595 1.158 . . . . 0.0 113.146 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.38 -156.39 33.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.824 1.678 . . . . 0.0 112.271 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -63.64 134.02 54.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.601 0.76 . . . . 0.0 111.691 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.76 175.35 26.67 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 122.156 0.864 . . . . 0.0 113.074 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.8 mt -124.65 138.82 52.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.724 1.609 . . . . 0.0 108.368 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -134.2 123.58 24.56 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.878 1.271 . . . . 0.0 109.96 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.86 143.4 50.37 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.347 1.059 . . . . 0.0 112.962 -169.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -139.54 126.49 20.94 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.851 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -71.07 133.88 46.62 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.739 0.815 . . . . 0.0 110.914 169.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.6 p -168.15 147.96 4.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.016 1.726 . . . . 0.0 111.924 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.0 t -82.55 -0.4 46.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.088 0.955 . . . . 0.0 113.103 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.25 22.56 6.08 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.038 1.735 . . . . 0.0 112.661 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.22 -41.26 49.58 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.567 1.147 . . . . 0.0 113.923 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.35 -35.29 73.48 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.479 1.112 . . . . 0.0 113.225 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -66.33 -39.61 89.34 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.468 -0.77 . . . . 0.0 110.816 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.81 -47.54 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.243 0.617 . . . . 0.0 110.167 172.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -37.83 85.69 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.843 0.857 . . . . 0.0 112.673 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -72.54 -30.69 64.67 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.16 -42.22 21.19 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.911 0.778 . . . . 0.0 110.684 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.9 mt -50.24 -56.93 9.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.667 1.187 . . . . 0.0 113.096 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -60.79 -20.54 61.69 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.06 -23.37 33.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.663 1.185 . . . . 0.0 113.012 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.4 mt -94.9 -35.72 11.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.513 1.125 . . . . 0.0 111.749 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.1 mtp -64.48 -27.03 68.7 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.557 1.143 . . . . 0.0 112.808 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -83.44 -10.76 58.18 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 169.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 19.7 t -101.26 -28.02 12.87 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.463 1.505 . . . . 0.0 112.604 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -59.9 147.63 37.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.142 1.777 . . . . 0.0 111.505 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -64.22 98.98 0.25 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.971 1.309 . . . . 0.0 113.445 -173.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.8 mm -76.99 -40.67 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.371 -0.831 . . . . 0.0 111.929 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -143.81 5.06 1.34 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -171.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.1 t -77.68 -28.33 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 125.323 1.449 . . . . 0.0 111.518 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 26.3 mmt -128.03 147.26 50.51 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.106 1.763 . . . . 0.0 110.893 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -82.34 128.37 34.15 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.015 0.926 . . . . 0.0 110.271 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.84 144.63 80.18 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.604 0.762 . . . . 0.0 112.137 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.99 159.12 41.76 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.44 2.76 . . . . 0.0 111.284 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.9 p -97.68 133.12 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.398 1.079 . . . . 0.0 110.196 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.97 126.39 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.095 1.358 . . . . 0.0 107.972 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.8 mm -106.93 138.41 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.923 1.289 . . . . 0.0 108.484 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t -136.41 157.22 47.3 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.304 1.442 . . . . 0.0 110.384 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -57.78 140.05 52.54 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.841 1.256 . . . . 0.0 112.396 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -113.09 164.18 13.81 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.782 1.233 . . . . 0.0 112.426 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 t -159.64 151.93 20.98 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.225 1.41 . . . . 0.0 110.334 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -69.52 141.1 90.29 Favored Pre-proline 0 CA--C 1.554 1.129 0 O-C-N 121.238 -0.914 . . . . 0.0 112.409 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.82 157.77 54.43 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.531 2.821 . . . . 0.0 111.541 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.25 145.92 51.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.771 0.828 . . . . 0.0 112.172 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -110.06 135.98 50.03 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.646 1.578 . . . . 0.0 110.523 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.9 tt -87.93 141.34 28.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.116 1.366 . . . . 0.0 111.084 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -118.53 144.75 45.84 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.702 1.601 . . . . 0.0 111.318 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 pp -95.95 156.25 37.4 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.153 1.381 . . . . 0.0 112.347 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.72 153.5 20.04 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.138 2.558 . . . . 0.0 112.372 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.54 167.89 15.83 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.962 1.305 . . . . 0.0 113.334 172.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -141.98 149.63 53.31 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.646 1.578 . . . . 0.0 111.509 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.7 159.59 42.13 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.764 2.976 . . . . 0.0 112.328 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -91.33 151.3 42.67 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.442 1.097 . . . . 0.0 111.727 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.14 157.06 51.07 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.319 2.679 . . . . 0.0 111.727 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.73 154.94 49.32 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.786 2.991 . . . . 0.0 112.025 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -83.74 176.29 9.06 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.572 1.149 . . . . 0.0 113.3 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.53 167.23 25.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.905 1.682 . . . . 0.0 111.594 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -147.82 127.17 13.08 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.346 1.458 . . . . 0.0 109.303 -173.037 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -83.69 -120.94 0.79 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.448 1.499 . . . . 0.0 112.715 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -155.07 157.58 37.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.263 1.425 . . . . 0.0 112.345 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.2 p -74.99 -23.45 58.26 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.756 1.622 . . . . 0.0 114.499 -176.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 t 64.32 58.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.722 2.009 . . . . 0.0 109.854 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.0 m -74.72 139.97 43.81 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.878 0.871 . . . . 0.0 112.02 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 C--O 1.254 1.29 0 C-N-CA 125.557 1.543 . . . . 0.0 112.035 -179.24 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -78.41 131.65 37.02 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.094 0.558 . . . . 0.0 111.84 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.83 100.09 11.82 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.098 1.359 . . . . 0.0 111.081 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 56.8 mt -77.15 151.97 35.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.418 -0.801 . . . . 0.0 112.705 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -87.46 -30.22 20.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.364 1.466 . . . . 0.0 113.265 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -143.64 159.36 42.59 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.181 1.792 . . . . 0.0 111.521 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -80.12 124.26 82.93 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.408 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.47 -25.34 2.6 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.193 2.595 . . . . 0.0 114.071 -170.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.53 126.4 31.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.65 0.78 . . . . 0.0 111.28 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.25 -15.8 80.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.984 0.802 . . . . 0.0 113.999 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -122.69 120.25 33.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.468 1.507 . . . . 0.0 109.3 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.74 164.48 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.584 1.553 . . . . 0.0 111.018 -174.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -145.78 159.82 42.63 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.508 1.523 . . . . 0.0 111.721 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -124.39 108.28 12.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.018 1.327 . . . . 0.0 110.322 -169.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.6 -18.63 54.46 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 124.251 0.929 . . . . 0.0 113.993 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -135.78 133.54 38.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.932 1.693 . . . . 0.0 110.538 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -163.76 158.36 20.11 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.858 1.663 . . . . 0.0 110.434 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.18 161.33 22.13 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.413 1.485 . . . . 0.0 110.802 -175.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.188 0 C-N-CA 125.697 1.599 . . . . 0.0 112.917 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -84.94 166.98 16.34 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.844 -0.798 . . . . 0.0 112.258 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 m -157.69 113.82 2.85 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.42 1.488 . . . . 0.0 110.574 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.0 136.75 13.76 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.637 1.113 . . . . 0.0 111.687 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.2 m -151.94 144.19 23.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.446 1.098 . . . . 0.0 111.026 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 p -84.1 135.99 34.18 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.047 -1.033 . . . . 0.0 111.987 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.32 -166.35 29.93 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.296 1.427 . . . . 0.0 113.049 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.5 mt -133.77 118.93 18.63 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.453 1.501 . . . . 0.0 109.119 175.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -89.62 -12.21 40.37 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.27 142.51 45.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.392 1.077 . . . . 0.0 111.366 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -90.68 -0.0 57.55 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.286 1.434 . . . . 0.0 113.642 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.0 m -135.18 141.94 45.99 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.906 1.682 . . . . 0.0 110.78 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -71.65 131.31 86.24 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.983 0.913 . . . . 0.0 111.441 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.95 155.59 43.17 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.713 2.942 . . . . 0.0 112.185 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -68.44 -6.16 23.24 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.726 1.21 . . . . 0.0 114.039 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -123.72 21.41 9.22 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.546 1.939 . . . . 0.0 113.116 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -53.46 137.51 51.03 Favored Pre-proline 0 CA--C 1.553 1.091 0 O-C-N 121.162 -0.961 . . . . 0.0 112.665 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.32 -7.7 21.84 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.461 2.774 . . . . 0.0 114.808 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.8 p -132.67 -24.94 1.93 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.08 90.03 3.19 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.782 1.173 . . . . 0.0 110.677 174.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -91.14 118.4 30.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.777 1.231 . . . . 0.0 109.346 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -78.61 133.76 37.25 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.172 -0.955 . . . . 0.0 110.29 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.17 165.27 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.865 1.266 . . . . 0.0 111.548 -168.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.6 m -143.53 121.74 12.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.463 1.105 . . . . 0.0 109.063 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -63.77 133.67 53.9 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.097 0.559 . . . . 0.0 109.955 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.48 153.07 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.045 0.938 . . . . 0.0 112.346 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -85.98 -169.69 2.76 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -61.41 -31.66 71.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.016 1.326 . . . . 0.0 114.201 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.09 -9.66 59.78 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.109 1.363 . . . . 0.0 112.45 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.22 12.85 83.52 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 117.76 -1.578 . . . . 0.0 114.225 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 m -80.7 150.35 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 120.108 1.954 . . . . 0.0 111.662 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -83.0 124.52 30.49 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.567 -173.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.9 mt -104.02 -54.3 2.58 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.75 0.82 . . . . 0.0 111.948 -173.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.64 139.27 6.51 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 124.737 1.161 . . . . 0.0 114.003 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 p -85.23 153.16 22.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.248 1.419 . . . . 0.0 113.309 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.05 171.59 37.13 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.664 1.602 . . . . 0.0 113.327 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.11 120.74 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.7 tpp -89.14 134.34 34.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.031 1.332 . . . . 0.0 110.135 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -133.08 130.28 39.11 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.568 1.547 . . . . 0.0 109.461 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.51 128.4 54.48 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.874 2.07 . . . . 0.0 107.694 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -128.03 172.57 10.82 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.64 1.176 . . . . 0.0 110.601 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.49 3.16 4.1 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 121.28 -0.888 . . . . 0.0 112.759 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.7 m -110.89 -45.51 3.46 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.499 1.119 . . . . 0.0 113.34 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -173.63 173.71 3.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.338 1.055 . . . . 0.0 113.343 -169.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.99 139.77 30.25 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.033 0.933 . . . . 0.0 109.946 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.6 t -134.89 132.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.441 1.096 . . . . 0.0 111.413 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.9 mt -104.25 130.9 52.04 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.01 1.724 . . . . 0.0 110.558 168.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -105.13 129.02 53.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.691 1.996 . . . . 0.0 110.579 170.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -160.87 169.68 22.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.029 2.131 . . . . 0.0 111.397 -173.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -111.97 -18.44 12.64 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -73.62 -28.0 61.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.102 0.961 . . . . 0.0 113.044 -176.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -142.43 174.29 10.76 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.866 2.466 . . . . 0.0 108.963 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.04 162.54 7.01 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.461 0.704 . . . . 0.0 110.835 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.04 147.56 19.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.847 0.859 . . . . 0.0 112.423 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 t -126.06 136.86 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.275 1.03 . . . . 0.0 109.485 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.66 152.0 46.38 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.637 0.775 . . . . 0.0 111.842 -171.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -139.16 116.67 8.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.518 1.127 . . . . 0.0 111.37 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.98 145.42 73.89 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.59 2.193 . . . . 0.0 109.883 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -60.85 -24.83 66.21 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.84 -42.69 99.84 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.057 1.343 . . . . 0.0 111.992 173.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.4 m -79.74 -3.55 48.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.1 mt -86.71 106.98 18.02 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.686 1.13 . . . . 0.0 109.912 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -38.43 42.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.384 0.674 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -149.47 155.91 41.14 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.101 1.36 . . . . 0.0 111.085 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -150.78 136.31 17.96 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.868 1.667 . . . . 0.0 108.514 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -156.81 173.26 34.5 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-O 122.139 0.855 . . . . 0.0 113.979 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -142.2 159.76 41.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.52 1.128 . . . . 0.0 112.024 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -151.47 -174.75 4.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.111 1.764 . . . . 0.0 109.771 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -60.19 119.17 7.37 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.376 -0.828 . . . . 0.0 110.473 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.64 21.93 0.99 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 127.703 2.401 . . . . 0.0 116.464 -175.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -138.72 131.23 28.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.067 1.347 . . . . 0.0 111.214 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -125.86 141.29 52.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.218 1.807 . . . . 0.0 109.956 173.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -153.8 162.05 41.56 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.941 -1.099 . . . . 0.0 112.971 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -154.33 153.77 32.21 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.598 1.559 . . . . 0.0 112.412 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -112.65 128.74 56.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.513 1.925 . . . . 0.0 109.222 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.2 p -123.37 142.63 50.77 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.77 154.38 52.83 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.641 1.115 . . . . 0.0 113.138 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -61.81 -14.07 29.68 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -83.11 -17.42 43.12 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.0 p -74.66 -179.54 4.18 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -170.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.94 -38.1 69.87 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.645 1.178 . . . . 0.0 113.199 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -96.58 -23.19 16.63 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.246 1.418 . . . . 0.0 113.588 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.98 -160.7 43.03 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.356 1.455 . . . . 0.0 112.535 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -65.54 129.07 38.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.547 1.139 . . . . 0.0 112.378 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.8 172.59 30.46 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.231 1.396 . . . . 0.0 112.899 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 59.0 mt -119.36 136.3 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.55 1.54 . . . . 0.0 108.298 170.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -129.21 117.95 21.59 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.78 1.232 . . . . 0.0 109.801 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.8 141.18 48.7 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.675 1.19 . . . . 0.0 112.199 -172.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -138.33 127.7 24.59 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.192 0.997 . . . . 0.0 111.865 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -67.34 131.22 45.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.445 0.698 . . . . 0.0 111.044 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.3 t -169.53 118.73 0.64 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.249 1.819 . . . . 0.0 110.36 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.8 t -71.29 -8.06 51.14 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.229 -0.919 . . . . 0.0 113.151 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.73 9.46 35.03 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.538 1.935 . . . . 0.0 113.333 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.5 -38.53 20.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.31 1.844 . . . . 0.0 115.322 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.99 -35.67 80.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.773 0.829 . . . . 0.0 112.908 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -68.39 -37.87 80.78 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.536 -0.728 . . . . 0.0 110.96 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.45 -45.26 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 118.609 0.64 . . . . 0.0 110.24 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.61 -42.99 99.9 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.767 0.827 . . . . 0.0 111.841 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -70.31 -33.97 72.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.23 -33.93 43.24 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.12 0.873 . . . . 0.0 110.682 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.49 -55.21 36.58 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.299 -0.875 . . . . 0.0 111.981 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -61.23 -21.52 63.94 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -81.47 -20.14 40.85 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.215 1.406 . . . . 0.0 112.754 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.13 -35.78 10.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.468 1.507 . . . . 0.0 112.559 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 67.5 mmm -59.06 -33.83 71.24 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.855 1.262 . . . . 0.0 111.366 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -83.19 -8.77 59.44 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.5 t -87.57 0.55 55.45 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.813 1.245 . . . . 0.0 113.491 -172.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -73.75 171.71 12.83 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.446 1.098 . . . . 0.0 112.983 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.3 p -74.24 92.07 2.21 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.255 1.422 . . . . 0.0 112.17 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 21.0 mm -78.08 74.17 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.581 1.152 . . . . 0.0 109.545 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.53 -14.77 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 128.563 2.745 . . . . 0.0 116.248 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.4 m -59.21 -14.79 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 127.43 2.292 . . . . 0.0 115.473 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 74.2 mtm -140.77 141.89 34.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.256 1.423 . . . . 0.0 110.831 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.62 132.03 39.77 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.2 1.4 . . . . 0.0 110.836 174.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.31 149.73 16.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 125.66 1.584 . . . . 0.0 111.029 -175.921 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.82 148.31 40.86 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.06 2.507 . . . . 0.0 110.801 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.6 p -110.88 125.32 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.838 1.255 . . . . 0.0 109.387 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.1 mm -82.53 143.76 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.894 0.854 . . . . 0.0 110.349 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.2 pt -100.97 131.76 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.469 1.107 . . . . 0.0 110.681 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.5 p -139.71 142.69 36.85 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.371 1.869 . . . . 0.0 108.809 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -166.17 97.77 0.61 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.591 1.557 . . . . 0.0 109.107 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -122.08 71.95 1.02 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.091 1.356 . . . . 0.0 109.889 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.3 p -170.73 162.55 7.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 0.0 111.849 -168.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -77.48 146.25 73.32 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.607 1.163 . . . . 0.0 113.181 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.04 144.6 27.12 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.197 2.598 . . . . 0.0 110.247 169.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.24 142.66 5.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.467 1.507 . . . . 0.0 111.058 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -145.15 158.01 43.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.583 1.553 . . . . 0.0 110.181 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 54.8 tp -152.48 145.74 24.72 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.277 1.431 . . . . 0.0 110.928 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.01 134.33 55.99 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.739 1.216 . . . . 0.0 112.138 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.56 153.26 47.98 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.984 1.314 . . . . 0.0 111.81 -176.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.29 99.76 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.465 2.11 . . . . 0.0 110.575 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.88 163.73 27.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.375 1.07 . . . . 0.0 112.595 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -145.52 150.7 44.82 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.097 1.359 . . . . 0.0 111.929 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.5 175.41 11.31 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.05 3.167 . . . . 0.0 112.01 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -131.48 146.96 64.17 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.366 1.466 . . . . 0.0 109.848 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.35 141.29 38.63 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.132 2.555 . . . . 0.0 111.774 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -77.4 171.71 17.19 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.992 3.128 . . . . 0.0 111.894 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -153.29 144.84 23.32 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.891 1.276 . . . . 0.0 111.615 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -156.25 173.2 17.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.994 1.717 . . . . 0.0 111.641 -176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.9 tt -146.54 132.21 18.89 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.368 1.467 . . . . 0.0 110.623 -175.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.18 155.29 18.61 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.449 1.499 . . . . 0.0 112.446 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -159.53 160.53 34.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.384 1.474 . . . . 0.0 111.784 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.1 t -155.48 171.45 19.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.554 1.542 . . . . 0.0 111.623 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 m -150.46 171.93 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 127.701 2.4 . . . . 0.0 110.764 -169.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 t -152.96 161.93 41.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.902 1.281 . . . . 0.0 111.58 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.3 p . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.822 1.649 . . . . 0.0 114.864 -175.445 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -82.45 119.28 23.99 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.31 0.504 . . . . 0.0 110.944 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -89.59 110.06 20.95 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.824 1.25 . . . . 0.0 109.962 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 45.0 mt -76.53 157.15 32.31 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -80.32 -24.15 40.12 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.812 1.645 . . . . 0.0 113.702 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -160.26 170.03 21.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.517 1.927 . . . . 0.0 111.55 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -86.68 122.73 71.55 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.789 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -82.43 -24.92 3.42 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.362 2.708 . . . . 0.0 114.428 -170.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.4 m -79.75 129.02 34.12 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.843 0.747 . . . . 0.0 112.223 -171.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.08 -9.44 85.42 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.656 1.122 . . . . 0.0 114.563 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -139.0 128.07 23.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.71 1.604 . . . . 0.0 110.221 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.7 164.07 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.6 1.56 . . . . 0.0 111.252 -173.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -128.93 132.32 47.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.266 1.426 . . . . 0.0 109.376 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -99.01 111.86 24.15 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.861 1.264 . . . . 0.0 110.035 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.33 -92.9 0.88 Allowed Glycine 0 N--CA 1.468 0.782 0 C-N-CA 124.509 1.052 . . . . 0.0 113.002 -171.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -72.62 122.36 21.28 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.444 1.098 . . . . 0.0 110.815 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -148.25 176.37 10.3 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.862 2.065 . . . . 0.0 109.762 -170.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -132.68 157.17 45.52 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.912 1.285 . . . . 0.0 111.19 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.382 1.473 . . . . 0.0 112.716 -179.676 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.0 m -148.48 141.81 25.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.809 1.243 . . . . 0.0 111.277 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 p -101.76 -1.83 31.52 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.962 1.305 . . . . 0.0 114.181 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.03 -149.58 21.3 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.923 1.725 . . . . 0.0 112.276 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.1 m -142.17 142.78 32.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.977 1.311 . . . . 0.0 111.16 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.3 t -163.58 161.75 24.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.327 1.451 . . . . 0.0 110.744 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.61 8.95 86.33 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.46 1.028 . . . . 0.0 114.5 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.24 136.09 57.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.223 1.409 . . . . 0.0 111.406 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -160.3 151.46 19.23 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.141 1.376 . . . . 0.0 111.739 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -112.84 84.85 2.06 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.874 1.269 . . . . 0.0 109.696 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -165.55 143.39 5.88 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.311 1.845 . . . . 0.0 110.542 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.8 m 59.34 34.04 22.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.416 1.087 . . . . 0.0 113.797 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -41.51 121.25 2.13 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 126.521 1.928 . . . . 0.0 113.252 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.07 151.72 39.56 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.173 2.582 . . . . 0.0 110.811 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.43 -8.8 57.38 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -103.23 8.86 38.37 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.425 1.49 . . . . 0.0 113.26 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -59.61 140.34 89.13 Favored Pre-proline 0 CA--C 1.556 1.185 0 O-C-N 120.615 -1.303 . . . . 0.0 112.961 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.76 -18.41 22.09 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.852 2.368 . . . . 0.0 114.944 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.9 p -128.8 -19.22 3.71 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.173 1.352 . . . . 0.0 114.599 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -97.42 142.22 29.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.189 0.904 . . . . 0.0 110.851 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -143.55 107.16 4.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.012 1.325 . . . . 0.0 108.738 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -64.7 137.12 57.62 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.25 -0.906 . . . . 0.0 111.402 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 m -144.9 159.82 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.803 1.241 . . . . 0.0 111.587 -170.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -134.63 117.19 15.83 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.66 1.184 . . . . 0.0 108.824 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -67.59 135.63 53.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.543 0.737 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.0 m -129.07 154.47 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.298 1.039 . . . . 0.0 112.948 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.427 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.7 p-10 -90.78 -166.62 1.62 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.039 1.336 . . . . 0.0 113.989 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.85 -30.37 71.37 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.555 1.142 . . . . 0.0 113.008 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.9 -12.36 59.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.847 1.259 . . . . 0.0 112.106 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.04 14.52 80.53 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 117.787 -1.563 . . . . 0.0 114.228 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.427 HG22 ' OD1' ' A' ' 27' ' ' ASP . 14.2 m -76.15 150.34 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.995 1.897 . . . . 0.0 111.563 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -84.45 124.19 31.07 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.416 1.087 . . . . 0.0 110.926 -174.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 mt -104.73 -51.93 2.97 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.086 0.954 . . . . 0.0 112.062 -170.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.33 148.49 17.37 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 125.004 1.288 . . . . 0.0 113.533 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.8 p -90.38 151.74 21.3 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.853 1.261 . . . . 0.0 113.006 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.32 170.95 34.56 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.751 1.643 . . . . 0.0 112.793 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -118.63 120.22 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.8 ttm -88.3 141.19 28.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.098 0.959 . . . . 0.0 110.194 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -135.84 129.85 33.03 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.515 1.526 . . . . 0.0 108.903 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -108.44 130.5 55.24 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.678 1.591 . . . . 0.0 107.919 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.0 p -130.35 167.31 18.74 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.904 1.281 . . . . 0.0 109.941 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -66.47 -9.69 36.85 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.864 -0.522 . . . . 0.0 112.4 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.6 m -98.52 -45.35 6.13 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.449 1.1 . . . . 0.0 113.263 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -172.6 171.11 4.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.64 1.176 . . . . 0.0 113.718 -168.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.7 mt -86.86 139.77 30.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.579 1.552 . . . . 0.0 109.962 168.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.0 t -134.87 137.93 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.056 0.943 . . . . 0.0 111.176 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.84 130.3 55.62 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.449 1.5 . . . . 0.0 109.837 167.792 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -103.13 130.91 50.45 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.366 1.866 . . . . 0.0 110.833 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.3 mt -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.848 2.059 . . . . 0.0 111.148 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -95.42 -63.94 1.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.683 1.193 . . . . 0.0 113.543 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -82.95 2.67 33.49 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.068 1.347 . . . . 0.0 113.884 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -134.75 159.22 41.99 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.926 2.09 . . . . 0.0 110.286 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.78 164.87 25.9 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.92 0.888 . . . . 0.0 111.589 172.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.96 134.87 51.48 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.46 -0.775 . . . . 0.0 111.767 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -108.55 135.6 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.208 1.003 . . . . 0.0 110.494 -173.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -120.86 142.38 49.71 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.664 1.186 . . . . 0.0 113.384 -170.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -141.75 112.59 6.4 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.185 1.394 . . . . 0.0 111.42 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -69.56 150.02 68.9 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.386 2.058 . . . . 0.0 110.334 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -63.7 -19.64 65.09 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.9 mt -68.65 -31.52 70.71 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.21 1.404 . . . . 0.0 113.114 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.4 m -89.9 -6.86 55.34 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.5 mt -74.7 117.4 16.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.73 0.695 . . . . 0.0 109.559 172.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -80.34 -32.97 37.73 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.371 1.468 . . . . 0.0 112.305 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -166.58 159.09 13.9 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.006 2.123 . . . . 0.0 110.483 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -152.17 134.08 14.88 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.001 1.321 . . . . 0.0 111.414 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -150.66 175.73 29.54 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.477 1.036 . . . . 0.0 113.836 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.57 162.0 39.3 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.537 1.135 . . . . 0.0 113.535 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -146.2 -178.56 6.2 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.259 2.224 . . . . 0.0 109.327 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -62.37 -13.63 31.31 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -154.08 12.83 0.43 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.448 1.499 . . . . 0.0 114.242 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -141.47 130.98 23.85 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.329 1.452 . . . . 0.0 110.29 -168.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -121.67 142.14 50.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.912 1.685 . . . . 0.0 109.24 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -153.01 155.51 37.06 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.059 -1.026 . . . . 0.0 112.997 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -150.0 152.78 35.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.158 1.383 . . . . 0.0 111.977 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -106.39 140.8 38.74 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.357 1.463 . . . . 0.0 109.486 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.0 m -124.97 148.58 48.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.175 0.99 . . . . 0.0 112.136 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.62 164.57 45.28 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.276 0.941 . . . . 0.0 112.765 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -63.55 -15.07 57.0 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -82.39 -15.73 51.64 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.216 1.806 . . . . 0.0 115.154 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -79.7 -179.52 6.95 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.526 0.73 . . . . 0.0 112.872 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -58.26 -46.02 86.74 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.286 1.035 . . . . 0.0 112.836 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 36.1 p -89.16 -18.98 26.06 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.04 1.336 . . . . 0.0 113.721 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.49 -164.54 41.76 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.728 1.632 . . . . 0.0 112.474 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -66.68 134.25 51.87 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.923 0.889 . . . . 0.0 112.02 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.09 172.82 23.94 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.288 0.947 . . . . 0.0 113.065 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.6 mt -114.69 137.87 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.474 1.509 . . . . 0.0 108.396 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -129.95 122.97 29.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.64 1.176 . . . . 0.0 110.311 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.15 144.41 48.59 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.679 1.192 . . . . 0.0 113.03 -172.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -142.71 125.15 15.65 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.974 0.91 . . . . 0.0 112.397 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -70.46 134.49 47.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.28 1.032 . . . . 0.0 111.418 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.1 p -170.84 144.55 2.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.411 1.884 . . . . 0.0 111.566 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.4 p -78.03 0.79 23.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.177 1.391 . . . . 0.0 114.08 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -134.65 24.95 3.71 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.841 2.056 . . . . 0.0 112.811 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.98 -41.11 46.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.813 1.645 . . . . 0.0 113.911 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -67.87 -37.13 81.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.503 0.721 . . . . 0.0 112.521 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -68.41 -33.1 73.63 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.416 -0.802 . . . . 0.0 111.958 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.2 mt -63.4 -49.28 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 169.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.12 -42.62 91.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.072 0.949 . . . . 0.0 112.172 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -64.84 -34.87 79.4 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.881 1.273 . . . . 0.0 112.556 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -81.27 -37.8 27.9 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.22 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.9 mt -53.48 -55.75 22.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.369 0.986 . . . . 0.0 111.845 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -58.3 -31.43 67.5 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -28.47 65.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.607 1.163 . . . . 0.0 112.931 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 71.2 mt -93.22 -35.21 13.25 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.334 1.453 . . . . 0.0 111.082 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.8 mtp -78.54 -28.73 46.12 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.978 1.311 . . . . 0.0 113.593 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -65.56 -22.34 66.68 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.814 0.734 . . . . 0.0 112.578 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 12.1 t -69.23 -33.34 73.15 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 118.111 0.414 . . . . 0.0 111.989 -172.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 53.14 36.27 21.96 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.724 1.61 . . . . 0.0 112.433 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.7 m -39.33 112.37 0.24 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.964 2.506 . . . . 0.0 115.148 -169.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.74 -63.79 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.594 0.757 . . . . 0.0 110.933 -174.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -110.26 -18.07 13.37 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.6 p -78.51 -15.96 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.2 1.4 . . . . 0.0 113.92 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.4 mmt -121.22 174.54 6.63 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.342 1.857 . . . . 0.0 111.697 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -55.83 131.08 46.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.875 1.27 . . . . 0.0 111.749 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -151.95 146.62 18.8 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.162 1.385 . . . . 0.0 112.967 -168.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.5 178.04 7.47 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.421 3.414 . . . . 0.0 112.006 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.22 111.17 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.697 0.799 . . . . 0.0 111.092 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.45 140.64 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.907 2.083 . . . . 0.0 109.439 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.34 146.0 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.233 1.013 . . . . 0.0 112.144 173.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.7 t -137.68 150.0 46.99 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.442 1.497 . . . . 0.0 112.089 -171.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -85.87 73.2 10.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.281 1.433 . . . . 0.0 110.371 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.0 t30 57.83 30.5 19.13 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.82 1.648 . . . . 0.0 114.149 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.7 m -138.32 135.95 35.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.811 1.244 . . . . 0.0 111.284 -171.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -156.0 151.22 21.26 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.411 1.085 . . . . 0.0 112.85 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -72.97 152.12 51.25 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.396 2.731 . . . . 0.0 111.231 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.27 63.23 3.13 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.862 1.265 . . . . 0.0 111.954 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -67.42 108.88 2.96 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.341 1.456 . . . . 0.0 110.855 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.7 tt -165.83 148.28 7.38 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.911 2.084 . . . . 0.0 109.485 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -135.82 148.72 48.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.455 1.502 . . . . 0.0 110.981 173.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.14 135.78 19.41 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.401 1.08 . . . . 0.0 111.263 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.1 153.01 18.79 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.407 2.738 . . . . 0.0 111.07 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.63 171.27 14.6 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.614 0.721 . . . . 0.0 112.008 170.084 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.77 138.02 21.38 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.498 1.119 . . . . 0.0 111.715 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.34 172.07 16.8 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.571 2.848 . . . . 0.0 112.068 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -138.42 135.39 18.15 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.428 1.491 . . . . 0.0 108.891 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.3 136.01 35.85 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.675 2.25 . . . . 0.0 110.896 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -78.49 174.76 11.9 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.771 2.98 . . . . 0.0 112.039 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -125.66 155.7 40.43 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.516 1.527 . . . . 0.0 111.462 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -150.48 167.82 26.03 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.578 1.551 . . . . 0.0 111.893 -174.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.3 tt -148.41 130.3 15.23 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.147 1.379 . . . . 0.0 110.363 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -115.2 179.62 18.27 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.748 1.642 . . . . 0.0 112.705 173.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -155.29 155.55 33.95 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.993 1.317 . . . . 0.0 112.015 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 68.2 p -140.13 170.25 16.19 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.199 1.8 . . . . 0.0 111.191 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.58 149.18 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.64 1.576 . . . . 0.0 110.483 -172.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.6 m -142.48 153.45 43.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.127 1.371 . . . . 0.0 111.909 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 C--O 1.256 1.4 0 C-N-CA 125.678 1.591 . . . . 0.0 114.366 177.985 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -85.82 121.67 28.8 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.105 0.962 . . . . 0.0 111.193 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -82.52 107.76 15.42 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.887 1.275 . . . . 0.0 110.742 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -77.28 161.39 28.14 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.604 1.162 . . . . 0.0 112.13 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -101.02 -18.81 16.1 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.127 1.371 . . . . 0.0 114.233 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -139.12 154.3 48.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.524 1.93 . . . . 0.0 111.54 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -84.23 122.22 75.55 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.249 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.34 -20.34 2.73 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.051 2.501 . . . . 0.0 115.249 -169.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 86.9 m -81.59 -31.96 32.3 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.11 -64.44 2.0 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 125.189 1.375 . . . . 0.0 112.902 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -74.61 68.83 1.68 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.764 1.626 . . . . 0.0 111.382 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.7 156.29 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.367 1.867 . . . . 0.0 112.117 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -121.29 137.62 54.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.77 1.628 . . . . 0.0 110.167 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -107.6 101.63 10.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.776 1.23 . . . . 0.0 110.778 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.57 173.17 45.46 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.144 1.354 . . . . 0.0 112.083 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 56.7 37.28 28.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.584 1.154 . . . . 0.0 112.719 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -149.35 138.85 21.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.884 1.674 . . . . 0.0 109.635 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -101.48 159.77 15.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.569 1.148 . . . . 0.0 111.621 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.852 1.661 . . . . 0.0 111.815 -176.631 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -104.81 1.11 28.8 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -160.76 140.1 10.62 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.331 1.452 . . . . 0.0 110.678 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.98 -123.53 5.27 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.386 1.47 . . . . 0.0 111.798 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -139.13 147.0 41.33 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.313 1.445 . . . . 0.0 110.048 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.9 p -145.82 13.65 1.33 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.914 1.286 . . . . 0.0 113.652 -168.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.41 -147.07 18.43 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.635 1.112 . . . . 0.0 112.435 -174.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.86 147.92 51.88 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.1 0.96 . . . . 0.0 111.58 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -152.78 103.19 2.75 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.46 1.504 . . . . 0.0 110.6 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -81.25 128.1 33.43 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.96 0.904 . . . . 0.0 110.34 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -104.03 124.45 49.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.341 1.856 . . . . 0.0 110.754 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p -76.02 111.9 11.89 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.492 1.117 . . . . 0.0 111.273 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 p -149.2 123.59 4.74 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.63 1.172 . . . . 0.0 110.989 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.94 156.48 43.28 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.796 2.331 . . . . 0.0 110.421 169.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.53 -18.21 58.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.904 0.882 . . . . 0.0 112.883 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -115.12 16.42 17.0 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.42 1.888 . . . . 0.0 113.792 -172.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -48.96 142.68 9.25 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.768 1.227 . . . . 0.0 113.311 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.39 -15.02 47.49 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.271 2.648 . . . . 0.0 115.458 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.7 p -124.03 -24.91 4.3 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.827 1.194 . . . . 0.0 113.843 172.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -100.16 118.25 36.1 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.819 1.19 . . . . 0.0 111.943 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -114.51 110.57 20.03 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.281 1.433 . . . . 0.0 108.638 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -71.25 139.79 50.16 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.483 -0.761 . . . . 0.0 110.421 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -145.7 164.5 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.897 1.279 . . . . 0.0 111.964 -170.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.8 m -136.44 120.36 17.52 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.739 1.215 . . . . 0.0 109.271 172.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -67.3 137.53 56.15 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.859 0.864 . . . . 0.0 111.371 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.9 156.71 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.235 1.014 . . . . 0.0 112.706 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -90.8 -167.54 1.85 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.75 1.22 . . . . 0.0 113.705 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.23 -32.19 73.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.87 -11.54 59.81 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.821 1.248 . . . . 0.0 112.817 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 17.47 77.41 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.099 -1.39 . . . . 0.0 113.904 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 m -79.71 150.51 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.829 1.815 . . . . 0.0 111.339 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.57 126.43 34.93 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.308 1.043 . . . . 0.0 111.356 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.6 mt -109.08 -43.3 4.21 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.533 1.133 . . . . 0.0 112.681 -169.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.96 144.8 9.33 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.468 1.033 . . . . 0.0 114.2 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 p -83.79 148.26 27.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.448 1.099 . . . . 0.0 112.224 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.08 170.21 32.04 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.322 1.439 . . . . 0.0 113.457 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.04 119.8 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.7 ttm -91.11 134.05 34.84 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.058 0.943 . . . . 0.0 109.488 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -125.39 124.04 40.64 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.986 1.314 . . . . 0.0 109.235 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -111.35 126.87 55.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.546 1.938 . . . . 0.0 107.901 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -162.54 149.92 13.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.514 1.925 . . . . 0.0 108.266 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -58.89 -18.5 33.7 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -172.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 m -70.45 -42.26 71.75 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 170.95 167.05 0.07 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.594 1.958 . . . . 0.0 111.946 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mt -82.18 139.37 34.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.939 0.895 . . . . 0.0 109.545 167.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 t -134.64 138.62 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.331 0.653 . . . . 0.0 110.808 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.1 mt -113.74 130.74 56.39 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 125.735 1.614 . . . . 0.0 109.482 167.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -111.61 122.22 47.23 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.391 1.876 . . . . 0.0 109.945 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.34 127.29 8.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.84 1.256 . . . . 0.0 111.489 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -73.3 -14.31 61.28 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.536 1.134 . . . . 0.0 113.681 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -66.97 -25.97 66.59 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.568 1.547 . . . . 0.0 113.056 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -143.61 -72.36 0.29 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.66 1.584 . . . . 0.0 111.675 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -171.65 161.97 6.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.555 2.342 . . . . 0.0 109.863 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.75 148.97 39.97 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.884 -0.51 . . . . 0.0 111.666 170.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.95 136.95 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.515 1.126 . . . . 0.0 111.694 -169.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -117.15 146.83 42.94 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.844 1.658 . . . . 0.0 113.213 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -142.54 121.52 7.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.474 1.51 . . . . 0.0 111.797 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.77 149.99 61.31 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.094 2.529 . . . . 0.0 110.895 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -63.43 -19.42 64.69 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.4 mt -63.21 -33.67 75.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.422 1.089 . . . . 0.0 113.693 171.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.2 p -83.99 -9.35 58.73 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -89.9 73.6 7.43 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 111.87 -173.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -63.99 -41.24 97.58 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.042 -0.412 . . . . 0.0 112.058 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -134.03 129.6 36.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.098 1.759 . . . . 0.0 110.363 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -153.09 141.67 20.86 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.714 2.006 . . . . 0.0 109.764 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.67 179.44 41.56 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-O 122.053 0.807 . . . . 0.0 114.612 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -142.33 157.61 44.62 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.38 1.472 . . . . 0.0 112.56 -171.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.78 -173.17 4.28 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.699 2.0 . . . . 0.0 109.845 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 p -59.33 110.6 1.12 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.272 -0.892 . . . . 0.0 111.506 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 61.7 15.58 7.06 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 126.41 1.884 . . . . 0.0 114.268 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -133.04 129.3 37.9 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.231 1.378 . . . . 0.0 112.065 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -124.12 142.09 51.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.676 1.591 . . . . 0.0 110.474 171.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.8 t -153.87 157.06 38.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.489 1.116 . . . . 0.0 113.581 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.36 155.46 37.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.17 1.388 . . . . 0.0 113.488 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.04 154.32 17.7 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.142 1.777 . . . . 0.0 111.605 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 t -148.37 161.8 40.84 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.733 0.813 . . . . 0.0 113.054 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.37 173.63 19.75 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 126.481 1.991 . . . . 0.0 114.593 -170.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -26.54 68.44 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -169.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -81.21 -15.06 56.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.2 p -79.13 -178.45 6.16 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -61.62 -35.88 79.13 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.95 1.3 . . . . 0.0 113.341 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.9 p -99.41 -22.85 15.35 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.546 1.539 . . . . 0.0 114.374 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.76 -165.8 46.31 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.776 1.655 . . . . 0.0 112.925 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -58.34 132.48 53.76 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.006 0.922 . . . . 0.0 111.998 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.68 172.49 31.22 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 123.997 0.808 . . . . 0.0 113.375 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.7 mt -114.94 137.85 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.367 1.467 . . . . 0.0 108.261 169.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -131.53 126.9 36.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.745 1.218 . . . . 0.0 110.213 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.31 144.95 50.24 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.496 1.119 . . . . 0.0 113.284 -170.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -141.82 129.67 21.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.354 1.061 . . . . 0.0 111.75 -168.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -76.95 134.81 38.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.877 0.871 . . . . 0.0 111.608 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 22.3 p -174.45 137.31 0.49 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.635 1.974 . . . . 0.0 111.565 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -73.68 -3.8 30.42 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.993 -1.067 . . . . 0.0 113.273 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -110.94 13.31 22.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.163 2.585 . . . . 0.0 112.758 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.59 -43.25 35.86 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.204 1.402 . . . . 0.0 114.215 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -68.12 -35.18 77.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.521 0.728 . . . . 0.0 112.769 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.46 -31.27 66.98 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.379 -0.826 . . . . 0.0 112.141 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.42 -45.6 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.755 0.707 . . . . 0.0 109.861 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.82 -45.09 93.47 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.159 0.983 . . . . 0.0 111.735 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -65.24 -40.94 94.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.199 1.4 . . . . 0.0 112.261 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.5 tp -74.05 -38.57 63.95 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.955 0.798 . . . . 0.0 111.505 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 mt -54.76 -55.74 26.78 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.018 0.827 . . . . 0.0 111.247 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -62.17 -24.79 67.4 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -41.03 75.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.152 0.981 . . . . 0.0 112.219 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.7 mt -73.71 -40.12 63.82 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.787 0.835 . . . . 0.0 111.099 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 70.0 mmm -64.32 -34.0 77.13 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.912 1.285 . . . . 0.0 112.737 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -90.41 -12.97 35.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.4 t -61.82 -51.12 69.57 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.103 0.865 . . . . 0.0 111.713 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -152.52 119.63 5.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.705 1.602 . . . . 0.0 109.834 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 t -113.87 10.15 17.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.434 1.094 . . . . 0.0 112.529 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.3 mp -95.25 73.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.294 1.437 . . . . 0.0 109.384 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 43.2 45.54 4.88 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.542 2.337 . . . . 0.0 115.168 172.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.7 m -75.63 35.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 126.971 2.108 . . . . 0.0 114.021 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.6 mmt -128.29 26.45 5.72 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.274 2.23 . . . . 0.0 112.704 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -94.97 36.71 1.18 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.948 1.699 . . . . 0.0 112.284 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -127.91 148.38 66.98 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 126.279 1.832 . . . . 0.0 110.76 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.07 162.9 40.41 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.763 2.975 . . . . 0.0 111.977 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 83.5 t -102.7 129.27 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.97 1.308 . . . . 0.0 109.336 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.84 150.33 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.725 1.61 . . . . 0.0 109.012 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.4 pt -73.61 42.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.975 1.71 . . . . 0.0 113.006 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 88.2 m -54.08 117.34 3.15 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.917 2.087 . . . . 0.0 111.208 -172.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.29 7.67 35.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.498 1.519 . . . . 0.0 113.761 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -63.15 127.03 29.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.114 0.966 . . . . 0.0 110.877 173.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 t -162.08 95.25 0.95 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.326 1.051 . . . . 0.0 109.737 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -70.83 129.3 89.88 Favored Pre-proline 0 CA--C 1.551 0.989 0 O-C-N 121.265 -0.897 . . . . 0.0 111.822 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.11 163.23 39.38 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.115 2.543 . . . . 0.0 110.676 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -151.06 146.37 26.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.563 1.145 . . . . 0.0 111.112 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -68.98 154.5 41.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.458 0.703 . . . . 0.0 111.404 172.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.46 163.81 29.21 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.014 1.326 . . . . 0.0 112.186 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -116.12 131.32 56.97 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.371 1.468 . . . . 0.0 110.51 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.32 145.36 51.85 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.91 0.884 . . . . 0.0 110.742 174.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.14 165.65 25.65 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.146 2.564 . . . . 0.0 111.481 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -143.31 170.66 15.36 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.728 1.211 . . . . 0.0 112.207 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.12 148.07 35.57 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.225 1.41 . . . . 0.0 111.294 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -79.89 179.31 6.36 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.743 2.962 . . . . 0.0 110.281 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -134.57 131.62 20.39 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.28 1.032 . . . . 0.0 108.938 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.14 139.9 27.31 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.761 2.307 . . . . 0.0 111.132 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.84 163.06 34.12 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.541 2.827 . . . . 0.0 111.486 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -153.87 140.78 19.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.685 1.194 . . . . 0.0 111.961 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -165.09 160.44 18.8 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.093 1.757 . . . . 0.0 111.002 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 140' ' ' LEU . 2.1 pt? -77.72 37.48 0.23 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.895 1.678 . . . . 0.0 112.705 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.43 150.73 27.12 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.842 1.686 . . . . 0.0 110.907 -168.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -140.48 101.63 4.15 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.883 0.873 . . . . 0.0 111.692 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.6 m -151.46 114.85 4.81 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.154 1.782 . . . . 0.0 108.058 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.9 m -153.24 162.99 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.49 1.916 . . . . 0.0 110.251 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.6 t -157.24 163.77 38.43 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.941 1.296 . . . . 0.0 111.558 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 C--O 1.254 1.327 0 C-N-CA 126.476 1.911 . . . . 0.0 111.573 -174.427 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -143.28 127.18 17.28 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.973 1.309 . . . . 0.0 109.92 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -82.56 112.5 19.52 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.386 1.075 . . . . 0.0 111.256 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 57.8 mt -85.68 153.55 22.27 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.708 0.803 . . . . 0.0 112.103 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -88.34 -29.88 19.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.342 1.457 . . . . 0.0 112.794 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -137.86 157.09 47.14 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.235 1.814 . . . . 0.0 111.65 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -79.2 128.15 76.81 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.999 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -84.95 6.28 5.8 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.0 3.134 . . . . 0.0 114.066 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 t -127.01 139.44 53.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.411 1.485 . . . . 0.0 111.565 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.3 -39.38 7.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.182 0.896 . . . . 0.0 112.713 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.1 52.11 1.25 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.523 1.529 . . . . 0.0 113.199 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.53 141.66 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.236 -0.915 . . . . 0.0 111.407 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -111.42 118.44 35.81 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.388 1.475 . . . . 0.0 107.992 167.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -87.66 114.36 24.2 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.521 -0.737 . . . . 0.0 111.361 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.28 168.03 20.71 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.972 1.272 . . . . 0.0 114.255 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 55.11 36.61 27.35 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.452 1.501 . . . . 0.0 113.497 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -68.85 149.1 49.32 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.59 1.156 . . . . 0.0 111.044 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -144.47 159.4 42.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.251 1.42 . . . . 0.0 110.999 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 125.403 1.481 . . . . 0.0 112.905 -179.137 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t -163.29 164.8 24.76 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.469 1.507 . . . . 0.0 111.014 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 p -165.95 152.16 9.31 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.416 1.486 . . . . 0.0 112.119 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.53 170.02 47.94 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.489 1.042 . . . . 0.0 113.118 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.1 t -161.65 155.26 21.53 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.026 1.33 . . . . 0.0 111.357 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.5 p -166.34 164.64 17.51 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.704 1.602 . . . . 0.0 111.775 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.57 152.85 24.47 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.583 1.087 . . . . 0.0 113.077 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -165.12 173.13 11.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.34 1.856 . . . . 0.0 111.452 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -149.91 120.51 7.48 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.906 1.282 . . . . 0.0 110.881 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -145.93 157.55 43.89 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.995 2.118 . . . . 0.0 109.52 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -133.62 29.23 3.9 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.846 1.258 . . . . 0.0 113.922 -167.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -149.16 159.8 43.92 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.986 -1.071 . . . . 0.0 112.829 177.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.5 t -150.82 124.49 4.37 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 126.925 2.09 . . . . 0.0 108.395 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.08 164.05 19.94 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.177 2.585 . . . . 0.0 111.979 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -67.77 -8.06 32.57 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.52 1.128 . . . . 0.0 113.666 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -118.13 8.03 12.3 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.398 1.479 . . . . 0.0 114.427 -172.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -54.0 141.63 48.51 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 124.464 1.106 . . . . 0.0 112.679 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.71 -11.0 30.14 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.326 2.684 . . . . 0.0 115.086 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 p -130.32 -19.24 3.14 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.65 118.14 32.26 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.996 0.918 . . . . 0.0 111.295 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -116.37 105.42 12.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.328 1.051 . . . . 0.0 109.221 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -67.04 130.99 44.91 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.48 -0.763 . . . . 0.0 110.438 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.27 157.27 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.085 1.354 . . . . 0.0 112.024 -169.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.7 m -130.89 115.79 17.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.693 1.197 . . . . 0.0 108.822 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -62.34 128.42 35.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.372 0.533 . . . . 0.0 109.934 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.42 155.92 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.89 0.876 . . . . 0.0 112.522 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -87.26 -168.68 2.32 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.436 1.094 . . . . 0.0 113.758 179.001 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.37 -31.43 71.32 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.289 1.435 . . . . 0.0 114.344 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -84.06 -8.98 58.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.773 0.829 . . . . 0.0 113.018 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.24 15.62 78.17 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.431 -1.205 . . . . 0.0 113.979 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.422 HG22 ' OD1' ' A' ' 27' ' ' ASP . 18.6 m -79.72 150.61 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.49 1.645 . . . . 0.0 111.247 174.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -91.53 123.43 34.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.802 1.241 . . . . 0.0 110.922 -169.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.4 mt -106.55 -53.47 2.62 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.514 0.726 . . . . 0.0 112.114 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.77 160.98 29.32 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 125.535 1.541 . . . . 0.0 113.073 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 m -125.41 147.08 49.32 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.624 0.769 . . . . 0.0 112.824 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.86 174.58 30.13 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.775 1.655 . . . . 0.0 113.858 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.0 t -113.01 120.22 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.2 tpp -86.08 138.78 31.69 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.614 1.166 . . . . 0.0 109.819 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.1 130.0 26.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.672 1.589 . . . . 0.0 108.799 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.27 127.43 53.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.311 1.844 . . . . 0.0 107.344 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.1 p -127.55 172.83 10.37 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.802 1.241 . . . . 0.0 110.664 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -72.85 -0.48 13.59 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 121.235 -0.916 . . . . 0.0 112.541 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.1 t -106.47 -46.64 3.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.061 1.344 . . . . 0.0 112.971 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -174.8 174.41 2.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.943 1.297 . . . . 0.0 113.297 -166.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.9 138.61 31.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.234 1.014 . . . . 0.0 109.391 167.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.35 127.81 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.133 0.973 . . . . 0.0 111.109 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.17 130.73 46.34 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.816 1.647 . . . . 0.0 109.809 168.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -107.63 118.7 37.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.517 1.927 . . . . 0.0 110.188 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.6 mp -122.63 162.81 21.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.064 1.746 . . . . 0.0 110.929 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -90.9 -72.32 0.58 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.678 1.191 . . . . 0.0 113.08 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -74.12 -24.66 59.47 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -112.0 162.4 15.41 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.892 1.677 . . . . 0.0 110.297 174.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.6 158.9 23.1 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.697 1.599 . . . . 0.0 112.548 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.65 152.92 43.06 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.755 0.822 . . . . 0.0 111.877 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 t -134.76 133.78 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.67 0.788 . . . . 0.0 111.293 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -125.63 143.32 51.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.96 1.304 . . . . 0.0 112.311 -172.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 -140.11 112.53 7.41 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.788 1.235 . . . . 0.0 111.153 174.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.76 145.73 76.17 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.64 2.227 . . . . 0.0 110.284 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -60.33 -25.58 65.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.416 HD13 ' CD2' ' B' ' 16' ' ' TYR . 3.9 mm? -65.55 -38.84 90.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.028 1.331 . . . . 0.0 111.728 174.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.4 -5.31 58.57 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 99.3 mt -83.38 123.4 29.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.339 0.972 . . . . 0.0 109.861 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -83.94 -38.71 20.68 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.097 0.559 . . . . 0.0 112.123 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -161.97 156.18 21.99 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.462 1.505 . . . . 0.0 111.428 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -151.25 123.82 8.45 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.278 1.431 . . . . 0.0 109.538 -172.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.67 167.39 25.91 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 124.264 0.935 . . . . 0.0 113.795 -169.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -145.13 164.13 32.2 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.349 1.06 . . . . 0.0 113.342 -169.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -146.78 -166.99 2.64 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.223 2.209 . . . . 0.0 109.385 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 93.9 p -69.55 -19.06 63.7 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.277 -1.514 . . . . 0.0 114.71 -175.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -150.32 9.5 0.65 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.286 1.434 . . . . 0.0 114.032 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -137.42 132.21 33.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.774 1.63 . . . . 0.0 110.075 -169.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -126.89 139.66 52.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.078 1.751 . . . . 0.0 109.404 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.1 t -153.15 156.46 38.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.31 1.044 . . . . 0.0 112.448 -175.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -153.78 156.08 37.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.252 1.421 . . . . 0.0 111.901 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -116.86 137.65 52.06 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.743 1.617 . . . . 0.0 110.104 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -141.16 156.58 45.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.235 1.014 . . . . 0.0 112.011 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.6 175.39 37.24 Favored Glycine 0 N--CA 1.472 1.1 0 C-N-CA 125.458 1.504 . . . . 0.0 114.986 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -13.52 28.51 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -172.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.8 ptm85 -86.96 -15.82 37.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.58 1.552 . . . . 0.0 115.182 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.6 p -76.34 179.79 5.59 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.79 0.836 . . . . 0.0 112.81 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -59.01 -41.25 87.29 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.36 1.064 . . . . 0.0 113.052 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.3 p -92.09 -20.61 21.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.079 1.351 . . . . 0.0 113.758 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.59 -173.1 49.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.252 1.406 . . . . 0.0 112.43 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -67.7 127.65 33.56 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.55 0.74 . . . . 0.0 112.234 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.45 -177.39 38.62 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.124 0.869 . . . . 0.0 113.604 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -123.48 139.65 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.238 1.815 . . . . 0.0 109.128 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -134.63 126.96 30.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.127 1.371 . . . . 0.0 109.768 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.76 139.26 54.18 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.624 1.17 . . . . 0.0 112.442 -171.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -137.18 126.89 25.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.242 1.017 . . . . 0.0 111.549 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -74.25 134.46 42.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.644 0.777 . . . . 0.0 111.847 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.0 p -176.27 128.2 0.21 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.02 2.528 . . . . 0.0 110.331 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.4 m -68.36 -10.47 55.21 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.807 -1.183 . . . . 0.0 113.326 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -93.36 10.21 33.1 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.01 2.124 . . . . 0.0 112.883 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.9 -40.59 66.77 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.692 1.597 . . . . 0.0 114.658 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -70.95 -35.26 72.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.481 0.712 . . . . 0.0 112.68 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 -67.09 -37.58 84.2 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.199 -0.938 . . . . 0.0 111.314 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.6 mt -61.43 -46.34 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 118.751 0.705 . . . . 0.0 110.135 172.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.44 -43.16 97.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.382 1.073 . . . . 0.0 112.099 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -70.42 -32.32 69.88 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.245 1.018 . . . . 0.0 113.423 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -78.04 -37.33 47.07 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.126 0.875 . . . . 0.0 110.063 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.89 -52.02 65.54 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.434 -0.791 . . . . 0.0 112.567 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -60.24 -23.95 64.48 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.24 -17.51 52.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.991 1.317 . . . . 0.0 113.377 176.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.4 mt -102.41 -36.32 8.47 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.316 1.446 . . . . 0.0 111.929 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 62.7 mmm -61.7 -26.97 68.37 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.599 1.559 . . . . 0.0 112.741 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -13.88 62.05 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 35.7 t -71.3 -28.95 64.47 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -170.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 55.52 61.7 2.75 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.132 1.373 . . . . 0.0 110.755 -172.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.1 p -80.81 65.97 6.15 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.159 1.784 . . . . 0.0 112.814 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.2 mm -75.3 103.15 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.686 -1.259 . . . . 0.0 109.936 -174.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.9 p30 53.54 15.44 0.74 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 128.025 2.53 . . . . 0.0 116.342 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.96 -16.21 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 99.4 mtp -139.09 166.42 24.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.739 2.016 . . . . 0.0 111.782 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -52.53 114.58 1.42 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.582 1.953 . . . . 0.0 111.346 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -84.64 155.65 62.06 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -167.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.29 -169.56 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 124.327 3.351 . . . . 0.0 111.096 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.6 129.56 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.938 0.895 . . . . 0.0 109.924 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.35 146.05 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.781 1.632 . . . . 0.0 108.058 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.4 pt -67.65 20.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 126.713 2.005 . . . . 0.0 115.548 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.8 p -123.26 161.21 25.03 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.849 2.06 . . . . 0.0 111.143 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -64.21 107.72 1.38 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.331 1.053 . . . . 0.0 110.425 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -168.33 170.28 10.08 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.783 2.033 . . . . 0.0 110.047 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 t -70.08 139.74 52.62 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.124 -0.985 . . . . 0.0 110.481 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -128.78 136.6 29.4 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.973 1.309 . . . . 0.0 111.912 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.36 160.78 41.47 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.434 2.756 . . . . 0.0 112.218 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.09 -179.3 5.23 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.202 1.401 . . . . 0.0 112.682 175.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -120.8 161.91 20.68 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.873 1.669 . . . . 0.0 112.114 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.2 mt -111.71 151.51 28.81 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.159 1.384 . . . . 0.0 112.191 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.05 160.28 14.4 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.384 1.874 . . . . 0.0 112.795 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 pp -95.8 154.26 39.11 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.911 1.284 . . . . 0.0 112.541 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.84 150.85 27.45 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.06 2.507 . . . . 0.0 111.588 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -98.39 139.39 34.23 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.673 1.189 . . . . 0.0 111.127 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -77.22 149.17 78.99 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.685 1.194 . . . . 0.0 112.302 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.02 175.8 10.37 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.779 2.986 . . . . 0.0 111.667 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -126.59 147.81 62.06 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.136 1.375 . . . . 0.0 110.1 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.18 152.78 56.57 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.299 2.666 . . . . 0.0 112.105 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.86 174.77 12.16 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.026 3.151 . . . . 0.0 111.95 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -150.58 163.2 39.06 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.046 1.339 . . . . 0.0 112.232 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -156.93 170.55 22.26 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.709 1.604 . . . . 0.0 111.576 -174.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.2 tp -149.89 126.96 11.23 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.206 1.402 . . . . 0.0 110.234 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.96 -170.02 42.78 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.032 1.301 . . . . 0.0 113.562 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -156.13 150.22 25.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.155 1.382 . . . . 0.0 112.049 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 74.4 m -137.88 145.52 42.27 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.602 1.961 . . . . 0.0 108.987 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.9 p -131.5 140.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.569 1.548 . . . . 0.0 110.504 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.6 m -107.84 169.23 8.73 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.223 1.409 . . . . 0.0 113.301 -170.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.185 1.794 . . . . 0.0 113.5 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -132.36 124.62 29.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.382 1.073 . . . . 0.0 111.044 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -78.96 116.98 19.62 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.497 1.119 . . . . 0.0 110.957 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.8 mt -88.16 153.71 21.02 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.525 -0.734 . . . . 0.0 112.467 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -94.6 -2.11 52.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.815 1.646 . . . . 0.0 113.49 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -160.95 164.31 31.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.454 2.302 . . . . 0.0 110.737 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -94.78 119.01 66.68 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.227 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.39 -22.16 7.06 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.004 2.47 . . . . 0.0 113.489 -170.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.5 m -91.06 112.16 23.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.926 0.891 . . . . 0.0 111.047 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.18 -25.72 72.55 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.778 0.704 . . . . 0.0 112.881 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -91.97 119.17 31.46 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.675 1.19 . . . . 0.0 109.258 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.69 154.03 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.484 1.514 . . . . 0.0 110.749 -169.492 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -144.82 175.88 9.86 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.961 1.704 . . . . 0.0 112.25 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -138.62 134.08 33.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.637 1.575 . . . . 0.0 110.444 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.73 -25.4 5.18 Favored Glycine 0 N--CA 1.476 1.335 0 N-CA-C 115.561 0.984 . . . . 0.0 115.561 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 16' ' ' TYR . . . . . 0.416 ' CD2' HD13 ' A' ' 60' ' ' LEU . 51.3 m-85 -123.47 131.16 53.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.098 1.359 . . . . 0.0 110.361 -175.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -163.55 158.72 21.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.81 1.644 . . . . 0.0 111.162 -169.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -83.97 53.3 2.54 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.306 1.442 . . . . 0.0 112.977 -175.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.702 1.601 . . . . 0.0 111.756 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -164.09 168.72 18.76 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.231 1.412 . . . . 0.0 111.385 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -151.67 145.45 25.08 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.899 1.68 . . . . 0.0 110.937 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.35 -167.77 40.75 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.498 1.046 . . . . 0.0 113.495 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -163.71 179.28 7.25 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.567 1.547 . . . . 0.0 111.131 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 p -160.17 144.34 14.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.555 1.542 . . . . 0.0 111.9 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.12 -171.71 30.77 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.139 1.352 . . . . 0.0 113.153 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.75 139.57 47.22 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.34 1.056 . . . . 0.0 111.208 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -90.56 18.48 6.26 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.648 1.579 . . . . 0.0 113.757 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -74.83 28.32 0.09 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.581 2.352 . . . . 0.0 115.403 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -149.77 150.71 32.45 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.052 1.741 . . . . 0.0 110.952 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.8 m -76.4 139.34 40.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.812 0.845 . . . . 0.0 111.919 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 p -54.34 123.32 42.15 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 124.367 1.067 . . . . 0.0 111.964 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -84.08 159.58 13.51 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.093 2.528 . . . . 0.0 110.543 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -68.29 -14.11 62.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.959 0.903 . . . . 0.0 113.293 173.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -106.46 9.87 31.53 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.519 1.928 . . . . 0.0 113.863 -172.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -59.97 145.54 84.35 Favored Pre-proline 0 CA--C 1.557 1.244 0 O-C-N 120.82 -1.175 . . . . 0.0 112.431 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.33 -11.02 26.37 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.899 2.399 . . . . 0.0 115.259 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.7 p -130.96 -16.95 3.17 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 120.373 1.442 . . . . 0.0 114.088 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -111.61 144.69 40.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.816 1.247 . . . . 0.0 110.579 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -140.83 119.17 12.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.159 0.983 . . . . 0.0 109.099 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -70.24 129.71 40.07 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.65 -0.656 . . . . 0.0 110.227 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 m -136.74 160.73 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.844 1.658 . . . . 0.0 110.889 -170.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -132.75 118.79 19.48 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.857 0.863 . . . . 0.0 109.193 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.26 128.68 36.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.038 0.935 . . . . 0.0 110.164 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -124.34 155.03 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.918 0.887 . . . . 0.0 113.382 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' CG ' HG22 ' A' ' 31' ' ' VAL . 3.5 p-10 -83.51 -170.85 3.26 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.49 -24.15 67.7 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -92.82 -6.22 49.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.142 1.777 . . . . 0.0 112.642 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.19 15.2 75.08 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.282 -1.288 . . . . 0.0 114.29 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG22 ' CG ' ' A' ' 27' ' ' ASP . 3.3 m -76.67 143.98 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.721 1.76 . . . . 0.0 110.849 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -88.24 119.45 28.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.078 1.351 . . . . 0.0 110.495 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.6 mt -104.93 -54.73 2.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.149 0.58 . . . . 0.0 112.025 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.26 142.61 10.41 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 124.834 1.207 . . . . 0.0 113.799 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.5 p -94.56 142.19 27.73 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.943 1.297 . . . . 0.0 112.354 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.75 171.28 29.1 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.736 1.636 . . . . 0.0 113.486 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.56 120.71 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.2 tpp -87.19 139.23 30.77 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.698 1.199 . . . . 0.0 109.67 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.07 128.82 24.76 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.7 1.6 . . . . 0.0 108.667 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mp -108.52 134.26 51.54 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.211 1.804 . . . . 0.0 108.138 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.3 p -134.26 170.76 15.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.117 1.367 . . . . 0.0 109.745 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.05 -5.93 30.14 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.233 -0.917 . . . . 0.0 113.076 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.5 t -107.48 -43.52 4.52 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.247 1.019 . . . . 0.0 113.34 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -169.88 169.04 8.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.41 1.084 . . . . 0.0 113.194 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.2 mt -86.74 142.4 28.18 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.535 1.134 . . . . 0.0 110.031 168.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.69 130.15 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.616 1.166 . . . . 0.0 110.847 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.1 mt -105.55 133.62 49.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.145 1.778 . . . . 0.0 110.565 168.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -115.8 117.84 31.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.872 2.069 . . . . 0.0 110.329 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.0 mp -124.51 159.96 29.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.662 1.585 . . . . 0.0 110.57 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -100.92 -7.15 23.7 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -114.99 0.18 13.59 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.472 1.909 . . . . 0.0 113.634 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -148.36 157.3 43.39 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.697 1.999 . . . . 0.0 110.22 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -61.68 159.24 13.76 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.427 1.091 . . . . 0.0 110.414 168.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.34 140.97 58.92 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.475 -0.766 . . . . 0.0 111.413 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.58 136.33 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.917 0.887 . . . . 0.0 110.757 -172.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -134.44 148.96 50.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -140.76 112.58 6.97 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.426 1.491 . . . . 0.0 111.059 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.66 148.11 86.75 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.794 2.329 . . . . 0.0 110.347 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -61.95 -19.69 63.03 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.53 -44.83 95.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.635 1.574 . . . . 0.0 112.974 171.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.2 p -77.4 -15.18 59.5 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.94 115.14 10.8 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.783 0.833 . . . . 0.0 109.986 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -79.08 -32.67 44.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.447 1.099 . . . . 0.0 111.723 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -166.6 159.88 14.61 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.228 1.811 . . . . 0.0 111.528 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -150.07 126.35 10.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.167 1.387 . . . . 0.0 110.804 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.9 172.63 24.41 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.976 1.274 . . . . 0.0 113.45 -170.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -153.49 145.72 23.85 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.161 0.985 . . . . 0.0 112.161 -170.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -141.04 -177.5 5.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.469 1.908 . . . . 0.0 109.362 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -59.45 117.45 4.87 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.019 -1.051 . . . . 0.0 110.708 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.8 t30 60.54 12.85 3.8 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 127.111 2.165 . . . . 0.0 115.158 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -133.91 127.38 32.35 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.752 1.614 . . . . 0.0 111.922 -169.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -122.15 140.94 51.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.824 1.65 . . . . 0.0 109.972 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 t -153.55 155.34 35.99 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.047 -1.033 . . . . 0.0 112.886 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -147.97 153.58 39.2 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.245 1.418 . . . . 0.0 111.88 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -111.35 141.16 45.26 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.574 1.55 . . . . 0.0 109.439 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 p -138.91 150.56 46.08 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.786 0.834 . . . . 0.0 112.7 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.59 173.82 46.01 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.957 1.265 . . . . 0.0 113.715 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -63.66 -14.8 55.32 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -77.44 -16.84 58.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.128 1.771 . . . . 0.0 115.292 -176.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.2 p -79.29 -179.07 6.54 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.32 1.048 . . . . 0.0 113.498 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -62.02 -36.65 82.2 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.54 1.136 . . . . 0.0 113.296 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -94.94 -20.81 19.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.079 1.352 . . . . 0.0 114.338 -174.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.31 -179.07 49.38 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.886 1.232 . . . . 0.0 112.02 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -65.82 129.52 40.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.878 0.871 . . . . 0.0 111.823 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.09 -177.22 42.36 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 122.143 0.857 . . . . 0.0 113.508 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.2 mt -121.75 139.26 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.046 1.739 . . . . 0.0 108.698 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -133.85 128.06 33.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.971 1.308 . . . . 0.0 110.035 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.89 142.72 51.39 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.649 1.179 . . . . 0.0 112.725 -172.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -139.17 129.71 25.82 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.69 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -72.35 133.35 44.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.001 0.52 . . . . 0.0 110.754 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.0 t -168.46 124.34 0.98 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.185 1.794 . . . . 0.0 111.044 -171.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.8 m -70.97 -9.48 58.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -117.68 22.48 12.32 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.434 1.894 . . . . 0.0 112.405 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.67 -38.15 31.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.265 1.426 . . . . 0.0 114.299 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.56 -36.66 73.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.751 0.82 . . . . 0.0 112.926 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -65.07 -40.09 94.19 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.58 -0.7 . . . . 0.0 110.788 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.19 -47.89 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.941 0.497 . . . . 0.0 110.296 173.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.31 -44.64 92.54 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.555 1.142 . . . . 0.0 112.11 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -70.0 -33.63 72.29 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.854 0.862 . . . . 0.0 113.088 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -74.88 -41.67 59.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.951 0.796 . . . . 0.0 110.4 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.3 mt -52.12 -55.13 22.82 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.728 0.811 . . . . 0.0 112.869 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.59 -25.43 68.07 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.88 -29.42 68.52 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.505 1.048 . . . . 0.0 112.677 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.6 mt -96.09 -39.38 9.76 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.354 1.462 . . . . 0.0 110.999 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.3 mtp -70.82 -29.76 66.01 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.306 1.042 . . . . 0.0 113.3 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -65.27 -20.0 66.22 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 14.1 t -71.37 -26.17 62.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.372 0.669 . . . . 0.0 112.539 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 50.61 38.92 20.17 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.379 1.472 . . . . 0.0 112.582 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.5 t -60.82 135.04 57.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.58 -41.67 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.213 1.405 . . . . 0.0 109.616 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -70.7 -12.97 61.88 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.7 m -88.06 3.7 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.511 1.125 . . . . 0.0 113.422 171.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 47.0 mtt -136.61 -179.11 5.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.304 1.842 . . . . 0.0 111.283 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -79.77 175.66 10.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.032 0.933 . . . . 0.0 111.72 169.656 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.66 143.99 80.89 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.742 0.817 . . . . 0.0 112.984 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.92 159.12 53.54 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.579 2.853 . . . . 0.0 112.147 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -116.44 135.13 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.452 1.501 . . . . 0.0 110.658 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mp -87.91 121.93 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.663 1.185 . . . . 0.0 108.199 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.9 mt -89.2 108.89 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.606 0.763 . . . . 0.0 109.454 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.4 t -63.8 -32.12 73.53 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.89 1.276 . . . . 0.0 113.525 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -89.86 111.43 22.47 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.019 0.928 . . . . 0.0 110.052 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -154.56 160.0 41.23 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.266 1.426 . . . . 0.0 111.563 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -172.04 171.03 5.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.542 1.937 . . . . 0.0 110.286 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -158.09 147.57 15.01 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 125.704 1.602 . . . . 0.0 112.388 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.4 166.8 28.63 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.701 2.934 . . . . 0.0 111.425 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -134.22 126.64 30.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.619 1.167 . . . . 0.0 110.931 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -147.63 146.03 29.2 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.303 2.241 . . . . 0.0 108.993 -175.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.1 tp -156.78 131.21 8.65 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.544 1.138 . . . . 0.0 110.845 -176.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -85.71 166.65 15.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.356 1.462 . . . . 0.0 112.715 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.92 144.82 48.08 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.824 1.25 . . . . 0.0 111.91 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -80.51 160.25 22.39 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.833 3.022 . . . . 0.0 111.656 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -156.96 160.05 38.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.052 1.341 . . . . 0.0 111.868 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -164.55 148.17 7.72 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 126.153 1.781 . . . . 0.0 111.156 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.06 175.74 10.93 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.662 2.908 . . . . 0.0 111.0 172.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -128.07 116.11 20.38 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.294 1.038 . . . . 0.0 109.161 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.63 139.2 15.8 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.649 2.233 . . . . 0.0 111.108 -173.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.94 159.91 37.53 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.48 2.787 . . . . 0.0 111.271 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -156.05 132.47 10.17 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.308 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -159.26 135.92 9.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.537 1.535 . . . . 0.0 110.889 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.7 tp -163.01 131.06 3.75 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.092 1.757 . . . . 0.0 109.513 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.99 142.97 12.31 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.906 1.241 . . . . 0.0 112.512 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -163.91 158.64 20.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.881 1.672 . . . . 0.0 111.429 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 45.3 p -138.93 156.28 47.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.838 1.655 . . . . 0.0 110.88 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.1 m -143.76 156.44 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.921 1.689 . . . . 0.0 110.938 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.2 m -110.75 134.3 52.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.756 1.222 . . . . 0.0 111.512 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.254 1.335 0 C-N-CA 126.118 1.767 . . . . 0.0 111.388 -177.566 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -102.41 121.37 42.19 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.396 0.678 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -78.97 109.24 13.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.996 1.319 . . . . 0.0 111.005 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.53 153.4 24.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.536 0.735 . . . . 0.0 112.024 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -81.73 -28.22 33.47 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.89 1.276 . . . . 0.0 112.534 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -157.03 162.83 39.54 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.441 1.896 . . . . 0.0 111.359 -170.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -78.56 132.22 65.93 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 121.542 -0.724 . . . . 0.0 111.55 -173.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -83.62 -4.78 10.8 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.321 2.681 . . . . 0.0 114.358 -171.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 14.6 t -122.84 145.45 48.43 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.606 1.094 . . . . 0.0 113.44 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.08 -4.53 71.67 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.609 1.576 . . . . 0.0 114.532 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -119.39 123.23 43.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.791 1.636 . . . . 0.0 109.828 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -157.11 152.25 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.394 1.078 . . . . 0.0 110.882 -167.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -122.53 146.94 46.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.134 1.374 . . . . 0.0 110.307 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -118.7 112.3 19.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.157 1.783 . . . . 0.0 110.068 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.27 -64.15 0.9 Allowed Glycine 0 N--CA 1.473 1.155 0 C-N-CA 124.302 0.953 . . . . 0.0 112.874 -172.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -86.68 3.03 46.42 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -130.57 116.62 18.4 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.858 1.263 . . . . 0.0 109.02 171.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -90.06 71.82 7.38 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.383 1.073 . . . . 0.0 109.664 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 C-N-CA 125.695 1.598 . . . . 0.0 114.461 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.519 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.0 p -161.41 158.1 26.24 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.332 1.453 . . . . 0.0 110.724 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.5 t -165.66 167.2 17.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.134 1.374 . . . . 0.0 111.121 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.42 174.61 43.17 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.156 1.36 . . . . 0.0 113.549 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.5 t -158.92 134.06 8.37 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 110.559 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.5 m -169.92 143.47 2.58 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.983 2.113 . . . . 0.0 110.084 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.47 -136.95 30.31 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.679 0.657 . . . . 0.0 112.349 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt -105.56 131.14 53.33 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.989 1.316 . . . . 0.0 110.175 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -87.54 147.19 25.46 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.05 1.34 . . . . 0.0 112.721 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.06 141.94 49.24 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.526 0.73 . . . . 0.0 112.667 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -159.55 147.1 17.04 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.238 2.215 . . . . 0.0 110.008 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t 62.67 24.15 14.38 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.626 1.17 . . . . 0.0 113.247 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.5 t -58.14 128.04 81.09 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 125.565 1.546 . . . . 0.0 111.138 -170.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.13 148.96 85.85 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.155 2.57 . . . . 0.0 111.053 175.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -62.79 -8.05 6.13 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -124.04 19.96 9.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.318 1.447 . . . . 0.0 114.281 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -53.4 141.54 42.65 Favored Pre-proline 0 CA--C 1.557 1.215 0 O-C-N 121.171 -0.956 . . . . 0.0 113.4 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.67 -10.44 26.58 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.246 2.63 . . . . 0.0 115.177 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.2 p -128.87 -21.1 3.4 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -115.51 134.66 54.86 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.024 0.929 . . . . 0.0 110.83 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.29 121.19 24.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.214 1.406 . . . . 0.0 107.97 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 140.91 44.15 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.28 -0.888 . . . . 0.0 110.447 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.3 m -145.18 163.24 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.295 1.038 . . . . 0.0 111.608 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.1 m -143.87 123.2 13.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.427 1.091 . . . . 0.0 108.774 170.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.46 132.86 51.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.16 0.984 . . . . 0.0 110.339 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.67 156.08 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.806 1.242 . . . . 0.0 113.018 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' A' ' 31' ' ' VAL . 2.3 p-10 -93.37 -165.53 1.35 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.644 1.578 . . . . 0.0 114.309 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.14 -35.1 72.91 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.035 1.334 . . . . 0.0 113.656 172.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.27 -13.04 58.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.039 0.836 . . . . 0.0 113.167 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.72 17.84 74.37 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 118.295 -1.28 . . . . 0.0 113.624 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG22 ' OD1' ' A' ' 27' ' ' ASP . 11.3 m -76.31 150.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.537 1.669 . . . . 0.0 111.145 173.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.1 123.99 32.76 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.276 1.031 . . . . 0.0 111.309 -171.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.7 mt -104.85 -50.06 3.36 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.551 1.14 . . . . 0.0 111.786 -172.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.91 132.38 3.44 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 124.684 1.135 . . . . 0.0 113.633 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p -85.44 149.45 25.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.938 1.295 . . . . 0.0 112.635 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.41 171.7 39.18 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.829 1.204 . . . . 0.0 114.391 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.9 t -113.25 120.34 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 39.1 tpp -86.02 132.03 34.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.762 0.825 . . . . 0.0 109.424 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -128.89 128.74 44.43 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.869 1.668 . . . . 0.0 108.272 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.52 125.43 50.99 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.024 1.73 . . . . 0.0 108.029 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -131.59 168.29 17.95 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.684 1.193 . . . . 0.0 110.072 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -65.17 -10.87 34.74 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.121 0.569 . . . . 0.0 112.344 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -95.91 -41.89 8.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.42 1.088 . . . . 0.0 113.114 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -177.68 171.16 1.91 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.131 1.372 . . . . 0.0 112.837 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -87.29 136.64 32.85 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.064 0.945 . . . . 0.0 109.012 167.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.54 130.95 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.886 0.874 . . . . 0.0 111.492 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 mt -100.34 130.04 46.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.502 1.121 . . . . 0.0 110.532 168.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -106.26 131.53 53.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.461 1.904 . . . . 0.0 110.961 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mp -135.19 151.62 50.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.709 1.603 . . . . 0.0 110.73 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -70.07 112.81 6.71 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.632 -0.668 . . . . 0.0 111.984 173.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? 59.65 13.63 3.53 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.663 1.985 . . . . 0.0 115.859 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -107.99 160.39 15.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.058 1.743 . . . . 0.0 110.707 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -62.29 137.14 58.2 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.654 0.782 . . . . 0.0 110.496 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.75 151.72 46.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.52 0.728 . . . . 0.0 111.266 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 t -131.04 128.52 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.569 0.747 . . . . 0.0 110.79 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.29 147.18 48.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.442 1.497 . . . . 0.0 112.588 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -139.34 118.99 9.23 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.795 1.238 . . . . 0.0 111.437 173.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.89 146.25 64.9 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.503 2.135 . . . . 0.0 109.559 171.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -59.73 -26.41 65.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.1 mt -58.17 -27.76 64.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.281 1.833 . . . . 0.0 114.397 171.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.5 p -90.56 -9.71 46.13 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -94.6 84.96 4.38 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.873 1.269 . . . . 0.0 110.932 -172.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -73.44 -19.42 60.96 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.483 ' HG3' HG21 ' B' ' 12' ' ' VAL . 54.5 ttp180 -157.84 123.52 4.6 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.836 1.655 . . . . 0.0 110.051 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -140.87 109.66 6.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.987 1.715 . . . . 0.0 111.097 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.63 169.89 13.11 Favored Glycine 0 N--CA 1.462 0.411 0 C-N-CA 124.713 1.149 . . . . 0.0 113.731 -169.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -140.35 159.46 42.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.39 1.076 . . . . 0.0 112.738 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -154.45 174.98 14.15 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.508 2.323 . . . . 0.0 109.643 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 m -61.34 -12.56 14.36 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -172.052 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -154.63 18.29 0.46 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.151 1.38 . . . . 0.0 112.865 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.53 128.35 18.33 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.472 -1.393 . . . . 0.0 110.486 -169.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -118.98 133.2 55.98 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.124 1.77 . . . . 0.0 108.852 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 t -153.04 151.11 29.87 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.013 -1.054 . . . . 0.0 112.494 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -149.67 148.75 29.66 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.99 0.916 . . . . 0.0 112.388 -173.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -104.8 135.09 46.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.293 1.437 . . . . 0.0 110.058 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -126.47 145.89 50.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.292 1.037 . . . . 0.0 112.188 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.1 168.23 46.57 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.41 1.005 . . . . 0.0 113.282 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -65.94 -11.35 46.79 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -70.14 -19.87 63.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.659 1.584 . . . . 0.0 114.967 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -85.87 -179.88 6.9 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -63.21 -39.28 94.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.488 1.115 . . . . 0.0 113.181 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.5 p -96.45 -22.61 17.02 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.972 1.309 . . . . 0.0 113.492 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.99 -162.04 29.67 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.566 2.031 . . . . 0.0 113.644 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -56.75 125.88 24.34 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.354 1.062 . . . . 0.0 111.524 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.78 171.98 27.47 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.453 1.025 . . . . 0.0 113.304 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.2 mt -115.04 131.45 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.531 1.532 . . . . 0.0 108.337 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.49 113.64 18.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.91 1.284 . . . . 0.0 109.669 -172.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.27 140.57 45.73 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.177 1.391 . . . . 0.0 112.298 -173.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -138.76 125.55 20.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.199 1.0 . . . . 0.0 111.405 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -63.75 126.79 28.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.822 0.849 . . . . 0.0 110.434 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.6 t -167.86 126.65 1.25 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.635 1.574 . . . . 0.0 111.462 -170.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -69.74 -44.21 70.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.185 0.594 . . . . 0.0 112.459 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.1 mtm-85 -90.45 31.28 1.04 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.566 1.546 . . . . 0.0 113.889 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.04 -37.32 61.47 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.666 1.187 . . . . 0.0 113.967 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -70.53 -36.85 73.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.598 0.759 . . . . 0.0 112.843 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -64.54 -42.11 95.93 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.719 -0.613 . . . . 0.0 110.249 173.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.97 -48.44 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.322 0.649 . . . . 0.0 110.626 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.52 -40.47 83.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.51 1.124 . . . . 0.0 112.304 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -73.75 -31.87 63.55 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -77.93 -39.04 44.11 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.064 0.847 . . . . 0.0 110.342 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.51 -53.0 19.78 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.223 1.409 . . . . 0.0 113.852 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -64.82 -22.54 67.01 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -74.05 -25.06 59.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.088 0.955 . . . . 0.0 112.547 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.2 mt -96.47 -32.67 12.19 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.138 1.375 . . . . 0.0 111.795 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.1 mtt -55.1 -40.2 70.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.566 0.746 . . . . 0.0 112.685 171.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -75.05 -17.34 60.51 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 10.3 t -91.76 -22.15 20.33 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.32 1.448 . . . . 0.0 112.306 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -68.33 176.32 2.86 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.782 2.033 . . . . 0.0 114.399 -173.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.0 m 73.74 41.71 0.42 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.34 1.856 . . . . 0.0 111.908 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 mp -85.37 71.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.579 1.151 . . . . 0.0 109.893 -173.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 54.97 49.06 18.52 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.19 1.396 . . . . 0.0 112.094 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.4 m -60.22 -9.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -172.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.06 112.5 3.01 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.229 0.922 . . . . 0.0 110.239 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -161.91 167.15 25.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.908 1.683 . . . . 0.0 109.783 -169.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.69 145.37 61.81 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.443 1.097 . . . . 0.0 113.258 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.62 159.93 49.68 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.689 2.926 . . . . 0.0 112.105 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.6 t -113.28 126.11 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.177 1.391 . . . . 0.0 109.506 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.1 mp -78.38 129.91 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.439 1.096 . . . . 0.0 108.908 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.5 pt -73.05 136.27 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.858 -0.526 . . . . 0.0 111.927 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.8 p -78.39 161.88 26.83 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.335 1.454 . . . . 0.0 110.515 171.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.2 tpp85 -45.81 123.38 4.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.246 1.418 . . . . 0.0 111.752 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -63.98 124.21 21.0 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.279 1.032 . . . . 0.0 111.476 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.1 t -66.31 148.14 52.28 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.315 0.578 . . . . 0.0 112.158 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -63.35 143.67 97.72 Favored Pre-proline 0 CA--C 1.556 1.19 0 O-C-N 120.985 -1.072 . . . . 0.0 113.45 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.21 178.27 7.52 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.924 3.083 . . . . 0.0 111.759 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -144.04 169.75 17.25 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.535 1.534 . . . . 0.0 111.686 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.28 148.08 52.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.322 1.049 . . . . 0.0 112.085 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.42 171.41 9.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.101 1.76 . . . . 0.0 112.008 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -140.48 135.78 32.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.214 1.406 . . . . 0.0 110.545 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 pp -79.86 137.21 54.12 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.035 0.934 . . . . 0.0 110.834 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.94 126.48 8.76 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.411 2.074 . . . . 0.0 110.146 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -63.68 151.23 42.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.117 0.967 . . . . 0.0 111.374 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.13 144.3 60.34 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 124.709 1.203 . . . . 0.0 113.104 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.48 -178.54 4.55 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.281 3.321 . . . . 0.0 111.962 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -143.65 148.34 42.79 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.158 1.383 . . . . 0.0 110.761 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.1 131.76 15.83 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.963 2.442 . . . . 0.0 111.037 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.69 149.48 20.9 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.333 2.689 . . . . 0.0 111.448 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -90.58 140.76 29.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.108 0.963 . . . . 0.0 111.353 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -154.09 156.18 36.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.275 1.43 . . . . 0.0 111.598 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 pp -76.25 160.06 30.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.654 1.182 . . . . 0.0 113.021 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -86.82 -99.32 0.82 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 125.207 1.384 . . . . 0.0 111.434 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -158.85 150.05 20.41 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.887 1.275 . . . . 0.0 112.425 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 m -93.25 2.06 56.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.839 1.656 . . . . 0.0 113.675 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.1 t 68.06 35.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 126.189 1.795 . . . . 0.0 111.025 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.4 m -83.72 25.99 0.74 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.786 1.634 . . . . 0.0 114.044 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.255 1.379 0 C-N-CA 126.193 1.797 . . . . 0.0 113.129 179.202 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.981 -0.533 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -154.59 -175.88 5.63 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.389 1.875 . . . . 0.0 110.623 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.81 94.73 2.63 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.755 2.022 . . . . 0.0 110.514 172.096 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 15.8 mt -67.78 150.03 49.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.032 0.933 . . . . 0.0 112.521 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -84.92 -14.71 46.83 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -159.44 165.26 33.51 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.548 1.539 . . . . 0.0 111.708 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -87.0 123.33 70.44 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.091 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.48 -20.46 5.81 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.283 2.655 . . . . 0.0 114.009 -171.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 82.6 m -89.76 129.53 36.15 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.982 0.913 . . . . 0.0 111.937 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.25 -3.16 84.99 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.696 1.141 . . . . 0.0 114.795 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -141.49 136.82 31.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.326 1.451 . . . . 0.0 109.668 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.483 HG21 ' HG3' ' A' ' 64' ' ' ARG . 2.7 p -164.94 142.24 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.553 1.541 . . . . 0.0 111.36 -169.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -109.68 127.81 54.82 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.864 2.066 . . . . 0.0 109.243 172.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -83.02 117.85 23.11 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.692 0.797 . . . . 0.0 110.905 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.15 -110.67 1.41 Allowed Glycine 0 N--CA 1.469 0.884 0 C-N-CA 124.959 1.266 . . . . 0.0 112.082 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -62.47 111.39 2.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.072 0.949 . . . . 0.0 110.613 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -158.13 152.28 24.22 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.382 1.473 . . . . 0.0 109.197 -168.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -69.7 126.7 30.52 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.938 -0.476 . . . . 0.0 111.581 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 C--O 1.252 1.225 0 C-N-CA 125.639 1.576 . . . . 0.0 111.536 171.48 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 m -163.49 145.19 9.49 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.404 1.882 . . . . 0.0 110.441 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -166.58 177.99 6.29 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.422 1.489 . . . . 0.0 111.379 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 122.74 144.73 6.76 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 126.199 1.857 . . . . 0.0 113.223 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.9 t -167.95 162.06 13.22 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.291 1.837 . . . . 0.0 110.614 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.1 m -151.88 138.36 18.6 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.179 1.392 . . . . 0.0 111.531 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.63 179.03 30.29 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.097 1.332 . . . . 0.0 113.61 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.89 166.3 28.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.568 1.947 . . . . 0.0 111.578 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -157.82 157.27 32.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.167 1.387 . . . . 0.0 111.455 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -142.3 139.18 31.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.062 1.745 . . . . 0.0 111.234 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -81.57 -18.6 44.3 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.473 1.109 . . . . 0.0 113.432 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.7 t -162.08 171.6 17.25 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.845 1.658 . . . . 0.0 110.355 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.19 119.14 70.08 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.438 1.095 . . . . 0.0 110.252 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.61 166.75 23.49 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.224 2.616 . . . . 0.0 111.304 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.65 -5.15 7.55 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.65 1.18 . . . . 0.0 113.274 171.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -129.86 21.75 5.42 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.198 1.799 . . . . 0.0 114.043 -169.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -58.23 146.64 69.82 Favored Pre-proline 0 CA--C 1.56 1.342 0 O-C-N 120.886 -1.133 . . . . 0.0 112.899 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.72 -17.85 25.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.876 2.384 . . . . 0.0 115.253 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.1 p -127.51 -20.29 4.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.386 1.448 . . . . 0.0 114.688 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 149.63 28.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.11 0.868 . . . . 0.0 110.109 169.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.52 109.11 6.57 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -68.97 130.58 43.18 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.59 -0.694 . . . . 0.0 109.93 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.2 m -139.6 164.86 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.758 1.223 . . . . 0.0 112.219 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.4 m -139.62 121.03 15.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.785 1.234 . . . . 0.0 108.615 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -66.61 133.18 49.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.819 0.448 . . . . 0.0 110.127 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.39 155.63 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.085 0.954 . . . . 0.0 112.592 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -82.3 -166.95 1.39 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.452 1.501 . . . . 0.0 113.12 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -66.18 -33.71 76.38 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -81.6 -28.69 33.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.322 0.964 . . . . 0.0 112.173 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.22 16.88 7.5 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 125.202 1.382 . . . . 0.0 112.261 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 t -74.3 140.53 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.345 2.258 . . . . 0.0 108.948 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -88.36 123.77 33.26 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.529 1.532 . . . . 0.0 110.393 -171.146 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.9 mt -108.52 -53.25 2.66 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.896 0.878 . . . . 0.0 112.575 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.98 142.01 9.17 Favored Glycine 0 N--CA 1.47 0.953 0 C-N-CA 124.82 1.2 . . . . 0.0 113.602 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -87.89 148.03 24.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.633 1.173 . . . . 0.0 112.666 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.03 170.09 33.73 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.529 1.061 . . . . 0.0 114.045 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.3 t -116.85 120.41 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 38.4 tpp -88.16 139.56 30.38 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.942 1.297 . . . . 0.0 110.204 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.01 130.25 25.18 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.791 1.636 . . . . 0.0 109.185 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mp -106.46 138.54 42.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.67 1.988 . . . . 0.0 108.313 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -140.27 174.47 10.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.086 1.355 . . . . 0.0 111.049 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -76.73 9.57 2.74 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.259 -0.901 . . . . 0.0 112.535 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.6 t -118.19 -49.64 2.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.95 1.3 . . . . 0.0 112.954 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -173.3 171.3 4.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.072 1.349 . . . . 0.0 112.509 -168.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 mt -85.8 140.15 30.69 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.77 0.828 . . . . 0.0 109.528 168.068 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 36.0 t -134.61 127.88 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.884 0.874 . . . . 0.0 111.418 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.9 mt -100.38 132.92 45.49 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.169 1.388 . . . . 0.0 109.696 167.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -107.6 125.45 51.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.623 1.969 . . . . 0.0 110.315 171.411 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.23 171.62 13.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.346 1.858 . . . . 0.0 111.279 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -124.68 -8.44 7.35 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -116.71 7.98 13.63 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 126.214 1.806 . . . . 0.0 112.477 170.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -150.63 159.12 44.72 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 128.018 2.527 . . . . 0.0 109.696 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -67.29 160.1 27.83 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.966 0.506 . . . . 0.0 110.022 168.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.38 150.04 40.77 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.742 -0.599 . . . . 0.0 111.453 172.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.5 t -129.24 127.15 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.459 0.704 . . . . 0.0 111.118 -175.121 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.9 mtm-85 -119.14 143.63 47.09 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.204 1.802 . . . . 0.0 112.153 -169.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -139.37 114.2 8.16 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.367 1.067 . . . . 0.0 111.936 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.72 143.65 68.56 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.98 2.453 . . . . 0.0 110.391 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -60.71 -21.79 63.29 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.03 -46.76 89.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.946 1.698 . . . . 0.0 111.728 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 p -78.2 -17.31 56.93 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.53 65.96 6.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.993 1.717 . . . . 0.0 111.111 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -70.89 -24.15 62.43 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -172.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.619 ' HG3' HG21 ' B' ' 12' ' ' VAL . 53.0 ttp180 -147.43 118.53 7.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.157 1.783 . . . . 0.0 108.492 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -140.54 110.77 6.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.322 1.849 . . . . 0.0 110.717 -173.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.88 168.19 15.16 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 124.644 1.116 . . . . 0.0 114.104 -168.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -138.63 163.14 32.85 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.578 1.151 . . . . 0.0 112.648 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -148.7 -169.95 3.49 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.06 2.144 . . . . 0.0 109.524 170.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.3 m -68.4 -14.86 63.3 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -156.49 11.75 0.26 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.49 1.516 . . . . 0.0 114.126 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -136.59 129.89 31.52 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.915 1.686 . . . . 0.0 110.06 -168.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -123.39 135.85 54.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.924 1.69 . . . . 0.0 109.249 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 t -153.02 155.68 37.37 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.219 1.008 . . . . 0.0 112.277 -174.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.34 154.69 32.43 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.269 1.028 . . . . 0.0 112.647 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HG3' ' HE ' ' A' ' 64' ' ' ARG . 5.7 mm-40 -91.77 152.22 20.25 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.334 1.854 . . . . 0.0 110.66 171.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 90.8 p -141.29 152.1 44.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.414 1.085 . . . . 0.0 112.108 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.33 162.2 18.02 Favored Glycine 0 N--CA 1.473 1.144 0 C-N-CA 125.035 1.302 . . . . 0.0 114.312 -171.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -56.38 -20.69 20.55 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -82.49 -15.5 52.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.9 p -85.15 -178.27 6.74 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -56.11 -49.9 72.59 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.944 1.298 . . . . 0.0 112.173 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.4 p -88.1 -23.19 23.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.945 1.298 . . . . 0.0 112.938 -174.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.22 -154.62 35.26 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.89 1.709 . . . . 0.0 112.174 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -59.58 130.46 46.97 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.358 1.063 . . . . 0.0 111.895 173.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.09 164.41 18.06 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.152 0.882 . . . . 0.0 113.564 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.4 mt -113.49 134.02 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.687 1.195 . . . . 0.0 108.512 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -130.25 125.74 35.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.947 1.299 . . . . 0.0 109.941 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.78 141.82 50.83 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.587 1.155 . . . . 0.0 112.734 -172.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -140.87 127.86 20.66 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.83 0.852 . . . . 0.0 111.874 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -65.59 133.53 51.37 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.398 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.1 t -161.48 132.53 5.29 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.271 1.428 . . . . 0.0 111.587 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 m -68.64 -15.6 63.57 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -133.69 35.85 3.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.044 1.738 . . . . 0.0 112.967 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.57 -40.36 71.87 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -70.07 -39.49 75.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.782 0.719 . . . . 0.0 112.013 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -61.71 -39.72 92.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.286 1.034 . . . . 0.0 110.927 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.4 mt -62.19 -47.99 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 118.95 0.795 . . . . 0.0 110.631 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -58.04 -37.06 73.65 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.195 0.998 . . . . 0.0 112.426 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -79.62 -28.63 40.96 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 113.702 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt -80.47 -41.28 24.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.436 1.017 . . . . 0.0 110.184 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.1 mt -49.32 -56.47 9.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.62 1.168 . . . . 0.0 112.723 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -61.48 -21.68 64.4 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.88 -27.08 61.69 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.166 0.894 . . . . 0.0 112.589 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.4 mt -97.28 -41.83 8.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.772 1.629 . . . . 0.0 110.968 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.4 mtp -64.7 -28.74 69.8 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.938 1.295 . . . . 0.0 113.294 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -19.45 62.29 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 173.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.5 t -66.69 -30.26 70.47 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.642 0.656 . . . . 0.0 112.09 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 51.65 43.91 29.53 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.827 1.251 . . . . 0.0 110.959 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.1 p -56.06 127.54 31.06 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.771 1.628 . . . . 0.0 114.57 -169.332 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.46 -51.75 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.12 1.368 . . . . 0.0 111.307 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -69.18 -10.93 60.09 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -172.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.3 p -74.77 -13.22 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.39 1.876 . . . . 0.0 113.647 171.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.9 mtt -74.11 168.47 19.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.565 1.146 . . . . 0.0 112.422 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.19 176.41 3.89 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.22 1.008 . . . . 0.0 112.697 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -51.32 139.95 25.23 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.204 1.402 . . . . 0.0 113.693 -169.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.32 151.02 76.6 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.692 2.928 . . . . 0.0 112.498 -171.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 74.4 t -138.17 128.67 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.915 1.686 . . . . 0.0 108.601 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mp -76.81 130.41 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.882 0.873 . . . . 0.0 108.788 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -115.43 158.09 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.88 1.272 . . . . 0.0 110.618 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.5 t -64.61 131.02 45.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.928 0.891 . . . . 0.0 110.906 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -83.08 135.94 34.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.041 0.936 . . . . 0.0 111.137 -176.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -120.42 169.52 10.23 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.797 1.639 . . . . 0.0 111.3 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.3 p -62.76 151.58 38.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.157 0.983 . . . . 0.0 112.652 174.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -149.13 149.51 29.83 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.639 1.176 . . . . 0.0 113.137 -169.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.0 171.7 17.66 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.904 3.069 . . . . 0.0 111.567 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -148.96 149.75 31.72 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.841 1.257 . . . . 0.0 111.785 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -81.51 148.94 28.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.424 1.09 . . . . 0.0 111.965 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 pp -88.13 -175.25 4.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.181 1.393 . . . . 0.0 112.541 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -146.66 155.68 42.62 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.96 1.704 . . . . 0.0 111.819 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.4 pp -99.75 148.98 35.5 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.823 1.249 . . . . 0.0 112.474 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.7 152.03 19.51 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.653 2.902 . . . . 0.0 111.714 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.19 162.89 28.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.487 0.715 . . . . 0.0 112.867 171.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.23 154.29 39.79 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.802 1.641 . . . . 0.0 111.709 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -71.41 167.62 25.81 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.665 2.91 . . . . 0.0 111.767 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -129.44 130.76 23.32 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.969 1.307 . . . . 0.0 109.664 -176.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.52 162.13 33.54 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.633 2.889 . . . . 0.0 112.344 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.8 170.56 16.34 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.936 3.091 . . . . 0.0 111.802 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -141.5 132.08 25.48 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.397 1.079 . . . . 0.0 112.003 -172.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.93 175.29 10.81 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.185 1.394 . . . . 0.0 113.21 -176.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 40.2 tp -148.85 141.95 24.92 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.372 1.469 . . . . 0.0 110.883 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.67 -172.12 47.83 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.849 1.214 . . . . 0.0 113.819 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -157.9 160.92 38.15 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.309 1.444 . . . . 0.0 112.131 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -156.23 172.99 17.5 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.79 1.636 . . . . 0.0 111.39 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.3 p -164.37 154.17 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.802 2.041 . . . . 0.0 110.188 -169.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -155.64 172.97 17.39 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.111 1.364 . . . . 0.0 111.519 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.28 1.832 . . . . 0.0 111.512 -174.146 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -83.46 116.78 22.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.072 0.549 . . . . 0.0 111.435 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -77.92 113.92 16.29 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.605 1.162 . . . . 0.0 110.728 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 59.4 mt -82.37 153.36 25.79 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.731 0.777 . . . . 0.0 112.714 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -78.69 -26.12 44.85 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.939 1.696 . . . . 0.0 112.831 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -159.44 166.88 30.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.351 1.86 . . . . 0.0 111.725 -169.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -88.49 124.13 66.67 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.52 -0.753 . . . . 0.0 111.924 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -87.02 -22.48 1.79 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.209 2.606 . . . . 0.0 114.336 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 92.9 m -83.9 130.0 34.92 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.996 0.816 . . . . 0.0 112.281 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.17 -1.01 88.63 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.68 1.133 . . . . 0.0 115.142 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -143.32 142.15 31.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.851 1.26 . . . . 0.0 110.243 170.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.619 HG21 ' HG3' ' A' ' 64' ' ' ARG . 3.0 p -166.38 146.82 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.222 1.409 . . . . 0.0 111.639 -168.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -118.54 142.43 47.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.396 2.278 . . . . 0.0 109.814 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -102.75 107.61 18.56 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.924 1.289 . . . . 0.0 109.676 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.25 -25.03 45.46 Favored Glycine 0 N--CA 1.476 1.317 0 N-CA-C 115.83 1.092 . . . . 0.0 115.83 -168.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.6 16.61 19.67 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.426 1.49 . . . . 0.0 112.792 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -131.89 151.38 51.74 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.175 1.79 . . . . 0.0 110.091 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -160.66 152.54 19.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.088 1.355 . . . . 0.0 110.186 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 124.983 1.313 . . . . 0.0 114.299 177.719 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -165.73 -171.52 2.1 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.917 1.687 . . . . 0.0 110.613 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 t -153.56 132.27 12.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.386 1.474 . . . . 0.0 110.845 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.58 -150.05 21.28 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.404 1.478 . . . . 0.0 113.65 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -146.92 160.83 41.85 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.938 1.695 . . . . 0.0 110.793 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 t -158.61 -179.41 8.06 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.452 1.101 . . . . 0.0 111.87 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.61 163.41 29.21 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.795 1.664 . . . . 0.0 112.776 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -77.13 154.07 33.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.462 1.105 . . . . 0.0 111.793 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -136.34 129.64 31.65 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.031 1.732 . . . . 0.0 109.476 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -161.15 88.99 0.76 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.137 1.375 . . . . 0.0 109.281 -173.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -153.79 162.17 41.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.124 1.77 . . . . 0.0 110.921 -169.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.9 m -63.12 154.41 31.13 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.189 0.996 . . . . 0.0 111.875 169.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 p -51.79 122.73 22.63 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 124.257 1.023 . . . . 0.0 112.448 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.46 155.29 24.69 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.459 2.773 . . . . 0.0 112.187 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -65.17 -4.71 5.37 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.322 1.449 . . . . 0.0 113.885 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -117.03 10.77 14.06 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.553 1.941 . . . . 0.0 113.822 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -55.8 136.66 72.12 Favored Pre-proline 0 CA--C 1.552 1.039 0 O-C-N 121.298 -0.877 . . . . 0.0 112.41 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.41 -11.03 30.78 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.079 2.519 . . . . 0.0 114.921 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.1 p -132.73 -22.76 2.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.27 97.63 7.19 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.542 1.065 . . . . 0.0 111.295 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -96.94 126.78 42.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.219 1.408 . . . . 0.0 109.751 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -81.55 136.03 35.59 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.099 -1.001 . . . . 0.0 110.273 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.22 168.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.737 1.215 . . . . 0.0 112.329 -168.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.6 m -141.8 121.99 13.86 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.569 1.147 . . . . 0.0 109.49 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.92 130.72 44.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.211 1.004 . . . . 0.0 110.755 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.21 159.48 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.01 -171.03 2.99 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -58.41 -21.99 52.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.825 1.65 . . . . 0.0 114.705 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -103.93 -4.66 23.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.92 1.288 . . . . 0.0 112.606 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.51 17.28 66.62 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.057 -1.413 . . . . 0.0 114.38 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.95 144.76 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.081 1.94 . . . . 0.0 109.999 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -91.42 120.89 32.66 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.38 1.072 . . . . 0.0 110.27 -175.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.7 mt -107.94 -53.36 2.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.032 0.933 . . . . 0.0 112.027 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.14 132.03 3.93 Favored Glycine 0 N--CA 1.472 1.043 0 C-N-CA 124.726 1.155 . . . . 0.0 113.576 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.0 m -86.81 154.65 20.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.677 0.791 . . . . 0.0 112.659 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.13 171.34 33.93 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.099 1.333 . . . . 0.0 114.021 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -115.57 120.95 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 169.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.9 ttm -94.3 116.57 28.97 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.195 1.398 . . . . 0.0 109.754 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -109.18 128.5 55.08 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.832 1.653 . . . . 0.0 108.838 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.06 137.36 42.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.552 1.541 . . . . 0.0 108.278 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.6 p -135.41 173.2 11.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.006 1.322 . . . . 0.0 110.755 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -72.2 -0.25 11.56 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.558 -0.714 . . . . 0.0 112.608 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -115.37 -40.66 3.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -172.88 166.16 5.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.977 1.311 . . . . 0.0 112.963 -168.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mt -86.76 138.39 31.65 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.123 1.369 . . . . 0.0 109.272 168.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 t -134.75 131.77 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.664 0.785 . . . . 0.0 111.395 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.3 mt -104.75 130.66 52.78 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.221 1.408 . . . . 0.0 110.39 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -109.06 126.87 53.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.98 2.112 . . . . 0.0 110.245 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -159.28 166.46 31.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.006 1.723 . . . . 0.0 112.136 -172.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -108.24 -14.65 14.66 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -81.31 -3.29 52.13 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.261 1.425 . . . . 0.0 113.66 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -165.97 177.37 7.12 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.094 2.158 . . . . 0.0 110.102 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.89 160.71 31.32 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.407 0.683 . . . . 0.0 110.277 167.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.26 142.19 57.01 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.647 -0.658 . . . . 0.0 111.546 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 t -122.5 125.73 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.239 0.616 . . . . 0.0 111.172 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -115.81 143.79 44.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.86 1.664 . . . . 0.0 111.485 -173.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 -138.73 117.23 9.24 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.461 1.105 . . . . 0.0 111.167 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.25 144.53 68.86 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.237 1.958 . . . . 0.0 109.264 170.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -60.69 -27.29 67.75 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.02 -43.75 91.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.902 1.681 . . . . 0.0 111.588 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 79.1 m -78.86 1.58 22.97 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.26 117.29 25.92 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.844 1.202 . . . . 0.0 109.728 172.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -73.33 -35.66 66.07 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -166.13 162.75 17.88 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.721 2.008 . . . . 0.0 110.647 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -149.67 108.13 3.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.235 1.014 . . . . 0.0 110.418 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.31 161.88 12.66 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 124.875 1.226 . . . . 0.0 113.369 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -139.58 163.69 31.88 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.689 1.196 . . . . 0.0 112.61 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -153.63 -169.58 3.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.798 2.039 . . . . 0.0 109.566 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 t -64.82 -24.2 67.47 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.841 -1.162 . . . . 0.0 114.091 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -155.84 19.19 0.38 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.23 1.412 . . . . 0.0 112.996 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -142.67 128.33 19.19 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.999 1.319 . . . . 0.0 110.43 -169.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -120.84 140.98 51.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.081 1.752 . . . . 0.0 109.599 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -153.39 157.72 40.4 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.177 -0.952 . . . . 0.0 113.123 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -154.57 153.26 31.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.877 1.671 . . . . 0.0 111.136 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -108.13 133.09 52.89 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.798 0.839 . . . . 0.0 110.126 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 m -107.45 141.73 38.41 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.127 0.971 . . . . 0.0 112.588 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.79 157.12 53.53 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.832 1.206 . . . . 0.0 112.646 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -65.84 -15.79 63.23 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -168.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -91.49 -10.79 39.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.125 1.77 . . . . 0.0 115.367 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.4 p -75.86 -177.52 3.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -55.89 -40.23 72.71 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.504 1.122 . . . . 0.0 112.941 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.4 p -93.54 -23.4 18.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.943 1.297 . . . . 0.0 113.556 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.47 -161.85 41.2 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.056 1.312 . . . . 0.0 111.544 -171.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -66.12 128.46 36.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.811 0.844 . . . . 0.0 111.375 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.62 161.38 18.59 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 123.154 0.407 . . . . 0.0 114.036 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 88.1 mt -104.89 131.28 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.002 1.321 . . . . 0.0 108.514 169.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -127.76 125.23 39.52 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.819 1.248 . . . . 0.0 109.491 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.35 143.45 50.58 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.146 0.978 . . . . 0.0 112.663 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.93 124.3 19.28 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.901 -168.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -64.62 131.2 46.32 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.234 0.614 . . . . 0.0 110.706 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 37.3 t -169.98 122.88 0.71 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.111 1.764 . . . . 0.0 110.462 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -68.64 -14.42 63.0 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.62 -0.675 . . . . 0.0 112.812 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 mtt85 -108.56 22.76 15.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.442 1.897 . . . . 0.0 113.519 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.93 -37.81 21.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.583 1.153 . . . . 0.0 113.654 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.85 -40.45 79.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.451 1.101 . . . . 0.0 113.144 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.3 -34.65 77.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.466 -0.771 . . . . 0.0 111.384 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.44 -49.55 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.163 0.585 . . . . 0.0 110.291 170.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -37.31 82.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.559 0.744 . . . . 0.0 112.35 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -71.1 -29.39 65.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.758 0.823 . . . . 0.0 113.178 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.7 tp -86.77 -36.54 18.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.49 1.041 . . . . 0.0 112.419 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.1 mt -52.59 -55.9 19.07 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.971 0.908 . . . . 0.0 112.068 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -57.86 -21.01 40.62 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.53 -25.33 25.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.627 1.171 . . . . 0.0 113.42 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.5 mt -95.98 -33.53 12.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.797 1.239 . . . . 0.0 111.728 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 97.0 mtp -66.0 -19.55 65.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.857 1.663 . . . . 0.0 113.734 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -92.13 -8.18 46.42 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.117 1.367 . . . . 0.0 113.73 169.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.7 t -96.78 -1.49 46.19 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.248 1.419 . . . . 0.0 113.524 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -71.0 175.71 4.94 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.857 1.263 . . . . 0.0 112.643 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -71.62 96.25 1.54 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.5 1.12 . . . . 0.0 112.896 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.5 mm -86.33 -44.31 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.317 -0.864 . . . . 0.0 111.769 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -131.65 17.8 4.77 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.304 1.442 . . . . 0.0 113.062 -171.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.8 t -85.75 83.31 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 126.32 1.848 . . . . 0.0 108.057 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.0 ptp -40.6 119.19 1.06 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.448 2.299 . . . . 0.0 112.812 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -168.78 155.94 7.36 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.504 1.922 . . . . 0.0 109.174 -169.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.82 139.64 90.09 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.44 0.696 . . . . 0.0 112.49 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.58 156.69 36.13 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.677 2.918 . . . . 0.0 111.635 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.32 114.27 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.997 1.319 . . . . 0.0 109.174 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.51 123.26 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.848 1.659 . . . . 0.0 108.172 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.5 pt -82.53 -15.46 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.4 m -165.58 119.29 1.19 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.849 2.459 . . . . 0.0 108.145 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -85.09 159.36 20.19 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.558 1.143 . . . . 0.0 111.868 176.097 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -153.84 149.77 27.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.641 1.576 . . . . 0.0 110.865 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -77.84 148.49 34.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.83 0.852 . . . . 0.0 111.837 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -66.22 147.3 98.93 Favored Pre-proline 0 CA--C 1.556 1.186 0 O-C-N 121.073 -1.017 . . . . 0.0 112.855 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.56 147.68 58.28 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.337 2.691 . . . . 0.0 111.509 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.85 74.9 7.8 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.599 1.16 . . . . 0.0 111.291 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.89 143.86 57.24 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.207 1.403 . . . . 0.0 111.242 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.16 163.98 31.49 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.49 1.516 . . . . 0.0 112.239 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -166.33 174.01 9.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.414 1.886 . . . . 0.0 111.448 -172.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.97 147.12 64.63 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.327 1.451 . . . . 0.0 111.103 175.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.55 140.64 21.55 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.3 2.667 . . . . 0.0 111.39 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.72 176.06 8.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.052 0.941 . . . . 0.0 112.336 172.376 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.13 142.64 33.92 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.422 1.489 . . . . 0.0 111.346 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.82 158.42 38.99 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.504 2.803 . . . . 0.0 111.381 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -69.23 142.1 92.22 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.665 0.786 . . . . 0.0 111.042 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.54 145.96 43.22 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.868 2.378 . . . . 0.0 111.126 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.59 157.84 36.04 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.66 2.907 . . . . 0.0 111.476 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -142.85 132.51 23.86 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.07 1.348 . . . . 0.0 110.867 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -164.05 166.75 21.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.303 1.841 . . . . 0.0 111.101 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 pp -156.25 170.85 21.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.71 1.604 . . . . 0.0 111.755 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.93 178.35 31.68 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.025 1.297 . . . . 0.0 113.563 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -145.31 158.26 43.87 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.645 1.578 . . . . 0.0 112.183 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.0 m -133.09 143.91 49.62 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.388 1.875 . . . . 0.0 109.265 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 62.3 t -133.94 137.76 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.886 1.674 . . . . 0.0 108.89 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.8 t -158.55 169.92 23.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.202 1.401 . . . . 0.0 111.517 -176.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.254 1.338 0 C-N-CA 126.34 1.856 . . . . 0.0 111.54 -174.948 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -108.25 121.17 44.32 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.64 0.776 . . . . 0.0 110.005 171.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -85.54 121.29 28.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.304 1.042 . . . . 0.0 110.844 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 80.4 mt -83.83 164.1 19.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.629 0.728 . . . . 0.0 112.718 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -106.59 2.21 25.87 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.812 1.645 . . . . 0.0 113.835 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -160.33 164.93 32.13 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.509 2.324 . . . . 0.0 110.472 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -90.94 118.31 68.5 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.307 174.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.87 -24.47 3.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.314 2.676 . . . . 0.0 114.772 -168.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 81.7 m -80.19 127.84 32.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.028 0.831 . . . . 0.0 111.873 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.58 -7.07 88.77 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.522 1.058 . . . . 0.0 114.449 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.42 131.01 31.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.337 1.855 . . . . 0.0 109.814 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 p -164.62 147.27 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.176 1.39 . . . . 0.0 111.112 -169.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -132.05 170.42 14.97 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.612 2.365 . . . . 0.0 111.874 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -132.18 125.74 31.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.359 1.464 . . . . 0.0 110.96 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.81 -35.84 5.23 Favored Glycine 0 N--CA 1.476 1.316 0 C-N-CA 124.266 0.936 . . . . 0.0 113.778 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -103.39 73.92 1.24 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.094 1.357 . . . . 0.0 110.349 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -71.79 125.87 28.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.991 0.917 . . . . 0.0 110.042 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -101.97 170.43 8.14 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.726 1.21 . . . . 0.0 111.098 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 126.044 1.738 . . . . 0.0 111.617 -178.368 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 t -168.05 159.14 10.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.452 1.501 . . . . 0.0 110.305 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.2 t -161.33 152.93 19.11 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.986 1.315 . . . . 0.0 111.15 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.05 132.89 2.67 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.142 1.354 . . . . 0.0 111.52 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.0 p -149.3 116.26 5.99 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.928 0.891 . . . . 0.0 111.239 -173.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.5 p -93.19 151.17 19.99 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.35 144.79 9.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.287 1.899 . . . . 0.0 111.288 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.43 97.22 5.41 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.855 1.262 . . . . 0.0 108.999 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -169.48 173.7 6.34 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.582 1.953 . . . . 0.0 111.65 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -112.14 132.3 54.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.56 1.544 . . . . 0.0 111.469 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -160.7 145.39 14.17 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.879 2.072 . . . . 0.0 110.18 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.9 p -75.15 111.05 9.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.77 0.828 . . . . 0.0 110.396 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.69 122.07 74.39 Favored Pre-proline 0 N--CA 1.48 1.031 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.933 -174.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.89 149.37 42.21 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.04 2.494 . . . . 0.0 111.215 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -63.25 -13.27 36.23 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.56 1.144 . . . . 0.0 113.052 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -99.22 0.15 42.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.468 1.907 . . . . 0.0 113.244 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -51.92 137.41 35.81 Favored Pre-proline 0 CA--C 1.555 1.154 0 O-C-N 120.945 -1.097 . . . . 0.0 113.869 -171.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.15 -11.54 31.9 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.279 2.653 . . . . 0.0 115.253 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.0 p -131.42 -16.51 3.06 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.92 99.01 7.15 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.479 1.036 . . . . 0.0 111.29 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -97.47 116.38 29.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.777 1.231 . . . . 0.0 109.054 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -76.58 133.44 39.67 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.976 -1.078 . . . . 0.0 110.344 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.25 167.19 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.115 0.966 . . . . 0.0 112.485 -168.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.9 m -146.09 125.47 13.12 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.007 1.323 . . . . 0.0 108.797 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -66.37 132.6 48.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.515 0.726 . . . . 0.0 110.096 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.1 156.79 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.699 1.2 . . . . 0.0 112.809 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.435 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.4 p-10 -89.36 -166.49 1.61 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.965 1.306 . . . . 0.0 113.988 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.93 -35.14 74.3 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.415 1.486 . . . . 0.0 114.319 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -80.38 -12.98 59.52 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.285 0.948 . . . . 0.0 113.063 176.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.67 17.52 72.85 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.345 -1.253 . . . . 0.0 113.554 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.435 HG22 ' OD1' ' A' ' 27' ' ' ASP . 14.8 m -75.41 149.3 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.668 1.734 . . . . 0.0 110.936 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -90.58 124.91 35.41 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.358 1.063 . . . . 0.0 111.321 -170.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.2 mt -107.42 -49.82 3.18 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.23 1.012 . . . . 0.0 111.991 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.69 135.37 4.44 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.782 1.182 . . . . 0.0 113.602 176.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 p -84.06 154.66 23.09 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.769 1.228 . . . . 0.0 112.984 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.07 171.07 38.75 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.858 1.218 . . . . 0.0 113.88 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.51 120.9 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 41.5 tpp -90.9 137.36 32.42 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.685 1.194 . . . . 0.0 110.283 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -138.95 130.14 26.8 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.216 1.406 . . . . 0.0 109.251 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.61 134.78 49.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.338 1.855 . . . . 0.0 107.656 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.4 p -132.07 173.4 11.26 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.078 0.951 . . . . 0.0 111.01 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -66.2 0.23 2.14 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.678 0.791 . . . . 0.0 112.685 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -116.32 -43.25 2.96 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -172.98 177.07 2.87 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -169.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.13 138.28 31.56 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.387 1.075 . . . . 0.0 110.132 167.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.65 128.69 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.308 1.043 . . . . 0.0 111.184 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.2 mt -102.12 135.12 44.25 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.504 1.522 . . . . 0.0 110.378 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -110.21 124.86 52.36 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.39 1.876 . . . . 0.0 111.068 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.74 168.92 17.47 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.202 2.201 . . . . 0.0 111.164 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -98.43 -62.91 1.18 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.612 1.165 . . . . 0.0 113.565 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.59 -7.43 54.21 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -176.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HA ' ' HE ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -125.97 161.7 26.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.237 1.815 . . . . 0.0 110.24 175.046 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.5 pm0 -68.14 159.72 30.46 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.293 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.5 144.71 55.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.993 0.517 . . . . 0.0 111.054 172.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -123.14 126.59 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.272 0.629 . . . . 0.0 110.546 -173.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -120.76 138.43 54.01 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.569 1.548 . . . . 0.0 111.524 -169.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -139.1 114.08 8.33 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.389 1.076 . . . . 0.0 111.093 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.55 150.13 74.83 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 0.0 110.307 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -60.95 -20.67 62.59 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -65.27 -34.67 78.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.142 1.777 . . . . 0.0 113.268 170.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 89.1 m -92.63 -5.05 52.32 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.18 105.63 13.43 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.837 0.855 . . . . 0.0 109.253 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -79.76 -20.93 45.12 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.484 ' HG3' HG21 ' B' ' 12' ' ' VAL . 30.9 ttt180 -170.1 133.42 1.15 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.698 1.999 . . . . 0.0 108.753 -172.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -142.27 119.09 11.17 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.325 1.45 . . . . 0.0 110.26 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.55 164.87 22.91 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 124.077 0.846 . . . . 0.0 112.992 -169.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -130.45 155.32 46.63 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.343 1.057 . . . . 0.0 111.492 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.99 -174.11 4.76 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.878 1.671 . . . . 0.0 110.349 173.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.7 p -59.54 111.58 1.46 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.256 -0.902 . . . . 0.0 111.57 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.257 0.7 OUTLIER 51.52 23.15 1.74 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.391 2.276 . . . . 0.0 116.158 -174.25 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.33 126.39 29.6 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.424 1.49 . . . . 0.0 110.871 -172.019 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -120.18 135.16 55.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.748 1.619 . . . . 0.0 109.622 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -153.29 155.01 35.72 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.312 -0.867 . . . . 0.0 112.159 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -154.61 152.73 30.35 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.532 1.133 . . . . 0.0 112.268 -174.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -115.45 133.84 55.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.337 1.855 . . . . 0.0 110.493 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.6 m -133.26 154.38 50.73 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.354 1.062 . . . . 0.0 112.476 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.89 166.57 34.04 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.888 1.233 . . . . 0.0 113.588 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -6.37 16.71 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -174.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -82.69 -19.53 37.9 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.7 p -81.63 -179.46 7.39 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -55.13 -42.97 73.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.095 1.358 . . . . 0.0 113.003 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.4 p -93.15 -22.25 19.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.348 1.459 . . . . 0.0 113.637 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.1 -163.38 43.32 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.298 1.428 . . . . 0.0 112.539 -173.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -70.76 137.59 49.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.091 0.956 . . . . 0.0 112.793 -174.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.53 171.9 24.08 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.614 1.102 . . . . 0.0 113.355 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.63 123.11 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.091 1.356 . . . . 0.0 108.579 170.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -114.17 119.33 36.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.998 1.319 . . . . 0.0 109.393 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.61 139.15 53.39 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.394 1.078 . . . . 0.0 112.914 -169.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -140.29 131.22 26.07 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.887 0.851 . . . . 0.0 112.287 -169.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -69.39 135.32 50.14 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.813 168.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.7 t -159.03 142.75 15.05 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.131 1.372 . . . . 0.0 111.431 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.3 m -77.35 -27.48 52.68 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -127.66 40.24 3.73 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.692 1.197 . . . . 0.0 113.348 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.93 -40.88 15.09 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.52 -35.24 78.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.452 0.701 . . . . 0.0 112.8 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.93 -30.48 66.81 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.419 -0.8 . . . . 0.0 112.153 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.49 -47.28 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.688 0.676 . . . . 0.0 109.608 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -58.6 -42.61 88.51 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.177 0.991 . . . . 0.0 111.919 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -67.78 -42.44 81.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.687 1.195 . . . . 0.0 112.418 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.9 tp -75.21 -32.51 61.2 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.847 0.749 . . . . 0.0 112.177 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.2 mt -53.92 -54.36 39.92 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.698 0.799 . . . . 0.0 112.221 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -63.75 -30.97 72.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -34.19 77.38 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.221 1.008 . . . . 0.0 112.83 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.03 -35.57 21.82 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.341 1.056 . . . . 0.0 111.37 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 48.7 mtt -63.64 -46.81 83.97 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.593 0.757 . . . . 0.0 112.513 172.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -70.44 -17.62 63.0 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 13.9 t -67.76 -26.9 66.35 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.287 0.494 . . . . 0.0 112.104 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 53.47 74.72 0.29 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.981 2.112 . . . . 0.0 112.191 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 p -60.83 125.87 25.29 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.015 0.926 . . . . 0.0 112.203 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 42.2 mm -97.34 -49.94 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.174 0.99 . . . . 0.0 110.669 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.49 0.94 10.96 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.9 1.28 . . . . 0.0 114.214 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.01 -42.23 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.967 2.107 . . . . 0.0 112.613 169.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 67.3 mtm 58.54 24.92 12.48 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.414 2.286 . . . . 0.0 116.355 170.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -86.4 47.76 1.52 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.51 1.524 . . . . 0.0 111.596 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -146.71 157.91 46.87 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.903 2.081 . . . . 0.0 110.989 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.43 -176.13 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.332 3.354 . . . . 0.0 111.468 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.74 115.82 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.766 0.826 . . . . 0.0 110.961 172.851 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.4 mm -147.72 149.29 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 127.088 2.155 . . . . 0.0 109.111 -172.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -98.21 125.26 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.685 1.194 . . . . 0.0 108.862 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.0 t -161.21 155.25 22.5 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.452 1.501 . . . . 0.0 111.299 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -77.51 120.04 21.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.151 1.38 . . . . 0.0 110.655 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -63.17 147.27 51.35 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.976 0.911 . . . . 0.0 112.65 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.7 p -165.76 174.8 9.31 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.729 1.612 . . . . 0.0 111.649 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -150.23 128.63 5.97 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.636 1.174 . . . . 0.0 112.321 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.82 -176.12 3.07 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.236 3.291 . . . . 0.0 112.144 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -142.85 164.31 30.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.089 1.356 . . . . 0.0 112.568 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.2 170.82 17.17 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.596 1.958 . . . . 0.0 110.832 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.3 173.83 11.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.803 1.241 . . . . 0.0 113.072 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -145.79 134.11 21.81 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.98 1.712 . . . . 0.0 110.211 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 pp -87.42 140.06 31.95 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 123.473 0.709 . . . . 0.0 111.705 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.59 147.42 22.24 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.013 2.475 . . . . 0.0 111.295 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -77.52 137.5 38.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.713 0.805 . . . . 0.0 111.501 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.23 149.78 41.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.964 1.306 . . . . 0.0 112.251 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.83 176.18 10.34 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.039 3.159 . . . . 0.0 111.729 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -126.82 134.24 25.88 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.29 1.436 . . . . 0.0 109.7 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.67 153.25 54.16 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.305 2.67 . . . . 0.0 112.09 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.38 154.74 40.97 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.025 3.15 . . . . 0.0 112.38 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -93.27 164.77 13.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.932 1.293 . . . . 0.0 113.245 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -107.21 -174.59 2.57 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.764 1.626 . . . . 0.0 112.063 175.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.81 162.64 41.06 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.259 1.823 . . . . 0.0 112.265 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -113.19 -148.51 10.23 Favored Glycine 0 N--CA 1.474 1.232 0 C-N-CA 125.799 1.666 . . . . 0.0 113.518 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -154.78 170.52 21.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.576 1.55 . . . . 0.0 112.625 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 34.0 m -138.97 146.0 40.43 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.169 1.788 . . . . 0.0 109.505 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.35 153.25 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.584 1.154 . . . . 0.0 112.575 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.4 m -147.04 161.59 40.51 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.678 1.591 . . . . 0.0 111.815 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.252 1.235 0 C-N-CA 126.672 1.989 . . . . 0.0 112.767 177.941 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -78.45 137.57 38.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.696 0.799 . . . . 0.0 111.447 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.81 116.76 32.5 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.779 1.232 . . . . 0.0 109.721 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 98.3 mt -78.52 157.77 28.76 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -87.22 -7.97 57.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.798 1.639 . . . . 0.0 113.919 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -161.38 163.08 30.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.959 2.104 . . . . 0.0 110.499 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -86.95 122.84 71.09 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.769 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.67 -12.24 11.21 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.387 2.725 . . . . 0.0 113.75 -171.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 84.5 m -99.82 121.7 41.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.367 1.067 . . . . 0.0 111.531 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.45 -14.6 82.32 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.385 0.993 . . . . 0.0 114.576 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -127.16 138.45 53.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.478 1.511 . . . . 0.0 110.876 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 64' ' ' ARG . 2.0 p -163.97 142.45 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.888 1.675 . . . . 0.0 110.868 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -115.76 114.22 24.5 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.321 2.249 . . . . 0.0 107.921 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -74.45 126.75 31.4 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.634 -0.666 . . . . 0.0 110.449 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.22 -104.74 0.76 Allowed Glycine 0 N--CA 1.469 0.872 0 C-N-CA 124.521 1.058 . . . . 0.0 112.986 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -57.82 -42.83 85.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.135 0.974 . . . . 0.0 113.106 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 48.06 48.27 18.38 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.13 1.772 . . . . 0.0 112.331 170.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -68.82 155.92 39.33 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? . . . . . 0 C--O 1.251 1.183 0 C-N-CA 126.274 1.83 . . . . 0.0 112.998 -171.812 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.7 p -164.42 161.74 21.66 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.312 1.445 . . . . 0.0 111.798 -176.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.4 t -163.0 156.31 19.61 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.451 1.501 . . . . 0.0 110.997 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.97 176.38 34.96 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.108 1.337 . . . . 0.0 114.052 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 t -165.17 163.94 20.26 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.902 1.681 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 t -162.65 135.8 5.89 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.322 1.449 . . . . 0.0 111.051 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.76 152.04 20.36 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.908 1.242 . . . . 0.0 112.699 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt -145.58 158.73 43.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.486 1.914 . . . . 0.0 110.713 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -159.1 151.33 21.21 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.634 1.574 . . . . 0.0 112.009 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -143.61 137.42 28.31 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.917 1.687 . . . . 0.0 110.821 -176.593 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -94.68 -4.57 47.32 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.115 1.366 . . . . 0.0 113.525 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.5 m -128.38 140.92 51.6 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.873 1.669 . . . . 0.0 110.453 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.84 121.59 71.91 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.715 0.806 . . . . 0.0 111.601 -175.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.12 172.48 12.85 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.84 3.027 . . . . 0.0 112.527 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -69.87 6.64 1.13 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.64 1.976 . . . . 0.0 114.535 170.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -149.59 20.57 0.92 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -168.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -61.38 143.97 92.44 Favored Pre-proline 0 CA--C 1.558 1.265 0 O-C-N 120.749 -1.219 . . . . 0.0 113.023 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.34 -11.23 26.53 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.244 2.63 . . . . 0.0 115.287 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.2 p -127.5 -25.05 3.23 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.752 1.16 . . . . 0.0 114.0 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -104.79 134.47 47.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.066 0.946 . . . . 0.0 111.103 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -131.2 105.25 7.54 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.155 1.382 . . . . 0.0 108.478 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -65.82 127.56 32.48 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.638 0.775 . . . . 0.0 110.488 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.4 m -137.35 163.64 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.347 1.459 . . . . 0.0 111.352 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.1 m -134.25 119.44 18.76 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.307 1.043 . . . . 0.0 109.013 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.82 128.0 34.12 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.108 0.963 . . . . 0.0 109.961 175.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.99 154.88 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.547 0.739 . . . . 0.0 112.906 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -89.87 -166.94 1.71 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.649 1.18 . . . . 0.0 113.952 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.5 -29.57 70.83 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -83.33 -8.96 59.34 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.001 1.32 . . . . 0.0 112.562 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.15 16.51 80.57 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.182 -1.344 . . . . 0.0 113.729 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.1 m -81.28 150.45 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.568 1.684 . . . . 0.0 111.63 176.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.12 121.94 31.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.641 1.176 . . . . 0.0 111.151 -170.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.7 mt -102.8 -53.58 2.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.37 0.668 . . . . 0.0 111.843 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.76 149.05 20.72 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.795 1.188 . . . . 0.0 114.356 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.4 p -88.29 153.01 21.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.208 1.403 . . . . 0.0 113.152 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.46 171.39 35.26 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.243 1.401 . . . . 0.0 113.628 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.45 120.22 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.0 tpp -85.27 140.15 31.07 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.482 1.113 . . . . 0.0 109.259 170.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -133.32 129.96 38.22 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.119 1.368 . . . . 0.0 108.546 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.88 131.2 55.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.821 2.048 . . . . 0.0 108.471 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 p -133.83 173.36 11.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.847 1.259 . . . . 0.0 110.877 178.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -71.91 5.4 2.65 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.079 -1.013 . . . . 0.0 112.776 170.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.8 m -114.73 -45.85 2.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.773 1.229 . . . . 0.0 113.619 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -172.21 169.92 5.31 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.754 1.161 . . . . 0.0 113.449 -169.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.9 mt -87.44 139.96 30.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.356 1.063 . . . . 0.0 109.952 168.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.4 127.6 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.041 0.936 . . . . 0.0 111.496 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 mt -100.06 128.65 46.11 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.233 1.413 . . . . 0.0 110.374 168.13 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -108.24 129.48 55.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.305 2.242 . . . . 0.0 109.654 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.72 -11.92 0.68 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -169.18 -176.01 2.44 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.137 1.775 . . . . 0.0 110.971 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -63.27 -25.71 68.44 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.276 1.83 . . . . 0.0 111.885 168.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.78 153.31 24.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.377 1.871 . . . . 0.0 111.312 169.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -53.28 142.76 20.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.018 1.327 . . . . 0.0 113.301 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.32 154.78 41.51 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.998 0.919 . . . . 0.0 112.52 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.04 135.04 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.922 1.289 . . . . 0.0 108.119 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -131.63 149.78 52.38 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -166.831 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -141.82 116.44 6.85 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 124.549 1.14 . . . . 0.0 111.997 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.41 145.1 58.06 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.55 2.167 . . . . 0.0 109.565 170.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -61.6 -21.95 64.8 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.56 -47.64 85.28 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.705 2.002 . . . . 0.0 111.692 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.4 m -80.12 -16.56 54.69 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.13 119.63 11.19 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.939 0.791 . . . . 0.0 110.382 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -82.82 -32.08 27.78 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.356 1.063 . . . . 0.0 112.065 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -168.28 160.68 11.68 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.179 2.192 . . . . 0.0 110.725 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -149.45 116.96 6.14 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.831 1.252 . . . . 0.0 109.667 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.83 165.7 21.56 Favored Glycine 0 N--CA 1.463 0.466 0 C-N-CA 124.836 1.208 . . . . 0.0 113.358 -169.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -141.59 176.74 8.65 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.456 1.102 . . . . 0.0 113.136 -170.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -163.6 -168.01 1.55 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.677 2.391 . . . . 0.0 108.756 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 t -72.21 -19.66 61.69 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.691 -1.256 . . . . 0.0 113.198 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -152.22 8.19 0.47 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.619 1.167 . . . . 0.0 113.893 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -137.11 129.77 30.23 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.425 1.49 . . . . 0.0 110.242 -169.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -124.51 138.01 54.37 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.194 1.797 . . . . 0.0 109.208 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -153.33 152.84 31.56 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.094 -1.004 . . . . 0.0 112.326 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -150.84 153.58 35.65 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.262 1.025 . . . . 0.0 112.312 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -110.8 142.56 42.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.026 1.331 . . . . 0.0 109.379 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 t -129.32 150.55 50.64 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.476 0.71 . . . . 0.0 112.643 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.98 158.57 53.12 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.028 1.299 . . . . 0.0 113.619 -175.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -60.99 -20.93 63.04 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -170.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -80.12 -14.38 58.54 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.778 1.769 . . . . 0.0 115.778 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.87 -179.4 5.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -56.46 -47.18 79.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.495 1.518 . . . . 0.0 113.102 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.9 p -81.78 -26.13 34.7 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.52 -163.46 38.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.691 1.138 . . . . 0.0 111.79 -172.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -66.3 128.43 36.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.339 1.056 . . . . 0.0 111.342 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.37 164.2 22.6 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-O 121.557 0.532 . . . . 0.0 114.08 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.6 mt -114.89 136.07 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.493 1.517 . . . . 0.0 108.572 171.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -132.07 127.03 35.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.662 1.185 . . . . 0.0 110.614 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.29 140.88 52.57 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.3 1.44 . . . . 0.0 113.187 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -140.77 128.48 21.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.464 1.106 . . . . 0.0 111.988 -169.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -74.82 135.86 41.62 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.621 0.768 . . . . 0.0 111.738 171.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.5 p -172.33 140.06 1.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.063 2.145 . . . . 0.0 111.473 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.7 m -68.88 -20.28 64.25 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.344 -0.847 . . . . 0.0 113.272 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -100.63 17.88 20.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.989 1.716 . . . . 0.0 112.738 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.18 -39.92 31.21 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.839 1.255 . . . . 0.0 113.779 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -68.25 -37.71 81.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.302 1.041 . . . . 0.0 113.211 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.73 -34.05 76.08 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.149 -0.97 . . . . 0.0 111.911 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.95 -46.07 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.983 -0.448 . . . . 0.0 110.075 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.71 -43.15 94.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.33 1.052 . . . . 0.0 112.023 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -66.48 -37.45 85.13 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.845 1.258 . . . . 0.0 112.556 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.1 tp -80.63 -32.61 36.23 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.914 0.779 . . . . 0.0 112.43 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.6 mt -56.25 -50.42 71.39 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.65 0.659 . . . . 0.0 112.55 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -65.95 -18.79 65.57 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.69 -43.71 16.55 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.425 1.09 . . . . 0.0 110.977 173.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.0 mt -71.55 -28.18 63.68 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.845 -1.159 . . . . 0.0 111.959 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 33.6 mtt -61.32 -17.04 51.82 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 167.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -122.36 -16.22 7.42 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.8 m -91.82 4.81 52.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.527 1.931 . . . . 0.0 113.116 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -68.64 168.77 12.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.238 1.815 . . . . 0.0 112.253 169.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.4 m -73.48 79.71 1.43 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.051 1.34 . . . . 0.0 112.612 -175.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.9 mm -119.82 -54.58 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.795 1.638 . . . . 0.0 109.526 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -76.8 38.92 0.21 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.218 1.407 . . . . 0.0 112.627 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.1 p -156.4 113.88 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 128.565 2.746 . . . . 0.0 106.149 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.1 ptm -49.51 141.86 8.74 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.921 1.689 . . . . 0.0 113.274 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.0 -174.25 4.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.77 1.628 . . . . 0.0 112.228 -169.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -61.89 143.15 94.68 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.023 0.929 . . . . 0.0 111.777 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.66 154.33 73.67 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.527 2.818 . . . . 0.0 112.218 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.9 p -127.3 136.71 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.716 1.606 . . . . 0.0 110.578 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.6 mp -93.22 123.87 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.256 1.022 . . . . 0.0 108.782 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.55 21.02 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.559 1.544 . . . . 0.0 112.662 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.1 p -62.29 146.29 51.41 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.761 1.624 . . . . 0.0 112.197 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -168.19 170.81 9.89 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.975 1.71 . . . . 0.0 111.904 -170.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -67.58 137.85 56.0 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.466 0.707 . . . . 0.0 110.748 169.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.7 p -110.86 115.0 28.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.702 1.201 . . . . 0.0 110.147 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -85.08 147.57 48.19 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.834 0.854 . . . . 0.0 112.852 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.28 159.63 52.35 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.5 2.8 . . . . 0.0 111.271 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.98 150.79 27.74 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.907 1.283 . . . . 0.0 111.581 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.84 129.39 36.92 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.451 1.1 . . . . 0.0 110.916 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.06 150.95 25.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.519 1.128 . . . . 0.0 111.277 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -154.96 147.09 23.72 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.286 1.435 . . . . 0.0 111.299 -175.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 pp -92.7 146.64 32.62 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.875 1.27 . . . . 0.0 111.982 -174.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.16 145.51 21.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.059 2.506 . . . . 0.0 111.094 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 -70.65 152.4 43.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.422 0.689 . . . . 0.0 111.355 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -143.75 152.92 57.12 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.336 1.454 . . . . 0.0 111.798 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.53 174.56 12.0 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.938 3.092 . . . . 0.0 111.743 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -129.96 145.7 58.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.151 1.381 . . . . 0.0 110.059 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.51 147.27 45.84 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.21 2.607 . . . . 0.0 111.775 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.03 150.63 38.31 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.674 2.916 . . . . 0.0 111.87 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -84.77 164.21 18.66 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.431 1.092 . . . . 0.0 112.447 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.87 167.71 27.45 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.652 1.581 . . . . 0.0 111.81 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.9 165.0 37.78 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.539 1.535 . . . . 0.0 112.435 -174.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -122.81 -155.47 9.34 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.861 1.696 . . . . 0.0 113.178 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -156.7 175.11 14.48 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.565 1.546 . . . . 0.0 112.191 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.2 t -154.25 176.5 12.21 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.693 1.597 . . . . 0.0 111.068 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.0 p -166.8 148.95 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 127.006 2.122 . . . . 0.0 109.836 -171.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -156.28 151.38 26.4 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.382 1.473 . . . . 0.0 111.572 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 26.2 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 127.653 2.381 . . . . 0.0 112.151 -177.934 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -88.9 124.36 34.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.391 0.676 . . . . 0.0 110.428 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.15 109.09 18.64 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.989 0.916 . . . . 0.0 109.909 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 40.0 mt -77.46 154.78 32.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.748 0.819 . . . . 0.0 112.819 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -87.13 -19.02 29.1 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.576 1.55 . . . . 0.0 112.792 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -149.8 167.76 25.61 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.332 1.853 . . . . 0.0 111.751 -175.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -93.22 123.56 60.4 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.627 -0.702 . . . . 0.0 111.389 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.92 -18.03 6.64 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.197 2.598 . . . . 0.0 114.129 -171.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 84.0 m -101.15 115.35 30.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.154 0.982 . . . . 0.0 111.284 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.49 -41.1 45.71 Favored Glycine 0 N--CA 1.476 1.343 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -77.73 113.92 16.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.543 1.537 . . . . 0.0 110.055 169.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.36 151.03 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.737 2.015 . . . . 0.0 110.234 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -131.96 160.35 36.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.72 1.608 . . . . 0.0 111.484 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -113.77 123.9 50.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.989 1.316 . . . . 0.0 111.207 -169.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.28 160.29 38.07 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.35 0.976 . . . . 0.0 112.62 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 53.82 48.18 21.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.741 1.216 . . . . 0.0 112.785 171.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -61.4 130.25 45.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.386 1.074 . . . . 0.0 110.478 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -163.1 159.25 22.94 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.255 1.422 . . . . 0.0 110.058 -169.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.217 1.407 . . . . 0.0 113.126 174.308 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 112.039 -0.425 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.8 p -166.27 170.72 12.91 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.39 1.476 . . . . 0.0 111.819 -174.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -132.59 159.62 38.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.342 1.457 . . . . 0.0 111.425 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.07 -23.52 0.11 Allowed Glycine 0 N--CA 1.474 1.177 0 N-CA-C 115.254 0.862 . . . . 0.0 115.254 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.2 t -69.08 149.06 49.13 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.415 1.108 . . . . 0.0 111.54 169.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.6 t -160.59 148.71 16.3 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.803 1.241 . . . . 0.0 111.344 -174.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.16 111.21 3.2 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.074 0.845 . . . . 0.0 111.027 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 99.5 mt -137.15 128.01 27.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.921 1.688 . . . . 0.0 109.3 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -163.39 161.63 24.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.621 1.568 . . . . 0.0 111.745 -174.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -88.64 147.85 24.34 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.836 1.254 . . . . 0.0 111.228 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -85.05 -1.65 57.08 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.914 1.286 . . . . 0.0 113.313 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -142.61 145.66 33.74 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.074 1.75 . . . . 0.0 109.388 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.12 124.87 65.85 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.932 0.893 . . . . 0.0 110.961 -169.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.34 164.78 30.39 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.674 2.916 . . . . 0.0 112.092 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -74.4 5.35 4.71 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.557 1.543 . . . . 0.0 114.197 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -130.0 11.72 5.59 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.056 1.742 . . . . 0.0 113.263 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.01 145.08 45.63 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 124.521 1.128 . . . . 0.0 113.414 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.1 -14.71 32.02 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.051 2.501 . . . . 0.0 115.421 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.3 p -131.04 -18.74 2.93 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 120.229 1.377 . . . . 0.0 114.516 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -104.68 142.02 35.42 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.192 0.997 . . . . 0.0 110.447 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -141.73 108.32 5.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 145.35 52.0 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.254 -0.904 . . . . 0.0 110.51 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.36 156.7 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.609 0.763 . . . . 0.0 111.5 -172.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -132.95 115.15 14.85 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -65.24 133.52 51.66 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.86 154.46 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.076 0.95 . . . . 0.0 112.431 -176.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.4 p-10 -88.01 -167.5 1.9 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.342 1.057 . . . . 0.0 113.599 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.89 -32.35 73.85 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.751 1.221 . . . . 0.0 114.234 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -79.53 -9.08 59.55 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.959 0.799 . . . . 0.0 112.533 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.92 14.5 81.93 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 117.931 -1.483 . . . . 0.0 113.923 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.438 HG22 ' OD1' ' A' ' 27' ' ' ASP . 15.1 m -76.24 150.11 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.85 1.825 . . . . 0.0 111.338 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.28 125.31 34.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.53 1.132 . . . . 0.0 111.183 -171.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.7 mt -107.4 -52.35 2.78 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.994 0.918 . . . . 0.0 112.107 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.17 147.14 14.96 Favored Glycine 0 N--CA 1.47 0.924 0 C-N-CA 124.591 1.091 . . . . 0.0 113.737 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 p -91.12 150.05 21.55 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.943 1.297 . . . . 0.0 113.104 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.05 168.13 32.38 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.947 1.737 . . . . 0.0 113.006 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.76 120.63 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.8 ttm -93.9 140.95 29.07 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.938 1.295 . . . . 0.0 110.619 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -140.06 130.26 25.12 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.592 1.557 . . . . 0.0 108.935 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -107.91 137.77 45.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.166 1.787 . . . . 0.0 108.016 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.9 p -137.53 174.71 10.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.779 1.232 . . . . 0.0 110.649 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -73.59 3.21 6.55 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.408 -0.807 . . . . 0.0 112.616 171.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.6 m -120.77 -45.04 2.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.532 1.133 . . . . 0.0 113.663 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.96 166.17 11.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.194 1.398 . . . . 0.0 113.706 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.13 136.97 34.26 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.855 1.262 . . . . 0.0 109.34 168.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.6 t -134.4 132.56 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.523 0.729 . . . . 0.0 110.98 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.2 mt -109.65 130.35 55.52 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.151 1.78 . . . . 0.0 110.777 169.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -100.15 125.32 46.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.531 1.933 . . . . 0.0 110.285 169.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.3 mt -131.62 162.88 29.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.921 2.088 . . . . 0.0 111.087 -173.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -113.4 -20.27 11.39 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -172.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -117.41 7.64 12.84 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.422 1.889 . . . . 0.0 112.875 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -145.6 161.59 39.44 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 127.028 2.131 . . . . 0.0 110.649 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 -61.27 151.78 30.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.703 1.601 . . . . 0.0 110.488 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.5 138.43 58.02 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.718 -0.614 . . . . 0.0 110.512 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.3 134.53 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.293 0.637 . . . . 0.0 110.464 -174.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.44 144.37 48.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.585 1.154 . . . . 0.0 112.022 -169.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -144.29 122.05 6.69 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.877 1.271 . . . . 0.0 111.571 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.26 141.48 39.37 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.042 2.494 . . . . 0.0 110.303 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -58.8 -26.02 63.7 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.43 -41.78 69.78 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.451 1.9 . . . . 0.0 112.852 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.9 p -87.97 -10.69 49.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.9 mt -89.94 69.07 7.43 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.491 1.516 . . . . 0.0 110.775 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -67.67 -23.86 65.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.852 0.861 . . . . 0.0 113.269 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -141.54 119.65 12.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.513 1.525 . . . . 0.0 110.278 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -142.0 109.31 5.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.104 1.762 . . . . 0.0 110.591 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.56 170.26 14.0 Favored Glycine 0 N--CA 1.465 0.601 0 C-N-CA 124.733 1.159 . . . . 0.0 113.612 -169.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -141.61 158.68 43.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.054 0.942 . . . . 0.0 111.67 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.24 -173.89 4.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.136 1.774 . . . . 0.0 109.964 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.4 p -58.16 109.73 0.81 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.944 0.878 . . . . 0.0 111.771 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.261 0.8 OUTLIER 49.36 27.73 2.06 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 127.292 2.237 . . . . 0.0 115.836 -173.113 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -134.99 130.02 35.08 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.736 1.614 . . . . 0.0 110.564 -172.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -124.45 137.75 54.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.685 1.594 . . . . 0.0 109.852 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 t -153.44 156.7 38.68 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.259 1.024 . . . . 0.0 113.021 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.77 156.69 39.58 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.051 1.34 . . . . 0.0 112.082 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -121.87 137.86 54.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.374 1.87 . . . . 0.0 109.705 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.0 p -145.31 150.5 36.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.201 1.0 . . . . 0.0 112.887 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.84 166.9 49.36 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.863 1.221 . . . . 0.0 114.031 -175.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -63.52 -12.35 31.51 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -171.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -20.17 60.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.335 1.454 . . . . 0.0 114.709 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.55 176.58 8.18 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -57.4 -41.15 79.75 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.979 1.311 . . . . 0.0 113.137 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -91.54 -21.02 21.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.344 1.458 . . . . 0.0 113.884 -173.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.34 -176.56 52.79 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.253 1.406 . . . . 0.0 112.637 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.42 130.74 45.71 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.142 0.977 . . . . 0.0 112.671 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.76 178.91 36.08 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.862 1.22 . . . . 0.0 113.041 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.31 136.69 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.775 1.63 . . . . 0.0 108.834 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -130.57 121.54 25.88 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.735 1.214 . . . . 0.0 110.068 -173.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.36 141.98 50.99 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.54 1.136 . . . . 0.0 112.797 -170.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -141.11 130.62 23.9 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.817 0.847 . . . . 0.0 111.913 -170.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -69.57 131.98 45.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.798 0.839 . . . . 0.0 110.79 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.1 t -170.55 120.21 0.57 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.438 1.895 . . . . 0.0 110.337 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.4 t -71.11 -7.84 49.34 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 121.029 -1.044 . . . . 0.0 113.226 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -101.34 7.69 42.66 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.671 1.988 . . . . 0.0 112.688 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.85 -39.62 54.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.207 1.803 . . . . 0.0 115.592 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -68.48 -34.0 75.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.676 0.671 . . . . 0.0 112.789 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -70.59 -33.74 71.4 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.642 -0.661 . . . . 0.0 111.146 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.33 -47.0 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.59 0.632 . . . . 0.0 110.088 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.05 -43.06 99.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.758 0.823 . . . . 0.0 111.675 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -70.3 -30.58 67.61 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -80.68 -35.71 33.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.703 1.138 . . . . 0.0 111.861 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 mt -54.95 -50.36 69.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.29 0.95 . . . . 0.0 112.341 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -63.53 -24.92 68.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -25.75 47.08 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.32 1.048 . . . . 0.0 112.576 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.54 -30.15 17.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.423 1.089 . . . . 0.0 111.588 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 14.9 mmt -56.36 -24.89 47.13 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.208 1.403 . . . . 0.0 112.939 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -101.74 -6.16 24.03 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.278 1.431 . . . . 0.0 114.633 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 37.1 t -85.08 -27.8 26.06 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.363 1.065 . . . . 0.0 113.63 -171.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -67.05 155.75 37.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.211 1.004 . . . . 0.0 112.667 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.8 t -91.78 121.45 33.43 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.568 0.747 . . . . 0.0 110.738 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.5 mp -96.68 66.7 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 62.55 29.21 16.99 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.49 1.916 . . . . 0.0 113.536 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.36 8.56 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.084 1.353 . . . . 0.0 113.612 -175.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 60.0 mtt -143.61 158.42 43.68 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.426 1.891 . . . . 0.0 110.829 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -67.67 142.3 56.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.532 0.733 . . . . 0.0 110.642 173.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -148.47 154.73 41.87 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.165 1.386 . . . . 0.0 112.174 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.87 176.4 9.91 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.948 3.099 . . . . 0.0 111.903 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 80.6 t -84.25 124.37 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.411 1.084 . . . . 0.0 110.181 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.53 139.35 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.892 1.677 . . . . 0.0 108.346 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.83 119.1 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.776 0.83 . . . . 0.0 109.653 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.2 p -144.76 154.58 42.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.317 1.847 . . . . 0.0 110.778 -174.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -73.26 -23.03 60.27 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -149.23 134.38 18.21 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.048 1.739 . . . . 0.0 110.272 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 t -77.27 143.39 38.92 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.432 0.693 . . . . 0.0 111.297 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -61.47 123.7 77.68 Favored Pre-proline 0 CA--C 1.558 1.267 0 O-C-N 121.075 -1.016 . . . . 0.0 112.15 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.48 149.63 39.62 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.256 2.637 . . . . 0.0 111.163 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.19 67.82 3.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.505 1.122 . . . . 0.0 111.607 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -76.27 99.83 4.89 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.092 1.357 . . . . 0.0 110.22 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 pp -167.07 -175.9 3.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.217 2.207 . . . . 0.0 110.97 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -149.36 152.81 36.42 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.12 1.768 . . . . 0.0 109.844 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tt -49.95 114.43 4.27 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.549 1.94 . . . . 0.0 111.385 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.77 141.34 17.07 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.726 2.284 . . . . 0.0 111.566 -169.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.97 163.12 26.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.32 0.648 . . . . 0.0 112.183 172.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -147.72 149.1 32.62 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.413 1.485 . . . . 0.0 110.942 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.73 140.62 39.45 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.188 2.592 . . . . 0.0 110.852 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -94.55 129.44 36.56 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.744 0.817 . . . . 0.0 109.898 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.42 131.47 13.85 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.687 2.258 . . . . 0.0 110.406 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.73 114.17 3.97 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.857 2.372 . . . . 0.0 109.8 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -79.24 113.35 17.3 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.322 0.649 . . . . 0.0 111.316 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.52 130.46 39.64 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.987 0.915 . . . . 0.0 111.28 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.9 tt -97.06 109.32 22.1 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.703 1.201 . . . . 0.0 108.623 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.04 139.2 4.49 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.192 0.901 . . . . 0.0 113.241 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -152.62 171.39 18.23 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.942 2.097 . . . . 0.0 111.09 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 t -152.32 176.71 11.34 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.023 1.329 . . . . 0.0 111.646 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.97 137.2 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.66 1.984 . . . . 0.0 109.171 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.9 m -51.8 125.14 14.24 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.411 1.484 . . . . 0.0 113.627 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.2 p . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.915 1.686 . . . . 0.0 114.328 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -140.56 128.08 21.42 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.44 1.496 . . . . 0.0 110.184 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -88.39 117.26 27.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.49 1.116 . . . . 0.0 111.309 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 72.2 mt -84.0 156.34 22.32 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.98 0.912 . . . . 0.0 112.27 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -92.34 -5.37 52.32 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.643 1.577 . . . . 0.0 113.423 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -169.41 161.14 9.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.208 2.203 . . . . 0.0 110.977 -169.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -89.14 124.72 64.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.534 -173.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.6 -24.13 2.46 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.128 2.552 . . . . 0.0 113.813 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.7 m -83.4 124.23 30.46 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.636 0.775 . . . . 0.0 111.399 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.36 -4.46 89.07 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.342 0.972 . . . . 0.0 114.583 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -138.46 136.91 36.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.746 1.618 . . . . 0.0 110.219 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -162.8 139.73 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.075 1.35 . . . . 0.0 111.197 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -100.67 125.43 47.09 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.627 1.971 . . . . 0.0 108.945 171.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -86.11 124.1 32.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.229 0.612 . . . . 0.0 111.395 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.17 -101.11 0.59 Allowed Glycine 0 N--CA 1.47 0.951 0 C-N-CA 125.312 1.434 . . . . 0.0 112.574 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -75.87 67.1 2.22 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.017 1.327 . . . . 0.0 112.819 -173.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -73.23 -11.33 60.47 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.262 1.425 . . . . 0.0 113.259 172.458 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -136.35 149.18 48.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.843 2.057 . . . . 0.0 107.854 169.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 125.625 1.57 . . . . 0.0 111.34 -170.429 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.6 m -151.44 156.66 41.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.11 1.364 . . . . 0.0 111.434 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.5 p -162.95 170.09 18.64 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.896 1.279 . . . . 0.0 112.455 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.17 171.24 36.69 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.145 1.355 . . . . 0.0 113.686 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.4 t -164.2 168.7 18.58 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.646 1.578 . . . . 0.0 111.413 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.3 p -170.49 178.73 3.58 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.451 1.901 . . . . 0.0 111.679 -171.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.27 27.13 23.9 Favored Glycine 0 N--CA 1.474 1.204 0 O-C-N 121.4 -0.812 . . . . 0.0 114.646 173.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.54 149.26 43.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.656 1.182 . . . . 0.0 110.837 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -152.56 177.71 10.36 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.733 1.213 . . . . 0.0 113.55 -170.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -148.75 166.67 27.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.265 1.826 . . . . 0.0 111.676 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -76.88 -27.8 55.14 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.339 1.056 . . . . 0.0 113.06 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.1 m -75.96 52.69 0.72 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.859 1.664 . . . . 0.0 112.096 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.22 121.52 66.83 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.041 1.737 . . . . 0.0 111.815 -173.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.38 165.59 14.36 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.808 3.006 . . . . 0.0 111.431 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -73.7 6.11 3.44 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.351 1.461 . . . . 0.0 113.89 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -126.51 11.31 7.36 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.595 1.958 . . . . 0.0 113.138 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -58.0 145.2 73.32 Favored Pre-proline 0 CA--C 1.555 1.165 0 O-C-N 120.76 -1.212 . . . . 0.0 112.521 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.74 -12.64 35.12 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.0 2.466 . . . . 0.0 115.199 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.7 p -136.49 -18.39 1.46 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -112.58 148.56 34.29 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.431 1.093 . . . . 0.0 110.002 171.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -143.11 115.88 8.73 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.296 -0.878 . . . . 0.0 110.408 -173.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -71.02 133.93 46.72 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.458 -0.776 . . . . 0.0 110.242 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.44 163.77 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.927 1.291 . . . . 0.0 112.19 -169.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.3 m -134.46 119.77 18.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.426 1.091 . . . . 0.0 108.968 174.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.69 126.62 27.96 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 109.775 174.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.75 153.61 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.402 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.3 p-10 -91.88 -168.91 2.12 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.2 -22.66 67.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.481 1.512 . . . . 0.0 114.438 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -93.53 -5.84 48.1 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.665 1.186 . . . . 0.0 112.387 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.65 14.83 82.01 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 118.065 -1.408 . . . . 0.0 114.045 -173.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' OD1' ' A' ' 27' ' ' ASP . 18.2 m -81.04 150.99 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.674 1.737 . . . . 0.0 111.55 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.56 122.47 32.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.724 1.21 . . . . 0.0 110.996 -170.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.9 mt -103.65 -54.51 2.56 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.254 0.621 . . . . 0.0 111.86 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.59 146.72 16.98 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.869 1.223 . . . . 0.0 114.476 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 p -94.33 144.64 25.37 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.486 1.515 . . . . 0.0 112.558 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.41 171.68 32.92 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.701 1.143 . . . . 0.0 114.597 -177.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.5 t -115.35 121.17 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.663 1.185 . . . . 0.0 108.622 170.711 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.2 tpp -86.94 135.28 33.35 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.602 1.561 . . . . 0.0 109.933 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -138.85 129.82 26.57 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.564 1.546 . . . . 0.0 109.375 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mp -111.61 134.03 53.46 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.293 1.837 . . . . 0.0 108.247 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -137.12 167.68 21.07 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.949 1.299 . . . . 0.0 110.436 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -68.86 -6.85 29.59 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.449 -0.782 . . . . 0.0 112.68 173.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.9 m -95.74 -46.13 6.72 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.989 0.916 . . . . 0.0 112.832 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -176.02 174.33 2.11 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.704 1.201 . . . . 0.0 113.544 -168.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.8 mt -86.55 140.34 29.98 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.167 1.387 . . . . 0.0 110.035 168.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.57 136.57 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.532 1.133 . . . . 0.0 111.323 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.3 mt -108.94 133.28 53.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.371 1.869 . . . . 0.0 110.648 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -114.01 121.15 43.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.993 2.117 . . . . 0.0 110.377 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.7 mp -116.35 166.57 11.91 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.605 1.562 . . . . 0.0 111.323 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -51.72 -62.87 1.36 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.774 1.63 . . . . 0.0 114.504 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -134.71 -2.72 2.64 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.412 1.485 . . . . 0.0 113.795 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -72.97 154.33 40.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.975 0.807 . . . . 0.0 109.241 167.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -62.99 151.19 40.39 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.971 0.415 . . . . 0.0 111.074 172.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.58 147.24 53.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.219 0.608 . . . . 0.0 111.221 175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 t -128.99 137.0 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.603 0.761 . . . . 0.0 109.941 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 mtp85 -132.36 143.64 49.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.439 1.096 . . . . 0.0 112.388 -167.891 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -138.9 109.42 7.75 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.691 1.196 . . . . 0.0 111.622 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.5 150.99 83.94 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.914 2.409 . . . . 0.0 112.15 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -65.68 -7.27 14.52 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.58 -35.02 30.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.778 1.631 . . . . 0.0 113.583 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 16.5 p -88.11 -23.91 23.55 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.707 1.139 . . . . 0.0 113.709 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.11 107.25 0.84 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.619 1.568 . . . . 0.0 110.366 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -78.16 -38.33 43.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.35 1.46 . . . . 0.0 112.021 -174.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -163.94 156.52 17.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.836 2.055 . . . . 0.0 110.442 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.64 132.05 16.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.387 1.075 . . . . 0.0 109.877 -175.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.26 170.75 28.8 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-O 121.996 0.775 . . . . 0.0 114.373 -169.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.92 156.36 49.12 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.606 1.163 . . . . 0.0 112.136 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.05 -176.21 5.67 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.075 1.75 . . . . 0.0 110.107 175.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 t -63.13 114.86 3.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.107 0.956 . . . . 0.0 111.577 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 t30 57.02 18.66 4.11 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.035 2.134 . . . . 0.0 114.495 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.35 126.32 25.97 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.213 -1.554 . . . . 0.0 111.251 -169.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -119.88 138.06 53.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.536 1.535 . . . . 0.0 109.592 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.8 t -153.33 155.01 35.67 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.232 -0.917 . . . . 0.0 112.636 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -146.64 152.29 38.64 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.049 1.34 . . . . 0.0 111.759 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -110.51 143.05 41.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.713 1.605 . . . . 0.0 109.695 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -144.43 154.79 43.32 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.024 0.93 . . . . 0.0 111.983 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.22 176.62 37.38 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.403 1.478 . . . . 0.0 113.855 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -64.96 -8.91 17.72 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -76.81 -17.01 59.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.769 2.028 . . . . 0.0 115.424 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.0 p -85.66 -177.38 6.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.501 1.12 . . . . 0.0 113.961 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -61.53 -42.07 98.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.178 1.391 . . . . 0.0 112.879 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.4 p -93.01 -20.36 20.65 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.302 1.441 . . . . 0.0 114.123 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.45 -174.19 43.04 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.39 1.471 . . . . 0.0 112.7 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -67.63 134.41 51.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.655 0.782 . . . . 0.0 112.617 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.56 -176.37 35.49 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.503 1.049 . . . . 0.0 113.287 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.8 mt -121.26 137.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.799 1.64 . . . . 0.0 109.342 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -127.08 118.53 24.58 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.239 1.416 . . . . 0.0 109.32 -171.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.77 140.05 53.37 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.43 1.092 . . . . 0.0 113.196 -169.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -139.37 127.92 23.05 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.005 -169.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -67.7 129.02 38.62 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 168.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 35.3 t -165.31 126.63 1.99 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 111.103 -171.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.9 t -75.1 -10.22 59.27 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -107.39 18.6 21.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.311 1.845 . . . . 0.0 112.842 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.89 -40.27 79.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -169.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -71.0 -36.99 72.68 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.01 0.924 . . . . 0.0 112.274 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -64.64 -40.74 95.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.246 1.019 . . . . 0.0 110.707 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.0 -46.54 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.353 0.661 . . . . 0.0 110.63 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -39.36 83.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.503 1.121 . . . . 0.0 112.221 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -74.27 -30.88 62.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.256 1.022 . . . . 0.0 113.48 175.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -80.36 -34.96 36.07 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.354 0.979 . . . . 0.0 111.091 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.4 mt -52.44 -56.51 14.58 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.151 0.981 . . . . 0.0 112.897 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -55.65 -34.2 64.76 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.91 -17.03 56.21 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.285 1.434 . . . . 0.0 112.769 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.5 mt -95.24 -37.23 11.11 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.396 1.078 . . . . 0.0 110.917 169.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 57.8 mtp -65.86 -30.97 71.66 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.874 0.87 . . . . 0.0 112.663 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -78.09 -10.35 59.58 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.1 t -84.26 -9.24 58.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 113.04 -176.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -62.62 153.35 32.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.624 1.17 . . . . 0.0 112.726 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.0 m -94.94 73.03 3.48 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.555 1.142 . . . . 0.0 110.979 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -87.33 -159.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.556 1.143 . . . . 0.0 109.6 173.869 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -67.85 36.09 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.736 2.414 . . . . 0.0 115.105 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 p -82.88 14.0 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 128.129 2.572 . . . . 0.0 115.029 -168.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 21.7 ptp 51.99 29.4 6.16 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.802 2.441 . . . . 0.0 115.435 171.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -142.82 167.93 20.9 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.12 2.168 . . . . 0.0 109.816 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -60.59 142.31 91.41 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.18 0.992 . . . . 0.0 112.574 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.08 157.14 46.9 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.515 2.81 . . . . 0.0 111.989 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.23 118.51 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.889 1.676 . . . . 0.0 111.331 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.94 137.13 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.455 1.902 . . . . 0.0 108.515 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.8 pt -110.08 160.05 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.577 1.151 . . . . 0.0 111.198 170.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.8 p -125.45 148.52 48.8 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.321 1.448 . . . . 0.0 110.613 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -161.95 175.1 12.2 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.162 1.785 . . . . 0.0 111.517 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -131.77 -168.11 1.98 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.222 1.409 . . . . 0.0 112.839 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.4 p -144.76 177.92 8.37 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.951 2.1 . . . . 0.0 109.808 169.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -152.99 132.23 6.94 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.381 1.072 . . . . 0.0 111.772 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.17 152.19 27.35 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.443 2.762 . . . . 0.0 112.57 -172.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.55 166.21 15.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.634 1.174 . . . . 0.0 112.511 174.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -68.91 139.45 55.12 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.983 0.913 . . . . 0.0 111.539 176.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -85.42 176.44 8.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.339 1.456 . . . . 0.0 113.48 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -147.88 167.85 23.72 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.482 1.913 . . . . 0.0 111.41 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 pp -96.91 148.6 34.63 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.664 1.186 . . . . 0.0 112.448 -169.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.57 157.38 21.89 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.541 2.827 . . . . 0.0 111.84 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -69.96 139.39 52.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.818 0.847 . . . . 0.0 111.543 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.18 144.46 95.18 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.176 0.99 . . . . 0.0 112.768 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -78.15 168.22 22.17 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.057 3.171 . . . . 0.0 112.115 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -84.28 149.23 54.86 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.236 1.014 . . . . 0.0 111.175 174.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.08 154.38 52.4 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.569 2.846 . . . . 0.0 112.339 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.29 161.89 34.44 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.148 3.232 . . . . 0.0 112.357 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -92.99 148.04 22.33 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.608 1.163 . . . . 0.0 112.69 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.99 -174.23 5.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.198 1.399 . . . . 0.0 112.707 175.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -150.78 161.28 42.95 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.798 1.639 . . . . 0.0 112.444 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -92.83 -146.03 18.24 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.382 1.468 . . . . 0.0 113.42 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -155.5 -177.13 6.33 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.266 1.826 . . . . 0.0 111.987 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.8 t -148.05 175.6 10.88 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.206 1.402 . . . . 0.0 112.074 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.61 143.49 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.424 1.89 . . . . 0.0 112.178 -174.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.4 p -121.9 144.11 49.05 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.743 1.617 . . . . 0.0 112.269 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 126.669 1.987 . . . . 0.0 113.073 179.395 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -87.05 149.47 24.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.011 0.369 . . . . 0.0 110.972 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.03 97.4 5.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.911 1.684 . . . . 0.0 109.801 -173.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 57.7 mt -72.72 156.34 39.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.831 0.852 . . . . 0.0 111.872 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -98.56 -12.06 21.57 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.619 1.568 . . . . 0.0 113.0 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -144.8 149.64 35.8 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.509 1.924 . . . . 0.0 111.073 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -85.79 121.16 73.22 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.498 -0.751 . . . . 0.0 110.981 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.22 -19.88 4.42 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.291 2.661 . . . . 0.0 114.65 -169.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 87.3 m -89.54 124.64 34.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.163 0.892 . . . . 0.0 112.358 -172.131 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.68 -14.43 81.12 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.103 0.859 . . . . 0.0 114.42 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -115.31 129.39 56.6 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.371 1.468 . . . . 0.0 109.325 170.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 p -158.03 151.36 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.285 1.434 . . . . 0.0 110.921 -169.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -155.76 179.63 9.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.959 1.704 . . . . 0.0 112.442 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.43 135.35 33.52 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.185 1.794 . . . . 0.0 109.669 -173.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.13 -11.33 28.06 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -169.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -105.64 155.7 18.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.09 1.356 . . . . 0.0 112.427 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -156.7 151.74 26.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.455 1.502 . . . . 0.0 110.62 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -164.01 147.88 9.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.294 1.438 . . . . 0.0 109.581 -173.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 . . . . . 0 C--O 1.254 1.301 0 C-N-CA 124.879 1.271 . . . . 0.0 112.194 177.147 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -163.29 138.89 6.69 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.186 1.395 . . . . 0.0 110.517 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 t -167.37 161.6 14.24 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.543 1.537 . . . . 0.0 111.289 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.01 135.29 2.94 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.523 1.535 . . . . 0.0 113.082 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -156.17 162.56 40.19 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.135 1.774 . . . . 0.0 110.949 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 t -81.91 71.03 8.94 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 120.968 -1.082 . . . . 0.0 112.205 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.22 99.62 2.26 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.669 1.128 . . . . 0.0 111.892 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.6 mt -145.03 135.63 24.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.046 1.738 . . . . 0.0 110.486 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -169.81 161.63 9.17 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.083 2.153 . . . . 0.0 110.941 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -161.21 146.3 13.87 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.755 1.222 . . . . 0.0 111.661 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.37 0.04 47.76 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.431 1.492 . . . . 0.0 114.06 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -156.67 157.18 34.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.278 1.831 . . . . 0.0 110.466 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 p -72.9 119.54 76.04 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.595 0.758 . . . . 0.0 111.413 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.4 172.19 13.91 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.691 2.927 . . . . 0.0 111.835 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -73.3 6.59 2.76 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.176 1.39 . . . . 0.0 113.711 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -143.52 17.66 1.85 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.484 1.514 . . . . 0.0 114.982 -169.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -60.39 147.05 83.25 Favored Pre-proline 0 CA--C 1.558 1.261 0 O-C-N 121.041 -1.037 . . . . 0.0 113.256 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.9 -11.56 25.7 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.109 2.539 . . . . 0.0 115.359 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.5 p -131.35 -21.96 2.53 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 120.355 1.434 . . . . 0.0 114.553 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -102.34 140.9 36.01 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.306 1.042 . . . . 0.0 110.363 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.44 111.72 9.11 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.757 1.223 . . . . 0.0 108.35 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -67.94 133.22 48.73 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.647 -0.658 . . . . 0.0 110.293 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.54 164.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.324 1.449 . . . . 0.0 111.59 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.3 m -139.96 120.78 14.44 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.376 1.07 . . . . 0.0 109.117 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -64.58 131.9 48.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.453 0.701 . . . . 0.0 110.023 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.16 157.52 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.429 1.092 . . . . 0.0 112.389 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -85.76 -167.05 1.71 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.451 1.1 . . . . 0.0 113.28 176.774 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.38 -26.58 63.78 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.495 1.118 . . . . 0.0 113.639 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -80.42 -18.12 49.78 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.566 1.146 . . . . 0.0 112.567 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.36 17.94 59.76 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.115 -1.38 . . . . 0.0 114.167 -173.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' OD1' ' A' ' 27' ' ' ASP . 17.5 m -77.22 150.65 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.841 1.82 . . . . 0.0 111.269 171.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.65 126.73 35.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.839 1.256 . . . . 0.0 110.923 -172.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.5 mt -109.69 -51.21 2.9 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.115 0.966 . . . . 0.0 111.814 -170.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.14 136.38 5.2 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 124.593 1.092 . . . . 0.0 114.08 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 p -84.1 146.29 27.98 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.07 1.348 . . . . 0.0 112.652 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.93 170.06 32.53 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.369 1.462 . . . . 0.0 113.721 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.36 120.22 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.6 ttm -87.6 136.38 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.922 0.889 . . . . 0.0 109.636 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -130.94 129.66 42.46 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.392 1.477 . . . . 0.0 108.67 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.77 116.24 31.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.978 1.711 . . . . 0.0 106.967 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.5 p -114.95 168.0 10.29 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.61 1.164 . . . . 0.0 110.046 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -72.1 -2.4 18.37 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.528 -0.732 . . . . 0.0 112.659 170.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.5 m -96.77 -48.7 5.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.447 1.099 . . . . 0.0 112.51 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -176.31 175.91 1.75 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.016 1.726 . . . . 0.0 112.813 -170.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 mt -84.73 137.87 32.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.302 1.041 . . . . 0.0 110.214 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.01 134.38 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.027 0.931 . . . . 0.0 111.502 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.7 mt -104.08 133.72 48.55 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.894 1.677 . . . . 0.0 109.769 168.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -112.61 129.88 56.22 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.944 2.098 . . . . 0.0 110.899 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mp -130.92 167.37 19.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.748 1.619 . . . . 0.0 111.086 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -78.5 0.09 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.612 1.165 . . . . 0.0 112.764 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -95.16 -4.52 45.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.587 1.155 . . . . 0.0 113.969 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mmp_? -98.52 154.74 17.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.649 1.58 . . . . 0.0 111.13 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.13 156.63 31.03 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.29 1.036 . . . . 0.0 112.204 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.27 150.1 48.66 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.424 0.69 . . . . 0.0 111.621 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.04 130.19 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.815 0.846 . . . . 0.0 110.141 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 mtp85 -126.99 144.39 51.03 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.725 1.21 . . . . 0.0 112.416 -168.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -139.63 116.89 8.45 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.781 1.232 . . . . 0.0 111.581 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -64.13 143.2 83.48 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.714 2.276 . . . . 0.0 110.068 172.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -55.81 -31.66 62.87 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.45 -44.15 76.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.702 2.001 . . . . 0.0 112.752 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.2 p -75.41 -7.93 55.35 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.8 mt -83.17 108.78 16.66 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.152 0.981 . . . . 0.0 110.514 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -74.81 -37.94 62.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.842 0.857 . . . . 0.0 112.125 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -157.84 163.31 38.11 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.587 1.555 . . . . 0.0 110.961 170.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -151.9 141.05 21.3 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.613 1.565 . . . . 0.0 109.074 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.0 177.81 34.56 Favored Glycine 0 N--CA 1.463 0.447 0 CA-C-O 121.484 0.491 . . . . 0.0 113.794 -171.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -143.61 166.11 25.73 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.202 1.001 . . . . 0.0 113.44 -170.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -151.39 -170.52 3.68 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.681 1.992 . . . . 0.0 109.787 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 t -72.94 -13.05 61.17 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.596 -1.315 . . . . 0.0 114.234 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -157.39 5.85 0.14 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.631 1.572 . . . . 0.0 114.25 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.86 132.87 37.16 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.818 1.647 . . . . 0.0 110.451 -168.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -124.48 142.11 51.57 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.428 1.891 . . . . 0.0 109.773 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 t -157.08 161.15 39.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.648 1.179 . . . . 0.0 112.508 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.34 149.34 29.96 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.496 1.518 . . . . 0.0 112.013 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -93.86 139.47 30.85 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.92 1.288 . . . . 0.0 109.456 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.1 p -142.33 148.73 38.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.96 172.54 35.43 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.098 1.332 . . . . 0.0 113.986 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -13.75 54.37 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -174.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -72.81 -16.98 61.61 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.016 1.727 . . . . 0.0 115.653 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 p -83.73 -178.79 7.13 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.373 1.069 . . . . 0.0 113.723 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.2 -41.37 92.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.106 1.362 . . . . 0.0 113.049 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.5 p -91.04 -21.15 21.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.101 1.36 . . . . 0.0 113.876 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.24 -177.72 49.09 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.139 1.352 . . . . 0.0 112.271 -170.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -64.73 137.25 57.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.152 0.981 . . . . 0.0 112.789 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.06 -178.96 35.91 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.263 0.935 . . . . 0.0 113.483 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.3 mt -118.3 133.71 64.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.616 1.566 . . . . 0.0 108.81 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -127.92 124.57 37.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.98 1.312 . . . . 0.0 109.458 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.03 143.92 48.8 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.088 0.955 . . . . 0.0 112.886 -172.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -138.87 128.58 24.81 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.52 1.128 . . . . 0.0 111.36 -169.577 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -69.85 136.1 50.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.966 0.506 . . . . 0.0 110.667 169.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 23.8 t -163.42 138.95 6.59 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.243 1.417 . . . . 0.0 110.971 -174.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t -74.4 -11.32 60.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -137.3 34.48 2.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.979 1.712 . . . . 0.0 113.776 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.89 -37.86 33.22 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.964 1.306 . . . . 0.0 113.659 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.94 -37.48 81.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.222 1.009 . . . . 0.0 113.141 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.81 -37.78 82.43 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.319 -0.863 . . . . 0.0 110.931 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 77.4 mt -62.43 -46.4 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.156 0.582 . . . . 0.0 110.097 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -38.26 84.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.296 1.038 . . . . 0.0 112.481 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -72.11 -28.38 63.25 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.25 1.02 . . . . 0.0 113.469 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -85.63 -41.95 14.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.078 0.854 . . . . 0.0 110.713 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.2 mt -50.81 -54.48 23.33 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.299 1.04 . . . . 0.0 112.603 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -59.47 -22.46 61.59 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.08 -21.57 36.75 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.725 1.21 . . . . 0.0 112.867 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.1 mt -95.81 -35.34 11.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.097 1.359 . . . . 0.0 112.039 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 66.2 mmm -57.46 -28.64 63.53 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.49 1.516 . . . . 0.0 112.249 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -96.45 -9.3 30.1 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.767 1.227 . . . . 0.0 114.169 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 24.7 t -82.74 -32.57 27.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.187 0.995 . . . . 0.0 111.926 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -60.48 133.59 56.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.572 0.749 . . . . 0.0 109.602 169.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.1 m -58.52 106.58 0.41 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.785 1.234 . . . . 0.0 113.583 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.7 mm -91.74 92.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.13 -0.981 . . . . 0.0 109.167 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.5 m120 62.38 18.53 10.36 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.438 1.895 . . . . 0.0 114.365 175.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.56 -35.07 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.948 1.699 . . . . 0.0 111.657 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.8 mtt -81.66 144.68 31.02 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.232 1.013 . . . . 0.0 111.154 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -67.98 154.98 40.48 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.277 0.631 . . . . 0.0 111.746 171.734 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -145.25 146.56 30.8 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.279 1.432 . . . . 0.0 110.79 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.57 143.02 37.36 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.983 2.455 . . . . 0.0 110.736 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -81.51 100.03 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.1 tp -70.72 154.79 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.002 1.721 . . . . 0.0 112.302 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.78 142.56 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.478 -0.764 . . . . 0.0 110.112 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.1 t -154.63 135.33 13.57 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.782 1.233 . . . . 0.0 110.648 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -78.36 141.45 38.38 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.026 0.931 . . . . 0.0 110.872 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -147.57 156.47 42.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.263 1.425 . . . . 0.0 111.728 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.1 m -133.68 25.06 4.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.684 1.193 . . . . 0.0 112.418 -169.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -146.1 151.11 43.98 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.617 1.567 . . . . 0.0 112.774 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.56 159.63 39.1 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.694 2.93 . . . . 0.0 111.666 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.84 133.01 52.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.71 0.804 . . . . 0.0 111.968 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -92.79 171.15 9.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.85 1.26 . . . . 0.0 112.02 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.2 170.77 15.11 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.122 1.769 . . . . 0.0 111.51 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -145.01 135.99 24.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.034 1.334 . . . . 0.0 111.036 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 pp -95.37 146.74 31.85 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 124.903 1.281 . . . . 0.0 111.729 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.91 147.58 39.29 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.037 2.491 . . . . 0.0 110.875 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -138.56 142.58 39.24 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.977 1.311 . . . . 0.0 110.688 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -151.21 152.2 30.73 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.995 1.718 . . . . 0.0 110.87 -175.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.4 148.59 61.26 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.423 2.749 . . . . 0.0 111.308 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -103.46 128.74 26.81 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.319 1.048 . . . . 0.0 109.453 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.51 154.85 40.43 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.193 2.595 . . . . 0.0 111.848 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -72.68 167.34 27.41 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.852 3.035 . . . . 0.0 111.495 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -128.11 124.8 37.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.62 1.168 . . . . 0.0 111.18 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -165.95 173.43 10.48 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.18 2.192 . . . . 0.0 110.527 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.5 tp -150.83 128.57 11.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.78 1.232 . . . . 0.0 110.888 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -98.4 162.9 20.76 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.242 1.401 . . . . 0.0 113.116 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -161.96 157.12 23.26 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.849 1.66 . . . . 0.0 111.651 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -157.27 170.12 23.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.975 1.71 . . . . 0.0 110.874 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.0 p -163.79 144.38 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.434 1.894 . . . . 0.0 110.485 -169.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.1 t -161.74 162.13 29.54 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.869 1.668 . . . . 0.0 110.762 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.004 1.721 . . . . 0.0 111.892 -177.141 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -78.63 124.31 28.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.782 0.433 . . . . 0.0 111.27 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' B' ' 3' ' ' ARG . 0.0 OUTLIER -85.78 122.98 30.62 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.022 0.929 . . . . 0.0 111.246 177.567 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 52.2 mt -90.29 153.13 20.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.6 0.76 . . . . 0.0 112.752 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -88.27 -17.49 30.61 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.613 1.565 . . . . 0.0 113.469 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -156.16 168.64 26.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.269 1.828 . . . . 0.0 111.459 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.89 119.29 70.46 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.706 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.29 -23.69 3.4 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.125 2.55 . . . . 0.0 114.369 -169.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 81.8 m -78.68 126.96 31.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.13 0.877 . . . . 0.0 111.551 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.78 -22.63 63.67 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 124.031 0.824 . . . . 0.0 114.428 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -118.93 126.49 51.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.021 1.328 . . . . 0.0 109.645 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.23 164.42 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.743 1.617 . . . . 0.0 110.835 -172.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -134.25 134.43 41.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.037 1.335 . . . . 0.0 109.69 174.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -99.01 113.12 25.14 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.587 1.155 . . . . 0.0 110.941 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.29 -85.58 1.44 Allowed Glycine 0 N--CA 1.467 0.761 0 C-N-CA 124.678 1.132 . . . . 0.0 111.377 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -81.55 90.53 6.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.226 1.011 . . . . 0.0 110.635 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -155.55 132.91 10.96 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.87 1.668 . . . . 0.0 108.653 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -91.36 153.77 19.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.67 0.788 . . . . 0.0 110.979 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.139 1.776 . . . . 0.0 113.744 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.476 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.9 m -147.56 127.41 13.52 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.65 1.18 . . . . 0.0 110.878 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 m -151.7 159.05 44.14 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.338 1.455 . . . . 0.0 111.624 -173.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.91 -167.99 40.83 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.442 1.496 . . . . 0.0 112.546 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.4 p -146.6 140.96 26.45 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.652 0.781 . . . . 0.0 112.725 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.7 p -164.56 158.47 18.13 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.584 1.554 . . . . 0.0 111.154 -174.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.4 -143.22 4.7 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.937 1.256 . . . . 0.0 113.13 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.96 162.91 27.16 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.595 1.158 . . . . 0.0 112.473 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -121.18 131.57 54.32 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.019 1.328 . . . . 0.0 110.35 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -120.38 20.56 11.89 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.276 1.831 . . . . 0.0 112.751 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -157.93 159.08 36.15 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.543 1.937 . . . . 0.0 111.002 -175.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 t -79.32 37.47 0.33 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.451 1.5 . . . . 0.0 114.293 -168.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.0 p -147.23 133.55 9.69 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.167 1.787 . . . . 0.0 110.596 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -81.99 148.68 15.42 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.161 2.574 . . . . 0.0 111.806 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -64.92 2.67 0.67 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.298 1.439 . . . . 0.0 114.334 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -130.09 11.83 5.56 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.119 1.768 . . . . 0.0 114.248 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -53.75 135.51 55.36 Favored Pre-proline 0 CA--C 1.556 1.188 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.61 -16.75 51.64 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.184 2.589 . . . . 0.0 115.302 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.0 p -125.26 -15.7 6.16 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.916 1.234 . . . . 0.0 114.316 176.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -103.47 125.1 49.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.223 0.92 . . . . 0.0 112.119 172.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.29 106.71 10.94 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.12 1.768 . . . . 0.0 109.092 -176.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -69.2 132.49 46.6 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.618 -0.676 . . . . 0.0 109.982 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 m -140.8 158.95 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.722 1.209 . . . . 0.0 112.245 -169.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -134.18 118.37 17.58 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.679 1.192 . . . . 0.0 108.214 174.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -66.92 131.37 45.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 m -125.53 154.49 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.663 0.785 . . . . 0.0 112.557 -177.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -81.95 -169.6 2.45 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.747 1.219 . . . . 0.0 113.884 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -64.6 -29.13 70.14 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.658 1.583 . . . . 0.0 115.001 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.09 -24.22 20.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.137 0.575 . . . . 0.0 112.026 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.49 14.98 6.63 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 126.109 1.814 . . . . 0.0 112.459 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.57 140.48 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 126.681 1.992 . . . . 0.0 109.43 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.24 125.93 31.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.878 1.671 . . . . 0.0 110.652 -171.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.2 mt -109.88 -53.22 2.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.973 0.909 . . . . 0.0 112.141 -171.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.2 140.33 7.93 Favored Glycine 0 N--CA 1.469 0.848 0 C-N-CA 124.814 1.197 . . . . 0.0 113.574 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 p -92.18 143.64 26.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.194 1.398 . . . . 0.0 112.344 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.1 171.73 34.53 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.312 1.434 . . . . 0.0 113.028 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -118.62 119.47 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.198 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.9 tpp -83.16 133.62 35.02 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.144 0.977 . . . . 0.0 109.444 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -126.99 130.54 50.24 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.217 1.407 . . . . 0.0 108.877 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.69 119.17 38.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.329 1.852 . . . . 0.0 107.72 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -122.61 173.68 7.55 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.974 1.309 . . . . 0.0 110.307 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -74.69 2.54 9.71 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.386 -0.821 . . . . 0.0 113.209 172.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.8 p -107.39 -45.93 3.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.897 -1.127 . . . . 0.0 113.473 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -172.78 173.49 3.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.776 1.231 . . . . 0.0 113.09 -174.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -83.67 136.77 34.07 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.511 -0.743 . . . . 0.0 109.523 168.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.9 t -134.74 130.4 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.216 1.006 . . . . 0.0 111.632 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.7 mt -100.19 126.7 46.49 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.442 1.497 . . . . 0.0 110.19 168.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -102.74 133.83 47.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.283 2.233 . . . . 0.0 110.979 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp -133.79 150.74 51.45 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.196 1.398 . . . . 0.0 111.322 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -74.13 118.34 16.97 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.763 0.825 . . . . 0.0 111.506 169.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 56.67 27.13 12.11 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.532 1.533 . . . . 0.0 114.714 173.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -137.77 153.03 49.75 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.325 1.85 . . . . 0.0 110.591 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -61.33 136.94 58.21 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.239 1.415 . . . . 0.0 111.684 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.1 153.01 43.69 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.04 0.936 . . . . 0.0 112.004 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.62 135.52 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.217 1.007 . . . . 0.0 110.226 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -134.24 152.08 51.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.833 0.853 . . . . 0.0 113.222 -173.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -142.1 119.81 7.43 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.293 1.437 . . . . 0.0 111.794 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.22 145.93 68.01 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.957 2.438 . . . . 0.0 110.463 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -60.11 -22.88 63.33 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.8 tp -63.4 -41.61 98.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.659 1.984 . . . . 0.0 113.11 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.4 p -73.32 -14.23 61.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.65 84.57 7.63 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.9 1.28 . . . . 0.0 110.715 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.4 tpp85 -63.22 -30.77 71.85 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.986 0.914 . . . . 0.0 112.503 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.408 ' CG ' HG21 ' B' ' 12' ' ' VAL . 38.7 ttp-105 -156.0 128.51 7.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.499 1.52 . . . . 0.0 109.834 -170.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -138.92 104.84 5.16 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.535 1.534 . . . . 0.0 111.008 -175.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.18 167.14 12.24 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.088 1.328 . . . . 0.0 113.984 -168.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -144.92 159.0 43.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.248 1.019 . . . . 0.0 112.593 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -151.36 177.52 10.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.1 2.16 . . . . 0.0 109.588 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 m -60.91 -12.22 10.46 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -154.58 11.52 0.38 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.549 1.54 . . . . 0.0 114.248 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.52 131.99 26.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.415 1.486 . . . . 0.0 110.491 -168.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -122.98 133.64 54.36 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.985 1.714 . . . . 0.0 109.016 171.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.3 t -152.6 152.93 32.4 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.131 -0.981 . . . . 0.0 112.052 -174.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -149.71 151.35 33.52 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.351 1.06 . . . . 0.0 111.839 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -104.84 126.59 52.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.606 1.162 . . . . 0.0 109.106 171.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.4 p -124.44 122.58 38.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.449 1.1 . . . . 0.0 111.294 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.25 162.39 40.22 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.816 1.198 . . . . 0.0 114.856 -171.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -57.74 -16.98 12.81 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -23.04 61.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.526 1.53 . . . . 0.0 114.925 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.3 p -73.24 173.43 9.49 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -171.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -54.56 -39.77 68.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.76 1.624 . . . . 0.0 113.341 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -91.06 -20.91 21.55 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.469 1.508 . . . . 0.0 113.874 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.26 175.1 48.9 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.156 1.36 . . . . 0.0 112.169 -170.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -66.31 130.56 43.63 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.848 1.259 . . . . 0.0 111.86 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.54 -179.35 41.55 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.776 1.179 . . . . 0.0 113.13 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.6 mt -116.46 131.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.708 1.603 . . . . 0.0 108.616 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -125.56 121.13 32.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.742 1.217 . . . . 0.0 110.238 -174.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.2 136.36 53.11 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.856 1.263 . . . . 0.0 112.943 -171.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -137.07 129.2 29.47 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.077 0.951 . . . . 0.0 111.717 -170.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -75.63 135.22 40.48 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.639 1.176 . . . . 0.0 111.988 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.6 p -171.0 151.28 3.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.505 1.922 . . . . 0.0 112.146 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.3 m -73.58 -37.31 65.52 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.156 -0.965 . . . . 0.0 112.111 171.922 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -85.96 20.48 2.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.099 1.36 . . . . 0.0 114.216 -171.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.07 -42.48 50.0 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.159 1.384 . . . . 0.0 114.145 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -69.57 -36.71 76.53 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.795 0.838 . . . . 0.0 112.716 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -68.39 -34.11 75.45 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.464 -0.772 . . . . 0.0 111.743 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.33 -47.65 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 118.678 0.672 . . . . 0.0 109.871 169.497 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.68 -43.33 94.07 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.658 1.183 . . . . 0.0 112.109 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -67.01 -34.67 78.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.792 1.237 . . . . 0.0 112.841 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -78.7 -41.12 31.91 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.789 0.722 . . . . 0.0 110.367 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.01 -51.46 61.59 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.26 1.024 . . . . 0.0 112.911 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -62.19 -24.12 67.02 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.3 -28.18 56.87 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.662 0.785 . . . . 0.0 112.544 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.25 -35.0 23.71 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.258 1.023 . . . . 0.0 111.199 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.6 mmt -55.88 -35.68 66.77 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.993 0.917 . . . . 0.0 112.348 169.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -89.92 -8.47 51.75 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 174.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 15.7 t -83.21 -24.1 32.54 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.431 1.092 . . . . 0.0 112.549 173.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -72.78 164.61 26.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.18 1.392 . . . . 0.0 111.405 170.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.3 m -81.87 106.91 14.17 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.03 -1.043 . . . . 0.0 111.281 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.57 -51.03 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.778 0.831 . . . . 0.0 111.242 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -69.73 -3.0 13.46 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.7 m -80.5 -11.66 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.485 1.514 . . . . 0.0 113.013 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 58.7 mtt -77.6 147.09 35.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.004 0.921 . . . . 0.0 111.233 171.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 66.51 59.24 0.63 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.963 1.705 . . . . 0.0 110.36 -174.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.68 154.73 12.36 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 127.574 2.349 . . . . 0.0 113.917 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.01 171.91 5.57 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.943 3.096 . . . . 0.0 111.54 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.5 p -50.69 124.94 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.601 1.16 . . . . 0.0 113.021 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.0 mm -111.17 163.5 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.966 1.706 . . . . 0.0 109.986 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.4 pt -66.69 -13.5 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.972 1.309 . . . . 0.0 114.233 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 54.3 m -92.85 140.77 29.16 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.768 2.027 . . . . 0.0 109.324 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -49.88 134.87 20.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.194 0.998 . . . . 0.0 113.194 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -161.04 151.08 17.43 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.69 1.596 . . . . 0.0 111.225 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.4 t -99.68 139.81 34.79 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.152 0.981 . . . . 0.0 111.699 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -106.2 124.32 36.22 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.78 1.232 . . . . 0.0 111.902 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.55 161.38 37.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.295 2.664 . . . . 0.0 111.146 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.77 40.96 0.4 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.186 1.394 . . . . 0.0 112.581 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.68 117.05 24.32 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.887 1.675 . . . . 0.0 110.254 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -163.45 155.53 17.68 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.088 1.755 . . . . 0.0 111.793 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -163.34 152.49 14.62 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.624 1.97 . . . . 0.0 109.815 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.44 164.9 40.69 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.037 1.335 . . . . 0.0 111.532 -175.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.86 158.92 8.88 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.979 1.786 . . . . 0.0 112.406 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 -152.98 143.78 22.85 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.368 1.467 . . . . 0.0 110.514 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -153.76 149.57 21.31 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.5 1.52 . . . . 0.0 111.279 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.4 171.05 18.85 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.676 2.918 . . . . 0.0 111.234 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -129.35 128.57 23.21 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.44 1.096 . . . . 0.0 109.172 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.01 142.91 28.39 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.165 2.577 . . . . 0.0 111.745 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -79.6 166.67 21.63 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 124.0 3.133 . . . . 0.0 112.001 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -65.46 140.19 58.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.151 0.98 . . . . 0.0 112.002 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.31 -66.45 0.8 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.009 0.923 . . . . 0.0 112.967 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mp -147.02 151.26 36.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.526 1.93 . . . . 0.0 111.083 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -96.39 -155.44 30.75 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.399 1.476 . . . . 0.0 112.484 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -156.16 153.76 29.77 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.178 1.391 . . . . 0.0 112.165 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.3 m -141.35 144.6 34.64 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.621 1.568 . . . . 0.0 110.279 -169.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.92 171.43 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.577 1.951 . . . . 0.0 110.691 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.8 t -152.03 159.54 43.69 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.96 1.304 . . . . 0.0 111.568 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.37 1.868 . . . . 0.0 111.577 -173.915 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -86.25 128.39 34.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.663 0.785 . . . . 0.0 111.893 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -91.58 112.5 24.45 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.122 0.969 . . . . 0.0 109.495 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 78.2 mt -78.76 155.26 29.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.531 0.681 . . . . 0.0 112.283 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -91.72 -26.78 18.45 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.079 1.352 . . . . 0.0 113.077 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -140.68 158.61 43.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.418 1.887 . . . . 0.0 111.663 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -84.3 128.45 62.01 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.434 0.694 . . . . 0.0 112.008 -172.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -86.1 -10.97 6.64 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.431 2.754 . . . . 0.0 114.475 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 90.0 m -102.27 126.31 49.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.306 1.043 . . . . 0.0 111.511 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.49 -31.19 34.27 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.11 0.862 . . . . 0.0 114.2 -176.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -108.35 131.32 54.87 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.842 1.257 . . . . 0.0 110.494 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.408 HG21 ' CG ' ' A' ' 64' ' ' ARG . 7.2 p -165.18 140.61 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.638 1.175 . . . . 0.0 111.885 -173.124 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -102.49 147.65 26.49 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.571 2.348 . . . . 0.0 111.716 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.86 113.54 27.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.01 1.324 . . . . 0.0 109.125 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.95 -64.95 1.4 Allowed Glycine 0 N--CA 1.474 1.188 0 C-N-CA 124.134 0.873 . . . . 0.0 112.171 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -75.94 166.49 23.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.186 0.994 . . . . 0.0 111.368 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -54.18 146.23 15.57 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.304 1.042 . . . . 0.0 112.799 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.15 131.31 38.52 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.366 1.067 . . . . 0.0 111.193 -171.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 127.607 2.363 . . . . 0.0 110.585 -170.562 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.562 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -163.75 167.66 20.67 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.507 1.523 . . . . 0.0 110.761 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -165.64 170.59 14.01 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.577 1.551 . . . . 0.0 111.66 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.7 120.56 2.86 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.106 1.812 . . . . 0.0 112.581 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.0 t -167.08 118.04 0.9 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.885 1.674 . . . . 0.0 109.79 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.6 t -169.46 161.43 9.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.578 1.551 . . . . 0.0 110.986 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.59 145.66 22.03 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.438 1.018 . . . . 0.0 112.07 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.52 -33.74 73.27 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.976 0.91 . . . . 0.0 112.21 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -175.12 143.07 0.67 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.742 2.417 . . . . 0.0 110.452 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -144.78 63.44 1.3 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.865 1.666 . . . . 0.0 110.179 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -150.07 166.04 30.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.867 2.067 . . . . 0.0 109.999 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 p -65.54 139.3 58.46 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.486 0.714 . . . . 0.0 111.234 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.8 p -58.36 118.52 28.39 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 124.038 0.935 . . . . 0.0 112.543 -169.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.18 159.81 40.29 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.016 2.477 . . . . 0.0 110.686 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.0 -22.12 62.17 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -116.16 19.85 14.68 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.226 1.81 . . . . 0.0 113.848 -171.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -51.66 143.45 20.89 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.381 1.072 . . . . 0.0 112.556 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.07 -8.74 22.72 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.114 2.542 . . . . 0.0 114.933 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.0 p -129.89 -17.36 3.56 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 174.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 131.84 56.59 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.468 1.107 . . . . 0.0 111.796 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -127.46 113.13 15.77 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.907 1.283 . . . . 0.0 108.748 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -69.84 131.77 44.99 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.507 -0.746 . . . . 0.0 110.326 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.09 165.41 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.814 1.645 . . . . 0.0 111.795 -169.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.3 m -134.27 122.78 23.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.507 1.123 . . . . 0.0 109.087 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.4 127.83 33.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.291 1.037 . . . . 0.0 109.797 174.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.64 155.97 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.494 0.718 . . . . 0.0 112.707 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.1 p-10 -88.12 -167.85 2.02 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.608 1.163 . . . . 0.0 113.6 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.91 -30.3 71.43 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.944 1.298 . . . . 0.0 114.335 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -84.09 -10.38 57.86 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.944 0.793 . . . . 0.0 113.072 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.85 16.47 75.02 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.365 -1.242 . . . . 0.0 113.953 -172.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' OD1' ' A' ' 27' ' ' ASP . 16.4 m -78.25 149.89 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.599 1.699 . . . . 0.0 111.202 173.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -89.52 122.56 32.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.922 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.3 mt -103.41 -51.7 3.16 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.602 0.761 . . . . 0.0 111.68 -174.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.93 144.76 12.16 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 124.874 1.226 . . . . 0.0 114.277 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.3 p -89.8 150.36 22.29 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.08 1.352 . . . . 0.0 112.55 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.4 171.06 37.32 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 124.147 0.88 . . . . 0.0 115.094 -174.383 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -114.79 120.54 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 58.0 tpp -86.59 133.1 33.74 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.929 0.891 . . . . 0.0 109.118 170.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -130.14 130.17 44.43 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.034 1.334 . . . . 0.0 109.008 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.75 115.04 29.42 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.312 1.845 . . . . 0.0 107.004 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 p -110.57 174.55 5.81 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.237 1.015 . . . . 0.0 109.869 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -75.88 13.76 0.79 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 121.244 -0.91 . . . . 0.0 112.186 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.4 t -125.74 -41.51 1.98 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.557 1.543 . . . . 0.0 112.626 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -170.43 171.06 6.72 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.144 -0.972 . . . . 0.0 113.442 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.3 mt -87.36 133.88 33.65 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 165.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 t -133.36 134.2 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.797 0.839 . . . . 0.0 111.177 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.2 mt -101.03 129.36 46.86 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 124.461 1.104 . . . . 0.0 109.836 168.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -109.98 118.74 37.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.429 1.892 . . . . 0.0 109.734 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.2 mt -119.09 144.6 46.51 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.824 1.249 . . . . 0.0 110.329 -175.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -69.52 112.35 5.98 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.458 -0.776 . . . . 0.0 112.011 176.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 59.92 8.15 1.33 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.952 2.101 . . . . 0.0 116.05 174.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -96.4 -86.16 0.32 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.78 1.232 . . . . 0.0 110.63 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -158.53 172.55 18.11 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.665 2.386 . . . . 0.0 109.154 -171.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.1 138.26 52.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.257 1.023 . . . . 0.0 108.889 167.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 t -134.94 131.63 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.154 0.582 . . . . 0.0 110.961 -168.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -121.71 142.07 50.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.478 1.511 . . . . 0.0 112.118 -169.132 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -138.16 112.14 8.69 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.912 1.285 . . . . 0.0 110.703 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.19 146.69 82.23 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.489 2.126 . . . . 0.0 110.475 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -57.79 -28.13 63.73 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 mt -65.35 -25.23 67.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.762 1.625 . . . . 0.0 114.131 173.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.4 p -93.25 -8.17 43.0 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -79.48 115.2 18.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.885 0.874 . . . . 0.0 109.958 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -76.26 -37.91 56.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.361 0.665 . . . . 0.0 111.698 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -161.19 163.24 31.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.663 1.585 . . . . 0.0 111.947 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -150.44 138.03 19.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.368 1.867 . . . . 0.0 109.012 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -145.17 -178.94 21.13 Favored Glycine 0 N--CA 1.461 0.353 0 C-N-CA 123.859 0.742 . . . . 0.0 113.052 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -152.11 166.23 32.29 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.031 0.932 . . . . 0.0 112.916 -174.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -157.19 -178.41 7.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.309 2.244 . . . . 0.0 109.319 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.2 p -63.6 -21.65 66.47 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -152.68 10.65 0.49 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -133.65 127.7 33.52 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.747 -1.221 . . . . 0.0 110.463 -172.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -118.85 135.7 54.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.902 1.681 . . . . 0.0 109.678 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -153.75 156.67 38.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.656 1.182 . . . . 0.0 112.676 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -149.08 151.96 35.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.031 1.733 . . . . 0.0 111.518 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -111.68 132.84 54.33 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.024 1.33 . . . . 0.0 111.139 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m -132.89 147.85 52.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.765 1.226 . . . . 0.0 112.368 -172.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.65 174.51 41.31 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.787 1.184 . . . . 0.0 114.387 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -11.97 18.16 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -87.93 -15.45 36.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -174.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.7 p -80.08 179.21 7.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.949 0.899 . . . . 0.0 112.901 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -57.71 -37.88 74.26 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.843 1.257 . . . . 0.0 113.336 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.9 p -95.13 -20.88 18.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.426 1.49 . . . . 0.0 114.082 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.89 -167.46 42.12 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.371 1.462 . . . . 0.0 112.586 -173.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -67.08 132.28 47.53 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.62 0.768 . . . . 0.0 112.118 -173.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.05 -175.58 35.24 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 122.506 1.059 . . . . 0.0 113.454 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.8 mt -124.22 139.19 51.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 126.009 1.724 . . . . 0.0 108.432 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.11 127.72 36.62 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.842 1.257 . . . . 0.0 109.859 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.04 145.59 50.94 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.322 1.049 . . . . 0.0 113.594 -169.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -139.88 128.03 22.41 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.337 -168.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -66.38 127.68 33.22 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 43.8 t -164.92 114.85 1.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.189 1.396 . . . . 0.0 111.377 -167.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 m -71.19 -2.15 14.96 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -133.34 22.12 4.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.443 2.297 . . . . 0.0 112.427 -170.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.63 -36.07 33.52 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.388 1.475 . . . . 0.0 113.841 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -67.86 -37.87 82.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.639 0.775 . . . . 0.0 112.762 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.47 -33.68 73.24 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.434 -0.791 . . . . 0.0 111.665 175.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.79 -47.53 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.782 -0.574 . . . . 0.0 110.163 169.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.29 -42.9 87.64 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.025 1.33 . . . . 0.0 111.808 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -66.31 -33.22 75.24 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.738 1.215 . . . . 0.0 113.044 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.41 -42.52 20.28 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.082 0.855 . . . . 0.0 110.282 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.7 mt -49.69 -54.49 18.42 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.152 0.981 . . . . 0.0 112.273 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -59.48 -28.76 67.31 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -19.44 61.21 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.918 1.287 . . . . 0.0 113.045 175.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.1 mt -95.36 -35.83 11.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.434 1.493 . . . . 0.0 111.025 173.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 47.9 mmm -66.95 -34.19 77.23 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.617 1.167 . . . . 0.0 111.962 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -73.12 -9.45 58.73 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 174.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 12.4 t -69.98 -21.29 63.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.121 0.873 . . . . 0.0 112.434 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 63.0 t30 57.83 41.62 24.56 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.576 1.55 . . . . 0.0 112.479 172.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.9 p -27.4 109.41 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.486 2.714 . . . . 0.0 115.57 -170.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.1 mp -88.32 87.09 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 O-C-N 121.361 -0.837 . . . . 0.0 109.295 -172.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 62.62 21.51 12.74 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 126.14 1.776 . . . . 0.0 114.347 169.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.14 66.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.408 2.283 . . . . 0.0 111.205 -172.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 75.8 mtm 71.48 15.3 6.18 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 129.374 3.07 . . . . 0.0 115.506 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -103.33 -168.16 1.47 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.558 1.943 . . . . 0.0 109.174 167.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.48 154.26 17.5 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 121.164 -0.96 . . . . 0.0 112.498 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.26 140.26 52.79 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.43 2.087 . . . . 0.0 110.594 170.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.17 122.67 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.703 1.601 . . . . 0.0 109.025 -177.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 mp -80.76 115.91 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.6 mt -79.06 -53.77 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.984 0.513 . . . . 0.0 110.535 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.275 5.9 t 49.7 28.78 2.8 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.888 2.475 . . . . 0.0 114.778 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -156.7 159.0 37.96 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.901 1.681 . . . . 0.0 112.091 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -155.91 151.63 27.28 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.637 1.975 . . . . 0.0 109.856 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.5 m -158.4 148.56 19.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.795 1.638 . . . . 0.0 110.282 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -136.59 123.92 14.36 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.811 1.244 . . . . 0.0 111.136 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.99 166.45 27.96 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.363 2.709 . . . . 0.0 111.34 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.38 158.03 38.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.097 1.359 . . . . 0.0 111.408 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.28 167.2 28.04 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.945 1.698 . . . . 0.0 111.274 -174.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.3 pp -155.52 158.75 38.99 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.529 1.531 . . . . 0.0 111.475 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -149.18 142.46 25.12 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.198 1.799 . . . . 0.0 110.037 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.4 pp -95.38 145.7 30.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.3 1.04 . . . . 0.0 111.937 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.24 168.44 18.54 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.659 2.906 . . . . 0.0 111.574 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -147.96 144.18 27.82 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.96 1.304 . . . . 0.0 110.833 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -149.37 146.64 21.41 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.576 1.55 . . . . 0.0 111.352 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.99 176.18 10.29 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.04 3.16 . . . . 0.0 111.636 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -126.3 127.9 24.52 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.049 1.34 . . . . 0.0 108.78 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.06 150.91 30.12 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.458 2.772 . . . . 0.0 111.833 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.84 162.97 34.26 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.89 3.06 . . . . 0.0 111.743 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -157.94 138.7 13.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.736 1.214 . . . . 0.0 111.833 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -157.94 141.93 15.81 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.942 1.697 . . . . 0.0 110.782 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.3 tt -162.15 124.3 2.82 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.28 1.432 . . . . 0.0 109.547 -173.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -135.05 164.14 24.79 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.271 1.415 . . . . 0.0 113.814 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -151.12 151.62 32.22 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.012 1.725 . . . . 0.0 112.366 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.6 m -84.67 142.24 30.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.777 1.631 . . . . 0.0 109.714 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.9 m -142.15 153.24 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.776 1.631 . . . . 0.0 111.052 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.3 t -80.83 154.55 27.07 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.205 1.002 . . . . 0.0 112.677 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.6 p . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.007 1.723 . . . . 0.0 113.688 -178.368 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -143.34 122.42 12.88 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.294 1.038 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.72 124.76 28.16 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.579 1.151 . . . . 0.0 111.269 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 64.6 mt -94.47 154.13 17.58 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.007 0.923 . . . . 0.0 112.662 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -84.07 -21.2 31.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.447 1.499 . . . . 0.0 113.367 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -153.66 166.03 34.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.088 1.755 . . . . 0.0 111.751 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -87.9 118.53 69.79 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.223 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.0 -16.24 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.541 2.827 . . . . 0.0 114.076 -170.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 82.2 m -89.43 123.63 33.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.866 0.867 . . . . 0.0 110.749 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.06 -35.19 35.29 Favored Glycine 0 N--CA 1.473 1.128 0 C-N-CA 123.836 0.732 . . . . 0.0 113.043 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -97.05 120.31 37.17 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.55 1.14 . . . . 0.0 109.72 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.06 160.97 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.792 1.637 . . . . 0.0 110.447 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -122.14 124.89 44.94 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.537 1.135 . . . . 0.0 109.103 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -86.07 110.7 19.7 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.965 0.906 . . . . 0.0 110.709 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.73 -124.32 3.52 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.235 1.397 . . . . 0.0 112.124 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -57.8 121.94 11.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.799 1.24 . . . . 0.0 111.852 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -96.64 3.68 52.36 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.543 1.137 . . . . 0.0 113.474 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -76.93 159.06 30.28 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.154 0.982 . . . . 0.0 110.381 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 116.924 -1.512 . . . . 0.0 112.117 178.567 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 t -95.35 -6.41 41.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -124.01 128.01 48.75 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.263 1.425 . . . . 0.0 110.927 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.12 -133.05 7.57 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.415 1.483 . . . . 0.0 112.504 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -159.08 -163.39 1.21 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.985 1.714 . . . . 0.0 110.415 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.2 t -150.57 140.13 21.56 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.667 -1.271 . . . . 0.0 111.667 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.06 123.63 1.99 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.323 1.44 . . . . 0.0 111.707 -173.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -93.75 149.71 21.01 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.688 1.195 . . . . 0.0 110.745 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -145.38 -43.76 0.22 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.841 1.256 . . . . 0.0 112.281 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -69.15 151.72 46.01 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.804 0.841 . . . . 0.0 111.471 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -149.3 -62.12 0.22 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.025 1.33 . . . . 0.0 110.987 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.5 p -114.91 -2.56 12.85 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.7 t -151.83 120.41 3.36 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 128.021 2.528 . . . . 0.0 108.421 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.61 152.1 29.26 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.061 2.507 . . . . 0.0 110.612 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -68.72 -2.59 9.63 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.86 1.264 . . . . 0.0 114.091 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -134.04 31.12 3.59 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.451 1.9 . . . . 0.0 111.967 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -62.75 150.5 86.85 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.866 1.266 . . . . 0.0 112.983 173.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.0 -20.19 29.29 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.062 2.508 . . . . 0.0 115.668 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.3 p -126.14 -22.18 4.14 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.296 1.407 . . . . 0.0 114.303 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -97.11 144.74 26.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.231 1.012 . . . . 0.0 110.279 169.277 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -140.1 119.0 12.53 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.286 1.435 . . . . 0.0 108.207 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.44 135.24 45.71 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.382 -0.823 . . . . 0.0 109.932 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.83 169.34 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.966 1.306 . . . . 0.0 111.287 -171.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 35' ' ' SER . 20.9 m -142.67 122.39 13.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.67 1.188 . . . . 0.0 107.849 172.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -68.9 134.14 49.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.364 0.666 . . . . 0.0 110.462 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.71 155.87 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.521 1.128 . . . . 0.0 113.816 -173.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' CG ' HG22 ' A' ' 31' ' ' VAL . 2.9 p-10 -84.62 -170.17 2.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -63.41 -21.62 66.4 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.689 1.596 . . . . 0.0 115.112 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.34 -0.5 32.63 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.323 1.449 . . . . 0.0 112.403 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.94 14.57 77.09 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.0 -1.444 . . . . 0.0 114.389 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.444 HG22 ' CG ' ' A' ' 27' ' ' ASP . 3.3 m -73.58 144.87 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.901 1.85 . . . . 0.0 110.674 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -87.27 120.87 29.0 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.796 1.238 . . . . 0.0 110.143 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.9 mt -105.75 -52.68 2.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.721 0.809 . . . . 0.0 112.048 -169.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.14 137.16 5.78 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.185 1.374 . . . . 0.0 111.958 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 46.7 t -83.69 149.43 26.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.941 0.876 . . . . 0.0 111.555 176.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.54 167.44 27.55 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 125.991 1.758 . . . . 0.0 113.378 -172.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.1 t -120.43 120.24 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.9 ttm -97.13 143.03 28.34 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.152 1.381 . . . . 0.0 109.388 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -145.4 126.53 14.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.835 1.254 . . . . 0.0 109.695 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.48 132.17 54.68 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.123 1.369 . . . . 0.0 108.688 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.7 p -135.31 171.09 14.94 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.937 1.295 . . . . 0.0 110.385 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -68.32 0.05 4.28 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 170.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t -103.2 -52.18 3.08 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.596 1.089 . . . . 0.0 112.399 178.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.18 173.1 2.65 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.724 1.21 . . . . 0.0 112.844 -170.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.18 118.44 25.63 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.06 1.344 . . . . 0.0 110.38 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.8 t -109.77 140.03 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.864 1.266 . . . . 0.0 109.178 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -139.69 124.9 18.87 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.513 1.525 . . . . 0.0 109.84 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -115.48 137.26 52.24 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.561 1.944 . . . . 0.0 110.417 -172.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mp -136.61 169.61 17.43 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.842 1.257 . . . . 0.0 112.617 -170.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.02 -6.9 23.8 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.71 1.604 . . . . 0.0 115.145 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -134.98 13.44 3.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.685 1.994 . . . . 0.0 113.193 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -160.14 153.93 22.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.598 1.959 . . . . 0.0 109.819 -173.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -65.01 164.67 12.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.231 1.012 . . . . 0.0 110.913 173.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.79 134.84 57.41 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.259 -0.901 . . . . 0.0 111.15 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.08 130.82 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.198 1.399 . . . . 0.0 109.881 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.98 141.28 52.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.637 1.175 . . . . 0.0 111.406 -171.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -134.91 112.81 11.48 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.702 1.201 . . . . 0.0 111.587 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.21 138.3 42.82 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.991 2.46 . . . . 0.0 110.755 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -60.21 -28.47 68.01 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -65.85 -35.27 80.2 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 0.0 112.453 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.0 m -92.22 3.27 55.69 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.57 120.52 24.63 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.964 0.905 . . . . 0.0 109.053 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -83.2 -23.31 32.89 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.505 ' HG3' HG21 ' B' ' 12' ' ' VAL . 30.0 ttp-105 -176.24 140.51 0.39 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.909 2.084 . . . . 0.0 109.478 -169.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -144.89 106.46 4.24 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.214 1.405 . . . . 0.0 111.54 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.14 165.16 12.01 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 126.231 1.872 . . . . 0.0 113.522 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -150.85 154.08 36.57 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.7 1.2 . . . . 0.0 113.218 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -144.97 -168.99 3.08 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.855 1.662 . . . . 0.0 110.064 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 t -68.75 -11.67 60.59 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -173.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -158.19 10.87 0.17 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.926 1.69 . . . . 0.0 114.225 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -140.61 133.24 28.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.614 1.566 . . . . 0.0 110.549 -168.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -126.29 138.43 53.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.93 1.692 . . . . 0.0 109.18 172.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -153.06 152.95 31.92 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.888 -1.133 . . . . 0.0 112.277 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -153.69 158.11 40.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.045 0.938 . . . . 0.0 112.545 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -115.07 135.2 54.46 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.723 1.609 . . . . 0.0 111.231 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 62.6 p -120.31 152.46 37.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.233 1.413 . . . . 0.0 112.905 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.44 164.44 31.87 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.984 1.278 . . . . 0.0 113.27 176.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -66.07 -9.26 29.18 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -171.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -84.83 -11.49 55.57 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.566 1.946 . . . . 0.0 115.231 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.3 m -68.01 173.5 4.52 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.841 1.256 . . . . 0.0 112.965 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -57.25 -40.74 78.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 112.285 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.3 p -90.03 -23.01 21.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.442 1.497 . . . . 0.0 113.161 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.29 -146.74 27.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.992 1.282 . . . . 0.0 111.612 -171.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -75.23 141.37 43.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.254 1.022 . . . . 0.0 112.206 -175.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.79 171.02 23.25 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.295 0.95 . . . . 0.0 113.245 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.33 133.33 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.391 1.476 . . . . 0.0 108.346 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -130.39 123.81 30.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.496 1.118 . . . . 0.0 110.606 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.03 139.96 49.75 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.638 1.175 . . . . 0.0 112.368 -175.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -136.84 124.11 21.86 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.787 1.235 . . . . 0.0 111.258 -172.406 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -70.0 133.87 47.7 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.245 0.618 . . . . 0.0 110.791 169.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 36.7 t -166.49 130.64 2.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.123 1.769 . . . . 0.0 110.517 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.5 t -66.97 -26.5 66.85 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.614 -0.678 . . . . 0.0 112.812 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -109.32 29.21 7.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.206 1.802 . . . . 0.0 113.226 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.16 -35.49 26.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.064 1.346 . . . . 0.0 114.185 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -70.24 -37.97 75.08 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.767 0.827 . . . . 0.0 113.024 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -65.94 -36.83 84.42 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.387 -0.821 . . . . 0.0 111.424 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.91 -48.94 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.915 0.486 . . . . 0.0 110.124 171.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -38.42 86.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.265 1.026 . . . . 0.0 112.93 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.36 -35.46 65.96 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.743 0.817 . . . . 0.0 112.427 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -76.18 -34.53 59.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.074 0.852 . . . . 0.0 112.008 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.7 mt -54.64 -59.61 4.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.156 0.889 . . . . 0.0 111.45 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -60.8 -24.49 65.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -29.4 64.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.977 0.911 . . . . 0.0 113.374 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.6 mt -96.32 -35.5 11.2 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.384 1.473 . . . . 0.0 111.434 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.5 mtp -69.89 -29.91 67.23 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.339 1.456 . . . . 0.0 112.594 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -71.26 -13.16 61.81 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 172.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 21.8 t -77.1 -25.26 52.01 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.719 0.808 . . . . 0.0 112.509 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.65 37.13 27.61 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.647 1.579 . . . . 0.0 112.521 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.2 t -52.26 125.7 16.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.093 1.357 . . . . 0.0 113.427 -169.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.0 mp -100.05 67.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.785 1.234 . . . . 0.0 108.568 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 38.85 53.46 1.99 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.592 2.357 . . . . 0.0 113.991 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -75.95 4.92 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -169.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 62.1 mtt -137.5 152.44 49.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.54 1.936 . . . . 0.0 110.282 177.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.93 154.28 39.76 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.049 0.54 . . . . 0.0 111.785 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -143.72 151.83 54.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.177 1.391 . . . . 0.0 111.379 -172.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.63 146.63 55.28 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.12 2.547 . . . . 0.0 110.993 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.3 t -114.9 123.99 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.245 1.418 . . . . 0.0 108.169 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.2 mm -77.43 150.89 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 122.366 1.079 . . . . 0.0 111.582 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.4 pt -77.82 7.75 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.633 1.573 . . . . 0.0 114.185 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.4 t -162.56 153.72 17.61 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.037 2.535 . . . . 0.0 109.336 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -159.28 120.99 3.36 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.942 1.297 . . . . 0.0 109.935 -174.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.47 156.47 17.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.988 1.315 . . . . 0.0 112.65 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.2 p -86.07 169.23 13.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.839 1.255 . . . . 0.0 112.275 170.625 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -113.9 91.27 21.46 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.434 1.094 . . . . 0.0 110.855 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.09 173.98 13.55 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.576 2.851 . . . . 0.0 111.418 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -149.34 152.27 35.54 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.032 1.333 . . . . 0.0 111.482 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.54 125.17 26.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.353 1.061 . . . . 0.0 110.935 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 pp -78.45 149.68 33.18 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.015 0.926 . . . . 0.0 111.422 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -161.15 149.51 15.91 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.282 1.433 . . . . 0.0 110.83 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 pp -86.88 144.17 36.41 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.449 1.1 . . . . 0.0 111.441 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.69 153.5 30.03 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.165 2.577 . . . . 0.0 111.323 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.72 169.98 10.27 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.978 0.894 . . . . 0.0 112.773 175.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.78 145.81 31.24 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.237 1.415 . . . . 0.0 111.828 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.65 168.88 23.29 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.65 2.9 . . . . 0.0 111.642 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -65.96 141.29 97.49 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.261 0.624 . . . . 0.0 110.868 176.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.13 149.56 58.41 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.327 2.685 . . . . 0.0 111.893 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.66 151.29 46.49 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.778 2.985 . . . . 0.0 111.761 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -77.41 163.76 26.09 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.169 0.987 . . . . 0.0 112.231 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -129.59 168.38 16.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.964 1.705 . . . . 0.0 111.979 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 48.1 tp -151.33 137.63 18.47 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.046 1.338 . . . . 0.0 110.858 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.49 -154.8 30.55 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.087 1.327 . . . . 0.0 113.312 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -157.32 175.63 13.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.721 1.609 . . . . 0.0 111.527 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -144.62 -177.75 5.66 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.424 1.49 . . . . 0.0 111.755 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.66 136.55 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.363 1.865 . . . . 0.0 110.935 -171.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 56.5 p -101.11 167.91 9.92 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.909 1.683 . . . . 0.0 113.237 -176.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.139 1.375 . . . . 0.0 112.54 179.134 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -65.28 124.85 23.3 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.604 -0.685 . . . . 0.0 110.954 175.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -87.15 116.84 25.5 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.334 1.054 . . . . 0.0 111.169 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 32.9 mt -81.74 159.42 23.87 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.632 0.773 . . . . 0.0 112.711 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -100.66 -12.13 19.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.526 1.53 . . . . 0.0 113.614 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -163.11 167.14 22.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.087 2.155 . . . . 0.0 110.906 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -84.8 126.49 68.23 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.874 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.15 -2.37 11.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.836 3.024 . . . . 0.0 113.956 -174.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 22.2 t -115.0 135.51 54.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.052 1.341 . . . . 0.0 112.088 -171.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.55 -5.81 56.68 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.485 1.517 . . . . 0.0 115.656 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -137.07 111.73 8.73 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.043 1.422 . . . . 0.0 110.278 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 64' ' ' ARG . 7.5 p -147.75 138.18 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -168.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -99.3 117.24 33.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.875 2.07 . . . . 0.0 109.921 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -87.38 113.81 23.42 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.709 0.804 . . . . 0.0 110.466 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.15 -70.98 1.32 Allowed Glycine 0 N--CA 1.471 1.003 0 C-N-CA 124.409 1.004 . . . . 0.0 112.314 -174.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -80.14 114.24 18.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 110.238 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -164.6 157.29 16.77 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.989 1.716 . . . . 0.0 109.246 -173.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -67.65 134.03 50.4 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.687 -0.633 . . . . 0.0 110.881 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 C--O 1.257 1.449 0 C-N-CA 126.64 1.976 . . . . 0.0 111.686 -178.111 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.476 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 m -164.38 142.63 7.01 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.265 1.826 . . . . 0.0 110.52 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 m -149.61 153.71 37.5 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.123 1.369 . . . . 0.0 111.589 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.23 166.61 10.97 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.419 1.485 . . . . 0.0 113.675 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 p -163.58 140.1 6.94 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.103 1.361 . . . . 0.0 111.721 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.3 p -172.4 166.29 5.76 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.997 1.719 . . . . 0.0 111.455 -175.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.14 110.93 0.27 Allowed Glycine 0 C--N 1.341 0.845 0 C-N-CA 124.103 0.859 . . . . 0.0 112.839 174.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -168.69 162.33 11.7 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.807 2.043 . . . . 0.0 111.433 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -145.17 154.09 42.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.978 1.711 . . . . 0.0 111.007 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -161.87 147.6 13.43 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.557 1.543 . . . . 0.0 111.769 -173.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -114.38 7.67 16.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.655 1.582 . . . . 0.0 113.237 -172.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.6 p -150.52 143.34 24.64 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.794 1.638 . . . . 0.0 110.654 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.2 122.61 80.77 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.513 0.725 . . . . 0.0 111.071 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.82 163.9 18.27 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.464 2.776 . . . . 0.0 111.022 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.73 3.4 3.22 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.389 1.476 . . . . 0.0 113.021 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -135.62 16.12 3.37 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.459 1.903 . . . . 0.0 113.494 -169.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -59.62 147.21 78.37 Favored Pre-proline 0 CA--C 1.559 1.312 0 O-C-N 120.893 -1.129 . . . . 0.0 113.005 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.13 -21.58 23.6 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.723 2.282 . . . . 0.0 115.111 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.0 p -126.03 -20.83 4.46 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 120.691 1.587 . . . . 0.0 114.265 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -97.32 146.41 25.18 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.97 0.908 . . . . 0.0 109.145 168.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -141.6 113.5 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -67.85 134.4 50.83 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.565 -0.709 . . . . 0.0 110.12 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.28 164.44 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.82 1.248 . . . . 0.0 111.616 -171.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.4 m -139.97 123.08 16.8 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.502 1.121 . . . . 0.0 108.59 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -65.58 130.46 43.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.301 0.641 . . . . 0.0 109.722 175.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.32 156.46 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.327 1.051 . . . . 0.0 112.235 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.4 p-10 -85.15 -166.37 1.48 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.52 1.128 . . . . 0.0 113.126 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.11 -26.14 63.83 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.543 1.137 . . . . 0.0 113.695 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.51 -18.6 44.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.761 1.224 . . . . 0.0 112.591 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.06 17.39 59.43 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.021 1.296 . . . . 0.0 114.295 -173.163 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' A' ' 27' ' ' ASP . 16.7 m -76.77 150.25 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.68 1.74 . . . . 0.0 111.183 171.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -88.26 125.78 34.83 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.657 1.183 . . . . 0.0 110.849 -172.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -108.15 -49.57 3.18 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.184 0.994 . . . . 0.0 111.767 -171.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.57 137.21 5.56 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.919 1.247 . . . . 0.0 113.654 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.0 p -84.03 148.87 26.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.755 1.222 . . . . 0.0 112.356 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.06 170.82 34.95 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.794 1.188 . . . . 0.0 114.637 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.19 120.57 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.7 tpp -84.91 141.3 30.48 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.661 1.184 . . . . 0.0 109.576 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -140.26 130.31 24.85 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.071 1.348 . . . . 0.0 109.494 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.95 133.73 47.58 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.093 1.757 . . . . 0.0 108.133 175.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -133.89 173.87 11.08 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.091 1.357 . . . . 0.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -78.45 6.08 9.29 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.435 -0.791 . . . . 0.0 112.577 169.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.6 t -107.4 -49.31 3.28 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.537 1.135 . . . . 0.0 112.268 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -174.27 172.45 3.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.563 1.545 . . . . 0.0 112.484 -169.293 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.6 mt -85.04 139.79 31.5 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.17 0.988 . . . . 0.0 109.215 168.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.5 t -134.44 130.95 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.051 0.94 . . . . 0.0 111.217 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 mt -103.76 130.53 51.29 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.654 1.581 . . . . 0.0 110.026 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -111.42 124.09 51.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.868 2.067 . . . . 0.0 110.177 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.72 163.39 24.41 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.194 1.398 . . . . 0.0 111.838 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -89.25 -62.86 1.39 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.679 1.191 . . . . 0.0 113.087 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.8 mtt-85 -80.05 -13.58 59.19 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -120.58 162.39 19.71 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.713 2.005 . . . . 0.0 111.511 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -65.28 159.42 23.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.691 1.596 . . . . 0.0 112.618 174.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.27 145.7 41.67 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.385 0.674 . . . . 0.0 111.26 170.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 t -138.0 143.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.615 1.166 . . . . 0.0 109.842 -170.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.83 153.4 52.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.725 0.81 . . . . 0.0 113.003 -169.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -142.85 115.31 6.07 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.922 1.289 . . . . 0.0 111.348 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.02 150.26 66.36 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.628 2.219 . . . . 0.0 110.468 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -61.59 -22.98 65.69 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -38.84 92.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.112 1.765 . . . . 0.0 112.605 171.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.2 m -90.2 -9.56 47.65 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -69.43 127.94 34.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.572 0.749 . . . . 0.0 109.393 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -96.86 -26.8 14.96 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.574 0.75 . . . . 0.0 112.83 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -164.09 158.68 19.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.797 1.639 . . . . 0.0 111.454 169.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -144.84 107.96 4.55 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.773 1.229 . . . . 0.0 110.502 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.28 174.74 16.01 Favored Glycine 0 N--CA 1.463 0.478 0 C-N-CA 124.092 0.853 . . . . 0.0 113.531 -169.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -144.49 155.93 43.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.118 0.967 . . . . 0.0 111.384 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.37 -178.76 6.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.34 1.456 . . . . 0.0 110.532 171.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 t -62.59 120.44 11.15 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.359 -0.838 . . . . 0.0 110.774 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.33 15.16 0.62 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.81 2.444 . . . . 0.0 116.561 -174.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.11 126.25 26.26 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.893 1.277 . . . . 0.0 111.627 -169.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -118.13 134.42 55.01 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.693 1.597 . . . . 0.0 110.063 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.5 t -153.46 154.91 35.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.532 1.133 . . . . 0.0 112.385 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -148.69 150.61 33.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.423 1.489 . . . . 0.0 111.298 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -112.78 130.32 56.12 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.997 1.319 . . . . 0.0 109.747 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m -130.87 136.02 48.25 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.501 1.12 . . . . 0.0 110.594 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.74 175.54 51.73 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 123.783 0.706 . . . . 0.0 113.225 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -16.0 7.2 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -74.01 -18.38 60.86 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.028 2.531 . . . . 0.0 115.883 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.5 p -80.21 178.84 7.99 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -61.1 -44.4 97.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.832 1.253 . . . . 0.0 113.019 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.3 p -90.39 -18.81 24.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.73 1.212 . . . . 0.0 114.093 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.07 179.79 36.97 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.609 1.576 . . . . 0.0 112.391 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -66.94 126.51 29.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.273 0.629 . . . . 0.0 111.941 -169.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.85 178.42 40.34 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 122.448 1.026 . . . . 0.0 114.264 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.3 mt -116.1 133.74 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.968 1.707 . . . . 0.0 108.542 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -126.31 123.51 38.22 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.136 1.374 . . . . 0.0 109.627 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.1 143.01 50.71 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.297 1.046 . . . . 0.0 113.317 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -140.82 129.8 23.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.555 -169.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -68.07 131.26 45.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.81 0.444 . . . . 0.0 109.946 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 45.9 t -160.38 131.35 5.62 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.217 1.407 . . . . 0.0 111.377 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.8 t -71.32 -21.98 61.99 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -122.04 30.3 6.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.236 1.814 . . . . 0.0 113.4 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.66 -42.59 56.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.16 -36.64 77.62 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.248 0.619 . . . . 0.0 112.537 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.6 -35.77 80.99 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.602 -0.686 . . . . 0.0 111.588 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.8 mt -63.64 -47.73 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.534 0.606 . . . . 0.0 110.163 170.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.3 -38.47 77.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.333 1.053 . . . . 0.0 112.332 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -74.31 -29.0 61.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.237 1.415 . . . . 0.0 113.529 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 tt -84.22 -40.03 18.59 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.298 0.954 . . . . 0.0 110.464 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.8 mt -53.01 -54.01 41.53 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.737 0.815 . . . . 0.0 112.286 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -60.09 -25.08 65.14 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -20.37 53.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.96 1.304 . . . . 0.0 113.05 175.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.9 mt -91.59 -38.93 12.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.128 1.371 . . . . 0.0 110.873 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 60.6 mmm -66.29 -34.89 79.02 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.842 1.257 . . . . 0.0 112.421 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -74.01 -6.93 50.42 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 20.6 t -65.41 -25.06 67.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 119.067 0.849 . . . . 0.0 112.334 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 60.04 22.81 11.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.24 1.816 . . . . 0.0 113.368 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.5 m -17.51 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 130.528 3.531 . . . . 0.0 116.563 -170.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 28.6 mt -80.1 -51.21 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.601 0.76 . . . . 0.0 111.389 -171.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -122.06 6.51 9.77 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.107 1.363 . . . . 0.0 113.363 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.2 t -84.33 -21.59 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.079 1.752 . . . . 0.0 112.09 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.5 mmt -78.58 156.92 28.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.609 1.164 . . . . 0.0 112.313 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.99 -173.64 2.4 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.532 1.133 . . . . 0.0 112.289 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -55.4 144.17 53.55 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.413 1.085 . . . . 0.0 112.947 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.2 150.11 71.23 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.495 2.797 . . . . 0.0 112.094 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.2 t -103.83 122.97 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.033 1.333 . . . . 0.0 109.275 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 mp -88.5 126.8 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.379 1.072 . . . . 0.0 108.578 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 74.5 mt -116.97 142.05 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.53 1.532 . . . . 0.0 108.83 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 t -59.35 152.17 21.85 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.027 1.331 . . . . 0.0 112.285 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -55.82 133.41 51.14 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.048 0.939 . . . . 0.0 111.377 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.78 150.63 39.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.655 1.582 . . . . 0.0 111.45 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.5 p -84.85 158.11 20.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.891 1.276 . . . . 0.0 114.021 -170.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -141.28 146.29 42.05 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.621 1.569 . . . . 0.0 111.996 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.74 162.98 32.09 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.909 3.073 . . . . 0.0 112.205 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.07 150.39 24.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.52 1.128 . . . . 0.0 112.223 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -77.35 135.12 38.34 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.565 1.146 . . . . 0.0 111.219 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.33 123.97 35.17 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.004 1.322 . . . . 0.0 109.661 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -72.97 152.14 41.5 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.332 1.453 . . . . 0.0 113.968 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.97 146.3 34.87 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.587 1.155 . . . . 0.0 111.829 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.91 146.08 18.2 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.281 2.654 . . . . 0.0 111.766 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.88 156.5 39.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.816 0.847 . . . . 0.0 113.177 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.95 153.56 38.13 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.262 1.425 . . . . 0.0 111.839 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.4 177.09 8.36 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.94 3.093 . . . . 0.0 111.643 174.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -124.5 151.51 67.16 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.131 1.372 . . . . 0.0 111.179 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.52 152.21 59.73 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.163 2.576 . . . . 0.0 111.892 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.71 154.97 39.62 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.841 3.028 . . . . 0.0 112.12 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -81.17 165.47 21.51 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.471 1.108 . . . . 0.0 112.622 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -122.99 176.1 6.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.953 1.701 . . . . 0.0 111.598 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.2 tp -143.49 135.5 26.72 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.043 1.337 . . . . 0.0 110.846 -175.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.09 -138.92 7.41 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.296 1.427 . . . . 0.0 112.261 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -154.83 166.82 32.28 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.849 1.259 . . . . 0.0 112.603 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.7 p -125.84 163.63 22.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.35 1.86 . . . . 0.0 110.453 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.7 p -150.72 142.63 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.826 1.251 . . . . 0.0 110.41 -171.686 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.2 m -71.96 144.1 49.01 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.991 0.916 . . . . 0.0 113.034 -175.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.253 1.283 0 C-N-CA 125.36 1.464 . . . . 0.0 112.277 177.904 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -73.31 129.47 38.08 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.049 -0.407 . . . . 0.0 110.767 170.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' ARG . . . . . 0.436 ' H ' ' HD3' ' B' ' 3' ' ' ARG . 0.0 OUTLIER -100.26 127.35 46.57 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.189 1.396 . . . . 0.0 111.327 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 44.7 mt -93.58 153.62 18.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -80.48 -36.7 33.05 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.818 1.647 . . . . 0.0 112.598 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -138.99 160.98 38.47 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.492 1.917 . . . . 0.0 111.764 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -78.61 121.33 83.48 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.9 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -84.28 -15.0 6.74 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.227 2.618 . . . . 0.0 113.833 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 85.6 m -90.79 116.87 28.97 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.95 0.9 . . . . 0.0 110.882 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.73 -16.28 80.75 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.91 0.767 . . . . 0.0 114.022 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -120.96 133.6 55.28 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.836 1.654 . . . . 0.0 109.507 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -162.1 145.49 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.945 1.298 . . . . 0.0 111.475 -169.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -111.76 130.52 55.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.045 1.738 . . . . 0.0 109.393 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -96.2 107.3 19.62 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.513 1.125 . . . . 0.0 110.818 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.66 172.05 20.67 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.447 1.498 . . . . 0.0 113.233 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 60.16 21.0 10.3 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.877 1.671 . . . . 0.0 113.744 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -79.68 163.86 24.21 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.619 1.968 . . . . 0.0 112.243 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -156.47 138.09 14.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.708 1.203 . . . . 0.0 110.066 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . 0.269 29.9 pt20 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 127.504 2.322 . . . . 0.0 114.815 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t -161.6 155.85 22.45 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.826 1.65 . . . . 0.0 110.268 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 t -166.38 176.65 7.29 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.269 1.427 . . . . 0.0 111.902 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.51 156.45 32.6 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.796 1.665 . . . . 0.0 113.459 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -162.52 117.57 1.84 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.126 1.37 . . . . 0.0 110.077 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.9 t -170.12 163.56 9.15 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.045 1.738 . . . . 0.0 110.668 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.35 149.02 9.13 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.698 1.142 . . . . 0.0 113.342 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -91.34 152.4 20.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.024 1.33 . . . . 0.0 110.961 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -71.44 162.4 29.51 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.914 0.886 . . . . 0.0 112.288 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -148.13 136.88 21.75 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.323 1.449 . . . . 0.0 110.637 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.58 -27.67 62.33 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.0 m -151.14 138.58 19.5 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.844 1.658 . . . . 0.0 110.336 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 p -62.13 122.29 71.58 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 124.202 1.001 . . . . 0.0 111.973 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.75 163.79 20.9 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.202 2.601 . . . . 0.0 111.313 171.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.28 -10.51 55.22 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 176.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -124.02 16.14 9.25 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.708 1.603 . . . . 0.0 113.872 -171.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -54.46 145.41 38.27 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 124.482 1.113 . . . . 0.0 112.787 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.49 -14.98 47.64 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.073 2.515 . . . . 0.0 115.529 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.7 p -125.6 -19.13 5.04 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.043 1.292 . . . . 0.0 114.432 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.71 144.02 44.55 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.377 1.071 . . . . 0.0 112.682 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -139.8 120.88 14.69 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.097 1.359 . . . . 0.0 108.973 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -72.57 134.02 45.0 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.462 -0.774 . . . . 0.0 110.207 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.43 163.62 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.796 1.239 . . . . 0.0 111.572 -170.745 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.8 m -138.66 118.68 13.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.301 1.041 . . . . 0.0 109.576 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -64.68 131.22 46.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.484 0.714 . . . . 0.0 110.491 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.46 157.69 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 113.054 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' OD1' HG22 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -88.01 -168.95 2.38 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.97 -28.6 69.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.044 1.738 . . . . 0.0 114.037 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -87.24 -13.38 43.99 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.257 1.023 . . . . 0.0 113.143 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.61 15.94 67.16 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.137 -1.368 . . . . 0.0 114.255 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.415 HG22 ' OD1' ' A' ' 27' ' ' ASP . 16.8 m -76.89 150.41 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.947 1.874 . . . . 0.0 111.181 173.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -87.56 124.98 34.06 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.451 1.1 . . . . 0.0 111.303 -171.418 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 mt -108.3 -52.41 2.77 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.741 0.817 . . . . 0.0 112.038 -172.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.71 136.52 5.65 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 124.46 1.028 . . . . 0.0 114.339 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.0 p -85.71 139.38 31.4 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.038 1.335 . . . . 0.0 112.291 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.61 170.52 24.74 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.376 1.941 . . . . 0.0 112.986 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.4 t -116.71 120.25 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.7 ttm -92.54 118.6 31.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.057 1.343 . . . . 0.0 109.775 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -109.23 130.14 55.49 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.911 1.684 . . . . 0.0 108.969 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.9 122.02 45.59 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.77 1.628 . . . . 0.0 107.164 174.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.4 p -114.57 173.59 6.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.549 1.14 . . . . 0.0 109.762 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -70.17 -3.38 16.55 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.415 -0.803 . . . . 0.0 112.904 173.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -120.23 -35.24 3.49 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -167.29 163.79 15.3 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.086 -1.009 . . . . 0.0 113.331 -169.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -87.43 136.35 32.97 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.37 1.468 . . . . 0.0 109.524 168.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.69 126.34 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.758 0.823 . . . . 0.0 110.853 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.9 mt -100.89 130.05 46.84 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.883 1.273 . . . . 0.0 110.298 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -101.59 122.3 43.59 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.997 1.719 . . . . 0.0 111.31 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -125.34 165.99 17.36 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.69 2.396 . . . . 0.0 110.692 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -85.1 -71.68 0.51 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.504 1.122 . . . . 0.0 113.414 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -88.73 -17.21 30.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.836 1.254 . . . . 0.0 114.284 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -92.49 159.52 15.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.935 1.294 . . . . 0.0 110.369 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -60.46 154.03 21.69 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.862 0.865 . . . . 0.0 111.129 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.45 132.11 49.09 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.746 -0.596 . . . . 0.0 109.496 169.702 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -108.46 126.68 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -169.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -127.66 141.44 51.61 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -166.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -140.95 116.25 7.35 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.839 1.256 . . . . 0.0 111.168 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.87 144.96 66.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.036 1.824 . . . . 0.0 108.878 169.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -58.1 -29.98 65.91 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.04 -41.32 78.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.073 1.749 . . . . 0.0 112.283 175.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.9 m -86.48 4.62 38.97 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.4 mt -85.4 118.34 24.88 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.416 1.007 . . . . 0.0 109.487 171.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -75.43 -34.86 61.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.026 0.53 . . . . 0.0 111.781 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -165.92 158.4 14.83 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.011 2.125 . . . . 0.0 111.206 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -145.67 107.84 4.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.222 1.409 . . . . 0.0 112.045 -174.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -117.27 161.72 13.08 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.879 1.704 . . . . 0.0 114.172 -169.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -148.01 152.8 38.07 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.129 1.372 . . . . 0.0 113.109 -170.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -145.95 -179.14 6.5 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.387 1.875 . . . . 0.0 109.815 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 m -61.45 -12.7 15.76 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -154.13 10.0 0.38 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.406 1.482 . . . . 0.0 114.67 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -139.94 133.92 30.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.704 1.601 . . . . 0.0 110.633 -168.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -126.84 137.33 53.17 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.81 1.644 . . . . 0.0 110.013 172.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.1 t -153.47 158.16 40.94 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.444 1.098 . . . . 0.0 112.871 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -158.03 156.1 30.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.088 1.355 . . . . 0.0 112.938 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.47 139.77 32.08 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.421 1.489 . . . . 0.0 110.166 170.472 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.7 p -122.33 151.32 41.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.589 1.156 . . . . 0.0 112.718 169.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.43 164.28 26.79 Favored Glycine 0 N--CA 1.477 1.4 0 C-N-CA 125.228 1.394 . . . . 0.0 114.044 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -20.51 65.03 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -170.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 -82.52 -15.32 52.81 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.2 p -82.05 179.4 7.83 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -59.52 -44.28 93.21 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.686 1.594 . . . . 0.0 112.872 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.0 p -82.8 -29.14 29.76 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.55 -155.1 33.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.446 1.498 . . . . 0.0 112.157 -172.295 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -63.2 137.67 58.29 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.826 0.85 . . . . 0.0 112.363 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.66 165.55 18.74 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.217 0.913 . . . . 0.0 113.117 169.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.35 128.63 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.882 1.273 . . . . 0.0 107.756 168.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -127.18 122.92 35.43 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.59 1.156 . . . . 0.0 109.374 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.22 140.84 48.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.313 1.045 . . . . 0.0 112.132 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -133.44 122.02 23.1 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.503 1.121 . . . . 0.0 110.953 -171.35 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -71.46 132.93 45.47 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.4 0.68 . . . . 0.0 110.974 170.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 25.0 p -169.3 140.72 2.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.006 1.723 . . . . 0.0 111.448 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.4 m -83.09 4.83 24.66 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -133.18 25.85 4.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.158 1.383 . . . . 0.0 113.748 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.19 -37.71 23.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.599 1.559 . . . . 0.0 114.122 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.71 -36.47 80.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.0 0.92 . . . . 0.0 112.984 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.68 -32.54 71.21 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.236 0.925 . . . . 0.0 111.863 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.59 -48.01 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 122.976 0.51 . . . . 0.0 109.658 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -37.78 83.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.401 1.081 . . . . 0.0 112.721 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -68.75 -33.43 73.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.486 1.114 . . . . 0.0 112.478 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.0 tp -84.63 -37.49 21.01 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.961 0.8 . . . . 0.0 112.168 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.76 -56.35 14.39 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.143 0.883 . . . . 0.0 112.211 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -59.75 -23.57 63.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -24.7 45.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.627 1.171 . . . . 0.0 113.042 176.17 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.4 mt -98.05 -34.5 10.76 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.806 1.642 . . . . 0.0 111.686 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 96.8 mtp -68.85 -27.52 65.9 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.236 1.415 . . . . 0.0 113.034 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -78.49 -10.75 59.83 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 169.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 13.3 t -80.95 -28.81 35.55 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.926 0.785 . . . . 0.0 112.683 -171.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.4 m120 59.98 27.66 17.09 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.487 1.915 . . . . 0.0 114.72 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.3 m -79.79 75.96 6.47 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.378 -1.451 . . . . 0.0 110.911 171.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.8 mm -86.25 -138.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.76 1.224 . . . . 0.0 108.88 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.01 50.7 0.61 Allowed 'General case' 0 CA--C 1.552 1.056 0 O-C-N 119.616 -1.928 . . . . 0.0 112.142 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.9 m -90.56 2.3 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 126.386 1.874 . . . . 0.0 114.404 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 61.2 mtt -91.0 -161.17 0.78 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.364 1.466 . . . . 0.0 111.04 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -68.09 80.58 0.22 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 120.938 -1.101 . . . . 0.0 112.513 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -149.07 156.96 40.39 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.606 2.363 . . . . 0.0 110.161 -169.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.3 174.29 11.02 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.758 2.972 . . . . 0.0 112.443 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.2 t -89.52 133.07 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.052 1.341 . . . . 0.0 110.25 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.68 146.8 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.165 1.786 . . . . 0.0 108.46 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.0 mm -77.19 83.24 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.793 0.837 . . . . 0.0 109.903 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.8 p -145.86 145.7 30.84 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.962 2.105 . . . . 0.0 110.573 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -67.98 134.71 51.19 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.618 1.167 . . . . 0.0 111.331 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -161.15 179.99 7.93 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.826 1.651 . . . . 0.0 112.276 -176.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.0 m -146.82 162.66 38.14 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.611 1.565 . . . . 0.0 110.543 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -57.55 124.04 65.57 Favored Pre-proline 0 CA--C 1.555 1.139 0 O-C-N 121.324 -0.86 . . . . 0.0 112.414 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.8 166.3 21.54 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.606 2.87 . . . . 0.0 111.933 -175.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.79 -177.66 6.42 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.651 1.18 . . . . 0.0 112.221 171.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -150.94 156.61 41.55 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.509 1.524 . . . . 0.0 111.072 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 45.4 tp -72.04 134.67 46.0 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.296 1.038 . . . . 0.0 111.736 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.95 150.0 46.14 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.648 1.179 . . . . 0.0 112.624 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 pp -86.87 154.37 55.44 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.553 1.141 . . . . 0.0 111.84 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.91 152.6 25.04 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.746 2.297 . . . . 0.0 111.662 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 25.1 ttp-105 -74.9 155.66 37.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.328 1.051 . . . . 0.0 111.723 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.56 146.38 55.55 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.867 1.267 . . . . 0.0 112.674 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.58 163.37 36.12 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 124.1 3.2 . . . . 0.0 112.821 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -81.49 151.0 68.13 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.603 1.161 . . . . 0.0 112.284 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.81 157.22 43.72 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.582 2.855 . . . . 0.0 112.254 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.59 162.0 33.5 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 124.212 3.275 . . . . 0.0 112.536 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -82.08 160.51 23.16 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.733 1.213 . . . . 0.0 113.452 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.66 145.55 31.58 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.741 1.217 . . . . 0.0 112.381 177.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.55 148.73 26.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.139 1.376 . . . . 0.0 111.972 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.8 -157.7 23.29 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.093 1.33 . . . . 0.0 113.429 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -155.9 161.73 40.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.862 1.265 . . . . 0.0 112.806 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p -127.66 175.13 8.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.71 2.004 . . . . 0.0 111.423 -170.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.76 139.39 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.674 1.19 . . . . 0.0 111.391 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.4 m -75.14 158.52 32.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.103 1.361 . . . . 0.0 113.759 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.1 p . . . . . 0 C--O 1.253 1.262 0 C-N-CA 125.488 1.515 . . . . 0.0 113.815 174.501 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 79.6 mt . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -143.39 119.17 10.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.92 1.288 . . . . 0.0 109.821 172.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.33 121.53 25.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.157 0.583 . . . . 0.0 111.251 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 78.6 mt -86.46 155.19 20.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -84.71 -13.96 49.8 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.637 1.575 . . . . 0.0 113.506 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -163.35 169.21 19.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.527 2.331 . . . . 0.0 110.706 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -86.19 120.52 72.42 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.01 -9.23 17.97 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.488 2.792 . . . . 0.0 114.209 -172.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 44.7 t -92.03 -74.27 0.52 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.056 0.942 . . . . 0.0 113.13 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.02 -41.7 3.04 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.774 1.654 . . . . 0.0 114.066 -172.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -81.47 91.87 6.38 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.544 1.172 . . . . 0.0 109.997 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.41 139.88 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -100.06 141.77 32.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.138 2.175 . . . . 0.0 111.108 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -106.23 129.31 54.3 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.618 1.167 . . . . 0.0 111.273 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.38 -72.32 1.06 Allowed Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.657 1.122 . . . . 0.0 112.371 -175.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -92.75 18.09 9.4 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.141 1.376 . . . . 0.0 113.315 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -122.7 122.87 39.8 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.249 1.42 . . . . 0.0 108.278 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -99.25 144.94 27.81 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.445 1.098 . . . . 0.0 111.089 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 125.527 1.531 . . . . 0.0 112.514 -176.396 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 . . . . . 0 CA--C 1.558 1.279 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.73 -11.91 28.33 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.08 2.52 . . . . 0.0 115.478 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 51.5 p -131.87 -16.42 2.92 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 120.155 1.343 . . . . 0.0 114.604 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.9 147.76 37.93 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.614 1.166 . . . . 0.0 111.505 172.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -140.8 118.57 11.71 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.994 0.918 . . . . 0.0 108.844 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.2 mttm -67.35 127.05 31.22 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.801 -0.562 . . . . 0.0 109.706 170.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.9 m -134.97 159.93 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.696 1.598 . . . . 0.0 110.669 -171.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 m -135.27 119.17 17.34 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.175 0.99 . . . . 0.0 109.039 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -65.8 132.52 48.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.323 0.649 . . . . 0.0 110.267 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 m -127.95 155.59 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.293 1.037 . . . . 0.0 112.665 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.3 p-10 -91.05 -168.89 2.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.847 1.259 . . . . 0.0 114.34 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.07 -21.4 66.15 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.228 1.811 . . . . 0.0 114.044 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -95.89 -10.23 29.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.948 1.299 . . . . 0.0 112.95 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.17 16.28 72.31 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 117.934 -1.481 . . . . 0.0 114.239 -172.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.405 HG22 ' OD1' ' A' ' 27' ' ' ASP . 13.4 m -77.65 149.7 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.12 1.96 . . . . 0.0 111.353 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -86.68 126.96 34.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.349 1.059 . . . . 0.0 111.497 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.6 mt -108.94 -51.11 2.92 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.002 0.921 . . . . 0.0 112.0 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.33 143.44 9.19 Favored Glycine 0 N--CA 1.47 0.928 0 C-N-CA 124.76 1.171 . . . . 0.0 113.854 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.5 p -90.07 150.87 21.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.115 1.366 . . . . 0.0 112.909 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.11 172.63 35.85 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.195 1.855 . . . . 0.0 113.039 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.31 120.85 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.1 tpp -86.29 131.9 34.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.846 0.859 . . . . 0.0 109.354 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -118.5 127.93 54.1 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.405 1.482 . . . . 0.0 109.118 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.5 127.96 55.41 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.618 1.967 . . . . 0.0 107.993 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -160.45 152.28 19.96 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.47 1.908 . . . . 0.0 108.024 -171.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -57.23 -18.06 14.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.86 1.264 . . . . 0.0 113.943 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 t -78.16 -51.94 9.47 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -178.37 174.73 1.25 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.855 1.662 . . . . 0.0 112.501 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt -86.81 139.2 30.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.772 0.829 . . . . 0.0 110.688 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.59 134.42 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.951 0.901 . . . . 0.0 111.696 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.14 131.49 46.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.357 1.463 . . . . 0.0 110.537 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -110.92 139.51 46.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.153 2.181 . . . . 0.0 110.681 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.547 0.837 0 C-N-CA 125.356 1.463 . . . . 0.0 110.848 -173.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.683 0 CA-C-O 120.444 0.164 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 t -133.4 134.34 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.856 0.462 . . . . 0.0 111.566 -170.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -125.74 147.1 49.49 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.591 1.556 . . . . 0.0 112.836 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.2 m-90 -143.91 117.11 5.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.308 1.443 . . . . 0.0 111.429 174.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.86 148.62 58.38 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.73 2.287 . . . . 0.0 110.509 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -60.36 -27.51 67.44 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -56.59 -39.69 73.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.729 1.612 . . . . 0.0 112.076 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.84 -17.7 61.52 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 mt -84.63 81.41 8.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.544 1.066 . . . . 0.0 110.998 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.529 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -59.39 -30.98 68.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.831 0.852 . . . . 0.0 113.17 173.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -152.35 148.76 27.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.231 1.412 . . . . 0.0 111.594 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -146.45 112.12 5.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.62 1.568 . . . . 0.0 110.402 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.32 162.93 13.08 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 124.918 1.246 . . . . 0.0 114.566 -168.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -145.66 144.93 30.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.187 1.395 . . . . 0.0 111.879 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -144.05 -175.71 4.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.897 1.679 . . . . 0.0 109.906 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.1 m -56.53 112.48 1.28 Allowed 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.347 -0.846 . . . . 0.0 110.81 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.253 0.8 OUTLIER 49.33 23.59 0.87 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.666 2.387 . . . . 0.0 116.561 -173.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -132.22 129.41 39.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.488 1.515 . . . . 0.0 111.181 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -123.85 139.09 54.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.769 1.628 . . . . 0.0 109.997 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 t -153.57 155.56 36.37 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.962 -1.086 . . . . 0.0 113.41 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.22 148.23 29.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.982 1.313 . . . . 0.0 112.606 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.97 147.77 26.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.625 1.97 . . . . 0.0 108.403 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 m -155.0 134.85 12.86 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.625 -1.297 . . . . 0.0 112.153 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.57 170.44 54.54 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.247 0.927 . . . . 0.0 113.605 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -12.96 7.58 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -77.34 -16.51 58.88 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.4 p -86.42 176.69 7.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -55.75 -41.1 73.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.624 1.57 . . . . 0.0 113.528 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.9 p -91.79 -16.83 26.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.397 1.479 . . . . 0.0 113.94 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.15 -169.98 42.59 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.031 1.776 . . . . 0.0 112.138 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -67.68 126.68 30.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.648 0.779 . . . . 0.0 110.79 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.21 162.71 16.91 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 121.912 0.729 . . . . 0.0 114.345 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.57 133.5 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.107 1.363 . . . . 0.0 108.775 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -125.71 124.45 41.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.626 1.17 . . . . 0.0 109.759 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.44 143.88 49.86 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.473 1.109 . . . . 0.0 112.61 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -140.47 127.8 21.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.493 -169.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -72.47 136.24 45.92 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.085 0.554 . . . . 0.0 110.345 169.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 48.8 t -163.8 131.59 3.51 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.591 1.556 . . . . 0.0 110.644 -172.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.5 t -71.31 -8.31 52.86 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -129.48 26.01 5.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.26 1.824 . . . . 0.0 112.834 -173.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.17 -36.01 38.94 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -70.22 -38.01 75.16 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.429 0.692 . . . . 0.0 112.759 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -67.43 -33.18 74.63 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.497 -0.752 . . . . 0.0 111.612 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.58 -51.09 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 169.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.84 -37.62 82.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.841 0.857 . . . . 0.0 112.662 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.75 -30.33 67.88 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.6 1.16 . . . . 0.0 112.796 175.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.45 -37.11 21.81 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.006 0.821 . . . . 0.0 112.419 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 23.1 mt -53.43 -54.17 40.69 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.321 0.964 . . . . 0.0 111.832 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -59.0 -26.68 64.74 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -70.8 -30.71 67.24 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.723 1.209 . . . . 0.0 112.766 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.59 -38.33 12.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.6 1.56 . . . . 0.0 111.135 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.8 mtp . . . . . 0 N--CA 1.468 0.46 0 C-N-CA 125.2 1.4 . . . . 0.0 113.012 -178.95 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 32.1 t80 . . . . . 0 N--CA 1.468 0.465 0 CA-C-O 119.849 -0.12 . . . . 0.0 111.141 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -90.88 109.69 20.91 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.264 1.026 . . . . 0.0 109.607 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 37.7 mt -74.66 156.89 36.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.953 0.901 . . . . 0.0 113.015 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -79.76 -24.71 41.36 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.11 1.364 . . . . 0.0 113.582 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -162.05 169.75 20.45 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.535 1.934 . . . . 0.0 111.344 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -80.78 124.73 81.5 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.259 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.34 6.27 5.72 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.859 3.04 . . . . 0.0 113.786 -172.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 47.9 t -127.98 131.84 49.23 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.001 1.32 . . . . 0.0 112.07 -171.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.13 -17.31 40.75 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.91 1.243 . . . . 0.0 115.122 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -113.61 112.66 23.89 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.177 1.391 . . . . 0.0 110.286 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -154.89 134.51 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.777 0.799 . . . . 0.0 111.993 -169.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -93.8 120.03 33.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.043 2.137 . . . . 0.0 110.271 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 . . . . . 0 CA--C 1.541 0.597 0 C-N-CA 123.794 0.837 . . . . 0.0 110.242 177.926 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 . . . . . 0 CA--C 1.555 1.144 0 CA-C-O 118.841 -0.599 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.87 -15.0 47.25 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.163 2.575 . . . . 0.0 115.141 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.6 p -128.41 -18.14 4.06 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.19 1.359 . . . . 0.0 114.459 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 113.18 24.99 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.186 0.903 . . . . 0.0 111.112 174.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -107.94 113.23 26.28 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.127 0.971 . . . . 0.0 109.333 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -67.11 131.29 45.51 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.581 -0.7 . . . . 0.0 110.253 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.5 152.79 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.261 1.425 . . . . 0.0 111.125 -169.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.5 m -130.45 118.37 21.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.837 0.855 . . . . 0.0 109.09 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -66.29 133.97 51.66 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.941 0.896 . . . . 0.0 110.642 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.36 155.08 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.924 0.89 . . . . 0.0 112.733 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.83 -168.3 2.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.576 1.151 . . . . 0.0 113.695 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -72.52 -20.09 61.41 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.637 1.175 . . . . 0.0 113.592 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.76 -15.48 44.87 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.951 1.301 . . . . 0.0 112.408 171.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.98 16.48 67.44 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.042 -1.421 . . . . 0.0 114.449 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.49 151.08 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 119.844 1.822 . . . . 0.0 111.667 173.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.27 128.16 35.17 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.857 1.263 . . . . 0.0 111.308 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.0 mt -110.09 -52.17 2.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.964 0.906 . . . . 0.0 112.347 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.11 152.71 23.78 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.669 1.604 . . . . 0.0 112.569 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.0 t -116.28 149.35 39.37 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.939 0.896 . . . . 0.0 112.82 -172.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.99 174.7 33.19 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 126.784 2.135 . . . . 0.0 113.643 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.2 t -114.83 120.5 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.1 tpp -86.65 131.52 34.13 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.95 0.9 . . . . 0.0 109.475 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -127.36 129.99 48.6 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.63 1.572 . . . . 0.0 108.818 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.22 131.1 53.11 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.384 1.873 . . . . 0.0 107.804 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.0 p -130.55 171.3 13.18 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.023 1.329 . . . . 0.0 109.774 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -70.6 -7.65 45.72 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.218 -0.926 . . . . 0.0 112.62 172.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.3 m -102.4 -43.59 5.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.453 1.101 . . . . 0.0 113.428 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -173.94 170.68 3.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.174 1.389 . . . . 0.0 113.151 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.87 140.89 29.2 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.856 1.262 . . . . 0.0 110.275 168.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.6 t -135.31 129.99 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.545 1.138 . . . . 0.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.7 mt -100.23 126.36 46.52 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.679 1.192 . . . . 0.0 110.251 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -98.95 127.52 44.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.55 1.54 . . . . 0.0 110.704 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.8 mt . . . . . 0 CA--C 1.541 0.606 0 C-N-CA 127.167 2.187 . . . . 0.0 110.065 -172.348 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.644 0 N-CA-C 111.769 0.285 . . . . 0.0 111.769 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.24 134.49 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.129 0.971 . . . . 0.0 109.724 -174.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.3 150.21 48.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.574 1.15 . . . . 0.0 112.71 -168.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 -142.26 115.22 6.4 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.751 1.22 . . . . 0.0 111.421 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.09 146.6 71.11 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.549 2.166 . . . . 0.0 110.017 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -60.7 -29.98 69.67 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -34.13 70.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.196 1.798 . . . . 0.0 112.679 173.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.9 m -83.28 -9.38 59.14 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.57 88.17 7.03 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.641 1.109 . . . . 0.0 110.199 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -64.98 -29.74 70.69 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.758 0.823 . . . . 0.0 113.114 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -154.71 154.75 33.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.95 0.9 . . . . 0.0 112.691 167.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -151.41 144.84 24.84 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.255 1.422 . . . . 0.0 109.633 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.49 -179.65 34.45 Favored Glycine 0 N--CA 1.464 0.566 0 CA-C-O 121.558 0.532 . . . . 0.0 114.222 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -149.09 165.06 32.85 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.227 1.011 . . . . 0.0 113.12 -172.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.85 -169.47 3.37 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.706 2.002 . . . . 0.0 109.578 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 93.8 p -69.23 -18.22 63.86 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -152.49 8.79 0.46 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.795 1.638 . . . . 0.0 113.891 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.63 129.23 26.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.574 1.55 . . . . 0.0 110.754 -168.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -120.98 140.06 52.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.037 1.735 . . . . 0.0 109.504 174.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.4 t -153.35 159.24 42.41 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.31 1.044 . . . . 0.0 112.791 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.42 149.48 30.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.724 1.61 . . . . 0.0 111.689 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -113.22 134.23 54.68 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.525 1.93 . . . . 0.0 109.628 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -132.87 154.91 49.9 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.686 1.195 . . . . 0.0 112.192 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.9 167.51 18.54 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.069 1.319 . . . . 0.0 114.28 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -54.54 -27.34 37.74 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -73.43 -15.44 61.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.67 1.988 . . . . 0.0 115.706 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.2 p -83.47 -176.46 6.32 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -60.48 -46.34 90.45 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.391 1.076 . . . . 0.0 112.779 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.6 p -89.3 -21.39 23.19 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.595 1.158 . . . . 0.0 113.146 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.38 -156.39 33.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.824 1.678 . . . . 0.0 112.271 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -63.64 134.02 54.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.601 0.76 . . . . 0.0 111.691 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.76 175.35 26.67 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 122.156 0.864 . . . . 0.0 113.074 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.8 mt -124.65 138.82 52.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.724 1.609 . . . . 0.0 108.368 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -134.2 123.58 24.56 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.878 1.271 . . . . 0.0 109.96 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.86 143.4 50.37 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.347 1.059 . . . . 0.0 112.962 -169.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -139.54 126.49 20.94 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.851 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -71.07 133.88 46.62 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.739 0.815 . . . . 0.0 110.914 169.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.6 p -168.15 147.96 4.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.016 1.726 . . . . 0.0 111.924 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.0 t -82.55 -0.4 46.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.088 0.955 . . . . 0.0 113.103 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.25 22.56 6.08 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.038 1.735 . . . . 0.0 112.661 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.22 -41.26 49.58 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.567 1.147 . . . . 0.0 113.923 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.35 -35.29 73.48 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.479 1.112 . . . . 0.0 113.225 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -66.33 -39.61 89.34 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.468 -0.77 . . . . 0.0 110.816 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.81 -47.54 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.243 0.617 . . . . 0.0 110.167 172.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -37.83 85.69 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.843 0.857 . . . . 0.0 112.673 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -72.54 -30.69 64.67 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.16 -42.22 21.19 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.911 0.778 . . . . 0.0 110.684 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.9 mt -50.24 -56.93 9.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.667 1.187 . . . . 0.0 113.096 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -60.79 -20.54 61.69 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.06 -23.37 33.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.663 1.185 . . . . 0.0 113.012 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.4 mt -94.9 -35.72 11.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.513 1.125 . . . . 0.0 111.749 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.1 mtp . . . . . 0 N--CA 1.469 0.52 0 C-N-CA 124.557 1.143 . . . . 0.0 112.808 176.69 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 33.0 t80 . . . . . 0 N--CA 1.468 0.451 0 N-CA-C 111.84 0.311 . . . . 0.0 111.84 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.83 100.09 11.82 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.098 1.359 . . . . 0.0 111.081 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 56.8 mt -77.15 151.97 35.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.418 -0.801 . . . . 0.0 112.705 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -87.46 -30.22 20.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.364 1.466 . . . . 0.0 113.265 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -143.64 159.36 42.59 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.181 1.792 . . . . 0.0 111.521 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -80.12 124.26 82.93 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.408 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.47 -25.34 2.6 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.193 2.595 . . . . 0.0 114.071 -170.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.53 126.4 31.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.65 0.78 . . . . 0.0 111.28 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.25 -15.8 80.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.984 0.802 . . . . 0.0 113.999 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -122.69 120.25 33.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.468 1.507 . . . . 0.0 109.3 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.74 164.48 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.584 1.553 . . . . 0.0 111.018 -174.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -145.78 159.82 42.63 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.508 1.523 . . . . 0.0 111.721 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 . . . . . 0 CA--C 1.542 0.639 0 C-N-CA 125.018 1.327 . . . . 0.0 110.322 -169.705 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 . . . . . 0 CA--C 1.553 1.091 0 CA-C-O 118.742 -0.647 . . . . 0.0 112.665 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.32 -7.7 21.84 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.461 2.774 . . . . 0.0 114.808 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.8 p -132.67 -24.94 1.93 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.08 90.03 3.19 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.782 1.173 . . . . 0.0 110.677 174.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -91.14 118.4 30.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.777 1.231 . . . . 0.0 109.346 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -78.61 133.76 37.25 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.172 -0.955 . . . . 0.0 110.29 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.17 165.27 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.865 1.266 . . . . 0.0 111.548 -168.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.6 m -143.53 121.74 12.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.463 1.105 . . . . 0.0 109.063 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.77 133.67 53.9 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.097 0.559 . . . . 0.0 109.955 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.48 153.07 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.045 0.938 . . . . 0.0 112.346 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -85.98 -169.69 2.76 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -61.41 -31.66 71.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.016 1.326 . . . . 0.0 114.201 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.09 -9.66 59.78 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.109 1.363 . . . . 0.0 112.45 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.22 12.85 83.52 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 117.76 -1.578 . . . . 0.0 114.225 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 m -80.7 150.35 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 120.108 1.954 . . . . 0.0 111.662 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -83.0 124.52 30.49 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.567 -173.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.9 mt -104.02 -54.3 2.58 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.75 0.82 . . . . 0.0 111.948 -173.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.64 139.27 6.51 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 124.737 1.161 . . . . 0.0 114.003 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 p -85.23 153.16 22.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.248 1.419 . . . . 0.0 113.309 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.05 171.59 37.13 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.664 1.602 . . . . 0.0 113.327 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.11 120.74 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.7 tpp -89.14 134.34 34.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.031 1.332 . . . . 0.0 110.135 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -133.08 130.28 39.11 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.568 1.547 . . . . 0.0 109.461 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.51 128.4 54.48 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.874 2.07 . . . . 0.0 107.694 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -128.03 172.57 10.82 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.64 1.176 . . . . 0.0 110.601 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.49 3.16 4.1 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 121.28 -0.888 . . . . 0.0 112.759 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.7 m -110.89 -45.51 3.46 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.499 1.119 . . . . 0.0 113.34 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -173.63 173.71 3.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.338 1.055 . . . . 0.0 113.343 -169.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.99 139.77 30.25 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.033 0.933 . . . . 0.0 109.946 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.6 t -134.89 132.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.441 1.096 . . . . 0.0 111.413 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.9 mt -104.25 130.9 52.04 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.01 1.724 . . . . 0.0 110.558 168.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -105.13 129.02 53.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.691 1.996 . . . . 0.0 110.579 170.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 pt? . . . . . 0 CA--C 1.543 0.683 0 C-N-CA 127.029 2.131 . . . . 0.0 111.397 -173.558 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.73 0 N-CA-C 112.423 0.527 . . . . 0.0 112.423 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 t -126.06 136.86 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.275 1.03 . . . . 0.0 109.485 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.66 152.0 46.38 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.637 0.775 . . . . 0.0 111.842 -171.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -139.16 116.67 8.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.518 1.127 . . . . 0.0 111.37 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.98 145.42 73.89 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.59 2.193 . . . . 0.0 109.883 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -60.85 -24.83 66.21 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.84 -42.69 99.84 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.057 1.343 . . . . 0.0 111.992 173.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.4 m -79.74 -3.55 48.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.1 mt -86.71 106.98 18.02 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.686 1.13 . . . . 0.0 109.912 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -38.43 42.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.384 0.674 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -149.47 155.91 41.14 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.101 1.36 . . . . 0.0 111.085 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -150.78 136.31 17.96 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.868 1.667 . . . . 0.0 108.514 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -156.81 173.26 34.5 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-O 122.139 0.855 . . . . 0.0 113.979 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -142.2 159.76 41.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.52 1.128 . . . . 0.0 112.024 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -151.47 -174.75 4.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.111 1.764 . . . . 0.0 109.771 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -60.19 119.17 7.37 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.376 -0.828 . . . . 0.0 110.473 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.64 21.93 0.99 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 127.703 2.401 . . . . 0.0 116.464 -175.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -138.72 131.23 28.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.067 1.347 . . . . 0.0 111.214 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -125.86 141.29 52.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.218 1.807 . . . . 0.0 109.956 173.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -153.8 162.05 41.56 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.941 -1.099 . . . . 0.0 112.971 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -154.33 153.77 32.21 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.598 1.559 . . . . 0.0 112.412 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -112.65 128.74 56.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.513 1.925 . . . . 0.0 109.222 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.2 p -123.37 142.63 50.77 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.77 154.38 52.83 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.641 1.115 . . . . 0.0 113.138 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -61.81 -14.07 29.68 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -83.11 -17.42 43.12 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.0 p -74.66 -179.54 4.18 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -170.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.94 -38.1 69.87 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.645 1.178 . . . . 0.0 113.199 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -96.58 -23.19 16.63 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.246 1.418 . . . . 0.0 113.588 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.98 -160.7 43.03 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.356 1.455 . . . . 0.0 112.535 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -65.54 129.07 38.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.547 1.139 . . . . 0.0 112.378 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.8 172.59 30.46 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.231 1.396 . . . . 0.0 112.899 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 59.0 mt -119.36 136.3 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.55 1.54 . . . . 0.0 108.298 170.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -129.21 117.95 21.59 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.78 1.232 . . . . 0.0 109.801 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.8 141.18 48.7 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.675 1.19 . . . . 0.0 112.199 -172.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -138.33 127.7 24.59 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.192 0.997 . . . . 0.0 111.865 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -67.34 131.22 45.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.445 0.698 . . . . 0.0 111.044 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.3 t -169.53 118.73 0.64 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.249 1.819 . . . . 0.0 110.36 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.8 t -71.29 -8.06 51.14 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.229 -0.919 . . . . 0.0 113.151 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.73 9.46 35.03 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.538 1.935 . . . . 0.0 113.333 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.5 -38.53 20.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.31 1.844 . . . . 0.0 115.322 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.99 -35.67 80.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.773 0.829 . . . . 0.0 112.908 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -68.39 -37.87 80.78 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.536 -0.728 . . . . 0.0 110.96 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.45 -45.26 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 118.609 0.64 . . . . 0.0 110.24 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.61 -42.99 99.9 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.767 0.827 . . . . 0.0 111.841 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -70.31 -33.97 72.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.23 -33.93 43.24 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.12 0.873 . . . . 0.0 110.682 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.49 -55.21 36.58 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.299 -0.875 . . . . 0.0 111.981 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -61.23 -21.52 63.94 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -81.47 -20.14 40.85 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.215 1.406 . . . . 0.0 112.754 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.13 -35.78 10.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.468 1.507 . . . . 0.0 112.559 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 67.5 mmm . . . . . 0 N--CA 1.472 0.657 0 C-N-CA 124.855 1.262 . . . . 0.0 111.366 175.212 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 22.4 t80 . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 120.484 0.183 . . . . 0.0 110.944 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -89.59 110.06 20.95 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.824 1.25 . . . . 0.0 109.962 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 45.0 mt -76.53 157.15 32.31 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -80.32 -24.15 40.12 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.812 1.645 . . . . 0.0 113.702 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -160.26 170.03 21.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.517 1.927 . . . . 0.0 111.55 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -86.68 122.73 71.55 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.789 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -82.43 -24.92 3.42 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.362 2.708 . . . . 0.0 114.428 -170.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.4 m -79.75 129.02 34.12 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.843 0.747 . . . . 0.0 112.223 -171.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.08 -9.44 85.42 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.656 1.122 . . . . 0.0 114.563 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -139.0 128.07 23.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.71 1.604 . . . . 0.0 110.221 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.7 164.07 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.6 1.56 . . . . 0.0 111.252 -173.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -128.93 132.32 47.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.266 1.426 . . . . 0.0 109.376 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 . . . . . 0 CA--C 1.541 0.624 0 C-N-CA 124.861 1.264 . . . . 0.0 110.035 175.877 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 . . . . . 0 CA--C 1.556 1.185 0 N-CA-C 112.961 0.726 . . . . 0.0 112.961 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.76 -18.41 22.09 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.852 2.368 . . . . 0.0 114.944 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.9 p -128.8 -19.22 3.71 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.173 1.352 . . . . 0.0 114.599 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -97.42 142.22 29.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.189 0.904 . . . . 0.0 110.851 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -143.55 107.16 4.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.012 1.325 . . . . 0.0 108.738 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -64.7 137.12 57.62 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.25 -0.906 . . . . 0.0 111.402 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 m -144.9 159.82 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.803 1.241 . . . . 0.0 111.587 -170.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -134.63 117.19 15.83 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.66 1.184 . . . . 0.0 108.824 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -67.59 135.63 53.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.543 0.737 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.0 m -129.07 154.47 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.298 1.039 . . . . 0.0 112.948 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.427 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.7 p-10 -90.78 -166.62 1.62 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.039 1.336 . . . . 0.0 113.989 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.85 -30.37 71.37 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.555 1.142 . . . . 0.0 113.008 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.9 -12.36 59.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.847 1.259 . . . . 0.0 112.106 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.04 14.52 80.53 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 117.787 -1.563 . . . . 0.0 114.228 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.427 HG22 ' OD1' ' A' ' 27' ' ' ASP . 14.2 m -76.15 150.34 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.995 1.897 . . . . 0.0 111.563 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -84.45 124.19 31.07 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.416 1.087 . . . . 0.0 110.926 -174.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 mt -104.73 -51.93 2.97 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.086 0.954 . . . . 0.0 112.062 -170.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.33 148.49 17.37 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 125.004 1.288 . . . . 0.0 113.533 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.8 p -90.38 151.74 21.3 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.853 1.261 . . . . 0.0 113.006 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.32 170.95 34.56 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.751 1.643 . . . . 0.0 112.793 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -118.63 120.22 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.8 ttm -88.3 141.19 28.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.098 0.959 . . . . 0.0 110.194 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -135.84 129.85 33.03 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.515 1.526 . . . . 0.0 108.903 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -108.44 130.5 55.24 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.678 1.591 . . . . 0.0 107.919 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.0 p -130.35 167.31 18.74 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.904 1.281 . . . . 0.0 109.941 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -66.47 -9.69 36.85 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.864 -0.522 . . . . 0.0 112.4 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.6 m -98.52 -45.35 6.13 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.449 1.1 . . . . 0.0 113.263 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -172.6 171.11 4.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.64 1.176 . . . . 0.0 113.718 -168.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.7 mt -86.86 139.77 30.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.579 1.552 . . . . 0.0 109.962 168.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.0 t -134.87 137.93 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.056 0.943 . . . . 0.0 111.176 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.84 130.3 55.62 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.449 1.5 . . . . 0.0 109.837 167.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -103.13 130.91 50.45 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.366 1.866 . . . . 0.0 110.833 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.3 mt . . . . . 0 N--CA 1.474 0.771 0 C-N-CA 126.848 2.059 . . . . 0.0 111.148 -169.996 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.54 0.585 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -108.55 135.6 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.208 1.003 . . . . 0.0 110.494 -173.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -120.86 142.38 49.71 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.664 1.186 . . . . 0.0 113.384 -170.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -141.75 112.59 6.4 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.185 1.394 . . . . 0.0 111.42 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -69.56 150.02 68.9 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.386 2.058 . . . . 0.0 110.334 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -63.7 -19.64 65.09 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.9 mt -68.65 -31.52 70.71 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.21 1.404 . . . . 0.0 113.114 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.4 m -89.9 -6.86 55.34 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.5 mt -74.7 117.4 16.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.73 0.695 . . . . 0.0 109.559 172.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -80.34 -32.97 37.73 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.371 1.468 . . . . 0.0 112.305 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -166.58 159.09 13.9 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.006 2.123 . . . . 0.0 110.483 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -152.17 134.08 14.88 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.001 1.321 . . . . 0.0 111.414 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -150.66 175.73 29.54 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.477 1.036 . . . . 0.0 113.836 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.57 162.0 39.3 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.537 1.135 . . . . 0.0 113.535 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -146.2 -178.56 6.2 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.259 2.224 . . . . 0.0 109.327 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -62.37 -13.63 31.31 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -154.08 12.83 0.43 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.448 1.499 . . . . 0.0 114.242 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -141.47 130.98 23.85 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.329 1.452 . . . . 0.0 110.29 -168.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -121.67 142.14 50.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.912 1.685 . . . . 0.0 109.24 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -153.01 155.51 37.06 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.059 -1.026 . . . . 0.0 112.997 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -150.0 152.78 35.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.158 1.383 . . . . 0.0 111.977 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -106.39 140.8 38.74 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.357 1.463 . . . . 0.0 109.486 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.0 m -124.97 148.58 48.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.175 0.99 . . . . 0.0 112.136 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.62 164.57 45.28 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.276 0.941 . . . . 0.0 112.765 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -63.55 -15.07 57.0 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -82.39 -15.73 51.64 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.216 1.806 . . . . 0.0 115.154 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -79.7 -179.52 6.95 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.526 0.73 . . . . 0.0 112.872 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -58.26 -46.02 86.74 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.286 1.035 . . . . 0.0 112.836 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 36.1 p -89.16 -18.98 26.06 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.04 1.336 . . . . 0.0 113.721 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.49 -164.54 41.76 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.728 1.632 . . . . 0.0 112.474 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -66.68 134.25 51.87 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.923 0.889 . . . . 0.0 112.02 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.09 172.82 23.94 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.288 0.947 . . . . 0.0 113.065 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.6 mt -114.69 137.87 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.474 1.509 . . . . 0.0 108.396 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -129.95 122.97 29.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.64 1.176 . . . . 0.0 110.311 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.15 144.41 48.59 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.679 1.192 . . . . 0.0 113.03 -172.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -142.71 125.15 15.65 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.974 0.91 . . . . 0.0 112.397 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -70.46 134.49 47.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.28 1.032 . . . . 0.0 111.418 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.1 p -170.84 144.55 2.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.411 1.884 . . . . 0.0 111.566 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.4 p -78.03 0.79 23.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.177 1.391 . . . . 0.0 114.08 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -134.65 24.95 3.71 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.841 2.056 . . . . 0.0 112.811 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.98 -41.11 46.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.813 1.645 . . . . 0.0 113.911 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -67.87 -37.13 81.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.503 0.721 . . . . 0.0 112.521 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -68.41 -33.1 73.63 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.416 -0.802 . . . . 0.0 111.958 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.2 mt -63.4 -49.28 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 169.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.12 -42.62 91.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.072 0.949 . . . . 0.0 112.172 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -64.84 -34.87 79.4 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.881 1.273 . . . . 0.0 112.556 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -81.27 -37.8 27.9 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.22 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.9 mt -53.48 -55.75 22.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.369 0.986 . . . . 0.0 111.845 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -58.3 -31.43 67.5 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -28.47 65.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.607 1.163 . . . . 0.0 112.931 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 71.2 mt -93.22 -35.21 13.25 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.334 1.453 . . . . 0.0 111.082 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.8 mtp . . . . . 0 N--CA 1.467 0.406 0 C-N-CA 124.978 1.311 . . . . 0.0 113.593 -178.686 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.6 t80 . . . . . 0 N--CA 1.467 0.402 0 CA-C-O 120.283 0.087 . . . . 0.0 111.193 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -82.52 107.76 15.42 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.887 1.275 . . . . 0.0 110.742 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -77.28 161.39 28.14 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.604 1.162 . . . . 0.0 112.13 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -101.02 -18.81 16.1 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.127 1.371 . . . . 0.0 114.233 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -139.12 154.3 48.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.524 1.93 . . . . 0.0 111.54 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -84.23 122.22 75.55 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.249 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.34 -20.34 2.73 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.051 2.501 . . . . 0.0 115.249 -169.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 86.9 m -81.59 -31.96 32.3 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.11 -64.44 2.0 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 125.189 1.375 . . . . 0.0 112.902 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -74.61 68.83 1.68 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.764 1.626 . . . . 0.0 111.382 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.7 156.29 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.367 1.867 . . . . 0.0 112.117 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -121.29 137.62 54.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.77 1.628 . . . . 0.0 110.167 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 124.776 1.23 . . . . 0.0 110.778 -179.714 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 . . . . . 0 CA--C 1.558 1.264 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.39 -15.02 47.49 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.271 2.648 . . . . 0.0 115.458 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.7 p -124.03 -24.91 4.3 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.827 1.194 . . . . 0.0 113.843 172.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -100.16 118.25 36.1 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.819 1.19 . . . . 0.0 111.943 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -114.51 110.57 20.03 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.281 1.433 . . . . 0.0 108.638 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -71.25 139.79 50.16 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.483 -0.761 . . . . 0.0 110.421 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -145.7 164.5 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.897 1.279 . . . . 0.0 111.964 -170.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.8 m -136.44 120.36 17.52 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.739 1.215 . . . . 0.0 109.271 172.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -67.3 137.53 56.15 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.859 0.864 . . . . 0.0 111.371 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.9 156.71 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.235 1.014 . . . . 0.0 112.706 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -90.8 -167.54 1.85 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.75 1.22 . . . . 0.0 113.705 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.23 -32.19 73.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.87 -11.54 59.81 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.821 1.248 . . . . 0.0 112.817 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 17.47 77.41 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.099 -1.39 . . . . 0.0 113.904 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 m -79.71 150.51 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.829 1.815 . . . . 0.0 111.339 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.57 126.43 34.93 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.308 1.043 . . . . 0.0 111.356 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.6 mt -109.08 -43.3 4.21 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.533 1.133 . . . . 0.0 112.681 -169.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.96 144.8 9.33 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.468 1.033 . . . . 0.0 114.2 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 p -83.79 148.26 27.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.448 1.099 . . . . 0.0 112.224 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.08 170.21 32.04 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.322 1.439 . . . . 0.0 113.457 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.04 119.8 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.7 ttm -91.11 134.05 34.84 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.058 0.943 . . . . 0.0 109.488 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -125.39 124.04 40.64 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.986 1.314 . . . . 0.0 109.235 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -111.35 126.87 55.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.546 1.938 . . . . 0.0 107.901 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -162.54 149.92 13.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.514 1.925 . . . . 0.0 108.266 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -58.89 -18.5 33.7 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -172.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 m -70.45 -42.26 71.75 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 170.95 167.05 0.07 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.594 1.958 . . . . 0.0 111.946 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mt -82.18 139.37 34.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.939 0.895 . . . . 0.0 109.545 167.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 t -134.64 138.62 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.331 0.653 . . . . 0.0 110.808 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.1 mt -113.74 130.74 56.39 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 125.735 1.614 . . . . 0.0 109.482 167.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -111.61 122.22 47.23 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.391 1.876 . . . . 0.0 109.945 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pt? . . . . . 0 CA--C 1.535 0.394 0 C-N-CA 124.84 1.256 . . . . 0.0 111.489 -177.264 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.711 0 CA-C-O 120.738 0.304 . . . . 0.0 111.666 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.95 136.95 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.515 1.126 . . . . 0.0 111.694 -169.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -117.15 146.83 42.94 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.844 1.658 . . . . 0.0 113.213 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -142.54 121.52 7.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.474 1.51 . . . . 0.0 111.797 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.77 149.99 61.31 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.094 2.529 . . . . 0.0 110.895 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -63.43 -19.42 64.69 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.4 mt -63.21 -33.67 75.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.422 1.089 . . . . 0.0 113.693 171.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.2 p -83.99 -9.35 58.73 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -89.9 73.6 7.43 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 111.87 -173.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -63.99 -41.24 97.58 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.042 -0.412 . . . . 0.0 112.058 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -134.03 129.6 36.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.098 1.759 . . . . 0.0 110.363 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -153.09 141.67 20.86 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.714 2.006 . . . . 0.0 109.764 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.67 179.44 41.56 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-O 122.053 0.807 . . . . 0.0 114.612 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -142.33 157.61 44.62 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.38 1.472 . . . . 0.0 112.56 -171.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.78 -173.17 4.28 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.699 2.0 . . . . 0.0 109.845 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 p -59.33 110.6 1.12 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.272 -0.892 . . . . 0.0 111.506 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 61.7 15.58 7.06 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 126.41 1.884 . . . . 0.0 114.268 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -133.04 129.3 37.9 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.231 1.378 . . . . 0.0 112.065 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -124.12 142.09 51.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.676 1.591 . . . . 0.0 110.474 171.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.8 t -153.87 157.06 38.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.489 1.116 . . . . 0.0 113.581 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.36 155.46 37.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.17 1.388 . . . . 0.0 113.488 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.04 154.32 17.7 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.142 1.777 . . . . 0.0 111.605 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 t -148.37 161.8 40.84 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.733 0.813 . . . . 0.0 113.054 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.37 173.63 19.75 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 126.481 1.991 . . . . 0.0 114.593 -170.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -26.54 68.44 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -169.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -81.21 -15.06 56.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.2 p -79.13 -178.45 6.16 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -61.62 -35.88 79.13 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.95 1.3 . . . . 0.0 113.341 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.9 p -99.41 -22.85 15.35 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.546 1.539 . . . . 0.0 114.374 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.76 -165.8 46.31 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.776 1.655 . . . . 0.0 112.925 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -58.34 132.48 53.76 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.006 0.922 . . . . 0.0 111.998 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.68 172.49 31.22 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 123.997 0.808 . . . . 0.0 113.375 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.7 mt -114.94 137.85 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.367 1.467 . . . . 0.0 108.261 169.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -131.53 126.9 36.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.745 1.218 . . . . 0.0 110.213 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.31 144.95 50.24 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.496 1.119 . . . . 0.0 113.284 -170.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -141.82 129.67 21.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.354 1.061 . . . . 0.0 111.75 -168.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -76.95 134.81 38.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.877 0.871 . . . . 0.0 111.608 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 22.3 p -174.45 137.31 0.49 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.635 1.974 . . . . 0.0 111.565 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -73.68 -3.8 30.42 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.993 -1.067 . . . . 0.0 113.273 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -110.94 13.31 22.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.163 2.585 . . . . 0.0 112.758 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.59 -43.25 35.86 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.204 1.402 . . . . 0.0 114.215 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -68.12 -35.18 77.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.521 0.728 . . . . 0.0 112.769 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.46 -31.27 66.98 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.379 -0.826 . . . . 0.0 112.141 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.42 -45.6 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.755 0.707 . . . . 0.0 109.861 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.82 -45.09 93.47 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.159 0.983 . . . . 0.0 111.735 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -65.24 -40.94 94.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.199 1.4 . . . . 0.0 112.261 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.5 tp -74.05 -38.57 63.95 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.955 0.798 . . . . 0.0 111.505 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 mt -54.76 -55.74 26.78 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.018 0.827 . . . . 0.0 111.247 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -62.17 -24.79 67.4 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -41.03 75.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.152 0.981 . . . . 0.0 112.219 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.7 mt -73.71 -40.12 63.82 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.787 0.835 . . . . 0.0 111.099 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 70.0 mmm . . . . . 0 N--CA 1.47 0.559 0 C-N-CA 124.912 1.285 . . . . 0.0 112.737 178.516 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 36.1 t80 . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -82.56 112.5 19.52 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.386 1.075 . . . . 0.0 111.256 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 57.8 mt -85.68 153.55 22.27 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.708 0.803 . . . . 0.0 112.103 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -88.34 -29.88 19.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.342 1.457 . . . . 0.0 112.794 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -137.86 157.09 47.14 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.235 1.814 . . . . 0.0 111.65 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -79.2 128.15 76.81 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.999 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -84.95 6.28 5.8 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.0 3.134 . . . . 0.0 114.066 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 t -127.01 139.44 53.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.411 1.485 . . . . 0.0 111.565 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.3 -39.38 7.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.182 0.896 . . . . 0.0 112.713 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.1 52.11 1.25 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.523 1.529 . . . . 0.0 113.199 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.53 141.66 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.236 -0.915 . . . . 0.0 111.407 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -111.42 118.44 35.81 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.388 1.475 . . . . 0.0 107.992 167.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 . . . . . 0 CA--C 1.541 0.606 0 O-C-N 121.521 -0.737 . . . . 0.0 111.361 179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 . . . . . 0 CA--C 1.554 1.128 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.71 -11.0 30.14 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.326 2.684 . . . . 0.0 115.086 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 p -130.32 -19.24 3.14 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.65 118.14 32.26 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.996 0.918 . . . . 0.0 111.295 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -116.37 105.42 12.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.328 1.051 . . . . 0.0 109.221 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -67.04 130.99 44.91 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.48 -0.763 . . . . 0.0 110.438 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.27 157.27 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.085 1.354 . . . . 0.0 112.024 -169.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.7 m -130.89 115.79 17.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.693 1.197 . . . . 0.0 108.822 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -62.34 128.42 35.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.372 0.533 . . . . 0.0 109.934 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.42 155.92 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.89 0.876 . . . . 0.0 112.522 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.422 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -87.26 -168.68 2.32 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.436 1.094 . . . . 0.0 113.758 179.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.37 -31.43 71.32 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.289 1.435 . . . . 0.0 114.344 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -84.06 -8.98 58.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.773 0.829 . . . . 0.0 113.018 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.24 15.62 78.17 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.431 -1.205 . . . . 0.0 113.979 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.422 HG22 ' OD1' ' A' ' 27' ' ' ASP . 18.6 m -79.72 150.61 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.49 1.645 . . . . 0.0 111.247 174.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -91.53 123.43 34.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.802 1.241 . . . . 0.0 110.922 -169.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.4 mt -106.55 -53.47 2.62 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.514 0.726 . . . . 0.0 112.114 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.77 160.98 29.32 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 125.535 1.541 . . . . 0.0 113.073 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 m -125.41 147.08 49.32 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.624 0.769 . . . . 0.0 112.824 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.86 174.58 30.13 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.775 1.655 . . . . 0.0 113.858 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.0 t -113.01 120.22 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.2 tpp -86.08 138.78 31.69 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.614 1.166 . . . . 0.0 109.819 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.1 130.0 26.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.672 1.589 . . . . 0.0 108.799 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.27 127.43 53.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.311 1.844 . . . . 0.0 107.344 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.1 p -127.55 172.83 10.37 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.802 1.241 . . . . 0.0 110.664 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -72.85 -0.48 13.59 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 121.235 -0.916 . . . . 0.0 112.541 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.1 t -106.47 -46.64 3.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.061 1.344 . . . . 0.0 112.971 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -174.8 174.41 2.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.943 1.297 . . . . 0.0 113.297 -166.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.9 138.61 31.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.234 1.014 . . . . 0.0 109.391 167.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.35 127.81 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.133 0.973 . . . . 0.0 111.109 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.17 130.73 46.34 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.816 1.647 . . . . 0.0 109.809 168.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -107.63 118.7 37.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.517 1.927 . . . . 0.0 110.188 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 N--CA 1.476 0.871 0 C-N-CA 126.064 1.746 . . . . 0.0 110.929 -177.885 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.743 0 N-CA-C 111.877 0.325 . . . . 0.0 111.877 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 t -134.76 133.78 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.67 0.788 . . . . 0.0 111.293 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -125.63 143.32 51.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.96 1.304 . . . . 0.0 112.311 -172.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 -140.11 112.53 7.41 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.788 1.235 . . . . 0.0 111.153 174.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.76 145.73 76.17 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.64 2.227 . . . . 0.0 110.284 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -60.33 -25.58 65.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -65.55 -38.84 90.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.028 1.331 . . . . 0.0 111.728 174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.4 -5.31 58.57 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 99.3 mt -83.38 123.4 29.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.339 0.972 . . . . 0.0 109.861 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -83.94 -38.71 20.68 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.097 0.559 . . . . 0.0 112.123 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -161.97 156.18 21.99 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.462 1.505 . . . . 0.0 111.428 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -151.25 123.82 8.45 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.278 1.431 . . . . 0.0 109.538 -172.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.67 167.39 25.91 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 124.264 0.935 . . . . 0.0 113.795 -169.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -145.13 164.13 32.2 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.349 1.06 . . . . 0.0 113.342 -169.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -146.78 -166.99 2.64 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.223 2.209 . . . . 0.0 109.385 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 93.9 p -69.55 -19.06 63.7 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.277 -1.514 . . . . 0.0 114.71 -175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -150.32 9.5 0.65 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.286 1.434 . . . . 0.0 114.032 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -137.42 132.21 33.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.774 1.63 . . . . 0.0 110.075 -169.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -126.89 139.66 52.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.078 1.751 . . . . 0.0 109.404 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.1 t -153.15 156.46 38.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.31 1.044 . . . . 0.0 112.448 -175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -153.78 156.08 37.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.252 1.421 . . . . 0.0 111.901 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -116.86 137.65 52.06 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.743 1.617 . . . . 0.0 110.104 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -141.16 156.58 45.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.235 1.014 . . . . 0.0 112.011 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.6 175.39 37.24 Favored Glycine 0 N--CA 1.472 1.1 0 C-N-CA 125.458 1.504 . . . . 0.0 114.986 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -13.52 28.51 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -172.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.8 ptm85 -86.96 -15.82 37.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.58 1.552 . . . . 0.0 115.182 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.6 p -76.34 179.79 5.59 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.79 0.836 . . . . 0.0 112.81 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -59.01 -41.25 87.29 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.36 1.064 . . . . 0.0 113.052 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.3 p -92.09 -20.61 21.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.079 1.351 . . . . 0.0 113.758 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.59 -173.1 49.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.252 1.406 . . . . 0.0 112.43 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -67.7 127.65 33.56 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.55 0.74 . . . . 0.0 112.234 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.45 -177.39 38.62 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.124 0.869 . . . . 0.0 113.604 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -123.48 139.65 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.238 1.815 . . . . 0.0 109.128 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -134.63 126.96 30.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.127 1.371 . . . . 0.0 109.768 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.76 139.26 54.18 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.624 1.17 . . . . 0.0 112.442 -171.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -137.18 126.89 25.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.242 1.017 . . . . 0.0 111.549 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -74.25 134.46 42.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.644 0.777 . . . . 0.0 111.847 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.0 p -176.27 128.2 0.21 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.02 2.528 . . . . 0.0 110.331 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.4 m -68.36 -10.47 55.21 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.807 -1.183 . . . . 0.0 113.326 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -93.36 10.21 33.1 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.01 2.124 . . . . 0.0 112.883 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.9 -40.59 66.77 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.692 1.597 . . . . 0.0 114.658 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -70.95 -35.26 72.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.481 0.712 . . . . 0.0 112.68 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 -67.09 -37.58 84.2 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.199 -0.938 . . . . 0.0 111.314 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.6 mt -61.43 -46.34 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 118.751 0.705 . . . . 0.0 110.135 172.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.44 -43.16 97.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.382 1.073 . . . . 0.0 112.099 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -70.42 -32.32 69.88 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.245 1.018 . . . . 0.0 113.423 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -78.04 -37.33 47.07 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.126 0.875 . . . . 0.0 110.063 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.89 -52.02 65.54 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.434 -0.791 . . . . 0.0 112.567 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -60.24 -23.95 64.48 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.24 -17.51 52.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.991 1.317 . . . . 0.0 113.377 176.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.4 mt -102.41 -36.32 8.47 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.316 1.446 . . . . 0.0 111.929 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 62.7 mmm . . . . . 0 N--CA 1.471 0.623 0 C-N-CA 125.599 1.559 . . . . 0.0 112.741 178.06 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 37.3 t80 . . . . . 0 N--CA 1.471 0.602 0 CA-C-O 120.26 0.076 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -78.96 116.98 19.62 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.497 1.119 . . . . 0.0 110.957 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.8 mt -88.16 153.71 21.02 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.525 -0.734 . . . . 0.0 112.467 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -94.6 -2.11 52.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.815 1.646 . . . . 0.0 113.49 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -160.95 164.31 31.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.454 2.302 . . . . 0.0 110.737 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -94.78 119.01 66.68 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.227 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.39 -22.16 7.06 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.004 2.47 . . . . 0.0 113.489 -170.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.5 m -91.06 112.16 23.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.926 0.891 . . . . 0.0 111.047 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.18 -25.72 72.55 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.778 0.704 . . . . 0.0 112.881 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -91.97 119.17 31.46 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.675 1.19 . . . . 0.0 109.258 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.69 154.03 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.484 1.514 . . . . 0.0 110.749 -169.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -144.82 175.88 9.86 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.961 1.704 . . . . 0.0 112.25 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 . . . . . 0 CA--C 1.544 0.742 0 C-N-CA 125.637 1.575 . . . . 0.0 110.444 -169.021 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 . . . . . 0 CA--C 1.557 1.244 0 N-CA-C 112.431 0.53 . . . . 0.0 112.431 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.33 -11.02 26.37 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.899 2.399 . . . . 0.0 115.259 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.7 p -130.96 -16.95 3.17 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 120.373 1.442 . . . . 0.0 114.088 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -111.61 144.69 40.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.816 1.247 . . . . 0.0 110.579 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -140.83 119.17 12.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.159 0.983 . . . . 0.0 109.099 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -70.24 129.71 40.07 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.65 -0.656 . . . . 0.0 110.227 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 m -136.74 160.73 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.844 1.658 . . . . 0.0 110.889 -170.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -132.75 118.79 19.48 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.857 0.863 . . . . 0.0 109.193 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.26 128.68 36.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.038 0.935 . . . . 0.0 110.164 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -124.34 155.03 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.918 0.887 . . . . 0.0 113.382 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.411 ' CG ' HG22 ' A' ' 31' ' ' VAL . 3.5 p-10 -83.51 -170.85 3.26 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.49 -24.15 67.7 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -92.82 -6.22 49.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.142 1.777 . . . . 0.0 112.642 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.19 15.2 75.08 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.282 -1.288 . . . . 0.0 114.29 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.411 HG22 ' CG ' ' A' ' 27' ' ' ASP . 3.3 m -76.67 143.98 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.721 1.76 . . . . 0.0 110.849 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -88.24 119.45 28.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.078 1.351 . . . . 0.0 110.495 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.6 mt -104.93 -54.73 2.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.149 0.58 . . . . 0.0 112.025 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.26 142.61 10.41 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 124.834 1.207 . . . . 0.0 113.799 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.5 p -94.56 142.19 27.73 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.943 1.297 . . . . 0.0 112.354 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.75 171.28 29.1 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.736 1.636 . . . . 0.0 113.486 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.56 120.71 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.2 tpp -87.19 139.23 30.77 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.698 1.199 . . . . 0.0 109.67 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.07 128.82 24.76 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.7 1.6 . . . . 0.0 108.667 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mp -108.52 134.26 51.54 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.211 1.804 . . . . 0.0 108.138 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.3 p -134.26 170.76 15.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.117 1.367 . . . . 0.0 109.745 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.05 -5.93 30.14 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.233 -0.917 . . . . 0.0 113.076 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.5 t -107.48 -43.52 4.52 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.247 1.019 . . . . 0.0 113.34 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -169.88 169.04 8.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.41 1.084 . . . . 0.0 113.194 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.2 mt -86.74 142.4 28.18 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.535 1.134 . . . . 0.0 110.031 168.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.69 130.15 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.616 1.166 . . . . 0.0 110.847 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.1 mt -105.55 133.62 49.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.145 1.778 . . . . 0.0 110.565 168.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -115.8 117.84 31.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.872 2.069 . . . . 0.0 110.329 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.0 mp . . . . . 0 N--CA 1.475 0.792 0 C-N-CA 125.662 1.585 . . . . 0.0 110.57 -178.58 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.709 0 N-CA-C 111.413 0.153 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.58 136.33 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.917 0.887 . . . . 0.0 110.757 -172.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -134.44 148.96 50.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -140.76 112.58 6.97 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.426 1.491 . . . . 0.0 111.059 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.66 148.11 86.75 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.794 2.329 . . . . 0.0 110.347 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -61.95 -19.69 63.03 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.53 -44.83 95.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.635 1.574 . . . . 0.0 112.974 171.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.2 p -77.4 -15.18 59.5 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.94 115.14 10.8 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.783 0.833 . . . . 0.0 109.986 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -79.08 -32.67 44.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.447 1.099 . . . . 0.0 111.723 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -166.6 159.88 14.61 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.228 1.811 . . . . 0.0 111.528 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -150.07 126.35 10.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.167 1.387 . . . . 0.0 110.804 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.9 172.63 24.41 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.976 1.274 . . . . 0.0 113.45 -170.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -153.49 145.72 23.85 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.161 0.985 . . . . 0.0 112.161 -170.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -141.04 -177.5 5.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.469 1.908 . . . . 0.0 109.362 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -59.45 117.45 4.87 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.019 -1.051 . . . . 0.0 110.708 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.8 t30 60.54 12.85 3.8 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 127.111 2.165 . . . . 0.0 115.158 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -133.91 127.38 32.35 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.752 1.614 . . . . 0.0 111.922 -169.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -122.15 140.94 51.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.824 1.65 . . . . 0.0 109.972 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 t -153.55 155.34 35.99 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.047 -1.033 . . . . 0.0 112.886 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -147.97 153.58 39.2 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.245 1.418 . . . . 0.0 111.88 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -111.35 141.16 45.26 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.574 1.55 . . . . 0.0 109.439 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 p -138.91 150.56 46.08 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.786 0.834 . . . . 0.0 112.7 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.59 173.82 46.01 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.957 1.265 . . . . 0.0 113.715 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -63.66 -14.8 55.32 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -77.44 -16.84 58.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.128 1.771 . . . . 0.0 115.292 -176.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.2 p -79.29 -179.07 6.54 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.32 1.048 . . . . 0.0 113.498 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -62.02 -36.65 82.2 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.54 1.136 . . . . 0.0 113.296 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -94.94 -20.81 19.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.079 1.352 . . . . 0.0 114.338 -174.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.31 -179.07 49.38 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.886 1.232 . . . . 0.0 112.02 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -65.82 129.52 40.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.878 0.871 . . . . 0.0 111.823 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.09 -177.22 42.36 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 122.143 0.857 . . . . 0.0 113.508 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.2 mt -121.75 139.26 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.046 1.739 . . . . 0.0 108.698 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -133.85 128.06 33.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.971 1.308 . . . . 0.0 110.035 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.89 142.72 51.39 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.649 1.179 . . . . 0.0 112.725 -172.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -139.17 129.71 25.82 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.69 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -72.35 133.35 44.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.001 0.52 . . . . 0.0 110.754 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.0 t -168.46 124.34 0.98 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.185 1.794 . . . . 0.0 111.044 -171.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.8 m -70.97 -9.48 58.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -117.68 22.48 12.32 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.434 1.894 . . . . 0.0 112.405 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.67 -38.15 31.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.265 1.426 . . . . 0.0 114.299 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.56 -36.66 73.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.751 0.82 . . . . 0.0 112.926 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -65.07 -40.09 94.19 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.58 -0.7 . . . . 0.0 110.788 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.19 -47.89 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.941 0.497 . . . . 0.0 110.296 173.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.31 -44.64 92.54 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.555 1.142 . . . . 0.0 112.11 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -70.0 -33.63 72.29 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.854 0.862 . . . . 0.0 113.088 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -74.88 -41.67 59.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.951 0.796 . . . . 0.0 110.4 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.3 mt -52.12 -55.13 22.82 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.728 0.811 . . . . 0.0 112.869 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.59 -25.43 68.07 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.88 -29.42 68.52 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.505 1.048 . . . . 0.0 112.677 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.6 mt -96.09 -39.38 9.76 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.354 1.462 . . . . 0.0 110.999 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.3 mtp . . . . . 0 N--CA 1.466 0.332 0 C-N-CA 124.306 1.042 . . . . 0.0 113.3 -179.162 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 36.9 t80 . . . . . 0 N--CA 1.472 0.66 0 CA-C-O 120.557 0.218 . . . . 0.0 110.828 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -78.97 109.24 13.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.996 1.319 . . . . 0.0 111.005 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.53 153.4 24.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.536 0.735 . . . . 0.0 112.024 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -81.73 -28.22 33.47 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.89 1.276 . . . . 0.0 112.534 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -157.03 162.83 39.54 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.441 1.896 . . . . 0.0 111.359 -170.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -78.56 132.22 65.93 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 121.542 -0.724 . . . . 0.0 111.55 -173.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -83.62 -4.78 10.8 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.321 2.681 . . . . 0.0 114.358 -171.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 14.6 t -122.84 145.45 48.43 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.606 1.094 . . . . 0.0 113.44 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.08 -4.53 71.67 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.609 1.576 . . . . 0.0 114.532 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -119.39 123.23 43.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.791 1.636 . . . . 0.0 109.828 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -157.11 152.25 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.394 1.078 . . . . 0.0 110.882 -167.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -122.53 146.94 46.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.134 1.374 . . . . 0.0 110.307 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 126.157 1.783 . . . . 0.0 110.068 -178.17 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 . . . . . 0 CA--C 1.557 1.215 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.67 -10.44 26.58 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.246 2.63 . . . . 0.0 115.177 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.2 p -128.87 -21.1 3.4 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -115.51 134.66 54.86 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.024 0.929 . . . . 0.0 110.83 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.29 121.19 24.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.214 1.406 . . . . 0.0 107.97 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 140.91 44.15 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.28 -0.888 . . . . 0.0 110.447 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.3 m -145.18 163.24 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.295 1.038 . . . . 0.0 111.608 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.1 m -143.87 123.2 13.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.427 1.091 . . . . 0.0 108.774 170.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.46 132.86 51.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.16 0.984 . . . . 0.0 110.339 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.67 156.08 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.806 1.242 . . . . 0.0 113.018 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' A' ' 31' ' ' VAL . 2.3 p-10 -93.37 -165.53 1.35 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.644 1.578 . . . . 0.0 114.309 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.14 -35.1 72.91 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.035 1.334 . . . . 0.0 113.656 172.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.27 -13.04 58.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.039 0.836 . . . . 0.0 113.167 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.72 17.84 74.37 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 118.295 -1.28 . . . . 0.0 113.624 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.432 HG22 ' OD1' ' A' ' 27' ' ' ASP . 11.3 m -76.31 150.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.537 1.669 . . . . 0.0 111.145 173.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.1 123.99 32.76 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.276 1.031 . . . . 0.0 111.309 -171.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.7 mt -104.85 -50.06 3.36 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.551 1.14 . . . . 0.0 111.786 -172.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.91 132.38 3.44 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 124.684 1.135 . . . . 0.0 113.633 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p -85.44 149.45 25.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.938 1.295 . . . . 0.0 112.635 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.41 171.7 39.18 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.829 1.204 . . . . 0.0 114.391 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.9 t -113.25 120.34 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 39.1 tpp -86.02 132.03 34.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.762 0.825 . . . . 0.0 109.424 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -128.89 128.74 44.43 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.869 1.668 . . . . 0.0 108.272 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.52 125.43 50.99 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.024 1.73 . . . . 0.0 108.029 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -131.59 168.29 17.95 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.684 1.193 . . . . 0.0 110.072 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -65.17 -10.87 34.74 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.121 0.569 . . . . 0.0 112.344 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -95.91 -41.89 8.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.42 1.088 . . . . 0.0 113.114 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -177.68 171.16 1.91 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.131 1.372 . . . . 0.0 112.837 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -87.29 136.64 32.85 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.064 0.945 . . . . 0.0 109.012 167.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.54 130.95 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.886 0.874 . . . . 0.0 111.492 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 mt -100.34 130.04 46.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.502 1.121 . . . . 0.0 110.532 168.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -106.26 131.53 53.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.461 1.904 . . . . 0.0 110.961 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mp . . . . . 0 CA--C 1.537 0.474 0 C-N-CA 125.709 1.603 . . . . 0.0 110.73 -177.231 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 120.373 0.13 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 t -131.04 128.52 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.569 0.747 . . . . 0.0 110.79 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.29 147.18 48.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.442 1.497 . . . . 0.0 112.588 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -139.34 118.99 9.23 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.795 1.238 . . . . 0.0 111.437 173.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.89 146.25 64.9 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.503 2.135 . . . . 0.0 109.559 171.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -59.73 -26.41 65.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.1 mt -58.17 -27.76 64.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.281 1.833 . . . . 0.0 114.397 171.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.5 p -90.56 -9.71 46.13 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -94.6 84.96 4.38 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.873 1.269 . . . . 0.0 110.932 -172.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -73.44 -19.42 60.96 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.483 ' HG3' HG21 ' B' ' 12' ' ' VAL . 54.5 ttp180 -157.84 123.52 4.6 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.836 1.655 . . . . 0.0 110.051 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -140.87 109.66 6.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.987 1.715 . . . . 0.0 111.097 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.63 169.89 13.11 Favored Glycine 0 N--CA 1.462 0.411 0 C-N-CA 124.713 1.149 . . . . 0.0 113.731 -169.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -140.35 159.46 42.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.39 1.076 . . . . 0.0 112.738 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -154.45 174.98 14.15 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.508 2.323 . . . . 0.0 109.643 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 m -61.34 -12.56 14.36 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -172.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -154.63 18.29 0.46 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.151 1.38 . . . . 0.0 112.865 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.53 128.35 18.33 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.472 -1.393 . . . . 0.0 110.486 -169.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -118.98 133.2 55.98 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.124 1.77 . . . . 0.0 108.852 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 t -153.04 151.11 29.87 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.013 -1.054 . . . . 0.0 112.494 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -149.67 148.75 29.66 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.99 0.916 . . . . 0.0 112.388 -173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -104.8 135.09 46.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.293 1.437 . . . . 0.0 110.058 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -126.47 145.89 50.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.292 1.037 . . . . 0.0 112.188 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.1 168.23 46.57 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.41 1.005 . . . . 0.0 113.282 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -65.94 -11.35 46.79 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -70.14 -19.87 63.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.659 1.584 . . . . 0.0 114.967 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -85.87 -179.88 6.9 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -63.21 -39.28 94.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.488 1.115 . . . . 0.0 113.181 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.5 p -96.45 -22.61 17.02 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.972 1.309 . . . . 0.0 113.492 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.99 -162.04 29.67 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.566 2.031 . . . . 0.0 113.644 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -56.75 125.88 24.34 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.354 1.062 . . . . 0.0 111.524 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.78 171.98 27.47 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.453 1.025 . . . . 0.0 113.304 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.2 mt -115.04 131.45 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.531 1.532 . . . . 0.0 108.337 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.49 113.64 18.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.91 1.284 . . . . 0.0 109.669 -172.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.27 140.57 45.73 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.177 1.391 . . . . 0.0 112.298 -173.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -138.76 125.55 20.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.199 1.0 . . . . 0.0 111.405 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -63.75 126.79 28.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.822 0.849 . . . . 0.0 110.434 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.6 t -167.86 126.65 1.25 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.635 1.574 . . . . 0.0 111.462 -170.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -69.74 -44.21 70.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.185 0.594 . . . . 0.0 112.459 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.1 mtm-85 -90.45 31.28 1.04 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.566 1.546 . . . . 0.0 113.889 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.04 -37.32 61.47 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.666 1.187 . . . . 0.0 113.967 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -70.53 -36.85 73.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.598 0.759 . . . . 0.0 112.843 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -64.54 -42.11 95.93 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.719 -0.613 . . . . 0.0 110.249 173.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.97 -48.44 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.322 0.649 . . . . 0.0 110.626 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.52 -40.47 83.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.51 1.124 . . . . 0.0 112.304 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -73.75 -31.87 63.55 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -77.93 -39.04 44.11 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.064 0.847 . . . . 0.0 110.342 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.51 -53.0 19.78 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.223 1.409 . . . . 0.0 113.852 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -64.82 -22.54 67.01 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -74.05 -25.06 59.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.088 0.955 . . . . 0.0 112.547 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.2 mt -96.47 -32.67 12.19 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.138 1.375 . . . . 0.0 111.795 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.1 mtt . . . . . 0 N--CA 1.47 0.552 0 C-N-CA 123.566 0.746 . . . . 0.0 112.685 171.085 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 39.4 t80 . . . . . 0 CA--C 1.547 0.833 0 CA-C-O 120.417 0.151 . . . . 0.0 110.623 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.81 94.73 2.63 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.755 2.022 . . . . 0.0 110.514 172.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 15.8 mt -67.78 150.03 49.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.032 0.933 . . . . 0.0 112.521 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -84.92 -14.71 46.83 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -159.44 165.26 33.51 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.548 1.539 . . . . 0.0 111.708 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -87.0 123.33 70.44 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.091 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.48 -20.46 5.81 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.283 2.655 . . . . 0.0 114.009 -171.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 82.6 m -89.76 129.53 36.15 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.982 0.913 . . . . 0.0 111.937 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.25 -3.16 84.99 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.696 1.141 . . . . 0.0 114.795 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -141.49 136.82 31.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.326 1.451 . . . . 0.0 109.668 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.483 HG21 ' HG3' ' A' ' 64' ' ' ARG . 2.7 p -164.94 142.24 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.553 1.541 . . . . 0.0 111.36 -169.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -109.68 127.81 54.82 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.864 2.066 . . . . 0.0 109.243 172.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 . . . . . 0 CA--C 1.543 0.677 0 C-N-CA 123.692 0.797 . . . . 0.0 110.905 177.542 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 . . . . . 0 CA--C 1.56 1.342 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.72 -17.85 25.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.876 2.384 . . . . 0.0 115.253 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.1 p -127.51 -20.29 4.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.386 1.448 . . . . 0.0 114.688 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 149.63 28.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.11 0.868 . . . . 0.0 110.109 169.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.52 109.11 6.57 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -68.97 130.58 43.18 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.59 -0.694 . . . . 0.0 109.93 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.2 m -139.6 164.86 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.758 1.223 . . . . 0.0 112.219 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.4 m -139.62 121.03 15.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.785 1.234 . . . . 0.0 108.615 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -66.61 133.18 49.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.819 0.448 . . . . 0.0 110.127 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.39 155.63 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.085 0.954 . . . . 0.0 112.592 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -82.3 -166.95 1.39 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.452 1.501 . . . . 0.0 113.12 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -66.18 -33.71 76.38 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -81.6 -28.69 33.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.322 0.964 . . . . 0.0 112.173 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.22 16.88 7.5 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 125.202 1.382 . . . . 0.0 112.261 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 t -74.3 140.53 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.345 2.258 . . . . 0.0 108.948 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -88.36 123.77 33.26 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.529 1.532 . . . . 0.0 110.393 -171.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.9 mt -108.52 -53.25 2.66 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.896 0.878 . . . . 0.0 112.575 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.98 142.01 9.17 Favored Glycine 0 N--CA 1.47 0.953 0 C-N-CA 124.82 1.2 . . . . 0.0 113.602 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -87.89 148.03 24.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.633 1.173 . . . . 0.0 112.666 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.03 170.09 33.73 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.529 1.061 . . . . 0.0 114.045 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.3 t -116.85 120.41 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 38.4 tpp -88.16 139.56 30.38 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.942 1.297 . . . . 0.0 110.204 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.01 130.25 25.18 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.791 1.636 . . . . 0.0 109.185 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mp -106.46 138.54 42.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.67 1.988 . . . . 0.0 108.313 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -140.27 174.47 10.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.086 1.355 . . . . 0.0 111.049 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -76.73 9.57 2.74 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.259 -0.901 . . . . 0.0 112.535 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.6 t -118.19 -49.64 2.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.95 1.3 . . . . 0.0 112.954 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -173.3 171.3 4.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.072 1.349 . . . . 0.0 112.509 -168.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 mt -85.8 140.15 30.69 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.77 0.828 . . . . 0.0 109.528 168.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 36.0 t -134.61 127.88 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.884 0.874 . . . . 0.0 111.418 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.9 mt -100.38 132.92 45.49 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.169 1.388 . . . . 0.0 109.696 167.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -107.6 125.45 51.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.623 1.969 . . . . 0.0 110.315 171.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 mp . . . . . 0 N--CA 1.475 0.776 0 C-N-CA 126.346 1.858 . . . . 0.0 111.279 -177.6 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.545 0.785 0 N-CA-C 111.453 0.168 . . . . 0.0 111.453 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.5 t -129.24 127.15 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.459 0.704 . . . . 0.0 111.118 -175.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.9 mtm-85 -119.14 143.63 47.09 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.204 1.802 . . . . 0.0 112.153 -169.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -139.37 114.2 8.16 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.367 1.067 . . . . 0.0 111.936 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.72 143.65 68.56 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.98 2.453 . . . . 0.0 110.391 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -60.71 -21.79 63.29 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.03 -46.76 89.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.946 1.698 . . . . 0.0 111.728 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 p -78.2 -17.31 56.93 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.53 65.96 6.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.993 1.717 . . . . 0.0 111.111 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -70.89 -24.15 62.43 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -172.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.619 ' HG3' HG21 ' B' ' 12' ' ' VAL . 53.0 ttp180 -147.43 118.53 7.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.157 1.783 . . . . 0.0 108.492 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -140.54 110.77 6.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.322 1.849 . . . . 0.0 110.717 -173.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.88 168.19 15.16 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 124.644 1.116 . . . . 0.0 114.104 -168.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -138.63 163.14 32.85 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.578 1.151 . . . . 0.0 112.648 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -148.7 -169.95 3.49 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.06 2.144 . . . . 0.0 109.524 170.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.3 m -68.4 -14.86 63.3 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -156.49 11.75 0.26 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.49 1.516 . . . . 0.0 114.126 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -136.59 129.89 31.52 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.915 1.686 . . . . 0.0 110.06 -168.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -123.39 135.85 54.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.924 1.69 . . . . 0.0 109.249 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 t -153.02 155.68 37.37 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.219 1.008 . . . . 0.0 112.277 -174.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.34 154.69 32.43 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.269 1.028 . . . . 0.0 112.647 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HG3' ' HE ' ' A' ' 64' ' ' ARG . 5.7 mm-40 -91.77 152.22 20.25 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.334 1.854 . . . . 0.0 110.66 171.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 90.8 p -141.29 152.1 44.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.414 1.085 . . . . 0.0 112.108 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.33 162.2 18.02 Favored Glycine 0 N--CA 1.473 1.144 0 C-N-CA 125.035 1.302 . . . . 0.0 114.312 -171.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -56.38 -20.69 20.55 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -82.49 -15.5 52.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.9 p -85.15 -178.27 6.74 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -56.11 -49.9 72.59 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.944 1.298 . . . . 0.0 112.173 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.4 p -88.1 -23.19 23.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.945 1.298 . . . . 0.0 112.938 -174.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.22 -154.62 35.26 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.89 1.709 . . . . 0.0 112.174 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -59.58 130.46 46.97 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.358 1.063 . . . . 0.0 111.895 173.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.09 164.41 18.06 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.152 0.882 . . . . 0.0 113.564 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.4 mt -113.49 134.02 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.687 1.195 . . . . 0.0 108.512 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -130.25 125.74 35.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.947 1.299 . . . . 0.0 109.941 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.78 141.82 50.83 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.587 1.155 . . . . 0.0 112.734 -172.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -140.87 127.86 20.66 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.83 0.852 . . . . 0.0 111.874 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -65.59 133.53 51.37 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.398 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.1 t -161.48 132.53 5.29 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.271 1.428 . . . . 0.0 111.587 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 m -68.64 -15.6 63.57 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -133.69 35.85 3.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.044 1.738 . . . . 0.0 112.967 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.57 -40.36 71.87 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -70.07 -39.49 75.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.782 0.719 . . . . 0.0 112.013 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -61.71 -39.72 92.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.286 1.034 . . . . 0.0 110.927 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.4 mt -62.19 -47.99 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 118.95 0.795 . . . . 0.0 110.631 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -58.04 -37.06 73.65 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.195 0.998 . . . . 0.0 112.426 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -79.62 -28.63 40.96 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 113.702 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt -80.47 -41.28 24.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.436 1.017 . . . . 0.0 110.184 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.1 mt -49.32 -56.47 9.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.62 1.168 . . . . 0.0 112.723 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -61.48 -21.68 64.4 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.88 -27.08 61.69 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.166 0.894 . . . . 0.0 112.589 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.4 mt -97.28 -41.83 8.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.772 1.629 . . . . 0.0 110.968 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.4 mtp . . . . . 0 N--CA 1.468 0.467 0 C-N-CA 124.938 1.295 . . . . 0.0 113.294 -178.814 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 21.3 t80 . . . . . 0 CA--C 1.536 0.413 0 CA-C-O 120.486 0.184 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -77.92 113.92 16.29 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.605 1.162 . . . . 0.0 110.728 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 59.4 mt -82.37 153.36 25.79 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.731 0.777 . . . . 0.0 112.714 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -78.69 -26.12 44.85 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.939 1.696 . . . . 0.0 112.831 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -159.44 166.88 30.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.351 1.86 . . . . 0.0 111.725 -169.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -88.49 124.13 66.67 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.52 -0.753 . . . . 0.0 111.924 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -87.02 -22.48 1.79 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.209 2.606 . . . . 0.0 114.336 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 92.9 m -83.9 130.0 34.92 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.996 0.816 . . . . 0.0 112.281 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.17 -1.01 88.63 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.68 1.133 . . . . 0.0 115.142 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -143.32 142.15 31.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.851 1.26 . . . . 0.0 110.243 170.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.619 HG21 ' HG3' ' A' ' 64' ' ' ARG . 3.0 p -166.38 146.82 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.222 1.409 . . . . 0.0 111.639 -168.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -118.54 142.43 47.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.396 2.278 . . . . 0.0 109.814 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 . . . . . 0 CA--C 1.544 0.721 0 C-N-CA 124.924 1.289 . . . . 0.0 109.676 177.102 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 . . . . . 0 CA--C 1.552 1.039 0 CA-C-O 118.741 -0.647 . . . . 0.0 112.41 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.41 -11.03 30.78 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.079 2.519 . . . . 0.0 114.921 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.1 p -132.73 -22.76 2.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.27 97.63 7.19 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.542 1.065 . . . . 0.0 111.295 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -96.94 126.78 42.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.219 1.408 . . . . 0.0 109.751 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -81.55 136.03 35.59 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.099 -1.001 . . . . 0.0 110.273 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.22 168.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.737 1.215 . . . . 0.0 112.329 -168.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.6 m -141.8 121.99 13.86 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.569 1.147 . . . . 0.0 109.49 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.92 130.72 44.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.211 1.004 . . . . 0.0 110.755 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.21 159.48 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.01 -171.03 2.99 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -58.41 -21.99 52.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.825 1.65 . . . . 0.0 114.705 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -103.93 -4.66 23.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.92 1.288 . . . . 0.0 112.606 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.51 17.28 66.62 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.057 -1.413 . . . . 0.0 114.38 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.95 144.76 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.081 1.94 . . . . 0.0 109.999 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -91.42 120.89 32.66 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.38 1.072 . . . . 0.0 110.27 -175.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.7 mt -107.94 -53.36 2.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.032 0.933 . . . . 0.0 112.027 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.14 132.03 3.93 Favored Glycine 0 N--CA 1.472 1.043 0 C-N-CA 124.726 1.155 . . . . 0.0 113.576 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.0 m -86.81 154.65 20.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.677 0.791 . . . . 0.0 112.659 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.13 171.34 33.93 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.099 1.333 . . . . 0.0 114.021 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -115.57 120.95 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 169.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.9 ttm -94.3 116.57 28.97 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.195 1.398 . . . . 0.0 109.754 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -109.18 128.5 55.08 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.832 1.653 . . . . 0.0 108.838 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.06 137.36 42.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.552 1.541 . . . . 0.0 108.278 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.6 p -135.41 173.2 11.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.006 1.322 . . . . 0.0 110.755 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -72.2 -0.25 11.56 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.558 -0.714 . . . . 0.0 112.608 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -115.37 -40.66 3.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -172.88 166.16 5.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.977 1.311 . . . . 0.0 112.963 -168.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mt -86.76 138.39 31.65 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.123 1.369 . . . . 0.0 109.272 168.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 t -134.75 131.77 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.664 0.785 . . . . 0.0 111.395 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.3 mt -104.75 130.66 52.78 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.221 1.408 . . . . 0.0 110.39 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -109.06 126.87 53.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.98 2.112 . . . . 0.0 110.245 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pt? . . . . . 0 CA--C 1.54 0.566 0 C-N-CA 126.006 1.723 . . . . 0.0 112.136 -172.776 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 N-CA-C 111.546 0.202 . . . . 0.0 111.546 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 t -122.5 125.73 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.239 0.616 . . . . 0.0 111.172 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -115.81 143.79 44.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.86 1.664 . . . . 0.0 111.485 -173.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 -138.73 117.23 9.24 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.461 1.105 . . . . 0.0 111.167 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.25 144.53 68.86 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.237 1.958 . . . . 0.0 109.264 170.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -60.69 -27.29 67.75 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.02 -43.75 91.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.902 1.681 . . . . 0.0 111.588 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 79.1 m -78.86 1.58 22.97 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.26 117.29 25.92 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.844 1.202 . . . . 0.0 109.728 172.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -73.33 -35.66 66.07 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -166.13 162.75 17.88 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.721 2.008 . . . . 0.0 110.647 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -149.67 108.13 3.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.235 1.014 . . . . 0.0 110.418 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.31 161.88 12.66 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 124.875 1.226 . . . . 0.0 113.369 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -139.58 163.69 31.88 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.689 1.196 . . . . 0.0 112.61 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -153.63 -169.58 3.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.798 2.039 . . . . 0.0 109.566 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 t -64.82 -24.2 67.47 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.841 -1.162 . . . . 0.0 114.091 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -155.84 19.19 0.38 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.23 1.412 . . . . 0.0 112.996 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -142.67 128.33 19.19 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.999 1.319 . . . . 0.0 110.43 -169.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -120.84 140.98 51.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.081 1.752 . . . . 0.0 109.599 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -153.39 157.72 40.4 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.177 -0.952 . . . . 0.0 113.123 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -154.57 153.26 31.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.877 1.671 . . . . 0.0 111.136 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -108.13 133.09 52.89 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.798 0.839 . . . . 0.0 110.126 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 m -107.45 141.73 38.41 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.127 0.971 . . . . 0.0 112.588 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.79 157.12 53.53 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.832 1.206 . . . . 0.0 112.646 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -65.84 -15.79 63.23 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -168.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -91.49 -10.79 39.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.125 1.77 . . . . 0.0 115.367 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.4 p -75.86 -177.52 3.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -55.89 -40.23 72.71 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.504 1.122 . . . . 0.0 112.941 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.4 p -93.54 -23.4 18.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.943 1.297 . . . . 0.0 113.556 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.47 -161.85 41.2 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.056 1.312 . . . . 0.0 111.544 -171.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -66.12 128.46 36.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.811 0.844 . . . . 0.0 111.375 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.62 161.38 18.59 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 123.154 0.407 . . . . 0.0 114.036 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 88.1 mt -104.89 131.28 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.002 1.321 . . . . 0.0 108.514 169.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -127.76 125.23 39.52 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.819 1.248 . . . . 0.0 109.491 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.35 143.45 50.58 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.146 0.978 . . . . 0.0 112.663 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.93 124.3 19.28 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.901 -168.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -64.62 131.2 46.32 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.234 0.614 . . . . 0.0 110.706 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 37.3 t -169.98 122.88 0.71 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.111 1.764 . . . . 0.0 110.462 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -68.64 -14.42 63.0 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.62 -0.675 . . . . 0.0 112.812 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 mtt85 -108.56 22.76 15.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.442 1.897 . . . . 0.0 113.519 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.93 -37.81 21.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.583 1.153 . . . . 0.0 113.654 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.85 -40.45 79.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.451 1.101 . . . . 0.0 113.144 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.3 -34.65 77.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.466 -0.771 . . . . 0.0 111.384 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.44 -49.55 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.163 0.585 . . . . 0.0 110.291 170.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -37.31 82.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.559 0.744 . . . . 0.0 112.35 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -71.1 -29.39 65.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.758 0.823 . . . . 0.0 113.178 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.7 tp -86.77 -36.54 18.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.49 1.041 . . . . 0.0 112.419 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.1 mt -52.59 -55.9 19.07 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.971 0.908 . . . . 0.0 112.068 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -57.86 -21.01 40.62 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.53 -25.33 25.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.627 1.171 . . . . 0.0 113.42 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.5 mt -95.98 -33.53 12.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.797 1.239 . . . . 0.0 111.728 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 97.0 mtp . . . . . 0 N--CA 1.47 0.57 0 C-N-CA 125.857 1.663 . . . . 0.0 113.734 174.292 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.8 t80 . . . . . 0 N--CA 1.469 0.487 0 N-CA-C 110.005 -0.368 . . . . 0.0 110.005 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -85.54 121.29 28.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.304 1.042 . . . . 0.0 110.844 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 80.4 mt -83.83 164.1 19.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.629 0.728 . . . . 0.0 112.718 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -106.59 2.21 25.87 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.812 1.645 . . . . 0.0 113.835 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -160.33 164.93 32.13 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.509 2.324 . . . . 0.0 110.472 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -90.94 118.31 68.5 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.307 174.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.87 -24.47 3.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.314 2.676 . . . . 0.0 114.772 -168.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 81.7 m -80.19 127.84 32.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.028 0.831 . . . . 0.0 111.873 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.58 -7.07 88.77 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.522 1.058 . . . . 0.0 114.449 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.42 131.01 31.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.337 1.855 . . . . 0.0 109.814 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 p -164.62 147.27 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.176 1.39 . . . . 0.0 111.112 -169.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -132.05 170.42 14.97 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.612 2.365 . . . . 0.0 111.874 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 . . . . . 0 CA--C 1.541 0.615 0 C-N-CA 125.359 1.464 . . . . 0.0 110.96 -169.372 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.15 -11.54 31.9 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.279 2.653 . . . . 0.0 115.253 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.0 p -131.42 -16.51 3.06 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.92 99.01 7.15 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.479 1.036 . . . . 0.0 111.29 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -97.47 116.38 29.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.777 1.231 . . . . 0.0 109.054 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -76.58 133.44 39.67 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.976 -1.078 . . . . 0.0 110.344 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.25 167.19 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.115 0.966 . . . . 0.0 112.485 -168.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.9 m -146.09 125.47 13.12 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.007 1.323 . . . . 0.0 108.797 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -66.37 132.6 48.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.515 0.726 . . . . 0.0 110.096 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.1 156.79 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.699 1.2 . . . . 0.0 112.809 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.435 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.4 p-10 -89.36 -166.49 1.61 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.965 1.306 . . . . 0.0 113.988 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.93 -35.14 74.3 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.415 1.486 . . . . 0.0 114.319 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -80.38 -12.98 59.52 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.285 0.948 . . . . 0.0 113.063 176.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.67 17.52 72.85 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.345 -1.253 . . . . 0.0 113.554 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.435 HG22 ' OD1' ' A' ' 27' ' ' ASP . 14.8 m -75.41 149.3 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.668 1.734 . . . . 0.0 110.936 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -90.58 124.91 35.41 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.358 1.063 . . . . 0.0 111.321 -170.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.2 mt -107.42 -49.82 3.18 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.23 1.012 . . . . 0.0 111.991 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.69 135.37 4.44 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.782 1.182 . . . . 0.0 113.602 176.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 p -84.06 154.66 23.09 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.769 1.228 . . . . 0.0 112.984 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.07 171.07 38.75 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.858 1.218 . . . . 0.0 113.88 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.51 120.9 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 41.5 tpp -90.9 137.36 32.42 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.685 1.194 . . . . 0.0 110.283 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -138.95 130.14 26.8 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.216 1.406 . . . . 0.0 109.251 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.61 134.78 49.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.338 1.855 . . . . 0.0 107.656 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.4 p -132.07 173.4 11.26 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.078 0.951 . . . . 0.0 111.01 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -66.2 0.23 2.14 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.678 0.791 . . . . 0.0 112.685 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -116.32 -43.25 2.96 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -172.98 177.07 2.87 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -169.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.13 138.28 31.56 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.387 1.075 . . . . 0.0 110.132 167.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.65 128.69 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.308 1.043 . . . . 0.0 111.184 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.2 mt -102.12 135.12 44.25 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.504 1.522 . . . . 0.0 110.378 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -110.21 124.86 52.36 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.39 1.876 . . . . 0.0 111.068 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 CA--C 1.545 0.786 0 C-N-CA 127.202 2.201 . . . . 0.0 111.164 -179.637 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.641 0 CA-C-O 120.411 0.148 . . . . 0.0 111.054 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -123.14 126.59 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.272 0.629 . . . . 0.0 110.546 -173.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -120.76 138.43 54.01 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.569 1.548 . . . . 0.0 111.524 -169.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -139.1 114.08 8.33 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.389 1.076 . . . . 0.0 111.093 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.55 150.13 74.83 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 0.0 110.307 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -60.95 -20.67 62.59 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -65.27 -34.67 78.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.142 1.777 . . . . 0.0 113.268 170.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 89.1 m -92.63 -5.05 52.32 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.18 105.63 13.43 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.837 0.855 . . . . 0.0 109.253 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -79.76 -20.93 45.12 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.484 ' HG3' HG21 ' B' ' 12' ' ' VAL . 30.9 ttt180 -170.1 133.42 1.15 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.698 1.999 . . . . 0.0 108.753 -172.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -142.27 119.09 11.17 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.325 1.45 . . . . 0.0 110.26 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.55 164.87 22.91 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 124.077 0.846 . . . . 0.0 112.992 -169.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -130.45 155.32 46.63 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.343 1.057 . . . . 0.0 111.492 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.99 -174.11 4.76 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.878 1.671 . . . . 0.0 110.349 173.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.7 p -59.54 111.58 1.46 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.256 -0.902 . . . . 0.0 111.57 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.257 0.7 OUTLIER 51.52 23.15 1.74 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.391 2.276 . . . . 0.0 116.158 -174.25 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.33 126.39 29.6 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.424 1.49 . . . . 0.0 110.871 -172.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -120.18 135.16 55.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.748 1.619 . . . . 0.0 109.622 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -153.29 155.01 35.72 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.312 -0.867 . . . . 0.0 112.159 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -154.61 152.73 30.35 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.532 1.133 . . . . 0.0 112.268 -174.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -115.45 133.84 55.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.337 1.855 . . . . 0.0 110.493 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.6 m -133.26 154.38 50.73 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.354 1.062 . . . . 0.0 112.476 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.89 166.57 34.04 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.888 1.233 . . . . 0.0 113.588 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -6.37 16.71 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -174.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -82.69 -19.53 37.9 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.7 p -81.63 -179.46 7.39 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -55.13 -42.97 73.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.095 1.358 . . . . 0.0 113.003 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.4 p -93.15 -22.25 19.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.348 1.459 . . . . 0.0 113.637 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.1 -163.38 43.32 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.298 1.428 . . . . 0.0 112.539 -173.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -70.76 137.59 49.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.091 0.956 . . . . 0.0 112.793 -174.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.53 171.9 24.08 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.614 1.102 . . . . 0.0 113.355 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.63 123.11 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.091 1.356 . . . . 0.0 108.579 170.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -114.17 119.33 36.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.998 1.319 . . . . 0.0 109.393 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.61 139.15 53.39 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.394 1.078 . . . . 0.0 112.914 -169.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -140.29 131.22 26.07 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.887 0.851 . . . . 0.0 112.287 -169.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -69.39 135.32 50.14 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.813 168.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.7 t -159.03 142.75 15.05 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.131 1.372 . . . . 0.0 111.431 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.3 m -77.35 -27.48 52.68 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -127.66 40.24 3.73 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.692 1.197 . . . . 0.0 113.348 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.93 -40.88 15.09 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.52 -35.24 78.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.452 0.701 . . . . 0.0 112.8 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.93 -30.48 66.81 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.419 -0.8 . . . . 0.0 112.153 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.49 -47.28 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.688 0.676 . . . . 0.0 109.608 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -58.6 -42.61 88.51 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.177 0.991 . . . . 0.0 111.919 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -67.78 -42.44 81.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.687 1.195 . . . . 0.0 112.418 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.9 tp -75.21 -32.51 61.2 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.847 0.749 . . . . 0.0 112.177 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.2 mt -53.92 -54.36 39.92 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.698 0.799 . . . . 0.0 112.221 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -63.75 -30.97 72.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -34.19 77.38 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.221 1.008 . . . . 0.0 112.83 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.03 -35.57 21.82 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.341 1.056 . . . . 0.0 111.37 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 48.7 mtt . . . . . 0 N--CA 1.471 0.595 0 C-N-CA 123.593 0.757 . . . . 0.0 112.513 172.918 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 19.4 t80 . . . . . 0 CA--C 1.537 0.472 0 CA-C-O 119.678 -0.201 . . . . 0.0 111.447 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.81 116.76 32.5 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.779 1.232 . . . . 0.0 109.721 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 98.3 mt -78.52 157.77 28.76 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -87.22 -7.97 57.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.798 1.639 . . . . 0.0 113.919 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -161.38 163.08 30.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.959 2.104 . . . . 0.0 110.499 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -86.95 122.84 71.09 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.769 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.67 -12.24 11.21 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.387 2.725 . . . . 0.0 113.75 -171.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 84.5 m -99.82 121.7 41.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.367 1.067 . . . . 0.0 111.531 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.45 -14.6 82.32 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.385 0.993 . . . . 0.0 114.576 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -127.16 138.45 53.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.478 1.511 . . . . 0.0 110.876 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 64' ' ' ARG . 2.0 p -163.97 142.45 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.888 1.675 . . . . 0.0 110.868 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -115.76 114.22 24.5 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.321 2.249 . . . . 0.0 107.921 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 . . . . . 0 CA--C 1.543 0.687 0 O-C-N 121.634 -0.666 . . . . 0.0 110.449 178.848 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 . . . . . 0 CA--C 1.558 1.265 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.34 -11.23 26.53 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.244 2.63 . . . . 0.0 115.287 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.2 p -127.5 -25.05 3.23 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.752 1.16 . . . . 0.0 114.0 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -104.79 134.47 47.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.066 0.946 . . . . 0.0 111.103 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -131.2 105.25 7.54 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.155 1.382 . . . . 0.0 108.478 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -65.82 127.56 32.48 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.638 0.775 . . . . 0.0 110.488 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.4 m -137.35 163.64 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.347 1.459 . . . . 0.0 111.352 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.1 m -134.25 119.44 18.76 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.307 1.043 . . . . 0.0 109.013 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.82 128.0 34.12 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.108 0.963 . . . . 0.0 109.961 175.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.99 154.88 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.547 0.739 . . . . 0.0 112.906 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -89.87 -166.94 1.71 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.649 1.18 . . . . 0.0 113.952 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.5 -29.57 70.83 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -83.33 -8.96 59.34 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.001 1.32 . . . . 0.0 112.562 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.15 16.51 80.57 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.182 -1.344 . . . . 0.0 113.729 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.1 m -81.28 150.45 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.568 1.684 . . . . 0.0 111.63 176.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.12 121.94 31.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.641 1.176 . . . . 0.0 111.151 -170.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.7 mt -102.8 -53.58 2.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.37 0.668 . . . . 0.0 111.843 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.76 149.05 20.72 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.795 1.188 . . . . 0.0 114.356 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.4 p -88.29 153.01 21.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.208 1.403 . . . . 0.0 113.152 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.46 171.39 35.26 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.243 1.401 . . . . 0.0 113.628 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.45 120.22 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.0 tpp -85.27 140.15 31.07 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.482 1.113 . . . . 0.0 109.259 170.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -133.32 129.96 38.22 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.119 1.368 . . . . 0.0 108.546 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.88 131.2 55.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.821 2.048 . . . . 0.0 108.471 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 p -133.83 173.36 11.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.847 1.259 . . . . 0.0 110.877 178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -71.91 5.4 2.65 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.079 -1.013 . . . . 0.0 112.776 170.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.8 m -114.73 -45.85 2.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.773 1.229 . . . . 0.0 113.619 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -172.21 169.92 5.31 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.754 1.161 . . . . 0.0 113.449 -169.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.9 mt -87.44 139.96 30.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.356 1.063 . . . . 0.0 109.952 168.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.4 127.6 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.041 0.936 . . . . 0.0 111.496 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 mt -100.06 128.65 46.11 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.233 1.413 . . . . 0.0 110.374 168.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -108.24 129.48 55.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.305 2.242 . . . . 0.0 109.654 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.704 0 N-CA-C 112.52 0.563 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.04 135.04 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.922 1.289 . . . . 0.0 108.119 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -131.63 149.78 52.38 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -166.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -141.82 116.44 6.85 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 124.549 1.14 . . . . 0.0 111.997 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.41 145.1 58.06 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.55 2.167 . . . . 0.0 109.565 170.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -61.6 -21.95 64.8 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.56 -47.64 85.28 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.705 2.002 . . . . 0.0 111.692 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.4 m -80.12 -16.56 54.69 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.13 119.63 11.19 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.939 0.791 . . . . 0.0 110.382 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -82.82 -32.08 27.78 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.356 1.063 . . . . 0.0 112.065 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -168.28 160.68 11.68 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.179 2.192 . . . . 0.0 110.725 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -149.45 116.96 6.14 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.831 1.252 . . . . 0.0 109.667 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.83 165.7 21.56 Favored Glycine 0 N--CA 1.463 0.466 0 C-N-CA 124.836 1.208 . . . . 0.0 113.358 -169.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -141.59 176.74 8.65 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.456 1.102 . . . . 0.0 113.136 -170.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -163.6 -168.01 1.55 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.677 2.391 . . . . 0.0 108.756 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 t -72.21 -19.66 61.69 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.691 -1.256 . . . . 0.0 113.198 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -152.22 8.19 0.47 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.619 1.167 . . . . 0.0 113.893 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -137.11 129.77 30.23 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.425 1.49 . . . . 0.0 110.242 -169.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -124.51 138.01 54.37 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.194 1.797 . . . . 0.0 109.208 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -153.33 152.84 31.56 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.094 -1.004 . . . . 0.0 112.326 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -150.84 153.58 35.65 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.262 1.025 . . . . 0.0 112.312 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -110.8 142.56 42.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.026 1.331 . . . . 0.0 109.379 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 t -129.32 150.55 50.64 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.476 0.71 . . . . 0.0 112.643 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.98 158.57 53.12 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.028 1.299 . . . . 0.0 113.619 -175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -60.99 -20.93 63.04 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -170.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -80.12 -14.38 58.54 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.778 1.769 . . . . 0.0 115.778 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.87 -179.4 5.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -56.46 -47.18 79.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.495 1.518 . . . . 0.0 113.102 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.9 p -81.78 -26.13 34.7 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.52 -163.46 38.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.691 1.138 . . . . 0.0 111.79 -172.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -66.3 128.43 36.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.339 1.056 . . . . 0.0 111.342 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.37 164.2 22.6 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-O 121.557 0.532 . . . . 0.0 114.08 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.6 mt -114.89 136.07 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.493 1.517 . . . . 0.0 108.572 171.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -132.07 127.03 35.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.662 1.185 . . . . 0.0 110.614 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.29 140.88 52.57 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.3 1.44 . . . . 0.0 113.187 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -140.77 128.48 21.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.464 1.106 . . . . 0.0 111.988 -169.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -74.82 135.86 41.62 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.621 0.768 . . . . 0.0 111.738 171.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.5 p -172.33 140.06 1.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.063 2.145 . . . . 0.0 111.473 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.7 m -68.88 -20.28 64.25 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.344 -0.847 . . . . 0.0 113.272 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -100.63 17.88 20.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.989 1.716 . . . . 0.0 112.738 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.18 -39.92 31.21 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.839 1.255 . . . . 0.0 113.779 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -68.25 -37.71 81.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.302 1.041 . . . . 0.0 113.211 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.73 -34.05 76.08 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.149 -0.97 . . . . 0.0 111.911 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.95 -46.07 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.983 -0.448 . . . . 0.0 110.075 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.71 -43.15 94.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.33 1.052 . . . . 0.0 112.023 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -66.48 -37.45 85.13 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.845 1.258 . . . . 0.0 112.556 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.1 tp -80.63 -32.61 36.23 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.914 0.779 . . . . 0.0 112.43 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.6 mt -56.25 -50.42 71.39 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.65 0.659 . . . . 0.0 112.55 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -65.95 -18.79 65.57 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.69 -43.71 16.55 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.425 1.09 . . . . 0.0 110.977 173.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.0 mt -71.55 -28.18 63.68 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.845 -1.159 . . . . 0.0 111.959 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 33.6 mtt . . . . . 0 CA--C 1.543 0.682 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 167.942 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 39.8 t80 . . . . . 0 N--CA 1.472 0.659 0 N-CA-C 110.428 -0.212 . . . . 0.0 110.428 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.15 109.09 18.64 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.989 0.916 . . . . 0.0 109.909 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 40.0 mt -77.46 154.78 32.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.748 0.819 . . . . 0.0 112.819 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -87.13 -19.02 29.1 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.576 1.55 . . . . 0.0 112.792 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -149.8 167.76 25.61 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.332 1.853 . . . . 0.0 111.751 -175.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -93.22 123.56 60.4 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.627 -0.702 . . . . 0.0 111.389 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.92 -18.03 6.64 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.197 2.598 . . . . 0.0 114.129 -171.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 84.0 m -101.15 115.35 30.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.154 0.982 . . . . 0.0 111.284 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.49 -41.1 45.71 Favored Glycine 0 N--CA 1.476 1.343 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -77.73 113.92 16.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.543 1.537 . . . . 0.0 110.055 169.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.36 151.03 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.737 2.015 . . . . 0.0 110.234 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -131.96 160.35 36.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.72 1.608 . . . . 0.0 111.484 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 . . . . . 0 CA--C 1.537 0.477 0 C-N-CA 124.989 1.316 . . . . 0.0 111.207 -169.165 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 . . . . . 0 CA--C 1.558 1.269 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.1 -14.71 32.02 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.051 2.501 . . . . 0.0 115.421 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.3 p -131.04 -18.74 2.93 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 120.229 1.377 . . . . 0.0 114.516 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -104.68 142.02 35.42 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.192 0.997 . . . . 0.0 110.447 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -141.73 108.32 5.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 145.35 52.0 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.254 -0.904 . . . . 0.0 110.51 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.36 156.7 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.609 0.763 . . . . 0.0 111.5 -172.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -132.95 115.15 14.85 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -65.24 133.52 51.66 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.86 154.46 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.076 0.95 . . . . 0.0 112.431 -176.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.4 p-10 -88.01 -167.5 1.9 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.342 1.057 . . . . 0.0 113.599 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.89 -32.35 73.85 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.751 1.221 . . . . 0.0 114.234 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -79.53 -9.08 59.55 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.959 0.799 . . . . 0.0 112.533 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.92 14.5 81.93 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 117.931 -1.483 . . . . 0.0 113.923 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.438 HG22 ' OD1' ' A' ' 27' ' ' ASP . 15.1 m -76.24 150.11 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.85 1.825 . . . . 0.0 111.338 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.28 125.31 34.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.53 1.132 . . . . 0.0 111.183 -171.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.7 mt -107.4 -52.35 2.78 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.994 0.918 . . . . 0.0 112.107 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.17 147.14 14.96 Favored Glycine 0 N--CA 1.47 0.924 0 C-N-CA 124.591 1.091 . . . . 0.0 113.737 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 p -91.12 150.05 21.55 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.943 1.297 . . . . 0.0 113.104 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.05 168.13 32.38 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.947 1.737 . . . . 0.0 113.006 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.76 120.63 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.8 ttm -93.9 140.95 29.07 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.938 1.295 . . . . 0.0 110.619 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -140.06 130.26 25.12 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.592 1.557 . . . . 0.0 108.935 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -107.91 137.77 45.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.166 1.787 . . . . 0.0 108.016 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.9 p -137.53 174.71 10.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.779 1.232 . . . . 0.0 110.649 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -73.59 3.21 6.55 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.408 -0.807 . . . . 0.0 112.616 171.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.6 m -120.77 -45.04 2.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.532 1.133 . . . . 0.0 113.663 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.96 166.17 11.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.194 1.398 . . . . 0.0 113.706 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.13 136.97 34.26 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.855 1.262 . . . . 0.0 109.34 168.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.6 t -134.4 132.56 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.523 0.729 . . . . 0.0 110.98 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.2 mt -109.65 130.35 55.52 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.151 1.78 . . . . 0.0 110.777 169.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -100.15 125.32 46.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.531 1.933 . . . . 0.0 110.285 169.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.478 0.934 0 C-N-CA 126.921 2.088 . . . . 0.0 111.087 -173.429 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.541 0.612 0 N-CA-C 110.512 -0.181 . . . . 0.0 110.512 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.3 134.53 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.293 0.637 . . . . 0.0 110.464 -174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.44 144.37 48.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.585 1.154 . . . . 0.0 112.022 -169.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -144.29 122.05 6.69 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.877 1.271 . . . . 0.0 111.571 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.26 141.48 39.37 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.042 2.494 . . . . 0.0 110.303 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -58.8 -26.02 63.7 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.43 -41.78 69.78 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.451 1.9 . . . . 0.0 112.852 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.9 p -87.97 -10.69 49.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.9 mt -89.94 69.07 7.43 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.491 1.516 . . . . 0.0 110.775 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -67.67 -23.86 65.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.852 0.861 . . . . 0.0 113.269 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -141.54 119.65 12.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.513 1.525 . . . . 0.0 110.278 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -142.0 109.31 5.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.104 1.762 . . . . 0.0 110.591 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.56 170.26 14.0 Favored Glycine 0 N--CA 1.465 0.601 0 C-N-CA 124.733 1.159 . . . . 0.0 113.612 -169.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -141.61 158.68 43.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.054 0.942 . . . . 0.0 111.67 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.24 -173.89 4.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.136 1.774 . . . . 0.0 109.964 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.4 p -58.16 109.73 0.81 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.944 0.878 . . . . 0.0 111.771 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.261 0.8 OUTLIER 49.36 27.73 2.06 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 127.292 2.237 . . . . 0.0 115.836 -173.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -134.99 130.02 35.08 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.736 1.614 . . . . 0.0 110.564 -172.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -124.45 137.75 54.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.685 1.594 . . . . 0.0 109.852 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 t -153.44 156.7 38.68 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.259 1.024 . . . . 0.0 113.021 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.77 156.69 39.58 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.051 1.34 . . . . 0.0 112.082 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -121.87 137.86 54.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.374 1.87 . . . . 0.0 109.705 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.0 p -145.31 150.5 36.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.201 1.0 . . . . 0.0 112.887 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.84 166.9 49.36 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.863 1.221 . . . . 0.0 114.031 -175.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -63.52 -12.35 31.51 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -171.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -20.17 60.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.335 1.454 . . . . 0.0 114.709 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.55 176.58 8.18 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -57.4 -41.15 79.75 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.979 1.311 . . . . 0.0 113.137 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -91.54 -21.02 21.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.344 1.458 . . . . 0.0 113.884 -173.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.34 -176.56 52.79 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.253 1.406 . . . . 0.0 112.637 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.42 130.74 45.71 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.142 0.977 . . . . 0.0 112.671 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.76 178.91 36.08 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.862 1.22 . . . . 0.0 113.041 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.31 136.69 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.775 1.63 . . . . 0.0 108.834 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -130.57 121.54 25.88 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.735 1.214 . . . . 0.0 110.068 -173.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.36 141.98 50.99 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.54 1.136 . . . . 0.0 112.797 -170.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -141.11 130.62 23.9 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.817 0.847 . . . . 0.0 111.913 -170.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -69.57 131.98 45.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.798 0.839 . . . . 0.0 110.79 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.1 t -170.55 120.21 0.57 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.438 1.895 . . . . 0.0 110.337 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.4 t -71.11 -7.84 49.34 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 121.029 -1.044 . . . . 0.0 113.226 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -101.34 7.69 42.66 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.671 1.988 . . . . 0.0 112.688 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.85 -39.62 54.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.207 1.803 . . . . 0.0 115.592 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -68.48 -34.0 75.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.676 0.671 . . . . 0.0 112.789 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -70.59 -33.74 71.4 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.642 -0.661 . . . . 0.0 111.146 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.33 -47.0 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.59 0.632 . . . . 0.0 110.088 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.05 -43.06 99.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.758 0.823 . . . . 0.0 111.675 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -70.3 -30.58 67.61 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -80.68 -35.71 33.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.703 1.138 . . . . 0.0 111.861 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 mt -54.95 -50.36 69.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.29 0.95 . . . . 0.0 112.341 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -63.53 -24.92 68.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -25.75 47.08 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.32 1.048 . . . . 0.0 112.576 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.54 -30.15 17.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.423 1.089 . . . . 0.0 111.588 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 14.9 mmt . . . . . 0 N--CA 1.475 0.825 0 C-N-CA 125.208 1.403 . . . . 0.0 112.939 168.32 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 31.4 t80 . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 110.184 -0.302 . . . . 0.0 110.184 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -88.39 117.26 27.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.49 1.116 . . . . 0.0 111.309 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 72.2 mt -84.0 156.34 22.32 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.98 0.912 . . . . 0.0 112.27 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -92.34 -5.37 52.32 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.643 1.577 . . . . 0.0 113.423 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -169.41 161.14 9.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.208 2.203 . . . . 0.0 110.977 -169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -89.14 124.72 64.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.534 -173.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.6 -24.13 2.46 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.128 2.552 . . . . 0.0 113.813 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.7 m -83.4 124.23 30.46 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.636 0.775 . . . . 0.0 111.399 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.36 -4.46 89.07 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.342 0.972 . . . . 0.0 114.583 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -138.46 136.91 36.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.746 1.618 . . . . 0.0 110.219 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -162.8 139.73 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.075 1.35 . . . . 0.0 111.197 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -100.67 125.43 47.09 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.627 1.971 . . . . 0.0 108.945 171.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 . . . . . 0 CA--C 1.543 0.691 0 C-N-CA 123.229 0.612 . . . . 0.0 111.395 -179.707 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 . . . . . 0 CA--C 1.555 1.165 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.74 -12.64 35.12 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.0 2.466 . . . . 0.0 115.199 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.7 p -136.49 -18.39 1.46 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -112.58 148.56 34.29 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.431 1.093 . . . . 0.0 110.002 171.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -143.11 115.88 8.73 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.296 -0.878 . . . . 0.0 110.408 -173.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -71.02 133.93 46.72 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.458 -0.776 . . . . 0.0 110.242 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.44 163.77 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.927 1.291 . . . . 0.0 112.19 -169.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.3 m -134.46 119.77 18.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.426 1.091 . . . . 0.0 108.968 174.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.69 126.62 27.96 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 109.775 174.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.75 153.61 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.402 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.3 p-10 -91.88 -168.91 2.12 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.2 -22.66 67.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.481 1.512 . . . . 0.0 114.438 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -93.53 -5.84 48.1 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.665 1.186 . . . . 0.0 112.387 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.65 14.83 82.01 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 118.065 -1.408 . . . . 0.0 114.045 -173.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' OD1' ' A' ' 27' ' ' ASP . 18.2 m -81.04 150.99 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.674 1.737 . . . . 0.0 111.55 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.56 122.47 32.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.724 1.21 . . . . 0.0 110.996 -170.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.9 mt -103.65 -54.51 2.56 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.254 0.621 . . . . 0.0 111.86 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.59 146.72 16.98 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.869 1.223 . . . . 0.0 114.476 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 p -94.33 144.64 25.37 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.486 1.515 . . . . 0.0 112.558 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.41 171.68 32.92 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.701 1.143 . . . . 0.0 114.597 -177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.5 t -115.35 121.17 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.663 1.185 . . . . 0.0 108.622 170.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.2 tpp -86.94 135.28 33.35 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.602 1.561 . . . . 0.0 109.933 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -138.85 129.82 26.57 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.564 1.546 . . . . 0.0 109.375 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mp -111.61 134.03 53.46 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.293 1.837 . . . . 0.0 108.247 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -137.12 167.68 21.07 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.949 1.299 . . . . 0.0 110.436 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -68.86 -6.85 29.59 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.449 -0.782 . . . . 0.0 112.68 173.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.9 m -95.74 -46.13 6.72 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.989 0.916 . . . . 0.0 112.832 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -176.02 174.33 2.11 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.704 1.201 . . . . 0.0 113.544 -168.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.8 mt -86.55 140.34 29.98 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.167 1.387 . . . . 0.0 110.035 168.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.57 136.57 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.532 1.133 . . . . 0.0 111.323 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.3 mt -108.94 133.28 53.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.371 1.869 . . . . 0.0 110.648 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -114.01 121.15 43.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.993 2.117 . . . . 0.0 110.377 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.477 0.877 0 C-N-CA 125.605 1.562 . . . . 0.0 111.323 -176.025 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 120.757 0.313 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 t -128.99 137.0 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.603 0.761 . . . . 0.0 109.941 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 mtp85 -132.36 143.64 49.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.439 1.096 . . . . 0.0 112.388 -167.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -138.9 109.42 7.75 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.691 1.196 . . . . 0.0 111.622 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.5 150.99 83.94 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.914 2.409 . . . . 0.0 112.15 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -65.68 -7.27 14.52 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.58 -35.02 30.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.778 1.631 . . . . 0.0 113.583 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 16.5 p -88.11 -23.91 23.55 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.707 1.139 . . . . 0.0 113.709 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.11 107.25 0.84 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.619 1.568 . . . . 0.0 110.366 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -78.16 -38.33 43.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.35 1.46 . . . . 0.0 112.021 -174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -163.94 156.52 17.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.836 2.055 . . . . 0.0 110.442 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.64 132.05 16.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.387 1.075 . . . . 0.0 109.877 -175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.26 170.75 28.8 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-O 121.996 0.775 . . . . 0.0 114.373 -169.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.92 156.36 49.12 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.606 1.163 . . . . 0.0 112.136 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.05 -176.21 5.67 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.075 1.75 . . . . 0.0 110.107 175.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 t -63.13 114.86 3.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.107 0.956 . . . . 0.0 111.577 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 t30 57.02 18.66 4.11 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.035 2.134 . . . . 0.0 114.495 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.35 126.32 25.97 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.213 -1.554 . . . . 0.0 111.251 -169.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -119.88 138.06 53.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.536 1.535 . . . . 0.0 109.592 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.8 t -153.33 155.01 35.67 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.232 -0.917 . . . . 0.0 112.636 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -146.64 152.29 38.64 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.049 1.34 . . . . 0.0 111.759 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -110.51 143.05 41.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.713 1.605 . . . . 0.0 109.695 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -144.43 154.79 43.32 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.024 0.93 . . . . 0.0 111.983 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.22 176.62 37.38 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.403 1.478 . . . . 0.0 113.855 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -64.96 -8.91 17.72 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -76.81 -17.01 59.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.769 2.028 . . . . 0.0 115.424 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.0 p -85.66 -177.38 6.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.501 1.12 . . . . 0.0 113.961 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -61.53 -42.07 98.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.178 1.391 . . . . 0.0 112.879 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.4 p -93.01 -20.36 20.65 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.302 1.441 . . . . 0.0 114.123 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.45 -174.19 43.04 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.39 1.471 . . . . 0.0 112.7 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -67.63 134.41 51.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.655 0.782 . . . . 0.0 112.617 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.56 -176.37 35.49 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.503 1.049 . . . . 0.0 113.287 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.8 mt -121.26 137.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.799 1.64 . . . . 0.0 109.342 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -127.08 118.53 24.58 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.239 1.416 . . . . 0.0 109.32 -171.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.77 140.05 53.37 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.43 1.092 . . . . 0.0 113.196 -169.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -139.37 127.92 23.05 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.005 -169.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -67.7 129.02 38.62 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 168.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 35.3 t -165.31 126.63 1.99 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 111.103 -171.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.9 t -75.1 -10.22 59.27 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -107.39 18.6 21.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.311 1.845 . . . . 0.0 112.842 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.89 -40.27 79.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -169.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -71.0 -36.99 72.68 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.01 0.924 . . . . 0.0 112.274 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -64.64 -40.74 95.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.246 1.019 . . . . 0.0 110.707 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.0 -46.54 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.353 0.661 . . . . 0.0 110.63 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -39.36 83.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.503 1.121 . . . . 0.0 112.221 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -74.27 -30.88 62.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.256 1.022 . . . . 0.0 113.48 175.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -80.36 -34.96 36.07 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.354 0.979 . . . . 0.0 111.091 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.4 mt -52.44 -56.51 14.58 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.151 0.981 . . . . 0.0 112.897 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -55.65 -34.2 64.76 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.91 -17.03 56.21 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.285 1.434 . . . . 0.0 112.769 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.5 mt -95.24 -37.23 11.11 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.396 1.078 . . . . 0.0 110.917 169.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 57.8 mtp . . . . . 0 N--CA 1.471 0.577 0 C-N-CA 123.874 0.87 . . . . 0.0 112.663 178.445 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 29.1 t80 . . . . . 0 N--CA 1.47 0.541 0 CA-C-O 120.643 0.259 . . . . 0.0 110.972 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.03 97.4 5.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.911 1.684 . . . . 0.0 109.801 -173.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 57.7 mt -72.72 156.34 39.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.831 0.852 . . . . 0.0 111.872 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -98.56 -12.06 21.57 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.619 1.568 . . . . 0.0 113.0 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -144.8 149.64 35.8 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.509 1.924 . . . . 0.0 111.073 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -85.79 121.16 73.22 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.498 -0.751 . . . . 0.0 110.981 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.22 -19.88 4.42 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.291 2.661 . . . . 0.0 114.65 -169.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 87.3 m -89.54 124.64 34.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.163 0.892 . . . . 0.0 112.358 -172.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.68 -14.43 81.12 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.103 0.859 . . . . 0.0 114.42 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -115.31 129.39 56.6 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.371 1.468 . . . . 0.0 109.325 170.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 p -158.03 151.36 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.285 1.434 . . . . 0.0 110.921 -169.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -155.76 179.63 9.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.959 1.704 . . . . 0.0 112.442 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.545 0.779 0 C-N-CA 126.185 1.794 . . . . 0.0 109.669 -173.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 . . . . . 0 CA--C 1.558 1.261 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.9 -11.56 25.7 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.109 2.539 . . . . 0.0 115.359 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.5 p -131.35 -21.96 2.53 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 120.355 1.434 . . . . 0.0 114.553 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -102.34 140.9 36.01 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.306 1.042 . . . . 0.0 110.363 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.44 111.72 9.11 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.757 1.223 . . . . 0.0 108.35 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -67.94 133.22 48.73 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.647 -0.658 . . . . 0.0 110.293 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.54 164.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.324 1.449 . . . . 0.0 111.59 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.3 m -139.96 120.78 14.44 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.376 1.07 . . . . 0.0 109.117 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -64.58 131.9 48.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.453 0.701 . . . . 0.0 110.023 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.16 157.52 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.429 1.092 . . . . 0.0 112.389 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -85.76 -167.05 1.71 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.451 1.1 . . . . 0.0 113.28 176.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.38 -26.58 63.78 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.495 1.118 . . . . 0.0 113.639 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -80.42 -18.12 49.78 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.566 1.146 . . . . 0.0 112.567 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.36 17.94 59.76 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.115 -1.38 . . . . 0.0 114.167 -173.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' OD1' ' A' ' 27' ' ' ASP . 17.5 m -77.22 150.65 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.841 1.82 . . . . 0.0 111.269 171.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.65 126.73 35.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.839 1.256 . . . . 0.0 110.923 -172.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.5 mt -109.69 -51.21 2.9 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.115 0.966 . . . . 0.0 111.814 -170.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.14 136.38 5.2 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 124.593 1.092 . . . . 0.0 114.08 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 p -84.1 146.29 27.98 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.07 1.348 . . . . 0.0 112.652 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.93 170.06 32.53 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.369 1.462 . . . . 0.0 113.721 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.36 120.22 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.6 ttm -87.6 136.38 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.922 0.889 . . . . 0.0 109.636 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -130.94 129.66 42.46 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.392 1.477 . . . . 0.0 108.67 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.77 116.24 31.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.978 1.711 . . . . 0.0 106.967 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.5 p -114.95 168.0 10.29 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.61 1.164 . . . . 0.0 110.046 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -72.1 -2.4 18.37 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.528 -0.732 . . . . 0.0 112.659 170.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.5 m -96.77 -48.7 5.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.447 1.099 . . . . 0.0 112.51 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -176.31 175.91 1.75 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.016 1.726 . . . . 0.0 112.813 -170.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 mt -84.73 137.87 32.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.302 1.041 . . . . 0.0 110.214 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.01 134.38 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.027 0.931 . . . . 0.0 111.502 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.7 mt -104.08 133.72 48.55 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.894 1.677 . . . . 0.0 109.769 168.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -112.61 129.88 56.22 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.944 2.098 . . . . 0.0 110.899 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mp . . . . . 0 CA--C 1.543 0.678 0 C-N-CA 125.748 1.619 . . . . 0.0 111.086 -178.408 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.729 0 CA-C-O 120.762 0.315 . . . . 0.0 111.621 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.04 130.19 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.815 0.846 . . . . 0.0 110.141 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 mtp85 -126.99 144.39 51.03 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.725 1.21 . . . . 0.0 112.416 -168.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -139.63 116.89 8.45 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.781 1.232 . . . . 0.0 111.581 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -64.13 143.2 83.48 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.714 2.276 . . . . 0.0 110.068 172.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -55.81 -31.66 62.87 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.45 -44.15 76.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.702 2.001 . . . . 0.0 112.752 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.2 p -75.41 -7.93 55.35 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.8 mt -83.17 108.78 16.66 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.152 0.981 . . . . 0.0 110.514 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -74.81 -37.94 62.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.842 0.857 . . . . 0.0 112.125 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -157.84 163.31 38.11 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.587 1.555 . . . . 0.0 110.961 170.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -151.9 141.05 21.3 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.613 1.565 . . . . 0.0 109.074 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.0 177.81 34.56 Favored Glycine 0 N--CA 1.463 0.447 0 CA-C-O 121.484 0.491 . . . . 0.0 113.794 -171.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -143.61 166.11 25.73 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.202 1.001 . . . . 0.0 113.44 -170.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -151.39 -170.52 3.68 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.681 1.992 . . . . 0.0 109.787 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 t -72.94 -13.05 61.17 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.596 -1.315 . . . . 0.0 114.234 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -157.39 5.85 0.14 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.631 1.572 . . . . 0.0 114.25 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.86 132.87 37.16 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.818 1.647 . . . . 0.0 110.451 -168.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -124.48 142.11 51.57 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.428 1.891 . . . . 0.0 109.773 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 t -157.08 161.15 39.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.648 1.179 . . . . 0.0 112.508 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.34 149.34 29.96 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.496 1.518 . . . . 0.0 112.013 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -93.86 139.47 30.85 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.92 1.288 . . . . 0.0 109.456 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.1 p -142.33 148.73 38.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.96 172.54 35.43 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.098 1.332 . . . . 0.0 113.986 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -13.75 54.37 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -174.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -72.81 -16.98 61.61 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.016 1.727 . . . . 0.0 115.653 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 p -83.73 -178.79 7.13 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.373 1.069 . . . . 0.0 113.723 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.2 -41.37 92.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.106 1.362 . . . . 0.0 113.049 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.5 p -91.04 -21.15 21.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.101 1.36 . . . . 0.0 113.876 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.24 -177.72 49.09 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.139 1.352 . . . . 0.0 112.271 -170.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -64.73 137.25 57.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.152 0.981 . . . . 0.0 112.789 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.06 -178.96 35.91 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.263 0.935 . . . . 0.0 113.483 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.3 mt -118.3 133.71 64.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.616 1.566 . . . . 0.0 108.81 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -127.92 124.57 37.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.98 1.312 . . . . 0.0 109.458 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.03 143.92 48.8 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.088 0.955 . . . . 0.0 112.886 -172.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -138.87 128.58 24.81 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.52 1.128 . . . . 0.0 111.36 -169.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -69.85 136.1 50.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.966 0.506 . . . . 0.0 110.667 169.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 23.8 t -163.42 138.95 6.59 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.243 1.417 . . . . 0.0 110.971 -174.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t -74.4 -11.32 60.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -137.3 34.48 2.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.979 1.712 . . . . 0.0 113.776 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.89 -37.86 33.22 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.964 1.306 . . . . 0.0 113.659 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.94 -37.48 81.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.222 1.009 . . . . 0.0 113.141 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.81 -37.78 82.43 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.319 -0.863 . . . . 0.0 110.931 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 77.4 mt -62.43 -46.4 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.156 0.582 . . . . 0.0 110.097 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -38.26 84.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.296 1.038 . . . . 0.0 112.481 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -72.11 -28.38 63.25 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.25 1.02 . . . . 0.0 113.469 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -85.63 -41.95 14.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.078 0.854 . . . . 0.0 110.713 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.2 mt -50.81 -54.48 23.33 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.299 1.04 . . . . 0.0 112.603 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -59.47 -22.46 61.59 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.08 -21.57 36.75 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.725 1.21 . . . . 0.0 112.867 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.1 mt -95.81 -35.34 11.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.097 1.359 . . . . 0.0 112.039 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 66.2 mmm . . . . . 0 N--CA 1.472 0.635 0 C-N-CA 125.49 1.516 . . . . 0.0 112.249 170.945 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 29.0 t80 . . . . . 0 CA--C 1.536 0.442 0 N-CA-C 111.27 0.1 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' B' ' 3' ' ' ARG . 0.0 OUTLIER -85.78 122.98 30.62 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.022 0.929 . . . . 0.0 111.246 177.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 52.2 mt -90.29 153.13 20.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.6 0.76 . . . . 0.0 112.752 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -88.27 -17.49 30.61 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.613 1.565 . . . . 0.0 113.469 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -156.16 168.64 26.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.269 1.828 . . . . 0.0 111.459 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.89 119.29 70.46 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.706 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.29 -23.69 3.4 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.125 2.55 . . . . 0.0 114.369 -169.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 81.8 m -78.68 126.96 31.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.13 0.877 . . . . 0.0 111.551 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.78 -22.63 63.67 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 124.031 0.824 . . . . 0.0 114.428 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -118.93 126.49 51.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.021 1.328 . . . . 0.0 109.645 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.23 164.42 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.743 1.617 . . . . 0.0 110.835 -172.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -134.25 134.43 41.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.037 1.335 . . . . 0.0 109.69 174.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 . . . . . 0 CA--C 1.539 0.527 0 C-N-CA 124.587 1.155 . . . . 0.0 110.941 -177.088 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 . . . . . 0 CA--C 1.556 1.188 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.61 -16.75 51.64 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.184 2.589 . . . . 0.0 115.302 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.0 p -125.26 -15.7 6.16 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.916 1.234 . . . . 0.0 114.316 176.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -103.47 125.1 49.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.223 0.92 . . . . 0.0 112.119 172.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.29 106.71 10.94 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.12 1.768 . . . . 0.0 109.092 -176.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -69.2 132.49 46.6 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.618 -0.676 . . . . 0.0 109.982 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 m -140.8 158.95 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.722 1.209 . . . . 0.0 112.245 -169.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -134.18 118.37 17.58 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.679 1.192 . . . . 0.0 108.214 174.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -66.92 131.37 45.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 m -125.53 154.49 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.663 0.785 . . . . 0.0 112.557 -177.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -81.95 -169.6 2.45 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.747 1.219 . . . . 0.0 113.884 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -64.6 -29.13 70.14 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.658 1.583 . . . . 0.0 115.001 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.09 -24.22 20.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.137 0.575 . . . . 0.0 112.026 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.49 14.98 6.63 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 126.109 1.814 . . . . 0.0 112.459 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.57 140.48 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 126.681 1.992 . . . . 0.0 109.43 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.24 125.93 31.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.878 1.671 . . . . 0.0 110.652 -171.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.2 mt -109.88 -53.22 2.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.973 0.909 . . . . 0.0 112.141 -171.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.2 140.33 7.93 Favored Glycine 0 N--CA 1.469 0.848 0 C-N-CA 124.814 1.197 . . . . 0.0 113.574 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 p -92.18 143.64 26.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.194 1.398 . . . . 0.0 112.344 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.1 171.73 34.53 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.312 1.434 . . . . 0.0 113.028 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -118.62 119.47 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.9 tpp -83.16 133.62 35.02 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.144 0.977 . . . . 0.0 109.444 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -126.99 130.54 50.24 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.217 1.407 . . . . 0.0 108.877 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.69 119.17 38.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.329 1.852 . . . . 0.0 107.72 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -122.61 173.68 7.55 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.974 1.309 . . . . 0.0 110.307 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -74.69 2.54 9.71 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.386 -0.821 . . . . 0.0 113.209 172.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.8 p -107.39 -45.93 3.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.897 -1.127 . . . . 0.0 113.473 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -172.78 173.49 3.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.776 1.231 . . . . 0.0 113.09 -174.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -83.67 136.77 34.07 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.511 -0.743 . . . . 0.0 109.523 168.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.9 t -134.74 130.4 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.216 1.006 . . . . 0.0 111.632 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.7 mt -100.19 126.7 46.49 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.442 1.497 . . . . 0.0 110.19 168.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -102.74 133.83 47.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.283 2.233 . . . . 0.0 110.979 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp . . . . . 0 N--CA 1.471 0.584 0 C-N-CA 125.196 1.398 . . . . 0.0 111.322 -177.183 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 121.054 0.454 . . . . 0.0 112.004 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.62 135.52 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.217 1.007 . . . . 0.0 110.226 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -134.24 152.08 51.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.833 0.853 . . . . 0.0 113.222 -173.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -142.1 119.81 7.43 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.293 1.437 . . . . 0.0 111.794 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.22 145.93 68.01 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.957 2.438 . . . . 0.0 110.463 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -60.11 -22.88 63.33 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.8 tp -63.4 -41.61 98.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.659 1.984 . . . . 0.0 113.11 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.4 p -73.32 -14.23 61.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.65 84.57 7.63 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.9 1.28 . . . . 0.0 110.715 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.4 tpp85 -63.22 -30.77 71.85 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.986 0.914 . . . . 0.0 112.503 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.408 ' CG ' HG21 ' B' ' 12' ' ' VAL . 38.7 ttp-105 -156.0 128.51 7.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.499 1.52 . . . . 0.0 109.834 -170.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -138.92 104.84 5.16 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.535 1.534 . . . . 0.0 111.008 -175.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.18 167.14 12.24 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.088 1.328 . . . . 0.0 113.984 -168.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -144.92 159.0 43.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.248 1.019 . . . . 0.0 112.593 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -151.36 177.52 10.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.1 2.16 . . . . 0.0 109.588 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 m -60.91 -12.22 10.46 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -154.58 11.52 0.38 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.549 1.54 . . . . 0.0 114.248 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.52 131.99 26.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.415 1.486 . . . . 0.0 110.491 -168.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -122.98 133.64 54.36 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.985 1.714 . . . . 0.0 109.016 171.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.3 t -152.6 152.93 32.4 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.131 -0.981 . . . . 0.0 112.052 -174.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -149.71 151.35 33.52 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.351 1.06 . . . . 0.0 111.839 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -104.84 126.59 52.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.606 1.162 . . . . 0.0 109.106 171.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.4 p -124.44 122.58 38.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.449 1.1 . . . . 0.0 111.294 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.25 162.39 40.22 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.816 1.198 . . . . 0.0 114.856 -171.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -57.74 -16.98 12.81 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -23.04 61.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.526 1.53 . . . . 0.0 114.925 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.3 p -73.24 173.43 9.49 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -171.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -54.56 -39.77 68.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.76 1.624 . . . . 0.0 113.341 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -91.06 -20.91 21.55 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.469 1.508 . . . . 0.0 113.874 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.26 175.1 48.9 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.156 1.36 . . . . 0.0 112.169 -170.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -66.31 130.56 43.63 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.848 1.259 . . . . 0.0 111.86 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.54 -179.35 41.55 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.776 1.179 . . . . 0.0 113.13 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.6 mt -116.46 131.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.708 1.603 . . . . 0.0 108.616 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -125.56 121.13 32.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.742 1.217 . . . . 0.0 110.238 -174.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.2 136.36 53.11 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.856 1.263 . . . . 0.0 112.943 -171.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -137.07 129.2 29.47 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.077 0.951 . . . . 0.0 111.717 -170.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -75.63 135.22 40.48 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.639 1.176 . . . . 0.0 111.988 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.6 p -171.0 151.28 3.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.505 1.922 . . . . 0.0 112.146 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.3 m -73.58 -37.31 65.52 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.156 -0.965 . . . . 0.0 112.111 171.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -85.96 20.48 2.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.099 1.36 . . . . 0.0 114.216 -171.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.07 -42.48 50.0 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.159 1.384 . . . . 0.0 114.145 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -69.57 -36.71 76.53 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.795 0.838 . . . . 0.0 112.716 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -68.39 -34.11 75.45 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.464 -0.772 . . . . 0.0 111.743 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.33 -47.65 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 118.678 0.672 . . . . 0.0 109.871 169.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.68 -43.33 94.07 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.658 1.183 . . . . 0.0 112.109 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -67.01 -34.67 78.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.792 1.237 . . . . 0.0 112.841 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -78.7 -41.12 31.91 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.789 0.722 . . . . 0.0 110.367 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.01 -51.46 61.59 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.26 1.024 . . . . 0.0 112.911 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -62.19 -24.12 67.02 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.3 -28.18 56.87 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.662 0.785 . . . . 0.0 112.544 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.25 -35.0 23.71 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.258 1.023 . . . . 0.0 111.199 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.6 mmt . . . . . 0 N--CA 1.469 0.511 0 C-N-CA 123.993 0.917 . . . . 0.0 112.348 169.507 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 21.4 t80 . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -91.58 112.5 24.45 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.122 0.969 . . . . 0.0 109.495 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 78.2 mt -78.76 155.26 29.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.531 0.681 . . . . 0.0 112.283 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -91.72 -26.78 18.45 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.079 1.352 . . . . 0.0 113.077 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -140.68 158.61 43.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.418 1.887 . . . . 0.0 111.663 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -84.3 128.45 62.01 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.434 0.694 . . . . 0.0 112.008 -172.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -86.1 -10.97 6.64 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.431 2.754 . . . . 0.0 114.475 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 90.0 m -102.27 126.31 49.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.306 1.043 . . . . 0.0 111.511 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.49 -31.19 34.27 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.11 0.862 . . . . 0.0 114.2 -176.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -108.35 131.32 54.87 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.842 1.257 . . . . 0.0 110.494 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.408 HG21 ' CG ' ' A' ' 64' ' ' ARG . 7.2 p -165.18 140.61 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.638 1.175 . . . . 0.0 111.885 -173.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -102.49 147.65 26.49 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.571 2.348 . . . . 0.0 111.716 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 CA--C 1.542 0.653 0 C-N-CA 125.01 1.324 . . . . 0.0 109.125 175.541 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 . . . . . 0 CA--C 1.555 1.144 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.07 -8.74 22.72 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.114 2.542 . . . . 0.0 114.933 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.0 p -129.89 -17.36 3.56 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 174.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 131.84 56.59 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.468 1.107 . . . . 0.0 111.796 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -127.46 113.13 15.77 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.907 1.283 . . . . 0.0 108.748 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -69.84 131.77 44.99 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.507 -0.746 . . . . 0.0 110.326 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.09 165.41 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.814 1.645 . . . . 0.0 111.795 -169.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.3 m -134.27 122.78 23.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.507 1.123 . . . . 0.0 109.087 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.4 127.83 33.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.291 1.037 . . . . 0.0 109.797 174.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.64 155.97 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.494 0.718 . . . . 0.0 112.707 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.1 p-10 -88.12 -167.85 2.02 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.608 1.163 . . . . 0.0 113.6 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.91 -30.3 71.43 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.944 1.298 . . . . 0.0 114.335 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -84.09 -10.38 57.86 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.944 0.793 . . . . 0.0 113.072 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.85 16.47 75.02 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.365 -1.242 . . . . 0.0 113.953 -172.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' OD1' ' A' ' 27' ' ' ASP . 16.4 m -78.25 149.89 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.599 1.699 . . . . 0.0 111.202 173.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -89.52 122.56 32.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.922 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.3 mt -103.41 -51.7 3.16 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.602 0.761 . . . . 0.0 111.68 -174.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.93 144.76 12.16 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 124.874 1.226 . . . . 0.0 114.277 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.3 p -89.8 150.36 22.29 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.08 1.352 . . . . 0.0 112.55 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.4 171.06 37.32 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 124.147 0.88 . . . . 0.0 115.094 -174.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -114.79 120.54 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 58.0 tpp -86.59 133.1 33.74 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.929 0.891 . . . . 0.0 109.118 170.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -130.14 130.17 44.43 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.034 1.334 . . . . 0.0 109.008 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.75 115.04 29.42 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.312 1.845 . . . . 0.0 107.004 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 p -110.57 174.55 5.81 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.237 1.015 . . . . 0.0 109.869 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -75.88 13.76 0.79 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 121.244 -0.91 . . . . 0.0 112.186 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.4 t -125.74 -41.51 1.98 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.557 1.543 . . . . 0.0 112.626 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -170.43 171.06 6.72 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.144 -0.972 . . . . 0.0 113.442 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.3 mt -87.36 133.88 33.65 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 165.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 t -133.36 134.2 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.797 0.839 . . . . 0.0 111.177 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.2 mt -101.03 129.36 46.86 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 124.461 1.104 . . . . 0.0 109.836 168.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -109.98 118.74 37.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.429 1.892 . . . . 0.0 109.734 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.2 mt . . . . . 0 N--CA 1.471 0.602 0 C-N-CA 124.824 1.249 . . . . 0.0 110.329 -175.089 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.427 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 t -134.94 131.63 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.154 0.582 . . . . 0.0 110.961 -168.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -121.71 142.07 50.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.478 1.511 . . . . 0.0 112.118 -169.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -138.16 112.14 8.69 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.912 1.285 . . . . 0.0 110.703 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.19 146.69 82.23 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.489 2.126 . . . . 0.0 110.475 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -57.79 -28.13 63.73 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 mt -65.35 -25.23 67.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.762 1.625 . . . . 0.0 114.131 173.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.4 p -93.25 -8.17 43.0 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -79.48 115.2 18.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.885 0.874 . . . . 0.0 109.958 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -76.26 -37.91 56.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.361 0.665 . . . . 0.0 111.698 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -161.19 163.24 31.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.663 1.585 . . . . 0.0 111.947 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -150.44 138.03 19.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.368 1.867 . . . . 0.0 109.012 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -145.17 -178.94 21.13 Favored Glycine 0 N--CA 1.461 0.353 0 C-N-CA 123.859 0.742 . . . . 0.0 113.052 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -152.11 166.23 32.29 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.031 0.932 . . . . 0.0 112.916 -174.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -157.19 -178.41 7.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.309 2.244 . . . . 0.0 109.319 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.2 p -63.6 -21.65 66.47 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -152.68 10.65 0.49 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -133.65 127.7 33.52 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.747 -1.221 . . . . 0.0 110.463 -172.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -118.85 135.7 54.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.902 1.681 . . . . 0.0 109.678 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -153.75 156.67 38.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.656 1.182 . . . . 0.0 112.676 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -149.08 151.96 35.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.031 1.733 . . . . 0.0 111.518 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -111.68 132.84 54.33 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.024 1.33 . . . . 0.0 111.139 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m -132.89 147.85 52.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.765 1.226 . . . . 0.0 112.368 -172.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.65 174.51 41.31 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.787 1.184 . . . . 0.0 114.387 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -11.97 18.16 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -87.93 -15.45 36.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -174.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.7 p -80.08 179.21 7.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.949 0.899 . . . . 0.0 112.901 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -57.71 -37.88 74.26 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.843 1.257 . . . . 0.0 113.336 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.9 p -95.13 -20.88 18.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.426 1.49 . . . . 0.0 114.082 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.89 -167.46 42.12 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.371 1.462 . . . . 0.0 112.586 -173.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -67.08 132.28 47.53 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.62 0.768 . . . . 0.0 112.118 -173.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.05 -175.58 35.24 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 122.506 1.059 . . . . 0.0 113.454 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.8 mt -124.22 139.19 51.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 126.009 1.724 . . . . 0.0 108.432 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.11 127.72 36.62 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.842 1.257 . . . . 0.0 109.859 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.04 145.59 50.94 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.322 1.049 . . . . 0.0 113.594 -169.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -139.88 128.03 22.41 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.337 -168.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -66.38 127.68 33.22 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 43.8 t -164.92 114.85 1.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.189 1.396 . . . . 0.0 111.377 -167.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 m -71.19 -2.15 14.96 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -133.34 22.12 4.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.443 2.297 . . . . 0.0 112.427 -170.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.63 -36.07 33.52 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.388 1.475 . . . . 0.0 113.841 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -67.86 -37.87 82.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.639 0.775 . . . . 0.0 112.762 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.47 -33.68 73.24 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.434 -0.791 . . . . 0.0 111.665 175.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.79 -47.53 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.782 -0.574 . . . . 0.0 110.163 169.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.29 -42.9 87.64 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.025 1.33 . . . . 0.0 111.808 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -66.31 -33.22 75.24 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.738 1.215 . . . . 0.0 113.044 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.41 -42.52 20.28 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.082 0.855 . . . . 0.0 110.282 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.7 mt -49.69 -54.49 18.42 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.152 0.981 . . . . 0.0 112.273 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -59.48 -28.76 67.31 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -19.44 61.21 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.918 1.287 . . . . 0.0 113.045 175.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.1 mt -95.36 -35.83 11.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.434 1.493 . . . . 0.0 111.025 173.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 47.9 mmm . . . . . 0 N--CA 1.469 0.499 0 C-N-CA 124.617 1.167 . . . . 0.0 111.962 177.102 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 33.5 t80 . . . . . 0 N--CA 1.471 0.617 0 CA-C-O 120.332 0.111 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.72 124.76 28.16 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.579 1.151 . . . . 0.0 111.269 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 64.6 mt -94.47 154.13 17.58 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.007 0.923 . . . . 0.0 112.662 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -84.07 -21.2 31.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.447 1.499 . . . . 0.0 113.367 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -153.66 166.03 34.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.088 1.755 . . . . 0.0 111.751 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -87.9 118.53 69.79 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.223 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.0 -16.24 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.541 2.827 . . . . 0.0 114.076 -170.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 82.2 m -89.43 123.63 33.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.866 0.867 . . . . 0.0 110.749 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.06 -35.19 35.29 Favored Glycine 0 N--CA 1.473 1.128 0 C-N-CA 123.836 0.732 . . . . 0.0 113.043 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -97.05 120.31 37.17 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.55 1.14 . . . . 0.0 109.72 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.06 160.97 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.792 1.637 . . . . 0.0 110.447 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -122.14 124.89 44.94 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.537 1.135 . . . . 0.0 109.103 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 . . . . . 0 CA--C 1.538 0.504 0 C-N-CA 123.965 0.906 . . . . 0.0 110.709 179.683 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 . . . . . 0 CA--C 1.56 1.349 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.0 -20.19 29.29 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.062 2.508 . . . . 0.0 115.668 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.3 p -126.14 -22.18 4.14 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.296 1.407 . . . . 0.0 114.303 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -97.11 144.74 26.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.231 1.012 . . . . 0.0 110.279 169.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -140.1 119.0 12.53 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.286 1.435 . . . . 0.0 108.207 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.44 135.24 45.71 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.382 -0.823 . . . . 0.0 109.932 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.83 169.34 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.966 1.306 . . . . 0.0 111.287 -171.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 35' ' ' SER . 20.9 m -142.67 122.39 13.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.67 1.188 . . . . 0.0 107.849 172.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -68.9 134.14 49.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.364 0.666 . . . . 0.0 110.462 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.71 155.87 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.521 1.128 . . . . 0.0 113.816 -173.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.444 ' CG ' HG22 ' A' ' 31' ' ' VAL . 2.9 p-10 -84.62 -170.17 2.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -63.41 -21.62 66.4 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.689 1.596 . . . . 0.0 115.112 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.34 -0.5 32.63 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.323 1.449 . . . . 0.0 112.403 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.94 14.57 77.09 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.0 -1.444 . . . . 0.0 114.389 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.444 HG22 ' CG ' ' A' ' 27' ' ' ASP . 3.3 m -73.58 144.87 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.901 1.85 . . . . 0.0 110.674 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -87.27 120.87 29.0 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.796 1.238 . . . . 0.0 110.143 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.9 mt -105.75 -52.68 2.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.721 0.809 . . . . 0.0 112.048 -169.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.14 137.16 5.78 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.185 1.374 . . . . 0.0 111.958 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 46.7 t -83.69 149.43 26.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.941 0.876 . . . . 0.0 111.555 176.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.54 167.44 27.55 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 125.991 1.758 . . . . 0.0 113.378 -172.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.1 t -120.43 120.24 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.9 ttm -97.13 143.03 28.34 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.152 1.381 . . . . 0.0 109.388 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -145.4 126.53 14.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.835 1.254 . . . . 0.0 109.695 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.48 132.17 54.68 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.123 1.369 . . . . 0.0 108.688 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.7 p -135.31 171.09 14.94 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.937 1.295 . . . . 0.0 110.385 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -68.32 0.05 4.28 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 170.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t -103.2 -52.18 3.08 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.596 1.089 . . . . 0.0 112.399 178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.18 173.1 2.65 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.724 1.21 . . . . 0.0 112.844 -170.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.18 118.44 25.63 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.06 1.344 . . . . 0.0 110.38 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.8 t -109.77 140.03 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.864 1.266 . . . . 0.0 109.178 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -139.69 124.9 18.87 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.513 1.525 . . . . 0.0 109.84 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -115.48 137.26 52.24 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.561 1.944 . . . . 0.0 110.417 -172.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mp . . . . . 0 N--CA 1.475 0.786 0 C-N-CA 124.842 1.257 . . . . 0.0 112.617 -170.087 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.543 0.688 0 CA-C-O 120.672 0.272 . . . . 0.0 111.15 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.08 130.82 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.198 1.399 . . . . 0.0 109.881 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.98 141.28 52.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.637 1.175 . . . . 0.0 111.406 -171.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -134.91 112.81 11.48 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.702 1.201 . . . . 0.0 111.587 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.21 138.3 42.82 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.991 2.46 . . . . 0.0 110.755 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -60.21 -28.47 68.01 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -65.85 -35.27 80.2 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 0.0 112.453 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.0 m -92.22 3.27 55.69 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.57 120.52 24.63 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.964 0.905 . . . . 0.0 109.053 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -83.2 -23.31 32.89 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.505 ' HG3' HG21 ' B' ' 12' ' ' VAL . 30.0 ttp-105 -176.24 140.51 0.39 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.909 2.084 . . . . 0.0 109.478 -169.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -144.89 106.46 4.24 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.214 1.405 . . . . 0.0 111.54 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.14 165.16 12.01 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 126.231 1.872 . . . . 0.0 113.522 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -150.85 154.08 36.57 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.7 1.2 . . . . 0.0 113.218 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -144.97 -168.99 3.08 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.855 1.662 . . . . 0.0 110.064 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 t -68.75 -11.67 60.59 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -158.19 10.87 0.17 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.926 1.69 . . . . 0.0 114.225 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -140.61 133.24 28.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.614 1.566 . . . . 0.0 110.549 -168.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -126.29 138.43 53.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.93 1.692 . . . . 0.0 109.18 172.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -153.06 152.95 31.92 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.888 -1.133 . . . . 0.0 112.277 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -153.69 158.11 40.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.045 0.938 . . . . 0.0 112.545 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -115.07 135.2 54.46 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.723 1.609 . . . . 0.0 111.231 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 62.6 p -120.31 152.46 37.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.233 1.413 . . . . 0.0 112.905 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.44 164.44 31.87 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.984 1.278 . . . . 0.0 113.27 176.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -66.07 -9.26 29.18 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -171.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -84.83 -11.49 55.57 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.566 1.946 . . . . 0.0 115.231 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.3 m -68.01 173.5 4.52 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.841 1.256 . . . . 0.0 112.965 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -57.25 -40.74 78.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 112.285 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.3 p -90.03 -23.01 21.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.442 1.497 . . . . 0.0 113.161 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.29 -146.74 27.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.992 1.282 . . . . 0.0 111.612 -171.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -75.23 141.37 43.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.254 1.022 . . . . 0.0 112.206 -175.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.79 171.02 23.25 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.295 0.95 . . . . 0.0 113.245 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.33 133.33 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.391 1.476 . . . . 0.0 108.346 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -130.39 123.81 30.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.496 1.118 . . . . 0.0 110.606 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.03 139.96 49.75 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.638 1.175 . . . . 0.0 112.368 -175.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -136.84 124.11 21.86 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.787 1.235 . . . . 0.0 111.258 -172.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -70.0 133.87 47.7 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.245 0.618 . . . . 0.0 110.791 169.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 36.7 t -166.49 130.64 2.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.123 1.769 . . . . 0.0 110.517 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.5 t -66.97 -26.5 66.85 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.614 -0.678 . . . . 0.0 112.812 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -109.32 29.21 7.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.206 1.802 . . . . 0.0 113.226 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.16 -35.49 26.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.064 1.346 . . . . 0.0 114.185 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -70.24 -37.97 75.08 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.767 0.827 . . . . 0.0 113.024 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -65.94 -36.83 84.42 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.387 -0.821 . . . . 0.0 111.424 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.91 -48.94 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.915 0.486 . . . . 0.0 110.124 171.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -38.42 86.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.265 1.026 . . . . 0.0 112.93 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.36 -35.46 65.96 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.743 0.817 . . . . 0.0 112.427 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -76.18 -34.53 59.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.074 0.852 . . . . 0.0 112.008 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.7 mt -54.64 -59.61 4.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.156 0.889 . . . . 0.0 111.45 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -60.8 -24.49 65.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -29.4 64.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.977 0.911 . . . . 0.0 113.374 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.6 mt -96.32 -35.5 11.2 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.384 1.473 . . . . 0.0 111.434 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.5 mtp . . . . . 0 N--CA 1.469 0.5 0 C-N-CA 125.339 1.456 . . . . 0.0 112.594 179.074 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 31.2 t80 . . . . . 0 CA--C 1.539 0.554 0 N-CA-C 110.954 -0.017 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -87.15 116.84 25.5 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.334 1.054 . . . . 0.0 111.169 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 32.9 mt -81.74 159.42 23.87 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.632 0.773 . . . . 0.0 112.711 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -100.66 -12.13 19.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.526 1.53 . . . . 0.0 113.614 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -163.11 167.14 22.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.087 2.155 . . . . 0.0 110.906 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -84.8 126.49 68.23 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.874 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.15 -2.37 11.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.836 3.024 . . . . 0.0 113.956 -174.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 22.2 t -115.0 135.51 54.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.052 1.341 . . . . 0.0 112.088 -171.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.55 -5.81 56.68 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.485 1.517 . . . . 0.0 115.656 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -137.07 111.73 8.73 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.043 1.422 . . . . 0.0 110.278 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 64' ' ' ARG . 7.5 p -147.75 138.18 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -168.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -99.3 117.24 33.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.875 2.07 . . . . 0.0 109.921 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 CA--C 1.543 0.701 0 C-N-CA 123.709 0.804 . . . . 0.0 110.466 174.465 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 . . . . . 0 CA--C 1.559 1.312 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.13 -21.58 23.6 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.723 2.282 . . . . 0.0 115.111 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.0 p -126.03 -20.83 4.46 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 120.691 1.587 . . . . 0.0 114.265 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -97.32 146.41 25.18 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.97 0.908 . . . . 0.0 109.145 168.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -141.6 113.5 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -67.85 134.4 50.83 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.565 -0.709 . . . . 0.0 110.12 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.28 164.44 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.82 1.248 . . . . 0.0 111.616 -171.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.4 m -139.97 123.08 16.8 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.502 1.121 . . . . 0.0 108.59 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -65.58 130.46 43.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.301 0.641 . . . . 0.0 109.722 175.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.32 156.46 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.327 1.051 . . . . 0.0 112.235 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.408 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.4 p-10 -85.15 -166.37 1.48 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.52 1.128 . . . . 0.0 113.126 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.11 -26.14 63.83 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.543 1.137 . . . . 0.0 113.695 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.51 -18.6 44.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.761 1.224 . . . . 0.0 112.591 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.06 17.39 59.43 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.021 1.296 . . . . 0.0 114.295 -173.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' A' ' 27' ' ' ASP . 16.7 m -76.77 150.25 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.68 1.74 . . . . 0.0 111.183 171.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -88.26 125.78 34.83 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.657 1.183 . . . . 0.0 110.849 -172.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -108.15 -49.57 3.18 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.184 0.994 . . . . 0.0 111.767 -171.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.57 137.21 5.56 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.919 1.247 . . . . 0.0 113.654 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.0 p -84.03 148.87 26.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.755 1.222 . . . . 0.0 112.356 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.06 170.82 34.95 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.794 1.188 . . . . 0.0 114.637 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.19 120.57 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.7 tpp -84.91 141.3 30.48 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.661 1.184 . . . . 0.0 109.576 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -140.26 130.31 24.85 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.071 1.348 . . . . 0.0 109.494 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.95 133.73 47.58 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.093 1.757 . . . . 0.0 108.133 175.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -133.89 173.87 11.08 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.091 1.357 . . . . 0.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -78.45 6.08 9.29 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.435 -0.791 . . . . 0.0 112.577 169.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.6 t -107.4 -49.31 3.28 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.537 1.135 . . . . 0.0 112.268 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -174.27 172.45 3.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.563 1.545 . . . . 0.0 112.484 -169.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.6 mt -85.04 139.79 31.5 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.17 0.988 . . . . 0.0 109.215 168.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.5 t -134.44 130.95 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.051 0.94 . . . . 0.0 111.217 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 mt -103.76 130.53 51.29 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.654 1.581 . . . . 0.0 110.026 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -111.42 124.09 51.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.868 2.067 . . . . 0.0 110.177 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 mp . . . . . 0 N--CA 1.474 0.769 0 C-N-CA 125.194 1.398 . . . . 0.0 111.838 -179.351 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.721 0 CA-C-O 120.549 0.214 . . . . 0.0 111.26 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 t -138.0 143.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.615 1.166 . . . . 0.0 109.842 -170.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.83 153.4 52.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.725 0.81 . . . . 0.0 113.003 -169.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -142.85 115.31 6.07 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.922 1.289 . . . . 0.0 111.348 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.02 150.26 66.36 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.628 2.219 . . . . 0.0 110.468 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -61.59 -22.98 65.69 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -38.84 92.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.112 1.765 . . . . 0.0 112.605 171.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.2 m -90.2 -9.56 47.65 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -69.43 127.94 34.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.572 0.749 . . . . 0.0 109.393 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -96.86 -26.8 14.96 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.574 0.75 . . . . 0.0 112.83 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -164.09 158.68 19.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.797 1.639 . . . . 0.0 111.454 169.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -144.84 107.96 4.55 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.773 1.229 . . . . 0.0 110.502 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.28 174.74 16.01 Favored Glycine 0 N--CA 1.463 0.478 0 C-N-CA 124.092 0.853 . . . . 0.0 113.531 -169.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -144.49 155.93 43.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.118 0.967 . . . . 0.0 111.384 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.37 -178.76 6.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.34 1.456 . . . . 0.0 110.532 171.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 t -62.59 120.44 11.15 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.359 -0.838 . . . . 0.0 110.774 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.33 15.16 0.62 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.81 2.444 . . . . 0.0 116.561 -174.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.11 126.25 26.26 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.893 1.277 . . . . 0.0 111.627 -169.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -118.13 134.42 55.01 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.693 1.597 . . . . 0.0 110.063 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.5 t -153.46 154.91 35.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.532 1.133 . . . . 0.0 112.385 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -148.69 150.61 33.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.423 1.489 . . . . 0.0 111.298 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -112.78 130.32 56.12 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.997 1.319 . . . . 0.0 109.747 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m -130.87 136.02 48.25 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.501 1.12 . . . . 0.0 110.594 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.74 175.54 51.73 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 123.783 0.706 . . . . 0.0 113.225 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -16.0 7.2 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -74.01 -18.38 60.86 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.028 2.531 . . . . 0.0 115.883 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.5 p -80.21 178.84 7.99 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -61.1 -44.4 97.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.832 1.253 . . . . 0.0 113.019 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.3 p -90.39 -18.81 24.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.73 1.212 . . . . 0.0 114.093 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.07 179.79 36.97 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.609 1.576 . . . . 0.0 112.391 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -66.94 126.51 29.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.273 0.629 . . . . 0.0 111.941 -169.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.85 178.42 40.34 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 122.448 1.026 . . . . 0.0 114.264 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.3 mt -116.1 133.74 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.968 1.707 . . . . 0.0 108.542 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -126.31 123.51 38.22 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.136 1.374 . . . . 0.0 109.627 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.1 143.01 50.71 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.297 1.046 . . . . 0.0 113.317 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -140.82 129.8 23.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.555 -169.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -68.07 131.26 45.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.81 0.444 . . . . 0.0 109.946 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 45.9 t -160.38 131.35 5.62 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.217 1.407 . . . . 0.0 111.377 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.8 t -71.32 -21.98 61.99 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -122.04 30.3 6.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.236 1.814 . . . . 0.0 113.4 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.66 -42.59 56.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.16 -36.64 77.62 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.248 0.619 . . . . 0.0 112.537 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.6 -35.77 80.99 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.602 -0.686 . . . . 0.0 111.588 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.8 mt -63.64 -47.73 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.534 0.606 . . . . 0.0 110.163 170.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.3 -38.47 77.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.333 1.053 . . . . 0.0 112.332 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -74.31 -29.0 61.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.237 1.415 . . . . 0.0 113.529 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 tt -84.22 -40.03 18.59 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.298 0.954 . . . . 0.0 110.464 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.8 mt -53.01 -54.01 41.53 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.737 0.815 . . . . 0.0 112.286 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -60.09 -25.08 65.14 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -20.37 53.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.96 1.304 . . . . 0.0 113.05 175.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.9 mt -91.59 -38.93 12.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.128 1.371 . . . . 0.0 110.873 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 60.6 mmm . . . . . 0 N--CA 1.469 0.515 0 C-N-CA 124.842 1.257 . . . . 0.0 112.421 -179.547 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 23.6 t80 . . . . . 0 CA--C 1.538 0.519 0 N-CA-C 110.767 -0.086 . . . . 0.0 110.767 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . 0.436 ' H ' ' HD3' ' B' ' 3' ' ' ARG . 0.0 OUTLIER -100.26 127.35 46.57 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.189 1.396 . . . . 0.0 111.327 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 44.7 mt -93.58 153.62 18.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -80.48 -36.7 33.05 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.818 1.647 . . . . 0.0 112.598 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -138.99 160.98 38.47 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.492 1.917 . . . . 0.0 111.764 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -78.61 121.33 83.48 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.9 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -84.28 -15.0 6.74 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.227 2.618 . . . . 0.0 113.833 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 85.6 m -90.79 116.87 28.97 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.95 0.9 . . . . 0.0 110.882 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.73 -16.28 80.75 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.91 0.767 . . . . 0.0 114.022 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -120.96 133.6 55.28 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.836 1.654 . . . . 0.0 109.507 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -162.1 145.49 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.945 1.298 . . . . 0.0 111.475 -169.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -111.76 130.52 55.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.045 1.738 . . . . 0.0 109.393 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 CA--C 1.542 0.639 0 C-N-CA 124.513 1.125 . . . . 0.0 110.818 -178.84 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 . . . . . 0 CA--C 1.56 1.35 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.49 -14.98 47.64 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.073 2.515 . . . . 0.0 115.529 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.7 p -125.6 -19.13 5.04 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.043 1.292 . . . . 0.0 114.432 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.71 144.02 44.55 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.377 1.071 . . . . 0.0 112.682 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -139.8 120.88 14.69 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.097 1.359 . . . . 0.0 108.973 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -72.57 134.02 45.0 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.462 -0.774 . . . . 0.0 110.207 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.43 163.62 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.796 1.239 . . . . 0.0 111.572 -170.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.8 m -138.66 118.68 13.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.301 1.041 . . . . 0.0 109.576 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -64.68 131.22 46.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.484 0.714 . . . . 0.0 110.491 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.46 157.69 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 113.054 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' OD1' HG22 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -88.01 -168.95 2.38 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.97 -28.6 69.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.044 1.738 . . . . 0.0 114.037 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -87.24 -13.38 43.99 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.257 1.023 . . . . 0.0 113.143 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.61 15.94 67.16 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.137 -1.368 . . . . 0.0 114.255 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.415 HG22 ' OD1' ' A' ' 27' ' ' ASP . 16.8 m -76.89 150.41 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.947 1.874 . . . . 0.0 111.181 173.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -87.56 124.98 34.06 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.451 1.1 . . . . 0.0 111.303 -171.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 mt -108.3 -52.41 2.77 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.741 0.817 . . . . 0.0 112.038 -172.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.71 136.52 5.65 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 124.46 1.028 . . . . 0.0 114.339 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.0 p -85.71 139.38 31.4 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.038 1.335 . . . . 0.0 112.291 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.61 170.52 24.74 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.376 1.941 . . . . 0.0 112.986 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.4 t -116.71 120.25 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.7 ttm -92.54 118.6 31.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.057 1.343 . . . . 0.0 109.775 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -109.23 130.14 55.49 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.911 1.684 . . . . 0.0 108.969 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.9 122.02 45.59 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.77 1.628 . . . . 0.0 107.164 174.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.4 p -114.57 173.59 6.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.549 1.14 . . . . 0.0 109.762 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -70.17 -3.38 16.55 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.415 -0.803 . . . . 0.0 112.904 173.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -120.23 -35.24 3.49 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -167.29 163.79 15.3 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.086 -1.009 . . . . 0.0 113.331 -169.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -87.43 136.35 32.97 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.37 1.468 . . . . 0.0 109.524 168.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.69 126.34 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.758 0.823 . . . . 0.0 110.853 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.9 mt -100.89 130.05 46.84 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.883 1.273 . . . . 0.0 110.298 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -101.59 122.3 43.59 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.997 1.719 . . . . 0.0 111.31 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? . . . . . 0 CA--C 1.545 0.755 0 C-N-CA 127.69 2.396 . . . . 0.0 110.692 -176.269 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.497 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -108.46 126.68 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -169.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -127.66 141.44 51.61 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -166.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -140.95 116.25 7.35 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.839 1.256 . . . . 0.0 111.168 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.87 144.96 66.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.036 1.824 . . . . 0.0 108.878 169.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -58.1 -29.98 65.91 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.04 -41.32 78.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.073 1.749 . . . . 0.0 112.283 175.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.9 m -86.48 4.62 38.97 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.4 mt -85.4 118.34 24.88 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.416 1.007 . . . . 0.0 109.487 171.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -75.43 -34.86 61.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.026 0.53 . . . . 0.0 111.781 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -165.92 158.4 14.83 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.011 2.125 . . . . 0.0 111.206 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -145.67 107.84 4.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.222 1.409 . . . . 0.0 112.045 -174.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -117.27 161.72 13.08 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.879 1.704 . . . . 0.0 114.172 -169.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -148.01 152.8 38.07 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.129 1.372 . . . . 0.0 113.109 -170.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -145.95 -179.14 6.5 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.387 1.875 . . . . 0.0 109.815 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 m -61.45 -12.7 15.76 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -154.13 10.0 0.38 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.406 1.482 . . . . 0.0 114.67 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -139.94 133.92 30.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.704 1.601 . . . . 0.0 110.633 -168.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -126.84 137.33 53.17 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.81 1.644 . . . . 0.0 110.013 172.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.1 t -153.47 158.16 40.94 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.444 1.098 . . . . 0.0 112.871 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -158.03 156.1 30.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.088 1.355 . . . . 0.0 112.938 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.47 139.77 32.08 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.421 1.489 . . . . 0.0 110.166 170.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.7 p -122.33 151.32 41.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.589 1.156 . . . . 0.0 112.718 169.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.43 164.28 26.79 Favored Glycine 0 N--CA 1.477 1.4 0 C-N-CA 125.228 1.394 . . . . 0.0 114.044 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -20.51 65.03 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -170.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 -82.52 -15.32 52.81 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.2 p -82.05 179.4 7.83 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -59.52 -44.28 93.21 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.686 1.594 . . . . 0.0 112.872 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.0 p -82.8 -29.14 29.76 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.55 -155.1 33.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.446 1.498 . . . . 0.0 112.157 -172.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -63.2 137.67 58.29 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.826 0.85 . . . . 0.0 112.363 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.66 165.55 18.74 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.217 0.913 . . . . 0.0 113.117 169.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.35 128.63 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.882 1.273 . . . . 0.0 107.756 168.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -127.18 122.92 35.43 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.59 1.156 . . . . 0.0 109.374 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.22 140.84 48.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.313 1.045 . . . . 0.0 112.132 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -133.44 122.02 23.1 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.503 1.121 . . . . 0.0 110.953 -171.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -71.46 132.93 45.47 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.4 0.68 . . . . 0.0 110.974 170.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 25.0 p -169.3 140.72 2.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.006 1.723 . . . . 0.0 111.448 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.4 m -83.09 4.83 24.66 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -133.18 25.85 4.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.158 1.383 . . . . 0.0 113.748 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.19 -37.71 23.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.599 1.559 . . . . 0.0 114.122 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.71 -36.47 80.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.0 0.92 . . . . 0.0 112.984 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.68 -32.54 71.21 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.236 0.925 . . . . 0.0 111.863 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.59 -48.01 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 122.976 0.51 . . . . 0.0 109.658 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -37.78 83.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.401 1.081 . . . . 0.0 112.721 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -68.75 -33.43 73.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.486 1.114 . . . . 0.0 112.478 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.0 tp -84.63 -37.49 21.01 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.961 0.8 . . . . 0.0 112.168 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.76 -56.35 14.39 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.143 0.883 . . . . 0.0 112.211 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -59.75 -23.57 63.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -24.7 45.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.627 1.171 . . . . 0.0 113.042 176.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.4 mt -98.05 -34.5 10.76 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.806 1.642 . . . . 0.0 111.686 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 96.8 mtp . . . . . 0 N--CA 1.472 0.645 0 C-N-CA 125.236 1.415 . . . . 0.0 113.034 176.468 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.8 t80 . . . . . 0 N--CA 1.467 0.422 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.33 121.53 25.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.157 0.583 . . . . 0.0 111.251 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 78.6 mt -86.46 155.19 20.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -84.71 -13.96 49.8 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.637 1.575 . . . . 0.0 113.506 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -163.35 169.21 19.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.527 2.331 . . . . 0.0 110.706 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -86.19 120.52 72.42 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.01 -9.23 17.97 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.488 2.792 . . . . 0.0 114.209 -172.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 44.7 t -92.03 -74.27 0.52 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.056 0.942 . . . . 0.0 113.13 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.02 -41.7 3.04 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.774 1.654 . . . . 0.0 114.066 -172.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -81.47 91.87 6.38 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.544 1.172 . . . . 0.0 109.997 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.41 139.88 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -100.06 141.77 32.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.138 2.175 . . . . 0.0 111.108 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 . . . . . 0 CA--C 1.54 0.587 0 C-N-CA 124.618 1.167 . . . . 0.0 111.273 -177.258 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.475 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.3 t -165.49 175.3 9.13 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.044 1.738 . . . . 0.0 110.671 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.6 p -164.14 168.45 18.99 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 125.205 1.402 . . . . 0.0 112.841 -174.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.45 143.04 5.8 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.443 1.497 . . . . 0.0 112.783 179.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -154.28 157.3 38.47 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 126.239 1.816 . . . . 0.0 110.537 -176.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 23.3 m -159.96 146.64 16.11 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 125.344 1.458 . . . . 0.0 111.32 -179.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -81.77 36.63 2.48 Favored Glycine 0 N--CA 1.474 1.212 0 C-N-CA 125.303 1.43 . . . . 0.0 113.938 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.6 mt -103.1 136.59 42.61 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.592 1.557 . . . . 0.0 111.17 -176.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -71.05 165.04 24.34 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.134 0.974 . . . . 0.0 111.905 173.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -128.23 118.15 22.8 Favored 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 124.811 1.245 . . . . 0.0 109.466 175.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -77.88 -20.21 53.39 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.012 1.325 . . . . 0.0 113.44 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.5 p -169.43 162.33 10.18 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 126.979 2.112 . . . . 0.0 110.045 -177.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.627 HG13 ' HE2' ' A' ' 22' ' ' LYS . 10.7 p -96.81 127.8 37.99 Favored Pre-proline 0 N--CA 1.478 0.957 0 C-N-CA 123.911 0.885 . . . . 0.0 109.89 175.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.05 166.53 20.8 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 123.028 2.485 . . . . 0.0 111.701 178.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -68.79 -6.89 29.45 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 124.958 1.303 . . . . 0.0 113.582 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 38.0 p30 -131.1 18.6 4.97 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.596 1.558 . . . . 0.0 114.802 -170.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 39.5 t-80 -58.13 145.48 73.3 Favored Pre-proline 0 CA--C 1.558 1.279 0 O-C-N 121.143 -0.973 . . . . 0.0 112.747 177.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -71.73 -11.91 28.33 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.08 2.52 . . . . 0.0 115.478 -179.743 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 51.5 p -131.87 -16.42 2.92 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 120.155 1.343 . . . . 0.0 114.604 179.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.9 147.76 37.93 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.614 1.166 . . . . 0.0 111.505 172.715 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -140.8 118.57 11.71 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 123.994 0.918 . . . . 0.0 108.844 -177.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.627 ' HE2' HG13 ' A' ' 13' ' ' VAL . 51.2 mttm -67.35 127.05 31.22 Favored 'General case' 0 CA--C 1.54 0.591 0 O-C-N 121.801 -0.562 . . . . 0.0 109.706 170.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 22.9 m -134.97 159.93 41.3 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 C-N-CA 125.696 1.598 . . . . 0.0 110.669 -171.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.0 m -135.27 119.17 17.34 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.175 0.99 . . . . 0.0 109.039 175.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t-20 -65.8 132.52 48.92 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.323 0.649 . . . . 0.0 110.267 178.271 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.3 m -127.95 155.59 39.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.554 0 C-N-CA 124.293 1.037 . . . . 0.0 112.665 -176.252 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.405 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.3 p-10 -91.05 -168.89 2.18 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.847 1.259 . . . . 0.0 114.34 -177.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -63.07 -21.4 66.15 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.228 1.811 . . . . 0.0 114.044 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -95.89 -10.23 29.34 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.948 1.299 . . . . 0.0 112.95 174.313 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.17 16.28 72.31 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 117.934 -1.481 . . . . 0.0 114.239 -172.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.405 HG22 ' OD1' ' A' ' 27' ' ' ASP . 13.4 m -77.65 149.7 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.935 0 CA-C-N 120.12 1.96 . . . . 0.0 111.353 174.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -86.68 126.96 34.9 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.349 1.059 . . . . 0.0 111.497 -172.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 44.6 mt -108.94 -51.11 2.92 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 124.002 0.921 . . . . 0.0 112.0 -170.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.33 143.44 9.19 Favored Glycine 0 N--CA 1.47 0.928 0 C-N-CA 124.76 1.171 . . . . 0.0 113.854 178.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.5 p -90.07 150.87 21.89 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 125.115 1.366 . . . . 0.0 112.909 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -159.11 172.63 35.85 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 126.195 1.855 . . . . 0.0 113.039 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.6 t -115.31 120.85 65.85 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.658 0 N-CA-C 108.301 -1.0 . . . . 0.0 108.301 169.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.1 tpp -86.29 131.9 34.11 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 123.846 0.859 . . . . 0.0 109.354 170.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.6 tt0 -118.5 127.93 54.1 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.405 1.482 . . . . 0.0 109.118 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -110.5 127.96 55.41 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 126.618 1.967 . . . . 0.0 107.993 175.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -160.45 152.28 19.96 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 126.47 1.908 . . . . 0.0 108.024 -171.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -57.23 -18.06 14.38 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.86 1.264 . . . . 0.0 113.943 -172.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 10.7 t -78.16 -51.94 9.47 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 113.45 0.907 . . . . 0.0 113.45 177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -178.37 174.73 1.25 Allowed 'General case' 0 N--CA 1.478 0.929 0 C-N-CA 125.855 1.662 . . . . 0.0 112.501 -170.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.1 mt -86.81 139.2 30.93 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 123.772 0.829 . . . . 0.0 110.688 169.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 42.6 t -138.59 134.42 43.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 C-N-CA 123.951 0.901 . . . . 0.0 111.696 178.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.3 mt -100.14 131.49 46.06 Favored 'General case' 0 N--CA 1.467 0.388 0 C-N-CA 125.357 1.463 . . . . 0.0 110.537 167.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -110.92 139.51 46.19 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 127.153 2.181 . . . . 0.0 110.681 171.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.31 -151.25 0.37 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.356 1.463 . . . . 0.0 110.848 -173.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . 0.53 ' CG ' ' H ' ' A' ' 51' ' ' ARG . 16.6 t60 -70.65 -159.97 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.334 0 C-N-CA 125.592 1.557 . . . . 0.0 113.379 -178.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.53 ' H ' ' CG ' ' A' ' 50' ' ' HIS . 22.9 mmm180 -58.64 -12.68 4.4 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 125.928 1.691 . . . . 0.0 114.471 174.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -57.49 159.45 4.9 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 126.49 1.916 . . . . 0.0 111.679 168.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -61.14 140.56 57.87 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.297 0.639 . . . . 0.0 112.071 175.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.39 159.37 32.43 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 124.028 0.931 . . . . 0.0 111.247 171.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 6.3 t -133.4 134.34 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.951 0 C-N-CA 122.856 0.462 . . . . 0.0 111.566 -170.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 98.3 mtt180 -125.74 147.1 49.49 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.591 1.556 . . . . 0.0 112.836 -169.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.2 m-90 -143.91 117.11 5.81 Favored Pre-proline 0 CA--C 1.547 0.844 0 C-N-CA 125.308 1.443 . . . . 0.0 111.429 174.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -70.86 148.62 58.38 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.73 2.287 . . . . 0.0 110.509 174.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 49.1 m-85 -60.36 -27.51 67.44 Favored 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 113.067 0.765 . . . . 0.0 113.067 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -56.59 -39.69 73.97 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 125.729 1.612 . . . . 0.0 112.076 172.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.7 m -72.84 -17.7 61.52 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 114.13 1.159 . . . . 0.0 114.13 176.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 46.8 mt -84.63 81.41 8.87 Favored 'General case' 0 N--CA 1.468 0.439 0 CA-C-N 119.544 1.066 . . . . 0.0 110.998 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.529 ' HD2' ' H ' ' A' ' 63' ' ' ARG . 0.0 OUTLIER -59.39 -30.98 68.82 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.831 0.852 . . . . 0.0 113.17 173.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 10.6 ptp180 -152.35 148.76 27.88 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.231 1.412 . . . . 0.0 111.594 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.3 p90 -146.45 112.12 5.61 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.62 1.568 . . . . 0.0 110.402 -177.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.32 162.93 13.08 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 124.918 1.246 . . . . 0.0 114.566 -168.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 1.8 p90 -145.66 144.93 30.71 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.187 1.395 . . . . 0.0 111.879 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -144.05 -175.71 4.71 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 125.897 1.679 . . . . 0.0 109.906 176.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.1 m -56.53 112.48 1.28 Allowed 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.347 -0.846 . . . . 0.0 110.81 177.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.253 0.8 OUTLIER 49.33 23.59 0.87 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 127.666 2.387 . . . . 0.0 116.561 -173.133 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -132.22 129.41 39.66 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.488 1.515 . . . . 0.0 111.181 -172.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 49.4 t80 -123.85 139.09 54.31 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 125.769 1.628 . . . . 0.0 109.997 173.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 20.1 t -153.57 155.56 36.37 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 120.962 -1.086 . . . . 0.0 113.41 -176.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 48.2 p90 -149.22 148.23 29.35 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.982 1.313 . . . . 0.0 112.606 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -101.97 147.77 26.16 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.625 1.97 . . . . 0.0 108.403 177.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 25.0 m -155.0 134.85 12.86 Favored 'General case' 0 N--CA 1.471 0.6 0 O-C-N 120.625 -1.297 . . . . 0.0 112.153 -176.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.57 170.44 54.54 Favored Glycine 0 CA--C 1.529 0.942 0 C-N-CA 124.247 0.927 . . . . 0.0 113.605 -176.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.59 -12.96 7.58 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 -175.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 14.5 ptm180 -77.34 -16.51 58.88 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 115.855 1.798 . . . . 0.0 115.855 -174.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 18.4 p -86.42 176.69 7.73 Favored 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -174.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -55.75 -41.1 73.48 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.624 1.57 . . . . 0.0 113.528 -176.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 28.9 p -91.79 -16.83 26.24 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 125.397 1.479 . . . . 0.0 113.94 -173.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.15 -169.98 42.59 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 126.031 1.776 . . . . 0.0 112.138 -176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 44.1 tt0 -67.68 126.68 30.12 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 123.648 0.779 . . . . 0.0 110.79 -177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 165.21 162.71 16.91 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-O 121.912 0.729 . . . . 0.0 114.345 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 86.9 mt -105.57 133.5 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 125.107 1.363 . . . . 0.0 108.775 175.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -125.71 124.45 41.11 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.626 1.17 . . . . 0.0 109.759 -175.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.44 143.88 49.86 Favored 'General case' 0 C--O 1.239 0.505 0 C-N-CA 124.473 1.109 . . . . 0.0 112.61 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -140.47 127.8 21.2 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.493 -169.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 80.3 mttt -72.47 136.24 45.92 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 123.085 0.554 . . . . 0.0 110.345 169.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 48.8 t -163.8 131.59 3.51 Favored 'General case' 0 N--CA 1.467 0.416 0 C-N-CA 125.591 1.556 . . . . 0.0 110.644 -172.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.5 t -71.31 -8.31 52.86 Favored 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 113.668 0.988 . . . . 0.0 113.668 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 72.9 mtp85 -129.48 26.01 5.39 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 126.26 1.824 . . . . 0.0 112.834 -173.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -51.17 -36.01 38.94 Favored 'General case' 0 CA--C 1.544 0.719 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 -179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 79.4 tt0 -70.22 -38.01 75.16 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.429 0.692 . . . . 0.0 112.759 175.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -67.43 -33.18 74.63 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.497 -0.752 . . . . 0.0 111.612 174.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 97.4 mt -62.58 -51.09 76.44 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 169.166 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -60.84 -37.62 82.69 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.841 0.857 . . . . 0.0 112.662 -179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -69.75 -30.33 67.88 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 124.6 1.16 . . . . 0.0 112.796 175.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 38.1 tp -84.45 -37.11 21.81 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 119.006 0.821 . . . . 0.0 112.419 176.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 23.1 mt -53.43 -54.17 40.69 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 119.321 0.964 . . . . 0.0 111.832 179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -59.0 -26.68 64.74 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -70.8 -30.71 67.24 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.723 1.209 . . . . 0.0 112.766 176.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 45.0 mt -91.59 -38.33 12.55 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 125.6 1.56 . . . . 0.0 111.135 178.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.8 mtp -71.87 -27.88 63.16 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 125.2 1.4 . . . . 0.0 113.012 -178.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -75.66 -16.15 60.23 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 123.332 0.653 . . . . 0.0 112.54 168.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 7.7 t -89.09 -27.75 20.56 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 -170.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.1 m120 64.86 -24.86 0.08 Allowed 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 128.851 2.86 . . . . 0.0 116.581 177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 22.1 m 60.41 34.25 20.61 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 125.823 1.649 . . . . 0.0 114.886 167.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.62 ' H ' HD12 ' A' ' 110' ' ' ILE . 4.5 mp -54.45 98.21 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 C-N-CA 127.527 2.331 . . . . 0.0 111.299 -167.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 51.21 32.19 7.76 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 125.366 1.466 . . . . 0.0 112.815 -175.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.6 p -51.31 -24.05 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.075 0 N-CA-C 115.466 1.654 . . . . 0.0 115.466 -177.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -133.06 154.95 50.07 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.005 1.722 . . . . 0.0 111.154 170.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -74.48 105.53 5.66 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 123.343 0.657 . . . . 0.0 110.716 -178.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -83.67 156.29 65.02 Favored Pre-proline 0 CA--C 1.547 0.843 0 C-N-CA 125.045 1.338 . . . . 0.0 112.194 178.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 95.2 Cg_endo -70.42 178.9 4.49 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 124.017 3.145 . . . . 0.0 111.905 173.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.8 p -61.07 134.15 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 124.212 1.005 . . . . 0.0 111.379 172.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 30.1 mm -141.23 154.71 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 C-N-CA 126.288 1.835 . . . . 0.0 109.651 -174.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.7 pt -63.56 0.63 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 C-N-CA 126.498 1.919 . . . . 0.0 115.602 -175.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 6.4 t -71.16 -17.86 62.52 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.757 1.623 . . . . 0.0 112.456 169.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -56.28 155.31 6.98 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 125.702 1.601 . . . . 0.0 113.055 172.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -64.82 136.63 57.1 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.194 0.597 . . . . 0.0 111.7 174.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 86.6 p -171.6 -171.89 0.97 Allowed 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.037 1.735 . . . . 0.0 111.063 -173.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 57.2 p-80 -55.69 147.2 42.17 Favored Pre-proline 0 CA--C 1.556 1.174 0 O-C-N 121.034 -1.041 . . . . 0.0 113.104 170.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.29 152.36 66.56 Favored 'Trans proline' 0 C--N 1.353 0.77 0 C-N-CA 123.372 2.715 . . . . 0.0 111.168 177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -161.62 172.33 16.5 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.855 1.662 . . . . 0.0 111.063 -175.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -68.07 116.94 9.27 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.086 0.554 . . . . 0.0 109.638 172.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.8 tt -150.88 139.03 20.15 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.1 1.76 . . . . 0.0 108.62 -170.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -58.11 138.39 56.15 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.03 1.332 . . . . 0.0 114.364 -171.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.4 pp -92.46 151.98 41.77 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 124.906 1.282 . . . . 0.0 111.943 -175.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -81.58 -178.4 4.21 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.386 2.724 . . . . 0.0 111.493 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 8.7 ptp85 -60.53 160.68 8.6 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.811 0.845 . . . . 0.0 112.597 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -138.39 145.61 47.66 Favored Pre-proline 0 CA--C 1.547 0.853 0 C-N-CA 125.19 1.396 . . . . 0.0 111.196 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -73.59 153.56 49.36 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.522 2.815 . . . . 0.0 111.538 -178.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -74.42 129.9 83.13 Favored Pre-proline 0 CA--C 1.546 0.804 0 C-N-CA 123.406 0.682 . . . . 0.0 109.595 174.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.89 141.69 49.63 Favored 'Trans proline' 0 CA--C 1.544 0.977 0 C-N-CA 123.033 2.489 . . . . 0.0 111.351 -177.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -76.93 158.62 34.59 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.844 3.029 . . . . 0.0 112.215 -177.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 -78.08 145.99 35.48 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 124.325 1.05 . . . . 0.0 112.764 175.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -82.09 161.45 22.87 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.343 1.057 . . . . 0.0 112.197 174.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 34.2 tp -113.79 143.77 44.1 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.544 1.537 . . . . 0.0 110.432 177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -80.82 -162.44 27.86 Favored Glycine 0 CA--C 1.534 1.257 0 C-N-CA 124.599 1.095 . . . . 0.0 113.471 177.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -154.17 151.61 29.42 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 125.069 1.348 . . . . 0.0 112.068 -177.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.0 t -79.17 176.5 9.61 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.435 1.094 . . . . 0.0 111.493 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.5 p -130.43 136.23 58.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 C-N-CA 125.797 1.639 . . . . 0.0 110.793 -171.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.7 t -87.1 171.04 11.0 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 124.451 1.101 . . . . 0.0 113.141 -175.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 37.3 m . . . . . 0 C--O 1.254 1.342 0 C-N-CA 126.131 1.772 . . . . 0.0 113.694 -177.676 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.6 mm? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -78.78 130.56 35.88 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.968 0.907 . . . . 0.0 111.141 178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -90.88 109.69 20.91 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.264 1.026 . . . . 0.0 109.607 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 37.7 mt -74.66 156.89 36.21 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 123.953 0.901 . . . . 0.0 113.015 177.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -79.76 -24.71 41.36 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.11 1.364 . . . . 0.0 113.582 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 4.7 p80 -162.05 169.75 20.45 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.535 1.934 . . . . 0.0 111.344 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.5 t80 -80.78 124.73 81.5 Favored Pre-proline 0 CA--C 1.548 0.872 0 CA-C-O 118.745 -0.645 . . . . 0.0 111.259 -174.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -81.34 6.27 5.72 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 123.859 3.04 . . . . 0.0 113.786 -172.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 47.9 t -127.98 131.84 49.23 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 125.001 1.32 . . . . 0.0 112.07 -171.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -94.13 -17.31 40.75 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 124.91 1.243 . . . . 0.0 115.122 -179.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -113.61 112.66 23.89 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.177 1.391 . . . . 0.0 110.286 -179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.6 p -154.89 134.51 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-O 121.777 0.799 . . . . 0.0 111.993 -169.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -93.8 120.03 33.54 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 127.043 2.137 . . . . 0.0 110.271 171.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -83.75 111.35 19.09 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 123.794 0.837 . . . . 0.0 110.242 177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -87.06 -67.48 1.34 Allowed Glycine 0 N--CA 1.47 0.934 0 C-N-CA 124.277 0.942 . . . . 0.0 112.511 -172.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -98.54 121.06 40.01 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.279 1.032 . . . . 0.0 111.177 -174.158 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -94.9 27.74 3.01 Favored 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.584 1.554 . . . . 0.0 112.616 -179.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 33.4 tt0 -126.79 149.37 49.7 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 126.025 1.73 . . . . 0.0 109.618 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? . . . . . 0 C--O 1.25 1.097 0 C-N-CA 125.462 1.505 . . . . 0.0 113.973 -169.82 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 N-CA-C 112.097 -0.401 . . . . 0.0 112.097 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.0 p -165.89 173.79 10.19 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.692 1.597 . . . . 0.0 111.576 -175.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 57.0 p -156.11 151.67 27.02 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 124.742 1.217 . . . . 0.0 112.14 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -86.95 -171.15 47.43 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.697 1.141 . . . . 0.0 113.696 179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.5 t -160.26 166.14 30.11 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 125.579 1.552 . . . . 0.0 110.931 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 7.2 t -164.12 169.34 17.91 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.538 1.535 . . . . 0.0 111.557 -175.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -166.24 -160.83 14.05 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.265 1.412 . . . . 0.0 113.355 -178.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.6 pp -154.65 166.47 33.28 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 125.623 1.569 . . . . 0.0 111.658 -179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.2 m-80 -145.78 140.66 27.3 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.253 1.421 . . . . 0.0 111.262 -178.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 36.5 ptt180 -73.63 169.51 17.14 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 124.999 1.32 . . . . 0.0 112.336 174.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -80.85 -11.51 59.58 Favored 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.473 1.109 . . . . 0.0 113.91 -179.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.3 t -95.28 123.95 39.06 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.522 1.129 . . . . 0.0 111.877 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 41.0 t -79.26 123.06 84.78 Favored Pre-proline 0 N--CA 1.477 0.92 0 C-N-CA 124.576 1.15 . . . . 0.0 110.228 -173.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.54 154.86 27.72 Favored 'Trans proline' 0 C--N 1.349 0.56 0 C-N-CA 122.999 2.466 . . . . 0.0 110.995 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -66.74 -5.16 10.93 Favored 'General case' 0 CA--C 1.546 0.789 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 174.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -113.99 9.42 17.37 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 126.537 1.935 . . . . 0.0 113.936 -179.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -55.39 138.65 67.66 Favored Pre-proline 0 CA--C 1.555 1.144 0 O-C-N 121.05 -1.031 . . . . 0.0 112.29 178.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -65.87 -15.0 47.25 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 C-N-CA 123.163 2.575 . . . . 0.0 115.141 -176.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 62.6 p -128.41 -18.14 4.06 Favored 'General case' 0 N--CA 1.478 0.957 0 CA-C-N 120.19 1.359 . . . . 0.0 114.459 179.202 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.18 113.18 24.99 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 119.186 0.903 . . . . 0.0 111.112 174.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -107.94 113.23 26.28 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.127 0.971 . . . . 0.0 109.333 -179.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 48.8 mttm -67.11 131.29 45.51 Favored 'General case' 0 CA--C 1.543 0.701 0 O-C-N 121.581 -0.7 . . . . 0.0 110.253 174.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.2 m -140.5 152.79 21.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 125.261 1.425 . . . . 0.0 111.125 -169.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 76.5 m -130.45 118.37 21.05 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 123.837 0.855 . . . . 0.0 109.09 175.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 11.5 t-20 -66.29 133.97 51.66 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.941 0.896 . . . . 0.0 110.642 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.6 m -127.36 155.08 38.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 C-N-CA 123.924 0.89 . . . . 0.0 112.733 -176.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -86.83 -168.3 2.19 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 124.576 1.151 . . . . 0.0 113.695 178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -72.52 -20.09 61.41 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 124.637 1.175 . . . . 0.0 113.592 178.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -84.76 -15.48 44.87 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.951 1.301 . . . . 0.0 112.408 171.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.98 16.48 67.44 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.042 -1.421 . . . . 0.0 114.449 -174.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 15.6 m -79.49 151.08 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 CA-C-N 119.844 1.822 . . . . 0.0 111.667 173.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -87.27 128.16 35.17 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.857 1.263 . . . . 0.0 111.308 -174.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 49.0 mt -110.09 -52.17 2.8 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 123.964 0.906 . . . . 0.0 112.347 -169.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.11 152.71 23.78 Favored Glycine 0 CA--C 1.527 0.824 0 C-N-CA 125.669 1.604 . . . . 0.0 112.569 179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.0 t -116.28 149.35 39.37 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.939 0.896 . . . . 0.0 112.82 -172.447 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.99 174.7 33.19 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 126.784 2.135 . . . . 0.0 113.643 -169.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.2 t -114.83 120.5 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 170.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.1 tpp -86.65 131.52 34.13 Favored 'General case' 0 CA--C 1.529 0.145 0 C-N-CA 123.95 0.9 . . . . 0.0 109.475 172.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -127.36 129.99 48.6 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 125.63 1.572 . . . . 0.0 108.818 -178.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.22 131.1 53.11 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 126.384 1.873 . . . . 0.0 107.804 178.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.0 p -130.55 171.3 13.18 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.023 1.329 . . . . 0.0 109.774 179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -70.6 -7.65 45.72 Favored 'General case' 0 CA--C 1.545 0.767 0 O-C-N 121.218 -0.926 . . . . 0.0 112.62 172.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 58.3 m -102.4 -43.59 5.62 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.453 1.101 . . . . 0.0 113.428 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.4 pt-20 -173.94 170.68 3.82 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.174 1.389 . . . . 0.0 113.151 -169.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -86.87 140.89 29.2 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.856 1.262 . . . . 0.0 110.275 168.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 62.6 t -135.31 129.99 50.48 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.959 0 C-N-CA 124.545 1.138 . . . . 0.0 111.463 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.7 mt -100.23 126.36 46.52 Favored 'General case' 0 N--CA 1.468 0.453 0 C-N-CA 124.679 1.192 . . . . 0.0 110.251 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -98.95 127.52 44.89 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.55 1.54 . . . . 0.0 110.704 169.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 83.8 mt -136.39 158.13 45.17 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 127.167 2.187 . . . . 0.0 110.065 -172.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.65 -82.43 0.11 Allowed 'General case' 0 CA--C 1.551 0.991 0 C-N-CA 123.963 0.905 . . . . 0.0 112.604 -176.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 57.7 mmm-85 -85.53 -2.87 58.59 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 124.567 1.147 . . . . 0.0 113.793 -175.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.4 mpt_? -107.85 155.26 20.46 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 125.97 1.708 . . . . 0.0 110.874 177.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -67.5 148.37 51.59 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.223 1.009 . . . . 0.0 111.231 175.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.54 137.74 55.97 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.684 0.794 . . . . 0.0 111.769 178.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.5 t -120.24 134.49 63.57 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 C-N-CA 124.129 0.971 . . . . 0.0 109.724 -174.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -136.3 150.21 48.79 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.574 1.15 . . . . 0.0 112.71 -168.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 27.3 m-90 -142.26 115.22 6.4 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.751 1.22 . . . . 0.0 111.421 -178.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -68.09 146.6 71.11 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 122.549 2.166 . . . . 0.0 110.017 172.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -60.7 -29.98 69.67 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 113.445 0.906 . . . . 0.0 113.445 -178.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.31 -34.13 70.24 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.196 1.798 . . . . 0.0 112.679 173.31 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.9 m -83.28 -9.38 59.14 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 115.178 1.547 . . . . 0.0 115.178 176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.57 88.17 7.03 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 119.641 1.109 . . . . 0.0 110.199 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -64.98 -29.74 70.69 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 123.758 0.823 . . . . 0.0 113.114 177.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 3.1 ptp180 -154.71 154.75 33.38 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.95 0.9 . . . . 0.0 112.691 167.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.3 p90 -151.41 144.84 24.84 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 125.255 1.422 . . . . 0.0 109.633 178.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -159.49 -179.65 34.45 Favored Glycine 0 N--CA 1.464 0.566 0 CA-C-O 121.558 0.532 . . . . 0.0 114.222 -172.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -149.09 165.06 32.85 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 124.227 1.011 . . . . 0.0 113.12 -172.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -148.85 -169.47 3.37 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 126.706 2.002 . . . . 0.0 109.578 172.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 93.8 p -69.23 -18.22 63.86 Favored 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -174.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.7 p-10 -152.49 8.79 0.46 Allowed 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.795 1.638 . . . . 0.0 113.891 -177.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -138.63 129.23 26.21 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.574 1.55 . . . . 0.0 110.754 -168.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 51.4 t80 -120.98 140.06 52.42 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.037 1.735 . . . . 0.0 109.504 174.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.4 t -153.35 159.24 42.41 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.31 1.044 . . . . 0.0 112.791 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.7 p90 -149.42 149.48 30.88 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.724 1.61 . . . . 0.0 111.689 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -113.22 134.23 54.68 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.525 1.93 . . . . 0.0 109.628 -179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.4 m -132.87 154.91 49.9 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.686 1.195 . . . . 0.0 112.192 -171.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.9 167.51 18.54 Favored Glycine 0 CA--C 1.536 1.348 0 C-N-CA 125.069 1.319 . . . . 0.0 114.28 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 40.0 mtp180 -54.54 -27.34 37.74 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 115.467 1.655 . . . . 0.0 115.467 -173.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -73.43 -15.44 61.34 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.67 1.988 . . . . 0.0 115.706 -177.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.2 p -83.47 -176.46 6.32 Favored 'General case' 0 CA--C 1.553 1.063 0 N-CA-C 113.615 0.968 . . . . 0.0 113.615 178.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.3 tt0 -60.48 -46.34 90.45 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.391 1.076 . . . . 0.0 112.779 -178.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.6 p -89.3 -21.39 23.19 Favored 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.595 1.158 . . . . 0.0 113.146 -177.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.38 -156.39 33.6 Favored Glycine 0 CA--C 1.529 0.967 0 C-N-CA 125.824 1.678 . . . . 0.0 112.271 -176.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -63.64 134.02 54.7 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.601 0.76 . . . . 0.0 111.691 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 155.76 175.35 26.67 Favored Glycine 0 CA--C 1.523 0.555 0 CA-C-O 122.156 0.864 . . . . 0.0 113.074 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 55.8 mt -124.65 138.82 52.78 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.724 1.609 . . . . 0.0 108.368 174.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -134.2 123.58 24.56 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.878 1.271 . . . . 0.0 109.96 -175.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.86 143.4 50.37 Favored 'General case' 0 C--O 1.238 0.49 0 C-N-CA 124.347 1.059 . . . . 0.0 112.962 -169.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -139.54 126.49 20.94 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 115.111 -0.949 . . . . 0.0 111.851 -169.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.6 mttm -71.07 133.88 46.62 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 123.739 0.815 . . . . 0.0 110.914 169.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 20.6 p -168.15 147.96 4.76 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 126.016 1.726 . . . . 0.0 111.924 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 9.0 t -82.55 -0.4 46.57 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 124.088 0.955 . . . . 0.0 113.103 -179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -128.25 22.56 6.08 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 126.038 1.735 . . . . 0.0 112.661 -174.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.22 -41.26 49.58 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.567 1.147 . . . . 0.0 113.923 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -70.35 -35.29 73.48 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.479 1.112 . . . . 0.0 113.225 176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -66.33 -39.61 89.34 Favored 'General case' 0 N--CA 1.468 0.445 0 O-C-N 121.468 -0.77 . . . . 0.0 110.816 174.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.2 mt -60.81 -47.54 92.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 C-N-CA 123.243 0.617 . . . . 0.0 110.167 172.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -61.74 -37.83 85.69 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 123.843 0.857 . . . . 0.0 112.673 179.074 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -72.54 -30.69 64.67 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 175.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -81.16 -42.22 21.19 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 118.911 0.778 . . . . 0.0 110.684 180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.9 mt -50.24 -56.93 9.1 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.667 1.187 . . . . 0.0 113.096 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -60.79 -20.54 61.69 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.8 1.037 . . . . 0.0 113.8 -178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.06 -23.37 33.2 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.663 1.185 . . . . 0.0 113.012 175.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 58.4 mt -94.9 -35.72 11.91 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 124.513 1.125 . . . . 0.0 111.749 175.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.1 mtp -64.48 -27.03 68.7 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.557 1.143 . . . . 0.0 112.808 176.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -83.44 -10.76 58.18 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 113.979 1.103 . . . . 0.0 113.979 169.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 19.7 t -101.26 -28.02 12.87 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 125.463 1.505 . . . . 0.0 112.604 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 21.4 t-20 -59.9 147.63 37.88 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.142 1.777 . . . . 0.0 111.505 173.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.5 m -64.22 98.98 0.25 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.971 1.309 . . . . 0.0 113.445 -173.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 36.8 mm -76.99 -40.67 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 O-C-N 121.371 -0.831 . . . . 0.0 111.929 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 46.6 p30 -143.81 5.06 1.34 Allowed 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 -171.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 71.1 t -77.68 -28.33 15.74 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.734 0 C-N-CA 125.323 1.449 . . . . 0.0 111.518 -178.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 26.3 mmt -128.03 147.26 50.51 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.106 1.763 . . . . 0.0 110.893 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -82.34 128.37 34.15 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.015 0.926 . . . . 0.0 110.271 175.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -74.84 144.63 80.18 Favored Pre-proline 0 CA--C 1.548 0.884 0 C-N-CA 123.604 0.762 . . . . 0.0 112.137 179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -74.99 159.12 41.76 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 123.44 2.76 . . . . 0.0 111.284 175.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 12.9 p -97.68 133.12 40.79 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.398 1.079 . . . . 0.0 110.196 172.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.97 126.39 73.67 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 C-N-CA 125.095 1.358 . . . . 0.0 107.972 174.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 45.8 mm -106.93 138.41 32.87 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 124.923 1.289 . . . . 0.0 108.484 172.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.6 t -136.41 157.22 47.3 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.304 1.442 . . . . 0.0 110.384 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -57.78 140.05 52.54 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 124.841 1.256 . . . . 0.0 112.396 -174.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 15.0 p30 -113.09 164.18 13.81 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.782 1.233 . . . . 0.0 112.426 -178.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 12.4 t -159.64 151.93 20.98 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.225 1.41 . . . . 0.0 110.334 -178.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -69.52 141.1 90.29 Favored Pre-proline 0 CA--C 1.554 1.129 0 O-C-N 121.238 -0.914 . . . . 0.0 112.409 -176.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -71.82 157.77 54.43 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.531 2.821 . . . . 0.0 111.541 178.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -70.25 145.92 51.0 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 123.771 0.828 . . . . 0.0 112.172 176.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -110.06 135.98 50.03 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 125.646 1.578 . . . . 0.0 110.523 -178.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.9 tt -87.93 141.34 28.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.116 1.366 . . . . 0.0 111.084 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -118.53 144.75 45.84 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 125.702 1.601 . . . . 0.0 111.318 175.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 pp -95.95 156.25 37.4 Favored Pre-proline 0 CA--C 1.55 0.962 0 C-N-CA 125.153 1.381 . . . . 0.0 112.347 178.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -80.72 153.5 20.04 Favored 'Trans proline' 0 C--N 1.351 0.678 0 C-N-CA 123.138 2.558 . . . . 0.0 112.372 -176.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.54 167.89 15.83 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.962 1.305 . . . . 0.0 113.334 172.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -141.98 149.63 53.31 Favored Pre-proline 0 CA--C 1.55 0.973 0 C-N-CA 125.646 1.578 . . . . 0.0 111.509 178.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.7 159.59 42.13 Favored 'Trans proline' 0 C--N 1.352 0.731 0 C-N-CA 123.764 2.976 . . . . 0.0 112.328 -177.086 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.4 pt20 -91.33 151.3 42.67 Favored Pre-proline 0 CA--C 1.548 0.894 0 C-N-CA 124.442 1.097 . . . . 0.0 111.727 176.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.14 157.06 51.07 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.319 2.679 . . . . 0.0 111.727 176.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -73.73 154.94 49.32 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.786 2.991 . . . . 0.0 112.025 178.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 16.5 p30 -83.74 176.29 9.06 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.572 1.149 . . . . 0.0 113.3 177.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -147.53 167.23 25.02 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.905 1.682 . . . . 0.0 111.594 178.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 tt -147.82 127.17 13.08 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.346 1.458 . . . . 0.0 109.303 -173.037 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -83.69 -120.94 0.79 Allowed Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.448 1.499 . . . . 0.0 112.715 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.5 t80 -155.07 157.58 37.76 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.263 1.425 . . . . 0.0 112.345 -173.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 41.2 p -74.99 -23.45 58.26 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.756 1.622 . . . . 0.0 114.499 -176.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.5 t 64.32 58.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 126.722 2.009 . . . . 0.0 109.854 -178.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.0 m -74.72 139.97 43.81 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.878 0.871 . . . . 0.0 112.02 179.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.3 t . . . . . 0 C--O 1.254 1.29 0 C-N-CA 125.557 1.543 . . . . 0.0 112.035 -179.24 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 33.0 t80 -78.41 131.65 37.02 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.094 0.558 . . . . 0.0 111.84 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.83 100.09 11.82 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.098 1.359 . . . . 0.0 111.081 179.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 56.8 mt -77.15 151.97 35.08 Favored 'General case' 0 N--CA 1.472 0.653 0 O-C-N 121.418 -0.801 . . . . 0.0 112.705 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 60.5 mtm-85 -87.46 -30.22 20.82 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 125.364 1.466 . . . . 0.0 113.265 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 -143.64 159.36 42.59 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.181 1.792 . . . . 0.0 111.521 -177.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -80.12 124.26 82.93 Favored Pre-proline 0 CA--C 1.548 0.868 0 CA-C-O 118.662 -0.685 . . . . 0.0 111.408 -176.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -83.47 -25.34 2.6 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 123.193 2.595 . . . . 0.0 114.071 -170.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 79.1 m -81.53 126.4 31.65 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.65 0.78 . . . . 0.0 111.28 -176.042 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.25 -15.8 80.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 123.984 0.802 . . . . 0.0 113.999 178.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -122.69 120.25 33.12 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.468 1.507 . . . . 0.0 109.3 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.74 164.48 28.37 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.584 1.553 . . . . 0.0 111.018 -174.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.6 p-10 -145.78 159.82 42.63 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 125.508 1.523 . . . . 0.0 111.721 171.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 28.3 m-85 -124.39 108.28 12.01 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.018 1.327 . . . . 0.0 110.322 -169.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -88.6 -18.63 54.46 Favored Glycine 0 N--CA 1.475 1.268 0 C-N-CA 124.251 0.929 . . . . 0.0 113.993 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 68.2 m-85 -135.78 133.54 38.02 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.932 1.693 . . . . 0.0 110.538 -178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 29.0 pt20 -163.76 158.36 20.11 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.858 1.663 . . . . 0.0 110.434 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -164.18 161.33 22.13 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 125.413 1.485 . . . . 0.0 110.802 -175.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.188 0 C-N-CA 125.697 1.599 . . . . 0.0 112.917 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.569 0 N-CA-C 111.809 -0.516 . . . . 0.0 111.809 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -84.94 166.98 16.34 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 121.844 -0.798 . . . . 0.0 112.258 174.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 25.5 m -157.69 113.82 2.85 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 125.42 1.488 . . . . 0.0 110.574 179.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -109.0 136.75 13.76 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 124.637 1.113 . . . . 0.0 111.687 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.2 m -151.94 144.19 23.99 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.446 1.098 . . . . 0.0 111.026 -175.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 12.5 p -84.1 135.99 34.18 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.047 -1.033 . . . . 0.0 111.987 176.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.32 -166.35 29.93 Favored Glycine 0 CA--C 1.534 1.244 0 C-N-CA 125.296 1.427 . . . . 0.0 113.049 176.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.5 mt -133.77 118.93 18.63 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 125.453 1.501 . . . . 0.0 109.119 175.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -89.62 -12.21 40.37 Favored 'General case' 0 CA--C 1.55 0.956 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -74.27 142.51 45.27 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.392 1.077 . . . . 0.0 111.366 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -90.68 -0.0 57.55 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 125.286 1.434 . . . . 0.0 113.642 -179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 74.0 m -135.18 141.94 45.99 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.906 1.682 . . . . 0.0 110.78 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.9 p -71.65 131.31 86.24 Favored Pre-proline 0 CA--C 1.55 0.971 0 C-N-CA 123.983 0.913 . . . . 0.0 111.441 -176.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.95 155.59 43.17 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.713 2.942 . . . . 0.0 112.185 178.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -68.44 -6.16 23.24 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.726 1.21 . . . . 0.0 114.039 177.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -123.72 21.41 9.22 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 126.546 1.939 . . . . 0.0 113.116 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 32.3 t-80 -53.46 137.51 51.03 Favored Pre-proline 0 CA--C 1.553 1.091 0 O-C-N 121.162 -0.961 . . . . 0.0 112.665 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.32 -7.7 21.84 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.461 2.774 . . . . 0.0 114.808 -176.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 60.8 p -132.67 -24.94 1.93 Allowed 'General case' 0 N--CA 1.48 1.047 0 N-CA-C 114.949 1.463 . . . . 0.0 114.949 177.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.08 90.03 3.19 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 119.782 1.173 . . . . 0.0 110.677 174.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 90.4 m-85 -91.14 118.4 30.4 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.777 1.231 . . . . 0.0 109.346 -176.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 17.3 mttp -78.61 133.76 37.25 Favored 'General case' 0 N--CA 1.472 0.667 0 O-C-N 121.172 -0.955 . . . . 0.0 110.29 -179.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.8 m -139.17 165.27 23.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.865 1.266 . . . . 0.0 111.548 -168.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 16.6 m -143.53 121.74 12.24 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.463 1.105 . . . . 0.0 109.063 173.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -63.77 133.67 53.9 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.097 0.559 . . . . 0.0 109.955 178.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.48 153.07 27.01 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 C-N-CA 124.045 0.938 . . . . 0.0 112.346 178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 13.5 p-10 -85.98 -169.69 2.76 Favored 'General case' 0 CA--C 1.548 0.88 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 177.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.5 p30 -61.41 -31.66 71.59 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.016 1.326 . . . . 0.0 114.201 174.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -81.09 -9.66 59.78 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.109 1.363 . . . . 0.0 112.45 176.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.22 12.85 83.52 Favored Glycine 0 CA--C 1.531 1.073 0 CA-C-O 117.76 -1.578 . . . . 0.0 114.225 -176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 10.8 m -80.7 150.35 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 CA-C-N 120.108 1.954 . . . . 0.0 111.662 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -83.0 124.52 30.49 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 114.762 -1.108 . . . . 0.0 111.567 -173.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 34.9 mt -104.02 -54.3 2.58 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.75 0.82 . . . . 0.0 111.948 -173.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -155.64 139.27 6.51 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 124.737 1.161 . . . . 0.0 114.003 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.1 p -85.23 153.16 22.8 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.248 1.419 . . . . 0.0 113.309 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.05 171.59 37.13 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.664 1.602 . . . . 0.0 113.327 -178.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.7 t -117.11 120.74 65.94 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 172.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.7 tpp -89.14 134.34 34.06 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.031 1.332 . . . . 0.0 110.135 175.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 59.3 tt0 -133.08 130.28 39.11 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 125.568 1.547 . . . . 0.0 109.461 -178.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -107.51 128.4 54.48 Favored 'General case' 0 C--O 1.237 0.413 0 C-N-CA 126.874 2.07 . . . . 0.0 107.694 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.1 p -128.03 172.57 10.82 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.64 1.176 . . . . 0.0 110.601 178.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -71.49 3.16 4.1 Favored 'General case' 0 CA--C 1.548 0.904 0 O-C-N 121.28 -0.888 . . . . 0.0 112.759 171.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 57.7 m -110.89 -45.51 3.46 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.499 1.119 . . . . 0.0 113.34 177.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.1 pt-20 -173.63 173.71 3.33 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 124.338 1.055 . . . . 0.0 113.343 -169.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.8 mt -86.99 139.77 30.25 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 124.033 0.933 . . . . 0.0 109.946 168.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 99.6 t -134.89 132.12 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.441 1.096 . . . . 0.0 111.413 177.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 23.9 mt -104.25 130.9 52.04 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 126.01 1.724 . . . . 0.0 110.558 168.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -105.13 129.02 53.63 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 126.691 1.996 . . . . 0.0 110.579 170.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -160.87 169.68 22.17 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 127.029 2.131 . . . . 0.0 111.397 -173.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 29.6 p80 -111.97 -18.44 12.64 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.426 1.639 . . . . 0.0 115.426 -178.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 3.1 mmp_? -73.62 -28.0 61.58 Favored 'General case' 0 N--CA 1.479 0.987 0 C-N-CA 124.102 0.961 . . . . 0.0 113.044 -176.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -142.43 174.29 10.76 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.866 2.466 . . . . 0.0 108.963 173.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -61.04 162.54 7.01 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 123.461 0.704 . . . . 0.0 110.835 168.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.04 147.56 19.71 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 123.847 0.859 . . . . 0.0 112.423 177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.8 t -126.06 136.86 59.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.275 1.03 . . . . 0.0 109.485 -174.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -139.66 152.0 46.38 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 123.637 0.775 . . . . 0.0 111.842 -171.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.3 m-90 -139.16 116.67 8.77 Favored Pre-proline 0 CA--C 1.54 0.596 0 C-N-CA 124.518 1.127 . . . . 0.0 111.37 179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -66.98 145.42 73.89 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.59 2.193 . . . . 0.0 109.883 173.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -60.85 -24.83 66.21 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 113.807 1.04 . . . . 0.0 113.807 -177.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -62.84 -42.69 99.84 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 125.057 1.343 . . . . 0.0 111.992 173.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 94.4 m -79.74 -3.55 48.03 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 90.1 mt -86.71 106.98 18.02 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 119.686 1.13 . . . . 0.0 109.912 175.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.28 -38.43 42.58 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.384 0.674 . . . . 0.0 111.487 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 14.2 ptp180 -149.47 155.91 41.14 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 125.101 1.36 . . . . 0.0 111.085 173.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.5 p90 -150.78 136.31 17.96 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 125.868 1.667 . . . . 0.0 108.514 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -156.81 173.26 34.5 Favored Glycine 0 C--N 1.333 0.364 0 CA-C-O 122.139 0.855 . . . . 0.0 113.979 -169.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.1 p90 -142.2 159.76 41.59 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.52 1.128 . . . . 0.0 112.024 -173.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -151.47 -174.75 4.93 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.111 1.764 . . . . 0.0 109.771 174.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -60.19 119.17 7.37 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.376 -0.828 . . . . 0.0 110.473 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 50.64 21.93 0.99 Allowed 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 127.703 2.401 . . . . 0.0 116.464 -175.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -138.72 131.23 28.86 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.067 1.347 . . . . 0.0 111.214 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -125.86 141.29 52.05 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.218 1.807 . . . . 0.0 109.956 173.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -153.8 162.05 41.56 Favored 'General case' 0 CA--C 1.541 0.601 0 O-C-N 120.941 -1.099 . . . . 0.0 112.971 -178.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.6 p90 -154.33 153.77 32.21 Favored 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 125.598 1.559 . . . . 0.0 112.412 178.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.0 tt0 -112.65 128.74 56.47 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 126.513 1.925 . . . . 0.0 109.222 177.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 65.2 p -123.37 142.63 50.77 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -174.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.77 154.38 52.83 Favored Glycine 0 CA--C 1.534 1.25 0 C-N-CA 124.641 1.115 . . . . 0.0 113.138 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.3 ptt180 -61.81 -14.07 29.68 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 116.726 2.121 . . . . 0.0 116.726 -170.044 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 10.7 ptp85 -83.11 -17.42 43.12 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 115.246 1.573 . . . . 0.0 115.246 -176.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 17.0 p -74.66 -179.54 4.18 Favored 'General case' 0 CA--C 1.55 0.962 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -170.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 51.9 tt0 -55.94 -38.1 69.87 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 124.645 1.178 . . . . 0.0 113.199 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.5 p -96.58 -23.19 16.63 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.246 1.418 . . . . 0.0 113.588 -178.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.98 -160.7 43.03 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 125.356 1.455 . . . . 0.0 112.535 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -65.54 129.07 38.45 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.547 1.139 . . . . 0.0 112.378 -179.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.8 172.59 30.46 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.231 1.396 . . . . 0.0 112.899 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 59.0 mt -119.36 136.3 56.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 C-N-CA 125.55 1.54 . . . . 0.0 108.298 170.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -129.21 117.95 21.59 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.78 1.232 . . . . 0.0 109.801 -173.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.8 141.18 48.7 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 124.675 1.19 . . . . 0.0 112.199 -172.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -138.33 127.7 24.59 Favored 'General case' 0 C--O 1.232 0.184 0 C-N-CA 124.192 0.997 . . . . 0.0 111.865 -169.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.3 mttp -67.34 131.22 45.29 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 123.445 0.698 . . . . 0.0 111.044 169.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.3 t -169.53 118.73 0.64 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.249 1.819 . . . . 0.0 110.36 -175.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.8 t -71.29 -8.06 51.14 Favored 'General case' 0 N--CA 1.478 0.975 0 O-C-N 121.229 -0.919 . . . . 0.0 113.151 175.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -104.73 9.46 35.03 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.538 1.935 . . . . 0.0 113.333 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.5 -38.53 20.44 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.31 1.844 . . . . 0.0 115.322 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -66.99 -35.67 80.47 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.773 0.829 . . . . 0.0 112.908 178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -68.39 -37.87 80.78 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 121.536 -0.728 . . . . 0.0 110.96 173.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 64.2 mt -61.45 -45.26 99.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.752 0 CA-C-N 118.609 0.64 . . . . 0.0 110.24 173.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -62.61 -42.99 99.9 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.767 0.827 . . . . 0.0 111.841 179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -70.31 -33.97 72.16 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 177.237 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -79.23 -33.93 43.24 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 119.12 0.873 . . . . 0.0 110.682 178.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 10.5 mt -56.49 -55.21 36.58 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 121.299 -0.875 . . . . 0.0 111.981 173.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -61.23 -21.52 63.94 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 113.741 1.015 . . . . 0.0 113.741 -179.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 71.5 m-20 -81.47 -20.14 40.85 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 125.215 1.406 . . . . 0.0 112.754 175.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 96.6 mt -98.13 -35.78 10.29 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.468 1.507 . . . . 0.0 112.559 174.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 67.5 mmm -59.06 -33.83 71.24 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.855 1.262 . . . . 0.0 111.366 175.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -83.19 -8.77 59.44 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 175.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 8.5 t -87.57 0.55 55.45 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.813 1.245 . . . . 0.0 113.491 -172.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -73.75 171.71 12.83 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.446 1.098 . . . . 0.0 112.983 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.3 p -74.24 92.07 2.21 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.255 1.422 . . . . 0.0 112.17 178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 21.0 mm -78.08 74.17 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 124.581 1.152 . . . . 0.0 109.545 176.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.3 m-20 61.53 -14.77 0.04 OUTLIER 'General case' 0 CA--C 1.553 1.089 0 C-N-CA 128.563 2.745 . . . . 0.0 116.248 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.4 m -59.21 -14.79 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.182 0 C-N-CA 127.43 2.292 . . . . 0.0 115.473 179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 74.2 mtm -140.77 141.89 34.77 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 125.256 1.423 . . . . 0.0 110.831 177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -94.62 132.03 39.77 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.2 1.4 . . . . 0.0 110.836 174.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -158.31 149.73 16.75 Favored Pre-proline 0 CA--C 1.545 0.769 0 C-N-CA 125.66 1.584 . . . . 0.0 111.029 -175.921 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.82 148.31 40.86 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.06 2.507 . . . . 0.0 110.801 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 13.6 p -110.88 125.32 68.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 C-N-CA 124.838 1.255 . . . . 0.0 109.387 173.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.1 mm -82.53 143.76 11.47 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 CA-C-O 121.894 0.854 . . . . 0.0 110.349 177.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.2 pt -100.97 131.76 48.0 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 C-N-CA 124.469 1.107 . . . . 0.0 110.681 176.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 29.5 p -139.71 142.69 36.85 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.371 1.869 . . . . 0.0 108.809 178.739 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.4 tmm_? -166.17 97.77 0.61 Allowed 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.591 1.557 . . . . 0.0 109.107 178.094 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 48.8 t30 -122.08 71.95 1.02 Allowed 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.091 1.356 . . . . 0.0 109.889 -178.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 49.3 p -170.73 162.55 7.77 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.285 1.434 . . . . 0.0 111.849 -168.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -77.48 146.25 73.32 Favored Pre-proline 0 CA--C 1.554 1.131 0 C-N-CA 124.607 1.163 . . . . 0.0 113.181 177.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -76.04 144.6 27.12 Favored 'Trans proline' 0 CA--C 1.537 0.631 0 C-N-CA 123.197 2.598 . . . . 0.0 110.247 169.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -165.24 142.66 5.92 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.467 1.507 . . . . 0.0 111.058 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 81.8 mm-40 -145.15 158.01 43.94 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 125.583 1.553 . . . . 0.0 110.181 -179.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 54.8 tp -152.48 145.74 24.72 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.277 1.431 . . . . 0.0 110.928 -172.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -63.01 134.33 55.99 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.739 1.216 . . . . 0.0 112.138 177.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -89.56 153.26 47.98 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 124.984 1.314 . . . . 0.0 111.81 -176.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -77.29 99.76 1.33 Allowed 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 122.465 2.11 . . . . 0.0 110.575 -179.025 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.88 163.73 27.69 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.375 1.07 . . . . 0.0 112.595 175.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -145.52 150.7 44.82 Favored Pre-proline 0 CA--C 1.549 0.923 0 C-N-CA 125.097 1.359 . . . . 0.0 111.929 -177.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -75.5 175.41 11.31 Favored 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 124.05 3.167 . . . . 0.0 112.01 179.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -131.48 146.96 64.17 Favored Pre-proline 0 CA--C 1.544 0.718 0 C-N-CA 125.366 1.466 . . . . 0.0 109.848 177.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -71.35 141.29 38.63 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.132 2.555 . . . . 0.0 111.774 -174.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -77.4 171.71 17.19 Favored 'Trans proline' 0 CA--C 1.538 0.703 0 C-N-CA 123.992 3.128 . . . . 0.0 111.894 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -153.29 144.84 23.32 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.891 1.276 . . . . 0.0 111.615 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -156.25 173.2 17.2 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.994 1.717 . . . . 0.0 111.641 -176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 9.9 tt -146.54 132.21 18.89 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.368 1.467 . . . . 0.0 110.623 -175.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -102.18 155.29 18.61 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.449 1.499 . . . . 0.0 112.446 174.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 60.2 t80 -159.53 160.53 34.65 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.384 1.474 . . . . 0.0 111.784 -176.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 9.1 t -155.48 171.45 19.89 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 125.554 1.542 . . . . 0.0 111.623 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 30.7 m -150.46 171.93 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 C-N-CA 127.701 2.4 . . . . 0.0 110.764 -169.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 6.4 t -152.96 161.93 41.93 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 124.902 1.281 . . . . 0.0 111.58 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 42.3 p . . . . . 0 C--O 1.253 1.269 0 C-N-CA 125.822 1.649 . . . . 0.0 114.864 -175.445 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 77.4 mt . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 22.4 t80 -82.45 119.28 23.99 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 118.31 0.504 . . . . 0.0 110.944 174.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -89.59 110.06 20.95 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.824 1.25 . . . . 0.0 109.962 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 45.0 mt -76.53 157.15 32.31 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.695 0.998 . . . . 0.0 113.695 -177.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 93.2 mtt-85 -80.32 -24.15 40.12 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.812 1.645 . . . . 0.0 113.702 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 31.2 p80 -160.26 170.03 21.96 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 126.517 1.927 . . . . 0.0 111.55 -174.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 8.8 t80 -86.68 122.73 71.55 Favored Pre-proline 0 CA--C 1.549 0.915 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.789 -177.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -82.43 -24.92 3.42 Favored 'Trans proline' 0 C--N 1.352 0.727 0 C-N-CA 123.362 2.708 . . . . 0.0 114.428 -170.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.4 m -79.75 129.02 34.12 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 118.843 0.747 . . . . 0.0 112.223 -171.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.08 -9.44 85.42 Favored Glycine 0 CA--C 1.534 1.274 0 C-N-CA 124.656 1.122 . . . . 0.0 114.563 179.067 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 68.4 m-80 -139.0 128.07 23.83 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.71 1.604 . . . . 0.0 110.221 175.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -137.7 164.07 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 125.6 1.56 . . . . 0.0 111.252 -173.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 -128.93 132.32 47.63 Favored 'General case' 0 CA--C 1.547 0.835 0 C-N-CA 125.266 1.426 . . . . 0.0 109.376 170.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 71.4 m-85 -99.01 111.86 24.15 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.861 1.264 . . . . 0.0 110.035 175.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.33 -92.9 0.88 Allowed Glycine 0 N--CA 1.468 0.782 0 C-N-CA 124.509 1.052 . . . . 0.0 113.002 -171.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 24.0 m-85 -72.62 122.36 21.28 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.444 1.098 . . . . 0.0 110.815 -173.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 -148.25 176.37 10.3 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.862 2.065 . . . . 0.0 109.762 -170.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -132.68 157.17 45.52 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.912 1.285 . . . . 0.0 111.19 -178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.382 1.473 . . . . 0.0 112.716 -179.676 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.53 0 N-CA-C 111.961 -0.456 . . . . 0.0 111.961 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 42.0 m -148.48 141.81 25.19 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.809 1.243 . . . . 0.0 111.277 -175.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 54.6 p -101.76 -1.83 31.52 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.962 1.305 . . . . 0.0 114.181 -177.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 142.03 -149.58 21.3 Favored Glycine 0 CA--C 1.531 1.061 0 C-N-CA 125.923 1.725 . . . . 0.0 112.276 -174.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 70.1 m -142.17 142.78 32.74 Favored 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 124.977 1.311 . . . . 0.0 111.16 -177.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 9.3 t -163.58 161.75 24.04 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 125.327 1.451 . . . . 0.0 110.744 -177.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 76.61 8.95 86.33 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 124.46 1.028 . . . . 0.0 114.5 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 93.3 mt -63.24 136.09 57.49 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.223 1.409 . . . . 0.0 111.406 -176.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -160.3 151.46 19.23 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.141 1.376 . . . . 0.0 111.739 -174.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 11.9 mpt_? -112.84 84.85 2.06 Favored 'General case' 0 N--CA 1.473 0.68 0 C-N-CA 124.874 1.269 . . . . 0.0 109.696 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -165.55 143.39 5.88 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 126.311 1.845 . . . . 0.0 110.542 -177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 63.8 m 59.34 34.04 22.7 Favored 'General case' 0 N--CA 1.482 1.127 0 C-N-CA 124.416 1.087 . . . . 0.0 113.797 171.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.4 p -41.51 121.25 2.13 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 126.521 1.928 . . . . 0.0 113.252 -174.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -75.07 151.72 39.56 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 123.173 2.582 . . . . 0.0 110.811 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -73.43 -8.8 57.38 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.091 0.774 . . . . 0.0 113.091 175.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -103.23 8.86 38.37 Favored 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 125.425 1.49 . . . . 0.0 113.26 -178.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -59.61 140.34 89.13 Favored Pre-proline 0 CA--C 1.556 1.185 0 O-C-N 120.615 -1.303 . . . . 0.0 112.961 -176.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -73.76 -18.41 22.09 Favored 'Trans proline' 0 C--N 1.353 0.812 0 C-N-CA 122.852 2.368 . . . . 0.0 114.944 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 63.9 p -128.8 -19.22 3.71 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 120.173 1.352 . . . . 0.0 114.599 -178.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.5 mptt -97.42 142.22 29.54 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-N 119.189 0.904 . . . . 0.0 110.851 171.094 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -143.55 107.16 4.61 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 125.012 1.325 . . . . 0.0 108.738 -178.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 31.5 mtmt -64.7 137.12 57.62 Favored 'General case' 0 CA--C 1.541 0.602 0 O-C-N 121.25 -0.906 . . . . 0.0 111.402 174.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.6 m -144.9 159.82 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.803 1.241 . . . . 0.0 111.587 -170.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -134.63 117.19 15.83 Favored 'General case' 0 N--CA 1.47 0.526 0 C-N-CA 124.66 1.184 . . . . 0.0 108.824 176.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -67.59 135.63 53.2 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 123.543 0.737 . . . . 0.0 110.904 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.0 m -129.07 154.47 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.298 1.039 . . . . 0.0 112.948 -176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.427 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.7 p-10 -90.78 -166.62 1.62 Allowed 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 125.039 1.336 . . . . 0.0 113.989 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -64.85 -30.37 71.37 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.555 1.142 . . . . 0.0 113.008 176.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -80.9 -12.36 59.42 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.847 1.259 . . . . 0.0 112.106 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.04 14.52 80.53 Favored Glycine 0 CA--C 1.532 1.133 0 CA-C-O 117.787 -1.563 . . . . 0.0 114.228 -174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.427 HG22 ' OD1' ' A' ' 27' ' ' ASP . 14.2 m -76.15 150.34 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 CA-C-N 119.995 1.897 . . . . 0.0 111.563 176.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -84.45 124.19 31.07 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.416 1.087 . . . . 0.0 110.926 -174.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 51.7 mt -104.73 -51.93 2.97 Favored 'General case' 0 N--CA 1.469 0.475 0 C-N-CA 124.086 0.954 . . . . 0.0 112.062 -170.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -159.33 148.49 17.37 Favored Glycine 0 N--CA 1.468 0.773 0 C-N-CA 125.004 1.288 . . . . 0.0 113.533 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 44.8 p -90.38 151.74 21.3 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.853 1.261 . . . . 0.0 113.006 178.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.32 170.95 34.56 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 125.751 1.643 . . . . 0.0 112.793 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -118.63 120.22 63.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 172.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.8 ttm -88.3 141.19 28.75 Favored 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.098 0.959 . . . . 0.0 110.194 175.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 56.5 tt0 -135.84 129.85 33.03 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 125.515 1.526 . . . . 0.0 108.903 -178.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -108.44 130.5 55.24 Favored 'General case' 0 C--O 1.236 0.39 0 C-N-CA 125.678 1.591 . . . . 0.0 107.919 177.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.0 p -130.35 167.31 18.74 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.904 1.281 . . . . 0.0 109.941 179.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.0 mp0 -66.47 -9.69 36.85 Favored 'General case' 0 CA--C 1.547 0.834 0 O-C-N 121.864 -0.522 . . . . 0.0 112.4 172.717 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.6 m -98.52 -45.35 6.13 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.449 1.1 . . . . 0.0 113.263 178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.4 pt-20 -172.6 171.11 4.63 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 124.64 1.176 . . . . 0.0 113.718 -168.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.7 mt -86.86 139.77 30.34 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.579 1.552 . . . . 0.0 109.962 168.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 34.0 t -134.87 137.93 50.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.056 0.943 . . . . 0.0 111.176 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.4 mt -110.84 130.3 55.62 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.449 1.5 . . . . 0.0 109.837 167.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -103.13 130.91 50.45 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 126.366 1.866 . . . . 0.0 110.833 172.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 86.3 mt -134.47 166.93 21.73 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.848 2.059 . . . . 0.0 111.148 -169.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 10.0 t-80 -95.42 -63.94 1.11 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.683 1.193 . . . . 0.0 113.543 -178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -82.95 2.67 33.49 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.068 1.347 . . . . 0.0 113.884 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 34.7 mmt180 -134.75 159.22 41.99 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.926 2.09 . . . . 0.0 110.286 177.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.78 164.87 25.9 Favored 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 123.92 0.888 . . . . 0.0 111.589 172.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.96 134.87 51.48 Favored 'General case' 0 CA--C 1.54 0.585 0 O-C-N 121.46 -0.775 . . . . 0.0 111.767 -179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 11.8 t -108.55 135.6 46.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 C-N-CA 124.208 1.003 . . . . 0.0 110.494 -173.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -120.86 142.38 49.71 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 124.664 1.186 . . . . 0.0 113.384 -170.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 24.3 m-90 -141.75 112.59 6.4 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.185 1.394 . . . . 0.0 111.42 173.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -69.56 150.02 68.9 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 122.386 2.058 . . . . 0.0 110.334 171.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 43.6 m-85 -63.7 -19.64 65.09 Favored 'General case' 0 CA--C 1.544 0.725 0 N-CA-C 113.698 0.999 . . . . 0.0 113.698 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 17.9 mt -68.65 -31.52 70.71 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.21 1.404 . . . . 0.0 113.114 170.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 97.4 m -89.9 -6.86 55.34 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.5 mt -74.7 117.4 16.49 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 118.73 0.695 . . . . 0.0 109.559 172.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -80.34 -32.97 37.73 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.371 1.468 . . . . 0.0 112.305 178.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -166.58 159.09 13.9 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 127.006 2.123 . . . . 0.0 110.483 174.399 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 44.6 p90 -152.17 134.08 14.88 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.001 1.321 . . . . 0.0 111.414 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -150.66 175.73 29.54 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.477 1.036 . . . . 0.0 113.836 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -146.57 162.0 39.3 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.537 1.135 . . . . 0.0 113.535 -173.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -146.2 -178.56 6.2 Favored 'General case' 0 CA--C 1.549 0.925 0 C-N-CA 127.259 2.224 . . . . 0.0 109.327 171.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.4 m -62.37 -13.63 31.31 Favored 'General case' 0 CA--C 1.546 0.812 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 33.0 p-10 -154.08 12.83 0.43 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.448 1.499 . . . . 0.0 114.242 177.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -141.47 130.98 23.85 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.329 1.452 . . . . 0.0 110.29 -168.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 50.1 t80 -121.67 142.14 50.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.912 1.685 . . . . 0.0 109.24 173.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.8 t -153.01 155.51 37.06 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.059 -1.026 . . . . 0.0 112.997 -178.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 53.4 p90 -150.0 152.78 35.44 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.158 1.383 . . . . 0.0 111.977 178.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.6 tt0 -106.39 140.8 38.74 Favored 'General case' 0 N--CA 1.467 0.423 0 C-N-CA 125.357 1.463 . . . . 0.0 109.486 174.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 50.0 m -124.97 148.58 48.34 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 124.175 0.99 . . . . 0.0 112.136 177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -81.62 164.57 45.28 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.276 0.941 . . . . 0.0 112.765 177.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 ppt_? -63.55 -15.07 57.0 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 115.707 1.743 . . . . 0.0 115.707 -173.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.1 ptp180 -82.39 -15.73 51.64 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 126.216 1.806 . . . . 0.0 115.154 -176.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -79.7 -179.52 6.95 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.526 0.73 . . . . 0.0 112.872 -178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -58.26 -46.02 86.74 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 124.286 1.035 . . . . 0.0 112.836 -178.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 36.1 p -89.16 -18.98 26.06 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 125.04 1.336 . . . . 0.0 113.721 -174.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.49 -164.54 41.76 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.728 1.632 . . . . 0.0 112.474 -179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -66.68 134.25 51.87 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.923 0.889 . . . . 0.0 112.02 -177.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 156.09 172.82 23.94 Favored Glycine 0 C--N 1.339 0.728 0 C-N-CA 124.288 0.947 . . . . 0.0 113.065 179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 77.6 mt -114.69 137.87 46.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 C-N-CA 125.474 1.509 . . . . 0.0 108.396 174.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -129.95 122.97 29.56 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.64 1.176 . . . . 0.0 110.311 -176.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.15 144.41 48.59 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.679 1.192 . . . . 0.0 113.03 -172.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -142.71 125.15 15.65 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.974 0.91 . . . . 0.0 112.397 -169.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 36.6 mttp -70.46 134.49 47.82 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.28 1.032 . . . . 0.0 111.418 170.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.1 p -170.84 144.55 2.25 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 126.411 1.884 . . . . 0.0 111.566 177.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 41.4 p -78.03 0.79 23.16 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.177 1.391 . . . . 0.0 114.08 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 7.5 ptm85 -134.65 24.95 3.71 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 126.841 2.056 . . . . 0.0 112.811 -173.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.98 -41.11 46.2 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.813 1.645 . . . . 0.0 113.911 174.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 54.4 tt0 -67.87 -37.13 81.42 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.503 0.721 . . . . 0.0 112.521 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -68.41 -33.1 73.63 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 121.416 -0.802 . . . . 0.0 111.958 175.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 82.2 mt -63.4 -49.28 83.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.727 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 169.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -59.12 -42.62 91.0 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 124.072 0.949 . . . . 0.0 112.172 178.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 -64.84 -34.87 79.4 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.881 1.273 . . . . 0.0 112.556 177.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 33.3 tp -81.27 -37.8 27.9 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-O 118.479 -0.772 . . . . 0.0 112.22 177.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 21.9 mt -53.48 -55.75 22.71 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-N 119.369 0.986 . . . . 0.0 111.845 178.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.7 pt20 -58.3 -31.43 67.5 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.72 -28.47 65.85 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.607 1.163 . . . . 0.0 112.931 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 71.2 mt -93.22 -35.21 13.25 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.334 1.453 . . . . 0.0 111.082 178.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.8 mtp -78.54 -28.73 46.12 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 124.978 1.311 . . . . 0.0 113.593 -178.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.1 pp0? -65.56 -22.34 66.68 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 118.814 0.734 . . . . 0.0 112.578 169.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 12.1 t -69.23 -33.34 73.15 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 118.111 0.414 . . . . 0.0 111.989 -172.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 52.1 m-80 53.14 36.27 21.96 Favored 'General case' 0 CA--C 1.55 0.959 0 C-N-CA 125.724 1.61 . . . . 0.0 112.433 177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 19.7 m -39.33 112.37 0.24 Allowed 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.964 2.506 . . . . 0.0 115.148 -169.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.6 mp -91.74 -63.79 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 123.594 0.757 . . . . 0.0 110.933 -174.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.8 m-20 -110.26 -18.07 13.37 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 -173.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 5.6 p -78.51 -15.96 13.75 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.775 0 C-N-CA 125.2 1.4 . . . . 0.0 113.92 -174.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 15.4 mmt -121.22 174.54 6.63 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 126.342 1.857 . . . . 0.0 111.697 175.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -55.83 131.08 46.0 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 124.875 1.27 . . . . 0.0 111.749 -179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -151.95 146.62 18.8 Favored Pre-proline 0 CA--C 1.548 0.896 0 C-N-CA 125.162 1.385 . . . . 0.0 112.967 -168.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_endo -80.5 178.04 7.47 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 124.421 3.414 . . . . 0.0 112.006 -178.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 58.3 t -76.22 111.17 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.871 0 C-N-CA 123.697 0.799 . . . . 0.0 111.092 -176.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 1.7 mp -111.45 140.64 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 126.907 2.083 . . . . 0.0 109.439 172.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -75.34 146.0 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 C-N-CA 124.233 1.013 . . . . 0.0 112.144 173.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 9.7 t -137.68 150.0 46.99 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 125.442 1.497 . . . . 0.0 112.089 -171.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 38.8 ttm180 -85.87 73.2 10.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.281 1.433 . . . . 0.0 110.371 175.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 65.0 t30 57.83 30.5 19.13 Favored 'General case' 0 CA--C 1.553 1.083 0 C-N-CA 125.82 1.648 . . . . 0.0 114.149 172.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 56.7 m -138.32 135.95 35.93 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.811 1.244 . . . . 0.0 111.284 -171.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 16.9 p80 -156.0 151.22 21.26 Favored Pre-proline 0 CA--C 1.552 1.044 0 C-N-CA 124.411 1.085 . . . . 0.0 112.85 -172.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_endo -72.97 152.12 51.25 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.396 2.731 . . . . 0.0 111.231 179.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.27 63.23 3.13 Favored 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 124.862 1.265 . . . . 0.0 111.954 179.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -67.42 108.88 2.96 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.341 1.456 . . . . 0.0 110.855 -178.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.7 tt -165.83 148.28 7.38 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 126.911 2.084 . . . . 0.0 109.485 -175.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -135.82 148.72 48.82 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 125.455 1.502 . . . . 0.0 110.981 173.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.2 pp -106.14 135.78 19.41 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.401 1.08 . . . . 0.0 111.263 -177.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -81.1 153.01 18.79 Favored 'Trans proline' 0 CA--C 1.536 0.614 0 C-N-CA 123.407 2.738 . . . . 0.0 111.07 177.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -75.63 171.27 14.6 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-O 121.614 0.721 . . . . 0.0 112.008 170.084 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -96.77 138.02 21.38 Favored Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 124.498 1.119 . . . . 0.0 111.715 -179.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -74.34 172.07 16.8 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.571 2.848 . . . . 0.0 112.068 -177.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -138.42 135.39 18.15 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.428 1.491 . . . . 0.0 108.891 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -68.3 136.01 35.85 Favored 'Trans proline' 0 CA--C 1.543 0.961 0 C-N-CA 122.675 2.25 . . . . 0.0 110.896 -179.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_endo -78.49 174.76 11.9 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.771 2.98 . . . . 0.0 112.039 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -125.66 155.7 40.43 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.516 1.527 . . . . 0.0 111.462 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -150.48 167.82 26.03 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.578 1.551 . . . . 0.0 111.893 -174.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 10.3 tt -148.41 130.3 15.23 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 125.147 1.379 . . . . 0.0 110.363 -174.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -115.2 179.62 18.27 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.748 1.642 . . . . 0.0 112.705 173.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 44.7 t80 -155.29 155.55 33.95 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.993 1.317 . . . . 0.0 112.015 -179.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 68.2 p -140.13 170.25 16.19 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 126.199 1.8 . . . . 0.0 111.191 -172.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.58 149.18 13.25 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 C-N-CA 125.64 1.576 . . . . 0.0 110.483 -172.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.6 m -142.48 153.45 43.66 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.127 1.371 . . . . 0.0 111.909 -172.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 31.6 p . . . . . 0 C--O 1.256 1.4 0 C-N-CA 125.678 1.591 . . . . 0.0 114.366 177.985 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 109.72 -0.474 . . . . 0.0 109.72 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -85.82 121.67 28.8 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 124.105 0.962 . . . . 0.0 111.193 -178.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 85.0 mtt85 -82.52 107.76 15.42 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.887 1.275 . . . . 0.0 110.742 178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 89.0 mt -77.28 161.39 28.14 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.604 1.162 . . . . 0.0 112.13 174.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 9.1 mmp_? -101.02 -18.81 16.1 Favored 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 125.127 1.371 . . . . 0.0 114.233 178.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -139.12 154.3 48.11 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 126.524 1.93 . . . . 0.0 111.54 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 13.8 t80 -84.23 122.22 75.55 Favored Pre-proline 0 CA--C 1.547 0.86 0 CA-C-O 118.715 -0.66 . . . . 0.0 111.249 -178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -86.34 -20.34 2.73 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 123.051 2.501 . . . . 0.0 115.249 -169.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 86.9 m -81.59 -31.96 32.3 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 -169.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 74.11 -64.44 2.0 Favored Glycine 0 N--CA 1.475 1.25 0 C-N-CA 125.189 1.375 . . . . 0.0 112.902 -177.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 26.0 m120 -74.61 68.83 1.68 Allowed 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.764 1.626 . . . . 0.0 111.382 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 p -84.7 156.29 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 C-N-CA 126.367 1.867 . . . . 0.0 112.117 -177.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -121.29 137.62 54.61 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.77 1.628 . . . . 0.0 110.167 173.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 56.1 m-85 -107.6 101.63 10.93 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.776 1.23 . . . . 0.0 110.778 -179.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.57 173.17 45.46 Favored Glycine 0 CA--C 1.533 1.177 0 C-N-CA 125.144 1.354 . . . . 0.0 112.083 173.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 27.6 m-85 56.7 37.28 28.69 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 124.584 1.154 . . . . 0.0 112.719 176.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 68.8 tp60 -149.35 138.85 21.62 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.884 1.674 . . . . 0.0 109.635 -174.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 21.7 pt20 -101.48 159.77 15.01 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.569 1.148 . . . . 0.0 111.621 175.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 . . . . . 0 C--O 1.251 1.173 0 C-N-CA 125.852 1.661 . . . . 0.0 111.815 -176.631 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.665 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.1 m -104.81 1.11 28.8 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 114.058 1.132 . . . . 0.0 114.058 -176.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 23.2 t -160.76 140.1 10.62 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.331 1.452 . . . . 0.0 110.678 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.98 -123.53 5.27 Favored Glycine 0 CA--C 1.531 1.069 0 C-N-CA 125.386 1.47 . . . . 0.0 111.798 177.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.3 t -139.13 147.0 41.33 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 125.313 1.445 . . . . 0.0 110.048 175.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 74.9 p -145.82 13.65 1.33 Allowed 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.914 1.286 . . . . 0.0 113.652 -168.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 93.41 -147.07 18.43 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 124.635 1.112 . . . . 0.0 112.435 -174.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.6 mp -67.86 147.92 51.88 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.1 0.96 . . . . 0.0 111.58 -178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 21.9 p-10 -152.78 103.19 2.75 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.46 1.504 . . . . 0.0 110.6 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 2.0 mpp_? -81.25 128.1 33.43 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.96 0.904 . . . . 0.0 110.34 -177.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -104.03 124.45 49.05 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.341 1.856 . . . . 0.0 110.754 -179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 23.5 p -76.02 111.9 11.89 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.492 1.117 . . . . 0.0 111.273 178.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 13.7 p -149.2 123.59 4.74 Favored Pre-proline 0 N--CA 1.473 0.716 0 C-N-CA 124.63 1.172 . . . . 0.0 110.989 -178.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.94 156.48 43.28 Favored 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.796 2.331 . . . . 0.0 110.421 169.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -61.53 -18.21 58.17 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.904 0.882 . . . . 0.0 112.883 176.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 30.4 p30 -115.12 16.42 17.0 Favored 'General case' 0 CA--C 1.55 0.95 0 C-N-CA 126.42 1.888 . . . . 0.0 113.792 -172.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 61.3 t-80 -48.96 142.68 9.25 Favored Pre-proline 0 CA--C 1.558 1.264 0 C-N-CA 124.768 1.227 . . . . 0.0 113.311 176.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -64.39 -15.02 47.49 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.271 2.648 . . . . 0.0 115.458 -175.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.7 p -124.03 -24.91 4.3 Favored 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 119.827 1.194 . . . . 0.0 113.843 172.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -100.16 118.25 36.1 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 119.819 1.19 . . . . 0.0 111.943 175.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -114.51 110.57 20.03 Favored 'General case' 0 C--N 1.33 -0.273 0 C-N-CA 125.281 1.433 . . . . 0.0 108.638 176.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -71.25 139.79 50.16 Favored 'General case' 0 N--CA 1.468 0.449 0 O-C-N 121.483 -0.761 . . . . 0.0 110.421 177.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 27.4 m -145.7 164.5 10.78 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 C-N-CA 124.897 1.279 . . . . 0.0 111.964 -170.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.8 m -136.44 120.36 17.52 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.739 1.215 . . . . 0.0 109.271 172.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 9.2 t-20 -67.3 137.53 56.15 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 123.859 0.864 . . . . 0.0 111.371 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.6 m -131.9 156.71 42.79 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 124.235 1.014 . . . . 0.0 112.706 -176.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -90.8 -167.54 1.85 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 124.75 1.22 . . . . 0.0 113.705 178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.23 -32.19 73.53 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.415 1.265 . . . . 0.0 114.415 175.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.5 mm-40 -79.87 -11.54 59.81 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.821 1.248 . . . . 0.0 112.817 175.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.66 17.47 77.41 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.099 -1.39 . . . . 0.0 113.904 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 11.7 m -79.71 150.51 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.833 0 CA-C-N 119.829 1.815 . . . . 0.0 111.339 174.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -87.57 126.43 34.93 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.308 1.043 . . . . 0.0 111.356 -171.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 37.6 mt -109.08 -43.3 4.21 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.533 1.133 . . . . 0.0 112.681 -169.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -166.96 144.8 9.33 Favored Glycine 0 CA--C 1.526 0.738 0 C-N-CA 124.468 1.033 . . . . 0.0 114.2 177.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.0 p -83.79 148.26 27.12 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.448 1.099 . . . . 0.0 112.224 176.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.08 170.21 32.04 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.322 1.439 . . . . 0.0 113.457 -179.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.04 119.8 62.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 172.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 47.7 ttm -91.11 134.05 34.84 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.058 0.943 . . . . 0.0 109.488 174.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 49.7 tt0 -125.39 124.04 40.64 Favored 'General case' 0 C--O 1.24 0.583 0 C-N-CA 124.986 1.314 . . . . 0.0 109.235 -177.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.6 mp -111.35 126.87 55.38 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 126.546 1.938 . . . . 0.0 107.901 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.7 t -162.54 149.92 13.67 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 126.514 1.925 . . . . 0.0 108.266 -172.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.6 mm-40 -58.89 -18.5 33.7 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.895 1.072 . . . . 0.0 113.895 -172.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 m -70.45 -42.26 71.75 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 113.705 1.002 . . . . 0.0 113.705 175.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 170.95 167.05 0.07 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 126.594 1.958 . . . . 0.0 111.946 -170.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.1 mt -82.18 139.37 34.35 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.939 0.895 . . . . 0.0 109.545 167.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 12.8 t -134.64 138.62 49.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 C-N-CA 123.331 0.653 . . . . 0.0 110.808 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.1 mt -113.74 130.74 56.39 Favored 'General case' 0 N--CA 1.461 0.124 0 C-N-CA 125.735 1.614 . . . . 0.0 109.482 167.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -111.61 122.22 47.23 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.391 1.876 . . . . 0.0 109.945 176.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -154.34 127.29 8.26 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.84 1.256 . . . . 0.0 111.489 -177.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.4 p-80 -73.3 -14.31 61.28 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 124.536 1.134 . . . . 0.0 113.681 177.323 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 23.7 mmm180 -66.97 -25.97 66.59 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.568 1.547 . . . . 0.0 113.056 -177.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 3.4 mpt_? -143.61 -72.36 0.29 Allowed 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.66 1.584 . . . . 0.0 111.675 173.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -171.65 161.97 6.24 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 127.555 2.342 . . . . 0.0 109.863 -173.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.75 148.97 39.97 Favored 'General case' 0 CA--C 1.543 0.711 0 O-C-N 121.884 -0.51 . . . . 0.0 111.666 170.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 24.3 t -137.95 136.95 45.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.809 0 C-N-CA 124.515 1.126 . . . . 0.0 111.694 -169.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 75.0 mtt85 -117.15 146.83 42.94 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.844 1.658 . . . . 0.0 113.213 -175.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.6 m-90 -142.54 121.52 7.65 Favored Pre-proline 0 CA--C 1.549 0.936 0 C-N-CA 125.474 1.51 . . . . 0.0 111.797 173.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -70.77 149.99 61.31 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.094 2.529 . . . . 0.0 110.895 176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -63.43 -19.42 64.69 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 15.4 mt -63.21 -33.67 75.98 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.422 1.089 . . . . 0.0 113.693 171.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 12.2 p -83.99 -9.35 58.73 Favored 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.6 mt -89.9 73.6 7.43 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.535 1.134 . . . . 0.0 111.87 -173.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 55.8 ttt85 -63.99 -41.24 97.58 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.042 -0.412 . . . . 0.0 112.058 177.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 8.4 ttp180 -134.03 129.6 36.33 Favored 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 126.098 1.759 . . . . 0.0 110.363 -176.238 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -153.09 141.67 20.86 Favored 'General case' 0 N--CA 1.468 0.44 0 C-N-CA 126.714 2.006 . . . . 0.0 109.764 179.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -168.67 179.44 41.56 Favored Glycine 0 CA--C 1.522 0.487 0 CA-C-O 122.053 0.807 . . . . 0.0 114.612 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.5 p90 -142.33 157.61 44.62 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 125.38 1.472 . . . . 0.0 112.56 -171.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -148.78 -173.17 4.28 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 126.699 2.0 . . . . 0.0 109.845 174.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 23.2 p -59.33 110.6 1.12 Allowed 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.272 -0.892 . . . . 0.0 111.506 177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.6 t30 61.7 15.58 7.06 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 126.41 1.884 . . . . 0.0 114.268 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -133.04 129.3 37.9 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 120.231 1.378 . . . . 0.0 112.065 -169.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -124.12 142.09 51.5 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 125.676 1.591 . . . . 0.0 110.474 171.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.8 t -153.87 157.06 38.71 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.489 1.116 . . . . 0.0 113.581 -176.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 52.1 p90 -152.36 155.46 37.65 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 125.17 1.388 . . . . 0.0 113.488 -179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -94.04 154.32 17.7 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 126.142 1.777 . . . . 0.0 111.605 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 t -148.37 161.8 40.84 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.733 0.813 . . . . 0.0 113.054 169.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -106.37 173.63 19.75 Favored Glycine 0 N--CA 1.475 1.276 0 C-N-CA 126.481 1.991 . . . . 0.0 114.593 -170.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -26.54 68.44 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.539 1.681 . . . . 0.0 115.539 -169.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 31.1 ptt180 -81.21 -15.06 56.79 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.2 p -79.13 -178.45 6.16 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 113.141 0.793 . . . . 0.0 113.141 -174.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -61.62 -35.88 79.13 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.95 1.3 . . . . 0.0 113.341 -178.109 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.9 p -99.41 -22.85 15.35 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.546 1.539 . . . . 0.0 114.374 -177.468 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.76 -165.8 46.31 Favored Glycine 0 CA--C 1.534 1.269 0 C-N-CA 125.776 1.655 . . . . 0.0 112.925 -175.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -58.34 132.48 53.76 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 124.006 0.922 . . . . 0.0 111.998 178.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.68 172.49 31.22 Favored Glycine 0 C--N 1.339 0.707 0 C-N-CA 123.997 0.808 . . . . 0.0 113.375 173.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.7 mt -114.94 137.85 47.09 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 C-N-CA 125.367 1.467 . . . . 0.0 108.261 169.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -131.53 126.9 36.06 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.745 1.218 . . . . 0.0 110.213 -174.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.31 144.95 50.24 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.496 1.119 . . . . 0.0 113.284 -170.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -141.82 129.67 21.77 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.354 1.061 . . . . 0.0 111.75 -168.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 47.1 mttm -76.95 134.81 38.79 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 123.877 0.871 . . . . 0.0 111.608 169.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 22.3 p -174.45 137.31 0.49 Allowed 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 126.635 1.974 . . . . 0.0 111.565 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 7.8 t -73.68 -3.8 30.42 Favored 'General case' 0 N--CA 1.48 1.07 0 O-C-N 120.993 -1.067 . . . . 0.0 113.273 -179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 5.0 ptp85 -110.94 13.31 22.13 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 128.163 2.585 . . . . 0.0 112.758 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.59 -43.25 35.86 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.204 1.402 . . . . 0.0 114.215 -179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -68.12 -35.18 77.7 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 123.521 0.728 . . . . 0.0 112.769 176.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.46 -31.27 66.98 Favored 'General case' 0 N--CA 1.469 0.499 0 O-C-N 121.379 -0.826 . . . . 0.0 112.141 175.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.4 mt -65.42 -45.6 92.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.78 0 CA-C-N 118.755 0.707 . . . . 0.0 109.861 168.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -59.82 -45.09 93.47 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.159 0.983 . . . . 0.0 111.735 176.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 87.0 m-20 -65.24 -40.94 94.68 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.199 1.4 . . . . 0.0 112.261 178.117 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.5 tp -74.05 -38.57 63.95 Favored 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 118.955 0.798 . . . . 0.0 111.505 177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.8 mt -54.76 -55.74 26.78 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 119.018 0.827 . . . . 0.0 111.247 176.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -62.17 -24.79 67.4 Favored 'General case' 0 CA--C 1.54 0.558 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -177.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -69.81 -41.03 75.56 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.152 0.981 . . . . 0.0 112.219 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 59.7 mt -73.71 -40.12 63.82 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.787 0.835 . . . . 0.0 111.099 176.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 70.0 mmm -64.32 -34.0 77.13 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.912 1.285 . . . . 0.0 112.737 178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -90.41 -12.97 35.94 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 114.033 1.123 . . . . 0.0 114.033 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 49.4 t -61.82 -51.12 69.57 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 119.103 0.865 . . . . 0.0 111.713 -176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -152.52 119.63 5.86 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.705 1.602 . . . . 0.0 109.834 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 4.0 t -113.87 10.15 17.66 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 124.434 1.094 . . . . 0.0 112.529 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.3 mp -95.25 73.4 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 C-N-CA 125.294 1.437 . . . . 0.0 109.384 -175.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 43.2 45.54 4.88 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 127.542 2.337 . . . . 0.0 115.168 172.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 29.7 m -75.63 35.99 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 C-N-CA 126.971 2.108 . . . . 0.0 114.021 -177.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 20.6 mmt -128.29 26.45 5.72 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 127.274 2.23 . . . . 0.0 112.704 -170.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -94.97 36.71 1.18 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.948 1.699 . . . . 0.0 112.284 -178.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -127.91 148.38 66.98 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 126.279 1.832 . . . . 0.0 110.76 -174.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_endo -72.07 162.9 40.41 Favored 'Trans proline' 0 C--N 1.352 0.74 0 C-N-CA 123.763 2.975 . . . . 0.0 111.977 177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 83.5 t -102.7 129.27 54.58 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 124.97 1.308 . . . . 0.0 109.336 177.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.5 mp -124.84 150.33 29.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 125.725 1.61 . . . . 0.0 109.012 179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 39.4 pt -73.61 42.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 125.975 1.71 . . . . 0.0 113.006 174.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 88.2 m -54.08 117.34 3.15 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 126.917 2.087 . . . . 0.0 111.208 -172.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.29 7.67 35.89 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.498 1.519 . . . . 0.0 113.761 -178.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 29.3 t-20 -63.15 127.03 29.37 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.114 0.966 . . . . 0.0 110.877 173.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 9.4 t -162.08 95.25 0.95 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.326 1.051 . . . . 0.0 109.737 -179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -70.83 129.3 89.88 Favored Pre-proline 0 CA--C 1.551 0.989 0 O-C-N 121.265 -0.897 . . . . 0.0 111.822 -178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -72.11 163.23 39.38 Favored 'Trans proline' 0 C--N 1.352 0.713 0 C-N-CA 123.115 2.543 . . . . 0.0 110.676 174.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -151.06 146.37 26.14 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.563 1.145 . . . . 0.0 111.112 -179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 1.8 pp20? -68.98 154.5 41.96 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.458 0.703 . . . . 0.0 111.404 172.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.6 pp -135.46 163.81 29.21 Favored 'General case' 0 N--CA 1.468 0.462 0 C-N-CA 125.014 1.326 . . . . 0.0 112.186 -169.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.9 m-20 -116.12 131.32 56.97 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.371 1.468 . . . . 0.0 110.51 179.603 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.5 pp -82.32 145.36 51.85 Favored Pre-proline 0 CA--C 1.545 0.775 0 C-N-CA 123.91 0.884 . . . . 0.0 110.742 174.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.14 165.65 25.65 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.146 2.564 . . . . 0.0 111.481 -179.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -143.31 170.66 15.36 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.728 1.211 . . . . 0.0 112.207 177.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -105.12 148.07 35.57 Favored Pre-proline 0 CA--C 1.547 0.851 0 C-N-CA 125.225 1.41 . . . . 0.0 111.294 173.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -79.89 179.31 6.36 Favored 'Trans proline' 0 CA--C 1.54 0.81 0 C-N-CA 123.743 2.962 . . . . 0.0 110.281 169.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -134.57 131.62 20.39 Favored Pre-proline 0 CA--C 1.542 0.66 0 C-N-CA 124.28 1.032 . . . . 0.0 108.938 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -74.14 139.9 27.31 Favored 'Trans proline' 0 CA--C 1.541 0.861 0 C-N-CA 122.761 2.307 . . . . 0.0 111.132 -175.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -75.84 163.06 34.12 Favored 'Trans proline' 0 CA--C 1.538 0.678 0 C-N-CA 123.541 2.827 . . . . 0.0 111.486 176.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -153.87 140.78 19.21 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.685 1.194 . . . . 0.0 111.961 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -165.09 160.44 18.8 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 126.093 1.757 . . . . 0.0 111.002 -176.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 140' ' ' LEU . 2.1 pt? -77.72 37.48 0.23 Allowed 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.895 1.678 . . . . 0.0 112.705 173.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . 93.43 150.73 27.12 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 125.842 1.686 . . . . 0.0 110.907 -168.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 39.4 p90 -140.48 101.63 4.15 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.883 0.873 . . . . 0.0 111.692 -176.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 31.6 m -151.46 114.85 4.81 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.154 1.782 . . . . 0.0 108.058 -177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.9 m -153.24 162.99 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 C-N-CA 126.49 1.916 . . . . 0.0 110.251 -174.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.6 t -157.24 163.77 38.43 Favored 'General case' 0 N--CA 1.473 0.701 0 C-N-CA 124.941 1.296 . . . . 0.0 111.558 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 16.0 t . . . . . 0 C--O 1.254 1.327 0 C-N-CA 126.476 1.911 . . . . 0.0 111.573 -174.427 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.3 mm? . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 36.1 t80 -143.28 127.18 17.28 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.973 1.309 . . . . 0.0 109.92 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 14.6 ptp180 -82.56 112.5 19.52 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.386 1.075 . . . . 0.0 111.256 -177.374 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 57.8 mt -85.68 153.55 22.27 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.708 0.803 . . . . 0.0 112.103 174.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -88.34 -29.88 19.99 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.342 1.457 . . . . 0.0 112.794 178.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 93.2 m-70 -137.86 157.09 47.14 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 126.235 1.814 . . . . 0.0 111.65 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.3 t80 -79.2 128.15 76.81 Favored Pre-proline 0 CA--C 1.548 0.879 0 CA-C-O 118.655 -0.688 . . . . 0.0 110.999 -179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -84.95 6.28 5.8 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 124.0 3.134 . . . . 0.0 114.066 -172.314 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 4.5 t -127.01 139.44 53.02 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.411 1.485 . . . . 0.0 111.565 -175.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.3 -39.38 7.34 Favored Glycine 0 CA--C 1.533 1.179 0 C-N-CA 124.182 0.896 . . . . 0.0 112.713 169.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.1 52.11 1.25 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.523 1.529 . . . . 0.0 113.199 -177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.4 p -71.53 141.66 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 O-C-N 121.236 -0.915 . . . . 0.0 111.407 173.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 60.2 t-20 -111.42 118.44 35.81 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.388 1.475 . . . . 0.0 107.992 167.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 99.7 m-85 -87.66 114.36 24.2 Favored 'General case' 0 CA--C 1.541 0.606 0 O-C-N 121.521 -0.737 . . . . 0.0 111.361 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -100.28 168.03 20.71 Favored Glycine 0 N--CA 1.473 1.117 0 C-N-CA 124.972 1.272 . . . . 0.0 114.255 -175.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 20.2 m-85 55.11 36.61 27.35 Favored 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.452 1.501 . . . . 0.0 113.497 175.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -68.85 149.1 49.32 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.59 1.156 . . . . 0.0 111.044 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 50.9 mm-40 -144.47 159.4 42.82 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.251 1.42 . . . . 0.0 110.999 -175.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 62.3 tp60 . . . . . 0 C--O 1.254 1.291 0 C-N-CA 125.403 1.481 . . . . 0.0 112.905 -179.137 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.533 0 N-CA-C 111.632 -0.587 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 9.6 t -163.29 164.8 24.76 Favored 'General case' 0 N--CA 1.475 0.784 0 C-N-CA 125.469 1.507 . . . . 0.0 111.014 179.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 48.0 p -165.95 152.16 9.31 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.416 1.486 . . . . 0.0 112.119 -174.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.53 170.02 47.94 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 124.489 1.042 . . . . 0.0 113.118 175.368 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.1 t -161.65 155.26 21.53 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.026 1.33 . . . . 0.0 111.357 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 80.5 p -166.34 164.64 17.51 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.704 1.602 . . . . 0.0 111.775 -177.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -152.57 152.85 24.47 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 124.583 1.087 . . . . 0.0 113.077 177.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -165.12 173.13 11.76 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 126.34 1.856 . . . . 0.0 111.452 -177.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 14.8 p-10 -149.91 120.51 7.48 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.906 1.282 . . . . 0.0 110.881 175.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 49.5 mmm-85 -145.93 157.55 43.89 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 126.995 2.118 . . . . 0.0 109.52 -176.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -133.62 29.23 3.9 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 124.846 1.258 . . . . 0.0 113.922 -167.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 12.2 t -149.16 159.8 43.92 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.986 -1.071 . . . . 0.0 112.829 177.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.5 t -150.82 124.49 4.37 Favored Pre-proline 0 N--CA 1.477 0.89 0 C-N-CA 126.925 2.09 . . . . 0.0 108.395 -177.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -81.08 164.05 19.94 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.177 2.585 . . . . 0.0 111.979 178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -67.77 -8.06 32.57 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.52 1.128 . . . . 0.0 113.666 175.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -118.13 8.03 12.3 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.398 1.479 . . . . 0.0 114.427 -172.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.9 t-80 -54.0 141.63 48.51 Favored Pre-proline 0 CA--C 1.554 1.128 0 C-N-CA 124.464 1.106 . . . . 0.0 112.679 -177.211 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -66.71 -11.0 30.14 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 123.326 2.684 . . . . 0.0 115.086 -176.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 53.2 p -130.32 -19.24 3.14 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 177.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.65 118.14 32.26 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.996 0.918 . . . . 0.0 111.295 175.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -116.37 105.42 12.5 Favored 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 124.328 1.051 . . . . 0.0 109.221 -175.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 52.1 mttm -67.04 130.99 44.91 Favored 'General case' 0 CA--C 1.543 0.698 0 O-C-N 121.48 -0.763 . . . . 0.0 110.438 177.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 11.8 m -140.27 157.27 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 125.085 1.354 . . . . 0.0 112.024 -169.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.7 m -130.89 115.79 17.02 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.693 1.197 . . . . 0.0 108.822 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -62.34 128.42 35.96 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.372 0.533 . . . . 0.0 109.934 174.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 27.7 m -122.42 155.92 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 123.89 0.876 . . . . 0.0 112.522 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.422 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -87.26 -168.68 2.32 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 124.436 1.094 . . . . 0.0 113.758 179.001 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -61.37 -31.43 71.32 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 125.289 1.435 . . . . 0.0 114.344 174.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -84.06 -8.98 58.97 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.773 0.829 . . . . 0.0 113.018 175.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.24 15.62 78.17 Favored Glycine 0 CA--C 1.533 1.175 0 CA-C-O 118.431 -1.205 . . . . 0.0 113.979 -173.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.422 HG22 ' OD1' ' A' ' 27' ' ' ASP . 18.6 m -79.72 150.61 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-N 119.49 1.645 . . . . 0.0 111.247 174.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -91.53 123.43 34.93 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.802 1.241 . . . . 0.0 110.922 -169.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 33.4 mt -106.55 -53.47 2.62 Favored 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.514 0.726 . . . . 0.0 112.114 -172.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.77 160.98 29.32 Favored Glycine 0 N--CA 1.471 0.998 0 C-N-CA 125.535 1.541 . . . . 0.0 113.073 178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.8 m -125.41 147.08 49.32 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 123.624 0.769 . . . . 0.0 112.824 -169.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -150.86 174.58 30.13 Favored Glycine 0 CA--C 1.53 1.025 0 C-N-CA 125.775 1.655 . . . . 0.0 113.858 -173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 92.0 t -113.01 120.22 62.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.215 -1.032 . . . . 0.0 108.215 169.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.2 tpp -86.08 138.78 31.69 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.614 1.166 . . . . 0.0 109.819 172.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -139.1 130.0 26.32 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 125.672 1.589 . . . . 0.0 108.799 -175.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.7 mp -107.27 127.43 53.54 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.311 1.844 . . . . 0.0 107.344 -179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.1 p -127.55 172.83 10.37 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.802 1.241 . . . . 0.0 110.664 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.8 mp0 -72.85 -0.48 13.59 Favored 'General case' 0 CA--C 1.549 0.941 0 O-C-N 121.235 -0.916 . . . . 0.0 112.541 171.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.1 t -106.47 -46.64 3.97 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.061 1.344 . . . . 0.0 112.971 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -174.8 174.41 2.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.943 1.297 . . . . 0.0 113.297 -166.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.7 mt -86.9 138.61 31.4 Favored 'General case' 0 N--CA 1.465 0.316 0 C-N-CA 124.234 1.014 . . . . 0.0 109.391 167.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 45.6 t -134.35 127.81 51.04 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 C-N-CA 124.133 0.973 . . . . 0.0 111.109 177.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 18.6 mt -100.17 130.73 46.34 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.816 1.647 . . . . 0.0 109.809 168.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -107.63 118.7 37.42 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.517 1.927 . . . . 0.0 110.188 172.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.6 mp -122.63 162.81 21.21 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 126.064 1.746 . . . . 0.0 110.929 -177.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.8 t-80 -90.9 -72.32 0.58 Allowed 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 124.678 1.191 . . . . 0.0 113.08 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -74.12 -24.66 59.47 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 113.873 1.064 . . . . 0.0 113.873 -174.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -112.0 162.4 15.41 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 125.892 1.677 . . . . 0.0 110.297 174.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -64.6 158.9 23.1 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.697 1.599 . . . . 0.0 112.548 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.65 152.92 43.06 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.755 0.822 . . . . 0.0 111.877 170.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.8 t -134.76 133.78 54.07 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 C-N-CA 123.67 0.788 . . . . 0.0 111.293 -174.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 39.4 mtp85 -125.63 143.32 51.08 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.96 1.304 . . . . 0.0 112.311 -172.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 25.4 m-90 -140.11 112.53 7.41 Favored Pre-proline 0 CA--C 1.543 0.682 0 C-N-CA 124.788 1.235 . . . . 0.0 111.153 174.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -66.76 145.73 76.17 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 122.64 2.227 . . . . 0.0 110.284 172.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.1 m-85 -60.33 -25.58 65.91 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -176.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.416 HD13 ' CD2' ' B' ' 16' ' ' TYR . 3.9 mm? -65.55 -38.84 90.77 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 125.028 1.331 . . . . 0.0 111.728 174.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 82.6 m -82.4 -5.31 58.57 Favored 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.523 1.305 . . . . 0.0 114.523 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 99.3 mt -83.38 123.4 29.62 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 119.339 0.972 . . . . 0.0 109.861 173.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 2.3 mpt_? -83.94 -38.71 20.68 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.097 0.559 . . . . 0.0 112.123 176.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.9 ptt180 -161.97 156.18 21.99 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 125.462 1.505 . . . . 0.0 111.428 -177.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -151.25 123.82 8.45 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.278 1.431 . . . . 0.0 109.538 -172.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.67 167.39 25.91 Favored Glycine 0 C--N 1.336 0.564 0 C-N-CA 124.264 0.935 . . . . 0.0 113.795 -169.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -145.13 164.13 32.2 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.349 1.06 . . . . 0.0 113.342 -169.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -146.78 -166.99 2.64 Favored 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 127.223 2.209 . . . . 0.0 109.385 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 93.9 p -69.55 -19.06 63.7 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 120.277 -1.514 . . . . 0.0 114.71 -175.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 41.0 p-10 -150.32 9.5 0.65 Allowed 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.286 1.434 . . . . 0.0 114.032 -177.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -137.42 132.21 33.1 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 125.774 1.63 . . . . 0.0 110.075 -169.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -126.89 139.66 52.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.078 1.751 . . . . 0.0 109.404 175.215 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.1 t -153.15 156.46 38.66 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 124.31 1.044 . . . . 0.0 112.448 -175.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.3 p90 -153.78 156.08 37.04 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.252 1.421 . . . . 0.0 111.901 -178.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -116.86 137.65 52.06 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.743 1.617 . . . . 0.0 110.104 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.3 t -141.16 156.58 45.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.235 1.014 . . . . 0.0 112.011 179.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -92.6 175.39 37.24 Favored Glycine 0 N--CA 1.472 1.1 0 C-N-CA 125.458 1.504 . . . . 0.0 114.986 -172.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.2 -13.52 28.51 Favored 'General case' 0 N--CA 1.48 1.046 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -172.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.8 ptm85 -86.96 -15.82 37.7 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 125.58 1.552 . . . . 0.0 115.182 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.6 p -76.34 179.79 5.59 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 123.79 0.836 . . . . 0.0 112.81 179.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -59.01 -41.25 87.29 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.36 1.064 . . . . 0.0 113.052 -179.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.3 p -92.09 -20.61 21.09 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.079 1.351 . . . . 0.0 113.758 -173.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.59 -173.1 49.23 Favored Glycine 0 CA--C 1.533 1.169 0 C-N-CA 125.252 1.406 . . . . 0.0 112.43 -172.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 22.9 pt20 -67.7 127.65 33.56 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 123.55 0.74 . . . . 0.0 112.234 -174.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 162.45 -177.39 38.62 Favored Glycine 0 CA--C 1.526 0.77 0 C-N-CA 124.124 0.869 . . . . 0.0 113.604 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 63.8 mt -123.48 139.65 49.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.55 0 C-N-CA 126.238 1.815 . . . . 0.0 109.128 178.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 63.0 m-85 -134.63 126.96 30.23 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.127 1.371 . . . . 0.0 109.768 -176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.76 139.26 54.18 Favored 'General case' 0 C--O 1.238 0.482 0 C-N-CA 124.624 1.17 . . . . 0.0 112.442 -171.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -137.18 126.89 25.43 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.242 1.017 . . . . 0.0 111.549 -169.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -74.25 134.46 42.66 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.644 0.777 . . . . 0.0 111.847 172.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 15.0 p -176.27 128.2 0.21 Allowed 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 128.02 2.528 . . . . 0.0 110.331 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 17.4 m -68.36 -10.47 55.21 Favored 'General case' 0 N--CA 1.48 1.026 0 O-C-N 120.807 -1.183 . . . . 0.0 113.326 175.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 13.1 tpt180 -93.36 10.21 33.1 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 127.01 2.124 . . . . 0.0 112.883 179.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.9 -40.59 66.77 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.692 1.597 . . . . 0.0 114.658 -173.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 71.1 tt0 -70.95 -35.26 72.11 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 123.481 0.712 . . . . 0.0 112.68 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 42.8 mp0 -67.09 -37.58 84.2 Favored 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.199 -0.938 . . . . 0.0 111.314 172.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 78.6 mt -61.43 -46.34 96.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.882 0 CA-C-N 118.751 0.705 . . . . 0.0 110.135 172.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.1 t80 -60.44 -43.16 97.11 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.382 1.073 . . . . 0.0 112.099 178.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 28.8 m-80 -70.42 -32.32 69.88 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.245 1.018 . . . . 0.0 113.423 177.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -78.04 -37.33 47.07 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 119.126 0.875 . . . . 0.0 110.063 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.5 mt -55.89 -52.02 65.54 Favored 'General case' 0 N--CA 1.464 0.266 0 O-C-N 121.434 -0.791 . . . . 0.0 112.567 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.7 pt20 -60.24 -23.95 64.48 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.667 0.988 . . . . 0.0 113.667 179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.24 -17.51 52.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 124.991 1.317 . . . . 0.0 113.377 176.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 83.4 mt -102.41 -36.32 8.47 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 125.316 1.446 . . . . 0.0 111.929 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 62.7 mmm -61.7 -26.97 68.37 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.599 1.559 . . . . 0.0 112.741 178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.25 -13.88 62.05 Favored 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.975 1.102 . . . . 0.0 113.975 174.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 35.7 t -71.3 -28.95 64.47 Favored 'General case' 0 CA--C 1.542 0.662 0 N-CA-C 113.384 0.883 . . . . 0.0 113.384 -170.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 18.0 m-80 55.52 61.7 2.75 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.132 1.373 . . . . 0.0 110.755 -172.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.1 p -80.81 65.97 6.15 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.159 1.784 . . . . 0.0 112.814 -170.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 32.2 mm -75.3 103.15 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 120.686 -1.259 . . . . 0.0 109.936 -174.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 10.9 p30 53.54 15.44 0.74 Allowed 'General case' 0 CA--C 1.554 1.113 0 C-N-CA 128.025 2.53 . . . . 0.0 116.342 178.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.5 m -61.96 -16.21 15.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 115.307 1.595 . . . . 0.0 115.307 -175.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 99.4 mtp -139.09 166.42 24.57 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.739 2.016 . . . . 0.0 111.782 -177.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -52.53 114.58 1.42 Allowed 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 126.582 1.953 . . . . 0.0 111.346 -173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -84.64 155.65 62.06 Favored Pre-proline 0 CA--C 1.549 0.933 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 -167.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.29 -169.56 0.54 Allowed 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 124.327 3.351 . . . . 0.0 111.096 168.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 48.7 t -78.6 129.56 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.915 0 C-N-CA 123.938 0.895 . . . . 0.0 109.924 169.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.7 mp -123.35 146.05 29.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.865 0 C-N-CA 125.781 1.632 . . . . 0.0 108.058 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 50.4 pt -67.65 20.14 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 C-N-CA 126.713 2.005 . . . . 0.0 115.548 -178.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.8 p -123.26 161.21 25.03 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 126.849 2.06 . . . . 0.0 111.143 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -64.21 107.72 1.38 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 124.331 1.053 . . . . 0.0 110.425 179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -168.33 170.28 10.08 Favored 'General case' 0 CA--C 1.549 0.924 0 C-N-CA 126.783 2.033 . . . . 0.0 110.047 -176.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 t -70.08 139.74 52.62 Favored 'General case' 0 CA--C 1.542 0.668 0 O-C-N 121.124 -0.985 . . . . 0.0 110.481 169.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 31.2 m170 -128.78 136.6 29.4 Favored Pre-proline 0 CA--C 1.552 1.042 0 C-N-CA 124.973 1.309 . . . . 0.0 111.912 -174.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.36 160.78 41.47 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 123.434 2.756 . . . . 0.0 112.218 179.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -92.09 -179.3 5.23 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.202 1.401 . . . . 0.0 112.682 175.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -120.8 161.91 20.68 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.873 1.669 . . . . 0.0 112.114 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.2 mt -111.71 151.51 28.81 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.159 1.384 . . . . 0.0 112.191 -174.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -98.05 160.28 14.4 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.384 1.874 . . . . 0.0 112.795 177.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.3 pp -95.8 154.26 39.11 Favored Pre-proline 0 CA--C 1.549 0.927 0 C-N-CA 124.911 1.284 . . . . 0.0 112.541 179.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -77.84 150.85 27.45 Favored 'Trans proline' 0 C--N 1.35 0.632 0 C-N-CA 123.06 2.507 . . . . 0.0 111.588 178.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -98.39 139.39 34.23 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.673 1.189 . . . . 0.0 111.127 178.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -77.22 149.17 78.99 Favored Pre-proline 0 CA--C 1.552 1.037 0 C-N-CA 124.685 1.194 . . . . 0.0 112.302 178.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -74.02 175.8 10.37 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.779 2.986 . . . . 0.0 111.667 175.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -126.59 147.81 62.06 Favored Pre-proline 0 CA--C 1.543 0.698 0 C-N-CA 125.136 1.375 . . . . 0.0 110.1 177.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.18 152.78 56.57 Favored 'Trans proline' 0 CA--C 1.544 0.996 0 C-N-CA 123.299 2.666 . . . . 0.0 112.105 -174.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -74.86 174.77 12.16 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 124.026 3.151 . . . . 0.0 111.95 177.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 11.7 p30 -150.58 163.2 39.06 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.046 1.339 . . . . 0.0 112.232 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -156.93 170.55 22.26 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.709 1.604 . . . . 0.0 111.576 -174.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 62.2 tp -149.89 126.96 11.23 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.206 1.402 . . . . 0.0 110.234 -177.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.96 -170.02 42.78 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.032 1.301 . . . . 0.0 113.562 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.8 t80 -156.13 150.22 25.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 125.155 1.382 . . . . 0.0 112.049 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 74.4 m -137.88 145.52 42.27 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 126.602 1.961 . . . . 0.0 108.987 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.9 p -131.5 140.14 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 C-N-CA 125.569 1.548 . . . . 0.0 110.504 -176.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.6 m -107.84 169.23 8.73 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.223 1.409 . . . . 0.0 113.301 -170.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 79.7 p . . . . . 0 C--O 1.254 1.336 0 C-N-CA 126.185 1.794 . . . . 0.0 113.5 -179.993 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 10.7 mp . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -132.36 124.62 29.1 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.382 1.073 . . . . 0.0 111.044 175.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 11.2 ptp180 -78.96 116.98 19.62 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.497 1.119 . . . . 0.0 110.957 178.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.8 mt -88.16 153.71 21.02 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 121.525 -0.734 . . . . 0.0 112.467 175.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 85.0 mtm180 -94.6 -2.11 52.04 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.815 1.646 . . . . 0.0 113.49 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 33.3 p80 -160.95 164.31 31.18 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 127.454 2.302 . . . . 0.0 110.737 -173.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -94.78 119.01 66.68 Favored Pre-proline 0 CA--C 1.548 0.877 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.227 177.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -80.39 -22.16 7.06 Favored 'Trans proline' 0 C--N 1.353 0.771 0 C-N-CA 123.004 2.47 . . . . 0.0 113.489 -170.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.5 m -91.06 112.16 23.94 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.926 0.891 . . . . 0.0 111.047 -175.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.18 -25.72 72.55 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 123.778 0.704 . . . . 0.0 112.881 175.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 74.8 m-80 -91.97 119.17 31.46 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.675 1.19 . . . . 0.0 109.258 169.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.3 p -156.69 154.03 6.48 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.484 1.514 . . . . 0.0 110.749 -169.492 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 29.8 p-10 -144.82 175.88 9.86 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.961 1.704 . . . . 0.0 112.25 173.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -138.62 134.08 33.27 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.637 1.575 . . . . 0.0 110.444 -169.021 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.73 -25.4 5.18 Favored Glycine 0 N--CA 1.476 1.335 0 N-CA-C 115.561 0.984 . . . . 0.0 115.561 -174.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . 0.416 ' CD2' HD13 ' A' ' 60' ' ' LEU . 51.3 m-85 -123.47 131.16 53.56 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.098 1.359 . . . . 0.0 110.361 -175.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -163.55 158.72 21.09 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 125.81 1.644 . . . . 0.0 111.162 -169.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 17.2 pt20 -83.97 53.3 2.54 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.306 1.442 . . . . 0.0 112.977 -175.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.254 1.328 0 C-N-CA 125.702 1.601 . . . . 0.0 111.756 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.598 0 N-CA-C 112.031 -0.428 . . . . 0.0 112.031 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.6 t -164.09 168.72 18.76 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.231 1.412 . . . . 0.0 111.385 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 m -151.67 145.45 25.08 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 125.899 1.68 . . . . 0.0 110.937 -177.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 169.35 -167.77 40.75 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.498 1.046 . . . . 0.0 113.495 -178.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.4 t -163.71 179.28 7.25 Favored 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 125.567 1.547 . . . . 0.0 111.131 -178.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 51.7 p -160.17 144.34 14.35 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 125.555 1.542 . . . . 0.0 111.9 -176.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.12 -171.71 30.77 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.139 1.352 . . . . 0.0 113.153 -176.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -72.75 139.57 47.22 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.34 1.056 . . . . 0.0 111.208 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 54.7 p30 -90.56 18.48 6.26 Favored 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 125.648 1.579 . . . . 0.0 113.757 178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.7 ptt180 -74.83 28.32 0.09 Allowed 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 127.581 2.352 . . . . 0.0 115.403 -172.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.1 t0 -149.77 150.71 32.45 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 126.052 1.741 . . . . 0.0 110.952 -175.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.8 m -76.4 139.34 40.88 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 123.812 0.845 . . . . 0.0 111.919 -178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 3.7 p -54.34 123.32 42.15 Favored Pre-proline 0 N--CA 1.48 1.05 0 C-N-CA 124.367 1.067 . . . . 0.0 111.964 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -84.08 159.58 13.51 Favored 'Trans proline' 0 N--CA 1.457 -0.665 0 C-N-CA 123.093 2.528 . . . . 0.0 110.543 174.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -68.29 -14.11 62.75 Favored 'General case' 0 CA--C 1.544 0.724 0 C-N-CA 123.959 0.903 . . . . 0.0 113.293 173.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -106.46 9.87 31.53 Favored 'General case' 0 CA--C 1.552 1.021 0 C-N-CA 126.519 1.928 . . . . 0.0 113.863 -172.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 47.7 t-80 -59.97 145.54 84.35 Favored Pre-proline 0 CA--C 1.557 1.244 0 O-C-N 120.82 -1.175 . . . . 0.0 112.431 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -72.33 -11.02 26.37 Favored 'Trans proline' 0 CA--C 1.541 0.834 0 C-N-CA 122.899 2.399 . . . . 0.0 115.259 -178.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.7 p -130.96 -16.95 3.17 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 120.373 1.442 . . . . 0.0 114.088 176.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.0 mttt -111.61 144.69 40.46 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 124.816 1.247 . . . . 0.0 110.579 177.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -140.83 119.17 12.14 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 124.159 0.983 . . . . 0.0 109.099 -174.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.1 mttm -70.24 129.71 40.07 Favored 'General case' 0 CA--C 1.541 0.614 0 O-C-N 121.65 -0.656 . . . . 0.0 110.227 173.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.7 m -136.74 160.73 37.02 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 C-N-CA 125.844 1.658 . . . . 0.0 110.889 -170.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 36.5 m -132.75 118.79 19.48 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 123.857 0.863 . . . . 0.0 109.193 174.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -63.26 128.68 36.94 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.038 0.935 . . . . 0.0 110.164 175.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 30.9 m -124.34 155.03 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 C-N-CA 123.918 0.887 . . . . 0.0 113.382 -177.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.411 ' CG ' HG22 ' A' ' 31' ' ' VAL . 3.5 p-10 -83.51 -170.85 3.26 Favored 'General case' 0 CA--C 1.55 0.967 0 N-CA-C 113.904 1.076 . . . . 0.0 113.904 175.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -63.49 -24.15 67.7 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -92.82 -6.22 49.33 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.142 1.777 . . . . 0.0 112.642 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 82.19 15.2 75.08 Favored Glycine 0 CA--C 1.532 1.13 0 CA-C-O 118.282 -1.288 . . . . 0.0 114.29 -176.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.411 HG22 ' CG ' ' A' ' 27' ' ' ASP . 3.3 m -76.67 143.98 12.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.804 0 CA-C-N 119.721 1.76 . . . . 0.0 110.849 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -88.24 119.45 28.65 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 125.078 1.351 . . . . 0.0 110.495 -169.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.6 mt -104.93 -54.73 2.44 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 123.149 0.58 . . . . 0.0 112.025 -171.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -147.26 142.61 10.41 Favored Glycine 0 N--CA 1.472 1.063 0 C-N-CA 124.834 1.207 . . . . 0.0 113.799 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 72.5 p -94.56 142.19 27.73 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.943 1.297 . . . . 0.0 112.354 179.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -148.75 171.28 29.1 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 125.736 1.636 . . . . 0.0 113.486 -176.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 65.0 t -114.56 120.71 64.99 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 169.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.2 tpp -87.19 139.23 30.77 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.698 1.199 . . . . 0.0 109.67 171.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -139.07 128.82 24.76 Favored 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.7 1.6 . . . . 0.0 108.667 -175.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mp -108.52 134.26 51.54 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 126.211 1.804 . . . . 0.0 108.138 -178.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.3 p -134.26 170.76 15.22 Favored 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 125.117 1.367 . . . . 0.0 109.745 -178.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -70.05 -5.93 30.14 Favored 'General case' 0 CA--C 1.544 0.717 0 O-C-N 121.233 -0.917 . . . . 0.0 113.076 173.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.5 t -107.48 -43.52 4.52 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.247 1.019 . . . . 0.0 113.34 -177.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.5 pt-20 -169.88 169.04 8.49 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.41 1.084 . . . . 0.0 113.194 -169.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.2 mt -86.74 142.4 28.18 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 124.535 1.134 . . . . 0.0 110.031 168.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.2 t -134.69 130.15 52.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.72 0 C-N-CA 124.616 1.166 . . . . 0.0 110.847 179.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.1 mt -105.55 133.62 49.99 Favored 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 126.145 1.778 . . . . 0.0 110.565 168.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -115.8 117.84 31.35 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 126.872 2.069 . . . . 0.0 110.329 172.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.0 mp -124.51 159.96 29.41 Favored 'General case' 0 N--CA 1.475 0.792 0 C-N-CA 125.662 1.585 . . . . 0.0 110.57 -178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -100.92 -7.15 23.7 Favored 'General case' 0 CA--C 1.552 1.039 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 177.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.0 mmm-85 -114.99 0.18 13.59 Favored 'General case' 0 N--CA 1.48 1.046 0 C-N-CA 126.472 1.909 . . . . 0.0 113.634 176.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.9 mmm180 -148.36 157.3 43.39 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 126.697 1.999 . . . . 0.0 110.22 -175.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 35.9 mp0 -61.68 159.24 13.76 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 124.427 1.091 . . . . 0.0 110.414 168.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.34 140.97 58.92 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 121.475 -0.766 . . . . 0.0 111.413 174.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.2 t -128.58 136.33 60.21 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.159 0 C-N-CA 123.917 0.887 . . . . 0.0 110.757 -172.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.3 mpp_? -134.44 148.96 50.7 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.657 0.984 . . . . 0.0 113.657 -170.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -140.76 112.58 6.97 Favored Pre-proline 0 CA--C 1.544 0.735 0 C-N-CA 125.426 1.491 . . . . 0.0 111.059 179.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -65.66 148.11 86.75 Favored 'Trans proline' 0 C--N 1.352 0.718 0 C-N-CA 122.794 2.329 . . . . 0.0 110.347 172.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.1 m-85 -61.95 -19.69 63.03 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.752 1.019 . . . . 0.0 113.752 -179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.53 -44.83 95.38 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.635 1.574 . . . . 0.0 112.974 171.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 4.2 p -77.4 -15.18 59.5 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 114.224 1.194 . . . . 0.0 114.224 -176.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 67.3 mt -71.94 115.14 10.8 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 123.783 0.833 . . . . 0.0 109.986 178.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 56.3 mmm-85 -79.08 -32.67 44.79 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.447 1.099 . . . . 0.0 111.723 177.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -166.6 159.88 14.61 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 126.228 1.811 . . . . 0.0 111.528 176.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 42.7 p90 -150.07 126.35 10.72 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.167 1.387 . . . . 0.0 110.804 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -142.9 172.63 24.41 Favored Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.976 1.274 . . . . 0.0 113.45 -170.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.0 p90 -153.49 145.72 23.85 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.161 0.985 . . . . 0.0 112.161 -170.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -141.04 -177.5 5.13 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 126.469 1.908 . . . . 0.0 109.362 175.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.7 t -59.45 117.45 4.87 Favored 'General case' 0 CA--C 1.538 0.518 0 O-C-N 121.019 -1.051 . . . . 0.0 110.708 173.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.8 t30 60.54 12.85 3.8 Favored 'General case' 0 CA--C 1.555 1.162 0 C-N-CA 127.111 2.165 . . . . 0.0 115.158 -176.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -133.91 127.38 32.35 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-N 120.752 1.614 . . . . 0.0 111.922 -169.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -122.15 140.94 51.96 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.824 1.65 . . . . 0.0 109.972 172.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.6 t -153.55 155.34 35.99 Favored 'General case' 0 CA--C 1.54 0.567 0 O-C-N 121.047 -1.033 . . . . 0.0 112.886 -178.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.7 p90 -147.97 153.58 39.2 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.245 1.418 . . . . 0.0 111.88 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 -111.35 141.16 45.26 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 125.574 1.55 . . . . 0.0 109.439 176.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.1 p -138.91 150.56 46.08 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.786 0.834 . . . . 0.0 112.7 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -86.59 173.82 46.01 Favored Glycine 0 CA--C 1.533 1.192 0 C-N-CA 124.957 1.265 . . . . 0.0 113.715 -178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.2 ppt_? -63.66 -14.8 55.32 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 -174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.9 ptp180 -77.44 -16.84 58.57 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.128 1.771 . . . . 0.0 115.292 -176.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.2 p -79.29 -179.07 6.54 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 124.32 1.048 . . . . 0.0 113.498 -176.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 49.6 tt0 -62.02 -36.65 82.2 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.54 1.136 . . . . 0.0 113.296 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -94.94 -20.81 19.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.079 1.352 . . . . 0.0 114.338 -174.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.31 -179.07 49.38 Favored Glycine 0 CA--C 1.533 1.158 0 C-N-CA 124.886 1.232 . . . . 0.0 112.02 -169.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.9 tm0? -65.82 129.52 40.08 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.878 0.871 . . . . 0.0 111.823 -171.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.09 -177.22 42.36 Favored Glycine 0 CA--C 1.524 0.643 0 CA-C-O 122.143 0.857 . . . . 0.0 113.508 177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.2 mt -121.75 139.26 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 C-N-CA 126.046 1.739 . . . . 0.0 108.698 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 79.9 m-85 -133.85 128.06 33.88 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.971 1.308 . . . . 0.0 110.035 -176.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -125.89 142.72 51.39 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.649 1.179 . . . . 0.0 112.725 -172.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 36.6 m-85 -139.17 129.71 25.82 Favored 'General case' 0 CA--C 1.53 0.183 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.69 -168.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 79.3 mttt -72.35 133.35 44.91 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 123.001 0.52 . . . . 0.0 110.754 169.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.0 t -168.46 124.34 0.98 Allowed 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.185 1.794 . . . . 0.0 111.044 -171.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.8 m -70.97 -9.48 58.02 Favored 'General case' 0 N--CA 1.478 0.968 0 N-CA-C 113.534 0.939 . . . . 0.0 113.534 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 83.5 mtt85 -117.68 22.48 12.32 Favored 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 126.434 1.894 . . . . 0.0 112.405 -177.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.67 -38.15 31.48 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.265 1.426 . . . . 0.0 114.299 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -70.56 -36.66 73.77 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.751 0.82 . . . . 0.0 112.926 176.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 18.9 mt-10 -65.07 -40.09 94.19 Favored 'General case' 0 N--CA 1.47 0.553 0 O-C-N 121.58 -0.7 . . . . 0.0 110.788 173.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 88.5 mt -61.19 -47.89 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 122.941 0.497 . . . . 0.0 110.296 173.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -59.31 -44.64 92.54 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 124.555 1.142 . . . . 0.0 112.11 178.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -70.0 -33.63 72.29 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.854 0.862 . . . . 0.0 113.088 177.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -74.88 -41.67 59.32 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.951 0.796 . . . . 0.0 110.4 177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.3 mt -52.12 -55.13 22.82 Favored 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 123.728 0.811 . . . . 0.0 112.869 178.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -62.59 -25.43 68.07 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 -179.094 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -67.88 -29.42 68.52 Favored 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 119.505 1.048 . . . . 0.0 112.677 176.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 43.6 mt -96.09 -39.38 9.76 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.354 1.462 . . . . 0.0 110.999 -178.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.3 mtp -70.82 -29.76 66.01 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 124.306 1.042 . . . . 0.0 113.3 -179.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 24.1 pt20 -65.27 -20.0 66.22 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.27 0.841 . . . . 0.0 113.27 173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 14.1 t -71.37 -26.17 62.68 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.372 0.669 . . . . 0.0 112.539 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 53.4 m-80 50.61 38.92 20.17 Favored 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 125.379 1.472 . . . . 0.0 112.582 176.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.5 t -60.82 135.04 57.66 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.855 1.058 . . . . 0.0 113.855 -169.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.6 mp -87.58 -41.67 14.65 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 C-N-CA 125.213 1.405 . . . . 0.0 109.616 175.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -70.7 -12.97 61.88 Favored 'General case' 0 CA--C 1.544 0.742 0 N-CA-C 113.853 1.057 . . . . 0.0 113.853 -169.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 31.7 m -88.06 3.7 5.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.511 1.125 . . . . 0.0 113.422 171.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 47.0 mtt -136.61 -179.11 5.49 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.304 1.842 . . . . 0.0 111.283 -178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -79.77 175.66 10.43 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.032 0.933 . . . . 0.0 111.72 169.656 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -58.66 143.99 80.89 Favored Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 123.742 0.817 . . . . 0.0 112.984 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -70.92 159.12 53.54 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.579 2.853 . . . . 0.0 112.147 -176.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.6 p -116.44 135.13 57.67 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 C-N-CA 125.452 1.501 . . . . 0.0 110.658 -177.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mp -87.91 121.93 38.96 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 C-N-CA 124.663 1.185 . . . . 0.0 108.199 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 40.9 mt -89.2 108.89 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 123.606 0.763 . . . . 0.0 109.454 -173.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.4 t -63.8 -32.12 73.53 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.89 1.276 . . . . 0.0 113.525 -174.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 5.2 tpm_? -89.86 111.43 22.47 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.019 0.928 . . . . 0.0 110.052 173.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 18.1 p30 -154.56 160.0 41.23 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 125.266 1.426 . . . . 0.0 111.563 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -172.04 171.03 5.12 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.542 1.937 . . . . 0.0 110.286 -177.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 48.8 p-80 -158.09 147.57 15.01 Favored Pre-proline 0 CA--C 1.553 1.096 0 C-N-CA 125.704 1.602 . . . . 0.0 112.388 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -74.4 166.8 28.63 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.701 2.934 . . . . 0.0 111.425 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -134.22 126.64 30.28 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.619 1.167 . . . . 0.0 110.931 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 16.1 mm-40 -147.63 146.03 29.2 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 127.303 2.241 . . . . 0.0 108.993 -175.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 52.1 tp -156.78 131.21 8.65 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 124.544 1.138 . . . . 0.0 110.845 -176.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -85.71 166.65 15.96 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 125.356 1.462 . . . . 0.0 112.715 175.311 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.2 pp -124.92 144.82 48.08 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 124.824 1.25 . . . . 0.0 111.91 179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_endo -80.51 160.25 22.39 Favored 'Trans proline' 0 C--N 1.351 0.695 0 C-N-CA 123.833 3.022 . . . . 0.0 111.656 -179.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -156.96 160.05 38.67 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 125.052 1.341 . . . . 0.0 111.868 176.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -164.55 148.17 7.72 Favored Pre-proline 0 CA--C 1.547 0.839 0 C-N-CA 126.153 1.781 . . . . 0.0 111.156 179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -76.06 175.74 10.93 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.662 2.908 . . . . 0.0 111.0 172.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.0 pt20 -128.07 116.11 20.38 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 124.294 1.038 . . . . 0.0 109.161 172.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -78.63 139.2 15.8 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 122.649 2.233 . . . . 0.0 111.108 -173.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.94 159.91 37.53 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.48 2.787 . . . . 0.0 111.271 175.276 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -156.05 132.47 10.17 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.61 1.164 . . . . 0.0 111.308 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -159.26 135.92 9.34 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.537 1.535 . . . . 0.0 110.889 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 61.7 tp -163.01 131.06 3.75 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 126.092 1.757 . . . . 0.0 109.513 -179.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -141.99 142.97 12.31 Favored Glycine 0 N--CA 1.469 0.88 0 C-N-CA 124.906 1.241 . . . . 0.0 112.512 177.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 40.6 t80 -163.91 158.64 20.04 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.881 1.672 . . . . 0.0 111.429 -178.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 45.3 p -138.93 156.28 47.39 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.838 1.655 . . . . 0.0 110.88 -177.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.1 m -143.76 156.44 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 C-N-CA 125.921 1.689 . . . . 0.0 110.938 -172.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 70.2 m -110.75 134.3 52.6 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 124.756 1.222 . . . . 0.0 111.512 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 16.6 t . . . . . 0 C--O 1.254 1.335 0 C-N-CA 126.118 1.767 . . . . 0.0 111.388 -177.566 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.4 mm? . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 36.9 t80 -102.41 121.37 42.19 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.396 0.678 . . . . 0.0 110.828 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -78.97 109.24 13.08 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.996 1.319 . . . . 0.0 111.005 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 60.3 mt -83.53 153.4 24.4 Favored 'General case' 0 N--CA 1.47 0.546 0 C-N-CA 123.536 0.735 . . . . 0.0 112.024 175.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 34.4 ttp180 -81.73 -28.22 33.47 Favored 'General case' 0 N--CA 1.474 0.77 0 C-N-CA 124.89 1.276 . . . . 0.0 112.534 178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -157.03 162.83 39.54 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 126.441 1.896 . . . . 0.0 111.359 -170.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -78.56 132.22 65.93 Favored Pre-proline 0 CA--C 1.548 0.866 0 O-C-N 121.542 -0.724 . . . . 0.0 111.55 -173.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -83.62 -4.78 10.8 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.321 2.681 . . . . 0.0 114.358 -171.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 14.6 t -122.84 145.45 48.43 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 119.606 1.094 . . . . 0.0 113.44 -176.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -90.08 -4.53 71.67 Favored Glycine 0 CA--C 1.538 1.511 0 C-N-CA 125.609 1.576 . . . . 0.0 114.532 170.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 24.9 m120 -119.39 123.23 43.61 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.791 1.636 . . . . 0.0 109.828 176.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 9.2 p -157.11 152.25 7.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 C-N-CA 124.394 1.078 . . . . 0.0 110.882 -167.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -122.53 146.94 46.95 Favored 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.134 1.374 . . . . 0.0 110.307 175.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -118.7 112.3 19.61 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.157 1.783 . . . . 0.0 110.068 -178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -97.27 -64.15 0.9 Allowed Glycine 0 N--CA 1.473 1.155 0 C-N-CA 124.302 0.953 . . . . 0.0 112.874 -172.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 10.5 m-85 -86.68 3.03 46.42 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -174.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 60.1 mt-30 -130.57 116.62 18.4 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 124.858 1.263 . . . . 0.0 109.02 171.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 51.0 tt0 -90.06 71.82 7.38 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.383 1.073 . . . . 0.0 109.664 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.235 0 C-N-CA 125.695 1.598 . . . . 0.0 114.461 -177.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.519 0 N-CA-C 110.554 -1.018 . . . . 0.0 110.554 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 79.0 p -161.41 158.1 26.24 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.332 1.453 . . . . 0.0 110.724 172.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.5 t -165.66 167.2 17.42 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 125.134 1.374 . . . . 0.0 111.121 -176.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -168.42 174.61 43.17 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.156 1.36 . . . . 0.0 113.549 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.5 t -158.92 134.06 8.37 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.801 1.24 . . . . 0.0 110.559 179.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 14.5 m -169.92 143.47 2.58 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 126.983 2.113 . . . . 0.0 110.084 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 68.47 -136.95 30.31 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 123.679 0.657 . . . . 0.0 112.349 -179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 94.4 mt -105.56 131.14 53.33 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.989 1.316 . . . . 0.0 110.175 175.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 32.1 p30 -87.54 147.19 25.46 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.05 1.34 . . . . 0.0 112.721 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -72.06 141.94 49.24 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.526 0.73 . . . . 0.0 112.667 -178.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -159.55 147.1 17.04 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 127.238 2.215 . . . . 0.0 110.008 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t 62.67 24.15 14.38 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 124.626 1.17 . . . . 0.0 113.247 174.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.5 t -58.14 128.04 81.09 Favored Pre-proline 0 N--CA 1.478 0.934 0 C-N-CA 125.565 1.546 . . . . 0.0 111.138 -170.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -66.13 148.96 85.85 Favored 'Trans proline' 0 C--N 1.353 0.782 0 C-N-CA 123.155 2.57 . . . . 0.0 111.053 175.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -62.79 -8.05 6.13 Favored 'General case' 0 CA--C 1.542 0.658 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 p-10 -124.04 19.96 9.14 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 125.318 1.447 . . . . 0.0 114.281 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 26.4 t-80 -53.4 141.54 42.65 Favored Pre-proline 0 CA--C 1.557 1.215 0 O-C-N 121.171 -0.956 . . . . 0.0 113.4 177.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -71.67 -10.44 26.58 Favored 'Trans proline' 0 CA--C 1.54 0.788 0 C-N-CA 123.246 2.63 . . . . 0.0 115.177 -178.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 64.2 p -128.87 -21.1 3.4 Favored 'General case' 0 N--CA 1.482 1.148 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -178.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.9 mppt? -115.51 134.66 54.86 Favored 'General case' 0 N--CA 1.471 0.621 0 C-N-CA 124.024 0.929 . . . . 0.0 110.83 175.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 77.9 m-85 -131.29 121.19 24.3 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 125.214 1.406 . . . . 0.0 107.97 -175.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.89 140.91 44.15 Favored 'General case' 0 N--CA 1.468 0.44 0 O-C-N 121.28 -0.888 . . . . 0.0 110.447 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 28.3 m -145.18 163.24 12.68 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 124.295 1.038 . . . . 0.0 111.608 -169.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.1 m -143.87 123.2 13.05 Favored 'General case' 0 CA--C 1.514 -0.437 0 C-N-CA 124.427 1.091 . . . . 0.0 108.774 170.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -64.46 132.86 51.21 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.16 0.984 . . . . 0.0 110.339 177.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.67 156.08 41.97 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.806 1.242 . . . . 0.0 113.018 -175.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.432 ' OD1' HG22 ' A' ' 31' ' ' VAL . 2.3 p-10 -93.37 -165.53 1.35 Allowed 'General case' 0 CA--C 1.555 1.169 0 C-N-CA 125.644 1.578 . . . . 0.0 114.309 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -59.14 -35.1 72.91 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 125.035 1.334 . . . . 0.0 113.656 172.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -81.27 -13.04 58.89 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 119.039 0.836 . . . . 0.0 113.167 177.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.72 17.84 74.37 Favored Glycine 0 CA--C 1.534 1.265 0 CA-C-O 118.295 -1.28 . . . . 0.0 113.624 -171.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.432 HG22 ' OD1' ' A' ' 27' ' ' ASP . 11.3 m -76.31 150.23 6.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.768 0 CA-C-N 119.537 1.669 . . . . 0.0 111.145 173.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.1 123.99 32.76 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.276 1.031 . . . . 0.0 111.309 -171.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 40.7 mt -104.85 -50.06 3.36 Favored 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.551 1.14 . . . . 0.0 111.786 -172.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.91 132.38 3.44 Favored Glycine 0 N--CA 1.472 1.054 0 C-N-CA 124.684 1.135 . . . . 0.0 113.633 176.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.7 p -85.44 149.45 25.4 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 124.938 1.295 . . . . 0.0 112.635 177.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.41 171.7 39.18 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.829 1.204 . . . . 0.0 114.391 -174.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 30.9 t -113.25 120.34 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 169.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 39.1 tpp -86.02 132.03 34.14 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.762 0.825 . . . . 0.0 109.424 172.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 tt0 -128.89 128.74 44.43 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 125.869 1.668 . . . . 0.0 108.272 -175.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.5 mp -106.52 125.43 50.99 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 126.024 1.73 . . . . 0.0 108.029 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.0 p -131.59 168.29 17.95 Favored 'General case' 0 N--CA 1.476 0.873 0 C-N-CA 124.684 1.193 . . . . 0.0 110.072 174.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 22.7 mp0 -65.17 -10.87 34.74 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.121 0.569 . . . . 0.0 112.344 174.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 50.3 m -95.91 -41.89 8.57 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.42 1.088 . . . . 0.0 113.114 -177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -177.68 171.16 1.91 Allowed 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 125.131 1.372 . . . . 0.0 112.837 -171.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -87.29 136.64 32.85 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.064 0.945 . . . . 0.0 109.012 167.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.0 t -134.54 130.95 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 C-N-CA 123.886 0.874 . . . . 0.0 111.492 -177.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 57.8 mt -100.34 130.04 46.4 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 124.502 1.121 . . . . 0.0 110.532 168.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.7 m-70 -106.26 131.53 53.38 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.461 1.904 . . . . 0.0 110.961 170.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.5 mp -135.19 151.62 50.82 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 125.709 1.603 . . . . 0.0 110.73 -177.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 -70.07 112.81 6.71 Favored 'General case' 0 CA--C 1.548 0.866 0 O-C-N 121.632 -0.668 . . . . 0.0 111.984 173.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 4.3 mmp_? 59.65 13.63 3.53 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 126.663 1.985 . . . . 0.0 115.859 173.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.6 mmt180 -107.99 160.39 15.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.058 1.743 . . . . 0.0 110.707 171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 66.4 mt-10 -62.29 137.14 58.2 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 123.654 0.782 . . . . 0.0 110.496 176.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.75 151.72 46.77 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.52 0.728 . . . . 0.0 111.266 173.599 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.3 t -131.04 128.52 62.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 C-N-CA 123.569 0.747 . . . . 0.0 110.79 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 96.6 mtt180 -124.29 147.18 48.31 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 125.442 1.497 . . . . 0.0 112.588 -170.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -139.34 118.99 9.23 Favored Pre-proline 0 CA--C 1.541 0.608 0 C-N-CA 124.795 1.238 . . . . 0.0 111.437 173.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -68.89 146.25 64.9 Favored 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 122.503 2.135 . . . . 0.0 109.559 171.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -59.73 -26.41 65.61 Favored 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 176.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.1 mt -58.17 -27.76 64.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.281 1.833 . . . . 0.0 114.397 171.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.5 p -90.56 -9.71 46.13 Favored 'General case' 0 N--CA 1.479 1.006 0 N-CA-C 114.776 1.398 . . . . 0.0 114.776 176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.2 mt -94.6 84.96 4.38 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.873 1.269 . . . . 0.0 110.932 -172.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -73.44 -19.42 60.96 Favored 'General case' 0 N--CA 1.473 0.713 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.483 ' HG3' HG21 ' B' ' 12' ' ' VAL . 54.5 ttp180 -157.84 123.52 4.6 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 125.836 1.655 . . . . 0.0 110.051 -173.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 47.7 p90 -140.87 109.66 6.04 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 125.987 1.715 . . . . 0.0 111.097 -177.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.63 169.89 13.11 Favored Glycine 0 N--CA 1.462 0.411 0 C-N-CA 124.713 1.149 . . . . 0.0 113.731 -169.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -140.35 159.46 42.13 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.39 1.076 . . . . 0.0 112.738 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 43.7 t0 -154.45 174.98 14.15 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 127.508 2.323 . . . . 0.0 109.643 175.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 m -61.34 -12.56 14.36 Favored 'General case' 0 N--CA 1.478 0.959 0 N-CA-C 116.404 2.001 . . . . 0.0 116.404 -172.052 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.3 t30 -154.63 18.29 0.46 Allowed 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 125.151 1.38 . . . . 0.0 112.865 174.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -143.53 128.35 18.33 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 120.472 -1.393 . . . . 0.0 110.486 -169.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.3 t80 -118.98 133.2 55.98 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 126.124 1.77 . . . . 0.0 108.852 171.53 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.3 t -153.04 151.11 29.87 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 121.013 -1.054 . . . . 0.0 112.494 -173.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -149.67 148.75 29.66 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.99 0.916 . . . . 0.0 112.388 -173.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -104.8 135.09 46.83 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.293 1.437 . . . . 0.0 110.058 175.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -126.47 145.89 50.32 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 124.292 1.037 . . . . 0.0 112.188 -176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -83.1 168.23 46.57 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 124.41 1.005 . . . . 0.0 113.282 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 2.7 ppt_? -65.94 -11.35 46.79 Favored 'General case' 0 N--CA 1.481 1.118 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 -174.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.5 ptp180 -70.14 -19.87 63.19 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.659 1.584 . . . . 0.0 114.967 177.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.3 p -85.87 -179.88 6.9 Favored 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -174.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -63.21 -39.28 94.18 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.488 1.115 . . . . 0.0 113.181 -176.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 64.5 p -96.45 -22.61 17.02 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.972 1.309 . . . . 0.0 113.492 -176.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.99 -162.04 29.67 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 126.566 2.031 . . . . 0.0 113.644 175.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.1 mm-40 -56.75 125.88 24.34 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 124.354 1.062 . . . . 0.0 111.524 174.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.78 171.98 27.47 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 124.453 1.025 . . . . 0.0 113.304 178.621 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 72.2 mt -115.04 131.45 67.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 125.531 1.532 . . . . 0.0 108.337 172.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -124.49 113.64 18.38 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.91 1.284 . . . . 0.0 109.669 -172.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -111.27 140.57 45.73 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.177 1.391 . . . . 0.0 112.298 -173.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -138.76 125.55 20.94 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.199 1.0 . . . . 0.0 111.405 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 42.1 mttm -63.75 126.79 28.73 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.822 0.849 . . . . 0.0 110.434 169.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.6 t -167.86 126.65 1.25 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.635 1.574 . . . . 0.0 111.462 -170.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 28.2 t -69.74 -44.21 70.7 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.185 0.594 . . . . 0.0 112.459 179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.1 mtm-85 -90.45 31.28 1.04 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.566 1.546 . . . . 0.0 113.889 -176.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -53.04 -37.32 61.47 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 124.666 1.187 . . . . 0.0 113.967 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.6 tt0 -70.53 -36.85 73.95 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.598 0.759 . . . . 0.0 112.843 176.398 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -64.54 -42.11 95.93 Favored 'General case' 0 N--CA 1.468 0.458 0 O-C-N 121.719 -0.613 . . . . 0.0 110.249 173.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 93.0 mt -59.97 -48.44 87.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.855 0 C-N-CA 123.322 0.649 . . . . 0.0 110.626 173.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -58.52 -40.47 83.01 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.51 1.124 . . . . 0.0 112.304 179.099 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -73.75 -31.87 63.55 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 113.532 0.938 . . . . 0.0 113.532 176.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -77.93 -39.04 44.11 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-N 119.064 0.847 . . . . 0.0 110.342 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 12.3 mt -48.51 -53.0 19.78 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.223 1.409 . . . . 0.0 113.852 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -64.82 -22.54 67.01 Favored 'General case' 0 CA--C 1.543 0.702 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -74.05 -25.06 59.64 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.088 0.955 . . . . 0.0 112.547 174.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 46.2 mt -96.47 -32.67 12.19 Favored 'General case' 0 C--N 1.338 0.103 0 C-N-CA 125.138 1.375 . . . . 0.0 111.795 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 18.1 mtt -55.1 -40.2 70.17 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 123.566 0.746 . . . . 0.0 112.685 171.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.2 pp0? -75.05 -17.34 60.51 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 175.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 10.3 t -91.76 -22.15 20.33 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 125.32 1.448 . . . . 0.0 112.306 -177.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -68.33 176.32 2.86 Favored 'General case' 0 CA--C 1.552 1.051 0 C-N-CA 126.782 2.033 . . . . 0.0 114.399 -173.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.0 m 73.74 41.71 0.42 Allowed 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 126.34 1.856 . . . . 0.0 111.908 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 2.5 mp -85.37 71.35 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 124.579 1.151 . . . . 0.0 109.893 -173.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 54.97 49.06 18.52 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 125.19 1.396 . . . . 0.0 112.094 179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.4 m -60.22 -9.12 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.325 0 N-CA-C 115.946 1.832 . . . . 0.0 115.946 -172.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 23.3 mmt -64.06 112.5 3.01 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 119.229 0.922 . . . . 0.0 110.239 169.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -161.91 167.15 25.14 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.908 1.683 . . . . 0.0 109.783 -169.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -56.69 145.37 61.81 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 124.443 1.097 . . . . 0.0 113.258 -179.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -71.62 159.93 49.68 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.689 2.926 . . . . 0.0 112.105 -178.003 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 84.6 t -113.28 126.11 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.177 1.391 . . . . 0.0 109.506 -176.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.1 mp -78.38 129.91 36.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.439 1.096 . . . . 0.0 108.908 177.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 44.5 pt -73.05 136.27 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 O-C-N 121.858 -0.526 . . . . 0.0 111.927 176.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 73.8 p -78.39 161.88 26.83 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 125.335 1.454 . . . . 0.0 110.515 171.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 21.2 tpp85 -45.81 123.38 4.38 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.246 1.418 . . . . 0.0 111.752 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -63.98 124.21 21.0 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.279 1.032 . . . . 0.0 111.476 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 10.1 t -66.31 148.14 52.28 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-O 121.315 0.578 . . . . 0.0 112.158 175.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 47.5 p-80 -63.35 143.67 97.72 Favored Pre-proline 0 CA--C 1.556 1.19 0 O-C-N 120.985 -1.072 . . . . 0.0 113.45 -176.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.21 178.27 7.52 Favored 'Trans proline' 0 C--N 1.352 0.729 0 C-N-CA 123.924 3.083 . . . . 0.0 111.759 -179.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -144.04 169.75 17.25 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 125.535 1.534 . . . . 0.0 111.686 -179.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 -65.28 148.08 52.32 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.322 1.049 . . . . 0.0 112.085 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -124.42 171.41 9.97 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 126.101 1.76 . . . . 0.0 112.008 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -140.48 135.78 32.3 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.214 1.406 . . . . 0.0 110.545 178.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.3 pp -79.86 137.21 54.12 Favored Pre-proline 0 CA--C 1.544 0.749 0 C-N-CA 124.035 0.934 . . . . 0.0 110.834 -175.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.94 126.48 8.76 Favored 'Trans proline' 0 N--CA 1.456 -0.729 0 C-N-CA 122.411 2.074 . . . . 0.0 110.146 -177.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -63.68 151.23 42.41 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.117 0.967 . . . . 0.0 111.374 177.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.13 144.3 60.34 Favored Pre-proline 0 CA--C 1.554 1.108 0 C-N-CA 124.709 1.203 . . . . 0.0 113.104 -176.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -76.48 -178.54 4.55 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 124.281 3.321 . . . . 0.0 111.962 -179.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 26.6 pt20 -143.65 148.34 42.79 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.158 1.383 . . . . 0.0 110.761 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 69.6 Cg_endo -74.1 131.76 15.83 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 122.963 2.442 . . . . 0.0 111.037 -177.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -79.69 149.48 20.9 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 123.333 2.689 . . . . 0.0 111.448 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.9 t-20 -90.58 140.76 29.44 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.108 0.963 . . . . 0.0 111.353 173.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -154.09 156.18 36.81 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.275 1.43 . . . . 0.0 111.598 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.4 pp -76.25 160.06 30.02 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.654 1.182 . . . . 0.0 113.021 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -86.82 -99.32 0.82 Allowed Glycine 0 N--CA 1.471 0.972 0 C-N-CA 125.207 1.384 . . . . 0.0 111.434 178.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -158.85 150.05 20.41 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 124.887 1.275 . . . . 0.0 112.425 176.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 m -93.25 2.06 56.78 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 125.839 1.656 . . . . 0.0 113.675 -169.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.1 t 68.06 35.01 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 C-N-CA 126.189 1.795 . . . . 0.0 111.025 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.4 m -83.72 25.99 0.74 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.786 1.634 . . . . 0.0 114.044 -174.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.8 t . . . . . 0 C--O 1.255 1.379 0 C-N-CA 126.193 1.797 . . . . 0.0 113.129 179.202 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 66.8 mt . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 118.981 -0.533 . . . . 0.0 109.606 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -154.59 -175.88 5.63 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.389 1.875 . . . . 0.0 110.623 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.81 94.73 2.63 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 126.755 2.022 . . . . 0.0 110.514 172.096 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 15.8 mt -67.78 150.03 49.17 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.032 0.933 . . . . 0.0 112.521 177.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 80.9 mtt-85 -84.92 -14.71 46.83 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.005 1.113 . . . . 0.0 114.005 174.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 34.0 p80 -159.44 165.26 33.51 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 125.548 1.539 . . . . 0.0 111.708 -174.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -87.0 123.33 70.44 Favored Pre-proline 0 CA--C 1.547 0.838 0 CA-C-O 118.65 -0.69 . . . . 0.0 111.091 -178.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -82.48 -20.46 5.81 Favored 'Trans proline' 0 C--N 1.351 0.706 0 C-N-CA 123.283 2.655 . . . . 0.0 114.009 -171.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 82.6 m -89.76 129.53 36.15 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.982 0.913 . . . . 0.0 111.937 -174.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.25 -3.16 84.99 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 124.696 1.141 . . . . 0.0 114.795 -178.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 31.3 t-20 -141.49 136.82 31.6 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.326 1.451 . . . . 0.0 109.668 176.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.483 HG21 ' HG3' ' A' ' 64' ' ' ARG . 2.7 p -164.94 142.24 1.52 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.332 0 C-N-CA 125.553 1.541 . . . . 0.0 111.36 -169.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 22.8 t30 -109.68 127.81 54.82 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.864 2.066 . . . . 0.0 109.243 172.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 64.8 m-85 -83.02 117.85 23.11 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.692 0.797 . . . . 0.0 110.905 177.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.15 -110.67 1.41 Allowed Glycine 0 N--CA 1.469 0.884 0 C-N-CA 124.959 1.266 . . . . 0.0 112.082 -177.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -62.47 111.39 2.02 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 124.072 0.949 . . . . 0.0 110.613 176.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 4.3 tp-100 -158.13 152.28 24.22 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.382 1.473 . . . . 0.0 109.197 -168.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 68.9 tp60 -69.7 126.7 30.52 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.938 -0.476 . . . . 0.0 111.581 -177.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 C--O 1.252 1.225 0 C-N-CA 125.639 1.576 . . . . 0.0 111.536 171.48 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.628 0 N-CA-C 111.815 -0.514 . . . . 0.0 111.815 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.8 m -163.49 145.19 9.49 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 126.404 1.882 . . . . 0.0 110.441 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.0 t -166.58 177.99 6.29 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.422 1.489 . . . . 0.0 111.379 -177.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 122.74 144.73 6.76 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 126.199 1.857 . . . . 0.0 113.223 178.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.9 t -167.95 162.06 13.22 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 126.291 1.837 . . . . 0.0 110.614 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 24.1 m -151.88 138.36 18.6 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 125.179 1.392 . . . . 0.0 111.531 -176.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -99.63 179.03 30.29 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.097 1.332 . . . . 0.0 113.61 176.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -160.89 166.3 28.67 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 126.568 1.947 . . . . 0.0 111.578 178.05 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -157.82 157.27 32.99 Favored 'General case' 0 CA--C 1.547 0.846 0 C-N-CA 125.167 1.387 . . . . 0.0 111.455 -178.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 23.6 mmm180 -142.3 139.18 31.77 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.062 1.745 . . . . 0.0 111.234 -175.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -81.57 -18.6 44.3 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.473 1.109 . . . . 0.0 113.432 177.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.7 t -162.08 171.6 17.25 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.845 1.658 . . . . 0.0 110.355 175.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 40.9 t -70.19 119.14 70.08 Favored Pre-proline 0 N--CA 1.475 0.797 0 C-N-CA 124.438 1.095 . . . . 0.0 110.252 -172.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.61 166.75 23.49 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 123.224 2.616 . . . . 0.0 111.304 176.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -65.65 -5.15 7.55 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 124.65 1.18 . . . . 0.0 113.274 171.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 72.0 m-80 -129.86 21.75 5.42 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 126.198 1.799 . . . . 0.0 114.043 -169.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 35.6 t-80 -58.23 146.64 69.82 Favored Pre-proline 0 CA--C 1.56 1.342 0 O-C-N 120.886 -1.133 . . . . 0.0 112.899 178.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -72.72 -17.85 25.63 Favored 'Trans proline' 0 CA--C 1.541 0.835 0 C-N-CA 122.876 2.384 . . . . 0.0 115.253 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 40.1 p -127.51 -20.29 4.03 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 120.386 1.448 . . . . 0.0 114.688 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 149.63 28.72 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-N 119.11 0.868 . . . . 0.0 110.109 169.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 75.7 m-85 -138.52 109.11 6.57 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.922 -0.769 . . . . 0.0 108.922 -176.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -68.97 130.58 43.18 Favored 'General case' 0 CA--C 1.541 0.615 0 O-C-N 121.59 -0.694 . . . . 0.0 109.93 174.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.2 m -139.6 164.86 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 124.758 1.223 . . . . 0.0 112.219 -169.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 78.4 m -139.62 121.03 15.03 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 124.785 1.234 . . . . 0.0 108.615 175.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -66.61 133.18 49.76 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 122.819 0.448 . . . . 0.0 110.127 176.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 15.9 m -129.39 155.63 41.36 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 C-N-CA 124.085 0.954 . . . . 0.0 112.592 -177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -82.3 -166.95 1.39 Allowed 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.452 1.501 . . . . 0.0 113.12 176.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -66.18 -33.71 76.38 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 114.46 1.281 . . . . 0.0 114.46 176.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -81.6 -28.69 33.63 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-N 119.322 0.964 . . . . 0.0 112.173 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 114.22 16.88 7.5 Favored Glycine 0 N--CA 1.47 0.935 0 C-N-CA 125.202 1.382 . . . . 0.0 112.261 174.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 5.4 t -74.3 140.53 17.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.345 2.258 . . . . 0.0 108.948 179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -88.36 123.77 33.26 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 125.529 1.532 . . . . 0.0 110.393 -171.146 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.9 mt -108.52 -53.25 2.66 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 123.896 0.878 . . . . 0.0 112.575 -169.062 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.98 142.01 9.17 Favored Glycine 0 N--CA 1.47 0.953 0 C-N-CA 124.82 1.2 . . . . 0.0 113.602 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.8 p -87.89 148.03 24.81 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.633 1.173 . . . . 0.0 112.666 179.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.03 170.09 33.73 Favored Glycine 0 CA--C 1.528 0.898 0 C-N-CA 124.529 1.061 . . . . 0.0 114.045 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 83.3 t -116.85 120.41 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.795 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 38.4 tpp -88.16 139.56 30.38 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.942 1.297 . . . . 0.0 110.204 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -140.01 130.25 25.18 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.791 1.636 . . . . 0.0 109.185 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.8 mp -106.46 138.54 42.45 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.67 1.988 . . . . 0.0 108.313 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -140.27 174.47 10.48 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.086 1.355 . . . . 0.0 111.049 -176.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 28.5 mm-40 -76.73 9.57 2.74 Favored 'General case' 0 CA--C 1.55 0.974 0 O-C-N 121.259 -0.901 . . . . 0.0 112.535 169.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 40.6 t -118.19 -49.64 2.49 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 124.95 1.3 . . . . 0.0 112.954 -178.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.6 pt-20 -173.3 171.3 4.07 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 125.072 1.349 . . . . 0.0 112.509 -168.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.9 mt -85.8 140.15 30.69 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.77 0.828 . . . . 0.0 109.528 168.068 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 36.0 t -134.61 127.88 50.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 123.884 0.874 . . . . 0.0 111.418 178.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 45.9 mt -100.38 132.92 45.49 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.169 1.388 . . . . 0.0 109.696 167.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -107.6 125.45 51.34 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.623 1.969 . . . . 0.0 110.315 171.411 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.3 mp -131.23 171.62 13.1 Favored 'General case' 0 N--CA 1.475 0.776 0 C-N-CA 126.346 1.858 . . . . 0.0 111.279 -177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 17.3 p80 -124.68 -8.44 7.35 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -116.71 7.98 13.63 Favored 'General case' 0 N--CA 1.484 1.264 0 C-N-CA 126.214 1.806 . . . . 0.0 112.477 170.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 36.7 mmt180 -150.63 159.12 44.72 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 128.018 2.527 . . . . 0.0 109.696 -173.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 44.6 mm-40 -67.29 160.1 27.83 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 122.966 0.506 . . . . 0.0 110.022 168.588 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.38 150.04 40.77 Favored 'General case' 0 CA--C 1.545 0.785 0 O-C-N 121.742 -0.599 . . . . 0.0 111.453 172.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 18.5 t -129.24 127.15 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 C-N-CA 123.459 0.704 . . . . 0.0 111.118 -175.121 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 37.9 mtm-85 -119.14 143.63 47.09 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.204 1.802 . . . . 0.0 112.153 -169.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.9 m-90 -139.37 114.2 8.16 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 124.367 1.067 . . . . 0.0 111.936 174.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -66.72 143.65 68.56 Favored 'Trans proline' 0 C--N 1.352 0.745 0 C-N-CA 122.98 2.453 . . . . 0.0 110.391 174.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 30.9 m-85 -60.71 -21.79 63.29 Favored 'General case' 0 CA--C 1.541 0.611 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -179.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.4 tt -61.03 -46.76 89.43 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.946 1.698 . . . . 0.0 111.728 172.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 1.5 p -78.2 -17.31 56.93 Favored 'General case' 0 CA--C 1.544 0.748 0 N-CA-C 113.876 1.065 . . . . 0.0 113.876 179.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 97.1 mt -81.53 65.96 6.89 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.993 1.717 . . . . 0.0 111.111 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -70.89 -24.15 62.43 Favored 'General case' 0 N--CA 1.475 0.789 0 N-CA-C 113.763 1.023 . . . . 0.0 113.763 -172.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.619 ' HG3' HG21 ' B' ' 12' ' ' VAL . 53.0 ttp180 -147.43 118.53 7.73 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 126.157 1.783 . . . . 0.0 108.492 -175.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.0 p90 -140.54 110.77 6.62 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 126.322 1.849 . . . . 0.0 110.717 -173.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -122.88 168.19 15.16 Favored Glycine 0 N--CA 1.462 0.39 0 C-N-CA 124.644 1.116 . . . . 0.0 114.104 -168.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.4 p90 -138.63 163.14 32.85 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 124.578 1.151 . . . . 0.0 112.648 -175.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -148.7 -169.95 3.49 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 127.06 2.144 . . . . 0.0 109.524 170.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.3 m -68.4 -14.86 63.3 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 114.928 1.455 . . . . 0.0 114.928 -172.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.0 p-10 -156.49 11.75 0.26 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 125.49 1.516 . . . . 0.0 114.126 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -136.59 129.89 31.52 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.915 1.686 . . . . 0.0 110.06 -168.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -123.39 135.85 54.34 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.924 1.69 . . . . 0.0 109.249 175.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 18.6 t -153.02 155.68 37.37 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.219 1.008 . . . . 0.0 112.277 -174.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -155.34 154.69 32.43 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 124.269 1.028 . . . . 0.0 112.647 -174.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.402 ' HG3' ' HE ' ' A' ' 64' ' ' ARG . 5.7 mm-40 -91.77 152.22 20.25 Favored 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 126.334 1.854 . . . . 0.0 110.66 171.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 90.8 p -141.29 152.1 44.2 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.414 1.085 . . . . 0.0 112.108 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -101.33 162.2 18.02 Favored Glycine 0 N--CA 1.473 1.144 0 C-N-CA 125.035 1.302 . . . . 0.0 114.312 -171.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 36.5 ptt-85 -56.38 -20.69 20.55 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 11.0 ptp180 -82.49 -15.5 52.23 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 115.481 1.66 . . . . 0.0 115.481 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 8.9 p -85.15 -178.27 6.74 Favored 'General case' 0 CA--C 1.547 0.851 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -174.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.1 tt0 -56.11 -49.9 72.59 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.944 1.298 . . . . 0.0 112.173 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 53.4 p -88.1 -23.19 23.77 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.945 1.298 . . . . 0.0 112.938 -174.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.22 -154.62 35.26 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 125.89 1.709 . . . . 0.0 112.174 -176.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -59.58 130.46 46.97 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 124.358 1.063 . . . . 0.0 111.895 173.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 163.09 164.41 18.06 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.152 0.882 . . . . 0.0 113.564 172.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.4 mt -113.49 134.02 57.55 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 C-N-CA 124.687 1.195 . . . . 0.0 108.512 169.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 67.0 m-85 -130.25 125.74 35.59 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 124.947 1.299 . . . . 0.0 109.941 -176.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.78 141.82 50.83 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 124.587 1.155 . . . . 0.0 112.734 -172.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -140.87 127.86 20.66 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 123.83 0.852 . . . . 0.0 111.874 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 33.8 mttp -65.59 133.53 51.37 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.398 169.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 49.1 t -161.48 132.53 5.29 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.271 1.428 . . . . 0.0 111.587 -172.184 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 19.3 m -68.64 -15.6 63.57 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 178.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 71.5 mtp85 -133.69 35.85 3.35 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.044 1.738 . . . . 0.0 112.967 -169.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -55.57 -40.36 71.87 Favored 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -178.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 68.4 tt0 -70.07 -39.49 75.6 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-N 118.782 0.719 . . . . 0.0 112.013 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.2 mp0 -61.71 -39.72 92.49 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.286 1.034 . . . . 0.0 110.927 174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 75.4 mt -62.19 -47.99 90.5 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 118.95 0.795 . . . . 0.0 110.631 171.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.3 t80 -58.04 -37.06 73.65 Favored 'General case' 0 CA--C 1.547 0.86 0 C-N-CA 124.195 0.998 . . . . 0.0 112.426 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -79.62 -28.63 40.96 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.95 1.3 . . . . 0.0 113.702 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt -80.47 -41.28 24.64 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 119.436 1.017 . . . . 0.0 110.184 177.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 14.1 mt -49.32 -56.47 9.38 Favored 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.62 1.168 . . . . 0.0 112.723 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -61.48 -21.68 64.4 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 -177.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -72.88 -27.08 61.69 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 119.166 0.894 . . . . 0.0 112.589 174.554 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 38.4 mt -97.28 -41.83 8.08 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.772 1.629 . . . . 0.0 110.968 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 98.4 mtp -64.7 -28.74 69.8 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.938 1.295 . . . . 0.0 113.294 -178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.63 -19.45 62.29 Favored 'General case' 0 CA--C 1.541 0.615 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 173.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 38.5 t -66.69 -30.26 70.47 Favored 'General case' 0 CA--C 1.543 0.687 0 CA-C-N 118.642 0.656 . . . . 0.0 112.09 -179.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 51.65 43.91 29.53 Favored 'General case' 0 CA--C 1.55 0.97 0 C-N-CA 124.827 1.251 . . . . 0.0 110.959 -177.754 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 3.1 p -56.06 127.54 31.06 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.771 1.628 . . . . 0.0 114.57 -169.332 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 4.3 mp -102.46 -51.75 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.022 0 C-N-CA 125.12 1.368 . . . . 0.0 111.307 -175.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -69.18 -10.93 60.09 Favored 'General case' 0 CA--C 1.548 0.871 0 N-CA-C 113.974 1.102 . . . . 0.0 113.974 -172.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 4.3 p -74.77 -13.22 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.759 0 C-N-CA 126.39 1.876 . . . . 0.0 113.647 171.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 66.9 mtt -74.11 168.47 19.49 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.565 1.146 . . . . 0.0 112.422 175.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -70.19 176.41 3.89 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 124.22 1.008 . . . . 0.0 112.697 171.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -51.32 139.95 25.23 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 125.204 1.402 . . . . 0.0 113.693 -169.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 62.8 Cg_endo -68.32 151.02 76.6 Favored 'Trans proline' 0 C--N 1.352 0.716 0 C-N-CA 123.692 2.928 . . . . 0.0 112.498 -171.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 74.4 t -138.17 128.67 35.92 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 125.915 1.686 . . . . 0.0 108.601 -177.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.0 mp -76.81 130.41 36.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 123.882 0.873 . . . . 0.0 108.788 176.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -115.43 158.09 15.92 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.88 1.272 . . . . 0.0 110.618 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 14.5 t -64.61 131.02 45.82 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 123.928 0.891 . . . . 0.0 110.906 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 76.6 ttt180 -83.08 135.94 34.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.041 0.936 . . . . 0.0 111.137 -176.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -120.42 169.52 10.23 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.797 1.639 . . . . 0.0 111.3 177.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 18.3 p -62.76 151.58 38.23 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.157 0.983 . . . . 0.0 112.652 174.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -149.13 149.51 29.83 Favored Pre-proline 0 CA--C 1.555 1.158 0 C-N-CA 124.639 1.176 . . . . 0.0 113.137 -169.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -76.0 171.7 17.66 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 123.904 3.069 . . . . 0.0 111.567 177.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -148.96 149.75 31.72 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.841 1.257 . . . . 0.0 111.785 -179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 47.0 mm-40 -81.51 148.94 28.94 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.424 1.09 . . . . 0.0 111.965 -178.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 pp -88.13 -175.25 4.99 Favored 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.181 1.393 . . . . 0.0 112.541 175.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -146.66 155.68 42.62 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 125.96 1.704 . . . . 0.0 111.819 -178.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.4 pp -99.75 148.98 35.5 Favored Pre-proline 0 CA--C 1.547 0.862 0 C-N-CA 124.823 1.249 . . . . 0.0 112.474 -174.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -80.7 152.03 19.51 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 123.653 2.902 . . . . 0.0 111.714 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.19 162.89 28.08 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.487 0.715 . . . . 0.0 112.867 171.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -106.23 154.29 39.79 Favored Pre-proline 0 CA--C 1.55 0.958 0 C-N-CA 125.802 1.641 . . . . 0.0 111.709 177.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_endo -71.41 167.62 25.81 Favored 'Trans proline' 0 C--N 1.353 0.767 0 C-N-CA 123.665 2.91 . . . . 0.0 111.767 176.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.9 tp60 -129.44 130.76 23.32 Favored Pre-proline 0 CA--C 1.547 0.848 0 C-N-CA 124.969 1.307 . . . . 0.0 109.664 -176.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -76.52 162.13 33.54 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.633 2.889 . . . . 0.0 112.344 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -69.8 170.56 16.34 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.936 3.091 . . . . 0.0 111.802 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -141.5 132.08 25.48 Favored 'General case' 0 CA--C 1.545 0.788 0 C-N-CA 124.397 1.079 . . . . 0.0 112.003 -172.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.93 175.29 10.81 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 125.185 1.394 . . . . 0.0 113.21 -176.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 40.2 tp -148.85 141.95 24.92 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.372 1.469 . . . . 0.0 110.883 -176.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.67 -172.12 47.83 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 124.849 1.214 . . . . 0.0 113.819 178.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -157.9 160.92 38.15 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.309 1.444 . . . . 0.0 112.131 -176.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -156.23 172.99 17.5 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.79 1.636 . . . . 0.0 111.39 -179.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.3 p -164.37 154.17 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 126.802 2.041 . . . . 0.0 110.188 -169.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.4 t -155.64 172.97 17.39 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 125.111 1.364 . . . . 0.0 111.519 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 12.0 t . . . . . 0 C--O 1.252 1.22 0 C-N-CA 126.28 1.832 . . . . 0.0 111.512 -174.146 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 91.8 mt . . . . . 0 N--CA 1.489 1.482 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 21.3 t80 -83.46 116.78 22.68 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.072 0.549 . . . . 0.0 111.435 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -77.92 113.92 16.29 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.605 1.162 . . . . 0.0 110.728 175.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 59.4 mt -82.37 153.36 25.79 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-O 121.731 0.777 . . . . 0.0 112.714 178.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 62.4 ttm-85 -78.69 -26.12 44.85 Favored 'General case' 0 N--CA 1.473 0.71 0 C-N-CA 125.939 1.696 . . . . 0.0 112.831 177.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 2.0 p-80 -159.44 166.88 30.05 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 126.351 1.86 . . . . 0.0 111.725 -169.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -88.49 124.13 66.67 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.52 -0.753 . . . . 0.0 111.924 -172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -87.02 -22.48 1.79 Allowed 'Trans proline' 0 C--N 1.354 0.843 0 C-N-CA 123.209 2.606 . . . . 0.0 114.336 -171.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 92.9 m -83.9 130.0 34.92 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.996 0.816 . . . . 0.0 112.281 -171.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -85.17 -1.01 88.63 Favored Glycine 0 N--CA 1.473 1.149 0 C-N-CA 124.68 1.133 . . . . 0.0 115.142 -177.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 35.6 t-20 -143.32 142.15 31.22 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 124.851 1.26 . . . . 0.0 110.243 170.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.619 HG21 ' HG3' ' A' ' 64' ' ' ARG . 3.0 p -166.38 146.82 1.62 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 125.222 1.409 . . . . 0.0 111.639 -168.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 39.4 t30 -118.54 142.43 47.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.396 2.278 . . . . 0.0 109.814 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 47.4 m-85 -102.75 107.61 18.56 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.924 1.289 . . . . 0.0 109.676 177.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.25 -25.03 45.46 Favored Glycine 0 N--CA 1.476 1.317 0 N-CA-C 115.83 1.092 . . . . 0.0 115.83 -168.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -112.6 16.61 19.67 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.426 1.49 . . . . 0.0 112.792 -176.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 27.6 mp0 -131.89 151.38 51.74 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.175 1.79 . . . . 0.0 110.091 -174.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -160.66 152.54 19.91 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.088 1.355 . . . . 0.0 110.186 -174.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 28.9 pt20 . . . . . 0 C--O 1.253 1.271 0 C-N-CA 124.983 1.313 . . . . 0.0 114.299 177.719 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.636 0 N-CA-C 111.346 -0.702 . . . . 0.0 111.346 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.5 t -165.73 -171.52 2.1 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 125.917 1.687 . . . . 0.0 110.613 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 18.6 t -153.56 132.27 12.3 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.386 1.474 . . . . 0.0 110.845 178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -103.58 -150.05 21.28 Favored Glycine 0 CA--C 1.532 1.14 0 C-N-CA 125.404 1.478 . . . . 0.0 113.65 -175.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.9 m -146.92 160.83 41.85 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 125.938 1.695 . . . . 0.0 110.793 -178.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 6.3 t -158.61 -179.41 8.06 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.452 1.101 . . . . 0.0 111.87 -177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 99.61 163.41 29.21 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.795 1.664 . . . . 0.0 112.776 -172.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -77.13 154.07 33.6 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.462 1.105 . . . . 0.0 111.793 -176.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -136.34 129.64 31.65 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.031 1.732 . . . . 0.0 109.476 173.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 21.0 tpt180 -161.15 88.99 0.76 Allowed 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.137 1.375 . . . . 0.0 109.281 -173.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -153.79 162.17 41.46 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 126.124 1.77 . . . . 0.0 110.921 -169.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 19.9 m -63.12 154.41 31.13 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 124.189 0.996 . . . . 0.0 111.875 169.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.1 p -51.79 122.73 22.63 Favored Pre-proline 0 N--CA 1.481 1.092 0 C-N-CA 124.257 1.023 . . . . 0.0 112.448 -174.105 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -79.46 155.29 24.69 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.459 2.773 . . . . 0.0 112.187 -173.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 17.8 m-20 -65.17 -4.71 5.37 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.322 1.449 . . . . 0.0 113.885 176.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -117.03 10.77 14.06 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.553 1.941 . . . . 0.0 113.822 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -55.8 136.66 72.12 Favored Pre-proline 0 CA--C 1.552 1.039 0 O-C-N 121.298 -0.877 . . . . 0.0 112.41 -179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -68.41 -11.03 30.78 Favored 'Trans proline' 0 CA--C 1.537 0.661 0 C-N-CA 123.079 2.519 . . . . 0.0 114.921 -177.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.1 p -132.73 -22.76 2.1 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.144 1.535 . . . . 0.0 115.144 -179.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.27 97.63 7.19 Favored 'General case' 0 N--CA 1.474 0.765 0 CA-C-N 119.542 1.065 . . . . 0.0 111.295 174.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -96.94 126.78 42.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.219 1.408 . . . . 0.0 109.751 -179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.4 mttp -81.55 136.03 35.59 Favored 'General case' 0 N--CA 1.474 0.753 0 O-C-N 121.099 -1.001 . . . . 0.0 110.273 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.7 m -141.22 168.97 15.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.737 1.215 . . . . 0.0 112.329 -168.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 94.6 m -141.8 121.99 13.86 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.569 1.147 . . . . 0.0 109.49 173.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 5.0 t30 -64.92 130.72 44.45 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.211 1.004 . . . . 0.0 110.755 175.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 33.9 m -130.21 159.48 42.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 114.374 1.25 . . . . 0.0 114.374 -175.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -90.01 -171.03 2.99 Favored 'General case' 0 CA--C 1.551 0.99 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -58.41 -21.99 52.58 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.825 1.65 . . . . 0.0 114.705 176.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -103.93 -4.66 23.14 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 124.92 1.288 . . . . 0.0 112.606 178.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 83.51 17.28 66.62 Favored Glycine 0 CA--C 1.532 1.136 0 CA-C-O 118.057 -1.413 . . . . 0.0 114.38 -174.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 3.3 m -68.95 144.76 13.86 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 CA-C-N 120.081 1.94 . . . . 0.0 109.999 175.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -91.42 120.89 32.66 Favored 'General case' 0 N--CA 1.467 0.381 0 C-N-CA 124.38 1.072 . . . . 0.0 110.27 -175.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 71.7 mt -107.94 -53.36 2.64 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 124.032 0.933 . . . . 0.0 112.027 -170.808 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -149.14 132.03 3.93 Favored Glycine 0 N--CA 1.472 1.043 0 C-N-CA 124.726 1.155 . . . . 0.0 113.576 178.579 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.0 m -86.81 154.65 20.74 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 123.677 0.791 . . . . 0.0 112.659 179.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -156.13 171.34 33.93 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 125.099 1.333 . . . . 0.0 114.021 -177.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 56.0 t -115.57 120.95 66.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 169.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.9 ttm -94.3 116.57 28.97 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.195 1.398 . . . . 0.0 109.754 177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 58.0 tt0 -109.18 128.5 55.08 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 125.832 1.653 . . . . 0.0 108.838 179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -104.06 137.36 42.13 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.552 1.541 . . . . 0.0 108.278 172.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.6 p -135.41 173.2 11.98 Favored 'General case' 0 N--CA 1.476 0.874 0 C-N-CA 125.006 1.322 . . . . 0.0 110.755 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -72.2 -0.25 11.56 Favored 'General case' 0 CA--C 1.548 0.871 0 O-C-N 121.558 -0.714 . . . . 0.0 112.608 170.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.3 m -115.37 -40.66 3.39 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 114.006 1.113 . . . . 0.0 114.006 -177.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -172.88 166.16 5.18 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.977 1.311 . . . . 0.0 112.963 -168.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mt -86.76 138.39 31.65 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.123 1.369 . . . . 0.0 109.272 168.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.7 t -134.75 131.77 53.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 123.664 0.785 . . . . 0.0 111.395 178.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 33.3 mt -104.75 130.66 52.78 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 125.221 1.408 . . . . 0.0 110.39 168.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.2 m-70 -109.06 126.87 53.61 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 126.98 2.112 . . . . 0.0 110.245 171.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -159.28 166.46 31.23 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.006 1.723 . . . . 0.0 112.136 -172.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 22.5 p-80 -108.24 -14.65 14.66 Favored 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.638 1.347 . . . . 0.0 114.638 179.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -81.31 -3.29 52.13 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 125.261 1.425 . . . . 0.0 113.66 177.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.5 tpt180 -165.97 177.37 7.12 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 127.094 2.158 . . . . 0.0 110.102 -179.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -69.89 160.71 31.32 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 123.407 0.683 . . . . 0.0 110.277 167.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.26 142.19 57.01 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 121.647 -0.658 . . . . 0.0 111.546 176.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 19.7 t -122.5 125.73 73.08 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.091 0 C-N-CA 123.239 0.616 . . . . 0.0 111.172 -171.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -115.81 143.79 44.9 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 125.86 1.664 . . . . 0.0 111.485 -173.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.8 m-90 -138.73 117.23 9.24 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 124.461 1.105 . . . . 0.0 111.167 173.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -67.25 144.53 68.86 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 122.237 1.958 . . . . 0.0 109.264 170.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 39.1 m-85 -60.69 -27.29 67.75 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.671 0.989 . . . . 0.0 113.671 -178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.5 tt -59.02 -43.75 91.62 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.902 1.681 . . . . 0.0 111.588 174.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 79.1 m -78.86 1.58 22.97 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 -179.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 81.4 mt -87.26 117.29 25.92 Favored 'General case' 0 N--CA 1.469 0.478 0 CA-C-N 119.844 1.202 . . . . 0.0 109.728 172.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -73.33 -35.66 66.07 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 176.383 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 7.6 ptp85 -166.13 162.75 17.88 Favored 'General case' 0 N--CA 1.471 0.585 0 C-N-CA 126.721 2.008 . . . . 0.0 110.647 -177.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -149.67 108.13 3.8 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.235 1.014 . . . . 0.0 110.418 -174.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -115.31 161.88 12.66 Favored Glycine 0 C--N 1.334 0.454 0 C-N-CA 124.875 1.226 . . . . 0.0 113.369 -169.334 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -139.58 163.69 31.88 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 124.689 1.196 . . . . 0.0 112.61 -178.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -153.63 -169.58 3.33 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 126.798 2.039 . . . . 0.0 109.566 175.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 11.7 t -64.82 -24.2 67.47 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.841 -1.162 . . . . 0.0 114.091 -174.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 64.4 t30 -155.84 19.19 0.38 Allowed 'General case' 0 CA--C 1.552 1.024 0 C-N-CA 125.23 1.412 . . . . 0.0 112.996 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -142.67 128.33 19.19 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 124.999 1.319 . . . . 0.0 110.43 -169.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -120.84 140.98 51.0 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.081 1.752 . . . . 0.0 109.599 175.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.1 t -153.39 157.72 40.4 Favored 'General case' 0 CA--C 1.536 0.428 0 O-C-N 121.177 -0.952 . . . . 0.0 113.123 -177.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -154.57 153.26 31.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.877 1.671 . . . . 0.0 111.136 178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -108.13 133.09 52.89 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 123.798 0.839 . . . . 0.0 110.126 172.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.2 m -107.45 141.73 38.41 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.127 0.971 . . . . 0.0 112.588 -176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -69.79 157.12 53.53 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.832 1.206 . . . . 0.0 112.646 176.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 22.4 mtm180 -65.84 -15.79 63.23 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 -168.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.6 ptp180 -91.49 -10.79 39.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.125 1.77 . . . . 0.0 115.367 -174.052 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.4 p -75.86 -177.52 3.86 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 113.362 0.875 . . . . 0.0 113.362 -175.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -55.89 -40.23 72.71 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.504 1.122 . . . . 0.0 112.941 -178.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 40.4 p -93.54 -23.4 18.34 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 124.943 1.297 . . . . 0.0 113.556 -176.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.47 -161.85 41.2 Favored Glycine 0 CA--C 1.529 0.918 0 C-N-CA 125.056 1.312 . . . . 0.0 111.544 -171.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -66.12 128.46 36.2 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.811 0.844 . . . . 0.0 111.375 -177.343 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.62 161.38 18.59 Favored Glycine 0 C--N 1.339 0.749 0 C-N-CA 123.154 0.407 . . . . 0.0 114.036 174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 88.1 mt -104.89 131.28 54.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 C-N-CA 125.002 1.321 . . . . 0.0 108.514 169.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 39.8 m-85 -127.76 125.23 39.52 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.819 1.248 . . . . 0.0 109.491 -177.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.35 143.45 50.58 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.146 0.978 . . . . 0.0 112.663 -174.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.9 m-85 -138.93 124.3 19.28 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 114.446 -1.252 . . . . 0.0 111.901 -168.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 43.0 mttm -64.62 131.2 46.32 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.234 0.614 . . . . 0.0 110.706 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 37.3 t -169.98 122.88 0.71 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.111 1.764 . . . . 0.0 110.462 -175.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.3 t -68.64 -14.42 63.0 Favored 'General case' 0 N--CA 1.477 0.903 0 O-C-N 121.62 -0.675 . . . . 0.0 112.812 177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 52.8 mtt85 -108.56 22.76 15.49 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 126.442 1.897 . . . . 0.0 113.519 179.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -48.93 -37.81 21.06 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.583 1.153 . . . . 0.0 113.654 172.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -68.85 -40.45 79.38 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.451 1.101 . . . . 0.0 113.144 175.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -67.3 -34.65 77.81 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 121.466 -0.771 . . . . 0.0 111.384 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 95.2 mt -62.44 -49.55 83.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 123.163 0.585 . . . . 0.0 110.291 170.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -61.19 -37.31 82.51 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.559 0.744 . . . . 0.0 112.35 -179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -71.1 -29.39 65.22 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 123.758 0.823 . . . . 0.0 113.178 175.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.7 tp -86.77 -36.54 18.53 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 119.49 1.041 . . . . 0.0 112.419 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.1 mt -52.59 -55.9 19.07 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.971 0.908 . . . . 0.0 112.068 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -57.86 -21.01 40.62 Favored 'General case' 0 CA--C 1.544 0.743 0 N-CA-C 114.327 1.232 . . . . 0.0 114.327 177.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -86.53 -25.33 25.13 Favored 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.627 1.171 . . . . 0.0 113.42 176.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.5 mt -95.98 -33.53 12.12 Favored 'General case' 0 N--CA 1.47 0.543 0 C-N-CA 124.797 1.239 . . . . 0.0 111.728 178.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 97.0 mtp -66.0 -19.55 65.9 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 125.857 1.663 . . . . 0.0 113.734 174.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -92.13 -8.18 46.42 Favored 'General case' 0 CA--C 1.546 0.815 0 C-N-CA 125.117 1.367 . . . . 0.0 113.73 169.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 5.7 t -96.78 -1.49 46.19 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.248 1.419 . . . . 0.0 113.524 -171.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.1 p-10 -71.0 175.71 4.94 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 124.857 1.263 . . . . 0.0 112.643 173.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 71.1 m -71.62 96.25 1.54 Allowed 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 124.5 1.12 . . . . 0.0 112.896 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 40.5 mm -86.33 -44.31 16.56 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.163 0 O-C-N 121.317 -0.864 . . . . 0.0 111.769 176.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 77.7 m-20 -131.65 17.8 4.77 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.304 1.442 . . . . 0.0 113.062 -171.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.8 t -85.75 83.31 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 C-N-CA 126.32 1.848 . . . . 0.0 108.057 -176.05 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 16.0 ptp -40.6 119.19 1.06 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 127.448 2.299 . . . . 0.0 112.812 172.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -168.78 155.94 7.36 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.504 1.922 . . . . 0.0 109.174 -169.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.82 139.64 90.09 Favored Pre-proline 0 CA--C 1.551 1.006 0 C-N-CA 123.44 0.696 . . . . 0.0 112.49 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -76.58 156.69 36.13 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.677 2.918 . . . . 0.0 111.635 -178.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 60.1 t -138.32 114.27 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.997 1.319 . . . . 0.0 109.174 178.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.9 mp -131.51 123.26 52.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 125.848 1.659 . . . . 0.0 108.172 177.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.5 pt -82.53 -15.46 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.194 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -175.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.4 m -165.58 119.29 1.19 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.849 2.459 . . . . 0.0 108.145 176.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 97.8 mtt180 -85.09 159.36 20.19 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.558 1.143 . . . . 0.0 111.868 176.097 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -153.84 149.77 27.72 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 125.641 1.576 . . . . 0.0 110.865 177.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 8.5 t -77.84 148.49 34.67 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.83 0.852 . . . . 0.0 111.837 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 52.8 p-80 -66.22 147.3 98.93 Favored Pre-proline 0 CA--C 1.556 1.186 0 O-C-N 121.073 -1.017 . . . . 0.0 112.855 178.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.56 147.68 58.28 Favored 'Trans proline' 0 C--N 1.35 0.656 0 C-N-CA 123.337 2.691 . . . . 0.0 111.509 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -80.85 74.9 7.8 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 124.599 1.16 . . . . 0.0 111.291 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -62.89 143.86 57.24 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 125.207 1.403 . . . . 0.0 111.242 175.596 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.5 pp -141.16 163.98 31.49 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 125.49 1.516 . . . . 0.0 112.239 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 4.3 p30 -166.33 174.01 9.5 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 126.414 1.886 . . . . 0.0 111.448 -172.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 pp -131.97 147.12 64.63 Favored Pre-proline 0 CA--C 1.546 0.792 0 C-N-CA 125.327 1.451 . . . . 0.0 111.103 175.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -76.55 140.64 21.55 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.3 2.667 . . . . 0.0 111.39 -176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -76.72 176.06 8.8 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.052 0.941 . . . . 0.0 112.336 172.376 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -120.13 142.64 33.92 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 125.422 1.489 . . . . 0.0 111.346 -178.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.82 158.42 38.99 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.504 2.803 . . . . 0.0 111.381 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -69.23 142.1 92.22 Favored Pre-proline 0 CA--C 1.548 0.872 0 C-N-CA 123.665 0.786 . . . . 0.0 111.042 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.54 145.96 43.22 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 122.868 2.378 . . . . 0.0 111.126 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -76.59 157.84 36.04 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 123.66 2.907 . . . . 0.0 111.476 176.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 32.0 m120 -142.85 132.51 23.86 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.07 1.348 . . . . 0.0 110.867 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -164.05 166.75 21.12 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 126.303 1.841 . . . . 0.0 111.101 -176.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 pp -156.25 170.85 21.29 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.71 1.604 . . . . 0.0 111.755 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -154.93 178.35 31.68 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 125.025 1.297 . . . . 0.0 113.563 178.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -145.31 158.26 43.87 Favored 'General case' 0 CA--C 1.544 0.715 0 C-N-CA 125.645 1.578 . . . . 0.0 112.183 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 90.0 m -133.09 143.91 49.62 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 126.388 1.875 . . . . 0.0 109.265 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 62.3 t -133.94 137.76 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 125.886 1.674 . . . . 0.0 108.89 -177.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.8 t -158.55 169.92 23.36 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.202 1.401 . . . . 0.0 111.517 -176.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 15.9 t . . . . . 0 C--O 1.254 1.338 0 C-N-CA 126.34 1.856 . . . . 0.0 111.54 -174.948 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 80.4 mt . . . . . 0 N--CA 1.494 1.74 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -108.25 121.17 44.32 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 123.64 0.776 . . . . 0.0 110.005 171.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 50.1 ptt85 -85.54 121.29 28.02 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 124.304 1.042 . . . . 0.0 110.844 177.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 80.4 mt -83.83 164.1 19.71 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.629 0.728 . . . . 0.0 112.718 176.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -106.59 2.21 25.87 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.812 1.645 . . . . 0.0 113.835 179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 23.1 p80 -160.33 164.93 32.13 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 127.509 2.324 . . . . 0.0 110.472 179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 14.2 t80 -90.94 118.31 68.5 Favored Pre-proline 0 CA--C 1.549 0.913 0 CA-C-O 118.543 -0.741 . . . . 0.0 110.307 174.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.87 -24.47 3.32 Favored 'Trans proline' 0 C--N 1.351 0.685 0 C-N-CA 123.314 2.676 . . . . 0.0 114.772 -168.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 81.7 m -80.19 127.84 32.81 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 119.028 0.831 . . . . 0.0 111.873 -173.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.58 -7.07 88.77 Favored Glycine 0 CA--C 1.535 1.303 0 C-N-CA 124.522 1.058 . . . . 0.0 114.449 -179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -137.42 131.01 31.38 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 126.337 1.855 . . . . 0.0 109.814 178.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 4.9 p -164.62 147.27 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 C-N-CA 125.176 1.39 . . . . 0.0 111.112 -169.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -132.05 170.42 14.97 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 127.612 2.365 . . . . 0.0 111.874 177.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -132.18 125.74 31.92 Favored 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 125.359 1.464 . . . . 0.0 110.96 -169.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -96.81 -35.84 5.23 Favored Glycine 0 N--CA 1.476 1.316 0 C-N-CA 124.266 0.936 . . . . 0.0 113.778 -176.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 43.9 m-85 -103.39 73.92 1.24 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 125.094 1.357 . . . . 0.0 110.349 -176.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 70.4 tp60 -71.79 125.87 28.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.991 0.917 . . . . 0.0 110.042 178.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 22.0 mm100 -101.97 170.43 8.14 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.726 1.21 . . . . 0.0 111.098 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 . . . . . 0 C--O 1.254 1.315 0 C-N-CA 126.044 1.738 . . . . 0.0 111.617 -178.368 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.574 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.4 t -168.05 159.14 10.93 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.452 1.501 . . . . 0.0 110.305 -176.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.2 t -161.33 152.93 19.11 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.986 1.315 . . . . 0.0 111.15 177.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -169.05 132.89 2.67 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.142 1.354 . . . . 0.0 111.52 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.0 p -149.3 116.26 5.99 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.928 0.891 . . . . 0.0 111.239 -173.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 29.5 p -93.19 151.17 19.99 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 113.764 1.024 . . . . 0.0 113.764 -177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -164.35 144.79 9.7 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.287 1.899 . . . . 0.0 111.288 174.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 96.0 mt -121.43 97.22 5.41 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.855 1.262 . . . . 0.0 108.999 -178.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 24.1 p30 -169.48 173.7 6.34 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 126.582 1.953 . . . . 0.0 111.65 -169.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -112.14 132.3 54.95 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 125.56 1.544 . . . . 0.0 111.469 177.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -160.7 145.39 14.17 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 126.879 2.072 . . . . 0.0 110.18 -178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.9 p -75.15 111.05 9.99 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.77 0.828 . . . . 0.0 110.396 171.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 t -63.69 122.07 74.39 Favored Pre-proline 0 N--CA 1.48 1.031 0 CA-C-O 118.467 -0.778 . . . . 0.0 109.933 -174.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -73.89 149.37 42.21 Favored 'Trans proline' 0 C--N 1.349 0.585 0 C-N-CA 123.04 2.494 . . . . 0.0 111.215 -176.353 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -63.25 -13.27 36.23 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.56 1.144 . . . . 0.0 113.052 173.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.2 t30 -99.22 0.15 42.66 Favored 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 126.468 1.907 . . . . 0.0 113.244 -175.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.4 t-80 -51.92 137.41 35.81 Favored Pre-proline 0 CA--C 1.555 1.154 0 O-C-N 120.945 -1.097 . . . . 0.0 113.869 -171.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -69.15 -11.54 31.9 Favored 'Trans proline' 0 C--N 1.354 0.831 0 C-N-CA 123.279 2.653 . . . . 0.0 115.253 -175.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.0 p -131.42 -16.51 3.06 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 114.548 1.314 . . . . 0.0 114.548 177.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -114.92 99.01 7.15 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 119.479 1.036 . . . . 0.0 111.29 174.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -97.47 116.38 29.56 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.777 1.231 . . . . 0.0 109.054 -175.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.1 mttp -76.58 133.44 39.67 Favored 'General case' 0 N--CA 1.473 0.713 0 O-C-N 120.976 -1.078 . . . . 0.0 110.344 179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.1 m -139.25 167.19 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.115 0.966 . . . . 0.0 112.485 -168.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 15.9 m -146.09 125.47 13.12 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.007 1.323 . . . . 0.0 108.797 173.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -66.37 132.6 48.69 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 123.515 0.726 . . . . 0.0 110.096 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.4 m -131.1 156.79 43.02 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 C-N-CA 124.699 1.2 . . . . 0.0 112.809 -175.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.435 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.4 p-10 -89.36 -166.49 1.61 Allowed 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.965 1.306 . . . . 0.0 113.988 178.572 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -59.93 -35.14 74.3 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.415 1.486 . . . . 0.0 114.319 172.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -80.38 -12.98 59.52 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 119.285 0.948 . . . . 0.0 113.063 176.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.67 17.52 72.85 Favored Glycine 0 CA--C 1.532 1.15 0 CA-C-O 118.345 -1.253 . . . . 0.0 113.554 -171.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.435 HG22 ' OD1' ' A' ' 27' ' ' ASP . 14.8 m -75.41 149.3 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 119.668 1.734 . . . . 0.0 110.936 173.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -90.58 124.91 35.41 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.358 1.063 . . . . 0.0 111.321 -170.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.2 mt -107.42 -49.82 3.18 Favored 'General case' 0 N--CA 1.468 0.467 0 C-N-CA 124.23 1.012 . . . . 0.0 111.991 -169.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -156.69 135.37 4.44 Favored Glycine 0 N--CA 1.47 0.939 0 C-N-CA 124.782 1.182 . . . . 0.0 113.602 176.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 p -84.06 154.66 23.09 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.769 1.228 . . . . 0.0 112.984 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -163.07 171.07 38.75 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.858 1.218 . . . . 0.0 113.88 -177.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 61.2 t -115.51 120.9 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 172.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 41.5 tpp -90.9 137.36 32.42 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.685 1.194 . . . . 0.0 110.283 175.115 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -138.95 130.14 26.8 Favored 'General case' 0 C--O 1.237 0.44 0 C-N-CA 125.216 1.406 . . . . 0.0 109.251 -175.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.4 mp -106.61 134.78 49.21 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 126.338 1.855 . . . . 0.0 107.656 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.4 p -132.07 173.4 11.26 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.078 0.951 . . . . 0.0 111.01 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 26.7 mp0 -66.2 0.23 2.14 Favored 'General case' 0 CA--C 1.548 0.898 0 C-N-CA 123.678 0.791 . . . . 0.0 112.685 169.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -116.32 -43.25 2.96 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.8 pt-20 -172.98 177.07 2.87 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 114.347 1.24 . . . . 0.0 114.347 -169.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.0 mt -89.13 138.28 31.56 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 124.387 1.075 . . . . 0.0 110.132 167.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.4 t -134.65 128.69 51.24 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 124.308 1.043 . . . . 0.0 111.184 177.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 25.2 mt -102.12 135.12 44.25 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 125.504 1.522 . . . . 0.0 110.378 168.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -110.21 124.86 52.36 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.39 1.876 . . . . 0.0 111.068 173.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 mp -132.74 168.92 17.47 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 127.202 2.201 . . . . 0.0 111.164 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 7.7 t-80 -98.43 -62.91 1.18 Allowed 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 124.612 1.165 . . . . 0.0 113.565 176.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -75.59 -7.43 54.21 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -176.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.458 ' HA ' ' HE ' ' A' ' 52' ' ' ARG . 0.3 OUTLIER -125.97 161.7 26.93 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 126.237 1.815 . . . . 0.0 110.24 175.046 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 15.5 pm0 -68.14 159.72 30.46 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 115.115 -0.948 . . . . 0.0 111.293 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.5 144.71 55.69 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.993 0.517 . . . . 0.0 111.054 172.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 16.6 t -123.14 126.59 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.999 0 C-N-CA 123.272 0.629 . . . . 0.0 110.546 -173.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 80.7 mtp180 -120.76 138.43 54.01 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.569 1.548 . . . . 0.0 111.524 -169.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 23.5 m-90 -139.1 114.08 8.33 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 124.389 1.076 . . . . 0.0 111.093 174.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 68.1 Cg_endo -68.55 150.13 74.83 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.652 2.235 . . . . 0.0 110.307 174.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.1 m-85 -60.95 -20.67 62.59 Favored 'General case' 0 CA--C 1.545 0.751 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 178.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 6.7 mt -65.27 -34.67 78.91 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.142 1.777 . . . . 0.0 113.268 170.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 89.1 m -92.63 -5.05 52.32 Favored 'General case' 0 N--CA 1.477 0.911 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.3 mt -82.18 105.63 13.43 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.837 0.855 . . . . 0.0 109.253 173.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 84.3 mtt180 -79.76 -20.93 45.12 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 177.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.484 ' HG3' HG21 ' B' ' 12' ' ' VAL . 30.9 ttt180 -170.1 133.42 1.15 Allowed 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.698 1.999 . . . . 0.0 108.753 -172.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -142.27 119.09 11.17 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.325 1.45 . . . . 0.0 110.26 178.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -130.55 164.87 22.91 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 124.077 0.846 . . . . 0.0 112.992 -169.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.9 p90 -130.45 155.32 46.63 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 124.343 1.057 . . . . 0.0 111.492 177.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.99 -174.11 4.76 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 125.878 1.671 . . . . 0.0 110.349 173.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.7 p -59.54 111.58 1.46 Allowed 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.256 -0.902 . . . . 0.0 111.57 177.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.257 0.7 OUTLIER 51.52 23.15 1.74 Allowed 'General case' 0 CA--C 1.554 1.121 0 C-N-CA 127.391 2.276 . . . . 0.0 116.158 -174.25 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -134.33 126.39 29.6 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.424 1.49 . . . . 0.0 110.871 -172.019 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 56.8 t80 -120.18 135.16 55.07 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.748 1.619 . . . . 0.0 109.622 171.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.3 t -153.29 155.01 35.72 Favored 'General case' 0 CA--C 1.535 0.391 0 O-C-N 121.312 -0.867 . . . . 0.0 112.159 -175.423 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 47.8 p90 -154.61 152.73 30.35 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 124.532 1.133 . . . . 0.0 112.268 -174.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 67.2 tt0 -115.45 133.84 55.65 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 126.337 1.855 . . . . 0.0 110.493 -176.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.6 m -133.26 154.38 50.73 Favored 'General case' 0 N--CA 1.475 0.787 0 C-N-CA 124.354 1.062 . . . . 0.0 112.476 -174.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -88.89 166.57 34.04 Favored Glycine 0 CA--C 1.535 1.302 0 C-N-CA 124.888 1.233 . . . . 0.0 113.588 -179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -6.37 16.71 Favored 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 -174.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -82.69 -19.53 37.9 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 115.086 1.513 . . . . 0.0 115.086 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.7 p -81.63 -179.46 7.39 Favored 'General case' 0 CA--C 1.55 0.955 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -173.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 58.2 tt0 -55.13 -42.97 73.71 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 125.095 1.358 . . . . 0.0 113.003 -177.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 38.4 p -93.15 -22.25 19.19 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.348 1.459 . . . . 0.0 113.637 -176.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.1 -163.38 43.32 Favored Glycine 0 CA--C 1.531 1.091 0 C-N-CA 125.298 1.428 . . . . 0.0 112.539 -173.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -70.76 137.59 49.76 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.091 0.956 . . . . 0.0 112.793 -174.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.53 171.9 24.08 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.614 1.102 . . . . 0.0 113.355 177.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 85.2 mt -110.63 123.11 66.24 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 125.091 1.356 . . . . 0.0 108.579 170.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -114.17 119.33 36.71 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.998 1.319 . . . . 0.0 109.393 -175.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -120.61 139.15 53.39 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 124.394 1.078 . . . . 0.0 112.914 -169.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 51.2 m-85 -140.29 131.22 26.07 Favored 'General case' 0 CA--C 1.529 0.137 0 CA-C-O 121.887 0.851 . . . . 0.0 112.287 -169.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 72.9 mttt -69.39 135.32 50.14 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.813 168.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 42.7 t -159.03 142.75 15.05 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 125.131 1.372 . . . . 0.0 111.431 -169.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.3 m -77.35 -27.48 52.68 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.848 1.055 . . . . 0.0 113.848 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 56.5 mtp180 -127.66 40.24 3.73 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 124.692 1.197 . . . . 0.0 113.348 -176.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -46.93 -40.88 15.09 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 179.016 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.52 -35.24 78.71 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.452 0.701 . . . . 0.0 112.8 177.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -70.93 -30.48 66.81 Favored 'General case' 0 N--CA 1.468 0.471 0 O-C-N 121.419 -0.8 . . . . 0.0 112.153 175.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.5 mt -65.49 -47.28 87.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-N 118.688 0.676 . . . . 0.0 109.608 168.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.8 t80 -58.6 -42.61 88.51 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.177 0.991 . . . . 0.0 111.919 177.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -67.78 -42.44 81.68 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.687 1.195 . . . . 0.0 112.418 176.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 27.9 tp -75.21 -32.51 61.2 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 118.847 0.749 . . . . 0.0 112.177 -177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.2 mt -53.92 -54.36 39.92 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 123.698 0.799 . . . . 0.0 112.221 176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -63.75 -30.97 72.01 Favored 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.44 -34.19 77.38 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 124.221 1.008 . . . . 0.0 112.83 176.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 85.1 mt -85.03 -35.57 21.82 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.341 1.056 . . . . 0.0 111.37 178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 48.7 mtt -63.64 -46.81 83.97 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 123.593 0.757 . . . . 0.0 112.513 172.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 3.9 pp0? -70.44 -17.62 63.0 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.666 0.617 . . . . 0.0 112.666 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 13.9 t -67.76 -26.9 66.35 Favored 'General case' 0 CA--C 1.546 0.825 0 CA-C-N 118.287 0.494 . . . . 0.0 112.104 -178.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 44.9 t-20 53.47 74.72 0.29 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 126.981 2.112 . . . . 0.0 112.191 177.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 2.6 p -60.83 125.87 25.29 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.015 0.926 . . . . 0.0 112.203 177.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 42.2 mm -97.34 -49.94 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 C-N-CA 124.174 0.99 . . . . 0.0 110.669 -176.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -73.49 0.94 10.96 Favored 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 124.9 1.28 . . . . 0.0 114.214 -172.254 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 14.8 p -74.01 -42.23 52.59 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 C-N-CA 126.967 2.107 . . . . 0.0 112.613 169.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 67.3 mtm 58.54 24.92 12.48 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 127.414 2.286 . . . . 0.0 116.355 170.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mm-40 -86.4 47.76 1.52 Allowed 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.51 1.524 . . . . 0.0 111.596 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -146.71 157.91 46.87 Favored Pre-proline 0 CA--C 1.549 0.91 0 C-N-CA 126.903 2.081 . . . . 0.0 110.989 -172.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 92.4 Cg_endo -73.43 -176.13 2.35 Favored 'Trans proline' 0 CA--C 1.54 0.824 0 C-N-CA 124.332 3.354 . . . . 0.0 111.468 174.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.74 115.82 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.83 0 C-N-CA 123.766 0.826 . . . . 0.0 110.961 172.851 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 28.4 mm -147.72 149.29 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 127.088 2.155 . . . . 0.0 109.111 -172.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 70.8 mt -98.21 125.26 51.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.685 1.194 . . . . 0.0 108.862 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 15.0 t -161.21 155.25 22.5 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.452 1.501 . . . . 0.0 111.299 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.1 tpm_? -77.51 120.04 21.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.151 1.38 . . . . 0.0 110.655 -179.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -63.17 147.27 51.35 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 123.976 0.911 . . . . 0.0 112.65 176.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 95.7 p -165.76 174.8 9.31 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 125.729 1.612 . . . . 0.0 111.649 -177.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 47.1 t-80 -150.23 128.63 5.97 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 124.636 1.174 . . . . 0.0 112.321 -176.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -79.82 -176.12 3.07 Favored 'Trans proline' 0 CA--C 1.542 0.879 0 C-N-CA 124.236 3.291 . . . . 0.0 112.144 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -142.85 164.31 30.44 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.089 1.356 . . . . 0.0 112.568 -177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.2 170.82 17.17 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 126.596 1.958 . . . . 0.0 110.832 -171.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.4 pp -144.3 173.83 11.43 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 124.803 1.241 . . . . 0.0 113.072 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -145.79 134.11 21.81 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.98 1.712 . . . . 0.0 110.211 -175.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.6 pp -87.42 140.06 31.95 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 123.473 0.709 . . . . 0.0 111.705 -174.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.59 147.42 22.24 Favored 'Trans proline' 0 C--N 1.35 0.636 0 C-N-CA 123.013 2.475 . . . . 0.0 111.295 -178.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 44.0 ttt85 -77.52 137.5 38.66 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.713 0.805 . . . . 0.0 111.501 179.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -90.23 149.78 41.95 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 124.964 1.306 . . . . 0.0 112.251 -179.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -75.83 176.18 10.34 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.039 3.159 . . . . 0.0 111.729 175.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -126.82 134.24 25.88 Favored Pre-proline 0 CA--C 1.546 0.802 0 C-N-CA 125.29 1.436 . . . . 0.0 109.7 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -72.67 153.25 54.16 Favored 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.305 2.67 . . . . 0.0 112.09 -178.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -75.38 154.74 40.97 Favored 'Trans proline' 0 C--N 1.35 0.623 0 C-N-CA 124.025 3.15 . . . . 0.0 112.38 -177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 5.5 p-10 -93.27 164.77 13.1 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 124.932 1.293 . . . . 0.0 113.245 177.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -107.21 -174.59 2.57 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 125.764 1.626 . . . . 0.0 112.063 175.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -153.81 162.64 41.06 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 126.259 1.823 . . . . 0.0 112.265 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -113.19 -148.51 10.23 Favored Glycine 0 N--CA 1.474 1.232 0 C-N-CA 125.799 1.666 . . . . 0.0 113.518 -177.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -154.78 170.52 21.43 Favored 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 125.576 1.55 . . . . 0.0 112.625 179.331 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 34.0 m -138.97 146.0 40.43 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 126.169 1.788 . . . . 0.0 109.505 -177.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.4 m -66.35 153.25 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.018 0 C-N-CA 124.584 1.154 . . . . 0.0 112.575 178.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 68.4 m -147.04 161.59 40.51 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 125.678 1.591 . . . . 0.0 111.815 -176.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 36.9 m . . . . . 0 C--O 1.252 1.235 0 C-N-CA 126.672 1.989 . . . . 0.0 112.767 177.941 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 94.7 mt . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 110.143 -0.317 . . . . 0.0 110.143 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 19.4 t80 -78.45 137.57 38.04 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 123.696 0.799 . . . . 0.0 111.447 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -105.81 116.76 32.5 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 124.779 1.232 . . . . 0.0 109.721 175.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 98.3 mt -78.52 157.77 28.76 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 113.195 0.813 . . . . 0.0 113.195 178.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 17.2 mmt85 -87.22 -7.97 57.35 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 125.798 1.639 . . . . 0.0 113.919 174.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -161.38 163.08 30.86 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 126.959 2.104 . . . . 0.0 110.499 -174.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 8.1 t80 -86.95 122.84 71.09 Favored Pre-proline 0 CA--C 1.546 0.807 0 CA-C-O 118.735 -0.65 . . . . 0.0 110.769 -179.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -81.67 -12.24 11.21 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.387 2.725 . . . . 0.0 113.75 -171.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 84.5 m -99.82 121.7 41.68 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.367 1.067 . . . . 0.0 111.531 -173.702 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.45 -14.6 82.32 Favored Glycine 0 CA--C 1.532 1.136 0 C-N-CA 124.385 0.993 . . . . 0.0 114.576 -177.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 -127.16 138.45 53.15 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.478 1.511 . . . . 0.0 110.876 176.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.484 HG21 ' HG3' ' A' ' 64' ' ' ARG . 2.0 p -163.97 142.45 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.888 1.675 . . . . 0.0 110.868 -173.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -115.76 114.22 24.5 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 127.321 2.249 . . . . 0.0 107.921 172.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -74.45 126.75 31.4 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.634 -0.666 . . . . 0.0 110.449 178.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.22 -104.74 0.76 Allowed Glycine 0 N--CA 1.469 0.872 0 C-N-CA 124.521 1.058 . . . . 0.0 112.986 -172.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -57.82 -42.83 85.1 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.135 0.974 . . . . 0.0 113.106 -174.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 10.1 tt0 48.06 48.27 18.38 Favored 'General case' 0 CA--C 1.55 0.972 0 C-N-CA 126.13 1.772 . . . . 0.0 112.331 170.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -68.82 155.92 39.33 Favored 'General case' 0 CA--C 1.543 0.704 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 -170.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 4.3 pp0? . . . . . 0 C--O 1.251 1.183 0 C-N-CA 126.274 1.83 . . . . 0.0 112.998 -171.812 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.57 -0.612 . . . . 0.0 111.57 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.7 p -164.42 161.74 21.66 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 125.312 1.445 . . . . 0.0 111.798 -176.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.4 t -163.0 156.31 19.61 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.451 1.501 . . . . 0.0 110.997 179.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 162.97 176.38 34.96 Favored Glycine 0 CA--C 1.53 1.005 0 C-N-CA 125.108 1.337 . . . . 0.0 114.052 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.3 t -165.17 163.94 20.26 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 125.902 1.681 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 18.5 t -162.65 135.8 5.89 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 125.322 1.449 . . . . 0.0 111.051 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -94.76 152.04 20.36 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 124.908 1.242 . . . . 0.0 112.699 177.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 82.5 mt -145.58 158.73 43.8 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 126.486 1.914 . . . . 0.0 110.713 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 10.8 p-10 -159.1 151.33 21.21 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.634 1.574 . . . . 0.0 112.009 -177.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 88.5 mtm-85 -143.61 137.42 28.31 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.917 1.687 . . . . 0.0 110.821 -176.593 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -94.68 -4.57 47.32 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.115 1.366 . . . . 0.0 113.525 -176.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 70.5 m -128.38 140.92 51.6 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 125.873 1.669 . . . . 0.0 110.453 177.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.84 121.59 71.91 Favored Pre-proline 0 N--CA 1.479 1.001 0 C-N-CA 123.715 0.806 . . . . 0.0 111.601 -175.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -81.12 172.48 12.85 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 123.84 3.027 . . . . 0.0 112.527 -178.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -69.87 6.64 1.13 Allowed 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 126.64 1.976 . . . . 0.0 114.535 170.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 18.6 p30 -149.59 20.57 0.92 Allowed 'General case' 0 CA--C 1.55 0.95 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 -168.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 29.6 t-80 -61.38 143.97 92.44 Favored Pre-proline 0 CA--C 1.558 1.265 0 O-C-N 120.749 -1.219 . . . . 0.0 113.023 -179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -72.34 -11.23 26.53 Favored 'Trans proline' 0 CA--C 1.542 0.875 0 C-N-CA 123.244 2.63 . . . . 0.0 115.287 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 69.2 p -127.5 -25.05 3.23 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 119.752 1.16 . . . . 0.0 114.0 178.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.4 mppt? -104.79 134.47 47.88 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.066 0.946 . . . . 0.0 111.103 173.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -131.2 105.25 7.54 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.155 1.382 . . . . 0.0 108.478 -174.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.8 mttm -65.82 127.56 32.48 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.638 0.775 . . . . 0.0 110.488 175.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.4 m -137.35 163.64 31.07 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 125.347 1.459 . . . . 0.0 111.352 -169.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.1 m -134.25 119.44 18.76 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.307 1.043 . . . . 0.0 109.013 174.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -61.82 128.0 34.12 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.108 0.963 . . . . 0.0 109.961 175.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.7 m -125.99 154.88 35.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 C-N-CA 123.547 0.739 . . . . 0.0 112.906 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -89.87 -166.94 1.71 Allowed 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.649 1.18 . . . . 0.0 113.952 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -63.5 -29.57 70.83 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 114.712 1.375 . . . . 0.0 114.712 176.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -83.33 -8.96 59.34 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.001 1.32 . . . . 0.0 112.562 175.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.15 16.51 80.57 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 118.182 -1.344 . . . . 0.0 113.729 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 17.1 m -81.28 150.45 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.568 1.684 . . . . 0.0 111.63 176.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -88.12 121.94 31.11 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.641 1.176 . . . . 0.0 111.151 -170.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 18.7 mt -102.8 -53.58 2.82 Favored 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.37 0.668 . . . . 0.0 111.843 -175.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -151.76 149.05 20.72 Favored Glycine 0 N--CA 1.472 1.04 0 C-N-CA 124.795 1.188 . . . . 0.0 114.356 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 28.4 p -88.29 153.01 21.55 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.208 1.403 . . . . 0.0 113.152 178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.46 171.39 35.26 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 125.243 1.401 . . . . 0.0 113.628 179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 84.4 t -119.45 120.22 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 49.0 tpp -85.27 140.15 31.07 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.482 1.113 . . . . 0.0 109.259 170.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.5 tt0 -133.32 129.96 38.22 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 125.119 1.368 . . . . 0.0 108.546 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.88 131.2 55.28 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.821 2.048 . . . . 0.0 108.471 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.6 p -133.83 173.36 11.63 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.847 1.259 . . . . 0.0 110.877 178.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -71.91 5.4 2.65 Favored 'General case' 0 CA--C 1.547 0.847 0 O-C-N 121.079 -1.013 . . . . 0.0 112.776 170.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.8 m -114.73 -45.85 2.97 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 124.773 1.229 . . . . 0.0 113.619 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -172.21 169.92 5.31 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 119.754 1.161 . . . . 0.0 113.449 -169.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.9 mt -87.44 139.96 30.02 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 124.356 1.063 . . . . 0.0 109.952 168.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 25.4 t -135.4 127.6 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 124.041 0.936 . . . . 0.0 111.496 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 13.5 mt -100.06 128.65 46.11 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 125.233 1.413 . . . . 0.0 110.374 168.13 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -108.24 129.48 55.2 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 127.305 2.242 . . . . 0.0 109.654 169.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -143.72 -11.92 0.68 Allowed 'General case' 0 N--CA 1.475 0.813 0 N-CA-C 116.04 1.867 . . . . 0.0 116.04 -174.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -169.18 -176.01 2.44 Favored 'General case' 0 CA--C 1.554 1.104 0 C-N-CA 126.137 1.775 . . . . 0.0 110.971 -179.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -63.27 -25.71 68.44 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 126.276 1.83 . . . . 0.0 111.885 168.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.78 153.31 24.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 126.377 1.871 . . . . 0.0 111.312 169.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 37.0 mm-40 -53.28 142.76 20.26 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.018 1.327 . . . . 0.0 113.301 -175.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.32 154.78 41.51 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 123.998 0.919 . . . . 0.0 112.52 179.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 20.8 t -107.04 135.04 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.143 0 C-N-CA 124.922 1.289 . . . . 0.0 108.119 -178.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 91.0 mtt180 -131.63 149.78 52.38 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 115.043 1.497 . . . . 0.0 115.043 -166.831 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 19.3 m-90 -141.82 116.44 6.85 Favored Pre-proline 0 N--CA 1.473 0.677 0 C-N-CA 124.549 1.14 . . . . 0.0 111.997 173.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -69.41 145.1 58.06 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.55 2.167 . . . . 0.0 109.565 170.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 34.9 m-85 -61.6 -21.95 64.8 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 113.494 0.924 . . . . 0.0 113.494 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 tt -60.56 -47.64 85.28 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.705 2.002 . . . . 0.0 111.692 173.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 81.4 m -80.12 -16.56 54.69 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 114.693 1.368 . . . . 0.0 114.693 -175.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 86.5 mt -65.13 119.63 11.19 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-N 118.939 0.791 . . . . 0.0 110.382 176.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 54.6 mmm-85 -82.82 -32.08 27.78 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.356 1.063 . . . . 0.0 112.065 -179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 18.3 ptt-85 -168.28 160.68 11.68 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 127.179 2.192 . . . . 0.0 110.725 173.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 36.6 p90 -149.45 116.96 6.14 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 124.831 1.252 . . . . 0.0 109.667 -175.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -128.83 165.7 21.56 Favored Glycine 0 N--CA 1.463 0.466 0 C-N-CA 124.836 1.208 . . . . 0.0 113.358 -169.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -141.59 176.74 8.65 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.456 1.102 . . . . 0.0 113.136 -170.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -163.6 -168.01 1.55 Allowed 'General case' 0 CA--C 1.55 0.971 0 C-N-CA 127.677 2.391 . . . . 0.0 108.756 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 9.6 t -72.21 -19.66 61.69 Favored 'General case' 0 CA--C 1.546 0.805 0 O-C-N 120.691 -1.256 . . . . 0.0 113.198 178.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -152.22 8.19 0.47 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 124.619 1.167 . . . . 0.0 113.893 -176.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -137.11 129.77 30.23 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.425 1.49 . . . . 0.0 110.242 -169.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -124.51 138.01 54.37 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.194 1.797 . . . . 0.0 109.208 175.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -153.33 152.84 31.56 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 121.094 -1.004 . . . . 0.0 112.326 -173.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.3 p90 -150.84 153.58 35.65 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.262 1.025 . . . . 0.0 112.312 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -110.8 142.56 42.64 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 125.026 1.331 . . . . 0.0 109.379 170.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.2 t -129.32 150.55 50.64 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.476 0.71 . . . . 0.0 112.643 173.132 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -72.98 158.57 53.12 Favored Glycine 0 CA--C 1.533 1.166 0 C-N-CA 125.028 1.299 . . . . 0.0 113.619 -175.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 44.1 mtt180 -60.99 -20.93 63.04 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 114.413 1.264 . . . . 0.0 114.413 -170.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.2 ptm180 -80.12 -14.38 58.54 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 115.778 1.769 . . . . 0.0 115.778 -176.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.0 p -76.87 -179.4 5.42 Favored 'General case' 0 CA--C 1.546 0.8 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -173.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 7.0 tm0? -56.46 -47.18 79.73 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 125.495 1.518 . . . . 0.0 113.102 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 67.9 p -81.78 -26.13 34.7 Favored 'General case' 0 N--CA 1.473 0.707 0 N-CA-C 114.071 1.137 . . . . 0.0 114.071 178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.52 -163.46 38.87 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.691 1.138 . . . . 0.0 111.79 -172.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -66.3 128.43 36.11 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.339 1.056 . . . . 0.0 111.342 -176.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 167.37 164.2 22.6 Favored Glycine 0 C--N 1.339 0.721 0 CA-C-O 121.557 0.532 . . . . 0.0 114.08 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 81.6 mt -114.89 136.07 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 C-N-CA 125.493 1.517 . . . . 0.0 108.572 171.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -132.07 127.03 35.23 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.662 1.185 . . . . 0.0 110.614 -175.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.29 140.88 52.57 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.3 1.44 . . . . 0.0 113.187 -173.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -140.77 128.48 21.62 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.464 1.106 . . . . 0.0 111.988 -169.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 45.5 mttm -74.82 135.86 41.62 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.621 0.768 . . . . 0.0 111.738 171.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 17.5 p -172.33 140.06 1.08 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 127.063 2.145 . . . . 0.0 111.473 176.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 12.7 m -68.88 -20.28 64.25 Favored 'General case' 0 N--CA 1.476 0.866 0 O-C-N 121.344 -0.847 . . . . 0.0 113.272 178.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 40.2 mtm-85 -100.63 17.88 20.68 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.989 1.716 . . . . 0.0 112.738 -175.006 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.18 -39.92 31.21 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.839 1.255 . . . . 0.0 113.779 -176.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 47.4 tt0 -68.25 -37.71 81.04 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.302 1.041 . . . . 0.0 113.211 175.7 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -67.73 -34.05 76.08 Favored 'General case' 0 N--CA 1.472 0.665 0 O-C-N 121.149 -0.97 . . . . 0.0 111.911 175.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 73.3 mt -64.95 -46.07 92.77 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 O-C-N 121.983 -0.448 . . . . 0.0 110.075 170.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.5 t80 -59.71 -43.15 94.23 Favored 'General case' 0 CA--C 1.546 0.79 0 C-N-CA 124.33 1.052 . . . . 0.0 112.023 176.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.2 m-20 -66.48 -37.45 85.13 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.845 1.258 . . . . 0.0 112.556 177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.1 tp -80.63 -32.61 36.23 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.914 0.779 . . . . 0.0 112.43 -179.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 9.6 mt -56.25 -50.42 71.39 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 118.65 0.659 . . . . 0.0 112.55 178.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.1 pt20 -65.95 -18.79 65.57 Favored 'General case' 0 CA--C 1.54 0.568 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.69 -43.71 16.55 Favored 'General case' 0 N--CA 1.463 0.219 0 C-N-CA 124.425 1.09 . . . . 0.0 110.977 173.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 88.0 mt -71.55 -28.18 63.68 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 120.845 -1.159 . . . . 0.0 111.959 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 33.6 mtt -61.32 -17.04 51.82 Favored 'General case' 0 CA--C 1.543 0.682 0 N-CA-C 114.697 1.369 . . . . 0.0 114.697 167.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -122.36 -16.22 7.42 Favored 'General case' 0 N--CA 1.474 0.76 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 91.8 m -91.82 4.81 52.02 Favored 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 126.527 1.931 . . . . 0.0 113.116 175.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 26.8 p-10 -68.64 168.77 12.42 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.238 1.815 . . . . 0.0 112.253 169.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 40.4 m -73.48 79.71 1.43 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.051 1.34 . . . . 0.0 112.612 -175.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 38.9 mm -119.82 -54.58 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 125.795 1.638 . . . . 0.0 109.526 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -76.8 38.92 0.21 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 125.218 1.407 . . . . 0.0 112.627 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 1.1 p -156.4 113.88 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 C-N-CA 128.565 2.746 . . . . 0.0 106.149 -176.212 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 10.1 ptm -49.51 141.86 8.74 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 125.921 1.689 . . . . 0.0 113.274 174.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -147.0 -174.25 4.45 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 125.77 1.628 . . . . 0.0 112.228 -169.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 39.7 mm-40 -61.89 143.15 94.68 Favored Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 124.023 0.929 . . . . 0.0 111.777 176.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 63.9 Cg_endo -67.66 154.33 73.67 Favored 'Trans proline' 0 CA--C 1.537 0.629 0 C-N-CA 123.527 2.818 . . . . 0.0 112.218 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 11.9 p -127.3 136.71 59.86 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 125.716 1.606 . . . . 0.0 110.578 -175.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.6 mp -93.22 123.87 45.46 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 C-N-CA 124.256 1.022 . . . . 0.0 108.782 -177.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.55 21.02 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 C-N-CA 125.559 1.544 . . . . 0.0 112.662 -175.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 25.1 p -62.29 146.29 51.41 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 125.761 1.624 . . . . 0.0 112.197 -176.679 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 13.1 ptm180 -168.19 170.81 9.89 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.975 1.71 . . . . 0.0 111.904 -170.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 87.2 m-20 -67.58 137.85 56.0 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.466 0.707 . . . . 0.0 110.748 169.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 11.7 p -110.86 115.0 28.77 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.702 1.201 . . . . 0.0 110.147 176.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 81.2 m-70 -85.08 147.57 48.19 Favored Pre-proline 0 CA--C 1.551 0.991 0 C-N-CA 123.834 0.854 . . . . 0.0 112.852 -172.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -70.28 159.63 52.35 Favored 'Trans proline' 0 C--N 1.351 0.71 0 C-N-CA 123.5 2.8 . . . . 0.0 111.271 176.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -154.98 150.79 27.74 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 124.907 1.283 . . . . 0.0 111.581 -177.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -75.84 129.39 36.92 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.451 1.1 . . . . 0.0 110.916 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 95.0 mt -84.06 150.95 25.25 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.519 1.128 . . . . 0.0 111.277 176.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.7 t0 -154.96 147.09 23.72 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.286 1.435 . . . . 0.0 111.299 -175.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.0 pp -92.7 146.64 32.62 Favored Pre-proline 0 CA--C 1.546 0.825 0 C-N-CA 124.875 1.27 . . . . 0.0 111.982 -174.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -78.16 145.51 21.85 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 123.059 2.506 . . . . 0.0 111.094 178.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 27.9 ttp85 -70.65 152.4 43.92 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.422 0.689 . . . . 0.0 111.355 175.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -143.75 152.92 57.12 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 125.336 1.454 . . . . 0.0 111.798 -177.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.53 174.56 12.0 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.938 3.092 . . . . 0.0 111.743 176.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -129.96 145.7 58.28 Favored Pre-proline 0 CA--C 1.544 0.743 0 C-N-CA 125.151 1.381 . . . . 0.0 110.059 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -72.51 147.27 45.84 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.21 2.607 . . . . 0.0 111.775 -175.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -75.03 150.63 38.31 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.674 2.916 . . . . 0.0 111.87 179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -84.77 164.21 18.66 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 124.431 1.092 . . . . 0.0 112.447 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -151.87 167.71 27.45 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 125.652 1.581 . . . . 0.0 111.81 -178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -155.9 165.0 37.78 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.539 1.535 . . . . 0.0 112.435 -174.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -122.81 -155.47 9.34 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 125.861 1.696 . . . . 0.0 113.178 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.4 p90 -156.7 175.11 14.48 Favored 'General case' 0 CA--C 1.547 0.864 0 C-N-CA 125.565 1.546 . . . . 0.0 112.191 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.2 t -154.25 176.5 12.21 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 125.693 1.597 . . . . 0.0 111.068 177.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 14.0 p -166.8 148.95 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 127.006 2.122 . . . . 0.0 109.836 -171.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.1 p -156.28 151.38 26.4 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 125.382 1.473 . . . . 0.0 111.572 -178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 26.2 m . . . . . 0 C--O 1.253 1.278 0 C-N-CA 127.653 2.381 . . . . 0.0 112.151 -177.934 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 39.8 t80 -88.9 124.36 34.14 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.391 0.676 . . . . 0.0 110.428 -179.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.15 109.09 18.64 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.989 0.916 . . . . 0.0 109.909 -179.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 40.0 mt -77.46 154.78 32.25 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.748 0.819 . . . . 0.0 112.819 177.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 39.0 ttm180 -87.13 -19.02 29.1 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 125.576 1.55 . . . . 0.0 112.792 175.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 30.4 p80 -149.8 167.76 25.61 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 126.332 1.853 . . . . 0.0 111.751 -175.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -93.22 123.56 60.4 Favored Pre-proline 0 CA--C 1.546 0.821 0 CA-C-O 118.627 -0.702 . . . . 0.0 111.389 -179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -82.92 -18.03 6.64 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 123.197 2.598 . . . . 0.0 114.129 -171.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 84.0 m -101.15 115.35 30.28 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 124.154 0.982 . . . . 0.0 111.284 -173.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -73.49 -41.1 45.71 Favored Glycine 0 N--CA 1.476 1.343 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 175.63 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -77.73 113.92 16.07 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.543 1.537 . . . . 0.0 110.055 169.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -156.36 151.03 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.737 2.015 . . . . 0.0 110.234 -169.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -131.96 160.35 36.06 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.72 1.608 . . . . 0.0 111.484 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 62.7 m-85 -113.77 123.9 50.96 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.989 1.316 . . . . 0.0 111.207 -169.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -83.28 160.29 38.07 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 124.35 0.976 . . . . 0.0 112.62 -179.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 14.9 m-85 53.82 48.18 21.94 Favored 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 124.741 1.216 . . . . 0.0 112.785 171.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 78.4 mt-30 -61.4 130.25 45.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.386 1.074 . . . . 0.0 110.478 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 29.2 tt0 -163.1 159.25 22.94 Favored 'General case' 0 CA--C 1.545 0.775 0 C-N-CA 125.255 1.422 . . . . 0.0 110.058 -169.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 52.4 mt-30 . . . . . 0 C--O 1.253 1.245 0 C-N-CA 125.217 1.407 . . . . 0.0 113.126 174.308 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.614 0 N-CA-C 112.039 -0.425 . . . . 0.0 112.039 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 55.8 p -166.27 170.72 12.91 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.39 1.476 . . . . 0.0 111.819 -174.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.3 m -132.59 159.62 38.97 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 125.342 1.457 . . . . 0.0 111.425 178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.07 -23.52 0.11 Allowed Glycine 0 N--CA 1.474 1.177 0 N-CA-C 115.254 0.862 . . . . 0.0 115.254 -179.558 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 12.2 t -69.08 149.06 49.13 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-N 118.415 1.108 . . . . 0.0 111.54 169.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.6 t -160.59 148.71 16.3 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 124.803 1.241 . . . . 0.0 111.344 -174.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -79.16 111.21 3.2 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 124.074 0.845 . . . . 0.0 111.027 178.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 99.5 mt -137.15 128.01 27.34 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 125.921 1.688 . . . . 0.0 109.3 179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -163.39 161.63 24.5 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.621 1.568 . . . . 0.0 111.745 -174.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 80.3 mtt85 -88.64 147.85 24.34 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.836 1.254 . . . . 0.0 111.228 -177.841 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -85.05 -1.65 57.08 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.914 1.286 . . . . 0.0 113.313 177.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.7 t -142.61 145.66 33.74 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 126.074 1.75 . . . . 0.0 109.388 169.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -88.12 124.87 65.85 Favored Pre-proline 0 N--CA 1.474 0.77 0 C-N-CA 123.932 0.893 . . . . 0.0 110.961 -169.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -76.34 164.78 30.39 Favored 'Trans proline' 0 C--N 1.35 0.654 0 C-N-CA 123.674 2.916 . . . . 0.0 112.092 -179.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -74.4 5.35 4.71 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.557 1.543 . . . . 0.0 114.197 173.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 69.9 m-80 -130.0 11.72 5.59 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.056 1.742 . . . . 0.0 113.263 -177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.1 t-80 -55.01 145.08 45.63 Favored Pre-proline 0 CA--C 1.558 1.269 0 C-N-CA 124.521 1.128 . . . . 0.0 113.414 -177.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -71.1 -14.71 32.02 Favored 'Trans proline' 0 CA--C 1.541 0.845 0 C-N-CA 123.051 2.501 . . . . 0.0 115.421 -178.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 37.3 p -131.04 -18.74 2.93 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 120.229 1.377 . . . . 0.0 114.516 179.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.4 mptt -104.68 142.02 35.42 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.192 0.997 . . . . 0.0 110.447 170.562 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -141.73 108.32 5.34 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 -176.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.92 145.35 52.0 Favored 'General case' 0 N--CA 1.467 0.419 0 O-C-N 121.254 -0.904 . . . . 0.0 110.51 176.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -144.36 156.7 15.09 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.585 0 C-N-CA 123.609 0.763 . . . . 0.0 111.5 -172.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -132.95 115.15 14.85 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 173.701 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 19.0 t-20 -65.24 133.52 51.66 Favored 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 110.101 -0.333 . . . . 0.0 110.101 178.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.3 m -126.86 154.46 36.9 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 C-N-CA 124.076 0.95 . . . . 0.0 112.431 -176.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.438 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.4 p-10 -88.01 -167.5 1.9 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.342 1.057 . . . . 0.0 113.599 178.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -63.89 -32.35 73.85 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.751 1.221 . . . . 0.0 114.234 174.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 9.4 mt-10 -79.53 -9.08 59.55 Favored 'General case' 0 CA--C 1.543 0.688 0 CA-C-N 118.959 0.799 . . . . 0.0 112.533 174.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.92 14.5 81.93 Favored Glycine 0 CA--C 1.532 1.107 0 CA-C-O 117.931 -1.483 . . . . 0.0 113.923 -174.34 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.438 HG22 ' OD1' ' A' ' 27' ' ' ASP . 15.1 m -76.24 150.11 6.42 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.737 0 CA-C-N 119.85 1.825 . . . . 0.0 111.338 175.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -87.28 125.31 34.14 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.53 1.132 . . . . 0.0 111.183 -171.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 46.7 mt -107.4 -52.35 2.78 Favored 'General case' 0 N--CA 1.468 0.461 0 C-N-CA 123.994 0.918 . . . . 0.0 112.107 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -157.17 147.14 14.96 Favored Glycine 0 N--CA 1.47 0.924 0 C-N-CA 124.591 1.091 . . . . 0.0 113.737 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.4 p -91.12 150.05 21.55 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.943 1.297 . . . . 0.0 113.104 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.05 168.13 32.38 Favored Glycine 0 CA--C 1.525 0.714 0 C-N-CA 125.947 1.737 . . . . 0.0 113.006 179.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 46.6 t -116.76 120.63 65.59 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 171.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.8 ttm -93.9 140.95 29.07 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.938 1.295 . . . . 0.0 110.619 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.1 tt0 -140.06 130.26 25.12 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 125.592 1.557 . . . . 0.0 108.935 -176.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.0 mp -107.91 137.77 45.33 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.166 1.787 . . . . 0.0 108.016 178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.9 p -137.53 174.71 10.3 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.779 1.232 . . . . 0.0 110.649 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 23.1 mp0 -73.59 3.21 6.55 Favored 'General case' 0 CA--C 1.549 0.939 0 O-C-N 121.408 -0.807 . . . . 0.0 112.616 171.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.6 m -120.77 -45.04 2.41 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 124.532 1.133 . . . . 0.0 113.663 -176.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -168.96 166.17 11.23 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.194 1.398 . . . . 0.0 113.706 -174.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.4 mt -83.13 136.97 34.26 Favored 'General case' 0 N--CA 1.464 0.266 0 C-N-CA 124.855 1.262 . . . . 0.0 109.34 168.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 87.6 t -134.4 132.56 55.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.523 0.729 . . . . 0.0 110.98 -178.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.2 mt -109.65 130.35 55.52 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 126.151 1.78 . . . . 0.0 110.777 169.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 91.7 m-70 -100.15 125.32 46.27 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.531 1.933 . . . . 0.0 110.285 169.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 92.3 mt -131.62 162.88 29.32 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 126.921 2.088 . . . . 0.0 111.087 -173.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -113.4 -20.27 11.39 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 -172.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 17.8 mmm180 -117.41 7.64 12.84 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 126.422 1.889 . . . . 0.0 112.875 174.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -145.6 161.59 39.44 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 127.028 2.131 . . . . 0.0 110.649 -177.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.2 mp0 -61.27 151.78 30.87 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.703 1.601 . . . . 0.0 110.488 170.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.5 138.43 58.02 Favored 'General case' 0 CA--C 1.541 0.612 0 O-C-N 121.718 -0.614 . . . . 0.0 110.512 171.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 3.6 t -112.3 134.53 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.293 0.637 . . . . 0.0 110.464 -174.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -134.44 144.37 48.09 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.585 1.154 . . . . 0.0 112.022 -169.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 18.7 m-90 -144.29 122.05 6.69 Favored Pre-proline 0 CA--C 1.545 0.777 0 C-N-CA 124.877 1.271 . . . . 0.0 111.571 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -71.26 141.48 39.37 Favored 'Trans proline' 0 C--N 1.351 0.699 0 C-N-CA 123.042 2.494 . . . . 0.0 110.303 175.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -58.8 -26.02 63.7 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 176.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -54.43 -41.78 69.78 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.451 1.9 . . . . 0.0 112.852 174.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.9 p -87.97 -10.69 49.7 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 114.519 1.303 . . . . 0.0 114.519 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 87.9 mt -89.94 69.07 7.43 Favored 'General case' 0 N--CA 1.467 0.411 0 C-N-CA 125.491 1.516 . . . . 0.0 110.775 -177.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -67.67 -23.86 65.36 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 123.852 0.861 . . . . 0.0 113.269 179.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -141.54 119.65 12.08 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 125.513 1.525 . . . . 0.0 110.278 -173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 43.4 p90 -142.0 109.31 5.58 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.104 1.762 . . . . 0.0 110.591 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.56 170.26 14.0 Favored Glycine 0 N--CA 1.465 0.601 0 C-N-CA 124.733 1.159 . . . . 0.0 113.612 -169.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -141.61 158.68 43.53 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.054 0.942 . . . . 0.0 111.67 174.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -151.24 -173.89 4.64 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 126.136 1.774 . . . . 0.0 109.964 174.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.4 p -58.16 109.73 0.81 Allowed 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 121.944 0.878 . . . . 0.0 111.771 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . 0.261 0.8 OUTLIER 49.36 27.73 2.06 Favored 'General case' 0 CA--C 1.553 1.086 0 C-N-CA 127.292 2.237 . . . . 0.0 115.836 -173.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.0 tm? -134.99 130.02 35.08 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 125.736 1.614 . . . . 0.0 110.564 -172.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 62.5 t80 -124.45 137.75 54.41 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.685 1.594 . . . . 0.0 109.852 175.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.6 t -153.44 156.7 38.68 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.259 1.024 . . . . 0.0 113.021 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 42.7 p90 -152.77 156.69 39.58 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 125.051 1.34 . . . . 0.0 112.082 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -121.87 137.86 54.62 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.374 1.87 . . . . 0.0 109.705 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 35.0 p -145.31 150.5 36.74 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 124.201 1.0 . . . . 0.0 112.887 -175.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -80.84 166.9 49.36 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 124.863 1.221 . . . . 0.0 114.031 -175.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.0 ppt_? -63.52 -12.35 31.51 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 115.639 1.718 . . . . 0.0 115.639 -171.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.28 -20.17 60.23 Favored 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 125.335 1.454 . . . . 0.0 114.709 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 15.7 p -76.55 176.58 8.18 Favored 'General case' 0 CA--C 1.547 0.862 0 N-CA-C 113.068 0.766 . . . . 0.0 113.068 -176.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.4 tt0 -57.4 -41.15 79.75 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.979 1.311 . . . . 0.0 113.137 -177.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 29.1 p -91.54 -21.02 21.09 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.344 1.458 . . . . 0.0 113.884 -173.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.34 -176.56 52.79 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 125.253 1.406 . . . . 0.0 112.637 -174.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 15.6 pt20 -63.42 130.74 45.71 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.142 0.977 . . . . 0.0 112.671 -175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.76 178.91 36.08 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.862 1.22 . . . . 0.0 113.041 -179.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 70.5 mt -119.31 136.69 55.67 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.775 1.63 . . . . 0.0 108.834 174.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -130.57 121.54 25.88 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.735 1.214 . . . . 0.0 110.068 -173.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -122.36 141.98 50.99 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.54 1.136 . . . . 0.0 112.797 -170.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 25.9 m-85 -141.11 130.62 23.9 Favored 'General case' 0 CA--C 1.528 0.129 0 C-N-CA 123.817 0.847 . . . . 0.0 111.913 -170.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.7 mttp -69.57 131.98 45.52 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 123.798 0.839 . . . . 0.0 110.79 169.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 54.1 t -170.55 120.21 0.57 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.438 1.895 . . . . 0.0 110.337 -176.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.4 t -71.11 -7.84 49.34 Favored 'General case' 0 N--CA 1.479 0.975 0 O-C-N 121.029 -1.044 . . . . 0.0 113.226 176.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.4 tpt180 -101.34 7.69 42.66 Favored 'General case' 0 CA--C 1.546 0.817 0 C-N-CA 126.671 1.988 . . . . 0.0 112.688 179.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.85 -39.62 54.0 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.207 1.803 . . . . 0.0 115.592 -172.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -68.48 -34.0 75.16 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 118.676 0.671 . . . . 0.0 112.789 178.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 34.7 mm-40 -70.59 -33.74 71.4 Favored 'General case' 0 N--CA 1.468 0.453 0 O-C-N 121.642 -0.661 . . . . 0.0 111.146 174.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 73.8 mt -63.33 -47.0 94.04 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.824 0 CA-C-N 118.59 0.632 . . . . 0.0 110.088 170.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -62.05 -43.06 99.66 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.758 0.823 . . . . 0.0 111.675 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 33.0 m-80 -70.3 -30.58 67.61 Favored 'General case' 0 CA--C 1.539 0.551 0 N-CA-C 113.426 0.898 . . . . 0.0 113.426 176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 31.9 tp -80.68 -35.71 33.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.703 1.138 . . . . 0.0 111.861 177.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 8.2 mt -54.95 -50.36 69.08 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.29 0.95 . . . . 0.0 112.341 177.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 pt20 -63.53 -24.92 68.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.6 0.963 . . . . 0.0 113.6 179.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.23 -25.75 47.08 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 124.32 1.048 . . . . 0.0 112.576 174.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 82.7 mt -90.54 -30.15 17.43 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.423 1.089 . . . . 0.0 111.588 177.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 14.9 mmt -56.36 -24.89 47.13 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.208 1.403 . . . . 0.0 112.939 168.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 16.0 pt20 -101.74 -6.16 24.03 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.278 1.431 . . . . 0.0 114.633 174.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 37.1 t -85.08 -27.8 26.06 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 124.363 1.065 . . . . 0.0 113.63 -171.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 12.5 p-10 -67.05 155.75 37.86 Favored 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 124.211 1.004 . . . . 0.0 112.667 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 43.8 t -91.78 121.45 33.43 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.568 0.747 . . . . 0.0 110.738 172.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.5 mp -96.68 66.7 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.504 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 41.3 m-80 62.55 29.21 16.99 Favored 'General case' 0 CA--C 1.552 1.055 0 C-N-CA 126.49 1.916 . . . . 0.0 113.536 -179.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 27.8 m -95.36 8.56 6.18 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 125.084 1.353 . . . . 0.0 113.612 -175.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 60.0 mtt -143.61 158.42 43.68 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 126.426 1.891 . . . . 0.0 110.829 178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.0 mm-40 -67.67 142.3 56.41 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 123.532 0.733 . . . . 0.0 110.642 173.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -148.47 154.73 41.87 Favored Pre-proline 0 CA--C 1.548 0.899 0 C-N-CA 125.165 1.386 . . . . 0.0 112.174 -171.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -74.87 176.4 9.91 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.948 3.099 . . . . 0.0 111.903 177.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 80.6 t -84.25 124.37 39.74 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.786 0 C-N-CA 124.411 1.084 . . . . 0.0 110.181 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.9 mp -114.53 139.35 40.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 C-N-CA 125.892 1.677 . . . . 0.0 108.346 172.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 74.7 mt -66.83 119.1 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 C-N-CA 123.776 0.83 . . . . 0.0 109.653 177.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 27.2 p -144.76 154.58 42.86 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 126.317 1.847 . . . . 0.0 110.778 -174.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 84.3 mtp180 -73.26 -23.03 60.27 Favored 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 178.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 21.5 m120 -149.23 134.38 18.21 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 126.048 1.739 . . . . 0.0 110.272 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 13.6 t -77.27 143.39 38.92 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 123.432 0.693 . . . . 0.0 111.297 174.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 44.8 t-80 -61.47 123.7 77.68 Favored Pre-proline 0 CA--C 1.558 1.267 0 O-C-N 121.075 -1.016 . . . . 0.0 112.15 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 91.2 Cg_endo -74.48 149.63 39.62 Favored 'Trans proline' 0 C--N 1.351 0.698 0 C-N-CA 123.256 2.637 . . . . 0.0 111.163 -179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -77.19 67.82 3.22 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 124.505 1.122 . . . . 0.0 111.607 178.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -76.27 99.83 4.89 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 125.092 1.357 . . . . 0.0 110.22 178.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 pp -167.07 -175.9 3.17 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 127.217 2.207 . . . . 0.0 110.97 -177.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -149.36 152.81 36.42 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.12 1.768 . . . . 0.0 109.844 175.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.2 tt -49.95 114.43 4.27 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 126.549 1.94 . . . . 0.0 111.385 -173.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.77 141.34 17.07 Favored 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 122.726 2.284 . . . . 0.0 111.566 -169.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.97 163.12 26.75 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.32 0.648 . . . . 0.0 112.183 172.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -147.72 149.1 32.62 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 125.413 1.485 . . . . 0.0 110.942 -178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -70.73 140.62 39.45 Favored 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.188 2.592 . . . . 0.0 110.852 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 28.8 pt20 -94.55 129.44 36.56 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.744 0.817 . . . . 0.0 109.898 175.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.42 131.47 13.85 Favored 'Trans proline' 0 CA--C 1.542 0.897 0 C-N-CA 122.687 2.258 . . . . 0.0 110.406 -177.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -74.73 114.17 3.97 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 122.857 2.372 . . . . 0.0 109.8 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -79.24 113.35 17.3 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.322 0.649 . . . . 0.0 111.316 -178.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -74.52 130.46 39.64 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.987 0.915 . . . . 0.0 111.28 176.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.9 tt -97.06 109.32 22.1 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.703 1.201 . . . . 0.0 108.623 177.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -176.04 139.2 4.49 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 124.192 0.901 . . . . 0.0 113.241 178.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -152.62 171.39 18.23 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 126.942 2.097 . . . . 0.0 111.09 -178.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 8.4 t -152.32 176.71 11.34 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 125.023 1.329 . . . . 0.0 111.646 -177.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 58.9 t -91.97 137.2 22.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.687 0 C-N-CA 126.66 1.984 . . . . 0.0 109.171 -178.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 21.9 m -51.8 125.14 14.24 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.411 1.484 . . . . 0.0 113.627 -176.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 40.2 p . . . . . 0 C--O 1.253 1.274 0 C-N-CA 125.915 1.686 . . . . 0.0 114.328 -179.241 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 N--CA 1.492 1.636 0 N-CA-C 110.294 -0.262 . . . . 0.0 110.294 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 31.4 t80 -140.56 128.08 21.42 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.44 1.496 . . . . 0.0 110.184 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 8.2 ptm85 -88.39 117.26 27.19 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 124.49 1.116 . . . . 0.0 111.309 179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 72.2 mt -84.0 156.34 22.32 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.98 0.912 . . . . 0.0 112.27 174.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 82.9 mtp180 -92.34 -5.37 52.32 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.643 1.577 . . . . 0.0 113.423 179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -169.41 161.14 9.71 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 127.208 2.203 . . . . 0.0 110.977 -169.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 10.1 t80 -89.14 124.72 64.21 Favored Pre-proline 0 CA--C 1.547 0.836 0 CA-C-O 118.531 -0.747 . . . . 0.0 111.534 -173.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -84.6 -24.13 2.46 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.128 2.552 . . . . 0.0 113.813 -171.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 73.7 m -83.4 124.23 30.46 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.636 0.775 . . . . 0.0 111.399 -175.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.36 -4.46 89.07 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 124.342 0.972 . . . . 0.0 114.583 -179.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -138.46 136.91 36.67 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.746 1.618 . . . . 0.0 110.219 175.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 2.3 p -162.8 139.73 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 C-N-CA 125.075 1.35 . . . . 0.0 111.197 -172.632 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 51.2 t-20 -100.67 125.43 47.09 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.627 1.971 . . . . 0.0 108.945 171.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -86.11 124.1 32.14 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.229 0.612 . . . . 0.0 111.395 -179.707 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -84.17 -101.11 0.59 Allowed Glycine 0 N--CA 1.47 0.951 0 C-N-CA 125.312 1.434 . . . . 0.0 112.574 -175.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 22.5 m-85 -75.87 67.1 2.22 Favored 'General case' 0 CA--C 1.547 0.857 0 C-N-CA 125.017 1.327 . . . . 0.0 112.819 -173.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 19.0 pt20 -73.23 -11.33 60.47 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.262 1.425 . . . . 0.0 113.259 172.458 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 40.7 mt-30 -136.35 149.18 48.25 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 126.843 2.057 . . . . 0.0 107.854 169.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 97.8 mt-30 . . . . . 0 C--O 1.251 1.178 0 C-N-CA 125.625 1.57 . . . . 0.0 111.34 -170.429 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.534 0 N-CA-C 110.984 -0.846 . . . . 0.0 110.984 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.6 m -151.44 156.66 41.08 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 125.11 1.364 . . . . 0.0 111.434 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 86.5 p -162.95 170.09 18.64 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 124.896 1.279 . . . . 0.0 112.455 -177.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.17 171.24 36.69 Favored Glycine 0 CA--C 1.533 1.215 0 C-N-CA 125.145 1.355 . . . . 0.0 113.686 -179.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 7.4 t -164.2 168.7 18.58 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.646 1.578 . . . . 0.0 111.413 -178.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 75.3 p -170.49 178.73 3.58 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 126.451 1.901 . . . . 0.0 111.679 -171.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 89.27 27.13 23.9 Favored Glycine 0 N--CA 1.474 1.204 0 O-C-N 121.4 -0.812 . . . . 0.0 114.646 173.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 10.0 mp -62.54 149.26 43.52 Favored 'General case' 0 CA--C 1.543 0.708 0 C-N-CA 124.656 1.182 . . . . 0.0 110.837 176.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 7.4 p-10 -152.56 177.71 10.36 Favored 'General case' 0 CA--C 1.548 0.895 0 C-N-CA 124.733 1.213 . . . . 0.0 113.55 -170.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -148.75 166.67 27.72 Favored 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 126.265 1.826 . . . . 0.0 111.676 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -76.88 -27.8 55.14 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 124.339 1.056 . . . . 0.0 113.06 176.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.1 m -75.96 52.69 0.72 Allowed 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 125.859 1.664 . . . . 0.0 112.096 175.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.3 p -62.22 121.52 66.83 Favored Pre-proline 0 CA--C 1.546 0.81 0 C-N-CA 126.041 1.737 . . . . 0.0 111.815 -173.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -83.38 165.59 14.36 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 123.808 3.006 . . . . 0.0 111.431 171.623 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -73.7 6.11 3.44 Favored 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.351 1.461 . . . . 0.0 113.89 173.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 71.3 m-80 -126.51 11.31 7.36 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 126.595 1.958 . . . . 0.0 113.138 -178.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 36.6 t-80 -58.0 145.2 73.32 Favored Pre-proline 0 CA--C 1.555 1.165 0 O-C-N 120.76 -1.212 . . . . 0.0 112.521 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -68.74 -12.64 35.12 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.0 2.466 . . . . 0.0 115.199 -179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 57.7 p -136.49 -18.39 1.46 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 115.372 1.619 . . . . 0.0 115.372 -177.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mptp? -112.58 148.56 34.29 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.431 1.093 . . . . 0.0 110.002 171.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 61.3 m-85 -143.11 115.88 8.73 Favored 'General case' 0 N--CA 1.466 0.336 0 O-C-N 121.296 -0.878 . . . . 0.0 110.408 -173.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 55.5 mttm -71.02 133.93 46.72 Favored 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.458 -0.776 . . . . 0.0 110.242 173.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 31.6 m -142.44 163.77 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 124.927 1.291 . . . . 0.0 112.19 -169.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.3 m -134.46 119.77 18.93 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 124.426 1.091 . . . . 0.0 108.968 174.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.69 126.62 27.96 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.17 0.988 . . . . 0.0 109.775 174.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 32.7 m -124.75 153.61 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.402 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.3 p-10 -91.88 -168.91 2.12 Favored 'General case' 0 CA--C 1.549 0.938 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -175.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.2 -22.66 67.01 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.481 1.512 . . . . 0.0 114.438 176.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -93.53 -5.84 48.1 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 124.665 1.186 . . . . 0.0 112.387 174.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 77.65 14.83 82.01 Favored Glycine 0 CA--C 1.533 1.202 0 CA-C-O 118.065 -1.408 . . . . 0.0 114.045 -173.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.402 HG22 ' OD1' ' A' ' 27' ' ' ASP . 18.2 m -81.04 150.99 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-N 119.674 1.737 . . . . 0.0 111.55 176.262 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -88.56 122.47 32.06 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 124.724 1.21 . . . . 0.0 110.996 -170.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 21.9 mt -103.65 -54.51 2.56 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 123.254 0.621 . . . . 0.0 111.86 -175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -146.59 146.72 16.98 Favored Glycine 0 N--CA 1.472 1.072 0 C-N-CA 124.869 1.223 . . . . 0.0 114.476 -178.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.2 p -94.33 144.64 25.37 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.486 1.515 . . . . 0.0 112.558 178.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -154.41 171.68 32.92 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.701 1.143 . . . . 0.0 114.597 -177.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 68.5 t -115.35 121.17 66.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.654 0 C-N-CA 124.663 1.185 . . . . 0.0 108.622 170.711 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.2 tpp -86.94 135.28 33.35 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 125.602 1.561 . . . . 0.0 109.933 172.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -138.85 129.82 26.57 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.564 1.546 . . . . 0.0 109.375 -173.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.2 mp -111.61 134.03 53.46 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 126.293 1.837 . . . . 0.0 108.247 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 32.3 p -137.12 167.68 21.07 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 124.949 1.299 . . . . 0.0 110.436 -179.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -68.86 -6.85 29.59 Favored 'General case' 0 CA--C 1.544 0.722 0 O-C-N 121.449 -0.782 . . . . 0.0 112.68 173.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 55.9 m -95.74 -46.13 6.72 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 123.989 0.916 . . . . 0.0 112.832 176.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -176.02 174.33 2.11 Favored 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 124.704 1.201 . . . . 0.0 113.544 -168.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.8 mt -86.55 140.34 29.98 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 125.167 1.387 . . . . 0.0 110.035 168.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -135.57 136.57 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.532 1.133 . . . . 0.0 111.323 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 14.3 mt -108.94 133.28 53.16 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.371 1.869 . . . . 0.0 110.648 168.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -114.01 121.15 43.01 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.993 2.117 . . . . 0.0 110.377 172.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.7 mp -116.35 166.57 11.91 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.605 1.562 . . . . 0.0 111.323 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -51.72 -62.87 1.36 Allowed 'General case' 0 CA--C 1.55 0.977 0 C-N-CA 125.774 1.63 . . . . 0.0 114.504 -175.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 7.7 mmm180 -134.71 -2.72 2.64 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 125.412 1.485 . . . . 0.0 113.795 177.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -72.97 154.33 40.58 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-N 118.975 0.807 . . . . 0.0 109.241 167.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 43.7 mm-40 -62.99 151.19 40.39 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 120.971 0.415 . . . . 0.0 111.074 172.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.58 147.24 53.74 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 123.219 0.608 . . . . 0.0 111.221 175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 4.6 t -128.99 137.0 58.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 C-N-CA 123.603 0.761 . . . . 0.0 109.941 -174.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 41.7 mtp85 -132.36 143.64 49.98 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.439 1.096 . . . . 0.0 112.388 -167.891 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -138.9 109.42 7.75 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 124.691 1.196 . . . . 0.0 111.622 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.5 150.99 83.94 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 122.914 2.409 . . . . 0.0 112.15 174.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.3 m-85 -65.68 -7.27 14.52 Favored 'General case' 0 CA--C 1.545 0.779 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 177.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 27.7 mt -81.58 -35.02 30.66 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.778 1.631 . . . . 0.0 113.583 170.204 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 16.5 p -88.11 -23.91 23.55 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 119.707 1.139 . . . . 0.0 113.709 179.364 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 32.3 mt -62.11 107.25 0.84 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 125.619 1.568 . . . . 0.0 110.366 176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 7.3 tpm_? -78.16 -38.33 43.85 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.35 1.46 . . . . 0.0 112.021 -174.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.0 ptt180 -163.94 156.52 17.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.836 2.055 . . . . 0.0 110.442 174.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.4 p90 -148.64 132.05 16.63 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 124.387 1.075 . . . . 0.0 109.877 -175.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -148.26 170.75 28.8 Favored Glycine 0 C--N 1.333 0.41 0 CA-C-O 121.996 0.775 . . . . 0.0 114.373 -169.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -134.92 156.36 49.12 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 124.606 1.163 . . . . 0.0 112.136 -178.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.05 -176.21 5.67 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 126.075 1.75 . . . . 0.0 110.107 175.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 20.8 t -63.13 114.86 3.99 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 122.107 0.956 . . . . 0.0 111.577 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.0 t30 57.02 18.66 4.11 Favored 'General case' 0 CA--C 1.557 1.217 0 C-N-CA 127.035 2.134 . . . . 0.0 114.495 -174.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.35 126.32 25.97 Favored 'General case' 0 CA--C 1.535 0.403 0 O-C-N 120.213 -1.554 . . . . 0.0 111.251 -169.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 64.3 t80 -119.88 138.06 53.64 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.536 1.535 . . . . 0.0 109.592 170.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 27.8 t -153.33 155.01 35.67 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 121.232 -0.917 . . . . 0.0 112.636 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 40.8 p90 -146.64 152.29 38.64 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.049 1.34 . . . . 0.0 111.759 178.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 -110.51 143.05 41.45 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 125.713 1.605 . . . . 0.0 109.695 178.142 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.8 t -144.43 154.79 43.32 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.024 0.93 . . . . 0.0 111.983 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.22 176.62 37.38 Favored Glycine 0 CA--C 1.532 1.095 0 C-N-CA 125.403 1.478 . . . . 0.0 113.855 -179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.7 ptt180 -64.96 -8.91 17.72 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 115.105 1.521 . . . . 0.0 115.105 -177.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.4 ptm180 -76.81 -17.01 59.28 Favored 'General case' 0 N--CA 1.473 0.696 0 C-N-CA 126.769 2.028 . . . . 0.0 115.424 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 14.0 p -85.66 -177.38 6.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.501 1.12 . . . . 0.0 113.961 -176.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 57.8 tt0 -61.53 -42.07 98.27 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.178 1.391 . . . . 0.0 112.879 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.4 p -93.01 -20.36 20.65 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.302 1.441 . . . . 0.0 114.123 -173.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.45 -174.19 43.04 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 125.39 1.471 . . . . 0.0 112.7 -173.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -67.63 134.41 51.12 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.655 0.782 . . . . 0.0 112.617 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.56 -176.37 35.49 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 124.503 1.049 . . . . 0.0 113.287 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.8 mt -121.26 137.31 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.799 1.64 . . . . 0.0 109.342 177.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -127.08 118.53 24.58 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.239 1.416 . . . . 0.0 109.32 -171.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -123.77 140.05 53.37 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.43 1.092 . . . . 0.0 113.196 -169.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 43.2 m-85 -139.37 127.92 23.05 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 114.832 -1.076 . . . . 0.0 112.005 -169.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.9 mttm -67.7 129.02 38.62 Favored 'General case' 0 CA--C 1.537 0.48 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 168.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 35.3 t -165.31 126.63 1.99 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 125.436 1.494 . . . . 0.0 111.103 -171.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.9 t -75.1 -10.22 59.27 Favored 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 175.718 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 27.7 mmm180 -107.39 18.6 21.37 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 126.311 1.845 . . . . 0.0 112.842 -175.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -57.89 -40.27 79.89 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -169.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 74.5 tt0 -71.0 -36.99 72.68 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.01 0.924 . . . . 0.0 112.274 177.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 33.2 mp0 -64.64 -40.74 95.99 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.246 1.019 . . . . 0.0 110.707 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.5 mt -62.0 -46.54 96.26 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 C-N-CA 123.353 0.661 . . . . 0.0 110.63 172.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -59.6 -39.36 83.93 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.503 1.121 . . . . 0.0 112.221 178.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 31.2 m-80 -74.27 -30.88 62.31 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.256 1.022 . . . . 0.0 113.48 175.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -80.36 -34.96 36.07 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-N 119.354 0.979 . . . . 0.0 111.091 -179.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 7.4 mt -52.44 -56.51 14.58 Favored 'General case' 0 N--CA 1.468 0.471 0 C-N-CA 124.151 0.981 . . . . 0.0 112.897 178.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -55.65 -34.2 64.76 Favored 'General case' 0 CA--C 1.543 0.69 0 N-CA-C 112.998 0.74 . . . . 0.0 112.998 177.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -78.91 -17.03 56.21 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 125.285 1.434 . . . . 0.0 112.769 -173.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 79.5 mt -95.24 -37.23 11.11 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.396 1.078 . . . . 0.0 110.917 169.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 57.8 mtp -65.86 -30.97 71.66 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 123.874 0.87 . . . . 0.0 112.663 178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -78.09 -10.35 59.58 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 171.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 6.1 t -84.26 -9.24 58.66 Favored 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.368 1.067 . . . . 0.0 113.04 -176.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -62.62 153.35 32.45 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.624 1.17 . . . . 0.0 112.726 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.0 m -94.94 73.03 3.48 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.555 1.142 . . . . 0.0 110.979 -176.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . 0.494 ' H ' HD12 ' A' ' 110' ' ' ILE . 0.1 OUTLIER -87.33 -159.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 124.556 1.143 . . . . 0.0 109.6 173.869 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 41.6 p30 -67.85 36.09 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 127.736 2.414 . . . . 0.0 115.105 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 2.5 p -82.88 14.0 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 128.129 2.572 . . . . 0.0 115.029 -168.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 21.7 ptp 51.99 29.4 6.16 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 127.802 2.441 . . . . 0.0 115.435 171.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -142.82 167.93 20.9 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 127.12 2.168 . . . . 0.0 109.816 179.334 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 4.4 pm0 -60.59 142.31 91.41 Favored Pre-proline 0 CA--C 1.551 1.0 0 C-N-CA 124.18 0.992 . . . . 0.0 112.574 179.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -74.08 157.14 46.9 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 123.515 2.81 . . . . 0.0 111.989 -176.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 9.1 p -142.23 118.51 6.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 125.889 1.676 . . . . 0.0 111.331 -178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.7 mp -136.94 137.13 47.31 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 126.455 1.902 . . . . 0.0 108.515 -179.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.8 pt -110.08 160.05 9.39 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.577 1.151 . . . . 0.0 111.198 170.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 46.8 p -125.45 148.52 48.8 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 125.321 1.448 . . . . 0.0 110.613 177.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 2.1 ppt_? -161.95 175.1 12.2 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 126.162 1.785 . . . . 0.0 111.517 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -131.77 -168.11 1.98 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 125.222 1.409 . . . . 0.0 112.839 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 80.4 p -144.76 177.92 8.37 Favored 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 126.951 2.1 . . . . 0.0 109.808 169.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 57.7 t-80 -152.99 132.23 6.94 Favored Pre-proline 0 CA--C 1.555 1.152 0 C-N-CA 124.381 1.072 . . . . 0.0 111.772 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -78.17 152.19 27.35 Favored 'Trans proline' 0 C--N 1.353 0.803 0 C-N-CA 123.443 2.762 . . . . 0.0 112.57 -172.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -86.55 166.21 15.61 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.634 1.174 . . . . 0.0 112.511 174.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.4 mm-40 -68.91 139.45 55.12 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.983 0.913 . . . . 0.0 111.539 176.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -85.42 176.44 8.27 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 125.339 1.456 . . . . 0.0 113.48 -179.506 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -147.88 167.85 23.72 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 126.482 1.913 . . . . 0.0 111.41 173.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 pp -96.91 148.6 34.63 Favored Pre-proline 0 CA--C 1.545 0.766 0 C-N-CA 124.664 1.186 . . . . 0.0 112.448 -169.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -80.57 157.38 21.89 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.541 2.827 . . . . 0.0 111.84 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -69.96 139.39 52.84 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.818 0.847 . . . . 0.0 111.543 178.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.18 144.46 95.18 Favored Pre-proline 0 CA--C 1.554 1.101 0 C-N-CA 124.176 0.99 . . . . 0.0 112.768 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_endo -78.15 168.22 22.17 Favored 'Trans proline' 0 CA--C 1.538 0.689 0 C-N-CA 124.057 3.171 . . . . 0.0 112.115 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 86.4 mt-30 -84.28 149.23 54.86 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.236 1.014 . . . . 0.0 111.175 174.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.08 154.38 52.4 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.569 2.846 . . . . 0.0 112.339 -177.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.29 161.89 34.44 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 124.148 3.232 . . . . 0.0 112.357 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 77.1 m-20 -92.99 148.04 22.33 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.608 1.163 . . . . 0.0 112.69 179.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -83.99 -174.23 5.16 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 125.198 1.399 . . . . 0.0 112.707 175.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -150.78 161.28 42.95 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.798 1.639 . . . . 0.0 112.444 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -92.83 -146.03 18.24 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 125.382 1.468 . . . . 0.0 113.42 -179.009 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -155.5 -177.13 6.33 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.266 1.826 . . . . 0.0 111.987 -176.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 7.8 t -148.05 175.6 10.88 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.206 1.402 . . . . 0.0 112.074 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.0 p -63.61 143.49 15.57 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 126.424 1.89 . . . . 0.0 112.178 -174.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 49.4 p -121.9 144.11 49.05 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 125.743 1.617 . . . . 0.0 112.269 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 48.8 m . . . . . 0 C--O 1.254 1.308 0 C-N-CA 126.669 1.987 . . . . 0.0 113.073 179.395 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 3.9 mm? . . . . . 0 N--CA 1.491 1.607 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 29.1 t80 -87.05 149.47 24.7 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 118.011 0.369 . . . . 0.0 110.972 176.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.03 97.4 5.67 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.911 1.684 . . . . 0.0 109.801 -173.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 57.7 mt -72.72 156.34 39.04 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.831 0.852 . . . . 0.0 111.872 177.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 11.4 mpt_? -98.56 -12.06 21.57 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.619 1.568 . . . . 0.0 113.0 177.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -144.8 149.64 35.8 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.509 1.924 . . . . 0.0 111.073 -176.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 11.4 t80 -85.79 121.16 73.22 Favored Pre-proline 0 CA--C 1.549 0.94 0 O-C-N 121.498 -0.751 . . . . 0.0 110.981 -177.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 81.8 Cg_endo -84.22 -19.88 4.42 Favored 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 123.291 2.661 . . . . 0.0 114.65 -169.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 87.3 m -89.54 124.64 34.71 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.163 0.892 . . . . 0.0 112.358 -172.131 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.68 -14.43 81.12 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.103 0.859 . . . . 0.0 114.42 178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -115.31 129.39 56.6 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.371 1.468 . . . . 0.0 109.325 170.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 8.9 p -158.03 151.36 7.65 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 C-N-CA 125.285 1.434 . . . . 0.0 110.921 -169.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 23.1 p-10 -155.76 179.63 9.02 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 125.959 1.704 . . . . 0.0 112.442 -179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.43 135.35 33.52 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.185 1.794 . . . . 0.0 109.669 -173.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -106.13 -11.33 28.06 Favored Glycine 0 N--CA 1.475 1.25 0 N-CA-C 115.987 1.155 . . . . 0.0 115.987 -169.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -105.64 155.7 18.97 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 125.09 1.356 . . . . 0.0 112.427 -178.123 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 14.1 pt20 -156.7 151.74 26.2 Favored 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 125.455 1.502 . . . . 0.0 110.62 -176.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 46.9 tt0 -164.01 147.88 9.92 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 125.294 1.438 . . . . 0.0 109.581 -173.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 . . . . . 0 C--O 1.254 1.301 0 C-N-CA 124.879 1.271 . . . . 0.0 112.194 177.147 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 22.7 t -163.29 138.89 6.69 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.186 1.395 . . . . 0.0 110.517 179.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 10.8 t -167.37 161.6 14.24 Favored 'General case' 0 N--CA 1.474 0.76 0 C-N-CA 125.543 1.537 . . . . 0.0 111.289 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 144.01 135.29 2.94 Favored Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.523 1.535 . . . . 0.0 113.082 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 50.4 m -156.17 162.56 40.19 Favored 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 126.135 1.774 . . . . 0.0 110.949 -176.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.0 t -81.91 71.03 8.94 Favored 'General case' 0 N--CA 1.475 0.809 0 O-C-N 120.968 -1.082 . . . . 0.0 112.205 -179.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.22 99.62 2.26 Favored Glycine 0 CA--C 1.529 0.968 0 C-N-CA 124.669 1.128 . . . . 0.0 111.892 179.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 76.6 mt -145.03 135.63 24.4 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 126.046 1.738 . . . . 0.0 110.486 178.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 13.0 p30 -169.81 161.63 9.17 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 127.083 2.153 . . . . 0.0 110.941 178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 41.9 ttt85 -161.21 146.3 13.87 Favored 'General case' 0 N--CA 1.473 0.717 0 C-N-CA 124.755 1.222 . . . . 0.0 111.661 179.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.37 0.04 47.76 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 125.431 1.492 . . . . 0.0 114.06 -177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 77.4 p -156.67 157.18 34.73 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 126.278 1.831 . . . . 0.0 110.466 178.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.1 p -72.9 119.54 76.04 Favored Pre-proline 0 N--CA 1.477 0.921 0 C-N-CA 123.595 0.758 . . . . 0.0 111.413 -176.033 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -80.4 172.19 13.91 Favored 'Trans proline' 0 C--N 1.35 0.625 0 C-N-CA 123.691 2.927 . . . . 0.0 111.835 176.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -73.3 6.59 2.76 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.176 1.39 . . . . 0.0 113.711 173.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 29.0 p30 -143.52 17.66 1.85 Allowed 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.484 1.514 . . . . 0.0 114.982 -169.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 31.4 t-80 -60.39 147.05 83.25 Favored Pre-proline 0 CA--C 1.558 1.261 0 O-C-N 121.041 -1.037 . . . . 0.0 113.256 -177.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -72.9 -11.56 25.7 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 123.109 2.539 . . . . 0.0 115.359 179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.5 p -131.35 -21.96 2.53 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 120.355 1.434 . . . . 0.0 114.553 178.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.5 mptp? -102.34 140.9 36.01 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.306 1.042 . . . . 0.0 110.363 169.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 86.0 m-85 -136.44 111.72 9.11 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 124.757 1.223 . . . . 0.0 108.35 -178.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 53.9 mttm -67.94 133.22 48.73 Favored 'General case' 0 CA--C 1.543 0.696 0 O-C-N 121.647 -0.658 . . . . 0.0 110.293 176.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.3 m -142.54 164.44 17.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 C-N-CA 125.324 1.449 . . . . 0.0 111.59 -169.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.3 m -139.96 120.78 14.44 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 124.376 1.07 . . . . 0.0 109.117 173.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.3 t-20 -64.58 131.9 48.32 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.453 0.701 . . . . 0.0 110.023 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.7 m -128.16 157.52 40.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.596 0 C-N-CA 124.429 1.092 . . . . 0.0 112.389 -176.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -85.76 -167.05 1.71 Allowed 'General case' 0 CA--C 1.552 1.026 0 C-N-CA 124.451 1.1 . . . . 0.0 113.28 176.774 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -70.38 -26.58 63.78 Favored 'General case' 0 CA--C 1.546 0.826 0 C-N-CA 124.495 1.118 . . . . 0.0 113.639 176.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -80.42 -18.12 49.78 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.566 1.146 . . . . 0.0 112.567 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 86.36 17.94 59.76 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 118.115 -1.38 . . . . 0.0 114.167 -173.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' OD1' ' A' ' 27' ' ' ASP . 17.5 m -77.22 150.65 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.86 0 CA-C-N 119.841 1.82 . . . . 0.0 111.269 171.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -88.65 126.73 35.44 Favored 'General case' 0 C--N 1.328 -0.332 0 C-N-CA 124.839 1.256 . . . . 0.0 110.923 -172.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.5 mt -109.69 -51.21 2.9 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.115 0.966 . . . . 0.0 111.814 -170.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.14 136.38 5.2 Favored Glycine 0 N--CA 1.471 0.975 0 C-N-CA 124.593 1.092 . . . . 0.0 114.08 177.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 25.1 p -84.1 146.29 27.98 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.07 1.348 . . . . 0.0 112.652 177.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -153.93 170.06 32.53 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 125.369 1.462 . . . . 0.0 113.721 -178.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.7 t -116.36 120.22 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 169.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 46.6 ttm -87.6 136.38 32.97 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 123.922 0.889 . . . . 0.0 109.636 173.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.2 tt0 -130.94 129.66 42.46 Favored 'General case' 0 C--O 1.24 0.566 0 C-N-CA 125.392 1.477 . . . . 0.0 108.67 -179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.9 mp -105.77 116.24 31.6 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 125.978 1.711 . . . . 0.0 106.967 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 29.5 p -114.95 168.0 10.29 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.61 1.164 . . . . 0.0 110.046 179.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 66.4 mt-30 -72.1 -2.4 18.37 Favored 'General case' 0 CA--C 1.546 0.813 0 O-C-N 121.528 -0.732 . . . . 0.0 112.659 170.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 56.5 m -96.77 -48.7 5.37 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.447 1.099 . . . . 0.0 112.51 175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -176.31 175.91 1.75 Allowed 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 126.016 1.726 . . . . 0.0 112.813 -170.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 5.7 mt -84.73 137.87 32.96 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 124.302 1.041 . . . . 0.0 110.214 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.6 t -135.01 134.38 53.32 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 124.027 0.931 . . . . 0.0 111.502 177.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.7 mt -104.08 133.72 48.55 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 125.894 1.677 . . . . 0.0 109.769 168.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -112.61 129.88 56.22 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.944 2.098 . . . . 0.0 110.899 173.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.2 mp -130.92 167.37 19.09 Favored 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 125.748 1.619 . . . . 0.0 111.086 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.03 -78.5 0.09 Allowed 'General case' 0 CA--C 1.552 1.025 0 C-N-CA 124.612 1.165 . . . . 0.0 112.764 -176.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 53.2 mtm-85 -95.16 -4.52 45.92 Favored 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 124.587 1.155 . . . . 0.0 113.969 -177.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 16.8 mmp_? -98.52 154.74 17.68 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 125.649 1.58 . . . . 0.0 111.13 174.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -65.13 156.63 31.03 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 124.29 1.036 . . . . 0.0 112.204 174.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.27 150.1 48.66 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 123.424 0.69 . . . . 0.0 111.621 173.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 22.0 t -129.04 130.19 68.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 C-N-CA 123.815 0.846 . . . . 0.0 110.141 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 54.7 mtp85 -126.99 144.39 51.03 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.725 1.21 . . . . 0.0 112.416 -168.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 28.1 m-90 -139.63 116.89 8.45 Favored Pre-proline 0 CA--C 1.542 0.652 0 C-N-CA 124.781 1.232 . . . . 0.0 111.581 176.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -64.13 143.2 83.48 Favored 'Trans proline' 0 C--N 1.352 0.746 0 C-N-CA 122.714 2.276 . . . . 0.0 110.068 172.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -55.81 -31.66 62.87 Favored 'General case' 0 CA--C 1.541 0.622 0 N-CA-C 112.997 0.739 . . . . 0.0 112.997 179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.2 tt -55.45 -44.15 76.11 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.702 2.001 . . . . 0.0 112.752 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.2 p -75.41 -7.93 55.35 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 -176.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 77.8 mt -83.17 108.78 16.66 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.152 0.981 . . . . 0.0 110.514 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -74.81 -37.94 62.21 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.842 0.857 . . . . 0.0 112.125 -177.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 13.4 ptp180 -157.84 163.31 38.11 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.587 1.555 . . . . 0.0 110.961 170.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 41.8 p90 -151.9 141.05 21.3 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 125.613 1.565 . . . . 0.0 109.074 -178.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -158.0 177.81 34.56 Favored Glycine 0 N--CA 1.463 0.447 0 CA-C-O 121.484 0.491 . . . . 0.0 113.794 -171.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -143.61 166.11 25.73 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.202 1.001 . . . . 0.0 113.44 -170.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -151.39 -170.52 3.68 Favored 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 126.681 1.992 . . . . 0.0 109.787 173.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.3 t -72.94 -13.05 61.17 Favored 'General case' 0 CA--C 1.548 0.901 0 O-C-N 120.596 -1.315 . . . . 0.0 114.234 -174.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 43.2 p-10 -157.39 5.85 0.14 Allowed 'General case' 0 CA--C 1.547 0.852 0 C-N-CA 125.631 1.572 . . . . 0.0 114.25 -178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -135.86 132.87 37.16 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.818 1.647 . . . . 0.0 110.451 -168.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -124.48 142.11 51.57 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 126.428 1.891 . . . . 0.0 109.773 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 13.3 t -157.08 161.15 39.45 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.648 1.179 . . . . 0.0 112.508 -177.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 49.4 p90 -150.34 149.34 29.96 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 125.496 1.518 . . . . 0.0 112.013 177.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -93.86 139.47 30.85 Favored 'General case' 0 N--CA 1.47 0.558 0 C-N-CA 124.92 1.288 . . . . 0.0 109.456 171.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 79.1 p -142.33 148.73 38.43 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 112.885 0.698 . . . . 0.0 112.885 176.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -91.96 172.54 35.43 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 125.098 1.332 . . . . 0.0 113.986 -177.017 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -13.75 54.37 Favored 'General case' 0 N--CA 1.478 0.958 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -174.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 15.7 ptm180 -72.81 -16.98 61.61 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 126.016 1.727 . . . . 0.0 115.653 -179.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.2 p -83.73 -178.79 7.13 Favored 'General case' 0 CA--C 1.549 0.933 0 C-N-CA 124.373 1.069 . . . . 0.0 113.723 -177.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -60.2 -41.37 92.83 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 125.106 1.362 . . . . 0.0 113.049 -178.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 35.5 p -91.04 -21.15 21.39 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.101 1.36 . . . . 0.0 113.876 -172.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.24 -177.72 49.09 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 125.139 1.352 . . . . 0.0 112.271 -170.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -64.73 137.25 57.69 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.152 0.981 . . . . 0.0 112.789 -174.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 160.06 -178.96 35.91 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 124.263 0.935 . . . . 0.0 113.483 177.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 75.3 mt -118.3 133.71 64.24 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.616 1.566 . . . . 0.0 108.81 172.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.4 m-85 -127.92 124.57 37.69 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.98 1.312 . . . . 0.0 109.458 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.03 143.92 48.8 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.088 0.955 . . . . 0.0 112.886 -172.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -138.87 128.58 24.81 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.52 1.128 . . . . 0.0 111.36 -169.577 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 44.5 mttm -69.85 136.1 50.34 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.966 0.506 . . . . 0.0 110.667 169.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 23.8 t -163.42 138.95 6.59 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.243 1.417 . . . . 0.0 110.971 -174.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 6.2 t -74.4 -11.32 60.21 Favored 'General case' 0 N--CA 1.477 0.91 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 178.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -137.3 34.48 2.53 Favored 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 125.979 1.712 . . . . 0.0 113.776 -169.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.89 -37.86 33.22 Favored 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.964 1.306 . . . . 0.0 113.659 173.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -67.94 -37.48 81.67 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.222 1.009 . . . . 0.0 113.141 176.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -67.81 -37.78 82.43 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 121.319 -0.863 . . . . 0.0 110.931 175.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 77.4 mt -62.43 -46.4 96.5 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 123.156 0.582 . . . . 0.0 110.097 171.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -60.84 -38.26 84.89 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 124.296 1.038 . . . . 0.0 112.481 177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -72.11 -28.38 63.25 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.25 1.02 . . . . 0.0 113.469 176.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -85.63 -41.95 14.76 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 119.078 0.854 . . . . 0.0 110.713 178.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.2 mt -50.81 -54.48 23.33 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 124.299 1.04 . . . . 0.0 112.603 178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -59.47 -22.46 61.59 Favored 'General case' 0 CA--C 1.539 0.538 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 -178.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -82.08 -21.57 36.75 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.725 1.21 . . . . 0.0 112.867 175.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 75.1 mt -95.81 -35.34 11.54 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.097 1.359 . . . . 0.0 112.039 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 66.2 mmm -57.46 -28.64 63.53 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.49 1.516 . . . . 0.0 112.249 170.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -96.45 -9.3 30.1 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 124.767 1.227 . . . . 0.0 114.169 173.048 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 24.7 t -82.74 -32.57 27.84 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 124.187 0.995 . . . . 0.0 111.926 177.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -60.48 133.59 56.24 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.572 0.749 . . . . 0.0 109.602 169.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.1 m -58.52 106.58 0.41 Allowed 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.785 1.234 . . . . 0.0 113.583 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 41.7 mm -91.74 92.15 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.945 0 O-C-N 121.13 -0.981 . . . . 0.0 109.167 177.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 12.5 m120 62.38 18.53 10.36 Favored 'General case' 0 CA--C 1.553 1.087 0 C-N-CA 126.438 1.895 . . . . 0.0 114.365 175.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 53.7 t -69.56 -35.07 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 125.948 1.699 . . . . 0.0 111.657 -178.705 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 64.8 mtt -81.66 144.68 31.02 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.232 1.013 . . . . 0.0 111.154 174.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.5 pp20? -67.98 154.98 40.48 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.277 0.631 . . . . 0.0 111.746 171.734 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -145.25 146.56 30.8 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.279 1.432 . . . . 0.0 110.79 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -72.57 143.02 37.36 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 122.983 2.455 . . . . 0.0 110.736 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 54.3 t -81.51 100.03 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 174.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 9.1 tp -70.72 154.79 7.87 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.606 0 C-N-CA 126.002 1.721 . . . . 0.0 112.302 -177.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.5 pp -71.78 142.56 15.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 O-C-N 121.478 -0.764 . . . . 0.0 110.112 169.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.1 t -154.63 135.33 13.57 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 124.782 1.233 . . . . 0.0 110.648 -175.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 60.1 ttp85 -78.36 141.45 38.38 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.026 0.931 . . . . 0.0 110.872 -177.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -147.57 156.47 42.85 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 125.263 1.425 . . . . 0.0 111.728 -179.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 16.1 m -133.68 25.06 4.04 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.684 1.193 . . . . 0.0 112.418 -169.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -146.1 151.11 43.98 Favored Pre-proline 0 CA--C 1.554 1.133 0 C-N-CA 125.617 1.567 . . . . 0.0 112.774 -173.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -75.56 159.63 39.1 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 123.694 2.93 . . . . 0.0 111.666 -179.284 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -63.84 133.01 52.59 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 123.71 0.804 . . . . 0.0 111.968 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -92.79 171.15 9.17 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.85 1.26 . . . . 0.0 112.02 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -143.2 170.77 15.11 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.122 1.769 . . . . 0.0 111.51 178.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -145.01 135.99 24.76 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 125.034 1.334 . . . . 0.0 111.036 -174.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.3 pp -95.37 146.74 31.85 Favored Pre-proline 0 CA--C 1.544 0.75 0 C-N-CA 124.903 1.281 . . . . 0.0 111.729 -176.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -73.91 147.58 39.29 Favored 'Trans proline' 0 C--N 1.35 0.608 0 C-N-CA 123.037 2.491 . . . . 0.0 110.875 178.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 75.8 ttt180 -138.56 142.58 39.24 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.977 1.311 . . . . 0.0 110.688 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -151.21 152.2 30.73 Favored Pre-proline 0 CA--C 1.548 0.888 0 C-N-CA 125.995 1.718 . . . . 0.0 110.87 -175.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -70.4 148.59 61.26 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 123.423 2.749 . . . . 0.0 111.308 179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 37.4 tt0 -103.46 128.74 26.81 Favored Pre-proline 0 CA--C 1.545 0.779 0 C-N-CA 124.319 1.048 . . . . 0.0 109.453 177.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -75.51 154.85 40.43 Favored 'Trans proline' 0 CA--C 1.541 0.857 0 C-N-CA 123.193 2.595 . . . . 0.0 111.848 -177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -72.68 167.34 27.41 Favored 'Trans proline' 0 CA--C 1.537 0.672 0 C-N-CA 123.852 3.035 . . . . 0.0 111.495 174.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 70.2 m-80 -128.11 124.8 37.84 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.62 1.168 . . . . 0.0 111.18 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -165.95 173.43 10.48 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 127.18 2.192 . . . . 0.0 110.527 -175.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 59.5 tp -150.83 128.57 11.6 Favored 'General case' 0 N--CA 1.468 0.473 0 C-N-CA 124.78 1.232 . . . . 0.0 110.888 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -98.4 162.9 20.76 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.242 1.401 . . . . 0.0 113.116 176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 73.2 t80 -161.96 157.12 23.26 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 125.849 1.66 . . . . 0.0 111.651 179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.0 t -157.27 170.12 23.19 Favored 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 125.975 1.71 . . . . 0.0 110.874 177.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.0 p -163.79 144.38 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 C-N-CA 126.434 1.894 . . . . 0.0 110.485 -169.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 12.1 t -161.74 162.13 29.54 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 125.869 1.668 . . . . 0.0 110.762 -178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 8.4 t . . . . . 0 C--O 1.253 1.267 0 C-N-CA 126.004 1.721 . . . . 0.0 111.892 -177.141 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 83.5 mt . . . . . 0 N--CA 1.491 1.6 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 29.0 t80 -78.63 124.31 28.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 122.782 0.433 . . . . 0.0 111.27 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . 0.432 ' HD2' ' H ' ' B' ' 3' ' ' ARG . 0.0 OUTLIER -85.78 122.98 30.62 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.022 0.929 . . . . 0.0 111.246 177.567 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 52.2 mt -90.29 153.13 20.69 Favored 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.6 0.76 . . . . 0.0 112.752 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 60.4 ttm-85 -88.27 -17.49 30.61 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 125.613 1.565 . . . . 0.0 113.469 -178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -156.16 168.64 26.65 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.269 1.828 . . . . 0.0 111.459 -178.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 13.1 t80 -87.89 119.29 70.46 Favored Pre-proline 0 CA--C 1.547 0.839 0 CA-C-O 118.75 -0.643 . . . . 0.0 111.706 -178.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.29 -23.69 3.4 Favored 'Trans proline' 0 C--N 1.353 0.809 0 C-N-CA 123.125 2.55 . . . . 0.0 114.369 -169.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 81.8 m -78.68 126.96 31.45 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 119.13 0.877 . . . . 0.0 111.551 -176.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -79.78 -22.63 63.67 Favored Glycine 0 N--CA 1.474 1.199 0 C-N-CA 124.031 0.824 . . . . 0.0 114.428 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 21.1 t-20 -118.93 126.49 51.89 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.021 1.328 . . . . 0.0 109.645 173.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -135.23 164.42 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.248 0 C-N-CA 125.743 1.617 . . . . 0.0 110.835 -172.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 62.1 t-20 -134.25 134.43 41.97 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 125.037 1.335 . . . . 0.0 109.69 174.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 70.4 m-85 -99.01 113.12 25.14 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.587 1.155 . . . . 0.0 110.941 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.29 -85.58 1.44 Allowed Glycine 0 N--CA 1.467 0.761 0 C-N-CA 124.678 1.132 . . . . 0.0 111.377 179.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -81.55 90.53 6.27 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.226 1.011 . . . . 0.0 110.635 -179.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 -155.55 132.91 10.96 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.87 1.668 . . . . 0.0 108.653 -176.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -91.36 153.77 19.67 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 123.67 0.788 . . . . 0.0 110.979 177.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.253 1.238 0 C-N-CA 126.139 1.776 . . . . 0.0 113.744 -178.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.476 0 N-CA-C 111.522 -0.631 . . . . 0.0 111.522 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 45.9 m -147.56 127.41 13.52 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.65 1.18 . . . . 0.0 110.878 -175.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 72.5 m -151.7 159.05 44.14 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 125.338 1.455 . . . . 0.0 111.624 -173.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.91 -167.99 40.83 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.442 1.496 . . . . 0.0 112.546 179.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.4 p -146.6 140.96 26.45 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.652 0.781 . . . . 0.0 112.725 178.107 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 52.7 p -164.56 158.47 18.13 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 125.584 1.554 . . . . 0.0 111.154 -174.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -135.4 -143.22 4.7 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.937 1.256 . . . . 0.0 113.13 -177.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.3 pp -69.96 162.91 27.16 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.595 1.158 . . . . 0.0 112.473 175.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -121.18 131.57 54.32 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.019 1.328 . . . . 0.0 110.35 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 1.5 mmp_? -120.38 20.56 11.89 Favored 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.276 1.831 . . . . 0.0 112.751 -177.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -157.93 159.08 36.15 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.543 1.937 . . . . 0.0 111.002 -175.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.6 t -79.32 37.47 0.33 Allowed 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 125.451 1.5 . . . . 0.0 114.293 -168.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.0 p -147.23 133.55 9.69 Favored Pre-proline 0 CA--C 1.547 0.847 0 C-N-CA 126.167 1.787 . . . . 0.0 110.596 -178.851 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_endo -81.99 148.68 15.42 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.161 2.574 . . . . 0.0 111.806 -177.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -64.92 2.67 0.67 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 125.298 1.439 . . . . 0.0 114.334 174.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -130.09 11.83 5.56 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 126.119 1.768 . . . . 0.0 114.248 -173.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -53.75 135.51 55.36 Favored Pre-proline 0 CA--C 1.556 1.188 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -174.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -66.61 -16.75 51.64 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 C-N-CA 123.184 2.589 . . . . 0.0 115.302 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 46.0 p -125.26 -15.7 6.16 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 119.916 1.234 . . . . 0.0 114.316 176.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.4 mppt? -103.47 125.1 49.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 119.223 0.92 . . . . 0.0 112.119 172.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -123.29 106.71 10.94 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 126.12 1.768 . . . . 0.0 109.092 -176.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 41.1 mttp -69.2 132.49 46.6 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.618 -0.676 . . . . 0.0 109.982 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 5.6 m -140.8 158.95 23.95 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.722 1.209 . . . . 0.0 112.245 -169.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.8 m -134.18 118.37 17.58 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.679 1.192 . . . . 0.0 108.214 174.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 14.5 t-20 -66.92 131.37 45.74 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 176.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 13.5 m -125.53 154.49 34.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.663 0.785 . . . . 0.0 112.557 -177.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.5 p-10 -81.95 -169.6 2.45 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.747 1.219 . . . . 0.0 113.884 176.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.8 p-10 -64.6 -29.13 70.14 Favored 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 125.658 1.583 . . . . 0.0 115.001 177.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -91.09 -24.22 20.08 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.137 0.575 . . . . 0.0 112.026 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 117.49 14.98 6.63 Favored Glycine 0 C--N 1.341 0.818 0 C-N-CA 126.109 1.814 . . . . 0.0 112.459 171.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.57 140.48 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 126.681 1.992 . . . . 0.0 109.43 -172.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -82.24 125.93 31.52 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 125.878 1.671 . . . . 0.0 110.652 -171.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 55.2 mt -109.88 -53.22 2.69 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 123.973 0.909 . . . . 0.0 112.141 -171.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.2 140.33 7.93 Favored Glycine 0 N--CA 1.469 0.848 0 C-N-CA 124.814 1.197 . . . . 0.0 113.574 -179.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 29.8 p -92.18 143.64 26.22 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.194 1.398 . . . . 0.0 112.344 177.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -157.1 171.73 34.53 Favored Glycine 0 CA--C 1.528 0.895 0 C-N-CA 125.312 1.434 . . . . 0.0 113.028 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 19.8 t -118.62 119.47 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.525 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 171.198 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 48.9 tpp -83.16 133.62 35.02 Favored 'General case' 0 CA--C 1.529 0.152 0 C-N-CA 124.144 0.977 . . . . 0.0 109.444 173.838 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 50.0 tt0 -126.99 130.54 50.24 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 125.217 1.407 . . . . 0.0 108.877 177.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -103.69 119.17 38.37 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.329 1.852 . . . . 0.0 107.72 176.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -122.61 173.68 7.55 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.974 1.309 . . . . 0.0 110.307 177.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mt-30 -74.69 2.54 9.71 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.386 -0.821 . . . . 0.0 113.209 172.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 77.8 p -107.39 -45.93 3.97 Favored 'General case' 0 N--CA 1.473 0.689 0 O-C-N 120.897 -1.127 . . . . 0.0 113.473 175.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -172.78 173.49 3.85 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 124.776 1.231 . . . . 0.0 113.09 -174.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.4 mt -83.67 136.77 34.07 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 121.511 -0.743 . . . . 0.0 109.523 168.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 66.9 t -134.74 130.4 52.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 C-N-CA 124.216 1.006 . . . . 0.0 111.632 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.7 mt -100.19 126.7 46.49 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 125.442 1.497 . . . . 0.0 110.19 168.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 99.4 m-70 -102.74 133.83 47.13 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 127.283 2.233 . . . . 0.0 110.979 172.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 6.1 mp -133.79 150.74 51.45 Favored 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 125.196 1.398 . . . . 0.0 111.322 -177.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 77.4 t60 -74.13 118.34 16.97 Favored 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 123.763 0.825 . . . . 0.0 111.506 169.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 24.2 mmt85 56.67 27.13 12.11 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 125.532 1.533 . . . . 0.0 114.714 173.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 90.4 mmt-85 -137.77 153.03 49.75 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 126.325 1.85 . . . . 0.0 110.591 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -61.33 136.94 58.21 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.239 1.415 . . . . 0.0 111.684 -177.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.1 153.01 43.69 Favored 'General case' 0 CA--C 1.543 0.689 0 C-N-CA 124.04 0.936 . . . . 0.0 112.004 177.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 40.1 t -131.62 135.52 58.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.987 0 C-N-CA 124.217 1.007 . . . . 0.0 110.226 -175.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -134.24 152.08 51.63 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.833 0.853 . . . . 0.0 113.222 -173.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.8 m-90 -142.1 119.81 7.43 Favored Pre-proline 0 CA--C 1.544 0.747 0 C-N-CA 125.293 1.437 . . . . 0.0 111.794 177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.22 145.93 68.01 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.957 2.438 . . . . 0.0 110.463 174.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 52.0 m-85 -60.11 -22.88 63.33 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -179.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 30.8 tp -63.4 -41.61 98.74 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 126.659 1.984 . . . . 0.0 113.11 173.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 3.4 p -73.32 -14.23 61.26 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 83.5 mt -84.65 84.57 7.63 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.9 1.28 . . . . 0.0 110.715 -176.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 17.4 tpp85 -63.22 -30.77 71.85 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 123.986 0.914 . . . . 0.0 112.503 177.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.408 ' CG ' HG21 ' B' ' 12' ' ' VAL . 38.7 ttp-105 -156.0 128.51 7.75 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.499 1.52 . . . . 0.0 109.834 -170.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -138.92 104.84 5.16 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.535 1.534 . . . . 0.0 111.008 -175.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.18 167.14 12.24 Favored Glycine 0 CA--C 1.524 0.622 0 C-N-CA 125.088 1.328 . . . . 0.0 113.984 -168.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -144.92 159.0 43.61 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.248 1.019 . . . . 0.0 112.593 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 41.1 t0 -151.36 177.52 10.19 Favored 'General case' 0 CA--C 1.547 0.84 0 C-N-CA 127.1 2.16 . . . . 0.0 109.588 176.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 32.9 m -60.91 -12.22 10.46 Favored 'General case' 0 N--CA 1.477 0.909 0 N-CA-C 115.956 1.835 . . . . 0.0 115.956 -172.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 25.6 p-10 -154.58 11.52 0.38 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 125.549 1.54 . . . . 0.0 114.248 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -140.52 131.99 26.93 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.415 1.486 . . . . 0.0 110.491 -168.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -122.98 133.64 54.36 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.985 1.714 . . . . 0.0 109.016 171.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 30.3 t -152.6 152.93 32.4 Favored 'General case' 0 C--O 1.236 0.353 0 O-C-N 121.131 -0.981 . . . . 0.0 112.052 -174.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -149.71 151.35 33.52 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.351 1.06 . . . . 0.0 111.839 -175.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -104.84 126.59 52.07 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 124.606 1.162 . . . . 0.0 109.106 171.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.4 p -124.44 122.58 38.04 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.449 1.1 . . . . 0.0 111.294 -174.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -65.25 162.39 40.22 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 124.816 1.198 . . . . 0.0 114.856 -171.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 39.6 ptt180 -57.74 -16.98 12.81 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 116.19 1.922 . . . . 0.0 116.19 -169.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.28 -23.04 61.89 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.526 1.53 . . . . 0.0 114.925 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 19.3 p -73.24 173.43 9.49 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 113.878 1.066 . . . . 0.0 113.878 -171.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 55.6 tt0 -54.56 -39.77 68.09 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 125.76 1.624 . . . . 0.0 113.341 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 37.7 p -91.06 -20.91 21.55 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 125.469 1.508 . . . . 0.0 113.874 -172.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.26 175.1 48.9 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 125.156 1.36 . . . . 0.0 112.169 -170.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 16.6 tp60 -66.31 130.56 43.63 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.848 1.259 . . . . 0.0 111.86 -175.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.54 -179.35 41.55 Favored Glycine 0 CA--C 1.526 0.739 0 C-N-CA 124.776 1.179 . . . . 0.0 113.13 179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 80.6 mt -116.46 131.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.561 0 C-N-CA 125.708 1.603 . . . . 0.0 108.616 175.602 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -125.56 121.13 32.74 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.742 1.217 . . . . 0.0 110.238 -174.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -117.2 136.36 53.11 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 124.856 1.263 . . . . 0.0 112.943 -171.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -137.07 129.2 29.47 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.077 0.951 . . . . 0.0 111.717 -170.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 32.8 mttp -75.63 135.22 40.48 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.639 1.176 . . . . 0.0 111.988 174.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 24.6 p -171.0 151.28 3.25 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 126.505 1.922 . . . . 0.0 112.146 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 49.3 m -73.58 -37.31 65.52 Favored 'General case' 0 N--CA 1.481 1.088 0 O-C-N 121.156 -0.965 . . . . 0.0 112.111 171.922 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 45.5 mtm180 -85.96 20.48 2.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 125.099 1.36 . . . . 0.0 114.216 -171.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.07 -42.48 50.0 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.159 1.384 . . . . 0.0 114.145 -177.11 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 60.6 tt0 -69.57 -36.71 76.53 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.795 0.838 . . . . 0.0 112.716 176.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -68.39 -34.11 75.45 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.464 -0.772 . . . . 0.0 111.743 175.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.33 -47.65 92.05 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 118.678 0.672 . . . . 0.0 109.871 169.497 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -59.68 -43.33 94.07 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 124.658 1.183 . . . . 0.0 112.109 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.5 m-20 -67.01 -34.67 78.24 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.792 1.237 . . . . 0.0 112.841 177.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.9 tt -78.7 -41.12 31.91 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.789 0.722 . . . . 0.0 110.367 177.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 11.5 mt -53.01 -51.46 61.59 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.26 1.024 . . . . 0.0 112.911 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 18.6 pt20 -62.19 -24.12 67.02 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -76.3 -28.18 56.87 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 123.662 0.785 . . . . 0.0 112.544 174.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.3 mt -84.25 -35.0 23.71 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 124.258 1.023 . . . . 0.0 111.199 175.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 5.6 mmt -55.88 -35.68 66.77 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 123.993 0.917 . . . . 0.0 112.348 169.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 21.5 pt20 -89.92 -8.47 51.75 Favored 'General case' 0 CA--C 1.546 0.826 0 N-CA-C 114.308 1.225 . . . . 0.0 114.308 174.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 15.7 t -83.21 -24.1 32.54 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.431 1.092 . . . . 0.0 112.549 173.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -72.78 164.61 26.3 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.18 1.392 . . . . 0.0 111.405 170.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 24.3 m -81.87 106.91 14.17 Favored 'General case' 0 N--CA 1.473 0.721 0 O-C-N 121.03 -1.043 . . . . 0.0 111.281 179.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.5 mp -97.57 -51.03 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.168 0 C-N-CA 123.778 0.831 . . . . 0.0 111.242 -179.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 9.9 m120 -69.73 -3.0 13.46 Favored 'General case' 0 CA--C 1.548 0.891 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -169.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 34.7 m -80.5 -11.66 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.845 0 C-N-CA 125.485 1.514 . . . . 0.0 113.013 169.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 58.7 mtt -77.6 147.09 35.81 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 124.004 0.921 . . . . 0.0 111.233 171.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 66.51 59.24 0.63 Allowed 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.963 1.705 . . . . 0.0 110.36 -174.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -55.68 154.73 12.36 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 127.574 2.349 . . . . 0.0 113.917 -176.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -63.01 171.91 5.57 Favored 'Trans proline' 0 C--N 1.354 0.854 0 C-N-CA 123.943 3.096 . . . . 0.0 111.54 169.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 14.5 p -50.69 124.94 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.004 0 C-N-CA 124.601 1.16 . . . . 0.0 113.021 -177.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 36.0 mm -111.17 163.5 7.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 125.966 1.706 . . . . 0.0 109.986 179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.4 pt -66.69 -13.5 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 C-N-CA 124.972 1.309 . . . . 0.0 114.233 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 54.3 m -92.85 140.77 29.16 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 126.768 2.027 . . . . 0.0 109.324 177.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 32.6 ptt180 -49.88 134.87 20.59 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 124.194 0.998 . . . . 0.0 113.194 -177.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 9.4 p30 -161.04 151.08 17.43 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 125.69 1.596 . . . . 0.0 111.225 -175.136 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 15.4 t -99.68 139.81 34.79 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.152 0.981 . . . . 0.0 111.699 -177.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -106.2 124.32 36.22 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 124.78 1.232 . . . . 0.0 111.902 -176.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -75.55 161.38 37.23 Favored 'Trans proline' 0 C--N 1.351 0.682 0 C-N-CA 123.295 2.664 . . . . 0.0 111.146 177.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -78.77 40.96 0.4 Allowed 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 125.186 1.394 . . . . 0.0 112.581 176.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -85.68 117.05 24.32 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 125.887 1.675 . . . . 0.0 110.254 -178.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -163.45 155.53 17.68 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.088 1.755 . . . . 0.0 111.793 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -163.34 152.49 14.62 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 126.624 1.97 . . . . 0.0 109.815 179.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -134.44 164.9 40.69 Favored Pre-proline 0 CA--C 1.545 0.762 0 C-N-CA 125.037 1.335 . . . . 0.0 111.532 -175.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -86.86 158.92 8.88 Favored 'Trans proline' 0 N--CA 1.453 -0.87 0 C-N-CA 121.979 1.786 . . . . 0.0 112.406 176.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 71.3 ttt-85 -152.98 143.78 22.85 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 125.368 1.467 . . . . 0.0 110.514 -177.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -153.76 149.57 21.31 Favored Pre-proline 0 CA--C 1.548 0.87 0 C-N-CA 125.5 1.52 . . . . 0.0 111.279 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -74.4 171.05 18.85 Favored 'Trans proline' 0 CA--C 1.539 0.727 0 C-N-CA 123.676 2.918 . . . . 0.0 111.234 175.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 46.0 tp60 -129.35 128.57 23.21 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.44 1.096 . . . . 0.0 109.172 178.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.01 142.91 28.39 Favored 'Trans proline' 0 CA--C 1.543 0.973 0 C-N-CA 123.165 2.577 . . . . 0.0 111.745 -174.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -79.6 166.67 21.63 Favored 'Trans proline' 0 CA--C 1.537 0.658 0 C-N-CA 124.0 3.133 . . . . 0.0 112.001 177.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -65.46 140.19 58.58 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.151 0.98 . . . . 0.0 112.002 174.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -76.31 -66.45 0.8 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.009 0.923 . . . . 0.0 112.967 -174.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 4.3 mp -147.02 151.26 36.66 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.526 1.93 . . . . 0.0 111.083 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -96.39 -155.44 30.75 Favored Glycine 0 CA--C 1.535 1.318 0 C-N-CA 125.399 1.476 . . . . 0.0 112.484 169.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -156.16 153.76 29.77 Favored 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.178 1.391 . . . . 0.0 112.165 178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.3 m -141.35 144.6 34.64 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.621 1.568 . . . . 0.0 110.279 -169.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 27.1 m -141.92 171.43 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 C-N-CA 126.577 1.951 . . . . 0.0 110.691 -178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.8 t -152.03 159.54 43.69 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.96 1.304 . . . . 0.0 111.568 -178.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 17.0 t . . . . . 0 C--O 1.255 1.344 0 C-N-CA 126.37 1.868 . . . . 0.0 111.577 -173.915 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 97.5 mt . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 110.255 -0.276 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -86.25 128.39 34.9 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 123.663 0.785 . . . . 0.0 111.893 178.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -91.58 112.5 24.45 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 124.122 0.969 . . . . 0.0 109.495 176.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 78.2 mt -78.76 155.26 29.41 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.531 0.681 . . . . 0.0 112.283 175.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 88.6 mtm180 -91.72 -26.78 18.45 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 125.079 1.352 . . . . 0.0 113.077 177.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 93.1 m-70 -140.68 158.61 43.73 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.418 1.887 . . . . 0.0 111.663 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 6.2 t80 -84.3 128.45 62.01 Favored Pre-proline 0 CA--C 1.55 0.943 0 C-N-CA 123.434 0.694 . . . . 0.0 112.008 -172.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -86.1 -10.97 6.64 Favored 'Trans proline' 0 C--N 1.353 0.801 0 C-N-CA 123.431 2.754 . . . . 0.0 114.475 -174.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 90.0 m -102.27 126.31 49.23 Favored 'General case' 0 CA--C 1.54 0.562 0 C-N-CA 124.306 1.043 . . . . 0.0 111.511 -176.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -81.49 -31.19 34.27 Favored Glycine 0 CA--C 1.533 1.174 0 C-N-CA 124.11 0.862 . . . . 0.0 114.2 -176.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -108.35 131.32 54.87 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.842 1.257 . . . . 0.0 110.494 175.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.408 HG21 ' CG ' ' A' ' 64' ' ' ARG . 7.2 p -165.18 140.61 1.24 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.638 1.175 . . . . 0.0 111.885 -173.124 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -102.49 147.65 26.49 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 127.571 2.348 . . . . 0.0 111.716 169.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -104.86 113.54 27.2 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.01 1.324 . . . . 0.0 109.125 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -86.95 -64.95 1.4 Allowed Glycine 0 N--CA 1.474 1.188 0 C-N-CA 124.134 0.873 . . . . 0.0 112.171 -169.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 16.4 m-85 -75.94 166.49 23.43 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 124.186 0.994 . . . . 0.0 111.368 171.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -54.18 146.23 15.57 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.304 1.042 . . . . 0.0 112.799 -177.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 1.7 pm0 -134.15 131.31 38.52 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.366 1.067 . . . . 0.0 111.193 -171.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 . . . . . 0 C--O 1.253 1.257 0 C-N-CA 127.607 2.363 . . . . 0.0 110.585 -170.562 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.562 0 N-CA-C 111.572 -0.611 . . . . 0.0 111.572 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.2 t -163.75 167.66 20.67 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 125.507 1.523 . . . . 0.0 110.761 179.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.4 t -165.64 170.59 14.01 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 125.577 1.551 . . . . 0.0 111.66 -176.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 119.7 120.56 2.86 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 126.106 1.812 . . . . 0.0 112.581 178.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 27.0 t -167.08 118.04 0.9 Allowed 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.885 1.674 . . . . 0.0 109.79 177.242 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 8.6 t -169.46 161.43 9.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 125.578 1.551 . . . . 0.0 110.986 -176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -84.59 145.66 22.03 Favored Glycine 0 CA--C 1.531 1.084 0 C-N-CA 124.438 1.018 . . . . 0.0 112.07 174.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.52 -33.74 73.27 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 123.976 0.91 . . . . 0.0 112.21 -179.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -175.12 143.07 0.67 Allowed 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 127.742 2.417 . . . . 0.0 110.452 174.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 67.5 mtp180 -144.78 63.44 1.3 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 125.865 1.666 . . . . 0.0 110.179 -177.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -150.07 166.04 30.93 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.867 2.067 . . . . 0.0 109.999 -172.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.9 p -65.54 139.3 58.46 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.486 0.714 . . . . 0.0 111.234 169.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.8 p -58.36 118.52 28.39 Favored Pre-proline 0 N--CA 1.479 0.98 0 C-N-CA 124.038 0.935 . . . . 0.0 112.543 -169.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -75.18 159.81 40.29 Favored 'Trans proline' 0 C--N 1.352 0.735 0 C-N-CA 123.016 2.477 . . . . 0.0 110.686 172.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -60.0 -22.12 62.17 Favored 'General case' 0 CA--C 1.54 0.587 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 175.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 43.9 p30 -116.16 19.85 14.68 Favored 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.226 1.81 . . . . 0.0 113.848 -171.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -51.66 143.45 20.89 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.381 1.072 . . . . 0.0 112.556 176.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.07 -8.74 22.72 Favored 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 123.114 2.542 . . . . 0.0 114.933 -176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.0 p -129.89 -17.36 3.56 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 114.744 1.387 . . . . 0.0 114.744 174.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -117.64 131.84 56.59 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.468 1.107 . . . . 0.0 111.796 176.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -127.46 113.13 15.77 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.907 1.283 . . . . 0.0 108.748 -177.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.8 mttm -69.84 131.77 44.99 Favored 'General case' 0 CA--C 1.543 0.692 0 O-C-N 121.507 -0.746 . . . . 0.0 110.326 176.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.7 m -141.09 165.41 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 C-N-CA 125.814 1.645 . . . . 0.0 111.795 -169.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 42.3 m -134.27 122.78 23.2 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.507 1.123 . . . . 0.0 109.087 171.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -64.4 127.83 33.18 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.291 1.037 . . . . 0.0 109.797 174.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 36.0 m -126.64 155.97 37.37 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 123.494 0.718 . . . . 0.0 112.707 -179.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.41 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.1 p-10 -88.12 -167.85 2.02 Favored 'General case' 0 CA--C 1.552 1.02 0 C-N-CA 124.608 1.163 . . . . 0.0 113.6 178.579 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -62.91 -30.3 71.43 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.944 1.298 . . . . 0.0 114.335 174.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -84.09 -10.38 57.86 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 118.944 0.793 . . . . 0.0 113.072 175.327 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.85 16.47 75.02 Favored Glycine 0 CA--C 1.532 1.126 0 CA-C-O 118.365 -1.242 . . . . 0.0 113.953 -172.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.41 HG22 ' OD1' ' A' ' 27' ' ' ASP . 16.4 m -78.25 149.89 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.777 0 CA-C-N 119.599 1.699 . . . . 0.0 111.202 173.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 55.6 mt-10 -89.52 122.56 32.81 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.857 -1.065 . . . . 0.0 110.922 -170.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 31.3 mt -103.41 -51.7 3.16 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 123.602 0.761 . . . . 0.0 111.68 -174.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.93 144.76 12.16 Favored Glycine 0 N--CA 1.473 1.145 0 C-N-CA 124.874 1.226 . . . . 0.0 114.277 177.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.3 p -89.8 150.36 22.29 Favored 'General case' 0 CA--C 1.545 0.769 0 C-N-CA 125.08 1.352 . . . . 0.0 112.55 176.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -161.4 171.06 37.32 Favored Glycine 0 C--N 1.341 0.825 0 C-N-CA 124.147 0.88 . . . . 0.0 115.094 -174.383 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 49.0 t -114.79 120.54 64.71 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 169.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 58.0 tpp -86.59 133.1 33.74 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.929 0.891 . . . . 0.0 109.118 170.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -130.14 130.17 44.43 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 125.034 1.334 . . . . 0.0 109.008 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.8 mp -107.75 115.04 29.42 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 126.312 1.845 . . . . 0.0 107.004 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 20.0 p -110.57 174.55 5.81 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.237 1.015 . . . . 0.0 109.869 175.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 53.4 mt-30 -75.88 13.76 0.79 Allowed 'General case' 0 CA--C 1.549 0.915 0 O-C-N 121.244 -0.91 . . . . 0.0 112.186 169.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.4 t -125.74 -41.51 1.98 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.557 1.543 . . . . 0.0 112.626 -178.031 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -170.43 171.06 6.72 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 121.144 -0.972 . . . . 0.0 113.442 -174.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.3 mt -87.36 133.88 33.65 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 165.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 19.2 t -133.36 134.2 57.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 123.797 0.839 . . . . 0.0 111.177 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.2 mt -101.03 129.36 46.86 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 124.461 1.104 . . . . 0.0 109.836 168.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -109.98 118.74 37.25 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.429 1.892 . . . . 0.0 109.734 171.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 33.2 mt -119.09 144.6 46.51 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.824 1.249 . . . . 0.0 110.329 -175.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -69.52 112.35 5.98 Favored 'General case' 0 CA--C 1.547 0.855 0 O-C-N 121.458 -0.776 . . . . 0.0 112.011 176.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 28.8 mmt180 59.92 8.15 1.33 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.952 2.101 . . . . 0.0 116.05 174.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -96.4 -86.16 0.32 Allowed 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.78 1.232 . . . . 0.0 110.63 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -158.53 172.55 18.11 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 127.665 2.386 . . . . 0.0 109.154 -171.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -128.1 138.26 52.46 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.257 1.023 . . . . 0.0 108.889 167.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 17.1 t -134.94 131.63 53.11 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 C-N-CA 123.154 0.582 . . . . 0.0 110.961 -168.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 76.6 mtt85 -121.71 142.07 50.54 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.478 1.511 . . . . 0.0 112.118 -169.132 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 26.9 m-90 -138.16 112.14 8.69 Favored Pre-proline 0 CA--C 1.543 0.69 0 C-N-CA 124.912 1.285 . . . . 0.0 110.703 174.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.19 146.69 82.23 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 122.489 2.126 . . . . 0.0 110.475 173.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -57.79 -28.13 63.73 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 178.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 5.0 mt -65.35 -25.23 67.5 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 125.762 1.625 . . . . 0.0 114.131 173.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 2.4 p -93.25 -8.17 43.0 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 176.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 80.9 mt -79.48 115.2 18.97 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.885 0.874 . . . . 0.0 109.958 179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -76.26 -37.91 56.96 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 123.361 0.665 . . . . 0.0 111.698 176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 29.5 ptt180 -161.19 163.24 31.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.663 1.585 . . . . 0.0 111.947 175.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 35.6 p90 -150.44 138.03 19.78 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 126.368 1.867 . . . . 0.0 109.012 -177.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -145.17 -178.94 21.13 Favored Glycine 0 N--CA 1.461 0.353 0 C-N-CA 123.859 0.742 . . . . 0.0 113.052 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 11.4 p90 -152.11 166.23 32.29 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 124.031 0.932 . . . . 0.0 112.916 -174.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 45.3 t0 -157.19 -178.41 7.34 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 127.309 2.244 . . . . 0.0 109.319 178.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.2 p -63.6 -21.65 66.47 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 114.939 1.459 . . . . 0.0 114.939 -178.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -152.68 10.65 0.49 Allowed 'General case' 0 CA--C 1.549 0.915 0 N-CA-C 114.187 1.181 . . . . 0.0 114.187 -179.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -133.65 127.7 33.52 Favored 'General case' 0 CA--C 1.537 0.463 0 O-C-N 120.747 -1.221 . . . . 0.0 110.463 -172.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -118.85 135.7 54.41 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.902 1.681 . . . . 0.0 109.678 173.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.9 t -153.75 156.67 38.19 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.656 1.182 . . . . 0.0 112.676 -176.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 44.5 p90 -149.08 151.96 35.36 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 126.031 1.733 . . . . 0.0 111.518 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -111.68 132.84 54.33 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 125.024 1.33 . . . . 0.0 111.139 -178.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.3 m -132.89 147.85 52.29 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.765 1.226 . . . . 0.0 112.368 -172.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.65 174.51 41.31 Favored Glycine 0 CA--C 1.534 1.264 0 C-N-CA 124.787 1.184 . . . . 0.0 114.387 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -11.97 18.16 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 -174.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 17.4 ptm180 -87.93 -15.45 36.57 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 -174.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 16.7 p -80.08 179.21 7.74 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 123.949 0.899 . . . . 0.0 112.901 -178.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -57.71 -37.88 74.26 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.843 1.257 . . . . 0.0 113.336 -177.623 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 27.9 p -95.13 -20.88 18.91 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 125.426 1.49 . . . . 0.0 114.082 -176.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.89 -167.46 42.12 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 125.371 1.462 . . . . 0.0 112.586 -173.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 20.6 pt20 -67.08 132.28 47.53 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 123.62 0.768 . . . . 0.0 112.118 -173.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 158.05 -175.58 35.24 Favored Glycine 0 C--N 1.339 0.708 0 CA-C-O 122.506 1.059 . . . . 0.0 113.454 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 60.8 mt -124.22 139.19 51.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 126.009 1.724 . . . . 0.0 108.432 177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 89.2 m-85 -132.11 127.72 36.62 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.842 1.257 . . . . 0.0 109.859 -174.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -128.04 145.59 50.94 Favored 'General case' 0 C--O 1.241 0.633 0 C-N-CA 124.322 1.049 . . . . 0.0 113.594 -169.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 39.0 m-85 -139.88 128.03 22.41 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-N 114.607 -1.178 . . . . 0.0 111.337 -168.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 78.1 mttt -66.38 127.68 33.22 Favored 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 169.271 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 43.8 t -164.92 114.85 1.12 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.189 1.396 . . . . 0.0 111.377 -167.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.0 m -71.19 -2.15 14.96 Favored 'General case' 0 N--CA 1.479 0.978 0 N-CA-C 114.385 1.254 . . . . 0.0 114.385 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 6.5 ptp85 -133.34 22.12 4.04 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 127.443 2.297 . . . . 0.0 112.427 -170.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.63 -36.07 33.52 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.388 1.475 . . . . 0.0 113.841 177.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 55.4 tt0 -67.86 -37.87 82.39 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.639 0.775 . . . . 0.0 112.762 175.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 13.6 mm-40 -69.47 -33.68 73.24 Favored 'General case' 0 N--CA 1.471 0.62 0 O-C-N 121.434 -0.791 . . . . 0.0 111.665 175.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 87.1 mt -64.79 -47.53 88.16 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 O-C-N 121.782 -0.574 . . . . 0.0 110.163 169.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -58.29 -42.9 87.64 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.025 1.33 . . . . 0.0 111.808 177.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 87.3 m-20 -66.31 -33.22 75.24 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.738 1.215 . . . . 0.0 113.044 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.2 tt -81.41 -42.52 20.28 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 119.082 0.855 . . . . 0.0 110.282 178.017 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 16.7 mt -49.69 -54.49 18.42 Favored 'General case' 0 N--CA 1.467 0.395 0 C-N-CA 124.152 0.981 . . . . 0.0 112.273 178.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 17.0 pt20 -59.48 -28.76 67.31 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 -177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.99 -19.44 61.21 Favored 'General case' 0 CA--C 1.542 0.654 0 C-N-CA 124.918 1.287 . . . . 0.0 113.045 175.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 61.1 mt -95.36 -35.83 11.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.434 1.493 . . . . 0.0 111.025 173.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 47.9 mmm -66.95 -34.19 77.23 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 124.617 1.167 . . . . 0.0 111.962 177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -73.12 -9.45 58.73 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.928 1.084 . . . . 0.0 113.928 174.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 12.4 t -69.98 -21.29 63.25 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 119.121 0.873 . . . . 0.0 112.434 176.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 63.0 t30 57.83 41.62 24.56 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 125.576 1.55 . . . . 0.0 112.479 172.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 61.9 p -27.4 109.41 0.04 OUTLIER 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 128.486 2.714 . . . . 0.0 115.57 -170.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 5.1 mp -88.32 87.09 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.568 0 O-C-N 121.361 -0.837 . . . . 0.0 109.295 -172.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 62.62 21.51 12.74 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 126.14 1.776 . . . . 0.0 114.347 169.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.14 66.62 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 127.408 2.283 . . . . 0.0 111.205 -172.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 75.8 mtm 71.48 15.3 6.18 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 129.374 3.07 . . . . 0.0 115.506 175.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -103.33 -168.16 1.47 Allowed 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 126.558 1.943 . . . . 0.0 109.174 167.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -56.48 154.26 17.5 Favored Pre-proline 0 CA--C 1.548 0.878 0 O-C-N 121.164 -0.96 . . . . 0.0 112.498 172.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -67.26 140.26 52.79 Favored 'Trans proline' 0 N--CA 1.456 -0.678 0 C-N-CA 122.43 2.087 . . . . 0.0 110.594 170.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 95.9 t -125.17 122.67 63.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 C-N-CA 125.703 1.601 . . . . 0.0 109.025 -177.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 3.6 mp -80.76 115.91 24.13 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.586 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 175.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 42.6 mt -79.06 -53.77 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 C-N-CA 122.984 0.513 . . . . 0.0 110.535 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . 0.275 5.9 t 49.7 28.78 2.8 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 127.888 2.475 . . . . 0.0 114.778 179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.9 ptm180 -156.7 159.0 37.96 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 125.901 1.681 . . . . 0.0 112.091 177.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 26.8 m-20 -155.91 151.63 27.28 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.637 1.975 . . . . 0.0 109.856 172.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 31.5 m -158.4 148.56 19.95 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 125.795 1.638 . . . . 0.0 110.282 -177.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -136.59 123.92 14.36 Favored Pre-proline 0 CA--C 1.55 0.959 0 C-N-CA 124.811 1.244 . . . . 0.0 111.136 -178.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -75.99 166.45 27.96 Favored 'Trans proline' 0 C--N 1.351 0.691 0 C-N-CA 123.363 2.709 . . . . 0.0 111.34 178.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -155.38 158.03 38.01 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 125.097 1.359 . . . . 0.0 111.408 179.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -160.28 167.2 28.04 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.945 1.698 . . . . 0.0 111.274 -174.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.3 pp -155.52 158.75 38.99 Favored 'General case' 0 N--CA 1.468 0.438 0 C-N-CA 125.529 1.531 . . . . 0.0 111.475 -179.338 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -149.18 142.46 25.12 Favored 'General case' 0 N--CA 1.469 0.499 0 C-N-CA 126.198 1.799 . . . . 0.0 110.037 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.4 pp -95.38 145.7 30.01 Favored Pre-proline 0 CA--C 1.548 0.885 0 C-N-CA 124.3 1.04 . . . . 0.0 111.937 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -80.24 168.44 18.54 Favored 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 123.659 2.906 . . . . 0.0 111.574 178.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -147.96 144.18 27.82 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 124.96 1.304 . . . . 0.0 110.833 -179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -149.37 146.64 21.41 Favored Pre-proline 0 CA--C 1.549 0.912 0 C-N-CA 125.576 1.55 . . . . 0.0 111.352 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_endo -77.99 176.18 10.29 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 124.04 3.16 . . . . 0.0 111.636 178.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -126.3 127.9 24.52 Favored Pre-proline 0 CA--C 1.545 0.784 0 C-N-CA 125.049 1.34 . . . . 0.0 108.78 176.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -77.06 150.91 30.12 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.458 2.772 . . . . 0.0 111.833 -174.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -75.84 162.97 34.26 Favored 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.89 3.06 . . . . 0.0 111.743 176.523 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -157.94 138.7 13.04 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 124.736 1.214 . . . . 0.0 111.833 -179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -157.94 141.93 15.81 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.942 1.697 . . . . 0.0 110.782 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 3.3 tt -162.15 124.3 2.82 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 125.28 1.432 . . . . 0.0 109.547 -173.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -135.05 164.14 24.79 Favored Glycine 0 N--CA 1.474 1.191 0 C-N-CA 125.271 1.415 . . . . 0.0 113.814 178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -151.12 151.62 32.22 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 126.012 1.725 . . . . 0.0 112.366 179.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 51.6 m -84.67 142.24 30.03 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 125.777 1.631 . . . . 0.0 109.714 173.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 25.9 m -142.15 153.24 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 C-N-CA 125.776 1.631 . . . . 0.0 111.052 -178.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 7.3 t -80.83 154.55 27.07 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.205 1.002 . . . . 0.0 112.677 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 33.6 p . . . . . 0 C--O 1.253 1.253 0 C-N-CA 126.007 1.723 . . . . 0.0 113.688 -178.368 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.492 1.648 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -143.34 122.42 12.88 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.294 1.038 . . . . 0.0 111.225 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -76.72 124.76 28.16 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.579 1.151 . . . . 0.0 111.269 177.791 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 64.6 mt -94.47 154.13 17.58 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.007 0.923 . . . . 0.0 112.662 172.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 59.4 ttt85 -84.07 -21.2 31.62 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 125.447 1.499 . . . . 0.0 113.367 179.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -153.66 166.03 34.08 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.088 1.755 . . . . 0.0 111.751 -175.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -87.9 118.53 69.79 Favored Pre-proline 0 CA--C 1.547 0.849 0 CA-C-O 118.719 -0.658 . . . . 0.0 111.223 -177.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -82.0 -16.24 8.8 Favored 'Trans proline' 0 CA--C 1.538 0.684 0 C-N-CA 123.541 2.827 . . . . 0.0 114.076 -170.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 82.2 m -89.43 123.63 33.74 Favored 'General case' 0 CA--C 1.541 0.602 0 C-N-CA 123.866 0.867 . . . . 0.0 110.749 179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.06 -35.19 35.29 Favored Glycine 0 N--CA 1.473 1.128 0 C-N-CA 123.836 0.732 . . . . 0.0 113.043 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -97.05 120.31 37.17 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.55 1.14 . . . . 0.0 109.72 171.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -131.06 160.97 41.86 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 C-N-CA 125.792 1.637 . . . . 0.0 110.447 -178.093 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 56.7 t-20 -122.14 124.89 44.94 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 124.537 1.135 . . . . 0.0 109.103 170.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -86.07 110.7 19.7 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.965 0.906 . . . . 0.0 110.709 179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -92.73 -124.32 3.52 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 125.235 1.397 . . . . 0.0 112.124 -178.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 67.0 m-85 -57.8 121.94 11.68 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 124.799 1.24 . . . . 0.0 111.852 179.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -96.64 3.68 52.36 Favored 'General case' 0 N--CA 1.474 0.766 0 C-N-CA 124.543 1.137 . . . . 0.0 113.474 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -76.93 159.06 30.28 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 124.154 0.982 . . . . 0.0 110.381 169.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 9.3 tp60 . . . . . 0 C--O 1.252 1.187 0 CA-C-O 116.924 -1.512 . . . . 0.0 112.117 178.567 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.51 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 4.4 t -95.35 -6.41 41.16 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 113.601 0.963 . . . . 0.0 113.601 -176.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 67.7 m -124.01 128.01 48.75 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 125.263 1.425 . . . . 0.0 110.927 178.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -105.12 -133.05 7.57 Favored Glycine 0 CA--C 1.532 1.103 0 C-N-CA 125.415 1.483 . . . . 0.0 112.504 179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.5 t -159.08 -163.39 1.21 Allowed 'General case' 0 CA--C 1.548 0.89 0 C-N-CA 125.985 1.714 . . . . 0.0 110.415 179.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.2 t -150.57 140.13 21.56 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 120.667 -1.271 . . . . 0.0 111.667 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 88.06 123.63 1.99 Allowed Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.323 1.44 . . . . 0.0 111.707 -173.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.5 mp -93.75 149.71 21.01 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 124.688 1.195 . . . . 0.0 110.745 -179.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -145.38 -43.76 0.22 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.841 1.256 . . . . 0.0 112.281 -179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -69.15 151.72 46.01 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.804 0.841 . . . . 0.0 111.471 169.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -149.3 -62.12 0.22 Allowed 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.025 1.33 . . . . 0.0 110.987 178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 72.5 p -114.91 -2.56 12.85 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 179.735 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 56.7 t -151.83 120.41 3.36 Favored Pre-proline 0 N--CA 1.478 0.941 0 C-N-CA 128.021 2.528 . . . . 0.0 108.421 178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -77.61 152.1 29.26 Favored 'Trans proline' 0 N--CA 1.457 -0.641 0 C-N-CA 123.061 2.507 . . . . 0.0 110.612 172.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -68.72 -2.59 9.63 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 124.86 1.264 . . . . 0.0 114.091 174.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -134.04 31.12 3.59 Favored 'General case' 0 CA--C 1.552 1.05 0 C-N-CA 126.451 1.9 . . . . 0.0 111.967 -174.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 43.2 t-80 -62.75 150.5 86.85 Favored Pre-proline 0 CA--C 1.56 1.349 0 C-N-CA 124.866 1.266 . . . . 0.0 112.983 173.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -71.0 -20.19 29.29 Favored 'Trans proline' 0 CA--C 1.542 0.92 0 C-N-CA 123.062 2.508 . . . . 0.0 115.668 178.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.3 p -126.14 -22.18 4.14 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 120.296 1.407 . . . . 0.0 114.303 179.974 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -97.11 144.74 26.67 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 124.231 1.012 . . . . 0.0 110.279 169.277 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -140.1 119.0 12.53 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.286 1.435 . . . . 0.0 108.207 178.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.44 135.24 45.71 Favored 'General case' 0 N--CA 1.469 0.496 0 O-C-N 121.382 -0.823 . . . . 0.0 109.932 174.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 35.5 m -140.83 169.34 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.966 1.306 . . . . 0.0 111.287 -171.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.403 ' HA ' ' HA ' ' A' ' 35' ' ' SER . 20.9 m -142.67 122.39 13.41 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 124.67 1.188 . . . . 0.0 107.849 172.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -68.9 134.14 49.2 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 123.364 0.666 . . . . 0.0 110.462 177.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 35.1 m -128.71 155.87 40.86 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.521 1.128 . . . . 0.0 113.816 -173.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.444 ' CG ' HG22 ' A' ' 31' ' ' VAL . 2.9 p-10 -84.62 -170.17 2.98 Favored 'General case' 0 CA--C 1.549 0.931 0 N-CA-C 114.104 1.149 . . . . 0.0 114.104 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -63.41 -21.62 66.4 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 125.689 1.596 . . . . 0.0 115.112 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -102.34 -0.5 32.63 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 125.323 1.449 . . . . 0.0 112.403 178.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 81.94 14.57 77.09 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-O 118.0 -1.444 . . . . 0.0 114.389 -178.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.444 HG22 ' CG ' ' A' ' 27' ' ' ASP . 3.3 m -73.58 144.87 12.2 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 119.901 1.85 . . . . 0.0 110.674 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -87.27 120.87 29.0 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 124.796 1.238 . . . . 0.0 110.143 -171.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 39.9 mt -105.75 -52.68 2.77 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 123.721 0.809 . . . . 0.0 112.048 -169.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -152.14 137.16 5.78 Favored Glycine 0 CA--C 1.523 0.56 0 C-N-CA 125.185 1.374 . . . . 0.0 111.958 175.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.403 ' HA ' ' HA ' ' A' ' 24' ' ' THR . 46.7 t -83.69 149.43 26.5 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-O 121.941 0.876 . . . . 0.0 111.555 176.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -145.54 167.44 27.55 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 125.991 1.758 . . . . 0.0 113.378 -172.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 82.1 t -120.43 120.24 62.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 169.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 53.9 ttm -97.13 143.03 28.34 Favored 'General case' 0 C--N 1.33 -0.24 0 C-N-CA 125.152 1.381 . . . . 0.0 109.388 177.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 tt0 -145.4 126.53 14.69 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.835 1.254 . . . . 0.0 109.695 -170.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -111.48 132.17 54.68 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 125.123 1.369 . . . . 0.0 108.688 -177.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.7 p -135.31 171.09 14.94 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 124.937 1.295 . . . . 0.0 110.385 179.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 77.9 mt-30 -68.32 0.05 4.28 Favored 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 170.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.2 t -103.2 -52.18 3.08 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 119.596 1.089 . . . . 0.0 112.399 178.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -175.18 173.1 2.65 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.724 1.21 . . . . 0.0 112.844 -170.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mt -86.18 118.44 25.63 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.06 1.344 . . . . 0.0 110.38 175.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 40.8 t -109.77 140.03 30.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 124.864 1.266 . . . . 0.0 109.178 -179.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -139.69 124.9 18.87 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 125.513 1.525 . . . . 0.0 109.84 -174.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -115.48 137.26 52.24 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 126.561 1.944 . . . . 0.0 110.417 -172.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.0 mp -136.61 169.61 17.43 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.842 1.257 . . . . 0.0 112.617 -170.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -101.02 -6.9 23.8 Favored 'General case' 0 CA--C 1.554 1.116 0 C-N-CA 125.71 1.604 . . . . 0.0 115.145 -179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -134.98 13.44 3.61 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 126.685 1.994 . . . . 0.0 113.193 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 21.1 tpp180 -160.14 153.93 22.77 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 126.598 1.959 . . . . 0.0 109.819 -173.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 46.1 mm-40 -65.01 164.67 12.34 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 124.231 1.012 . . . . 0.0 110.913 173.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.79 134.84 57.41 Favored 'General case' 0 CA--C 1.543 0.688 0 O-C-N 121.259 -0.901 . . . . 0.0 111.15 175.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 23.5 t -116.08 130.82 70.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.587 0 C-N-CA 125.198 1.399 . . . . 0.0 109.881 -175.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.98 141.28 52.03 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 124.637 1.175 . . . . 0.0 111.406 -171.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 10.7 m-90 -134.91 112.81 11.48 Favored Pre-proline 0 CA--C 1.547 0.827 0 C-N-CA 124.702 1.201 . . . . 0.0 111.587 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -68.21 138.3 42.82 Favored 'Trans proline' 0 C--N 1.351 0.671 0 C-N-CA 122.991 2.46 . . . . 0.0 110.755 176.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 27.8 m-85 -60.21 -28.47 68.01 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -176.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 34.2 tp -65.85 -35.27 80.2 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.93 1.692 . . . . 0.0 112.453 176.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.0 m -92.22 3.27 55.69 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 92.9 mt -80.57 120.52 24.63 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 123.964 0.905 . . . . 0.0 109.053 169.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -83.2 -23.31 32.89 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 113.298 0.851 . . . . 0.0 113.298 179.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.505 ' HG3' HG21 ' B' ' 12' ' ' VAL . 30.0 ttp-105 -176.24 140.51 0.39 Allowed 'General case' 0 N--CA 1.476 0.859 0 C-N-CA 126.909 2.084 . . . . 0.0 109.478 -169.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -144.89 106.46 4.24 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 125.214 1.405 . . . . 0.0 111.54 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.14 165.16 12.01 Favored Glycine 0 N--CA 1.468 0.77 0 C-N-CA 126.231 1.872 . . . . 0.0 113.522 -169.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 2.9 p90 -150.85 154.08 36.57 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 124.7 1.2 . . . . 0.0 113.218 -172.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -144.97 -168.99 3.08 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 125.855 1.662 . . . . 0.0 110.064 175.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.5 t -68.75 -11.67 60.59 Favored 'General case' 0 CA--C 1.55 0.963 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -173.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 38.1 p-10 -158.19 10.87 0.17 Allowed 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 125.926 1.69 . . . . 0.0 114.225 -178.478 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -140.61 133.24 28.75 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.614 1.566 . . . . 0.0 110.549 -168.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 54.0 t80 -126.29 138.43 53.6 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.93 1.692 . . . . 0.0 109.18 172.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 23.2 t -153.06 152.95 31.92 Favored 'General case' 0 N--CA 1.467 0.399 0 O-C-N 120.888 -1.133 . . . . 0.0 112.277 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -153.69 158.11 40.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.045 0.938 . . . . 0.0 112.545 -176.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -115.07 135.2 54.46 Favored 'General case' 0 N--CA 1.468 0.448 0 C-N-CA 125.723 1.609 . . . . 0.0 111.231 178.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 62.6 p -120.31 152.46 37.78 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 125.233 1.413 . . . . 0.0 112.905 -178.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -89.44 164.44 31.87 Favored Glycine 0 CA--C 1.534 1.266 0 C-N-CA 124.984 1.278 . . . . 0.0 113.27 176.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 33.1 ptt180 -66.07 -9.26 29.18 Favored 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 116.598 2.073 . . . . 0.0 116.598 -171.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 25.8 ptt-85 -84.83 -11.49 55.57 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 126.566 1.946 . . . . 0.0 115.231 178.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 35.3 m -68.01 173.5 4.52 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 124.841 1.256 . . . . 0.0 112.965 177.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 48.3 tt0 -57.25 -40.74 78.26 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.061 0.944 . . . . 0.0 112.285 173.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 32.3 p -90.03 -23.01 21.58 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 125.442 1.497 . . . . 0.0 113.161 178.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.29 -146.74 27.93 Favored Glycine 0 CA--C 1.529 0.943 0 C-N-CA 124.992 1.282 . . . . 0.0 111.612 -171.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -75.23 141.37 43.55 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.254 1.022 . . . . 0.0 112.206 -175.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 157.79 171.02 23.25 Favored Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.295 0.95 . . . . 0.0 113.245 175.449 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 71.6 mt -118.33 133.33 65.48 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 125.391 1.476 . . . . 0.0 108.346 169.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -130.39 123.81 30.72 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.496 1.118 . . . . 0.0 110.606 -175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -116.03 139.96 49.75 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 124.638 1.175 . . . . 0.0 112.368 -175.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -136.84 124.11 21.86 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.787 1.235 . . . . 0.0 111.258 -172.406 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 46.7 mttm -70.0 133.87 47.7 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.245 0.618 . . . . 0.0 110.791 169.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 36.7 t -166.49 130.64 2.08 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 126.123 1.769 . . . . 0.0 110.517 -175.246 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.5 t -66.97 -26.5 66.85 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 121.614 -0.678 . . . . 0.0 112.812 178.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -109.32 29.21 7.75 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.206 1.802 . . . . 0.0 113.226 -175.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.16 -35.49 26.28 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 125.064 1.346 . . . . 0.0 114.185 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 52.1 tt0 -70.24 -37.97 75.08 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 123.767 0.827 . . . . 0.0 113.024 175.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -65.94 -36.83 84.42 Favored 'General case' 0 N--CA 1.471 0.602 0 O-C-N 121.387 -0.821 . . . . 0.0 111.424 173.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 92.3 mt -61.91 -48.94 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 C-N-CA 122.915 0.486 . . . . 0.0 110.124 171.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -61.38 -38.42 86.98 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 124.265 1.026 . . . . 0.0 112.93 179.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -73.36 -35.46 65.96 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 123.743 0.817 . . . . 0.0 112.427 175.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 32.2 tp -76.18 -34.53 59.33 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.074 0.852 . . . . 0.0 112.008 177.777 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 18.7 mt -54.64 -59.61 4.47 Favored 'General case' 0 N--CA 1.467 0.399 0 CA-C-N 119.156 0.889 . . . . 0.0 111.45 176.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -60.8 -24.49 65.85 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 -179.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -71.82 -29.4 64.38 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 123.977 0.911 . . . . 0.0 113.374 173.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 73.6 mt -96.32 -35.5 11.2 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.384 1.473 . . . . 0.0 111.434 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 99.5 mtp -69.89 -29.91 67.23 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.339 1.456 . . . . 0.0 112.594 179.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 23.3 pt20 -71.26 -13.16 61.81 Favored 'General case' 0 CA--C 1.543 0.701 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 172.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 21.8 t -77.1 -25.26 52.01 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 123.719 0.808 . . . . 0.0 112.509 178.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 54.65 37.13 27.61 Favored 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.647 1.579 . . . . 0.0 112.521 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 33.2 t -52.26 125.7 16.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 125.093 1.357 . . . . 0.0 113.427 -169.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.0 mp -100.05 67.18 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 C-N-CA 124.785 1.234 . . . . 0.0 108.568 -178.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 38.85 53.46 1.99 Allowed 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 127.592 2.357 . . . . 0.0 113.991 -179.469 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 18.2 m -75.95 4.92 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.243 0 N-CA-C 114.802 1.408 . . . . 0.0 114.802 -169.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 62.1 mtt -137.5 152.44 49.51 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.54 1.936 . . . . 0.0 110.282 177.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -65.93 154.28 39.76 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 123.049 0.54 . . . . 0.0 111.785 172.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -143.72 151.83 54.47 Favored Pre-proline 0 CA--C 1.545 0.752 0 C-N-CA 125.177 1.391 . . . . 0.0 111.379 -172.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -70.63 146.63 55.28 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.12 2.547 . . . . 0.0 110.993 178.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 94.3 t -114.9 123.99 71.12 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.756 0 C-N-CA 125.245 1.418 . . . . 0.0 108.169 177.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 33.2 mm -77.43 150.89 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-O 122.366 1.079 . . . . 0.0 111.582 -172.81 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.4 pt -77.82 7.75 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 125.633 1.573 . . . . 0.0 114.185 -176.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 13.4 t -162.56 153.72 17.61 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 128.037 2.535 . . . . 0.0 109.336 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -159.28 120.99 3.36 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.942 1.297 . . . . 0.0 109.935 -174.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -100.47 156.47 17.26 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.988 1.315 . . . . 0.0 112.65 -176.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 63.2 p -86.07 169.23 13.35 Favored 'General case' 0 CA--C 1.544 0.728 0 C-N-CA 124.839 1.255 . . . . 0.0 112.275 170.625 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 70.9 t60 -113.9 91.27 21.46 Favored Pre-proline 0 CA--C 1.552 1.045 0 C-N-CA 124.434 1.094 . . . . 0.0 110.855 172.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -77.09 173.98 13.55 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 123.576 2.851 . . . . 0.0 111.418 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -149.34 152.27 35.54 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 125.032 1.333 . . . . 0.0 111.482 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.54 125.17 26.37 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 124.353 1.061 . . . . 0.0 110.935 -179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 3.7 pp -78.45 149.68 33.18 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.015 0.926 . . . . 0.0 111.422 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 25.8 t0 -161.15 149.51 15.91 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.282 1.433 . . . . 0.0 110.83 -175.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 4.1 pp -86.88 144.17 36.41 Favored Pre-proline 0 CA--C 1.545 0.751 0 C-N-CA 124.449 1.1 . . . . 0.0 111.441 -178.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -77.69 153.5 30.03 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.165 2.577 . . . . 0.0 111.323 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -68.72 169.98 10.27 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.978 0.894 . . . . 0.0 112.773 175.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -102.78 145.81 31.24 Favored Pre-proline 0 CA--C 1.547 0.858 0 C-N-CA 125.237 1.415 . . . . 0.0 111.828 -179.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -72.65 168.88 23.29 Favored 'Trans proline' 0 CA--C 1.537 0.639 0 C-N-CA 123.65 2.9 . . . . 0.0 111.642 179.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -65.96 141.29 97.49 Favored Pre-proline 0 CA--C 1.548 0.869 0 C-N-CA 123.261 0.624 . . . . 0.0 110.868 176.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.13 149.56 58.41 Favored 'Trans proline' 0 CA--C 1.543 0.937 0 C-N-CA 123.327 2.685 . . . . 0.0 111.893 -174.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_endo -73.66 151.29 46.49 Favored 'Trans proline' 0 C--N 1.349 0.596 0 C-N-CA 123.778 2.985 . . . . 0.0 111.761 -179.725 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -77.41 163.76 26.09 Favored 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 124.169 0.987 . . . . 0.0 112.231 176.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -129.59 168.38 16.51 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.964 1.705 . . . . 0.0 111.979 -178.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 48.1 tp -151.33 137.63 18.47 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 125.046 1.338 . . . . 0.0 110.858 -173.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.49 -154.8 30.55 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.087 1.327 . . . . 0.0 113.312 177.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 19.5 t80 -157.32 175.63 13.76 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.721 1.609 . . . . 0.0 111.527 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -144.62 -177.75 5.66 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.424 1.49 . . . . 0.0 111.755 -175.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.1 p -118.66 136.55 55.51 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 C-N-CA 126.363 1.865 . . . . 0.0 110.935 -171.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 56.5 p -101.11 167.91 9.92 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.909 1.683 . . . . 0.0 113.237 -176.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 9.5 t . . . . . 0 C--O 1.255 1.352 0 C-N-CA 125.139 1.375 . . . . 0.0 112.54 179.134 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 24.3 mt . . . . . 0 N--CA 1.493 1.689 0 N-CA-C 109.928 -0.397 . . . . 0.0 109.928 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -65.28 124.85 23.3 Favored 'General case' 0 CA--C 1.539 0.554 0 O-C-N 121.604 -0.685 . . . . 0.0 110.954 175.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -87.15 116.84 25.5 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 124.334 1.054 . . . . 0.0 111.169 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 32.9 mt -81.74 159.42 23.87 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.632 0.773 . . . . 0.0 112.711 177.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 4.4 mmp_? -100.66 -12.13 19.43 Favored 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 125.526 1.53 . . . . 0.0 113.614 179.447 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 30.6 p80 -163.11 167.14 22.67 Favored 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 127.087 2.155 . . . . 0.0 110.906 -178.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 7.0 t80 -84.8 126.49 68.23 Favored Pre-proline 0 CA--C 1.549 0.91 0 CA-C-O 118.668 -0.682 . . . . 0.0 110.874 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -81.15 -2.37 11.66 Favored 'Trans proline' 0 CA--C 1.541 0.856 0 C-N-CA 123.836 3.024 . . . . 0.0 113.956 -174.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 22.2 t -115.0 135.51 54.14 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.052 1.341 . . . . 0.0 112.088 -171.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.55 -5.81 56.68 Favored Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.485 1.517 . . . . 0.0 115.656 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 71.1 m-80 -137.07 111.73 8.73 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 119.043 1.422 . . . . 0.0 110.278 -177.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . 0.505 HG21 ' HG3' ' A' ' 64' ' ' ARG . 7.5 p -147.75 138.18 17.15 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 N-CA-C 113.286 0.847 . . . . 0.0 113.286 -168.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 31.5 t30 -99.3 117.24 33.3 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 126.875 2.07 . . . . 0.0 109.921 174.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 83.6 m-85 -87.38 113.81 23.42 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.709 0.804 . . . . 0.0 110.466 174.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -82.15 -70.98 1.32 Allowed Glycine 0 N--CA 1.471 1.003 0 C-N-CA 124.409 1.004 . . . . 0.0 112.314 -174.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -80.14 114.24 18.9 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.05 0.94 . . . . 0.0 110.238 177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -164.6 157.29 16.77 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.989 1.716 . . . . 0.0 109.246 -173.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 72.0 tp60 -67.65 134.03 50.4 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 121.687 -0.633 . . . . 0.0 110.881 176.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 C--O 1.257 1.449 0 C-N-CA 126.64 1.976 . . . . 0.0 111.686 -178.111 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.476 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 8.7 m -164.38 142.63 7.01 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 126.265 1.826 . . . . 0.0 110.52 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 68.5 m -149.61 153.71 37.5 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.123 1.369 . . . . 0.0 111.589 -174.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 136.23 166.61 10.97 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 125.419 1.485 . . . . 0.0 113.675 178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 52.1 p -163.58 140.1 6.94 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.103 1.361 . . . . 0.0 111.721 -178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 78.3 p -172.4 166.29 5.76 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 125.997 1.719 . . . . 0.0 111.455 -175.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 176.14 110.93 0.27 Allowed Glycine 0 C--N 1.341 0.845 0 C-N-CA 124.103 0.859 . . . . 0.0 112.839 174.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -168.69 162.33 11.7 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.807 2.043 . . . . 0.0 111.433 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 68.5 m-80 -145.17 154.09 42.05 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.978 1.711 . . . . 0.0 111.007 179.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 34.0 ptt-85 -161.87 147.6 13.43 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 125.557 1.543 . . . . 0.0 111.769 -173.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -114.38 7.67 16.41 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 125.655 1.582 . . . . 0.0 113.237 -172.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 51.6 p -150.52 143.34 24.64 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.794 1.638 . . . . 0.0 110.654 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -65.2 122.61 80.77 Favored Pre-proline 0 N--CA 1.478 0.927 0 C-N-CA 123.513 0.725 . . . . 0.0 111.071 -176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -81.82 163.9 18.27 Favored 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 123.464 2.776 . . . . 0.0 111.022 174.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -70.73 3.4 3.22 Favored 'General case' 0 CA--C 1.55 0.953 0 C-N-CA 125.389 1.476 . . . . 0.0 113.021 173.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 -135.62 16.12 3.37 Favored 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 126.459 1.903 . . . . 0.0 113.494 -169.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 45.1 t-80 -59.62 147.21 78.37 Favored Pre-proline 0 CA--C 1.559 1.312 0 O-C-N 120.893 -1.129 . . . . 0.0 113.005 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -72.13 -21.58 23.6 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 122.723 2.282 . . . . 0.0 115.111 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 73.0 p -126.03 -20.83 4.46 Favored 'General case' 0 N--CA 1.484 1.225 0 CA-C-N 120.691 1.587 . . . . 0.0 114.265 -178.683 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 11.3 mptt -97.32 146.41 25.18 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 123.97 0.908 . . . . 0.0 109.145 168.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -141.6 113.5 7.9 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.59 -0.892 . . . . 0.0 108.59 178.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -67.85 134.4 50.83 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 121.565 -0.709 . . . . 0.0 110.12 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 m -143.28 164.44 15.83 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 124.82 1.248 . . . . 0.0 111.616 -171.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 23.4 m -139.97 123.08 16.8 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.502 1.121 . . . . 0.0 108.59 172.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.1 t-20 -65.58 130.46 43.37 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.301 0.641 . . . . 0.0 109.722 175.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 34.9 m -128.32 156.46 40.54 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 124.327 1.051 . . . . 0.0 112.235 -176.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.408 ' OD1' HG22 ' A' ' 31' ' ' VAL . 1.4 p-10 -85.15 -166.37 1.48 Allowed 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 124.52 1.128 . . . . 0.0 113.126 176.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -70.11 -26.14 63.83 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.543 1.137 . . . . 0.0 113.695 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.51 -18.6 44.51 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.761 1.224 . . . . 0.0 112.591 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 87.06 17.39 59.43 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 125.021 1.296 . . . . 0.0 114.295 -173.163 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.408 HG22 ' OD1' ' A' ' 27' ' ' ASP . 16.7 m -76.77 150.25 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.861 0 CA-C-N 119.68 1.74 . . . . 0.0 111.183 171.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -88.26 125.78 34.83 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.657 1.183 . . . . 0.0 110.849 -172.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 48.1 mt -108.15 -49.57 3.18 Favored 'General case' 0 N--CA 1.469 0.501 0 C-N-CA 124.184 0.994 . . . . 0.0 111.767 -171.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -154.57 137.21 5.56 Favored Glycine 0 N--CA 1.471 0.986 0 C-N-CA 124.919 1.247 . . . . 0.0 113.654 175.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.0 p -84.03 148.87 26.62 Favored 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.755 1.222 . . . . 0.0 112.356 176.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -158.06 170.82 34.95 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.794 1.188 . . . . 0.0 114.637 -174.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 98.8 t -119.19 120.57 64.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 169.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 51.7 tpp -84.91 141.3 30.48 Favored 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.661 1.184 . . . . 0.0 109.576 171.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 55.2 tt0 -140.26 130.31 24.85 Favored 'General case' 0 C--O 1.239 0.531 0 C-N-CA 125.071 1.348 . . . . 0.0 109.494 -178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.0 mp -102.95 133.73 47.58 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 126.093 1.757 . . . . 0.0 108.133 175.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.3 p -133.89 173.87 11.08 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 125.091 1.357 . . . . 0.0 110.272 179.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -78.45 6.08 9.29 Favored 'General case' 0 CA--C 1.546 0.823 0 O-C-N 121.435 -0.791 . . . . 0.0 112.577 169.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.6 t -107.4 -49.31 3.28 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 124.537 1.135 . . . . 0.0 112.268 176.469 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 18.1 pt-20 -174.27 172.45 3.25 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.563 1.545 . . . . 0.0 112.484 -169.293 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.6 mt -85.04 139.79 31.5 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.17 0.988 . . . . 0.0 109.215 168.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 58.5 t -134.44 130.95 54.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 C-N-CA 124.051 0.94 . . . . 0.0 111.217 179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.0 mt -103.76 130.53 51.29 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 125.654 1.581 . . . . 0.0 110.026 168.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -111.42 124.09 51.55 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 126.868 2.067 . . . . 0.0 110.177 172.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 5.3 mp -127.72 163.39 24.41 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 125.194 1.398 . . . . 0.0 111.838 -179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 13.0 t-80 -89.25 -62.86 1.39 Allowed 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 124.679 1.191 . . . . 0.0 113.087 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.8 mtt-85 -80.05 -13.58 59.19 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 114.036 1.125 . . . . 0.0 114.036 -178.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 66.2 mtt85 -120.58 162.39 19.71 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 126.713 2.005 . . . . 0.0 111.511 179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pm0 -65.28 159.42 23.86 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 125.691 1.596 . . . . 0.0 112.618 174.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.27 145.7 41.67 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.385 0.674 . . . . 0.0 111.26 170.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 12.4 t -138.0 143.69 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.217 0 C-N-CA 124.615 1.166 . . . . 0.0 109.842 -170.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -134.83 153.4 52.05 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 123.725 0.81 . . . . 0.0 113.003 -169.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 29.0 m-90 -142.85 115.31 6.07 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 124.922 1.289 . . . . 0.0 111.348 176.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -70.02 150.26 66.36 Favored 'Trans proline' 0 C--N 1.35 0.65 0 C-N-CA 122.628 2.219 . . . . 0.0 110.468 174.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -61.59 -22.98 65.69 Favored 'General case' 0 CA--C 1.542 0.668 0 N-CA-C 113.749 1.018 . . . . 0.0 113.749 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -64.27 -38.84 92.47 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 126.112 1.765 . . . . 0.0 112.605 171.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 76.2 m -90.2 -9.56 47.65 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 115.099 1.518 . . . . 0.0 115.099 -174.566 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 94.6 mt -69.43 127.94 34.78 Favored 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 123.572 0.749 . . . . 0.0 109.393 169.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 60.0 mtp85 -96.86 -26.8 14.96 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.574 0.75 . . . . 0.0 112.83 174.54 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 9.6 ptp85 -164.09 158.68 19.61 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 125.797 1.639 . . . . 0.0 111.454 169.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 46.6 p90 -144.84 107.96 4.55 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 124.773 1.229 . . . . 0.0 110.502 -174.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.28 174.74 16.01 Favored Glycine 0 N--CA 1.463 0.478 0 C-N-CA 124.092 0.853 . . . . 0.0 113.531 -169.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 7.8 p90 -144.49 155.93 43.94 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.118 0.967 . . . . 0.0 111.384 172.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -150.37 -178.76 6.71 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.34 1.456 . . . . 0.0 110.532 171.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 t -62.59 120.44 11.15 Favored 'General case' 0 CA--C 1.539 0.529 0 O-C-N 121.359 -0.838 . . . . 0.0 110.774 175.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 53.33 15.16 0.62 Allowed 'General case' 0 CA--C 1.555 1.137 0 C-N-CA 127.81 2.444 . . . . 0.0 116.561 -174.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -136.11 126.25 26.26 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.893 1.277 . . . . 0.0 111.627 -169.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 75.9 t80 -118.13 134.42 55.01 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.693 1.597 . . . . 0.0 110.063 172.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 29.5 t -153.46 154.91 35.3 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.532 1.133 . . . . 0.0 112.385 -177.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 51.9 p90 -148.69 150.61 33.49 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.423 1.489 . . . . 0.0 111.298 -177.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -112.78 130.32 56.12 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 124.997 1.319 . . . . 0.0 109.747 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 67.0 m -130.87 136.02 48.25 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 124.501 1.12 . . . . 0.0 110.594 -178.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -75.74 175.54 51.73 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 123.783 0.706 . . . . 0.0 113.225 -176.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.22 -16.0 7.2 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 179.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -74.01 -18.38 60.86 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 128.028 2.531 . . . . 0.0 115.883 179.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 13.5 p -80.21 178.84 7.99 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 113.88 1.067 . . . . 0.0 113.88 -176.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 56.1 tt0 -61.1 -44.4 97.41 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 124.832 1.253 . . . . 0.0 113.019 -178.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 21.3 p -90.39 -18.81 24.8 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.73 1.212 . . . . 0.0 114.093 -172.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 95.07 179.79 36.97 Favored Glycine 0 CA--C 1.53 0.996 0 C-N-CA 125.609 1.576 . . . . 0.0 112.391 -175.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -66.94 126.51 29.32 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.273 0.629 . . . . 0.0 111.941 -169.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 168.85 178.42 40.34 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 122.448 1.026 . . . . 0.0 114.264 177.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 65.3 mt -116.1 133.74 61.64 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.51 0 C-N-CA 125.968 1.707 . . . . 0.0 108.542 173.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -126.31 123.51 38.22 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 125.136 1.374 . . . . 0.0 109.627 -175.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -124.1 143.01 50.71 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 122.297 1.046 . . . . 0.0 113.317 -170.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 42.7 m-85 -140.82 129.8 23.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-N 114.553 -1.203 . . . . 0.0 111.555 -169.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 74.6 mttt -68.07 131.26 45.11 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 122.81 0.444 . . . . 0.0 109.946 169.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 45.9 t -160.38 131.35 5.62 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.217 1.407 . . . . 0.0 111.377 -169.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 8.8 t -71.32 -21.98 61.99 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 178.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 89.6 mtt-85 -122.04 30.3 6.68 Favored 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.236 1.814 . . . . 0.0 113.4 -170.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -50.66 -42.59 56.71 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -69.16 -36.64 77.62 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.248 0.619 . . . . 0.0 112.537 177.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 11.9 mm-40 -66.6 -35.77 80.99 Favored 'General case' 0 N--CA 1.468 0.47 0 O-C-N 121.602 -0.686 . . . . 0.0 111.588 175.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 81.8 mt -63.64 -47.73 89.97 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 CA-C-N 118.534 0.606 . . . . 0.0 110.163 170.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -58.3 -38.47 77.1 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 124.333 1.053 . . . . 0.0 112.332 176.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -74.31 -29.0 61.43 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.237 1.415 . . . . 0.0 113.529 177.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 tt -84.22 -40.03 18.59 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 119.298 0.954 . . . . 0.0 110.464 177.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 17.8 mt -53.01 -54.01 41.53 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 123.737 0.815 . . . . 0.0 112.286 176.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -60.09 -25.08 65.14 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.67 -20.37 53.83 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 124.96 1.304 . . . . 0.0 113.05 175.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 76.9 mt -91.59 -38.93 12.18 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 125.128 1.371 . . . . 0.0 110.873 171.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 60.6 mmm -66.29 -34.89 79.02 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.842 1.257 . . . . 0.0 112.421 -179.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -74.01 -6.93 50.42 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 178.015 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 20.6 t -65.41 -25.06 67.37 Favored 'General case' 0 CA--C 1.547 0.853 0 CA-C-N 119.067 0.849 . . . . 0.0 112.334 173.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 60.04 22.81 11.99 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 126.24 1.816 . . . . 0.0 113.368 175.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 47.5 m -17.51 91.75 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 130.528 3.531 . . . . 0.0 116.563 -170.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 28.6 mt -80.1 -51.21 16.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 C-N-CA 123.601 0.76 . . . . 0.0 111.389 -171.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -122.06 6.51 9.77 Favored 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.107 1.363 . . . . 0.0 113.363 -177.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 16.2 t -84.33 -21.59 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 126.079 1.752 . . . . 0.0 112.09 -177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 36.5 mmt -78.58 156.92 28.91 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 124.609 1.164 . . . . 0.0 112.313 176.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 13.3 pt-20 -75.99 -173.64 2.4 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 124.532 1.133 . . . . 0.0 112.289 172.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -55.4 144.17 53.55 Favored Pre-proline 0 CA--C 1.552 1.041 0 C-N-CA 124.413 1.085 . . . . 0.0 112.947 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -69.2 150.11 71.23 Favored 'Trans proline' 0 C--N 1.352 0.737 0 C-N-CA 123.495 2.797 . . . . 0.0 112.094 -173.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 90.2 t -103.83 122.97 57.2 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 125.033 1.333 . . . . 0.0 109.275 -178.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 2.4 mp -88.5 126.8 41.72 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.567 0 C-N-CA 124.379 1.072 . . . . 0.0 108.578 177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 74.5 mt -116.97 142.05 32.53 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.85 0 C-N-CA 125.53 1.532 . . . . 0.0 108.83 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 11.1 t -59.35 152.17 21.85 Favored 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 125.027 1.331 . . . . 0.0 112.285 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -55.82 133.41 51.14 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 124.048 0.939 . . . . 0.0 111.377 179.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -118.78 150.63 39.48 Favored 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 125.655 1.582 . . . . 0.0 111.45 -178.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 24.5 p -84.85 158.11 20.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.891 1.276 . . . . 0.0 114.021 -170.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -141.28 146.29 42.05 Favored Pre-proline 0 CA--C 1.554 1.096 0 C-N-CA 125.621 1.569 . . . . 0.0 111.996 -177.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -76.74 162.98 32.09 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 123.909 3.073 . . . . 0.0 112.205 -177.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.07 150.39 24.9 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 124.52 1.128 . . . . 0.0 112.223 174.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -77.35 135.12 38.34 Favored 'General case' 0 CA--C 1.543 0.673 0 C-N-CA 124.565 1.146 . . . . 0.0 111.219 177.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -91.33 123.97 35.17 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 125.004 1.322 . . . . 0.0 109.661 -179.298 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -72.97 152.14 41.5 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 125.332 1.453 . . . . 0.0 113.968 -176.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 3.9 pp -89.97 146.3 34.87 Favored Pre-proline 0 CA--C 1.546 0.79 0 C-N-CA 124.587 1.155 . . . . 0.0 111.829 -178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_endo -79.91 146.08 18.2 Favored 'Trans proline' 0 C--N 1.351 0.679 0 C-N-CA 123.281 2.654 . . . . 0.0 111.766 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -71.88 156.5 39.21 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 123.816 0.847 . . . . 0.0 113.177 177.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -97.95 153.56 38.13 Favored Pre-proline 0 CA--C 1.552 1.023 0 C-N-CA 125.262 1.425 . . . . 0.0 111.839 175.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -73.4 177.09 8.36 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.94 3.093 . . . . 0.0 111.643 174.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -124.5 151.51 67.16 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 125.131 1.372 . . . . 0.0 111.179 -178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -71.52 152.21 59.73 Favored 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 123.163 2.576 . . . . 0.0 111.892 -177.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -75.71 154.97 39.62 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 123.841 3.028 . . . . 0.0 112.12 -178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 26.9 m120 -81.17 165.47 21.51 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.471 1.108 . . . . 0.0 112.622 175.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -122.99 176.1 6.21 Favored 'General case' 0 CA--C 1.546 0.794 0 C-N-CA 125.953 1.701 . . . . 0.0 111.598 176.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 42.2 tp -143.49 135.5 26.72 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 125.043 1.337 . . . . 0.0 110.846 -175.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -90.09 -138.92 7.41 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 125.296 1.427 . . . . 0.0 112.261 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 9.2 p90 -154.83 166.82 32.28 Favored 'General case' 0 CA--C 1.545 0.759 0 C-N-CA 124.849 1.259 . . . . 0.0 112.603 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 38.7 p -125.84 163.63 22.5 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 126.35 1.86 . . . . 0.0 110.453 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.7 p -150.72 142.63 16.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.775 0 C-N-CA 124.826 1.251 . . . . 0.0 110.41 -171.686 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 75.2 m -71.96 144.1 49.01 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.991 0.916 . . . . 0.0 113.034 -175.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 10.0 t . . . . . 0 C--O 1.253 1.283 0 C-N-CA 125.36 1.464 . . . . 0.0 112.277 177.904 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 82.7 mt . . . . . 0 N--CA 1.492 1.647 0 N-CA-C 110.324 -0.25 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 23.6 t80 -73.31 129.47 38.08 Favored 'General case' 0 CA--C 1.538 0.519 0 O-C-N 122.049 -0.407 . . . . 0.0 110.767 170.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . 0.436 ' H ' ' HD3' ' B' ' 3' ' ' ARG . 0.0 OUTLIER -100.26 127.35 46.57 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.189 1.396 . . . . 0.0 111.327 179.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 44.7 mt -93.58 153.62 18.31 Favored 'General case' 0 N--CA 1.471 0.581 0 N-CA-C 113.644 0.979 . . . . 0.0 113.644 -179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 68.4 mtp85 -80.48 -36.7 33.05 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 125.818 1.647 . . . . 0.0 112.598 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 87.2 m-70 -138.99 160.98 38.47 Favored 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 126.492 1.917 . . . . 0.0 111.764 -179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -78.61 121.33 83.48 Favored Pre-proline 0 CA--C 1.549 0.92 0 CA-C-O 118.7 -0.667 . . . . 0.0 110.9 -179.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -84.28 -15.0 6.74 Favored 'Trans proline' 0 C--N 1.351 0.69 0 C-N-CA 123.227 2.618 . . . . 0.0 113.833 -170.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 85.6 m -90.79 116.87 28.97 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.95 0.9 . . . . 0.0 110.882 -179.583 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.73 -16.28 80.75 Favored Glycine 0 CA--C 1.534 1.236 0 C-N-CA 123.91 0.767 . . . . 0.0 114.022 -179.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -120.96 133.6 55.28 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.836 1.654 . . . . 0.0 109.507 177.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 6.8 p -162.1 145.49 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.468 0 C-N-CA 124.945 1.298 . . . . 0.0 111.475 -169.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 61.4 t-20 -111.76 130.52 55.77 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 126.045 1.738 . . . . 0.0 109.393 177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -96.2 107.3 19.62 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.513 1.125 . . . . 0.0 110.818 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -103.66 172.05 20.67 Favored Glycine 0 CA--C 1.532 1.132 0 C-N-CA 125.447 1.498 . . . . 0.0 113.233 178.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 60.16 21.0 10.3 Favored 'General case' 0 CA--C 1.554 1.115 0 C-N-CA 125.877 1.671 . . . . 0.0 113.744 176.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 4.4 pm0 -79.68 163.86 24.21 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 126.619 1.968 . . . . 0.0 112.243 177.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -156.47 138.09 14.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 124.708 1.203 . . . . 0.0 110.066 177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . 0.269 29.9 pt20 . . . . . 0 C--O 1.253 1.282 0 C-N-CA 127.504 2.322 . . . . 0.0 114.815 -179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.536 0 N-CA-C 111.708 -0.557 . . . . 0.0 111.708 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 33.0 t -161.6 155.85 22.45 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 125.826 1.65 . . . . 0.0 110.268 177.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.7 t -166.38 176.65 7.29 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 125.269 1.427 . . . . 0.0 111.902 -177.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 93.51 156.45 32.6 Favored Glycine 0 CA--C 1.533 1.172 0 C-N-CA 125.796 1.665 . . . . 0.0 113.459 -179.039 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 22.7 t -162.52 117.57 1.84 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.126 1.37 . . . . 0.0 110.077 179.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.9 t -170.12 163.56 9.15 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 126.045 1.738 . . . . 0.0 110.668 -176.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -177.35 149.02 9.13 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 124.698 1.142 . . . . 0.0 113.342 176.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 7.7 mp -91.34 152.4 20.47 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.024 1.33 . . . . 0.0 110.961 178.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -71.44 162.4 29.51 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.914 0.886 . . . . 0.0 112.288 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ARG . . . . . . . . . . . . . 26.9 tpt180 -148.13 136.88 21.75 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.323 1.449 . . . . 0.0 110.637 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -72.58 -27.67 62.33 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.054 1.131 . . . . 0.0 114.054 -171.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 58.0 m -151.14 138.58 19.5 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.844 1.658 . . . . 0.0 110.336 -177.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 4.3 p -62.13 122.29 71.58 Favored Pre-proline 0 N--CA 1.48 1.027 0 C-N-CA 124.202 1.001 . . . . 0.0 111.973 -177.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -80.75 163.79 20.9 Favored 'Trans proline' 0 C--N 1.351 0.675 0 C-N-CA 123.202 2.601 . . . . 0.0 111.313 171.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -68.28 -10.51 55.22 Favored 'General case' 0 CA--C 1.544 0.722 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 176.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASN . . . . . . . . . . . . . 52.5 p30 -124.02 16.14 9.25 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 125.708 1.603 . . . . 0.0 113.872 -171.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' HIS . . . . . . . . . . . . . 54.4 t-80 -54.46 145.41 38.27 Favored Pre-proline 0 CA--C 1.56 1.35 0 C-N-CA 124.482 1.113 . . . . 0.0 112.787 176.554 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -65.49 -14.98 47.64 Favored 'Trans proline' 0 CA--C 1.541 0.843 0 C-N-CA 123.073 2.515 . . . . 0.0 115.529 -178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.7 p -125.6 -19.13 5.04 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 120.043 1.292 . . . . 0.0 114.432 176.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.71 144.02 44.55 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 124.377 1.071 . . . . 0.0 112.682 176.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 93.8 m-85 -139.8 120.88 14.69 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.097 1.359 . . . . 0.0 108.973 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -72.57 134.02 45.0 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 121.462 -0.774 . . . . 0.0 110.207 176.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 29.5 m -142.43 163.62 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.927 0 C-N-CA 124.796 1.239 . . . . 0.0 111.572 -170.745 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 24.8 m -138.66 118.68 13.39 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 124.301 1.041 . . . . 0.0 109.576 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -64.68 131.22 46.31 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.484 0.714 . . . . 0.0 110.491 175.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 26.9 m -124.46 157.69 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.479 1.112 . . . . 0.0 113.054 -177.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' OD1' HG22 ' A' ' 31' ' ' VAL . 0.7 OUTLIER -88.01 -168.95 2.38 Favored 'General case' 0 CA--C 1.551 0.997 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -61.97 -28.6 69.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 126.044 1.738 . . . . 0.0 114.037 176.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -87.24 -13.38 43.99 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.257 1.023 . . . . 0.0 113.143 174.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.61 15.94 67.16 Favored Glycine 0 CA--C 1.534 1.223 0 CA-C-O 118.137 -1.368 . . . . 0.0 114.255 -171.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.415 HG22 ' OD1' ' A' ' 27' ' ' ASP . 16.8 m -76.89 150.41 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 CA-C-N 119.947 1.874 . . . . 0.0 111.181 173.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -87.56 124.98 34.06 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 124.451 1.1 . . . . 0.0 111.303 -171.418 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LEU . . . . . . . . . . . . . 41.8 mt -108.3 -52.41 2.77 Favored 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 123.741 0.817 . . . . 0.0 112.038 -172.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -150.71 136.52 5.65 Favored Glycine 0 N--CA 1.473 1.166 0 C-N-CA 124.46 1.028 . . . . 0.0 114.339 179.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.0 p -85.71 139.38 31.4 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 125.038 1.335 . . . . 0.0 112.291 175.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -141.61 170.52 24.74 Favored Glycine 0 CA--C 1.529 0.954 0 C-N-CA 126.376 1.941 . . . . 0.0 112.986 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 53.4 t -116.71 120.25 64.46 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' MET . . . . . . . . . . . . . 55.7 ttm -92.54 118.6 31.16 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.057 1.343 . . . . 0.0 109.775 179.119 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.6 tt0 -109.23 130.14 55.49 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 125.911 1.684 . . . . 0.0 108.969 177.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mp -106.9 122.02 45.59 Favored 'General case' 0 C--O 1.238 0.451 0 C-N-CA 125.77 1.628 . . . . 0.0 107.164 174.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 30.4 p -114.57 173.59 6.39 Favored 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 124.549 1.14 . . . . 0.0 109.762 178.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 62.8 mt-30 -70.17 -3.38 16.55 Favored 'General case' 0 CA--C 1.547 0.856 0 O-C-N 121.415 -0.803 . . . . 0.0 112.904 173.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.0 t -120.23 -35.24 3.49 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 113.996 1.11 . . . . 0.0 113.996 -174.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -167.29 163.79 15.3 Favored 'General case' 0 CA--C 1.545 0.762 0 O-C-N 121.086 -1.009 . . . . 0.0 113.331 -169.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.2 mt -87.43 136.35 32.97 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 125.37 1.468 . . . . 0.0 109.524 168.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 31.4 t -134.69 126.34 47.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.782 0 C-N-CA 123.758 0.823 . . . . 0.0 110.853 178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 61.9 mt -100.89 130.05 46.84 Favored 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 124.883 1.273 . . . . 0.0 110.298 169.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 98.9 m-70 -101.59 122.3 43.59 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.997 1.719 . . . . 0.0 111.31 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -125.34 165.99 17.36 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 127.69 2.396 . . . . 0.0 110.692 -176.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' HIS . . . . . . . . . . . . . 15.1 t-80 -85.1 -71.68 0.51 Allowed 'General case' 0 CA--C 1.552 1.035 0 C-N-CA 124.504 1.122 . . . . 0.0 113.414 179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 15.2 mmm180 -88.73 -17.21 30.37 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.836 1.254 . . . . 0.0 114.284 -177.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -92.49 159.52 15.48 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 124.935 1.294 . . . . 0.0 110.369 176.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -60.46 154.03 21.69 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.862 0.865 . . . . 0.0 111.129 169.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.45 132.11 49.09 Favored 'General case' 0 CA--C 1.538 0.497 0 O-C-N 121.746 -0.596 . . . . 0.0 109.496 169.702 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . . . . . . . . . 5.8 t -108.46 126.68 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 -169.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 61.1 mtp180 -127.66 141.44 51.61 Favored 'General case' 0 N--CA 1.472 0.649 0 N-CA-C 114.409 1.262 . . . . 0.0 114.409 -166.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TRP . . . . . . . . . . . . . 21.8 m-90 -140.95 116.25 7.35 Favored Pre-proline 0 CA--C 1.541 0.613 0 C-N-CA 124.839 1.256 . . . . 0.0 111.168 174.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -67.87 144.96 66.8 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.036 1.824 . . . . 0.0 108.878 169.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -58.1 -29.98 65.91 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 -178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.04 -41.32 78.4 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.073 1.749 . . . . 0.0 112.283 175.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.9 m -86.48 4.62 38.97 Favored 'General case' 0 CA--C 1.545 0.77 0 N-CA-C 115.109 1.522 . . . . 0.0 115.109 -178.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 91.4 mt -85.4 118.34 24.88 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-N 119.416 1.007 . . . . 0.0 109.487 171.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 18.0 tpp180 -75.43 -34.86 61.02 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 123.026 0.53 . . . . 0.0 111.781 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -165.92 158.4 14.83 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 127.011 2.125 . . . . 0.0 111.206 179.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -145.67 107.84 4.38 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 125.222 1.409 . . . . 0.0 112.045 -174.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -117.27 161.72 13.08 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 125.879 1.704 . . . . 0.0 114.172 -169.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -148.01 152.8 38.07 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 125.129 1.372 . . . . 0.0 113.109 -170.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 34.7 t0 -145.95 -179.14 6.5 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 126.387 1.875 . . . . 0.0 109.815 175.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.5 m -61.45 -12.7 15.76 Favored 'General case' 0 CA--C 1.548 0.903 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 -175.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 36.8 p-10 -154.13 10.0 0.38 Allowed 'General case' 0 CA--C 1.552 1.038 0 C-N-CA 125.406 1.482 . . . . 0.0 114.67 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -139.94 133.92 30.83 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.704 1.601 . . . . 0.0 110.633 -168.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -126.84 137.33 53.17 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.81 1.644 . . . . 0.0 110.013 172.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 14.1 t -153.47 158.16 40.94 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.444 1.098 . . . . 0.0 112.871 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -158.03 156.1 30.52 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 125.088 1.355 . . . . 0.0 112.938 -176.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -96.47 139.77 32.08 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 125.421 1.489 . . . . 0.0 110.166 170.472 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 77.7 p -122.33 151.32 41.28 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 124.589 1.156 . . . . 0.0 112.718 169.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLY . . . . . . . . . . . . . . . -93.43 164.28 26.79 Favored Glycine 0 N--CA 1.477 1.4 0 C-N-CA 125.228 1.394 . . . . 0.0 114.044 -175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -62.76 -20.51 65.03 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 115.507 1.669 . . . . 0.0 115.507 -170.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 12.1 ptp85 -82.52 -15.32 52.81 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 -176.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' CYS . . . . . . . . . . . . . 11.2 p -82.05 179.4 7.83 Favored 'General case' 0 CA--C 1.548 0.879 0 N-CA-C 112.781 0.66 . . . . 0.0 112.781 -175.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 8.1 tm0? -59.52 -44.28 93.21 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.686 1.594 . . . . 0.0 112.872 -175.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' THR . . . . . . . . . . . . . 78.0 p -82.8 -29.14 29.76 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 114.329 1.233 . . . . 0.0 114.329 174.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 82.55 -155.1 33.5 Favored Glycine 0 CA--C 1.533 1.159 0 C-N-CA 125.446 1.498 . . . . 0.0 112.157 -172.295 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -63.2 137.67 58.29 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 123.826 0.85 . . . . 0.0 112.363 177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 161.66 165.55 18.74 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 124.217 0.913 . . . . 0.0 113.117 169.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . . . . . . . . . 94.1 mt -114.35 128.63 71.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 C-N-CA 124.882 1.273 . . . . 0.0 107.756 168.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.8 m-85 -127.18 122.92 35.43 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.59 1.156 . . . . 0.0 109.374 -175.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -115.22 140.84 48.75 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 124.313 1.045 . . . . 0.0 112.132 -174.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.3 m-85 -133.44 122.02 23.1 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.503 1.121 . . . . 0.0 110.953 -171.35 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 77.0 mttt -71.46 132.93 45.47 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 123.4 0.68 . . . . 0.0 110.974 170.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 25.0 p -169.3 140.72 2.38 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 126.006 1.723 . . . . 0.0 111.448 -178.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 60.4 m -83.09 4.83 24.66 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -176.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -133.18 25.85 4.2 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.158 1.383 . . . . 0.0 113.748 -179.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -49.19 -37.71 23.5 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.599 1.559 . . . . 0.0 114.122 178.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -67.71 -36.47 80.68 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.0 0.92 . . . . 0.0 112.984 176.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 10.2 mm-40 -69.68 -32.54 71.21 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 119.236 0.925 . . . . 0.0 111.863 174.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.59 -48.01 86.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.729 0 C-N-CA 122.976 0.51 . . . . 0.0 109.658 169.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -60.81 -37.78 83.12 Favored 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 124.401 1.081 . . . . 0.0 112.721 176.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASN . . . . . . . . . . . . . 90.8 m-20 -68.75 -33.43 73.89 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.486 1.114 . . . . 0.0 112.478 175.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 34.0 tp -84.63 -37.49 21.01 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 118.961 0.8 . . . . 0.0 112.168 -179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 19.8 mt -51.76 -56.35 14.39 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.143 0.883 . . . . 0.0 112.211 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 12.2 pt20 -59.75 -23.57 63.34 Favored 'General case' 0 CA--C 1.545 0.785 0 N-CA-C 113.915 1.08 . . . . 0.0 113.915 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.58 -24.7 45.34 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 124.627 1.171 . . . . 0.0 113.042 176.17 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' LEU . . . . . . . . . . . . . 69.4 mt -98.05 -34.5 10.76 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 125.806 1.642 . . . . 0.0 111.686 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 96.8 mtp -68.85 -27.52 65.9 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 125.236 1.415 . . . . 0.0 113.034 176.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLN . . . . . . . . . . . . . 4.6 pp0? -78.49 -10.75 59.83 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 113.499 0.926 . . . . 0.0 113.499 169.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 13.3 t -80.95 -28.81 35.55 Favored 'General case' 0 CA--C 1.548 0.892 0 CA-C-N 118.926 0.785 . . . . 0.0 112.683 -171.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 25.4 m120 59.98 27.66 17.09 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 126.487 1.915 . . . . 0.0 114.72 174.438 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 63.3 m -79.79 75.96 6.47 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 120.378 -1.451 . . . . 0.0 110.911 171.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ILE . . . . . . . . . . . . . 3.8 mm -86.25 -138.33 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 124.76 1.224 . . . . 0.0 108.88 178.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -76.01 50.7 0.61 Allowed 'General case' 0 CA--C 1.552 1.056 0 O-C-N 119.616 -1.928 . . . . 0.0 112.142 179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 32.9 m -90.56 2.3 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.205 0 C-N-CA 126.386 1.874 . . . . 0.0 114.404 -169.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' MET . . . . . . . . . . . . . 61.2 mtt -91.0 -161.17 0.78 Allowed 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 125.364 1.466 . . . . 0.0 111.04 178.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 3.3 pm0 -68.09 80.58 0.22 Allowed 'General case' 0 CA--C 1.547 0.859 0 O-C-N 120.938 -1.101 . . . . 0.0 112.513 177.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -149.07 156.96 40.39 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 127.606 2.363 . . . . 0.0 110.161 -169.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -71.3 174.29 11.02 Favored 'Trans proline' 0 CA--C 1.541 0.832 0 C-N-CA 123.758 2.972 . . . . 0.0 112.443 178.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' VAL . . . . . . . . . . . . . 98.2 t -89.52 133.07 32.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 125.052 1.341 . . . . 0.0 110.25 178.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 4.4 mp -122.68 146.8 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 126.165 1.786 . . . . 0.0 108.46 174.623 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 32.0 mm -77.19 83.24 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 123.793 0.837 . . . . 0.0 109.903 176.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' THR . . . . . . . . . . . . . 2.8 p -145.86 145.7 30.84 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 126.962 2.105 . . . . 0.0 110.573 -178.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 75.6 mtp85 -67.98 134.71 51.19 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.618 1.167 . . . . 0.0 111.331 178.265 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASN . . . . . . . . . . . . . 22.2 p-10 -161.15 179.99 7.93 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 125.826 1.651 . . . . 0.0 112.276 -176.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' SER . . . . . . . . . . . . . 39.0 m -146.82 162.66 38.14 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 125.611 1.565 . . . . 0.0 110.543 -178.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -57.55 124.04 65.57 Favored Pre-proline 0 CA--C 1.555 1.139 0 O-C-N 121.324 -0.86 . . . . 0.0 112.414 -179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -79.8 166.3 21.54 Favored 'Trans proline' 0 C--N 1.351 0.687 0 C-N-CA 123.606 2.87 . . . . 0.0 111.933 -175.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -85.79 -177.66 6.42 Favored 'General case' 0 CA--C 1.549 0.908 0 C-N-CA 124.651 1.18 . . . . 0.0 112.221 171.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -150.94 156.61 41.55 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 125.509 1.524 . . . . 0.0 111.072 177.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 45.4 tp -72.04 134.67 46.0 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.296 1.038 . . . . 0.0 111.736 -174.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 24.7 m-20 -70.95 150.0 46.14 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.648 1.179 . . . . 0.0 112.624 177.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . . . . . . . . . 2.7 pp -86.87 154.37 55.44 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 124.553 1.141 . . . . 0.0 111.84 177.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -78.91 152.6 25.04 Favored 'Trans proline' 0 CA--C 1.537 0.667 0 C-N-CA 122.746 2.297 . . . . 0.0 111.662 -178.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ARG . . . . . . . . . . . . . 25.1 ttp-105 -74.9 155.66 37.22 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 124.328 1.051 . . . . 0.0 111.723 177.43 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -56.56 146.38 55.55 Favored Pre-proline 0 CA--C 1.555 1.144 0 C-N-CA 124.867 1.267 . . . . 0.0 112.674 174.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_endo -74.58 163.37 36.12 Favored 'Trans proline' 0 C--N 1.352 0.751 0 C-N-CA 124.1 3.2 . . . . 0.0 112.821 -174.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -81.49 151.0 68.13 Favored Pre-proline 0 CA--C 1.55 0.967 0 C-N-CA 124.603 1.161 . . . . 0.0 112.284 178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 98.7 Cg_endo -74.81 157.22 43.72 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 123.582 2.855 . . . . 0.0 112.254 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -76.59 162.0 33.5 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 C-N-CA 124.212 3.275 . . . . 0.0 112.536 179.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -82.08 160.51 23.16 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.733 1.213 . . . . 0.0 113.452 177.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ALA . . . . . . . . . . . . . . . -80.66 145.55 31.58 Favored 'General case' 0 CA--C 1.545 0.751 0 C-N-CA 124.741 1.217 . . . . 0.0 112.381 177.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LEU . . . . . . . . . . . . . 32.4 tp -84.55 148.73 26.34 Favored 'General case' 0 CA--C 1.544 0.739 0 C-N-CA 125.139 1.376 . . . . 0.0 111.972 -177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -82.8 -157.7 23.29 Favored Glycine 0 CA--C 1.536 1.379 0 C-N-CA 125.093 1.33 . . . . 0.0 113.429 173.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -155.9 161.73 40.52 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.862 1.265 . . . . 0.0 112.806 -176.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p -127.66 175.13 8.52 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 126.71 2.004 . . . . 0.0 111.423 -170.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 11.5 p -151.76 139.39 13.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 124.674 1.19 . . . . 0.0 111.391 -175.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.4 m -75.14 158.52 32.92 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 125.103 1.361 . . . . 0.0 113.759 -177.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . . . . . . . . . 24.1 p . . . . . 0 C--O 1.253 1.262 0 C-N-CA 125.488 1.515 . . . . 0.0 113.815 174.501 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' LEU . . . . . . . . . . . . . 79.6 mt . . . . . 0 N--CA 1.493 1.714 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' PHE . . . . . . . . . . . . . 25.8 t80 -143.39 119.17 10.52 Favored 'General case' 0 N--CA 1.467 0.422 0 C-N-CA 124.92 1.288 . . . . 0.0 109.821 172.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -79.33 121.53 25.23 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.157 0.583 . . . . 0.0 111.251 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' LEU . . . . . . . . . . . . . 78.6 mt -86.46 155.19 20.64 Favored 'General case' 0 N--CA 1.468 0.468 0 N-CA-C 113.293 0.849 . . . . 0.0 113.293 179.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . . . . . . . . . 79.3 mtm180 -84.71 -13.96 49.8 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 125.637 1.575 . . . . 0.0 113.506 -177.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' HIS . . . . . . . . . . . . . 22.0 p80 -163.35 169.21 19.38 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 127.527 2.331 . . . . 0.0 110.706 -177.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -86.19 120.52 72.42 Favored Pre-proline 0 CA--C 1.547 0.865 0 CA-C-O 118.61 -0.709 . . . . 0.0 111.109 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.01 -9.23 17.97 Favored 'Trans proline' 0 C--N 1.353 0.785 0 C-N-CA 123.488 2.792 . . . . 0.0 114.209 -172.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' CYS . . . . . . . . . . . . . 44.7 t -92.03 -74.27 0.52 Allowed 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 124.056 0.942 . . . . 0.0 113.13 -176.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLY . . . . . . . . . . . . . . . 89.02 -41.7 3.04 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 125.774 1.654 . . . . 0.0 114.066 -172.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' ASN . . . . . . . . . . . . . 29.2 m120 -81.47 91.87 6.38 Favored 'General case' 0 CA--C 1.542 0.639 0 CA-C-N 118.544 1.172 . . . . 0.0 109.997 175.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' VAL . . . . . . . . . . . . . 7.9 p -138.41 139.88 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.644 0 N-CA-C 114.138 1.162 . . . . 0.0 114.138 -167.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ASN . . . . . . . . . . . . . 14.5 p-10 -100.06 141.77 32.44 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 127.138 2.175 . . . . 0.0 111.108 169.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' TYR . . . . . . . . . . . . . 61.0 m-85 -106.23 129.31 54.3 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 124.618 1.167 . . . . 0.0 111.273 -177.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' GLY . . . . . . . . . . . . . . . -98.38 -72.32 1.06 Allowed Glycine 0 N--CA 1.472 1.08 0 C-N-CA 124.657 1.122 . . . . 0.0 112.371 -175.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -92.75 18.09 9.4 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 125.141 1.376 . . . . 0.0 113.315 -175.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -122.7 122.87 39.8 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.249 1.42 . . . . 0.0 108.278 175.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -99.25 144.94 27.81 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.445 1.098 . . . . 0.0 111.089 -173.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' GLN . . . . . . . . . . . . . 87.5 mt-30 . . . . . 0 C--O 1.253 1.273 0 C-N-CA 125.527 1.531 . . . . 0.0 112.514 -176.396 . . . . . . . . 0 0 . 1 stop_ save_